Analysis	O	0	8	title	38068763
of	O	9	11	title	38068763
the	O	12	15	title	38068763
Efficacy	O	16	24	title	38068763
of	O	25	27	title	38068763
Diet	O	28	32	title	38068763
and	O	33	36	title	38068763
Short-Term	O	37	47	title	38068763
Probiotic	O	48	57	title	38068763
Intervention	O	58	70	title	38068763
on	O	71	73	title	38068763
Depressive	B-DDF	74	84	title	38068763
Symptoms	I-DDF	85	93	title	38068763
in	O	94	96	title	38068763
Patients	B-human	97	105	title	38068763
after	O	106	111	title	38068763
Bariatric	O	112	121	title	38068763
Surgery	O	122	129	title	38068763
:	O	129	130	title	38068763
A	O	131	132	title	38068763
Randomized	O	133	143	title	38068763
Double-Blind	O	144	156	title	38068763
Placebo	O	157	164	title	38068763
Controlled	O	165	175	title	38068763
Pilot	O	176	181	title	38068763
Study	O	182	187	title	38068763
.	O	187	188	title	38068763

(	O	0	1	abstract	38068763
1	O	1	2	abstract	38068763
)	O	2	3	abstract	38068763
Background	O	4	14	abstract	38068763
:	O	14	15	abstract	38068763
studies	O	16	23	abstract	38068763
have	O	24	28	abstract	38068763
shown	O	29	34	abstract	38068763
that	O	35	39	abstract	38068763
some	O	40	44	abstract	38068763
patients	B-human	45	53	abstract	38068763
experience	O	54	64	abstract	38068763
mental	B-DDF	65	71	abstract	38068763
deterioration	I-DDF	72	85	abstract	38068763
after	O	86	91	abstract	38068763
bariatric	O	92	101	abstract	38068763
surgery	O	102	109	abstract	38068763
.	O	109	110	abstract	38068763

(	O	111	112	abstract	38068763
2	O	112	113	abstract	38068763
)	O	113	114	abstract	38068763
Methods	O	115	122	abstract	38068763
:	O	122	123	abstract	38068763
We	O	124	126	abstract	38068763
examined	O	127	135	abstract	38068763
whether	O	136	143	abstract	38068763
the	O	144	147	abstract	38068763
use	O	148	151	abstract	38068763
of	O	152	154	abstract	38068763
probiotics	B-dietary%supplement	155	165	abstract	38068763
and	O	166	169	abstract	38068763
improved	O	170	178	abstract	38068763
eating	O	179	185	abstract	38068763
habits	O	186	192	abstract	38068763
can	O	193	196	abstract	38068763
improve	O	197	204	abstract	38068763
the	O	205	208	abstract	38068763
mental	O	209	215	abstract	38068763
health	O	216	222	abstract	38068763
of	O	223	225	abstract	38068763
people	B-human	226	232	abstract	38068763
who	O	233	236	abstract	38068763
suffered	O	237	245	abstract	38068763
from	O	246	250	abstract	38068763
mood	B-DDF	251	255	abstract	38068763
disorders	I-DDF	256	265	abstract	38068763
after	O	266	271	abstract	38068763
bariatric	O	272	281	abstract	38068763
surgery	O	282	289	abstract	38068763
.	O	289	290	abstract	38068763

We	O	291	293	abstract	38068763
also	O	294	298	abstract	38068763
analyzed	O	299	307	abstract	38068763
patients	O	308	316	abstract	38068763
'	O	316	317	abstract	38068763
mental	O	318	324	abstract	38068763
states	O	325	331	abstract	38068763
,	O	331	332	abstract	38068763
eating	O	333	339	abstract	38068763
habits	O	340	346	abstract	38068763
and	O	347	350	abstract	38068763
microbiota	O	351	361	abstract	38068763
.	O	361	362	abstract	38068763

(	O	363	364	abstract	38068763
3	O	364	365	abstract	38068763
)	O	365	366	abstract	38068763
Results	O	367	374	abstract	38068763
:	O	374	375	abstract	38068763
Depressive	B-DDF	376	386	abstract	38068763
symptoms	I-DDF	387	395	abstract	38068763
were	O	396	400	abstract	38068763
observed	O	401	409	abstract	38068763
in	O	410	412	abstract	38068763
45	O	413	415	abstract	38068763
%	O	415	416	abstract	38068763
of	O	417	419	abstract	38068763
200	O	420	423	abstract	38068763
bariatric	B-human	424	433	abstract	38068763
patients	I-human	434	442	abstract	38068763
.	O	442	443	abstract	38068763

After	O	444	449	abstract	38068763
5	O	450	451	abstract	38068763
weeks	O	452	457	abstract	38068763
,	O	457	458	abstract	38068763
we	O	459	461	abstract	38068763
noted	O	462	467	abstract	38068763
an	O	468	470	abstract	38068763
improvement	O	471	482	abstract	38068763
in	O	483	485	abstract	38068763
patients	O	486	494	abstract	38068763
'	O	494	495	abstract	38068763
mental	O	496	502	abstract	38068763
functioning	O	503	514	abstract	38068763
(	O	515	516	abstract	38068763
reduction	O	516	525	abstract	38068763
in	O	526	528	abstract	38068763
BDI	O	529	532	abstract	38068763
and	O	533	536	abstract	38068763
HRSD	O	537	541	abstract	38068763
)	O	541	542	abstract	38068763
,	O	542	543	abstract	38068763
but	O	544	547	abstract	38068763
it	O	548	550	abstract	38068763
was	O	551	554	abstract	38068763
not	O	555	558	abstract	38068763
related	O	559	566	abstract	38068763
to	O	567	569	abstract	38068763
the	O	570	573	abstract	38068763
probiotic	B-dietary%supplement	574	583	abstract	38068763
used	O	584	588	abstract	38068763
.	O	588	589	abstract	38068763

The	O	590	593	abstract	38068763
consumption	O	594	605	abstract	38068763
of	O	606	608	abstract	38068763
vegetables	B-food	609	619	abstract	38068763
and	O	620	623	abstract	38068763
whole	B-food	624	629	abstract	38068763
grain	I-food	630	635	abstract	38068763
cereals	I-food	636	643	abstract	38068763
increased	O	644	653	abstract	38068763
(	O	654	655	abstract	38068763
DQI-I	O	655	660	abstract	38068763
adequacy	O	661	669	abstract	38068763
)	O	669	670	abstract	38068763
,	O	670	671	abstract	38068763
the	O	672	675	abstract	38068763
consumption	O	676	687	abstract	38068763
of	O	688	690	abstract	38068763
simple	B-chemical	691	697	abstract	38068763
sugars	I-chemical	698	704	abstract	38068763
and	O	705	708	abstract	38068763
SFA	B-chemical	709	712	abstract	38068763
decreased	O	713	722	abstract	38068763
(	O	723	724	abstract	38068763
moderation	O	724	734	abstract	38068763
DQI-I	B-biomedical%technique	735	740	abstract	38068763
)	O	740	741	abstract	38068763
,	O	741	742	abstract	38068763
and	O	743	746	abstract	38068763
the	O	747	750	abstract	38068763
consumption	O	751	762	abstract	38068763
of	O	763	765	abstract	38068763
monounsaturated	B-chemical	766	781	abstract	38068763
fatty	I-chemical	782	787	abstract	38068763
acids	I-chemical	788	793	abstract	38068763
increased	O	794	803	abstract	38068763
it	O	804	806	abstract	38068763
.	O	806	807	abstract	38068763

In	O	808	810	abstract	38068763
the	O	811	814	abstract	38068763
feces	O	815	820	abstract	38068763
of	O	821	823	abstract	38068763
patients	B-human	824	832	abstract	38068763
after	O	833	838	abstract	38068763
RYGB	O	839	843	abstract	38068763
,	O	843	844	abstract	38068763
there	O	845	850	abstract	38068763
was	O	851	854	abstract	38068763
a	O	855	856	abstract	38068763
significantly	O	857	870	abstract	38068763
higher	O	871	877	abstract	38068763
abundance	O	878	887	abstract	38068763
of	O	888	890	abstract	38068763
two	O	891	894	abstract	38068763
members	O	895	902	abstract	38068763
of	O	903	905	abstract	38068763
the	O	906	909	abstract	38068763
Muribaculaceae	O	910	924	abstract	38068763
family	O	925	931	abstract	38068763
,	O	931	932	abstract	38068763
namely	O	933	939	abstract	38068763
Veillonella	B-bacteria	940	951	abstract	38068763
and	O	952	955	abstract	38068763
Roseburia	B-bacteria	956	965	abstract	38068763
,	O	965	966	abstract	38068763
while	O	967	972	abstract	38068763
those	O	973	978	abstract	38068763
after	O	979	984	abstract	38068763
SG	O	985	987	abstract	38068763
had	O	988	991	abstract	38068763
more	O	992	996	abstract	38068763
Christensenellaceae	B-bacteria	997	1016	abstract	38068763
R-7	I-bacteria	1017	1020	abstract	38068763
group	I-bacteria	1021	1026	abstract	38068763
,	O	1026	1027	abstract	38068763
Subdoligranulum	B-bacteria	1028	1043	abstract	38068763
,	O	1043	1044	abstract	38068763
Oscillibacter	B-bacteria	1045	1058	abstract	38068763
,	O	1058	1059	abstract	38068763
and	O	1060	1063	abstract	38068763
UCG-005	B-bacteria	1064	1071	abstract	38068763
.	O	1071	1072	abstract	38068763
(	O	1073	1074	abstract	38068763
4	O	1074	1075	abstract	38068763
)	O	1075	1076	abstract	38068763
Conclusions	O	1077	1088	abstract	38068763
:	O	1088	1089	abstract	38068763
the	O	1090	1093	abstract	38068763
noted	O	1094	1099	abstract	38068763
differences	O	1100	1111	abstract	38068763
in	O	1112	1114	abstract	38068763
the	O	1115	1118	abstract	38068763
composition	O	1119	1130	abstract	38068763
of	O	1131	1133	abstract	38068763
the	O	1134	1137	abstract	38068763
gut	B-microbiome	1138	1141	abstract	38068763
microbiota	I-microbiome	1142	1152	abstract	38068763
(	O	1153	1154	abstract	38068763
RYGB	O	1154	1158	abstract	38068763
vs.	O	1159	1162	abstract	38068763
SG	O	1163	1165	abstract	38068763
)	O	1165	1166	abstract	38068763
may	O	1167	1170	abstract	38068763
be	O	1171	1173	abstract	38068763
one	O	1174	1177	abstract	38068763
of	O	1178	1180	abstract	38068763
the	O	1181	1184	abstract	38068763
determinants	O	1185	1197	abstract	38068763
of	O	1198	1200	abstract	38068763
the	O	1201	1204	abstract	38068763
proper	O	1205	1211	abstract	38068763
functioning	O	1212	1223	abstract	38068763
of	O	1224	1226	abstract	38068763
the	O	1227	1230	abstract	38068763
gut-brain	O	1231	1240	abstract	38068763
microbiota	O	1241	1251	abstract	38068763
axis	O	1252	1256	abstract	38068763
,	O	1256	1257	abstract	38068763
although	O	1258	1266	abstract	38068763
there	O	1267	1272	abstract	38068763
is	O	1273	1275	abstract	38068763
currently	O	1276	1285	abstract	38068763
a	O	1286	1287	abstract	38068763
need	O	1288	1292	abstract	38068763
for	O	1293	1296	abstract	38068763
further	O	1297	1304	abstract	38068763
research	O	1305	1313	abstract	38068763
into	O	1314	1318	abstract	38068763
this	O	1319	1323	abstract	38068763
topic	O	1324	1329	abstract	38068763
using	O	1330	1335	abstract	38068763
a	O	1336	1337	abstract	38068763
larger	O	1338	1344	abstract	38068763
group	O	1345	1350	abstract	38068763
of	O	1351	1353	abstract	38068763
patients	B-human	1354	1362	abstract	38068763
and	O	1363	1366	abstract	38068763
different	O	1367	1376	abstract	38068763
probiotic	O	1377	1386	abstract	38068763
doses	O	1387	1392	abstract	38068763
.	O	1392	1393	abstract	38068763

Systematic	O	0	10	title	35965349
profiling	O	11	20	title	35965349
of	O	21	23	title	35965349
the	O	24	27	title	35965349
chicken	B-microbiome	28	35	title	35965349
gut	I-microbiome	36	39	title	35965349
microbiome	I-microbiome	40	50	title	35965349
reveals	O	51	58	title	35965349
dietary	B-dietary%supplement	59	66	title	35965349
supplementation	I-dietary%supplement	67	82	title	35965349
with	O	83	87	title	35965349
antibiotics	B-drug	88	99	title	35965349
alters	O	100	106	title	35965349
expression	O	107	117	title	35965349
of	O	118	120	title	35965349
multiple	O	121	129	title	35965349
microbial	O	130	139	title	35965349
pathways	O	140	148	title	35965349
with	O	149	153	title	35965349
minimal	O	154	161	title	35965349
impact	O	162	168	title	35965349
on	O	169	171	title	35965349
community	O	172	181	title	35965349
structure	O	182	191	title	35965349
.	O	191	192	title	35965349

The	O	0	3	abstract	35965349
emergence	O	4	13	abstract	35965349
of	O	14	16	abstract	35965349
antimicrobial	B-DDF	17	30	abstract	35965349
resistance	I-DDF	31	41	abstract	35965349
is	O	42	44	abstract	35965349
a	O	45	46	abstract	35965349
major	O	47	52	abstract	35965349
threat	O	53	59	abstract	35965349
to	O	60	62	abstract	35965349
global	O	63	69	abstract	35965349
health	O	70	76	abstract	35965349
and	O	77	80	abstract	35965349
has	O	81	84	abstract	35965349
placed	O	85	91	abstract	35965349
pressure	O	92	100	abstract	35965349
on	O	101	103	abstract	35965349
the	O	104	107	abstract	35965349
livestock	O	108	117	abstract	35965349
industry	O	118	126	abstract	35965349
to	O	127	129	abstract	35965349
eliminate	O	130	139	abstract	35965349
the	O	140	143	abstract	35965349
use	O	144	147	abstract	35965349
of	O	148	150	abstract	35965349
antibiotic	B-drug	151	161	abstract	35965349
growth	I-drug	162	168	abstract	35965349
promotants	I-drug	169	179	abstract	35965349
(	O	180	181	abstract	35965349
AGPs	B-drug	181	185	abstract	35965349
)	O	185	186	abstract	35965349
as	O	187	189	abstract	35965349
feed	B-dietary%supplement	190	194	abstract	35965349
additives	I-dietary%supplement	195	204	abstract	35965349
.	O	204	205	abstract	35965349

To	O	206	208	abstract	35965349
mitigate	O	209	217	abstract	35965349
their	O	218	223	abstract	35965349
removal	O	224	231	abstract	35965349
,	O	231	232	abstract	35965349
efficacious	O	233	244	abstract	35965349
alternatives	O	245	257	abstract	35965349
are	O	258	261	abstract	35965349
required	O	262	270	abstract	35965349
.	O	270	271	abstract	35965349

AGPs	B-drug	272	276	abstract	35965349
are	O	277	280	abstract	35965349
thought	O	281	288	abstract	35965349
to	O	289	291	abstract	35965349
operate	O	292	299	abstract	35965349
through	O	300	307	abstract	35965349
modulating	O	308	318	abstract	35965349
the	O	319	322	abstract	35965349
gut	B-microbiome	323	326	abstract	35965349
microbiome	I-microbiome	327	337	abstract	35965349
to	O	338	340	abstract	35965349
limit	O	341	346	abstract	35965349
opportunities	O	347	360	abstract	35965349
for	O	361	364	abstract	35965349
colonization	O	365	377	abstract	35965349
by	O	378	380	abstract	35965349
pathogens	O	381	390	abstract	35965349
,	O	390	391	abstract	35965349
increase	O	392	400	abstract	35965349
nutrient	O	401	409	abstract	35965349
utilization	O	410	421	abstract	35965349
,	O	421	422	abstract	35965349
and	O	423	426	abstract	35965349
reduce	O	427	433	abstract	35965349
inflammation	B-DDF	434	446	abstract	35965349
.	O	446	447	abstract	35965349

However	O	448	455	abstract	35965349
,	O	455	456	abstract	35965349
little	O	457	463	abstract	35965349
is	O	464	466	abstract	35965349
known	O	467	472	abstract	35965349
concerning	O	473	483	abstract	35965349
the	O	484	487	abstract	35965349
underlying	O	488	498	abstract	35965349
mechanisms	O	499	509	abstract	35965349
.	O	509	510	abstract	35965349

Previous	O	511	519	abstract	35965349
studies	O	520	527	abstract	35965349
investigating	O	528	541	abstract	35965349
the	O	542	545	abstract	35965349
effects	O	546	553	abstract	35965349
of	O	554	556	abstract	35965349
AGPs	B-drug	557	561	abstract	35965349
on	O	562	564	abstract	35965349
the	O	565	568	abstract	35965349
poultry	B-microbiome	569	576	abstract	35965349
gut	I-microbiome	577	580	abstract	35965349
microbiome	I-microbiome	581	591	abstract	35965349
have	O	592	596	abstract	35965349
largely	O	597	604	abstract	35965349
focused	O	605	612	abstract	35965349
on	O	613	615	abstract	35965349
16S	B-biomedical%technique	616	619	abstract	35965349
rDNA	I-biomedical%technique	620	624	abstract	35965349
surveys	I-biomedical%technique	625	632	abstract	35965349
based	O	633	638	abstract	35965349
on	O	639	641	abstract	35965349
a	O	642	643	abstract	35965349
single	O	644	650	abstract	35965349
gastrointestinal	B-anatomical%location	651	667	abstract	35965349
(	I-anatomical%location	668	669	abstract	35965349
GI	I-anatomical%location	669	671	abstract	35965349
)	I-anatomical%location	671	672	abstract	35965349
site	I-anatomical%location	673	677	abstract	35965349
,	O	677	678	abstract	35965349
diet	O	679	683	abstract	35965349
,	O	683	684	abstract	35965349
and/or	O	685	691	abstract	35965349
timepoint	O	692	701	abstract	35965349
,	O	701	702	abstract	35965349
resulting	O	703	712	abstract	35965349
in	O	713	715	abstract	35965349
an	O	716	718	abstract	35965349
inconsistent	O	719	731	abstract	35965349
view	O	732	736	abstract	35965349
of	O	737	739	abstract	35965349
their	O	740	745	abstract	35965349
impact	O	746	752	abstract	35965349
on	O	753	755	abstract	35965349
community	O	756	765	abstract	35965349
composition	O	766	777	abstract	35965349
.	O	777	778	abstract	35965349

In	O	779	781	abstract	35965349
this	O	782	786	abstract	35965349
study	O	787	792	abstract	35965349
,	O	792	793	abstract	35965349
we	O	794	796	abstract	35965349
perform	O	797	804	abstract	35965349
a	O	805	806	abstract	35965349
systematic	O	807	817	abstract	35965349
investigation	O	818	831	abstract	35965349
of	O	832	834	abstract	35965349
both	O	835	839	abstract	35965349
the	O	840	843	abstract	35965349
composition	O	844	855	abstract	35965349
and	O	856	859	abstract	35965349
function	O	860	868	abstract	35965349
of	O	869	871	abstract	35965349
the	O	872	875	abstract	35965349
chicken	B-microbiome	876	883	abstract	35965349
gut	I-microbiome	884	887	abstract	35965349
microbiome	I-microbiome	888	898	abstract	35965349
,	O	898	899	abstract	35965349
in	O	900	902	abstract	35965349
response	O	903	911	abstract	35965349
to	O	912	914	abstract	35965349
AGPs	B-drug	915	919	abstract	35965349
.	O	919	920	abstract	35965349

Birds	B-animal	921	926	abstract	35965349
were	O	927	931	abstract	35965349
raised	O	932	938	abstract	35965349
under	O	939	944	abstract	35965349
two	O	945	948	abstract	35965349
different	O	949	958	abstract	35965349
diets	O	959	964	abstract	35965349
and	O	965	968	abstract	35965349
AGP	B-drug	969	972	abstract	35965349
treatments	I-drug	973	983	abstract	35965349
,	O	983	984	abstract	35965349
and	O	985	988	abstract	35965349
16S	B-biomedical%technique	989	992	abstract	35965349
rDNA	I-biomedical%technique	993	997	abstract	35965349
surveys	I-biomedical%technique	998	1005	abstract	35965349
applied	O	1006	1013	abstract	35965349
to	O	1014	1016	abstract	35965349
six	O	1017	1020	abstract	35965349
GI	B-anatomical%location	1021	1023	abstract	35965349
sites	I-anatomical%location	1024	1029	abstract	35965349
sampled	O	1030	1037	abstract	35965349
at	O	1038	1040	abstract	35965349
three	O	1041	1046	abstract	35965349
key	O	1047	1050	abstract	35965349
timepoints	O	1051	1061	abstract	35965349
of	O	1062	1064	abstract	35965349
the	O	1065	1068	abstract	35965349
poultry	O	1069	1076	abstract	35965349
life	O	1077	1081	abstract	35965349
cycle	O	1082	1087	abstract	35965349
.	O	1087	1088	abstract	35965349

Functional	O	1089	1099	abstract	35965349
investigations	O	1100	1114	abstract	35965349
were	O	1115	1119	abstract	35965349
performed	O	1120	1129	abstract	35965349
through	O	1130	1137	abstract	35965349
metatranscriptomics	B-biomedical%technique	1138	1157	abstract	35965349
analyses	I-biomedical%technique	1158	1166	abstract	35965349
and	O	1167	1170	abstract	35965349
metabolomics	B-biomedical%technique	1171	1183	abstract	35965349
.	O	1183	1184	abstract	35965349

Our	O	1185	1188	abstract	35965349
study	O	1189	1194	abstract	35965349
reveals	O	1195	1202	abstract	35965349
a	O	1203	1204	abstract	35965349
more	O	1205	1209	abstract	35965349
nuanced	O	1210	1217	abstract	35965349
view	O	1218	1222	abstract	35965349
of	O	1223	1225	abstract	35965349
the	O	1226	1229	abstract	35965349
impact	O	1230	1236	abstract	35965349
of	O	1237	1239	abstract	35965349
AGPs	B-drug	1240	1244	abstract	35965349
,	O	1244	1245	abstract	35965349
dependent	O	1246	1255	abstract	35965349
on	O	1256	1258	abstract	35965349
age	O	1259	1262	abstract	35965349
of	O	1263	1265	abstract	35965349
bird	B-animal	1266	1270	abstract	35965349
,	O	1270	1271	abstract	35965349
diet	O	1272	1276	abstract	35965349
,	O	1276	1277	abstract	35965349
and	O	1278	1281	abstract	35965349
intestinal	B-anatomical%location	1282	1292	abstract	35965349
site	I-anatomical%location	1293	1297	abstract	35965349
sampled	O	1298	1305	abstract	35965349
.	O	1305	1306	abstract	35965349

Although	O	1307	1315	abstract	35965349
AGPs	B-drug	1316	1320	abstract	35965349
have	O	1321	1325	abstract	35965349
a	O	1326	1327	abstract	35965349
limited	O	1328	1335	abstract	35965349
impact	O	1336	1342	abstract	35965349
on	O	1343	1345	abstract	35965349
taxonomic	O	1346	1355	abstract	35965349
abundances	O	1356	1366	abstract	35965349
,	O	1366	1367	abstract	35965349
they	O	1368	1372	abstract	35965349
do	O	1373	1375	abstract	35965349
appear	O	1376	1382	abstract	35965349
to	O	1383	1385	abstract	35965349
redefine	O	1386	1394	abstract	35965349
influential	O	1395	1406	abstract	35965349
taxa	O	1407	1411	abstract	35965349
that	O	1412	1416	abstract	35965349
may	O	1417	1420	abstract	35965349
promote	O	1421	1428	abstract	35965349
the	O	1429	1432	abstract	35965349
exclusion	O	1433	1442	abstract	35965349
of	O	1443	1445	abstract	35965349
other	O	1446	1451	abstract	35965349
taxa	O	1452	1456	abstract	35965349
.	O	1456	1457	abstract	35965349

Microbiome	O	1458	1468	abstract	35965349
expression	O	1469	1479	abstract	35965349
profiles	O	1480	1488	abstract	35965349
further	O	1489	1496	abstract	35965349
reveal	O	1497	1503	abstract	35965349
a	O	1504	1505	abstract	35965349
complex	O	1506	1513	abstract	35965349
landscape	O	1514	1523	abstract	35965349
in	O	1524	1526	abstract	35965349
both	O	1527	1531	abstract	35965349
the	O	1532	1535	abstract	35965349
expression	O	1536	1546	abstract	35965349
and	O	1547	1550	abstract	35965349
taxonomic	O	1551	1560	abstract	35965349
representation	O	1561	1575	abstract	35965349
of	O	1576	1578	abstract	35965349
multiple	O	1579	1587	abstract	35965349
pathways	O	1588	1596	abstract	35965349
including	O	1597	1606	abstract	35965349
cell	O	1607	1611	abstract	35965349
wall	O	1612	1616	abstract	35965349
biogenesis	O	1617	1627	abstract	35965349
,	O	1627	1628	abstract	35965349
antimicrobial	O	1629	1642	abstract	35965349
resistance	O	1643	1653	abstract	35965349
,	O	1653	1654	abstract	35965349
and	O	1655	1658	abstract	35965349
several	O	1659	1666	abstract	35965349
involved	O	1667	1675	abstract	35965349
in	O	1676	1678	abstract	35965349
energy	O	1679	1685	abstract	35965349
,	O	1685	1686	abstract	35965349
amino	O	1687	1692	abstract	35965349
acid	O	1693	1697	abstract	35965349
,	O	1697	1698	abstract	35965349
and	O	1699	1702	abstract	35965349
nucleotide	O	1703	1713	abstract	35965349
metabolism	O	1714	1724	abstract	35965349
.	O	1724	1725	abstract	35965349

Many	O	1726	1730	abstract	35965349
AGP-induced	O	1731	1742	abstract	35965349
changes	O	1743	1750	abstract	35965349
in	O	1751	1753	abstract	35965349
metabolic	O	1754	1763	abstract	35965349
enzyme	O	1764	1770	abstract	35965349
expression	O	1771	1781	abstract	35965349
likely	O	1782	1788	abstract	35965349
serve	O	1789	1794	abstract	35965349
to	O	1795	1797	abstract	35965349
redirect	O	1798	1806	abstract	35965349
metabolic	O	1807	1816	abstract	35965349
flux	O	1817	1821	abstract	35965349
with	O	1822	1826	abstract	35965349
the	O	1827	1830	abstract	35965349
potential	O	1831	1840	abstract	35965349
to	O	1841	1843	abstract	35965349
regulate	O	1844	1852	abstract	35965349
bacterial	O	1853	1862	abstract	35965349
growth	O	1863	1869	abstract	35965349
or	O	1870	1872	abstract	35965349
produce	O	1873	1880	abstract	35965349
metabolites	O	1881	1892	abstract	35965349
that	O	1893	1897	abstract	35965349
impact	O	1898	1904	abstract	35965349
the	O	1905	1908	abstract	35965349
host	O	1909	1913	abstract	35965349
.	O	1913	1914	abstract	35965349

As	O	1915	1917	abstract	35965349
alternative	O	1918	1929	abstract	35965349
feed	B-dietary%supplement	1930	1934	abstract	35965349
additives	I-dietary%supplement	1935	1944	abstract	35965349
are	O	1945	1948	abstract	35965349
developed	O	1949	1958	abstract	35965349
to	O	1959	1961	abstract	35965349
mimic	O	1962	1967	abstract	35965349
the	O	1968	1971	abstract	35965349
action	O	1972	1978	abstract	35965349
of	O	1979	1981	abstract	35965349
AGPs	B-drug	1982	1986	abstract	35965349
,	O	1986	1987	abstract	35965349
our	O	1988	1991	abstract	35965349
study	O	1992	1997	abstract	35965349
highlights	O	1998	2008	abstract	35965349
the	O	2009	2012	abstract	35965349
need	O	2013	2017	abstract	35965349
to	O	2018	2020	abstract	35965349
ensure	O	2021	2027	abstract	35965349
such	O	2028	2032	abstract	35965349
alternatives	O	2033	2045	abstract	35965349
result	O	2046	2052	abstract	35965349
in	O	2053	2055	abstract	35965349
functional	O	2056	2066	abstract	35965349
changes	O	2067	2074	abstract	35965349
that	O	2075	2079	abstract	35965349
are	O	2080	2083	abstract	35965349
consistent	O	2084	2094	abstract	35965349
with	O	2095	2099	abstract	35965349
site-	O	2100	2105	abstract	35965349
,	O	2105	2106	abstract	35965349
age-	O	2107	2111	abstract	35965349
,	O	2111	2112	abstract	35965349
and	O	2113	2116	abstract	35965349
diet-associated	O	2117	2132	abstract	35965349
taxa	O	2133	2137	abstract	35965349
.	O	2137	2138	abstract	35965349

The	O	2139	2142	abstract	35965349
genes	O	2143	2148	abstract	35965349
and	O	2149	2152	abstract	35965349
pathways	O	2153	2161	abstract	35965349
identified	O	2162	2172	abstract	35965349
in	O	2173	2175	abstract	35965349
this	O	2176	2180	abstract	35965349
study	O	2181	2186	abstract	35965349
are	O	2187	2190	abstract	35965349
therefore	O	2191	2200	abstract	35965349
expected	O	2201	2209	abstract	35965349
to	O	2210	2212	abstract	35965349
drive	O	2213	2218	abstract	35965349
future	O	2219	2225	abstract	35965349
studies	O	2226	2233	abstract	35965349
,	O	2233	2234	abstract	35965349
applying	O	2235	2243	abstract	35965349
tools	O	2244	2249	abstract	35965349
such	O	2250	2254	abstract	35965349
as	O	2255	2257	abstract	35965349
community-based	B-biomedical%technique	2258	2273	abstract	35965349
metabolic	I-biomedical%technique	2274	2283	abstract	35965349
modeling	I-biomedical%technique	2284	2292	abstract	35965349
,	O	2292	2293	abstract	35965349
focusing	O	2294	2302	abstract	35965349
on	O	2303	2305	abstract	35965349
the	O	2306	2309	abstract	35965349
mechanistic	O	2310	2321	abstract	35965349
impact	O	2322	2328	abstract	35965349
of	O	2329	2331	abstract	35965349
different	O	2332	2341	abstract	35965349
dietary	O	2342	2349	abstract	35965349
regimes	O	2350	2357	abstract	35965349
on	O	2358	2360	abstract	35965349
the	O	2361	2364	abstract	35965349
microbiome	O	2365	2375	abstract	35965349
.	O	2375	2376	abstract	35965349

Consequently	O	2377	2389	abstract	35965349
,	O	2389	2390	abstract	35965349
the	O	2391	2394	abstract	35965349
data	O	2395	2399	abstract	35965349
generated	O	2400	2409	abstract	35965349
in	O	2410	2412	abstract	35965349
this	O	2413	2417	abstract	35965349
study	O	2418	2423	abstract	35965349
will	O	2424	2428	abstract	35965349
be	O	2429	2431	abstract	35965349
crucial	O	2432	2439	abstract	35965349
for	O	2440	2443	abstract	35965349
the	O	2444	2447	abstract	35965349
development	O	2448	2459	abstract	35965349
of	O	2460	2462	abstract	35965349
next-generation	B-dietary%supplement	2463	2478	abstract	35965349
feed	I-dietary%supplement	2479	2483	abstract	35965349
additives	I-dietary%supplement	2484	2493	abstract	35965349
targeting	O	2494	2503	abstract	35965349
gut	O	2504	2507	abstract	35965349
health	O	2508	2514	abstract	35965349
and	O	2515	2518	abstract	35965349
poultry	O	2519	2526	abstract	35965349
production	O	2527	2537	abstract	35965349
.	O	2537	2538	abstract	35965349

Video	O	2539	2544	abstract	35965349
Abstract	O	2545	2553	abstract	35965349
.	O	2553	2554	abstract	35965349

Compositional	O	0	13	title	34870091
and	O	14	17	title	34870091
functional	O	18	28	title	34870091
alterations	O	29	40	title	34870091
in	O	41	43	title	34870091
the	O	44	47	title	34870091
oral	B-microbiome	48	52	title	34870091
and	I-microbiome	53	56	title	34870091
gut	I-microbiome	57	60	title	34870091
microbiota	I-microbiome	61	71	title	34870091
in	O	72	74	title	34870091
patients	B-human	75	83	title	34870091
with	O	84	88	title	34870091
psychosis	B-DDF	89	98	title	34870091
or	O	99	101	title	34870091
schizophrenia	B-DDF	102	115	title	34870091
:	O	115	116	title	34870091
A	O	117	118	title	34870091
systematic	O	119	129	title	34870091
review	O	130	136	title	34870091
.	O	136	137	title	34870091

<	O	0	1	abstract	34870091
b	O	1	2	abstract	34870091
>	O	2	3	abstract	34870091
Background:</b	O	3	17	abstract	34870091
>	O	17	18	abstract	34870091
Gut	B-microbiome	19	22	abstract	34870091
and	I-microbiome	23	26	abstract	34870091
oral	I-microbiome	27	31	abstract	34870091
microbiota	I-microbiome	32	42	abstract	34870091
are	O	43	46	abstract	34870091
intrinsically	O	47	60	abstract	34870091
linked	O	61	67	abstract	34870091
to	O	68	70	abstract	34870091
human	O	71	76	abstract	34870091
health	O	77	83	abstract	34870091
.	O	83	84	abstract	34870091

Recent	O	85	91	abstract	34870091
studies	O	92	99	abstract	34870091
suggest	O	100	107	abstract	34870091
a	O	108	109	abstract	34870091
direct	O	110	116	abstract	34870091
link	O	117	121	abstract	34870091
with	O	122	126	abstract	34870091
mental	O	127	133	abstract	34870091
health	O	134	140	abstract	34870091
through	O	141	148	abstract	34870091
bidirectional	O	149	162	abstract	34870091
gut-brain	O	163	172	abstract	34870091
pathways	O	173	181	abstract	34870091
.	O	181	182	abstract	34870091

Emerging	O	183	191	abstract	34870091
evidence	O	192	200	abstract	34870091
suggests	O	201	209	abstract	34870091
that	O	210	214	abstract	34870091
the	O	215	218	abstract	34870091
composition	O	219	230	abstract	34870091
and/or	O	231	237	abstract	34870091
function	O	238	246	abstract	34870091
of	O	247	249	abstract	34870091
intestinal	B-microbiome	250	260	abstract	34870091
microbiome	I-microbiome	261	271	abstract	34870091
differs	O	272	279	abstract	34870091
in	O	280	282	abstract	34870091
those	O	283	288	abstract	34870091
with	O	289	293	abstract	34870091
psychosis	B-DDF	294	303	abstract	34870091
and	O	304	307	abstract	34870091
schizophrenia	B-DDF	308	321	abstract	34870091
as	O	322	324	abstract	34870091
compared	O	325	333	abstract	34870091
with	O	334	338	abstract	34870091
controls	B-human	339	347	abstract	34870091
.	O	347	348	abstract	34870091

There	O	349	354	abstract	34870091
is	O	355	357	abstract	34870091
relatively	O	358	368	abstract	34870091
little	O	369	375	abstract	34870091
research	O	376	384	abstract	34870091
on	O	385	387	abstract	34870091
the	O	388	391	abstract	34870091
predicted	O	392	401	abstract	34870091
or	O	402	404	abstract	34870091
actual	O	405	411	abstract	34870091
functional	O	412	422	abstract	34870091
alterations	O	423	434	abstract	34870091
associated	O	435	445	abstract	34870091
with	O	446	450	abstract	34870091
the	O	451	454	abstract	34870091
composition	O	455	466	abstract	34870091
of	O	467	469	abstract	34870091
oral	B-microbiome	470	474	abstract	34870091
and	I-microbiome	475	478	abstract	34870091
gut	I-microbiome	479	482	abstract	34870091
microbiota	I-microbiome	483	493	abstract	34870091
in	O	494	496	abstract	34870091
patients	B-human	497	505	abstract	34870091
with	O	506	510	abstract	34870091
psychosis	B-DDF	511	520	abstract	34870091
.	O	520	521	abstract	34870091

We	O	522	524	abstract	34870091
will	O	525	529	abstract	34870091
perform	O	530	537	abstract	34870091
a	O	538	539	abstract	34870091
systematic	O	540	550	abstract	34870091
review	O	551	557	abstract	34870091
and	O	558	561	abstract	34870091
meta-analysis	O	562	575	abstract	34870091
to	O	576	578	abstract	34870091
identify	O	579	587	abstract	34870091
,	O	587	588	abstract	34870091
evaluate	O	589	597	abstract	34870091
and	O	598	601	abstract	34870091
if	O	602	604	abstract	34870091
possible	O	605	613	abstract	34870091
,	O	613	614	abstract	34870091
combine	O	615	622	abstract	34870091
the	O	623	626	abstract	34870091
published	O	627	636	abstract	34870091
literature	O	637	647	abstract	34870091
on	O	648	650	abstract	34870091
compositional	O	651	664	abstract	34870091
alterations	O	665	676	abstract	34870091
in	O	677	679	abstract	34870091
the	O	680	683	abstract	34870091
oral	B-microbiome	684	688	abstract	34870091
and	I-microbiome	689	692	abstract	34870091
gut	I-microbiome	693	696	abstract	34870091
microbiota	I-microbiome	697	707	abstract	34870091
in	O	708	710	abstract	34870091
patients	B-human	711	719	abstract	34870091
with	O	720	724	abstract	34870091
psychosis	B-DDF	725	734	abstract	34870091
or	O	735	737	abstract	34870091
schizophrenia	B-DDF	738	751	abstract	34870091
compared	O	752	760	abstract	34870091
with	O	761	765	abstract	34870091
healthy	B-human	766	773	abstract	34870091
controls	I-human	774	782	abstract	34870091
.	O	782	783	abstract	34870091

We	O	784	786	abstract	34870091
also	O	787	791	abstract	34870091
aim	O	792	795	abstract	34870091
to	O	796	798	abstract	34870091
explore	O	799	806	abstract	34870091
the	O	807	810	abstract	34870091
potential	O	811	820	abstract	34870091
functional	O	821	831	abstract	34870091
impact	O	832	838	abstract	34870091
of	O	839	841	abstract	34870091
any	O	842	845	abstract	34870091
compositional	O	846	859	abstract	34870091
changes	O	860	867	abstract	34870091
.	O	867	868	abstract	34870091

<	O	869	870	abstract	34870091
b	O	870	871	abstract	34870091
>	O	871	872	abstract	34870091
Methods:</b	O	872	883	abstract	34870091
>	O	883	884	abstract	34870091
Original	O	885	893	abstract	34870091
studies	O	894	901	abstract	34870091
involving	O	902	911	abstract	34870091
humans	B-human	912	918	abstract	34870091
and	O	919	922	abstract	34870091
animals	B-animal	923	930	abstract	34870091
using	O	931	936	abstract	34870091
a	O	937	938	abstract	34870091
case-control	O	939	951	abstract	34870091
,	O	951	952	abstract	34870091
cohort	O	953	959	abstract	34870091
or	O	960	962	abstract	34870091
cross-sectional	O	963	978	abstract	34870091
design	O	979	985	abstract	34870091
will	O	986	990	abstract	34870091
be	O	991	993	abstract	34870091
included	O	994	1002	abstract	34870091
.	O	1002	1003	abstract	34870091

The	O	1004	1007	abstract	34870091
electronic	O	1008	1018	abstract	34870091
databases	O	1019	1028	abstract	34870091
PsycINFO	O	1029	1037	abstract	34870091
,	O	1037	1038	abstract	34870091
EMBASE	O	1039	1045	abstract	34870091
,	O	1045	1046	abstract	34870091
Web	O	1047	1050	abstract	34870091
of	O	1051	1053	abstract	34870091
Science	O	1054	1061	abstract	34870091
,	O	1061	1062	abstract	34870091
PubMed/MEDLINE	O	1063	1077	abstract	34870091
and	O	1078	1081	abstract	34870091
Cochrane	O	1082	1090	abstract	34870091
will	O	1091	1095	abstract	34870091
be	O	1096	1098	abstract	34870091
systematically	O	1099	1113	abstract	34870091
searched	O	1114	1122	abstract	34870091
.	O	1122	1123	abstract	34870091

Quantitative	O	1124	1136	abstract	34870091
analyses	O	1137	1145	abstract	34870091
will	O	1146	1150	abstract	34870091
be	O	1151	1153	abstract	34870091
performed	O	1154	1163	abstract	34870091
using	O	1164	1169	abstract	34870091
random-effects	B-statistical%technique	1170	1184	abstract	34870091
meta-analyses	I-statistical%technique	1185	1198	abstract	34870091
to	O	1199	1201	abstract	34870091
calculate	O	1202	1211	abstract	34870091
mean	O	1212	1216	abstract	34870091
difference	O	1217	1227	abstract	34870091
with	O	1228	1232	abstract	34870091
95	O	1233	1235	abstract	34870091
%	O	1235	1236	abstract	34870091
confidence	O	1237	1247	abstract	34870091
intervals	O	1248	1257	abstract	34870091
.	O	1257	1258	abstract	34870091

<	O	1259	1260	abstract	34870091
b	O	1260	1261	abstract	34870091
>	O	1261	1262	abstract	34870091
Discussion:</b	O	1262	1276	abstract	34870091
>	O	1276	1277	abstract	34870091
Changes	O	1278	1285	abstract	34870091
in	O	1286	1288	abstract	34870091
microbiota	O	1289	1299	abstract	34870091
composition	O	1300	1311	abstract	34870091
in	O	1312	1314	abstract	34870091
psychosis	B-DDF	1315	1324	abstract	34870091
and	O	1325	1328	abstract	34870091
schizophrenia	B-DDF	1329	1342	abstract	34870091
have	O	1343	1347	abstract	34870091
been	O	1348	1352	abstract	34870091
correlated	O	1353	1363	abstract	34870091
with	O	1364	1368	abstract	34870091
alternations	O	1369	1381	abstract	34870091
in	O	1382	1384	abstract	34870091
brain	O	1385	1390	abstract	34870091
structure	O	1391	1400	abstract	34870091
and	O	1401	1404	abstract	34870091
function	O	1405	1413	abstract	34870091
,	O	1413	1414	abstract	34870091
altered	O	1415	1422	abstract	34870091
immunity	O	1423	1431	abstract	34870091
,	O	1431	1432	abstract	34870091
altered	O	1433	1440	abstract	34870091
metabolic	O	1441	1450	abstract	34870091
pathways	O	1451	1459	abstract	34870091
and	O	1460	1463	abstract	34870091
symptom	O	1464	1471	abstract	34870091
severity	O	1472	1480	abstract	34870091
.	O	1480	1481	abstract	34870091

Changes	O	1482	1489	abstract	34870091
have	O	1490	1494	abstract	34870091
also	O	1495	1499	abstract	34870091
been	O	1500	1504	abstract	34870091
identified	O	1505	1515	abstract	34870091
as	O	1516	1518	abstract	34870091
potential	O	1519	1528	abstract	34870091
biomarkers	O	1529	1539	abstract	34870091
for	O	1540	1543	abstract	34870091
psychosis	B-DDF	1544	1553	abstract	34870091
that	O	1554	1558	abstract	34870091
might	O	1559	1564	abstract	34870091
aid	O	1565	1568	abstract	34870091
in	O	1569	1571	abstract	34870091
diagnosis	O	1572	1581	abstract	34870091
.	O	1581	1582	abstract	34870091

Understanding	O	1583	1596	abstract	34870091
how	O	1597	1600	abstract	34870091
predicted	O	1601	1610	abstract	34870091
or	O	1611	1613	abstract	34870091
actual	O	1614	1620	abstract	34870091
functional	O	1621	1631	abstract	34870091
alterations	O	1632	1643	abstract	34870091
in	O	1644	1646	abstract	34870091
microbial	O	1647	1656	abstract	34870091
genes	O	1657	1662	abstract	34870091
or	O	1663	1665	abstract	34870091
metabolic	O	1666	1675	abstract	34870091
pathways	O	1676	1684	abstract	34870091
influence	O	1685	1694	abstract	34870091
symptomatic	O	1695	1706	abstract	34870091
expression	O	1707	1717	abstract	34870091
and	O	1718	1721	abstract	34870091
downstream	O	1722	1732	abstract	34870091
clinical	O	1733	1741	abstract	34870091
outcomes	O	1742	1750	abstract	34870091
may	O	1751	1754	abstract	34870091
contribute	O	1755	1765	abstract	34870091
to	O	1766	1768	abstract	34870091
the	O	1769	1772	abstract	34870091
development	O	1773	1784	abstract	34870091
of	O	1785	1787	abstract	34870091
microbiome	O	1788	1798	abstract	34870091
targeted	O	1799	1807	abstract	34870091
interventions	O	1808	1821	abstract	34870091
for	O	1822	1825	abstract	34870091
psychosis	B-DDF	1826	1835	abstract	34870091
.	O	1835	1836	abstract	34870091

<	O	1837	1838	abstract	34870091
b	O	1838	1839	abstract	34870091
>	O	1839	1840	abstract	34870091
Registration:</b	O	1840	1856	abstract	34870091
>	O	1856	1857	abstract	34870091
The	O	1858	1861	abstract	34870091
study	O	1862	1867	abstract	34870091
is	O	1868	1870	abstract	34870091
prospectively	O	1871	1884	abstract	34870091
registered	O	1885	1895	abstract	34870091
in	O	1896	1898	abstract	34870091
PROSPERO	O	1899	1907	abstract	34870091
,	O	1907	1908	abstract	34870091
the	O	1909	1912	abstract	34870091
International	O	1913	1926	abstract	34870091
Prospective	O	1927	1938	abstract	34870091
Register	O	1939	1947	abstract	34870091
of	O	1948	1950	abstract	34870091
Systematic	O	1951	1961	abstract	34870091
Reviews	O	1962	1969	abstract	34870091
(	O	1970	1971	abstract	34870091
CRD42021260208	O	1971	1985	abstract	34870091
)	O	1985	1986	abstract	34870091
.	O	1986	1987	abstract	34870091

Potential	O	0	9	title	28158162
Beneficial	O	10	20	title	28158162
Effects	O	21	28	title	28158162
of	O	29	31	title	28158162
Probiotics	B-dietary%supplement	32	42	title	28158162
on	O	43	45	title	28158162
Human	B-DDF	46	51	title	28158162
Migraine	I-DDF	52	60	title	28158162
Headache	I-DDF	61	69	title	28158162
:	O	69	70	title	28158162
A	O	71	72	title	28158162
Literature	O	73	83	title	28158162
Review	O	84	90	title	28158162
.	O	90	91	title	28158162

Recent	O	0	6	abstract	28158162
studies	O	7	14	abstract	28158162
have	O	15	19	abstract	28158162
shown	O	20	25	abstract	28158162
that	O	26	30	abstract	28158162
migraine	B-DDF	31	39	abstract	28158162
headache	I-DDF	40	48	abstract	28158162
is	O	49	51	abstract	28158162
often	O	52	57	abstract	28158162
associated	O	58	68	abstract	28158162
with	O	69	73	abstract	28158162
concomitant	O	74	85	abstract	28158162
gastrointestinal	B-DDF	86	102	abstract	28158162
diseases	I-DDF	103	111	abstract	28158162
.	O	111	112	abstract	28158162

There	O	113	118	abstract	28158162
is	O	119	121	abstract	28158162
a	O	122	123	abstract	28158162
higher	O	124	130	abstract	28158162
prevalence	O	131	141	abstract	28158162
of	O	142	144	abstract	28158162
headaches	B-DDF	145	154	abstract	28158162
in	O	155	157	abstract	28158162
patients	B-human	158	166	abstract	28158162
with	O	167	171	abstract	28158162
gastrointestinal	B-DDF	172	188	abstract	28158162
disorders	I-DDF	189	198	abstract	28158162
.	O	198	199	abstract	28158162

These	O	200	205	abstract	28158162
associations	O	206	218	abstract	28158162
between	O	219	226	abstract	28158162
migraine	B-DDF	227	235	abstract	28158162
and	O	236	239	abstract	28158162
gastrointestinal	B-DDF	240	256	abstract	28158162
disorders	I-DDF	257	266	abstract	28158162
suggest	O	267	274	abstract	28158162
a	O	275	276	abstract	28158162
potential	O	277	286	abstract	28158162
link	O	287	291	abstract	28158162
to	O	292	294	abstract	28158162
a	O	295	296	abstract	28158162
bidirectional	O	297	310	abstract	28158162
modulation	O	311	321	abstract	28158162
of	O	322	324	abstract	28158162
gut	B-microbiome	325	328	abstract	28158162
microbiota	I-microbiome	329	339	abstract	28158162
and	O	340	343	abstract	28158162
brain	O	344	349	abstract	28158162
function	O	350	358	abstract	28158162
.	O	358	359	abstract	28158162

The	O	360	363	abstract	28158162
underlying	O	364	374	abstract	28158162
working	O	375	382	abstract	28158162
mechanistic	O	383	394	abstract	28158162
links	O	395	400	abstract	28158162
between	O	401	408	abstract	28158162
migraine	B-DDF	409	417	abstract	28158162
and	O	418	421	abstract	28158162
gastrointestinal	B-DDF	422	438	abstract	28158162
diseases	I-DDF	439	447	abstract	28158162
may	O	448	451	abstract	28158162
include	O	452	459	abstract	28158162
increased	O	460	469	abstract	28158162
intestinal	O	470	480	abstract	28158162
epithelial	O	481	491	abstract	28158162
permeability	O	492	504	abstract	28158162
and	O	505	508	abstract	28158162
inflammation	B-DDF	509	521	abstract	28158162
.	O	521	522	abstract	28158162

This	O	523	527	abstract	28158162
review	O	528	534	abstract	28158162
presents	O	535	543	abstract	28158162
an	O	544	546	abstract	28158162
overview	O	547	555	abstract	28158162
of	O	556	558	abstract	28158162
the	O	559	562	abstract	28158162
relationship	O	563	575	abstract	28158162
between	O	576	583	abstract	28158162
gut	B-microbiome	584	587	abstract	28158162
microbiota	I-microbiome	588	598	abstract	28158162
and	O	599	602	abstract	28158162
brain	O	603	608	abstract	28158162
function	O	609	617	abstract	28158162
,	O	617	618	abstract	28158162
especially	O	619	629	abstract	28158162
with	O	630	634	abstract	28158162
regard	O	635	641	abstract	28158162
to	O	642	644	abstract	28158162
migraine	B-DDF	645	653	abstract	28158162
headache	I-DDF	654	662	abstract	28158162
.	O	662	663	abstract	28158162

Literature	O	664	674	abstract	28158162
review	O	675	681	abstract	28158162
.	O	681	682	abstract	28158162

Anesthesia	O	683	693	abstract	28158162
and	O	694	697	abstract	28158162
Operation	O	698	707	abstract	28158162
Center	O	708	714	abstract	28158162
,	O	714	715	abstract	28158162
Department	O	716	726	abstract	28158162
of	O	727	729	abstract	28158162
Anesthesiology	O	730	744	abstract	28158162
,	O	744	745	abstract	28158162
Chinese	O	746	753	abstract	28158162
PLA	O	754	757	abstract	28158162
General	O	758	765	abstract	28158162
Hospital	O	766	774	abstract	28158162
.	O	774	775	abstract	28158162

The	O	776	779	abstract	28158162
present	O	780	787	abstract	28158162
investigation	O	788	801	abstract	28158162
included	O	802	810	abstract	28158162
a	O	811	812	abstract	28158162
PubMed	O	813	819	abstract	28158162
search	O	820	826	abstract	28158162
using	O	827	832	abstract	28158162
the	O	833	836	abstract	28158162
following	O	837	846	abstract	28158162
terms	O	847	852	abstract	28158162
:	O	852	853	abstract	28158162
migraine	B-DDF	854	862	abstract	28158162
headache	I-DDF	863	871	abstract	28158162
,	O	871	872	abstract	28158162
gut	B-microbiome	873	876	abstract	28158162
microbiota	I-microbiome	877	887	abstract	28158162
,	O	887	888	abstract	28158162
brain	O	889	894	abstract	28158162
function	O	895	903	abstract	28158162
,	O	903	904	abstract	28158162
and	O	905	908	abstract	28158162
probiotics	B-dietary%supplement	909	919	abstract	28158162
.	O	919	920	abstract	28158162

In	O	921	923	abstract	28158162
this	O	924	928	abstract	28158162
literature	O	929	939	abstract	28158162
review	O	940	946	abstract	28158162
,	O	946	947	abstract	28158162
we	O	948	950	abstract	28158162
mainly	O	951	957	abstract	28158162
discussed	O	958	967	abstract	28158162
the	O	968	971	abstract	28158162
relationship	O	972	984	abstract	28158162
between	O	985	992	abstract	28158162
gut	B-microbiome	993	996	abstract	28158162
microbiota	I-microbiome	997	1007	abstract	28158162
and	O	1008	1011	abstract	28158162
brain	O	1012	1017	abstract	28158162
function	O	1018	1026	abstract	28158162
,	O	1026	1027	abstract	28158162
especially	O	1028	1038	abstract	28158162
with	O	1039	1043	abstract	28158162
regard	O	1044	1050	abstract	28158162
to	O	1051	1053	abstract	28158162
migraine	B-DDF	1054	1062	abstract	28158162
headache	I-DDF	1063	1071	abstract	28158162
.	O	1071	1072	abstract	28158162

The	O	1073	1076	abstract	28158162
potential	O	1077	1086	abstract	28158162
effects	O	1087	1094	abstract	28158162
of	O	1095	1097	abstract	28158162
probiotics	B-dietary%supplement	1098	1108	abstract	28158162
supplement	I-dietary%supplement	1109	1119	abstract	28158162
on	O	1120	1122	abstract	28158162
migraine	B-DDF	1123	1131	abstract	28158162
headache	I-DDF	1132	1140	abstract	28158162
were	O	1141	1145	abstract	28158162
also	O	1146	1150	abstract	28158162
included	O	1151	1159	abstract	28158162
.	O	1159	1160	abstract	28158162

There	O	1161	1166	abstract	28158162
is	O	1167	1169	abstract	28158162
limited	O	1170	1177	abstract	28158162
evidence	O	1178	1186	abstract	28158162
from	O	1187	1191	abstract	28158162
clinical	O	1192	1200	abstract	28158162
studies	O	1201	1208	abstract	28158162
of	O	1209	1211	abstract	28158162
the	O	1212	1215	abstract	28158162
positive	O	1216	1224	abstract	28158162
effects	O	1225	1232	abstract	28158162
of	O	1233	1235	abstract	28158162
probiotics	B-dietary%supplement	1236	1246	abstract	28158162
in	O	1247	1249	abstract	28158162
patients	B-human	1250	1258	abstract	28158162
with	O	1259	1263	abstract	28158162
migraine	B-DDF	1264	1272	abstract	28158162
headache	I-DDF	1273	1281	abstract	28158162
.	O	1281	1282	abstract	28158162

Large-scale	O	1283	1294	abstract	28158162
randomized	O	1295	1305	abstract	28158162
,	O	1305	1306	abstract	28158162
placebo-controlled	O	1307	1325	abstract	28158162
clinical	O	1326	1334	abstract	28158162
trials	O	1335	1341	abstract	28158162
are	O	1342	1345	abstract	28158162
warranted	O	1346	1355	abstract	28158162
to	O	1356	1358	abstract	28158162
evaluate	O	1359	1367	abstract	28158162
the	O	1368	1371	abstract	28158162
clinical	O	1372	1380	abstract	28158162
efficacy	O	1381	1389	abstract	28158162
and	O	1390	1393	abstract	28158162
safety	O	1394	1400	abstract	28158162
of	O	1401	1403	abstract	28158162
probiotics	B-dietary%supplement	1404	1414	abstract	28158162
in	O	1415	1417	abstract	28158162
patients	B-human	1418	1426	abstract	28158162
with	O	1427	1431	abstract	28158162
migraine	B-DDF	1432	1440	abstract	28158162
headache	I-DDF	1441	1449	abstract	28158162
.	O	1449	1450	abstract	28158162

Similar	O	1451	1458	abstract	28158162
to	O	1459	1461	abstract	28158162
migraine	B-DDF	1462	1470	abstract	28158162
headache	I-DDF	1471	1479	abstract	28158162
,	O	1479	1480	abstract	28158162
disorders	O	1481	1490	abstract	28158162
of	O	1491	1493	abstract	28158162
the	O	1494	1497	abstract	28158162
brain	O	1498	1503	abstract	28158162
involving	O	1504	1513	abstract	28158162
depression	B-DDF	1514	1524	abstract	28158162
and	O	1525	1528	abstract	28158162
anxiety	B-DDF	1529	1536	abstract	28158162
have	O	1537	1541	abstract	28158162
been	O	1542	1546	abstract	28158162
demonstrated	O	1547	1559	abstract	28158162
to	O	1560	1562	abstract	28158162
be	O	1563	1565	abstract	28158162
associated	O	1566	1576	abstract	28158162
with	O	1577	1581	abstract	28158162
increased	O	1582	1591	abstract	28158162
gut	O	1592	1595	abstract	28158162
permeability	O	1596	1608	abstract	28158162
.	O	1608	1609	abstract	28158162

An	O	1610	1612	abstract	28158162
improvement	O	1613	1624	abstract	28158162
in	O	1625	1627	abstract	28158162
gut	B-microbiome	1628	1631	abstract	28158162
microbiota	I-microbiome	1632	1642	abstract	28158162
and	O	1643	1646	abstract	28158162
reduction	O	1647	1656	abstract	28158162
of	O	1657	1659	abstract	28158162
inflammation	B-DDF	1660	1672	abstract	28158162
can	O	1673	1676	abstract	28158162
have	O	1677	1681	abstract	28158162
positive	O	1682	1690	abstract	28158162
effects	O	1691	1698	abstract	28158162
on	O	1699	1701	abstract	28158162
strengthening	O	1702	1715	abstract	28158162
gut	O	1716	1719	abstract	28158162
and	O	1720	1723	abstract	28158162
brain	O	1724	1729	abstract	28158162
function	O	1730	1738	abstract	28158162
.	O	1738	1739	abstract	28158162

Moreover	O	1740	1748	abstract	28158162
,	O	1748	1749	abstract	28158162
it	O	1750	1752	abstract	28158162
can	O	1753	1756	abstract	28158162
be	O	1757	1759	abstract	28158162
inferred	O	1760	1768	abstract	28158162
that	O	1769	1773	abstract	28158162
probiotics	B-dietary%supplement	1774	1784	abstract	28158162
may	O	1785	1788	abstract	28158162
have	O	1789	1793	abstract	28158162
a	O	1794	1795	abstract	28158162
beneficial	O	1796	1806	abstract	28158162
effect	O	1807	1813	abstract	28158162
on	O	1814	1816	abstract	28158162
the	O	1817	1820	abstract	28158162
frequency	O	1821	1830	abstract	28158162
and	O	1831	1834	abstract	28158162
severity	O	1835	1843	abstract	28158162
of	O	1844	1846	abstract	28158162
migraine	O	1847	1855	abstract	28158162
headache	O	1856	1864	abstract	28158162
attacks	O	1865	1872	abstract	28158162
.	O	1872	1873	abstract	28158162

Large-scale	O	1874	1885	abstract	28158162
randomized	O	1886	1896	abstract	28158162
,	O	1896	1897	abstract	28158162
placebo-controlled	O	1898	1916	abstract	28158162
studies	O	1917	1924	abstract	28158162
are	O	1925	1928	abstract	28158162
warranted	O	1929	1938	abstract	28158162
in	O	1939	1941	abstract	28158162
the	O	1942	1945	abstract	28158162
future	O	1946	1952	abstract	28158162
to	O	1953	1955	abstract	28158162
evaluate	O	1956	1964	abstract	28158162
the	O	1965	1968	abstract	28158162
clinical	O	1969	1977	abstract	28158162
efficacy	O	1978	1986	abstract	28158162
and	O	1987	1990	abstract	28158162
safety	O	1991	1997	abstract	28158162
of	O	1998	2000	abstract	28158162
probiotics	B-dietary%supplement	2001	2011	abstract	28158162
in	O	2012	2014	abstract	28158162
patients	B-human	2015	2023	abstract	28158162
with	O	2024	2028	abstract	28158162
migraine	B-DDF	2029	2037	abstract	28158162
headache	I-DDF	2038	2046	abstract	28158162
.	O	2046	2047	abstract	28158162

Key	O	2047	2050	abstract	28158162
words	O	2051	2056	abstract	28158162
:	O	2056	2057	abstract	28158162
Migraine	B-DDF	2058	2066	abstract	28158162
headache	I-DDF	2067	2075	abstract	28158162
,	O	2075	2076	abstract	28158162
gut	B-microbiome	2077	2080	abstract	28158162
microbiota	I-microbiome	2081	2091	abstract	28158162
,	O	2091	2092	abstract	28158162
brain	O	2093	2098	abstract	28158162
function	O	2099	2107	abstract	28158162
,	O	2107	2108	abstract	28158162
probiotics	B-dietary%supplement	2109	2119	abstract	28158162
.	O	2119	2120	abstract	28158162

Depletion	O	0	9	title	34172092
of	O	10	12	title	34172092
acetate-producing	B-bacteria	13	30	title	34172092
bacteria	I-bacteria	31	39	title	34172092
from	O	40	44	title	34172092
the	O	45	48	title	34172092
gut	B-microbiome	49	52	title	34172092
microbiota	I-microbiome	53	63	title	34172092
facilitates	O	64	75	title	34172092
cognitive	B-DDF	76	85	title	34172092
impairment	I-DDF	86	96	title	34172092
through	O	97	104	title	34172092
the	O	105	108	title	34172092
gut-brain	O	109	118	title	34172092
neural	O	119	125	title	34172092
mechanism	O	126	135	title	34172092
in	O	136	138	title	34172092
diabetic	B-animal	139	147	title	34172092
mice	I-animal	148	152	title	34172092
.	O	152	153	title	34172092

Modification	O	0	12	abstract	34172092
of	O	13	15	abstract	34172092
the	O	16	19	abstract	34172092
gut	B-microbiome	20	23	abstract	34172092
microbiota	I-microbiome	24	34	abstract	34172092
has	O	35	38	abstract	34172092
been	O	39	43	abstract	34172092
reported	O	44	52	abstract	34172092
to	O	53	55	abstract	34172092
reduce	O	56	62	abstract	34172092
the	O	63	66	abstract	34172092
incidence	O	67	76	abstract	34172092
of	O	77	79	abstract	34172092
type	B-DDF	80	84	abstract	34172092
1	I-DDF	85	86	abstract	34172092
diabetes	I-DDF	87	95	abstract	34172092
mellitus	I-DDF	96	104	abstract	34172092
(	O	105	106	abstract	34172092
T1D	B-DDF	106	109	abstract	34172092
)	O	109	110	abstract	34172092
.	O	110	111	abstract	34172092

We	O	112	114	abstract	34172092
hypothesized	O	115	127	abstract	34172092
that	O	128	132	abstract	34172092
the	O	133	136	abstract	34172092
gut	B-microbiome	137	140	abstract	34172092
microbiota	I-microbiome	141	151	abstract	34172092
shifts	O	152	158	abstract	34172092
might	O	159	164	abstract	34172092
also	O	165	169	abstract	34172092
have	O	170	174	abstract	34172092
an	O	175	177	abstract	34172092
effect	O	178	184	abstract	34172092
on	O	185	187	abstract	34172092
cognitive	O	188	197	abstract	34172092
functions	O	198	207	abstract	34172092
in	O	208	210	abstract	34172092
T1D	B-DDF	211	214	abstract	34172092
.	O	214	215	abstract	34172092

Herein	O	216	222	abstract	34172092
we	O	223	225	abstract	34172092
used	O	226	230	abstract	34172092
a	O	231	232	abstract	34172092
non-absorbable	B-drug	233	247	abstract	34172092
antibiotic	I-drug	248	258	abstract	34172092
vancomycin	I-drug	259	269	abstract	34172092
to	O	270	272	abstract	34172092
modify	O	273	279	abstract	34172092
the	O	280	283	abstract	34172092
gut	B-microbiome	284	287	abstract	34172092
microbiota	I-microbiome	288	298	abstract	34172092
in	O	299	301	abstract	34172092
streptozotocin	B-animal	302	316	abstract	34172092
(STZ)-induced	I-animal	317	330	abstract	34172092
T1D	I-animal	331	334	abstract	34172092
mice	I-animal	335	339	abstract	34172092
and	O	340	343	abstract	34172092
studied	O	344	351	abstract	34172092
the	O	352	355	abstract	34172092
impact	O	356	362	abstract	34172092
of	O	363	365	abstract	34172092
microbial	O	366	375	abstract	34172092
changes	O	376	383	abstract	34172092
on	O	384	386	abstract	34172092
cognitive	O	387	396	abstract	34172092
performances	O	397	409	abstract	34172092
in	O	410	412	abstract	34172092
T1D	B-animal	413	416	abstract	34172092
mice	I-animal	417	421	abstract	34172092
and	O	422	425	abstract	34172092
its	O	426	429	abstract	34172092
potential	O	430	439	abstract	34172092
gut-brain	O	440	449	abstract	34172092
neural	O	450	456	abstract	34172092
mechanism	O	457	466	abstract	34172092
.	O	466	467	abstract	34172092

We	O	468	470	abstract	34172092
found	O	471	476	abstract	34172092
that	O	477	481	abstract	34172092
vancomycin	O	482	492	abstract	34172092
exposure	O	493	501	abstract	34172092
disrupted	O	502	511	abstract	34172092
the	O	512	515	abstract	34172092
gut	B-microbiome	516	519	abstract	34172092
microbiome	I-microbiome	520	530	abstract	34172092
,	O	530	531	abstract	34172092
altered	O	532	539	abstract	34172092
host	O	540	544	abstract	34172092
metabolic	O	545	554	abstract	34172092
phenotypes	O	555	565	abstract	34172092
,	O	565	566	abstract	34172092
and	O	567	570	abstract	34172092
facilitated	O	571	582	abstract	34172092
cognitive	B-DDF	583	592	abstract	34172092
impairment	I-DDF	593	603	abstract	34172092
in	O	604	606	abstract	34172092
T1D	B-animal	607	610	abstract	34172092
mice	I-animal	611	615	abstract	34172092
.	O	615	616	abstract	34172092

Long-term	B-DDF	617	626	abstract	34172092
acetate	I-DDF	627	634	abstract	34172092
deficiency	I-DDF	635	645	abstract	34172092
due	O	646	649	abstract	34172092
to	O	650	652	abstract	34172092
depletion	O	653	662	abstract	34172092
of	O	663	665	abstract	34172092
acetate-producing	B-bacteria	666	683	abstract	34172092
bacteria	I-bacteria	684	692	abstract	34172092
resulted	O	693	701	abstract	34172092
in	O	702	704	abstract	34172092
the	O	705	708	abstract	34172092
reduction	O	709	718	abstract	34172092
of	O	719	721	abstract	34172092
synaptophysin	O	722	735	abstract	34172092
(	O	736	737	abstract	34172092
SYP	O	737	740	abstract	34172092
)	O	740	741	abstract	34172092
in	O	742	744	abstract	34172092
the	O	745	748	abstract	34172092
hippocampus	B-anatomical%location	749	760	abstract	34172092
as	O	761	763	abstract	34172092
well	O	764	768	abstract	34172092
as	O	769	771	abstract	34172092
learning	B-DDF	772	780	abstract	34172092
and	I-DDF	781	784	abstract	34172092
memory	I-DDF	785	791	abstract	34172092
impairments	I-DDF	792	803	abstract	34172092
.	O	803	804	abstract	34172092

Exogenous	O	805	814	abstract	34172092
acetate	O	815	822	abstract	34172092
supplement	O	823	833	abstract	34172092
or	O	834	836	abstract	34172092
fecal	O	837	842	abstract	34172092
microbiota	O	843	853	abstract	34172092
transplant	O	854	864	abstract	34172092
recovered	O	865	874	abstract	34172092
hippocampal	O	875	886	abstract	34172092
SYP	O	887	890	abstract	34172092
level	O	891	896	abstract	34172092
in	O	897	899	abstract	34172092
vancomycin-treated	O	900	918	abstract	34172092
T1D	B-animal	919	922	abstract	34172092
mice	I-animal	923	927	abstract	34172092
,	O	927	928	abstract	34172092
and	O	929	932	abstract	34172092
this	O	933	937	abstract	34172092
effect	O	938	944	abstract	34172092
was	O	945	948	abstract	34172092
attenuated	O	949	959	abstract	34172092
by	O	960	962	abstract	34172092
vagal	O	963	968	abstract	34172092
inhibition	O	969	979	abstract	34172092
or	O	980	982	abstract	34172092
vagotomy	O	983	991	abstract	34172092
.	O	991	992	abstract	34172092

Our	O	993	996	abstract	34172092
results	O	997	1004	abstract	34172092
demonstrate	O	1005	1016	abstract	34172092
the	O	1017	1020	abstract	34172092
protective	O	1021	1031	abstract	34172092
role	O	1032	1036	abstract	34172092
of	O	1037	1039	abstract	34172092
microbiota	O	1040	1050	abstract	34172092
metabolite	B-chemical	1051	1061	abstract	34172092
acetate	I-chemical	1062	1069	abstract	34172092
in	O	1070	1072	abstract	34172092
cognitive	O	1073	1082	abstract	34172092
functions	O	1083	1092	abstract	34172092
and	O	1093	1096	abstract	34172092
suggest	O	1097	1104	abstract	34172092
long-term	B-DDF	1105	1114	abstract	34172092
acetate	I-DDF	1115	1122	abstract	34172092
deficiency	I-DDF	1123	1133	abstract	34172092
as	O	1134	1136	abstract	34172092
a	O	1137	1138	abstract	34172092
risk	O	1139	1143	abstract	34172092
factor	O	1144	1150	abstract	34172092
of	O	1151	1153	abstract	34172092
cognitive	B-DDF	1154	1163	abstract	34172092
decline	I-DDF	1164	1171	abstract	34172092
.	O	1171	1172	abstract	34172092

Video	O	1173	1178	abstract	34172092
Abstract	O	1179	1187	abstract	34172092
.	O	1187	1188	abstract	34172092

Emerging	O	0	8	title	37845499
role	O	9	13	title	37845499
of	O	14	16	title	37845499
the	O	17	20	title	37845499
host	B-microbiome	21	25	title	37845499
microbiome	I-microbiome	26	36	title	37845499
in	O	37	39	title	37845499
neuropsychiatric	B-DDF	40	56	title	37845499
disorders	I-DDF	57	66	title	37845499
:	O	66	67	title	37845499
overview	O	68	76	title	37845499
and	O	77	80	title	37845499
future	O	81	87	title	37845499
directions	O	88	98	title	37845499
.	O	98	99	title	37845499

The	O	0	3	abstract	37845499
human	O	4	9	abstract	37845499
body	O	10	14	abstract	37845499
harbors	O	15	22	abstract	37845499
a	O	23	24	abstract	37845499
diverse	O	25	32	abstract	37845499
ecosystem	O	33	42	abstract	37845499
of	O	43	45	abstract	37845499
microorganisms	O	46	60	abstract	37845499
,	O	60	61	abstract	37845499
including	O	62	71	abstract	37845499
bacteria	B-bacteria	72	80	abstract	37845499
,	O	80	81	abstract	37845499
viruses	O	82	89	abstract	37845499
,	O	89	90	abstract	37845499
and	O	91	94	abstract	37845499
fungi	O	95	100	abstract	37845499
,	O	100	101	abstract	37845499
collectively	O	102	114	abstract	37845499
known	O	115	120	abstract	37845499
as	O	121	123	abstract	37845499
the	O	124	127	abstract	37845499
microbiota	B-microbiome	128	138	abstract	37845499
.	O	138	139	abstract	37845499

Current	O	140	147	abstract	37845499
research	O	148	156	abstract	37845499
is	O	157	159	abstract	37845499
increasingly	O	160	172	abstract	37845499
focusing	O	173	181	abstract	37845499
on	O	182	184	abstract	37845499
the	O	185	188	abstract	37845499
potential	O	189	198	abstract	37845499
association	O	199	210	abstract	37845499
between	O	211	218	abstract	37845499
the	O	219	222	abstract	37845499
microbiota	B-microbiome	223	233	abstract	37845499
and	O	234	237	abstract	37845499
various	O	238	245	abstract	37845499
neuropsychiatric	B-DDF	246	262	abstract	37845499
disorders	I-DDF	263	272	abstract	37845499
.	O	272	273	abstract	37845499

The	O	274	277	abstract	37845499
microbiota	B-microbiome	278	288	abstract	37845499
resides	O	289	296	abstract	37845499
in	O	297	299	abstract	37845499
various	O	300	307	abstract	37845499
parts	O	308	313	abstract	37845499
of	O	314	316	abstract	37845499
the	O	317	320	abstract	37845499
body	O	321	325	abstract	37845499
,	O	325	326	abstract	37845499
such	O	327	331	abstract	37845499
as	O	332	334	abstract	37845499
the	O	335	338	abstract	37845499
oral	B-anatomical%location	339	343	abstract	37845499
cavity	I-anatomical%location	344	350	abstract	37845499
,	O	350	351	abstract	37845499
nasal	B-anatomical%location	352	357	abstract	37845499
passages	I-anatomical%location	358	366	abstract	37845499
,	O	366	367	abstract	37845499
lungs	B-anatomical%location	368	373	abstract	37845499
,	O	373	374	abstract	37845499
gut	B-anatomical%location	375	378	abstract	37845499
,	O	378	379	abstract	37845499
skin	B-anatomical%location	380	384	abstract	37845499
,	O	384	385	abstract	37845499
bladder	B-anatomical%location	386	393	abstract	37845499
,	O	393	394	abstract	37845499
and	O	395	398	abstract	37845499
vagina	B-anatomical%location	399	405	abstract	37845499
.	O	405	406	abstract	37845499

The	O	407	410	abstract	37845499
gut	B-microbiome	411	414	abstract	37845499
microbiota	I-microbiome	415	425	abstract	37845499
in	O	426	428	abstract	37845499
the	O	429	432	abstract	37845499
gastrointestinal	B-anatomical%location	433	449	abstract	37845499
tract	I-anatomical%location	450	455	abstract	37845499
has	O	456	459	abstract	37845499
received	O	460	468	abstract	37845499
particular	O	469	479	abstract	37845499
attention	O	480	489	abstract	37845499
due	O	490	493	abstract	37845499
to	O	494	496	abstract	37845499
its	O	497	500	abstract	37845499
high	O	501	505	abstract	37845499
abundance	O	506	515	abstract	37845499
and	O	516	519	abstract	37845499
its	O	520	523	abstract	37845499
potential	O	524	533	abstract	37845499
role	O	534	538	abstract	37845499
in	O	539	541	abstract	37845499
psychiatric	B-DDF	542	553	abstract	37845499
and	I-DDF	554	557	abstract	37845499
neurodegenerative	I-DDF	558	575	abstract	37845499
disorders	I-DDF	576	585	abstract	37845499
.	O	585	586	abstract	37845499

However	O	587	594	abstract	37845499
,	O	594	595	abstract	37845499
the	O	596	599	abstract	37845499
microbiota	B-microbiome	600	610	abstract	37845499
presents	O	611	619	abstract	37845499
in	O	620	622	abstract	37845499
other	O	623	628	abstract	37845499
body	O	629	633	abstract	37845499
tissues	O	634	641	abstract	37845499
,	O	641	642	abstract	37845499
though	O	643	649	abstract	37845499
less	O	650	654	abstract	37845499
abundant	O	655	663	abstract	37845499
,	O	663	664	abstract	37845499
also	O	665	669	abstract	37845499
plays	O	670	675	abstract	37845499
crucial	O	676	683	abstract	37845499
role	O	684	688	abstract	37845499
in	O	689	691	abstract	37845499
immune	O	692	698	abstract	37845499
system	O	699	705	abstract	37845499
and	O	706	709	abstract	37845499
human	O	710	715	abstract	37845499
homeostasis	O	716	727	abstract	37845499
,	O	727	728	abstract	37845499
thus	O	729	733	abstract	37845499
influencing	O	734	745	abstract	37845499
the	O	746	749	abstract	37845499
development	O	750	761	abstract	37845499
and	O	762	765	abstract	37845499
progression	O	766	777	abstract	37845499
of	O	778	780	abstract	37845499
neuropsychiatric	B-DDF	781	797	abstract	37845499
disorders	I-DDF	798	807	abstract	37845499
.	O	807	808	abstract	37845499

For	O	809	812	abstract	37845499
example	O	813	820	abstract	37845499
,	O	820	821	abstract	37845499
oral	O	822	826	abstract	37845499
microbiota	O	827	837	abstract	37845499
imbalance	O	838	847	abstract	37845499
and	O	848	851	abstract	37845499
associated	O	852	862	abstract	37845499
periodontitis	B-DDF	863	876	abstract	37845499
might	O	877	882	abstract	37845499
increase	O	883	891	abstract	37845499
the	O	892	895	abstract	37845499
risk	O	896	900	abstract	37845499
for	O	901	904	abstract	37845499
neuropsychiatric	B-DDF	905	921	abstract	37845499
disorders	I-DDF	922	931	abstract	37845499
.	O	931	932	abstract	37845499

Additionally	O	933	945	abstract	37845499
,	O	945	946	abstract	37845499
studies	O	947	954	abstract	37845499
using	O	955	960	abstract	37845499
the	O	961	964	abstract	37845499
postmortem	O	965	975	abstract	37845499
brain	O	976	981	abstract	37845499
samples	O	982	989	abstract	37845499
have	O	990	994	abstract	37845499
detected	O	995	1003	abstract	37845499
the	O	1004	1007	abstract	37845499
widespread	O	1008	1018	abstract	37845499
presence	O	1019	1027	abstract	37845499
of	O	1028	1030	abstract	37845499
oral	B-bacteria	1031	1035	abstract	37845499
bacteria	I-bacteria	1036	1044	abstract	37845499
in	O	1045	1047	abstract	37845499
the	O	1048	1051	abstract	37845499
brains	B-anatomical%location	1052	1058	abstract	37845499
of	O	1059	1061	abstract	37845499
patients	B-human	1062	1070	abstract	37845499
with	O	1071	1075	abstract	37845499
Alzheimer	B-DDF	1076	1085	abstract	37845499
's	I-DDF	1085	1087	abstract	37845499
disease	I-DDF	1088	1095	abstract	37845499
.	O	1095	1096	abstract	37845499

This	O	1097	1101	abstract	37845499
article	O	1102	1109	abstract	37845499
provides	O	1110	1118	abstract	37845499
an	O	1119	1121	abstract	37845499
overview	O	1122	1130	abstract	37845499
of	O	1131	1133	abstract	37845499
the	O	1134	1137	abstract	37845499
emerging	O	1138	1146	abstract	37845499
role	O	1147	1151	abstract	37845499
of	O	1152	1154	abstract	37845499
the	O	1155	1158	abstract	37845499
host	B-microbiome	1159	1163	abstract	37845499
microbiota	I-microbiome	1164	1174	abstract	37845499
in	O	1175	1177	abstract	37845499
neuropsychiatric	B-DDF	1178	1194	abstract	37845499
disorders	I-DDF	1195	1204	abstract	37845499
and	O	1205	1208	abstract	37845499
discusses	O	1209	1218	abstract	37845499
future	O	1219	1225	abstract	37845499
directions	O	1226	1236	abstract	37845499
,	O	1236	1237	abstract	37845499
such	O	1238	1242	abstract	37845499
as	O	1243	1245	abstract	37845499
underlying	O	1246	1256	abstract	37845499
biological	O	1257	1267	abstract	37845499
mechanisms	O	1268	1278	abstract	37845499
,	O	1278	1279	abstract	37845499
reliable	O	1280	1288	abstract	37845499
biomarkers	O	1289	1299	abstract	37845499
associated	O	1300	1310	abstract	37845499
with	O	1311	1315	abstract	37845499
the	O	1316	1319	abstract	37845499
host	B-microbiome	1320	1324	abstract	37845499
microbiota	I-microbiome	1325	1335	abstract	37845499
,	O	1335	1336	abstract	37845499
and	O	1337	1340	abstract	37845499
microbiota-targeted	O	1341	1360	abstract	37845499
interventions	O	1361	1374	abstract	37845499
,	O	1374	1375	abstract	37845499
for	O	1376	1379	abstract	37845499
research	O	1380	1388	abstract	37845499
in	O	1389	1391	abstract	37845499
this	O	1392	1396	abstract	37845499
field	O	1397	1402	abstract	37845499
.	O	1402	1403	abstract	37845499

Using	O	0	5	title	37371676
the	O	6	9	title	37371676
Microbiome	O	10	20	title	37371676
as	O	21	23	title	37371676
a	O	24	25	title	37371676
Regenerative	O	26	38	title	37371676
Medicine	O	39	47	title	37371676
Strategy	O	48	56	title	37371676
for	O	57	60	title	37371676
Autoimmune	B-DDF	61	71	title	37371676
Diseases	I-DDF	72	80	title	37371676
.	O	80	81	title	37371676

Autoimmune	B-DDF	0	10	abstract	37371676
(	I-DDF	11	12	abstract	37371676
AI	I-DDF	12	14	abstract	37371676
)	I-DDF	14	15	abstract	37371676
diseases	I-DDF	16	24	abstract	37371676
,	O	24	25	abstract	37371676
which	O	26	31	abstract	37371676
present	O	32	39	abstract	37371676
in	O	40	42	abstract	37371676
a	O	43	44	abstract	37371676
multitude	O	45	54	abstract	37371676
of	O	55	57	abstract	37371676
systemic	O	58	66	abstract	37371676
manifestations	O	67	81	abstract	37371676
,	O	81	82	abstract	37371676
have	O	83	87	abstract	37371676
been	O	88	92	abstract	37371676
connected	O	93	102	abstract	37371676
to	O	103	105	abstract	37371676
many	O	106	110	abstract	37371676
underlying	O	111	121	abstract	37371676
factors	O	122	129	abstract	37371676
.	O	129	130	abstract	37371676

These	O	131	136	abstract	37371676
factors	O	137	144	abstract	37371676
include	O	145	152	abstract	37371676
the	O	153	156	abstract	37371676
environment	O	157	168	abstract	37371676
,	O	168	169	abstract	37371676
genetics	O	170	178	abstract	37371676
,	O	178	179	abstract	37371676
individual	O	180	190	abstract	37371676
microbiomes	O	191	202	abstract	37371676
,	O	202	203	abstract	37371676
and	O	204	207	abstract	37371676
diet	O	208	212	abstract	37371676
.	O	212	213	abstract	37371676

An	O	214	216	abstract	37371676
individual	B-microbiome	217	227	abstract	37371676
's	I-microbiome	227	229	abstract	37371676
gut	I-microbiome	230	233	abstract	37371676
microbiota	I-microbiome	234	244	abstract	37371676
is	O	245	247	abstract	37371676
an	O	248	250	abstract	37371676
integral	O	251	259	abstract	37371676
aspect	O	260	266	abstract	37371676
of	O	267	269	abstract	37371676
human	O	270	275	abstract	37371676
functioning	O	276	287	abstract	37371676
,	O	287	288	abstract	37371676
as	O	289	291	abstract	37371676
it	O	292	294	abstract	37371676
is	O	295	297	abstract	37371676
intimately	O	298	308	abstract	37371676
integrated	O	309	319	abstract	37371676
into	O	320	324	abstract	37371676
the	O	325	328	abstract	37371676
metabolic	O	329	338	abstract	37371676
,	O	338	339	abstract	37371676
mechanical	O	340	350	abstract	37371676
,	O	350	351	abstract	37371676
immunological	O	352	365	abstract	37371676
,	O	365	366	abstract	37371676
and	O	367	370	abstract	37371676
neurologic	O	371	381	abstract	37371676
pathways	O	382	390	abstract	37371676
of	O	391	393	abstract	37371676
the	O	394	397	abstract	37371676
body	O	398	402	abstract	37371676
.	O	402	403	abstract	37371676

The	O	404	407	abstract	37371676
microbiota	O	408	418	abstract	37371676
dynamically	O	419	430	abstract	37371676
changes	O	431	438	abstract	37371676
throughout	O	439	449	abstract	37371676
our	O	450	453	abstract	37371676
lifetimes	O	454	463	abstract	37371676
and	O	464	467	abstract	37371676
is	O	468	470	abstract	37371676
individually	O	471	483	abstract	37371676
unique	O	484	490	abstract	37371676
.	O	490	491	abstract	37371676

While	O	492	497	abstract	37371676
the	O	498	501	abstract	37371676
gut	B-microbiome	502	505	abstract	37371676
microbiome	I-microbiome	506	516	abstract	37371676
is	O	517	519	abstract	37371676
ever-adaptive	O	520	533	abstract	37371676
,	O	533	534	abstract	37371676
gut	B-DDF	535	538	abstract	37371676
dysbiosis	I-DDF	539	548	abstract	37371676
can	O	549	552	abstract	37371676
exert	O	553	558	abstract	37371676
a	O	559	560	abstract	37371676
significant	O	561	572	abstract	37371676
influence	O	573	582	abstract	37371676
on	O	583	585	abstract	37371676
physical	O	586	594	abstract	37371676
and	O	595	598	abstract	37371676
mental	O	599	605	abstract	37371676
health	O	606	612	abstract	37371676
.	O	612	613	abstract	37371676

Gut	B-DDF	614	617	abstract	37371676
dysbiosis	I-DDF	618	627	abstract	37371676
is	O	628	630	abstract	37371676
a	O	631	632	abstract	37371676
common	O	633	639	abstract	37371676
factor	O	640	646	abstract	37371676
in	O	647	649	abstract	37371676
various	O	650	657	abstract	37371676
AI	B-DDF	658	660	abstract	37371676
,	O	660	661	abstract	37371676
and	O	662	665	abstract	37371676
diets	O	666	671	abstract	37371676
with	O	672	676	abstract	37371676
elevated	O	677	685	abstract	37371676
fat	B-chemical	686	689	abstract	37371676
and	I-chemical	690	693	abstract	37371676
sugar	I-chemical	694	699	abstract	37371676
content	I-chemical	700	707	abstract	37371676
have	O	708	712	abstract	37371676
been	O	713	717	abstract	37371676
linked	O	718	724	abstract	37371676
to	O	725	727	abstract	37371676
gut	O	728	731	abstract	37371676
microbiome	O	732	742	abstract	37371676
alterations	O	743	754	abstract	37371676
,	O	754	755	abstract	37371676
contributing	O	756	768	abstract	37371676
to	O	769	771	abstract	37371676
increased	O	772	781	abstract	37371676
systemic	B-DDF	782	790	abstract	37371676
inflammation	I-DDF	791	803	abstract	37371676
.	O	803	804	abstract	37371676

Additionally	O	805	817	abstract	37371676
,	O	817	818	abstract	37371676
multiple	O	819	827	abstract	37371676
AI	O	828	830	abstract	37371676
's	O	830	832	abstract	37371676
have	O	833	837	abstract	37371676
increased	O	838	847	abstract	37371676
levels	O	848	854	abstract	37371676
of	O	855	857	abstract	37371676
certain	O	858	865	abstract	37371676
inflammatory	O	866	878	abstract	37371676
markers	O	879	886	abstract	37371676
such	O	887	891	abstract	37371676
as	O	892	894	abstract	37371676
TNF-a	B-chemical	895	900	abstract	37371676
,	O	900	901	abstract	37371676
IL-6	B-chemical	902	906	abstract	37371676
,	O	906	907	abstract	37371676
and	O	908	911	abstract	37371676
IL-17	B-chemical	912	917	abstract	37371676
that	O	918	922	abstract	37371676
have	O	923	927	abstract	37371676
been	O	928	932	abstract	37371676
shown	O	933	938	abstract	37371676
to	O	939	941	abstract	37371676
contribute	O	942	952	abstract	37371676
to	O	953	955	abstract	37371676
arthropathy	B-DDF	956	967	abstract	37371676
and	O	968	971	abstract	37371676
are	O	972	975	abstract	37371676
also	O	976	980	abstract	37371676
linked	O	981	987	abstract	37371676
to	O	988	990	abstract	37371676
increased	O	991	1000	abstract	37371676
levels	O	1001	1007	abstract	37371676
of	O	1008	1010	abstract	37371676
gut	B-DDF	1011	1014	abstract	37371676
dysbiosis	I-DDF	1015	1024	abstract	37371676
.	O	1024	1025	abstract	37371676

While	O	1026	1031	abstract	37371676
chronic	B-DDF	1032	1039	abstract	37371676
inflammation	I-DDF	1040	1052	abstract	37371676
has	O	1053	1056	abstract	37371676
been	O	1057	1061	abstract	37371676
shown	O	1062	1067	abstract	37371676
to	O	1068	1070	abstract	37371676
affect	O	1071	1077	abstract	37371676
many	O	1078	1082	abstract	37371676
physiologic	O	1083	1094	abstract	37371676
systems	O	1095	1102	abstract	37371676
,	O	1102	1103	abstract	37371676
this	O	1104	1108	abstract	37371676
review	O	1109	1115	abstract	37371676
explores	O	1116	1124	abstract	37371676
the	O	1125	1128	abstract	37371676
connection	O	1129	1139	abstract	37371676
between	O	1140	1147	abstract	37371676
gut	B-microbiome	1148	1151	abstract	37371676
microbiota	I-microbiome	1152	1162	abstract	37371676
,	O	1162	1163	abstract	37371676
bone	O	1164	1168	abstract	37371676
metabolism	O	1169	1179	abstract	37371676
,	O	1179	1180	abstract	37371676
and	O	1181	1184	abstract	37371676
the	O	1185	1188	abstract	37371676
skeletal	O	1189	1197	abstract	37371676
and	O	1198	1201	abstract	37371676
joint	O	1202	1207	abstract	37371676
destruction	O	1208	1219	abstract	37371676
associated	O	1220	1230	abstract	37371676
with	O	1231	1235	abstract	37371676
various	O	1236	1243	abstract	37371676
AI	B-DDF	1244	1246	abstract	37371676
,	O	1246	1247	abstract	37371676
including	O	1248	1257	abstract	37371676
psoriatic	B-DDF	1258	1267	abstract	37371676
arthritis	I-DDF	1268	1277	abstract	37371676
,	O	1277	1278	abstract	37371676
systemic	B-DDF	1279	1287	abstract	37371676
lupus	I-DDF	1288	1293	abstract	37371676
erythematosus	I-DDF	1294	1307	abstract	37371676
,	O	1307	1308	abstract	37371676
irritable	B-DDF	1309	1318	abstract	37371676
bowel	I-DDF	1319	1324	abstract	37371676
disease	I-DDF	1325	1332	abstract	37371676
,	O	1332	1333	abstract	37371676
and	O	1334	1337	abstract	37371676
rheumatoid	B-DDF	1338	1348	abstract	37371676
arthritis	I-DDF	1349	1358	abstract	37371676
.	O	1358	1359	abstract	37371676

This	O	1360	1364	abstract	37371676
review	O	1365	1371	abstract	37371676
aims	O	1372	1376	abstract	37371676
to	O	1377	1379	abstract	37371676
define	O	1380	1386	abstract	37371676
the	O	1387	1390	abstract	37371676
mechanisms	O	1391	1401	abstract	37371676
of	O	1402	1404	abstract	37371676
microbiome	O	1405	1415	abstract	37371676
crosstalk	O	1416	1425	abstract	37371676
between	O	1426	1433	abstract	37371676
the	O	1434	1437	abstract	37371676
cells	O	1438	1443	abstract	37371676
of	O	1444	1446	abstract	37371676
bone	O	1447	1451	abstract	37371676
and	O	1452	1455	abstract	37371676
cartilage	O	1456	1465	abstract	37371676
,	O	1465	1466	abstract	37371676
as	O	1467	1469	abstract	37371676
well	O	1470	1474	abstract	37371676
as	O	1475	1477	abstract	37371676
to	O	1478	1480	abstract	37371676
investigate	O	1481	1492	abstract	37371676
the	O	1493	1496	abstract	37371676
potential	O	1497	1506	abstract	37371676
bidirectional	O	1507	1520	abstract	37371676
connections	O	1521	1532	abstract	37371676
between	O	1533	1540	abstract	37371676
AI	B-DDF	1541	1543	abstract	37371676
,	O	1543	1544	abstract	37371676
bony	O	1545	1549	abstract	37371676
and	O	1550	1553	abstract	37371676
cartilaginous	O	1554	1567	abstract	37371676
tissue	O	1568	1574	abstract	37371676
,	O	1574	1575	abstract	37371676
and	O	1576	1579	abstract	37371676
the	O	1580	1583	abstract	37371676
gut	B-microbiome	1584	1587	abstract	37371676
microbiome	I-microbiome	1588	1598	abstract	37371676
.	O	1598	1599	abstract	37371676

By	O	1600	1602	abstract	37371676
doing	O	1603	1608	abstract	37371676
this	O	1609	1613	abstract	37371676
,	O	1613	1614	abstract	37371676
the	O	1615	1618	abstract	37371676
review	O	1619	1625	abstract	37371676
also	O	1626	1630	abstract	37371676
introduces	O	1631	1641	abstract	37371676
the	O	1642	1645	abstract	37371676
concept	O	1646	1653	abstract	37371676
of	O	1654	1656	abstract	37371676
altering	O	1657	1665	abstract	37371676
an	O	1666	1668	abstract	37371676
individual	B-microbiome	1669	1679	abstract	37371676
's	I-microbiome	1679	1681	abstract	37371676
specific	I-microbiome	1682	1690	abstract	37371676
gut	I-microbiome	1691	1694	abstract	37371676
microbiota	I-microbiome	1695	1705	abstract	37371676
as	O	1706	1708	abstract	37371676
a	O	1709	1710	abstract	37371676
form	O	1711	1715	abstract	37371676
of	O	1716	1718	abstract	37371676
regenerative	O	1719	1731	abstract	37371676
medicine	O	1732	1740	abstract	37371676
and	O	1741	1744	abstract	37371676
potential	O	1745	1754	abstract	37371676
tailored	O	1755	1763	abstract	37371676
therapy	O	1764	1771	abstract	37371676
for	O	1772	1775	abstract	37371676
joint	O	1776	1781	abstract	37371676
destruction	O	1782	1793	abstract	37371676
seen	O	1794	1798	abstract	37371676
in	O	1799	1801	abstract	37371676
AI	O	1802	1804	abstract	37371676
.	O	1804	1805	abstract	37371676

We	O	1806	1808	abstract	37371676
hope	O	1809	1813	abstract	37371676
to	O	1814	1816	abstract	37371676
show	O	1817	1821	abstract	37371676
multiple	O	1822	1830	abstract	37371676
,	O	1830	1831	abstract	37371676
specific	O	1832	1840	abstract	37371676
ways	O	1841	1845	abstract	37371676
to	O	1846	1848	abstract	37371676
target	O	1849	1855	abstract	37371676
the	O	1856	1859	abstract	37371676
microbiome	O	1860	1870	abstract	37371676
through	O	1871	1878	abstract	37371676
diet	O	1879	1883	abstract	37371676
changes	O	1884	1891	abstract	37371676
,	O	1891	1892	abstract	37371676
rebalancing	O	1893	1904	abstract	37371676
microbial	O	1905	1914	abstract	37371676
diversity	O	1915	1924	abstract	37371676
,	O	1924	1925	abstract	37371676
or	O	1926	1928	abstract	37371676
decreasing	O	1929	1939	abstract	37371676
specific	O	1940	1948	abstract	37371676
microbes	O	1949	1957	abstract	37371676
associated	O	1958	1968	abstract	37371676
with	O	1969	1973	abstract	37371676
increased	O	1974	1983	abstract	37371676
gut	O	1984	1987	abstract	37371676
permeability	O	1988	2000	abstract	37371676
,	O	2000	2001	abstract	37371676
leading	O	2002	2009	abstract	37371676
to	O	2010	2012	abstract	37371676
reduced	B-DDF	2013	2020	abstract	37371676
systemic	I-DDF	2021	2029	abstract	37371676
inflammation	I-DDF	2030	2042	abstract	37371676
contributing	O	2043	2055	abstract	37371676
to	O	2056	2058	abstract	37371676
joint	O	2059	2064	abstract	37371676
pathology	O	2065	2074	abstract	37371676
.	O	2074	2075	abstract	37371676

Additionally	O	2076	2088	abstract	37371676
,	O	2088	2089	abstract	37371676
we	O	2090	2092	abstract	37371676
plan	O	2093	2097	abstract	37371676
to	O	2098	2100	abstract	37371676
show	O	2101	2105	abstract	37371676
that	O	2106	2110	abstract	37371676
diet	O	2111	2115	abstract	37371676
alterations	O	2116	2127	abstract	37371676
can	O	2128	2131	abstract	37371676
promote	O	2132	2139	abstract	37371676
beneficial	O	2140	2150	abstract	37371676
changes	O	2151	2158	abstract	37371676
in	O	2159	2161	abstract	37371676
the	O	2162	2165	abstract	37371676
gut	B-microbiome	2166	2169	abstract	37371676
microbiota	I-microbiome	2170	2180	abstract	37371676
,	O	2180	2181	abstract	37371676
supporting	O	2182	2192	abstract	37371676
the	O	2193	2196	abstract	37371676
body	O	2197	2201	abstract	37371676
's	O	2201	2203	abstract	37371676
own	O	2204	2207	abstract	37371676
endogenous	O	2208	2218	abstract	37371676
processes	O	2219	2228	abstract	37371676
to	O	2229	2231	abstract	37371676
decrease	O	2232	2240	abstract	37371676
inflammation	B-DDF	2241	2253	abstract	37371676
and	O	2254	2257	abstract	37371676
increase	O	2258	2266	abstract	37371676
healing	O	2267	2274	abstract	37371676
.	O	2274	2275	abstract	37371676

This	O	2276	2280	abstract	37371676
concept	O	2281	2288	abstract	37371676
of	O	2289	2291	abstract	37371676
microbial	O	2292	2301	abstract	37371676
alteration	O	2302	2312	abstract	37371676
falls	O	2313	2318	abstract	37371676
under	O	2319	2324	abstract	37371676
the	O	2325	2328	abstract	37371676
definition	O	2329	2339	abstract	37371676
of	O	2340	2342	abstract	37371676
regenerative	O	2343	2355	abstract	37371676
medicine	O	2356	2364	abstract	37371676
and	O	2365	2368	abstract	37371676
should	O	2369	2375	abstract	37371676
be	O	2376	2378	abstract	37371676
included	O	2379	2387	abstract	37371676
accordingly	O	2388	2399	abstract	37371676
.	O	2399	2400	abstract	37371676

By	O	2401	2403	abstract	37371676
implementing	O	2404	2416	abstract	37371676
microbial	O	2417	2426	abstract	37371676
alterations	O	2427	2438	abstract	37371676
in	O	2439	2441	abstract	37371676
regenerative	O	2442	2454	abstract	37371676
medicine	O	2455	2463	abstract	37371676
,	O	2463	2464	abstract	37371676
this	O	2465	2469	abstract	37371676
current	O	2470	2477	abstract	37371676
study	O	2478	2483	abstract	37371676
could	O	2484	2489	abstract	37371676
lend	O	2490	2494	abstract	37371676
increasing	O	2495	2505	abstract	37371676
support	O	2506	2513	abstract	37371676
to	O	2514	2516	abstract	37371676
the	O	2517	2520	abstract	37371676
current	O	2521	2528	abstract	37371676
research	O	2529	2537	abstract	37371676
on	O	2538	2540	abstract	37371676
the	O	2541	2544	abstract	37371676
associations	O	2545	2557	abstract	37371676
of	O	2558	2560	abstract	37371676
the	O	2561	2564	abstract	37371676
gut	B-microbiome	2565	2568	abstract	37371676
microbiota	I-microbiome	2569	2579	abstract	37371676
,	O	2579	2580	abstract	37371676
bone	O	2581	2585	abstract	37371676
metabolism	O	2586	2596	abstract	37371676
,	O	2596	2597	abstract	37371676
and	O	2598	2601	abstract	37371676
AI-related	B-DDF	2602	2612	abstract	37371676
musculoskeletal	I-DDF	2613	2628	abstract	37371676
pathology	I-DDF	2629	2638	abstract	37371676
.	O	2638	2639	abstract	37371676

Ameliorative	O	0	12	title	37574818
effect	O	13	19	title	37574818
of	O	20	22	title	37574818
Lactobacillus	B-bacteria	23	36	title	37574818
plantarum	I-bacteria	37	46	title	37574818
CCFM8661	I-bacteria	47	55	title	37574818
on	O	56	58	title	37574818
oleic	B-DDF	59	64	title	37574818
acid-induced	I-DDF	65	77	title	37574818
acne	I-DDF	78	82	title	37574818
:	O	82	83	title	37574818
integrated	O	84	94	title	37574818
gut	B-microbiome	95	98	title	37574818
microbiota	I-microbiome	99	109	title	37574818
link	O	110	114	title	37574818
to	O	115	117	title	37574818
acne	B-DDF	118	122	title	37574818
pathogenesis	I-DDF	123	135	title	37574818
.	O	135	136	title	37574818

Acne	B-DDF	0	4	abstract	37574818
vulgaris	I-DDF	5	13	abstract	37574818
is	O	14	16	abstract	37574818
an	O	17	19	abstract	37574818
inflammatory	B-DDF	20	32	abstract	37574818
disease	I-DDF	33	40	abstract	37574818
of	O	41	43	abstract	37574818
the	O	44	47	abstract	37574818
pilosebaceous	B-anatomical%location	48	61	abstract	37574818
unit	I-anatomical%location	62	66	abstract	37574818
of	O	67	69	abstract	37574818
the	O	70	73	abstract	37574818
skin	B-anatomical%location	74	78	abstract	37574818
that	O	79	83	abstract	37574818
has	O	84	87	abstract	37574818
serious	O	88	95	abstract	37574818
adverse	O	96	103	abstract	37574818
effects	O	104	111	abstract	37574818
on	O	112	114	abstract	37574818
the	O	115	118	abstract	37574818
physical	O	119	127	abstract	37574818
and	O	128	131	abstract	37574818
mental	O	132	138	abstract	37574818
health	O	139	145	abstract	37574818
of	O	146	148	abstract	37574818
patients	B-human	149	157	abstract	37574818
.	O	157	158	abstract	37574818

Probiotics	B-dietary%supplement	159	169	abstract	37574818
are	O	170	173	abstract	37574818
extensively	O	174	185	abstract	37574818
employed	O	186	194	abstract	37574818
in	O	195	197	abstract	37574818
dermatology	O	198	209	abstract	37574818
and	O	210	213	abstract	37574818
could	O	214	219	abstract	37574818
be	O	220	222	abstract	37574818
an	O	223	225	abstract	37574818
alternative	O	226	237	abstract	37574818
option	O	238	244	abstract	37574818
for	O	245	248	abstract	37574818
acne	O	249	253	abstract	37574818
therapy	O	254	261	abstract	37574818
.	O	261	262	abstract	37574818

Here	O	263	267	abstract	37574818
,	O	267	268	abstract	37574818
we	O	269	271	abstract	37574818
evaluated	O	272	281	abstract	37574818
the	O	282	285	abstract	37574818
effect	O	286	292	abstract	37574818
of	O	293	295	abstract	37574818
oral	O	296	300	abstract	37574818
ingestion	O	301	310	abstract	37574818
of	O	311	313	abstract	37574818
live	B-bacteria	314	318	abstract	37574818
and	I-bacteria	319	322	abstract	37574818
inactivated	I-bacteria	323	334	abstract	37574818
Lactobacillus	I-bacteria	335	348	abstract	37574818
plantarum	I-bacteria	349	358	abstract	37574818
CCFM8661	I-bacteria	359	367	abstract	37574818
on	O	368	370	abstract	37574818
oleic	B-DDF	371	376	abstract	37574818
acid-induced	I-DDF	377	389	abstract	37574818
acne	I-DDF	390	394	abstract	37574818
using	O	395	400	abstract	37574818
a	O	401	402	abstract	37574818
mouse	O	403	408	abstract	37574818
model	O	409	414	abstract	37574818
.	O	414	415	abstract	37574818

Results	O	416	423	abstract	37574818
indicated	O	424	433	abstract	37574818
that	O	434	438	abstract	37574818
live	B-bacteria	439	443	abstract	37574818
L.	I-bacteria	444	446	abstract	37574818
plantarum	I-bacteria	447	456	abstract	37574818
CCFM8661	I-bacteria	457	465	abstract	37574818
suppressed	O	466	476	abstract	37574818
skin	B-DDF	477	481	abstract	37574818
inflammation	I-DDF	482	494	abstract	37574818
and	O	495	498	abstract	37574818
serum	B-chemical	499	504	abstract	37574818
hormone	I-chemical	505	512	abstract	37574818
(	O	513	514	abstract	37574818
insulin	B-chemical	514	521	abstract	37574818
and	O	522	525	abstract	37574818
testosterone	B-chemical	526	538	abstract	37574818
)	O	538	539	abstract	37574818
production	O	540	550	abstract	37574818
in	O	551	553	abstract	37574818
acne	B-animal	554	558	abstract	37574818
mice	I-animal	559	563	abstract	37574818
.	O	563	564	abstract	37574818

Parallelly	O	565	575	abstract	37574818
,	O	575	576	abstract	37574818
live	B-bacteria	577	581	abstract	37574818
L.	I-bacteria	582	584	abstract	37574818
plantarum	I-bacteria	585	594	abstract	37574818
CCFM8661	I-bacteria	595	603	abstract	37574818
effectively	O	604	615	abstract	37574818
reduced	O	616	623	abstract	37574818
the	O	624	627	abstract	37574818
formation	O	628	637	abstract	37574818
of	O	638	640	abstract	37574818
skin	B-chemical	641	645	abstract	37574818
lipids	I-chemical	646	652	abstract	37574818
(	O	653	654	abstract	37574818
triglycerides	B-chemical	654	667	abstract	37574818
and	O	668	671	abstract	37574818
non-esterified	B-chemical	672	686	abstract	37574818
free	I-chemical	687	691	abstract	37574818
fatty	I-chemical	692	697	abstract	37574818
acids	I-chemical	698	703	abstract	37574818
)	O	703	704	abstract	37574818
,	O	704	705	abstract	37574818
and	O	706	709	abstract	37574818
normalized	O	710	720	abstract	37574818
the	O	721	724	abstract	37574818
expression	O	725	735	abstract	37574818
of	O	736	738	abstract	37574818
skin	B-gene	739	743	abstract	37574818
lipid	I-gene	744	749	abstract	37574818
metabolism-related	I-gene	750	768	abstract	37574818
genes	I-gene	769	774	abstract	37574818
(	O	775	776	abstract	37574818
PPAR-	B-gene	776	782	abstract	37574818
,	O	782	783	abstract	37574818
SREBP-1c	B-gene	784	792	abstract	37574818
,	O	792	793	abstract	37574818
ACC	B-gene	794	798	abstract	37574818
,	O	798	799	abstract	37574818
FASN	B-gene	800	804	abstract	37574818
,	O	804	805	abstract	37574818
PPAR-	B-gene	806	812	abstract	37574818
,	O	812	813	abstract	37574818
ACOX1	B-gene	814	819	abstract	37574818
,	O	819	820	abstract	37574818
HSL	B-gene	821	824	abstract	37574818
and	O	825	828	abstract	37574818
ATGL	B-gene	829	833	abstract	37574818
)	O	833	834	abstract	37574818
.	O	834	835	abstract	37574818

In	O	836	838	abstract	37574818
comparison	O	839	849	abstract	37574818
,	O	849	850	abstract	37574818
inactivated	B-bacteria	851	862	abstract	37574818
L.	I-bacteria	863	865	abstract	37574818
plantarum	I-bacteria	866	875	abstract	37574818
CCFM8661	I-bacteria	876	884	abstract	37574818
had	O	885	888	abstract	37574818
no	O	889	891	abstract	37574818
effect	O	892	898	abstract	37574818
on	O	899	901	abstract	37574818
skin	B-DDF	902	906	abstract	37574818
inflammation	I-DDF	907	919	abstract	37574818
or	O	920	922	abstract	37574818
serum	B-DDF	923	928	abstract	37574818
hormone	I-DDF	929	936	abstract	37574818
secretion	I-DDF	937	946	abstract	37574818
,	O	946	947	abstract	37574818
but	O	948	951	abstract	37574818
decreased	O	952	961	abstract	37574818
skin	B-chemical	962	966	abstract	37574818
triglycerides	I-chemical	967	980	abstract	37574818
and	O	981	984	abstract	37574818
normalized	O	985	995	abstract	37574818
the	O	996	999	abstract	37574818
expression	O	1000	1010	abstract	37574818
of	O	1011	1013	abstract	37574818
skin	B-gene	1014	1018	abstract	37574818
lipid	I-gene	1019	1024	abstract	37574818
metabolism-related	I-gene	1025	1043	abstract	37574818
genes	I-gene	1044	1049	abstract	37574818
(	O	1050	1051	abstract	37574818
PPAR-	B-gene	1051	1057	abstract	37574818
,	O	1057	1058	abstract	37574818
SREBP-1c	B-gene	1059	1067	abstract	37574818
,	O	1067	1068	abstract	37574818
FASN	B-gene	1069	1073	abstract	37574818
and	O	1074	1077	abstract	37574818
ATGL	B-gene	1078	1082	abstract	37574818
)	O	1082	1083	abstract	37574818
in	O	1084	1086	abstract	37574818
acne	B-animal	1087	1091	abstract	37574818
mice	I-animal	1092	1096	abstract	37574818
.	O	1096	1097	abstract	37574818

Both	O	1098	1102	abstract	37574818
live	B-bacteria	1103	1107	abstract	37574818
and	I-bacteria	1108	1111	abstract	37574818
inactivated	I-bacteria	1112	1123	abstract	37574818
L.	I-bacteria	1124	1126	abstract	37574818
plantarum	I-bacteria	1127	1136	abstract	37574818
CCFM8661	I-bacteria	1137	1145	abstract	37574818
raised	O	1146	1152	abstract	37574818
the	O	1153	1156	abstract	37574818
richness	O	1157	1165	abstract	37574818
of	O	1166	1168	abstract	37574818
gut	B-microbiome	1169	1172	abstract	37574818
microbiota	I-microbiome	1173	1183	abstract	37574818
,	O	1183	1184	abstract	37574818
reduced	O	1185	1192	abstract	37574818
the	O	1193	1196	abstract	37574818
ratio	O	1197	1202	abstract	37574818
of	O	1203	1205	abstract	37574818
Bacteroidetes	O	1206	1219	abstract	37574818
to	O	1220	1222	abstract	37574818
Firmicutes	O	1223	1233	abstract	37574818
and	O	1234	1237	abstract	37574818
decreased	O	1238	1247	abstract	37574818
the	O	1248	1251	abstract	37574818
relative	O	1252	1260	abstract	37574818
abundance	O	1261	1270	abstract	37574818
of	O	1271	1273	abstract	37574818
Staphylococcus	B-bacteria	1274	1288	abstract	37574818
in	O	1289	1291	abstract	37574818
the	O	1292	1295	abstract	37574818
feces	O	1296	1301	abstract	37574818
of	O	1302	1304	abstract	37574818
acne	B-animal	1305	1309	abstract	37574818
mice	I-animal	1310	1314	abstract	37574818
.	O	1314	1315	abstract	37574818

Oral	O	1316	1320	abstract	37574818
ingestion	O	1321	1330	abstract	37574818
of	O	1331	1333	abstract	37574818
L.	B-bacteria	1334	1336	abstract	37574818
plantarum	I-bacteria	1337	1346	abstract	37574818
CCFM8661	I-bacteria	1347	1355	abstract	37574818
,	O	1355	1356	abstract	37574818
particularly	O	1357	1369	abstract	37574818
live	O	1370	1374	abstract	37574818
cells	O	1375	1380	abstract	37574818
,	O	1380	1381	abstract	37574818
could	O	1382	1387	abstract	37574818
alleviate	O	1388	1397	abstract	37574818
acne	B-DDF	1398	1402	abstract	37574818
by	O	1403	1405	abstract	37574818
suppressing	O	1406	1417	abstract	37574818
skin	B-DDF	1418	1422	abstract	37574818
inflammation	I-DDF	1423	1435	abstract	37574818
,	O	1435	1436	abstract	37574818
normalizing	O	1437	1448	abstract	37574818
the	O	1449	1452	abstract	37574818
metabolism	O	1453	1463	abstract	37574818
of	O	1464	1466	abstract	37574818
hormones	B-chemical	1467	1475	abstract	37574818
and	O	1476	1479	abstract	37574818
skin	B-chemical	1480	1484	abstract	37574818
lipids	I-chemical	1485	1491	abstract	37574818
,	O	1491	1492	abstract	37574818
which	O	1493	1498	abstract	37574818
may	O	1499	1502	abstract	37574818
be	O	1503	1505	abstract	37574818
achieved	O	1506	1514	abstract	37574818
by	O	1515	1517	abstract	37574818
improving	O	1518	1527	abstract	37574818
the	O	1528	1531	abstract	37574818
gut	B-microbiome	1532	1535	abstract	37574818
microbial	I-microbiome	1536	1545	abstract	37574818
ecosystem	I-microbiome	1546	1555	abstract	37574818
.	O	1555	1556	abstract	37574818

	O	1557	1558	abstract	37574818
2023	O	1559	1563	abstract	37574818
Society	O	1564	1571	abstract	37574818
of	O	1572	1574	abstract	37574818
Chemical	O	1575	1583	abstract	37574818
Industry	O	1584	1592	abstract	37574818
.	O	1592	1593	abstract	37574818

Underlying	O	0	10	title	37571393
Mechanisms	O	11	21	title	37571393
of	O	22	24	title	37571393
Brain	O	25	30	title	37571393
Aging	O	31	36	title	37571393
and	O	37	40	title	37571393
Neurodegenerative	B-DDF	41	58	title	37571393
Diseases	I-DDF	59	67	title	37571393
as	O	68	70	title	37571393
Potential	O	71	80	title	37571393
Targets	O	81	88	title	37571393
for	O	89	92	title	37571393
Preventive	O	93	103	title	37571393
or	O	104	106	title	37571393
Therapeutic	O	107	118	title	37571393
Strategies	O	119	129	title	37571393
Using	O	130	135	title	37571393
Phytochemicals	B-dietary%supplement	136	150	title	37571393
.	O	150	151	title	37571393

During	O	0	6	abstract	37571393
aging	O	7	12	abstract	37571393
,	O	12	13	abstract	37571393
several	O	14	21	abstract	37571393
tissues	O	22	29	abstract	37571393
and	O	30	33	abstract	37571393
biological	O	34	44	abstract	37571393
systems	O	45	52	abstract	37571393
undergo	O	53	60	abstract	37571393
a	O	61	62	abstract	37571393
progressive	O	63	74	abstract	37571393
decline	O	75	82	abstract	37571393
in	O	83	85	abstract	37571393
function	O	86	94	abstract	37571393
,	O	94	95	abstract	37571393
leading	O	96	103	abstract	37571393
to	O	104	106	abstract	37571393
age-associated	B-DDF	107	121	abstract	37571393
diseases	I-DDF	122	130	abstract	37571393
such	O	131	135	abstract	37571393
as	O	136	138	abstract	37571393
neurodegenerative	B-DDF	139	156	abstract	37571393
,	I-DDF	156	157	abstract	37571393
inflammatory	I-DDF	158	170	abstract	37571393
,	I-DDF	170	171	abstract	37571393
metabolic	I-DDF	172	181	abstract	37571393
,	I-DDF	181	182	abstract	37571393
and	I-DDF	183	186	abstract	37571393
cardiovascular	I-DDF	187	201	abstract	37571393
diseases	I-DDF	202	210	abstract	37571393
and	O	211	214	abstract	37571393
cancer	B-DDF	215	221	abstract	37571393
.	O	221	222	abstract	37571393

In	O	223	225	abstract	37571393
this	O	226	230	abstract	37571393
review	O	231	237	abstract	37571393
,	O	237	238	abstract	37571393
we	O	239	241	abstract	37571393
focus	O	242	247	abstract	37571393
on	O	248	250	abstract	37571393
the	O	251	254	abstract	37571393
molecular	O	255	264	abstract	37571393
underpinning	O	265	277	abstract	37571393
of	O	278	280	abstract	37571393
senescence	B-DDF	281	291	abstract	37571393
and	O	292	295	abstract	37571393
neurodegeneration	B-DDF	296	313	abstract	37571393
related	O	314	321	abstract	37571393
to	O	322	324	abstract	37571393
age-associated	B-DDF	325	339	abstract	37571393
brain	I-DDF	340	345	abstract	37571393
diseases	I-DDF	346	354	abstract	37571393
,	O	354	355	abstract	37571393
in	O	356	358	abstract	37571393
particular	O	359	369	abstract	37571393
,	O	369	370	abstract	37571393
Alzheimer	B-DDF	371	380	abstract	37571393
's	I-DDF	380	382	abstract	37571393
and	I-DDF	383	386	abstract	37571393
Parkinson	I-DDF	387	396	abstract	37571393
's	I-DDF	396	398	abstract	37571393
diseases	I-DDF	399	407	abstract	37571393
,	O	407	408	abstract	37571393
along	O	409	414	abstract	37571393
with	O	415	419	abstract	37571393
introducing	O	420	431	abstract	37571393
nutrients	B-dietary%supplement	432	441	abstract	37571393
or	O	442	444	abstract	37571393
phytochemicals	B-dietary%supplement	445	459	abstract	37571393
that	O	460	464	abstract	37571393
modulate	O	465	473	abstract	37571393
age-associated	B-DDF	474	488	abstract	37571393
molecular	I-DDF	489	498	abstract	37571393
dysfunctions	I-DDF	499	511	abstract	37571393
,	O	511	512	abstract	37571393
potentially	O	513	524	abstract	37571393
offering	O	525	533	abstract	37571393
preventive	O	534	544	abstract	37571393
or	O	545	547	abstract	37571393
therapeutic	O	548	559	abstract	37571393
benefits	O	560	568	abstract	37571393
.	O	568	569	abstract	37571393

Based	O	570	575	abstract	37571393
on	O	576	578	abstract	37571393
current	O	579	586	abstract	37571393
knowledge	O	587	596	abstract	37571393
,	O	596	597	abstract	37571393
the	O	598	601	abstract	37571393
dysregulation	B-DDF	602	615	abstract	37571393
of	I-DDF	616	618	abstract	37571393
microglia	I-DDF	619	628	abstract	37571393
genes	I-DDF	629	634	abstract	37571393
and	O	635	638	abstract	37571393
neuroinflammation	B-DDF	639	656	abstract	37571393
,	O	656	657	abstract	37571393
telomere	B-DDF	658	666	abstract	37571393
attrition	I-DDF	667	676	abstract	37571393
,	O	676	677	abstract	37571393
neuronal	B-DDF	678	686	abstract	37571393
stem	I-DDF	687	691	abstract	37571393
cell	I-DDF	692	696	abstract	37571393
degradation	I-DDF	697	708	abstract	37571393
,	O	708	709	abstract	37571393
vascular	B-DDF	710	718	abstract	37571393
system	I-DDF	719	725	abstract	37571393
dysfunction	I-DDF	726	737	abstract	37571393
,	O	737	738	abstract	37571393
reactive	O	739	747	abstract	37571393
oxygen	O	748	754	abstract	37571393
species	O	755	762	abstract	37571393
,	O	762	763	abstract	37571393
loss	B-DDF	764	768	abstract	37571393
of	I-DDF	769	771	abstract	37571393
chromosome	I-DDF	772	782	abstract	37571393
X	I-DDF	783	784	abstract	37571393
inactivation	I-DDF	785	797	abstract	37571393
in	O	798	800	abstract	37571393
females	B-human	801	808	abstract	37571393
,	O	808	809	abstract	37571393
and	O	810	813	abstract	37571393
gut	B-DDF	814	817	abstract	37571393
microbiome	I-DDF	818	828	abstract	37571393
dysbiosis	I-DDF	829	838	abstract	37571393
have	O	839	843	abstract	37571393
been	O	844	848	abstract	37571393
seen	O	849	853	abstract	37571393
to	O	854	856	abstract	37571393
play	O	857	861	abstract	37571393
pivotal	O	862	869	abstract	37571393
roles	O	870	875	abstract	37571393
in	O	876	878	abstract	37571393
neurodegeneration	B-DDF	879	896	abstract	37571393
in	O	897	899	abstract	37571393
an	O	900	902	abstract	37571393
interactive	O	903	914	abstract	37571393
manner	O	915	921	abstract	37571393
.	O	921	922	abstract	37571393

There	O	923	928	abstract	37571393
are	O	929	932	abstract	37571393
several	O	933	940	abstract	37571393
phytochemicals	B-dietary%supplement	941	955	abstract	37571393
(	O	956	957	abstract	37571393
e.g.	O	957	961	abstract	37571393
,	O	961	962	abstract	37571393
curcumin	B-dietary%supplement	963	971	abstract	37571393
,	O	971	972	abstract	37571393
EGCG	B-dietary%supplement	973	977	abstract	37571393
,	O	977	978	abstract	37571393
fucoidan	B-dietary%supplement	979	987	abstract	37571393
,	O	987	988	abstract	37571393
galangin	B-dietary%supplement	989	997	abstract	37571393
,	O	997	998	abstract	37571393
astin	B-dietary%supplement	999	1004	abstract	37571393
C	I-dietary%supplement	1005	1006	abstract	37571393
,	O	1006	1007	abstract	37571393
apigenin	B-dietary%supplement	1008	1016	abstract	37571393
,	O	1016	1017	abstract	37571393
resveratrol	B-dietary%supplement	1018	1029	abstract	37571393
,	O	1029	1030	abstract	37571393
phytic	B-dietary%supplement	1031	1037	abstract	37571393
acid	I-dietary%supplement	1038	1042	abstract	37571393
,	O	1042	1043	abstract	37571393
acacetin	B-dietary%supplement	1044	1052	abstract	37571393
,	O	1052	1053	abstract	37571393
daucosterol	B-dietary%supplement	1054	1065	abstract	37571393
,	O	1065	1066	abstract	37571393
silibinin	B-dietary%supplement	1067	1076	abstract	37571393
,	O	1076	1077	abstract	37571393
sulforaphane	B-dietary%supplement	1078	1090	abstract	37571393
,	O	1090	1091	abstract	37571393
withaferin	B-dietary%supplement	1092	1102	abstract	37571393
A	I-dietary%supplement	1103	1104	abstract	37571393
,	O	1104	1105	abstract	37571393
and	O	1106	1109	abstract	37571393
betulinic	B-dietary%supplement	1110	1119	abstract	37571393
acid	I-dietary%supplement	1120	1124	abstract	37571393
)	O	1124	1125	abstract	37571393
that	O	1126	1130	abstract	37571393
modulate	O	1131	1139	abstract	37571393
the	O	1140	1143	abstract	37571393
dysfunction	O	1144	1155	abstract	37571393
of	O	1156	1158	abstract	37571393
one	O	1159	1162	abstract	37571393
or	O	1163	1165	abstract	37571393
several	O	1166	1173	abstract	37571393
key	O	1174	1177	abstract	37571393
genes	O	1178	1183	abstract	37571393
(	O	1184	1185	abstract	37571393
e.g.	O	1185	1189	abstract	37571393
,	O	1189	1190	abstract	37571393
TREM2	B-gene	1191	1196	abstract	37571393
,	O	1196	1197	abstract	37571393
C3	B-gene	1198	1200	abstract	37571393
,	O	1200	1201	abstract	37571393
C3aR1	B-gene	1202	1207	abstract	37571393
,	O	1207	1208	abstract	37571393
TNFA	B-gene	1209	1213	abstract	37571393
,	O	1213	1214	abstract	37571393
NF-kb	B-gene	1215	1220	abstract	37571393
,	O	1220	1221	abstract	37571393
TGFB1&2	B-gene	1222	1229	abstract	37571393
,	O	1229	1230	abstract	37571393
SIRT1&6	B-gene	1231	1238	abstract	37571393
,	O	1238	1239	abstract	37571393
HMGB1	B-gene	1240	1245	abstract	37571393
,	O	1245	1246	abstract	37571393
and	O	1247	1250	abstract	37571393
STING	B-gene	1251	1256	abstract	37571393
)	O	1256	1257	abstract	37571393
affected	O	1258	1266	abstract	37571393
in	O	1267	1269	abstract	37571393
the	O	1270	1273	abstract	37571393
aged	O	1274	1278	abstract	37571393
brain	O	1279	1284	abstract	37571393
.	O	1284	1285	abstract	37571393

Although	O	1286	1294	abstract	37571393
phytochemicals	B-dietary%supplement	1295	1309	abstract	37571393
have	O	1310	1314	abstract	37571393
shown	O	1315	1320	abstract	37571393
promise	O	1321	1328	abstract	37571393
in	O	1329	1331	abstract	37571393
slowing	O	1332	1339	abstract	37571393
down	O	1340	1344	abstract	37571393
the	O	1345	1348	abstract	37571393
progression	O	1349	1360	abstract	37571393
of	O	1361	1363	abstract	37571393
age-related	B-DDF	1364	1375	abstract	37571393
brain	I-DDF	1376	1381	abstract	37571393
diseases	I-DDF	1382	1390	abstract	37571393
,	O	1390	1391	abstract	37571393
more	O	1392	1396	abstract	37571393
studies	O	1397	1404	abstract	37571393
to	O	1405	1407	abstract	37571393
identify	O	1408	1416	abstract	37571393
their	O	1417	1422	abstract	37571393
efficacy	O	1423	1431	abstract	37571393
,	O	1431	1432	abstract	37571393
alone	O	1433	1438	abstract	37571393
or	O	1439	1441	abstract	37571393
in	O	1442	1444	abstract	37571393
combinations	O	1445	1457	abstract	37571393
,	O	1457	1458	abstract	37571393
in	O	1459	1461	abstract	37571393
preclinical	O	1462	1473	abstract	37571393
systems	O	1474	1481	abstract	37571393
can	O	1482	1485	abstract	37571393
help	O	1486	1490	abstract	37571393
to	O	1491	1493	abstract	37571393
design	O	1494	1500	abstract	37571393
novel	O	1501	1506	abstract	37571393
nutritional	O	1507	1518	abstract	37571393
strategies	O	1519	1529	abstract	37571393
for	O	1530	1533	abstract	37571393
the	O	1534	1537	abstract	37571393
management	O	1538	1548	abstract	37571393
of	O	1549	1551	abstract	37571393
neurodegenerative	B-DDF	1552	1569	abstract	37571393
diseases	I-DDF	1570	1578	abstract	37571393
in	O	1579	1581	abstract	37571393
humans	B-human	1582	1588	abstract	37571393
.	O	1588	1589	abstract	37571393

Melanin	B-chemical	0	7	title	37841274
:	O	7	8	title	37841274
a	O	9	10	title	37841274
unifying	O	11	19	title	37841274
theory	O	20	26	title	37841274
of	O	27	29	title	37841274
disease	O	30	37	title	37841274
as	O	38	40	title	37841274
exemplified	O	41	52	title	37841274
by	O	53	55	title	37841274
Parkinson	B-DDF	56	65	title	37841274
's	I-DDF	65	67	title	37841274
,	O	67	68	title	37841274
Alzheimer	B-DDF	69	78	title	37841274
's	I-DDF	78	80	title	37841274
,	O	80	81	title	37841274
and	O	82	85	title	37841274
Lewy	B-DDF	86	90	title	37841274
body	I-DDF	91	95	title	37841274
dementia	I-DDF	96	104	title	37841274
.	O	104	105	title	37841274

Melanin	B-chemical	0	7	abstract	37841274
,	O	7	8	abstract	37841274
a	O	9	10	abstract	37841274
ubiquitous	O	11	21	abstract	37841274
dark	O	22	26	abstract	37841274
pigment	O	27	34	abstract	37841274
,	O	34	35	abstract	37841274
plays	O	36	41	abstract	37841274
important	O	42	51	abstract	37841274
roles	O	52	57	abstract	37841274
in	O	58	60	abstract	37841274
the	O	61	64	abstract	37841274
immune	O	65	71	abstract	37841274
system	O	72	78	abstract	37841274
,	O	78	79	abstract	37841274
including	O	80	89	abstract	37841274
scavenging	O	90	100	abstract	37841274
reactive	B-chemical	101	109	abstract	37841274
oxygen	I-chemical	110	116	abstract	37841274
species	I-chemical	117	124	abstract	37841274
formed	O	125	131	abstract	37841274
in	O	132	134	abstract	37841274
response	O	135	143	abstract	37841274
to	O	144	146	abstract	37841274
ultraviolet	O	147	158	abstract	37841274
radiation	O	159	168	abstract	37841274
absorption	O	169	179	abstract	37841274
,	O	179	180	abstract	37841274
absorbing	O	181	190	abstract	37841274
metals	O	191	197	abstract	37841274
,	O	197	198	abstract	37841274
thermal	O	199	206	abstract	37841274
regulation	O	207	217	abstract	37841274
,	O	217	218	abstract	37841274
drug	O	219	223	abstract	37841274
uptake	O	224	230	abstract	37841274
,	O	230	231	abstract	37841274
innate	O	232	238	abstract	37841274
immune	O	239	245	abstract	37841274
system	O	246	252	abstract	37841274
functions	O	253	262	abstract	37841274
,	O	262	263	abstract	37841274
redox	O	264	269	abstract	37841274
,	O	269	270	abstract	37841274
and	O	271	274	abstract	37841274
energy	O	275	281	abstract	37841274
transduction	O	282	294	abstract	37841274
.	O	294	295	abstract	37841274

Many	O	296	300	abstract	37841274
tissue	O	301	307	abstract	37841274
types	O	308	313	abstract	37841274
,	O	313	314	abstract	37841274
including	O	315	324	abstract	37841274
brain	B-anatomical%location	325	330	abstract	37841274
,	O	330	331	abstract	37841274
heart	B-anatomical%location	332	337	abstract	37841274
,	O	337	338	abstract	37841274
arteries	B-anatomical%location	339	347	abstract	37841274
,	O	347	348	abstract	37841274
ovaries	B-anatomical%location	349	356	abstract	37841274
,	O	356	357	abstract	37841274
and	O	358	361	abstract	37841274
others	O	362	368	abstract	37841274
,	O	368	369	abstract	37841274
contain	O	370	377	abstract	37841274
melanin	B-chemical	378	385	abstract	37841274
.	O	385	386	abstract	37841274

Almost	O	387	393	abstract	37841274
all	O	394	397	abstract	37841274
cells	O	398	403	abstract	37841274
contain	O	404	411	abstract	37841274
precursors	O	412	422	abstract	37841274
to	O	423	425	abstract	37841274
melanin	B-chemical	426	433	abstract	37841274
.	O	433	434	abstract	37841274

A	O	435	436	abstract	37841274
growing	O	437	444	abstract	37841274
number	O	445	451	abstract	37841274
of	O	452	454	abstract	37841274
diseases	O	455	463	abstract	37841274
in	O	464	466	abstract	37841274
which	O	467	472	abstract	37841274
there	O	473	478	abstract	37841274
is	O	479	481	abstract	37841274
a	O	482	483	abstract	37841274
loss	O	484	488	abstract	37841274
of	O	489	491	abstract	37841274
melanin	B-chemical	492	499	abstract	37841274
and/or	O	500	506	abstract	37841274
neuromelanin	B-chemical	507	519	abstract	37841274
are	O	520	523	abstract	37841274
increasingly	O	524	536	abstract	37841274
thought	O	537	544	abstract	37841274
to	O	545	547	abstract	37841274
have	O	548	552	abstract	37841274
infectious	O	553	563	abstract	37841274
etiologies	O	564	574	abstract	37841274
,	O	574	575	abstract	37841274
for	O	576	579	abstract	37841274
example	O	580	587	abstract	37841274
,	O	587	588	abstract	37841274
Alzheimer	B-DDF	589	598	abstract	37841274
's	I-DDF	598	600	abstract	37841274
disease	I-DDF	601	608	abstract	37841274
(	O	609	610	abstract	37841274
AD	B-DDF	610	612	abstract	37841274
)	O	612	613	abstract	37841274
,	O	613	614	abstract	37841274
Parkinson	B-DDF	615	624	abstract	37841274
's	I-DDF	624	626	abstract	37841274
disease	I-DDF	627	634	abstract	37841274
(	O	635	636	abstract	37841274
PD	B-DDF	636	638	abstract	37841274
)	O	638	639	abstract	37841274
,	O	639	640	abstract	37841274
Lewy	B-DDF	641	645	abstract	37841274
Body	I-DDF	646	650	abstract	37841274
Dementia	I-DDF	651	659	abstract	37841274
(	O	660	661	abstract	37841274
LBD	B-DDF	661	664	abstract	37841274
)	O	664	665	abstract	37841274
,	O	665	666	abstract	37841274
and	O	667	670	abstract	37841274
vitiligo	B-DDF	671	679	abstract	37841274
.	O	679	680	abstract	37841274

AD	B-DDF	681	683	abstract	37841274
,	O	683	684	abstract	37841274
PD	B-DDF	685	687	abstract	37841274
,	O	687	688	abstract	37841274
LBD	B-DDF	689	692	abstract	37841274
,	O	692	693	abstract	37841274
and	O	694	697	abstract	37841274
vitiligo	B-DDF	698	706	abstract	37841274
have	O	707	711	abstract	37841274
been	O	712	716	abstract	37841274
linked	O	717	723	abstract	37841274
with	O	724	728	abstract	37841274
herpesvirus	B-chemical	729	740	abstract	37841274
,	O	740	741	abstract	37841274
which	O	742	747	abstract	37841274
enters	O	748	754	abstract	37841274
melanosomes	B-chemical	755	766	abstract	37841274
and	O	767	770	abstract	37841274
causes	O	771	777	abstract	37841274
apoptosis	B-DDF	778	787	abstract	37841274
,	O	787	788	abstract	37841274
and	O	789	792	abstract	37841274
with	O	793	797	abstract	37841274
gut	B-DDF	798	801	abstract	37841274
dysbiosis	I-DDF	802	811	abstract	37841274
and	O	812	815	abstract	37841274
inflammation	B-DDF	816	828	abstract	37841274
.	O	828	829	abstract	37841274

Herpesvirus	B-chemical	830	841	abstract	37841274
is	O	842	844	abstract	37841274
also	O	845	849	abstract	37841274
linked	O	850	856	abstract	37841274
with	O	857	861	abstract	37841274
gut	B-DDF	862	865	abstract	37841274
dysbiosis	I-DDF	866	875	abstract	37841274
and	O	876	879	abstract	37841274
inflammation	B-DDF	880	892	abstract	37841274
.	O	892	893	abstract	37841274

We	O	894	896	abstract	37841274
theorize	O	897	905	abstract	37841274
that	O	906	910	abstract	37841274
under	O	911	916	abstract	37841274
normal	O	917	923	abstract	37841274
healthy	O	924	931	abstract	37841274
states	O	932	938	abstract	37841274
,	O	938	939	abstract	37841274
melanin	B-chemical	940	947	abstract	37841274
retains	O	948	955	abstract	37841274
some	O	956	960	abstract	37841274
of	O	961	963	abstract	37841274
the	O	964	967	abstract	37841274
energy	O	968	974	abstract	37841274
it	O	975	977	abstract	37841274
absorbs	O	978	985	abstract	37841274
from	O	986	990	abstract	37841274
electromagnetic	O	991	1006	abstract	37841274
radiation	O	1007	1016	abstract	37841274
,	O	1016	1017	abstract	37841274
which	O	1018	1023	abstract	37841274
is	O	1024	1026	abstract	37841274
then	O	1027	1031	abstract	37841274
used	O	1032	1036	abstract	37841274
to	O	1037	1039	abstract	37841274
fuel	O	1040	1044	abstract	37841274
cells	O	1045	1050	abstract	37841274
,	O	1050	1051	abstract	37841274
and	O	1052	1055	abstract	37841274
energy	O	1056	1062	abstract	37841274
from	O	1063	1067	abstract	37841274
ATP	B-chemical	1068	1071	abstract	37841274
is	O	1072	1074	abstract	37841274
used	O	1075	1079	abstract	37841274
to	O	1080	1082	abstract	37841274
compliment	O	1083	1093	abstract	37841274
that	O	1094	1098	abstract	37841274
energy	O	1099	1105	abstract	37841274
supply	O	1106	1112	abstract	37841274
.	O	1112	1113	abstract	37841274

We	O	1114	1116	abstract	37841274
further	O	1117	1124	abstract	37841274
theorize	O	1125	1133	abstract	37841274
that	O	1134	1138	abstract	37841274
loss	O	1139	1143	abstract	37841274
of	O	1144	1146	abstract	37841274
melanin	B-chemical	1147	1154	abstract	37841274
reduces	O	1155	1162	abstract	37841274
the	O	1163	1166	abstract	37841274
energy	O	1167	1173	abstract	37841274
supply	O	1174	1180	abstract	37841274
of	O	1181	1183	abstract	37841274
cells	O	1184	1189	abstract	37841274
,	O	1189	1190	abstract	37841274
which	O	1191	1196	abstract	37841274
in	O	1197	1199	abstract	37841274
the	O	1200	1203	abstract	37841274
case	O	1204	1208	abstract	37841274
of	O	1209	1211	abstract	37841274
AD	B-DDF	1212	1214	abstract	37841274
,	O	1214	1215	abstract	37841274
PD	B-DDF	1216	1218	abstract	37841274
,	O	1218	1219	abstract	37841274
and	O	1220	1223	abstract	37841274
LBD	B-DDF	1224	1227	abstract	37841274
results	O	1228	1235	abstract	37841274
in	O	1236	1238	abstract	37841274
an	O	1239	1241	abstract	37841274
inability	O	1242	1251	abstract	37841274
to	O	1252	1254	abstract	37841274
sustain	O	1255	1262	abstract	37841274
immune	O	1263	1269	abstract	37841274
system	O	1270	1276	abstract	37841274
defenses	O	1277	1285	abstract	37841274
and	O	1286	1289	abstract	37841274
remove	O	1290	1296	abstract	37841274
the	O	1297	1300	abstract	37841274
plaques	O	1301	1308	abstract	37841274
associated	O	1309	1319	abstract	37841274
with	O	1320	1324	abstract	37841274
the	O	1325	1328	abstract	37841274
disease	O	1329	1336	abstract	37841274
,	O	1336	1337	abstract	37841274
which	O	1338	1343	abstract	37841274
appear	O	1344	1350	abstract	37841274
to	O	1351	1353	abstract	37841274
be	O	1354	1356	abstract	37841274
part	O	1357	1361	abstract	37841274
of	O	1362	1364	abstract	37841274
the	O	1365	1368	abstract	37841274
immune	O	1369	1375	abstract	37841274
system	O	1376	1382	abstract	37841274
's	O	1382	1384	abstract	37841274
attempt	O	1385	1392	abstract	37841274
to	O	1393	1395	abstract	37841274
eradicate	O	1396	1405	abstract	37841274
the	O	1406	1409	abstract	37841274
pathogens	O	1410	1419	abstract	37841274
seen	O	1420	1424	abstract	37841274
in	O	1425	1427	abstract	37841274
these	O	1428	1433	abstract	37841274
neurodegenerative	B-DDF	1434	1451	abstract	37841274
diseases	I-DDF	1452	1460	abstract	37841274
.	O	1460	1461	abstract	37841274

In	O	1462	1464	abstract	37841274
addition	O	1465	1473	abstract	37841274
,	O	1473	1474	abstract	37841274
in	O	1475	1477	abstract	37841274
an	O	1478	1480	abstract	37841274
attempt	O	1481	1488	abstract	37841274
to	O	1489	1491	abstract	37841274
explain	O	1492	1499	abstract	37841274
why	O	1500	1503	abstract	37841274
removing	O	1504	1512	abstract	37841274
these	O	1513	1518	abstract	37841274
plaques	O	1519	1526	abstract	37841274
does	O	1527	1531	abstract	37841274
not	O	1532	1535	abstract	37841274
result	O	1536	1542	abstract	37841274
in	O	1543	1545	abstract	37841274
improvements	O	1546	1558	abstract	37841274
in	O	1559	1561	abstract	37841274
cognition	O	1562	1571	abstract	37841274
and	O	1572	1575	abstract	37841274
mood	O	1576	1580	abstract	37841274
and	O	1581	1584	abstract	37841274
why	O	1585	1588	abstract	37841274
cognitions	O	1589	1599	abstract	37841274
and	O	1600	1603	abstract	37841274
moods	O	1604	1609	abstract	37841274
in	O	1610	1612	abstract	37841274
these	O	1613	1618	abstract	37841274
individuals	O	1619	1630	abstract	37841274
have	O	1631	1635	abstract	37841274
ebbs	O	1636	1640	abstract	37841274
and	O	1641	1644	abstract	37841274
flows	O	1645	1650	abstract	37841274
,	O	1650	1651	abstract	37841274
we	O	1652	1654	abstract	37841274
postulate	O	1655	1664	abstract	37841274
that	O	1665	1669	abstract	37841274
it	O	1670	1672	abstract	37841274
is	O	1673	1675	abstract	37841274
not	O	1676	1679	abstract	37841274
the	O	1680	1683	abstract	37841274
plaques	O	1684	1691	abstract	37841274
that	O	1692	1696	abstract	37841274
cause	O	1697	1702	abstract	37841274
the	O	1703	1706	abstract	37841274
cognitive	O	1707	1716	abstract	37841274
symptoms	O	1717	1725	abstract	37841274
but	O	1726	1729	abstract	37841274
,	O	1729	1730	abstract	37841274
rather	O	1731	1737	abstract	37841274
,	O	1737	1738	abstract	37841274
inflammation	B-DDF	1739	1751	abstract	37841274
in	O	1752	1754	abstract	37841274
the	O	1755	1758	abstract	37841274
brain	B-anatomical%location	1759	1764	abstract	37841274
resulting	O	1765	1774	abstract	37841274
from	O	1775	1779	abstract	37841274
the	O	1780	1783	abstract	37841274
immune	O	1784	1790	abstract	37841274
system	O	1791	1797	abstract	37841274
's	O	1797	1799	abstract	37841274
response	O	1800	1808	abstract	37841274
to	O	1809	1811	abstract	37841274
pathogens	O	1812	1821	abstract	37841274
.	O	1821	1822	abstract	37841274

Our	O	1823	1826	abstract	37841274
theory	O	1827	1833	abstract	37841274
that	O	1834	1838	abstract	37841274
energy	O	1839	1845	abstract	37841274
retained	O	1846	1854	abstract	37841274
in	O	1855	1857	abstract	37841274
melanin	O	1858	1865	abstract	37841274
fuels	O	1866	1871	abstract	37841274
cells	O	1872	1877	abstract	37841274
in	O	1878	1880	abstract	37841274
an	O	1881	1883	abstract	37841274
inverse	O	1884	1891	abstract	37841274
relationship	O	1892	1904	abstract	37841274
with	O	1905	1909	abstract	37841274
ATP	B-chemical	1910	1913	abstract	37841274
is	O	1914	1916	abstract	37841274
supported	O	1917	1926	abstract	37841274
by	O	1927	1929	abstract	37841274
studies	O	1930	1937	abstract	37841274
showing	O	1938	1945	abstract	37841274
alterations	O	1946	1957	abstract	37841274
in	O	1958	1960	abstract	37841274
ATP	B-chemical	1961	1964	abstract	37841274
production	O	1965	1975	abstract	37841274
in	O	1976	1978	abstract	37841274
relationship	O	1979	1991	abstract	37841274
to	O	1992	1994	abstract	37841274
melanin	B-chemical	1995	2002	abstract	37841274
levels	O	2003	2009	abstract	37841274
in	O	2010	2012	abstract	37841274
melanomas	B-DDF	2013	2022	abstract	37841274
,	O	2022	2023	abstract	37841274
vitiligo	B-DDF	2024	2032	abstract	37841274
,	O	2032	2033	abstract	37841274
and	O	2034	2037	abstract	37841274
healthy	O	2038	2045	abstract	37841274
cells	O	2046	2051	abstract	37841274
.	O	2051	2052	abstract	37841274

Therefore	O	2053	2062	abstract	37841274
,	O	2062	2063	abstract	37841274
alteration	O	2064	2074	abstract	37841274
of	O	2075	2077	abstract	37841274
melanin	B-chemical	2078	2085	abstract	37841274
levels	O	2086	2092	abstract	37841274
may	O	2093	2096	abstract	37841274
be	O	2097	2099	abstract	37841274
at	O	2100	2102	abstract	37841274
the	O	2103	2106	abstract	37841274
core	O	2107	2111	abstract	37841274
of	O	2112	2114	abstract	37841274
many	O	2115	2119	abstract	37841274
diseases	O	2120	2128	abstract	37841274
.	O	2128	2129	abstract	37841274

We	O	2130	2132	abstract	37841274
propose	O	2133	2140	abstract	37841274
regulating	O	2141	2151	abstract	37841274
melanin	O	2152	2159	abstract	37841274
levels	O	2160	2166	abstract	37841274
may	O	2167	2170	abstract	37841274
offer	O	2171	2176	abstract	37841274
new	O	2177	2180	abstract	37841274
avenues	O	2181	2188	abstract	37841274
for	O	2189	2192	abstract	37841274
treatment	O	2193	2202	abstract	37841274
development	O	2203	2214	abstract	37841274
.	O	2214	2215	abstract	37841274

Flavonoids	B-dietary%supplement	0	10	title	37485660
from	I-dietary%supplement	11	15	title	37485660
Seabuckthorn	I-dietary%supplement	16	28	title	37485660
(	O	29	30	title	37485660
<	O	30	31	title	37485660
i	O	31	32	title	37485660
>	O	32	33	title	37485660
Hippophae	B-dietary%supplement	33	42	title	37485660
rhamnoides</i	I-dietary%supplement	43	56	title	37485660
>	O	56	57	title	37485660
L.	O	58	60	title	37485660
)	O	60	61	title	37485660
restore	O	62	69	title	37485660
CUMS-induced	B-DDF	70	82	title	37485660
depressive	I-DDF	83	93	title	37485660
disorder	I-DDF	94	102	title	37485660
and	O	103	106	title	37485660
regulate	O	107	115	title	37485660
the	O	116	119	title	37485660
gut	B-microbiome	120	123	title	37485660
microbiota	I-microbiome	124	134	title	37485660
in	O	135	137	title	37485660
mice	B-animal	138	142	title	37485660
.	O	142	143	title	37485660

Seabuckthorn	B-dietary%supplement	0	12	abstract	37485660
(	O	13	14	abstract	37485660
<	O	14	15	abstract	37485660
i	O	15	16	abstract	37485660
>	O	16	17	abstract	37485660
Hippophae	B-dietary%supplement	17	26	abstract	37485660
rhamnoides</i	I-dietary%supplement	27	40	abstract	37485660
>	O	40	41	abstract	37485660
L.	O	42	44	abstract	37485660
)	O	44	45	abstract	37485660
,	O	45	46	abstract	37485660
which	O	47	52	abstract	37485660
is	O	53	55	abstract	37485660
enriched	O	56	64	abstract	37485660
with	O	65	69	abstract	37485660
flavonoids	B-chemical	70	80	abstract	37485660
,	O	80	81	abstract	37485660
including	O	82	91	abstract	37485660
isorhamnetin	B-chemical	92	104	abstract	37485660
,	O	104	105	abstract	37485660
quercetin	B-chemical	106	115	abstract	37485660
and	O	116	119	abstract	37485660
kaempferol	B-chemical	120	130	abstract	37485660
,	O	130	131	abstract	37485660
is	O	132	134	abstract	37485660
a	O	135	136	abstract	37485660
representative	O	137	151	abstract	37485660
example	O	152	159	abstract	37485660
of	O	160	162	abstract	37485660
"	O	163	164	abstract	37485660
medicine	O	164	172	abstract	37485660
food	O	173	177	abstract	37485660
homology	O	178	186	abstract	37485660
"	O	186	187	abstract	37485660
targeting	O	188	197	abstract	37485660
several	O	198	205	abstract	37485660
diseases	O	206	214	abstract	37485660
.	O	214	215	abstract	37485660

Major	B-DDF	216	221	abstract	37485660
depressive	I-DDF	222	232	abstract	37485660
disorders	I-DDF	233	242	abstract	37485660
seriously	O	243	252	abstract	37485660
threaten	O	253	261	abstract	37485660
mental	O	262	268	abstract	37485660
health	O	269	275	abstract	37485660
worldwide	O	276	285	abstract	37485660
and	O	286	289	abstract	37485660
may	O	290	293	abstract	37485660
even	O	294	298	abstract	37485660
lead	O	299	303	abstract	37485660
to	O	304	306	abstract	37485660
death	O	307	312	abstract	37485660
.	O	312	313	abstract	37485660

Chronic	B-DDF	314	321	abstract	37485660
unpredictable	I-DDF	322	335	abstract	37485660
mild	I-DDF	336	340	abstract	37485660
stress	I-DDF	341	347	abstract	37485660
(CUMS)-induced	I-DDF	348	362	abstract	37485660
depressive-like	I-DDF	363	378	abstract	37485660
symptoms	I-DDF	379	387	abstract	37485660
in	O	388	390	abstract	37485660
mice	B-animal	391	395	abstract	37485660
are	O	396	399	abstract	37485660
usually	O	400	407	abstract	37485660
considered	O	408	418	abstract	37485660
as	O	419	421	abstract	37485660
the	O	422	425	abstract	37485660
highest	O	426	433	abstract	37485660
similarity	O	434	444	abstract	37485660
to	O	445	447	abstract	37485660
the	O	448	451	abstract	37485660
situation	O	452	461	abstract	37485660
in	O	462	464	abstract	37485660
humans	B-human	465	471	abstract	37485660
.	O	471	472	abstract	37485660

Herein	O	473	479	abstract	37485660
,	O	479	480	abstract	37485660
we	O	481	483	abstract	37485660
determined	O	484	494	abstract	37485660
the	O	495	498	abstract	37485660
potential	O	499	508	abstract	37485660
functions	O	509	518	abstract	37485660
of	O	519	521	abstract	37485660
the	O	522	525	abstract	37485660
flavonoid-enriched	B-dietary%supplement	526	544	abstract	37485660
fraction	I-dietary%supplement	545	553	abstract	37485660
from	I-dietary%supplement	554	558	abstract	37485660
Seabuckthorn	I-dietary%supplement	559	571	abstract	37485660
,	O	571	572	abstract	37485660
which	O	573	578	abstract	37485660
was	O	579	582	abstract	37485660
named	O	583	588	abstract	37485660
SBF	B-dietary%supplement	589	592	abstract	37485660
,	O	592	593	abstract	37485660
in	O	594	596	abstract	37485660
treating	O	597	605	abstract	37485660
major	B-DDF	606	611	abstract	37485660
depressive	I-DDF	612	622	abstract	37485660
disorder	I-DDF	623	631	abstract	37485660
in	O	632	634	abstract	37485660
mice	B-animal	635	639	abstract	37485660
.	O	639	640	abstract	37485660

In	O	641	643	abstract	37485660
the	O	644	647	abstract	37485660
CUMS-induced	O	648	660	abstract	37485660
mouse	O	661	666	abstract	37485660
model	O	667	672	abstract	37485660
,	O	672	673	abstract	37485660
the	O	674	677	abstract	37485660
intake	O	678	684	abstract	37485660
of	O	685	687	abstract	37485660
SBF	B-dietary%supplement	688	691	abstract	37485660
reversed	O	692	700	abstract	37485660
their	O	701	706	abstract	37485660
depressive	B-DDF	707	717	abstract	37485660
behaviors	I-DDF	718	727	abstract	37485660
and	O	728	731	abstract	37485660
relieved	O	732	740	abstract	37485660
the	O	741	744	abstract	37485660
CUMS-disturbed	O	745	759	abstract	37485660
levels	O	760	766	abstract	37485660
of	O	767	769	abstract	37485660
neurotrophins	B-chemical	770	783	abstract	37485660
,	O	783	784	abstract	37485660
neurotransmitters	B-chemical	785	802	abstract	37485660
,	O	802	803	abstract	37485660
stress-related	B-chemical	804	818	abstract	37485660
hormones	I-chemical	819	827	abstract	37485660
,	O	827	828	abstract	37485660
and	O	829	832	abstract	37485660
inflammation-related	B-chemical	833	853	abstract	37485660
cytokines	I-chemical	854	863	abstract	37485660
.	O	863	864	abstract	37485660

Additionally	O	865	877	abstract	37485660
,	O	877	878	abstract	37485660
the	O	879	882	abstract	37485660
treatment	O	883	892	abstract	37485660
of	O	893	895	abstract	37485660
depressive	B-animal	896	906	abstract	37485660
mice	I-animal	907	911	abstract	37485660
with	O	912	916	abstract	37485660
SBF	B-dietary%supplement	917	920	abstract	37485660
showed	O	921	927	abstract	37485660
ability	O	928	935	abstract	37485660
to	O	936	938	abstract	37485660
regulate	O	939	947	abstract	37485660
the	O	948	951	abstract	37485660
gut	B-microbiome	952	955	abstract	37485660
microbiota	I-microbiome	956	966	abstract	37485660
,	O	966	967	abstract	37485660
especially	O	968	978	abstract	37485660
in	O	979	981	abstract	37485660
decreasing	O	982	992	abstract	37485660
the	O	993	996	abstract	37485660
abundance	O	997	1006	abstract	37485660
of	O	1007	1009	abstract	37485660
<	O	1010	1011	abstract	37485660
i	O	1011	1012	abstract	37485660
>	O	1012	1013	abstract	37485660
Lactobacillaceae</i	B-bacteria	1013	1032	abstract	37485660
>	O	1032	1033	abstract	37485660
,	O	1033	1034	abstract	37485660
while	O	1035	1040	abstract	37485660
increasing	O	1041	1051	abstract	37485660
the	O	1052	1055	abstract	37485660
abundance	O	1056	1065	abstract	37485660
of	O	1066	1068	abstract	37485660
<	O	1069	1070	abstract	37485660
i	O	1070	1071	abstract	37485660
>	O	1071	1072	abstract	37485660
Lachnospiraceae</i	B-bacteria	1072	1090	abstract	37485660
>	O	1090	1091	abstract	37485660
at	O	1092	1094	abstract	37485660
the	O	1095	1098	abstract	37485660
family	O	1099	1105	abstract	37485660
level	O	1106	1111	abstract	37485660
.	O	1111	1112	abstract	37485660

The	O	1113	1116	abstract	37485660
results	O	1117	1124	abstract	37485660
suggest	O	1125	1132	abstract	37485660
the	O	1133	1136	abstract	37485660
beneficial	O	1137	1147	abstract	37485660
effects	O	1148	1155	abstract	37485660
of	O	1156	1158	abstract	37485660
Seabuckthorn	B-dietary%supplement	1159	1171	abstract	37485660
flavonoids	I-dietary%supplement	1172	1182	abstract	37485660
in	O	1183	1185	abstract	37485660
functioning	O	1186	1197	abstract	37485660
as	O	1198	1200	abstract	37485660
a	O	1201	1202	abstract	37485660
health	O	1203	1209	abstract	37485660
food	O	1210	1214	abstract	37485660
supplement	O	1215	1225	abstract	37485660
to	O	1226	1228	abstract	37485660
treat	O	1229	1234	abstract	37485660
major	B-DDF	1235	1240	abstract	37485660
depressive	I-DDF	1241	1251	abstract	37485660
disorders	I-DDF	1252	1261	abstract	37485660
.	O	1261	1262	abstract	37485660

Neuroactive	B-chemical	0	11	title	31955786
compounds	I-chemical	12	21	title	31955786
in	O	22	24	title	31955786
foods	O	25	30	title	31955786
:	O	30	31	title	31955786
Occurrence	O	32	42	title	31955786
,	O	42	43	title	31955786
mechanism	O	44	53	title	31955786
and	O	54	57	title	31955786
potential	O	58	67	title	31955786
health	O	68	74	title	31955786
effects	O	75	82	title	31955786
.	O	82	83	title	31955786

Neuroactive	B-chemical	0	11	abstract	31955786
compounds	I-chemical	12	21	abstract	31955786
are	O	22	25	abstract	31955786
synthesized	O	26	37	abstract	31955786
by	O	38	40	abstract	31955786
certain	O	41	48	abstract	31955786
plants	O	49	55	abstract	31955786
and	O	56	59	abstract	31955786
microorganisms	O	60	74	abstract	31955786
by	O	75	77	abstract	31955786
undertaking	O	78	89	abstract	31955786
different	O	90	99	abstract	31955786
tasks	O	100	105	abstract	31955786
,	O	105	106	abstract	31955786
especially	O	107	117	abstract	31955786
as	O	118	120	abstract	31955786
a	O	121	122	abstract	31955786
stress	O	123	129	abstract	31955786
response	O	130	138	abstract	31955786
.	O	138	139	abstract	31955786

Most	O	140	144	abstract	31955786
common	O	145	151	abstract	31955786
neuroactive	B-chemical	152	163	abstract	31955786
compounds	I-chemical	164	173	abstract	31955786
in	O	174	176	abstract	31955786
foods	O	177	182	abstract	31955786
are	O	183	186	abstract	31955786
gamma-aminobutyric	B-chemical	187	205	abstract	31955786
acid	I-chemical	206	210	abstract	31955786
(	O	211	212	abstract	31955786
GABA	B-chemical	212	216	abstract	31955786
)	O	216	217	abstract	31955786
,	O	217	218	abstract	31955786
serotonin	B-chemical	219	228	abstract	31955786
,	O	228	229	abstract	31955786
melatonin	B-chemical	230	239	abstract	31955786
,	O	239	240	abstract	31955786
kynurenine	B-chemical	241	251	abstract	31955786
,	O	251	252	abstract	31955786
kynurenic	B-chemical	253	262	abstract	31955786
acid	I-chemical	263	267	abstract	31955786
,	O	267	268	abstract	31955786
dopamine	B-chemical	269	277	abstract	31955786
,	O	277	278	abstract	31955786
norepinephrine	B-chemical	279	293	abstract	31955786
,	O	293	294	abstract	31955786
histamine	B-chemical	295	304	abstract	31955786
,	O	304	305	abstract	31955786
tryptamine	B-chemical	306	316	abstract	31955786
,	O	316	317	abstract	31955786
tyramine	B-chemical	318	326	abstract	31955786
and	O	327	330	abstract	31955786
-phenylethylamine	B-chemical	331	349	abstract	31955786
.	O	349	350	abstract	31955786

Fermented	B-dietary%supplement	351	360	abstract	31955786
foods	I-dietary%supplement	361	366	abstract	31955786
contain	O	367	374	abstract	31955786
some	O	375	379	abstract	31955786
of	O	380	382	abstract	31955786
these	O	383	388	abstract	31955786
compounds	O	389	398	abstract	31955786
,	O	398	399	abstract	31955786
which	O	400	405	abstract	31955786
can	O	406	409	abstract	31955786
affect	O	410	416	abstract	31955786
human	O	417	422	abstract	31955786
health	O	423	429	abstract	31955786
and	O	430	433	abstract	31955786
mood	O	434	438	abstract	31955786
.	O	438	439	abstract	31955786

Moreover	O	440	448	abstract	31955786
,	O	448	449	abstract	31955786
food	O	450	454	abstract	31955786
processing	O	455	465	abstract	31955786
such	O	466	470	abstract	31955786
as	O	471	473	abstract	31955786
roasting	O	474	482	abstract	31955786
and	O	483	486	abstract	31955786
malting	O	487	494	abstract	31955786
alter	O	495	500	abstract	31955786
amount	O	501	507	abstract	31955786
and	O	508	511	abstract	31955786
profile	O	512	519	abstract	31955786
of	O	520	522	abstract	31955786
neuroactive	B-chemical	523	534	abstract	31955786
compounds	I-chemical	535	544	abstract	31955786
in	O	545	547	abstract	31955786
foods	O	548	553	abstract	31955786
.	O	553	554	abstract	31955786

In	O	555	557	abstract	31955786
addition	O	558	566	abstract	31955786
to	O	567	569	abstract	31955786
plant-origin	B-chemical	570	582	abstract	31955786
and	I-chemical	583	586	abstract	31955786
microbially-formed	I-chemical	587	605	abstract	31955786
neuroactive	I-chemical	606	617	abstract	31955786
compounds	I-chemical	618	627	abstract	31955786
in	O	628	630	abstract	31955786
foods	O	631	636	abstract	31955786
,	O	636	637	abstract	31955786
these	O	638	643	abstract	31955786
substances	O	644	654	abstract	31955786
are	O	655	658	abstract	31955786
also	O	659	663	abstract	31955786
formed	O	664	670	abstract	31955786
by	O	671	673	abstract	31955786
gut	B-microbiome	674	677	abstract	31955786
microbiota	I-microbiome	678	688	abstract	31955786
,	O	688	689	abstract	31955786
which	O	690	695	abstract	31955786
is	O	696	698	abstract	31955786
the	O	699	702	abstract	31955786
most	O	703	707	abstract	31955786
attractive	O	708	718	abstract	31955786
subject	O	719	726	abstract	31955786
to	O	727	729	abstract	31955786
assess	O	730	736	abstract	31955786
the	O	737	740	abstract	31955786
interaction	O	741	752	abstract	31955786
between	O	753	760	abstract	31955786
gut	B-microbiome	761	764	abstract	31955786
microbiota	I-microbiome	765	775	abstract	31955786
and	O	776	779	abstract	31955786
mental	O	780	786	abstract	31955786
health	O	787	793	abstract	31955786
.	O	793	794	abstract	31955786

The	O	795	798	abstract	31955786
discovery	O	799	808	abstract	31955786
of	O	809	811	abstract	31955786
microbiota-gut-brain	O	812	832	abstract	31955786
axis	O	833	837	abstract	31955786
calls	O	838	843	abstract	31955786
for	O	844	847	abstract	31955786
the	O	848	851	abstract	31955786
investigation	O	852	865	abstract	31955786
of	O	866	868	abstract	31955786
the	O	869	872	abstract	31955786
effects	O	873	880	abstract	31955786
of	O	881	883	abstract	31955786
diet	O	884	888	abstract	31955786
on	O	889	891	abstract	31955786
the	O	892	895	abstract	31955786
formation	O	896	905	abstract	31955786
of	O	906	908	abstract	31955786
neuroactive	B-chemical	909	920	abstract	31955786
compounds	I-chemical	921	930	abstract	31955786
in	O	931	933	abstract	31955786
the	O	934	937	abstract	31955786
gut	B-anatomical%location	938	941	abstract	31955786
.	O	941	942	abstract	31955786

Furthermore	O	943	954	abstract	31955786
,	O	954	955	abstract	31955786
probiotics	B-dietary%supplement	956	966	abstract	31955786
and	O	967	970	abstract	31955786
prebiotics	B-dietary%supplement	971	981	abstract	31955786
are	O	982	985	abstract	31955786
indispensable	O	986	999	abstract	31955786
elements	O	1000	1008	abstract	31955786
for	O	1009	1012	abstract	31955786
the	O	1013	1016	abstract	31955786
understanding	O	1017	1030	abstract	31955786
of	O	1031	1033	abstract	31955786
the	O	1034	1037	abstract	31955786
food-mood	O	1038	1047	abstract	31955786
relationship	O	1048	1060	abstract	31955786
.	O	1060	1061	abstract	31955786

The	O	1062	1065	abstract	31955786
focus	O	1066	1071	abstract	31955786
of	O	1072	1074	abstract	31955786
this	O	1075	1079	abstract	31955786
comprehensive	O	1080	1093	abstract	31955786
review	O	1094	1100	abstract	31955786
is	O	1101	1103	abstract	31955786
to	O	1104	1106	abstract	31955786
investigate	O	1107	1118	abstract	31955786
the	O	1119	1122	abstract	31955786
neuroactive	B-chemical	1123	1134	abstract	31955786
compounds	I-chemical	1135	1144	abstract	31955786
found	O	1145	1150	abstract	31955786
naturally	O	1151	1160	abstract	31955786
in	O	1161	1163	abstract	31955786
foods	O	1164	1169	abstract	31955786
or	O	1170	1172	abstract	31955786
formed	O	1173	1179	abstract	31955786
during	O	1180	1186	abstract	31955786
fermentation	O	1187	1199	abstract	31955786
.	O	1199	1200	abstract	31955786

Their	O	1201	1206	abstract	31955786
formation	O	1207	1216	abstract	31955786
pathways	O	1217	1225	abstract	31955786
in	O	1226	1228	abstract	31955786
humans	O	1229	1235	abstract	31955786
,	O	1235	1236	abstract	31955786
plants	O	1237	1243	abstract	31955786
and	O	1244	1247	abstract	31955786
microorganisms	O	1248	1262	abstract	31955786
,	O	1262	1263	abstract	31955786
potential	O	1264	1273	abstract	31955786
health	O	1274	1280	abstract	31955786
effects	O	1281	1288	abstract	31955786
,	O	1288	1289	abstract	31955786
effects	O	1290	1297	abstract	31955786
of	O	1298	1300	abstract	31955786
diet	O	1301	1305	abstract	31955786
on	O	1306	1308	abstract	31955786
the	O	1309	1312	abstract	31955786
formation	O	1313	1322	abstract	31955786
of	O	1323	1325	abstract	31955786
microbial	B-chemical	1326	1335	abstract	31955786
metabolites	I-chemical	1336	1347	abstract	31955786
including	O	1348	1357	abstract	31955786
neuroactive	B-chemical	1358	1369	abstract	31955786
compounds	I-chemical	1370	1379	abstract	31955786
in	O	1380	1382	abstract	31955786
the	O	1383	1386	abstract	31955786
gut	B-anatomical%location	1387	1390	abstract	31955786
are	O	1391	1394	abstract	31955786
discussed	O	1395	1404	abstract	31955786
throughout	O	1405	1415	abstract	31955786
this	O	1416	1420	abstract	31955786
review	O	1421	1427	abstract	31955786
.	O	1427	1428	abstract	31955786

Furthermore	O	1429	1440	abstract	31955786
,	O	1440	1441	abstract	31955786
the	O	1442	1445	abstract	31955786
importance	O	1446	1456	abstract	31955786
of	O	1457	1459	abstract	31955786
gut-brain	O	1460	1469	abstract	31955786
axis	O	1470	1474	abstract	31955786
,	O	1474	1475	abstract	31955786
probiotics	B-dietary%supplement	1476	1486	abstract	31955786
and	O	1487	1490	abstract	31955786
prebiotics	B-dietary%supplement	1491	1501	abstract	31955786
are	O	1502	1505	abstract	31955786
discussed	O	1506	1515	abstract	31955786
.	O	1515	1516	abstract	31955786

Maternal	O	0	8	title	34098340
prenatal	O	9	17	title	34098340
gut	O	18	21	title	34098340
microbiota	O	22	32	title	34098340
composition	O	33	44	title	34098340
predicts	O	45	53	title	34098340
child	O	54	59	title	34098340
behaviour	O	60	69	title	34098340
.	O	69	70	title	34098340

Murine	O	0	6	abstract	34098340
studies	O	7	14	abstract	34098340
demonstrate	O	15	26	abstract	34098340
that	O	27	31	abstract	34098340
maternal	B-microbiome	32	40	abstract	34098340
prenatal	I-microbiome	41	49	abstract	34098340
gut	I-microbiome	50	53	abstract	34098340
microbiota	I-microbiome	54	64	abstract	34098340
influences	O	65	75	abstract	34098340
brain	O	76	81	abstract	34098340
development	O	82	93	abstract	34098340
and	O	94	97	abstract	34098340
behaviour	O	98	107	abstract	34098340
of	O	108	110	abstract	34098340
offspring	B-animal	111	120	abstract	34098340
.	O	120	121	abstract	34098340

No	O	122	124	abstract	34098340
human	O	125	130	abstract	34098340
study	O	131	136	abstract	34098340
has	O	137	140	abstract	34098340
related	O	141	148	abstract	34098340
maternal	B-microbiome	149	157	abstract	34098340
gut	I-microbiome	158	161	abstract	34098340
microbiota	I-microbiome	162	172	abstract	34098340
to	O	173	175	abstract	34098340
behavioural	O	176	187	abstract	34098340
outcomes	O	188	196	abstract	34098340
during	O	197	203	abstract	34098340
early	O	204	209	abstract	34098340
life	O	210	214	abstract	34098340
.	O	214	215	abstract	34098340

This	O	216	220	abstract	34098340
study	O	221	226	abstract	34098340
aimed	O	227	232	abstract	34098340
to	O	233	235	abstract	34098340
evaluate	O	236	244	abstract	34098340
relationships	O	245	258	abstract	34098340
between	O	259	266	abstract	34098340
the	O	267	270	abstract	34098340
prenatal	B-microbiome	271	279	abstract	34098340
faecal	I-microbiome	280	286	abstract	34098340
microbiota	I-microbiome	287	297	abstract	34098340
,	O	297	298	abstract	34098340
prenatal	O	299	307	abstract	34098340
diet	O	308	312	abstract	34098340
and	O	313	316	abstract	34098340
childhood	O	317	326	abstract	34098340
behaviour	O	327	336	abstract	34098340
.	O	336	337	abstract	34098340

A	O	338	339	abstract	34098340
sub-cohort	O	340	350	abstract	34098340
of	O	351	353	abstract	34098340
213	O	354	357	abstract	34098340
mothers	B-animal	358	365	abstract	34098340
and	O	366	369	abstract	34098340
215	O	370	373	abstract	34098340
children	B-animal	374	382	abstract	34098340
were	O	383	387	abstract	34098340
selected	O	388	396	abstract	34098340
from	O	397	401	abstract	34098340
a	O	402	403	abstract	34098340
longitudinal	O	404	416	abstract	34098340
pre-birth	O	417	426	abstract	34098340
cohort	O	427	433	abstract	34098340
.	O	433	434	abstract	34098340

Maternal	O	435	443	abstract	34098340
prenatal	O	444	452	abstract	34098340
exposure	O	453	461	abstract	34098340
measures	O	462	470	abstract	34098340
collected	O	471	480	abstract	34098340
during	O	481	487	abstract	34098340
the	O	488	491	abstract	34098340
third	O	492	497	abstract	34098340
trimester	O	498	507	abstract	34098340
included	O	508	516	abstract	34098340
the	O	517	520	abstract	34098340
faecal	B-microbiome	521	527	abstract	34098340
microbiota	I-microbiome	528	538	abstract	34098340
(	O	539	540	abstract	34098340
generated	O	540	549	abstract	34098340
using	O	550	555	abstract	34098340
16S	B-biomedical%technique	556	559	abstract	34098340
rRNA	I-biomedical%technique	560	564	abstract	34098340
amplicon	I-biomedical%technique	565	573	abstract	34098340
sequencing	I-biomedical%technique	574	584	abstract	34098340
)	O	584	585	abstract	34098340
,	O	585	586	abstract	34098340
and	O	587	590	abstract	34098340
dietary	O	591	598	abstract	34098340
intake	O	599	605	abstract	34098340
.	O	605	606	abstract	34098340

The	O	607	610	abstract	34098340
behavioural	O	611	622	abstract	34098340
outcome	O	623	630	abstract	34098340
used	O	631	635	abstract	34098340
the	O	636	639	abstract	34098340
Childhood	B-biomedical%technique	640	649	abstract	34098340
Behaviour	I-biomedical%technique	650	659	abstract	34098340
Checklist	I-biomedical%technique	660	669	abstract	34098340
at	O	670	672	abstract	34098340
age	O	673	676	abstract	34098340
two	O	677	680	abstract	34098340
.	O	680	681	abstract	34098340

Models	O	682	688	abstract	34098340
were	O	689	693	abstract	34098340
adjusted	O	694	702	abstract	34098340
for	O	703	706	abstract	34098340
prenatal	O	707	715	abstract	34098340
diet	O	716	720	abstract	34098340
,	O	720	721	abstract	34098340
smoking	O	722	729	abstract	34098340
,	O	729	730	abstract	34098340
perceived	O	731	740	abstract	34098340
stress	O	741	747	abstract	34098340
,	O	747	748	abstract	34098340
maternal	O	749	757	abstract	34098340
age	O	758	761	abstract	34098340
and	O	762	765	abstract	34098340
sample	O	766	772	abstract	34098340
batch	O	773	778	abstract	34098340
.	O	778	779	abstract	34098340

We	O	780	782	abstract	34098340
found	O	783	788	abstract	34098340
evidence	O	789	797	abstract	34098340
that	O	798	802	abstract	34098340
the	O	803	806	abstract	34098340
alpha	O	807	812	abstract	34098340
diversity	O	813	822	abstract	34098340
of	O	823	825	abstract	34098340
the	O	826	829	abstract	34098340
maternal	B-microbiome	830	838	abstract	34098340
faecal	I-microbiome	839	845	abstract	34098340
microbiota	I-microbiome	846	856	abstract	34098340
during	O	857	863	abstract	34098340
the	O	864	867	abstract	34098340
third	O	868	873	abstract	34098340
trimester	O	874	883	abstract	34098340
of	O	884	886	abstract	34098340
pregnancy	O	887	896	abstract	34098340
predicts	O	897	905	abstract	34098340
child	O	906	911	abstract	34098340
internalising	O	912	925	abstract	34098340
behaviour	O	926	935	abstract	34098340
at	O	936	938	abstract	34098340
two	O	939	942	abstract	34098340
years	O	943	948	abstract	34098340
of	O	949	951	abstract	34098340
age	O	952	955	abstract	34098340
(	O	956	957	abstract	34098340
-274	O	957	962	abstract	34098340
,	O	962	963	abstract	34098340
(	O	964	965	abstract	34098340
-471	O	965	970	abstract	34098340
,	O	970	971	abstract	34098340
-078	O	972	977	abstract	34098340
)	O	977	978	abstract	34098340
,	O	978	979	abstract	34098340
p	O	980	981	abstract	34098340
	O	981	982	abstract	34098340
=	O	982	983	abstract	34098340
	O	983	984	abstract	34098340
001	O	984	988	abstract	34098340
(	O	989	990	abstract	34098340
Wald	B-statistical%technique	990	994	abstract	34098340
test	I-statistical%technique	995	999	abstract	34098340
)	O	999	1000	abstract	34098340
,	O	1000	1001	abstract	34098340
R	O	1002	1003	abstract	34098340
<	O	1003	1004	abstract	34098340
sup>2</sup>=007	O	1004	1020	abstract	34098340
)	O	1020	1021	abstract	34098340
.	O	1021	1022	abstract	34098340

Taxa	O	1023	1027	abstract	34098340
from	O	1028	1032	abstract	34098340
butyrate-producing	O	1033	1051	abstract	34098340
families	O	1052	1060	abstract	34098340
,	O	1060	1061	abstract	34098340
Lachnospiraceae	B-bacteria	1062	1077	abstract	34098340
and	O	1078	1081	abstract	34098340
Ruminococcaceae	B-bacteria	1082	1097	abstract	34098340
,	O	1097	1098	abstract	34098340
were	O	1099	1103	abstract	34098340
more	O	1104	1108	abstract	34098340
abundant	O	1109	1117	abstract	34098340
in	O	1118	1120	abstract	34098340
mothers	B-animal	1121	1128	abstract	34098340
of	O	1129	1131	abstract	34098340
children	B-animal	1132	1140	abstract	34098340
with	O	1141	1145	abstract	34098340
normative	O	1146	1155	abstract	34098340
behaviour	O	1156	1165	abstract	34098340
.	O	1165	1166	abstract	34098340

A	O	1167	1168	abstract	34098340
healthy	O	1169	1176	abstract	34098340
prenatal	O	1177	1185	abstract	34098340
diet	O	1186	1190	abstract	34098340
indirectly	O	1191	1201	abstract	34098340
related	O	1202	1209	abstract	34098340
to	O	1210	1212	abstract	34098340
decreased	O	1213	1222	abstract	34098340
child	O	1223	1228	abstract	34098340
internalising	O	1229	1242	abstract	34098340
behaviours	O	1243	1253	abstract	34098340
via	O	1254	1257	abstract	34098340
higher	O	1258	1264	abstract	34098340
alpha	O	1265	1270	abstract	34098340
diversity	O	1271	1280	abstract	34098340
of	O	1281	1283	abstract	34098340
maternal	B-microbiome	1284	1292	abstract	34098340
faecal	I-microbiome	1293	1299	abstract	34098340
microbiota	I-microbiome	1300	1310	abstract	34098340
.	O	1310	1311	abstract	34098340

These	O	1312	1317	abstract	34098340
findings	O	1318	1326	abstract	34098340
support	O	1327	1334	abstract	34098340
animal	O	1335	1341	abstract	34098340
studies	O	1342	1349	abstract	34098340
showing	O	1350	1357	abstract	34098340
that	O	1358	1362	abstract	34098340
the	O	1363	1366	abstract	34098340
composition	O	1367	1378	abstract	34098340
of	O	1379	1381	abstract	34098340
maternal	B-microbiome	1382	1390	abstract	34098340
prenatal	I-microbiome	1391	1399	abstract	34098340
gut	I-microbiome	1400	1403	abstract	34098340
microbiota	I-microbiome	1404	1414	abstract	34098340
is	O	1415	1417	abstract	34098340
related	O	1418	1425	abstract	34098340
to	O	1426	1428	abstract	34098340
offspring	O	1429	1438	abstract	34098340
brain	O	1439	1444	abstract	34098340
development	O	1445	1456	abstract	34098340
and	O	1457	1460	abstract	34098340
behaviour	O	1461	1470	abstract	34098340
.	O	1470	1471	abstract	34098340

Our	O	1472	1475	abstract	34098340
findings	O	1476	1484	abstract	34098340
highlight	O	1485	1494	abstract	34098340
the	O	1495	1498	abstract	34098340
need	O	1499	1503	abstract	34098340
to	O	1504	1506	abstract	34098340
evaluate	O	1507	1515	abstract	34098340
potential	O	1516	1525	abstract	34098340
impacts	O	1526	1533	abstract	34098340
of	O	1534	1536	abstract	34098340
the	O	1537	1540	abstract	34098340
prenatal	B-microbiome	1541	1549	abstract	34098340
gut	I-microbiome	1550	1553	abstract	34098340
microbiota	I-microbiome	1554	1564	abstract	34098340
on	O	1565	1567	abstract	34098340
early	O	1568	1573	abstract	34098340
life	O	1574	1578	abstract	34098340
brain	O	1579	1584	abstract	34098340
development	O	1585	1596	abstract	34098340
.	O	1596	1597	abstract	34098340

This	O	1598	1602	abstract	34098340
study	O	1603	1608	abstract	34098340
was	O	1609	1612	abstract	34098340
funded	O	1613	1619	abstract	34098340
by	O	1620	1622	abstract	34098340
the	O	1623	1626	abstract	34098340
National	O	1627	1635	abstract	34098340
Health	O	1636	1642	abstract	34098340
and	O	1643	1646	abstract	34098340
Medical	O	1647	1654	abstract	34098340
Research	O	1655	1663	abstract	34098340
Council	O	1664	1671	abstract	34098340
of	O	1672	1674	abstract	34098340
Australia	O	1675	1684	abstract	34098340
(	O	1685	1686	abstract	34098340
1082307	O	1686	1693	abstract	34098340
,	O	1693	1694	abstract	34098340
1147980	O	1695	1702	abstract	34098340
)	O	1702	1703	abstract	34098340
,	O	1703	1704	abstract	34098340
Murdoch	O	1705	1712	abstract	34098340
Children	O	1713	1721	abstract	34098340
's	O	1721	1723	abstract	34098340
Research	O	1724	1732	abstract	34098340
Institute	O	1733	1742	abstract	34098340
,	O	1742	1743	abstract	34098340
Barwon	O	1744	1750	abstract	34098340
Health	O	1751	1757	abstract	34098340
and	O	1758	1761	abstract	34098340
Deakin	O	1762	1768	abstract	34098340
University	O	1769	1779	abstract	34098340
.	O	1779	1780	abstract	34098340

Gut	O	0	3	title	38350463
production	O	4	14	title	38350463
of	O	15	17	title	38350463
GABA	B-chemical	18	22	title	38350463
by	O	23	25	title	38350463
a	O	26	27	title	38350463
probiotic	B-dietary%supplement	28	37	title	38350463
formula	I-dietary%supplement	38	45	title	38350463
:	O	45	46	title	38350463
an	O	47	49	title	38350463
in	O	50	52	title	38350463
vitro	O	53	58	title	38350463
study	O	59	64	title	38350463
.	O	64	65	title	38350463

The	O	0	3	abstract	38350463
objective	O	4	13	abstract	38350463
of	O	14	16	abstract	38350463
this	O	17	21	abstract	38350463
study	O	22	27	abstract	38350463
was	O	28	31	abstract	38350463
to	O	32	34	abstract	38350463
evaluate	O	35	43	abstract	38350463
the	O	44	47	abstract	38350463
influence	O	48	57	abstract	38350463
of	O	58	60	abstract	38350463
a	O	61	62	abstract	38350463
probiotic	B-dietary%supplement	63	72	abstract	38350463
formula	I-dietary%supplement	73	80	abstract	38350463
on	O	81	83	abstract	38350463
the	O	84	87	abstract	38350463
production	O	88	98	abstract	38350463
of	O	99	101	abstract	38350463
neuroactive	B-chemical	102	113	abstract	38350463
compounds	I-chemical	114	123	abstract	38350463
in	O	124	126	abstract	38350463
different	O	127	136	abstract	38350463
parts	O	137	142	abstract	38350463
of	O	143	145	abstract	38350463
the	O	146	149	abstract	38350463
colon	B-anatomical%location	150	155	abstract	38350463
in	O	156	158	abstract	38350463
batch	O	159	164	abstract	38350463
culture	O	165	172	abstract	38350463
and	O	173	176	abstract	38350463
in	O	177	179	abstract	38350463
vitro	O	180	185	abstract	38350463
gut	O	186	189	abstract	38350463
simulator	O	190	199	abstract	38350463
experiments	O	200	211	abstract	38350463
.	O	211	212	abstract	38350463

Thirteen	O	213	221	abstract	38350463
lactic	O	222	228	abstract	38350463
acid	O	229	233	abstract	38350463
bacterial	O	234	243	abstract	38350463
strains	O	244	251	abstract	38350463
,	O	251	252	abstract	38350463
belonging	O	253	262	abstract	38350463
to	O	263	265	abstract	38350463
the	O	266	269	abstract	38350463
species	O	270	277	abstract	38350463
Levilactobacillus	B-bacteria	278	295	abstract	38350463
brevis	I-bacteria	296	302	abstract	38350463
,	O	302	303	abstract	38350463
Lactiplantibacillus	B-bacteria	304	323	abstract	38350463
plantarum	I-bacteria	324	333	abstract	38350463
,	O	333	334	abstract	38350463
Lacticaseibacillus	B-bacteria	335	353	abstract	38350463
paracasei	I-bacteria	354	363	abstract	38350463
,	O	363	364	abstract	38350463
Ligilactobacillus	B-bacteria	365	382	abstract	38350463
salivarius	I-bacteria	383	393	abstract	38350463
,	O	393	394	abstract	38350463
Streptococcus	B-bacteria	395	408	abstract	38350463
thermophilus	I-bacteria	409	421	abstract	38350463
,	O	421	422	abstract	38350463
were	O	423	427	abstract	38350463
characterised	O	428	441	abstract	38350463
for	O	442	445	abstract	38350463
their	O	446	451	abstract	38350463
in	O	452	454	abstract	38350463
vitro	O	455	460	abstract	38350463
ability	O	461	468	abstract	38350463
to	O	469	471	abstract	38350463
produce	O	472	479	abstract	38350463
neurotransmitters	O	480	497	abstract	38350463
.	O	497	498	abstract	38350463

L.	B-bacteria	499	501	abstract	38350463
brevis	I-bacteria	502	508	abstract	38350463
P30021	I-bacteria	509	515	abstract	38350463
and	O	516	519	abstract	38350463
L.	B-bacteria	520	522	abstract	38350463
plantarum	I-bacteria	523	532	abstract	38350463
P30025	I-bacteria	533	539	abstract	38350463
were	O	540	544	abstract	38350463
selected	O	545	553	abstract	38350463
based	O	554	559	abstract	38350463
on	O	560	562	abstract	38350463
their	O	563	568	abstract	38350463
capability	O	569	579	abstract	38350463
to	O	580	582	abstract	38350463
produce	O	583	590	abstract	38350463
-aminobutyric	B-chemical	591	605	abstract	38350463
acid	I-chemical	606	610	abstract	38350463
(	O	611	612	abstract	38350463
GABA	B-chemical	612	616	abstract	38350463
)	O	616	617	abstract	38350463
and	O	618	621	abstract	38350463
acetylcholine	B-chemical	622	635	abstract	38350463
in	O	636	638	abstract	38350463
vitro	O	639	644	abstract	38350463
.	O	644	645	abstract	38350463

A	O	646	647	abstract	38350463
probiotic	B-dietary%supplement	648	657	abstract	38350463
formulation	I-dietary%supplement	658	669	abstract	38350463
with	O	670	674	abstract	38350463
potential	O	675	684	abstract	38350463
psychobiotic	O	685	697	abstract	38350463
activity	O	698	706	abstract	38350463
was	O	707	710	abstract	38350463
prepared	O	711	719	abstract	38350463
and	O	720	723	abstract	38350463
tested	O	724	730	abstract	38350463
in	O	731	733	abstract	38350463
a	O	734	735	abstract	38350463
batch	O	736	741	abstract	38350463
culture	O	742	749	abstract	38350463
of	O	750	752	abstract	38350463
human	B-microbiome	753	758	abstract	38350463
microbiota	I-microbiome	759	769	abstract	38350463
monitoring	O	770	780	abstract	38350463
the	O	781	784	abstract	38350463
formation	O	785	794	abstract	38350463
of	O	795	797	abstract	38350463
GABA	B-chemical	798	802	abstract	38350463
and	O	803	806	abstract	38350463
acetylcholine	B-chemical	807	820	abstract	38350463
.	O	820	821	abstract	38350463

Samples	O	822	829	abstract	38350463
of	O	830	832	abstract	38350463
the	O	833	836	abstract	38350463
three	O	837	842	abstract	38350463
colonic	B-anatomical%location	843	850	abstract	38350463
tracts	I-anatomical%location	851	857	abstract	38350463
were	O	858	862	abstract	38350463
taken	O	863	868	abstract	38350463
from	O	869	873	abstract	38350463
the	O	874	877	abstract	38350463
Simulator	O	878	887	abstract	38350463
of	O	888	890	abstract	38350463
the	O	891	894	abstract	38350463
Human	O	895	900	abstract	38350463
Intestinal	O	901	911	abstract	38350463
Microbiota	O	912	922	abstract	38350463
(	O	923	924	abstract	38350463
SHIME	O	924	929	abstract	38350463
	O	929	930	abstract	38350463
)	O	930	931	abstract	38350463
evaluating	O	932	942	abstract	38350463
the	O	943	946	abstract	38350463
production	O	947	957	abstract	38350463
of	O	958	960	abstract	38350463
GABA	B-chemical	961	965	abstract	38350463
and	O	966	969	abstract	38350463
other	O	970	975	abstract	38350463
neurotransmitters	O	976	993	abstract	38350463
by	O	994	996	abstract	38350463
LC-MS	B-biomedical%technique	997	1002	abstract	38350463
.	O	1002	1003	abstract	38350463

Short	B-chemical	1004	1009	abstract	38350463
chain	I-chemical	1010	1015	abstract	38350463
fatty	I-chemical	1016	1021	abstract	38350463
acids	I-chemical	1022	1027	abstract	38350463
(	O	1028	1029	abstract	38350463
SCFA	B-chemical	1029	1033	abstract	38350463
)	O	1033	1034	abstract	38350463
by	O	1035	1037	abstract	38350463
GC	B-biomedical%technique	1038	1040	abstract	38350463
and	O	1041	1044	abstract	38350463
microbiota	O	1045	1055	abstract	38350463
composition	O	1056	1067	abstract	38350463
by	O	1068	1070	abstract	38350463
16S	B-biomedical%technique	1071	1074	abstract	38350463
rRNA	I-biomedical%technique	1075	1079	abstract	38350463
gene	I-biomedical%technique	1080	1084	abstract	38350463
sequencing	I-biomedical%technique	1085	1095	abstract	38350463
were	O	1096	1100	abstract	38350463
also	O	1101	1105	abstract	38350463
determined	O	1106	1116	abstract	38350463
.	O	1116	1117	abstract	38350463

Probiotic	B-dietary%supplement	1118	1127	abstract	38350463
supplementation	I-dietary%supplement	1128	1143	abstract	38350463
led	O	1144	1147	abstract	38350463
to	O	1148	1150	abstract	38350463
the	O	1151	1154	abstract	38350463
formation	O	1155	1164	abstract	38350463
of	O	1165	1167	abstract	38350463
GABA	B-chemical	1168	1172	abstract	38350463
and	O	1173	1176	abstract	38350463
acetylcholine	B-chemical	1177	1190	abstract	38350463
with	O	1191	1195	abstract	38350463
a	O	1196	1197	abstract	38350463
decrease	O	1198	1206	abstract	38350463
in	O	1207	1209	abstract	38350463
glutamate	B-chemical	1210	1219	abstract	38350463
concentrations	O	1220	1234	abstract	38350463
in	O	1235	1237	abstract	38350463
the	O	1238	1241	abstract	38350463
in	O	1242	1244	abstract	38350463
vitro	O	1245	1250	abstract	38350463
batch	O	1251	1256	abstract	38350463
fermentation	O	1257	1269	abstract	38350463
.	O	1269	1270	abstract	38350463

Production	O	1271	1281	abstract	38350463
of	O	1282	1284	abstract	38350463
GABA	B-chemical	1285	1289	abstract	38350463
after	O	1290	1295	abstract	38350463
the	O	1296	1299	abstract	38350463
treatment	O	1300	1309	abstract	38350463
with	O	1310	1314	abstract	38350463
probiotics	B-dietary%supplement	1315	1325	abstract	38350463
was	O	1326	1329	abstract	38350463
confirmed	O	1330	1339	abstract	38350463
in	O	1340	1342	abstract	38350463
the	O	1343	1346	abstract	38350463
SHIME	O	1347	1352	abstract	38350463
	O	1352	1353	abstract	38350463
short-term	O	1354	1364	abstract	38350463
experiment	O	1365	1375	abstract	38350463
.	O	1375	1376	abstract	38350463

No	O	1377	1379	abstract	38350463
differences	O	1380	1391	abstract	38350463
in	O	1392	1394	abstract	38350463
short-chain	B-chemical	1395	1406	abstract	38350463
fatty	I-chemical	1407	1412	abstract	38350463
acids	I-chemical	1413	1418	abstract	38350463
were	O	1419	1423	abstract	38350463
observed	O	1424	1432	abstract	38350463
up	O	1433	1435	abstract	38350463
to	O	1436	1438	abstract	38350463
72	O	1439	1441	abstract	38350463
	O	1441	1442	abstract	38350463
h	O	1442	1443	abstract	38350463
of	O	1444	1446	abstract	38350463
fermentation	O	1447	1459	abstract	38350463
.	O	1459	1460	abstract	38350463

Different	O	1461	1470	abstract	38350463
microbiota	O	1471	1481	abstract	38350463
composition	O	1482	1493	abstract	38350463
was	O	1494	1497	abstract	38350463
found	O	1498	1503	abstract	38350463
in	O	1504	1506	abstract	38350463
the	O	1507	1510	abstract	38350463
three	O	1511	1516	abstract	38350463
different	O	1517	1526	abstract	38350463
parts	O	1527	1532	abstract	38350463
of	O	1533	1535	abstract	38350463
the	O	1536	1539	abstract	38350463
colon	B-anatomical%location	1540	1545	abstract	38350463
,	O	1545	1546	abstract	38350463
with	O	1547	1551	abstract	38350463
a	O	1552	1553	abstract	38350463
higher	O	1554	1560	abstract	38350463
abundance	O	1561	1570	abstract	38350463
of	O	1571	1573	abstract	38350463
Veillonellaceae	B-bacteria	1574	1589	abstract	38350463
in	O	1590	1592	abstract	38350463
the	O	1593	1596	abstract	38350463
ascending	B-anatomical%location	1597	1606	abstract	38350463
colon	I-anatomical%location	1607	1612	abstract	38350463
vessels	I-anatomical%location	1613	1620	abstract	38350463
.	O	1620	1621	abstract	38350463

The	O	1622	1625	abstract	38350463
probiotic-exposed	B-microbiome	1626	1643	abstract	38350463
microbiota	I-microbiome	1644	1654	abstract	38350463
showed	O	1655	1661	abstract	38350463
higher	O	1662	1668	abstract	38350463
levels	O	1669	1675	abstract	38350463
of	O	1676	1678	abstract	38350463
Bacteroides	B-bacteria	1679	1690	abstract	38350463
,	O	1690	1691	abstract	38350463
a	O	1692	1693	abstract	38350463
gut	B-microbiome	1694	1697	abstract	38350463
microbe	I-microbiome	1698	1705	abstract	38350463
associated	O	1706	1716	abstract	38350463
with	O	1717	1721	abstract	38350463
anti-inflammatory	O	1722	1739	abstract	38350463
activities	O	1740	1750	abstract	38350463
and	O	1751	1754	abstract	38350463
a	O	1755	1756	abstract	38350463
potential	O	1757	1766	abstract	38350463
GABA	B-chemical	1767	1771	abstract	38350463
producer	O	1772	1780	abstract	38350463
.	O	1780	1781	abstract	38350463

Results	O	1782	1789	abstract	38350463
demonstrate	O	1790	1801	abstract	38350463
the	O	1802	1805	abstract	38350463
impact	O	1806	1812	abstract	38350463
of	O	1813	1815	abstract	38350463
the	O	1816	1819	abstract	38350463
tested	O	1820	1826	abstract	38350463
probiotic	B-dietary%supplement	1827	1836	abstract	38350463
formula	I-dietary%supplement	1837	1844	abstract	38350463
on	O	1845	1847	abstract	38350463
gut	O	1848	1851	abstract	38350463
microbiota	O	1852	1862	abstract	38350463
structure	O	1863	1872	abstract	38350463
and	O	1873	1876	abstract	38350463
GABA	B-chemical	1877	1881	abstract	38350463
production	O	1882	1892	abstract	38350463
.	O	1892	1893	abstract	38350463

In	O	1894	1896	abstract	38350463
conclusion	O	1897	1907	abstract	38350463
,	O	1907	1908	abstract	38350463
the	O	1909	1912	abstract	38350463
probiotic	B-dietary%supplement	1913	1922	abstract	38350463
treatment	I-dietary%supplement	1923	1932	abstract	38350463
changed	O	1933	1940	abstract	38350463
the	O	1941	1944	abstract	38350463
microbiota	O	1945	1955	abstract	38350463
composition	O	1956	1967	abstract	38350463
and	O	1968	1971	abstract	38350463
increased	O	1972	1981	abstract	38350463
neuroactive	O	1982	1993	abstract	38350463
metabolites	O	1994	2005	abstract	38350463
production	O	2006	2016	abstract	38350463
,	O	2016	2017	abstract	38350463
indicating	O	2018	2028	abstract	38350463
promising	O	2029	2038	abstract	38350463
potential	O	2039	2048	abstract	38350463
as	O	2049	2051	abstract	38350463
psychobiotics	O	2052	2065	abstract	38350463
,	O	2065	2066	abstract	38350463
even	O	2067	2071	abstract	38350463
if	O	2072	2074	abstract	38350463
further	O	2075	2082	abstract	38350463
clinical	O	2083	2091	abstract	38350463
evidence	O	2092	2100	abstract	38350463
is	O	2101	2103	abstract	38350463
needed	O	2104	2110	abstract	38350463
to	O	2111	2113	abstract	38350463
confirm	O	2114	2121	abstract	38350463
the	O	2122	2125	abstract	38350463
effectiveness	O	2126	2139	abstract	38350463
of	O	2140	2142	abstract	38350463
these	O	2143	2148	abstract	38350463
probiotics	O	2149	2159	abstract	38350463
in	O	2160	2162	abstract	38350463
improving	O	2163	2172	abstract	38350463
mental	O	2173	2179	abstract	38350463
health	O	2180	2186	abstract	38350463
.	O	2186	2187	abstract	38350463

Analysis	O	0	8	title	29352709
of	O	9	11	title	29352709
gut	O	12	15	title	29352709
microbiota	O	16	26	title	29352709
diversity	O	27	36	title	29352709
and	O	37	40	title	29352709
auxiliary	O	41	50	title	29352709
diagnosis	O	51	60	title	29352709
as	O	61	63	title	29352709
a	O	64	65	title	29352709
biomarker	O	66	75	title	29352709
in	O	76	78	title	29352709
patients	B-human	79	87	title	29352709
with	O	88	92	title	29352709
schizophrenia	B-DDF	93	106	title	29352709
:	O	106	107	title	29352709
A	O	108	109	title	29352709
cross-sectional	O	110	125	title	29352709
study	O	126	131	title	29352709
.	O	131	132	title	29352709

With	O	0	4	abstract	29352709
the	O	5	8	abstract	29352709
advent	O	9	15	abstract	29352709
of	O	16	18	abstract	29352709
sequencing	O	19	29	abstract	29352709
technology	O	30	40	abstract	29352709
,	O	40	41	abstract	29352709
characterization	O	42	58	abstract	29352709
of	O	59	61	abstract	29352709
schizophrenia	B-DDF	62	75	abstract	29352709
with	O	76	80	abstract	29352709
underlying	O	81	91	abstract	29352709
probing	O	92	99	abstract	29352709
of	O	100	102	abstract	29352709
gut	B-microbiome	103	106	abstract	29352709
microbiome	I-microbiome	107	117	abstract	29352709
can	O	118	121	abstract	29352709
provide	O	122	129	abstract	29352709
abundant	O	130	138	abstract	29352709
clues	O	139	144	abstract	29352709
for	O	145	148	abstract	29352709
diagnosis	O	149	158	abstract	29352709
and	O	159	162	abstract	29352709
prognosis	O	163	172	abstract	29352709
of	O	173	175	abstract	29352709
schizophrenia	B-DDF	176	189	abstract	29352709
.	O	189	190	abstract	29352709

In	O	191	193	abstract	29352709
this	O	194	198	abstract	29352709
study	O	199	204	abstract	29352709
,	O	204	205	abstract	29352709
we	O	206	208	abstract	29352709
first	O	209	214	abstract	29352709
compared	O	215	223	abstract	29352709
the	O	224	227	abstract	29352709
difference	O	228	238	abstract	29352709
of	O	239	241	abstract	29352709
gut	B-microbiome	242	245	abstract	29352709
microbiota	I-microbiome	246	256	abstract	29352709
between	O	257	264	abstract	29352709
schizophrenia	B-human	265	278	abstract	29352709
patients	I-human	279	287	abstract	29352709
and	O	288	291	abstract	29352709
healthy	B-human	292	299	abstract	29352709
controls	I-human	300	308	abstract	29352709
by	O	309	311	abstract	29352709
16S	B-biomedical%technique	312	315	abstract	29352709
rRNA	I-biomedical%technique	316	320	abstract	29352709
sequencing	I-biomedical%technique	321	331	abstract	29352709
.	O	331	332	abstract	29352709

We	O	333	335	abstract	29352709
further	O	336	343	abstract	29352709
explored	O	344	352	abstract	29352709
whether	O	353	360	abstract	29352709
gut	B-microbiome	361	364	abstract	29352709
microbiota	I-microbiome	365	375	abstract	29352709
can	O	376	379	abstract	29352709
be	O	380	382	abstract	29352709
used	O	383	387	abstract	29352709
as	O	388	390	abstract	29352709
a	O	391	392	abstract	29352709
biomarker	O	393	402	abstract	29352709
to	O	403	405	abstract	29352709
assist	O	406	412	abstract	29352709
in	O	413	415	abstract	29352709
the	O	416	419	abstract	29352709
diagnosis	O	420	429	abstract	29352709
of	O	430	432	abstract	29352709
schizophrenia	B-DDF	433	446	abstract	29352709
.	O	446	447	abstract	29352709

We	O	448	450	abstract	29352709
restricted	O	451	461	abstract	29352709
inclusion	O	462	471	abstract	29352709
criteria	O	472	480	abstract	29352709
strictly	O	481	489	abstract	29352709
to	O	490	492	abstract	29352709
control	O	493	500	abstract	29352709
confounding	O	501	512	abstract	29352709
bias	O	513	517	abstract	29352709
.	O	517	518	abstract	29352709

Finally	O	519	526	abstract	29352709
,	O	526	527	abstract	29352709
we	O	528	530	abstract	29352709
investigated	O	531	543	abstract	29352709
differences	O	544	555	abstract	29352709
in	O	556	558	abstract	29352709
fecal	B-microbiome	559	564	abstract	29352709
microbiota	I-microbiome	565	575	abstract	29352709
between	O	576	583	abstract	29352709
64	O	584	586	abstract	29352709
schizophrenia	B-human	587	600	abstract	29352709
patients	I-human	601	609	abstract	29352709
and	O	610	613	abstract	29352709
53	O	614	616	abstract	29352709
healthy	B-human	617	624	abstract	29352709
controls	I-human	625	633	abstract	29352709
.	O	633	634	abstract	29352709

At	O	635	637	abstract	29352709
the	O	638	641	abstract	29352709
phylum	O	642	648	abstract	29352709
level	O	649	654	abstract	29352709
,	O	654	655	abstract	29352709
we	O	656	658	abstract	29352709
found	O	659	664	abstract	29352709
that	O	665	669	abstract	29352709
the	O	670	673	abstract	29352709
abundance	O	674	683	abstract	29352709
of	O	684	686	abstract	29352709
Proteobacteria	B-bacteria	687	701	abstract	29352709
in	O	702	704	abstract	29352709
the	O	705	708	abstract	29352709
schizophrenia	B-human	709	722	abstract	29352709
patients	I-human	723	731	abstract	29352709
was	O	732	735	abstract	29352709
significantly	O	736	749	abstract	29352709
increased	O	750	759	abstract	29352709
.	O	759	760	abstract	29352709

At	O	761	763	abstract	29352709
the	O	764	767	abstract	29352709
genus	O	768	773	abstract	29352709
level	O	774	779	abstract	29352709
,	O	779	780	abstract	29352709
the	O	781	784	abstract	29352709
relative	O	785	793	abstract	29352709
abundance	O	794	803	abstract	29352709
of	O	804	806	abstract	29352709
Succinivibrio	B-bacteria	807	820	abstract	29352709
,	O	820	821	abstract	29352709
Megasphaera	B-bacteria	822	833	abstract	29352709
,	O	833	834	abstract	29352709
Collinsella	B-bacteria	835	846	abstract	29352709
,	O	846	847	abstract	29352709
Clostridium	B-bacteria	848	859	abstract	29352709
,	O	859	860	abstract	29352709
Klebsiella	B-bacteria	861	871	abstract	29352709
and	O	872	875	abstract	29352709
Methanobrevibacter	B-bacteria	876	894	abstract	29352709
was	O	895	898	abstract	29352709
significantly	O	899	912	abstract	29352709
higher	O	913	919	abstract	29352709
whereas	O	920	927	abstract	29352709
the	O	928	931	abstract	29352709
abundance	O	932	941	abstract	29352709
of	O	942	944	abstract	29352709
Blautia	B-bacteria	945	952	abstract	29352709
,	O	952	953	abstract	29352709
Coprococcus	B-bacteria	954	965	abstract	29352709
,	O	965	966	abstract	29352709
Roseburia	B-bacteria	967	976	abstract	29352709
was	O	977	980	abstract	29352709
decreased	O	981	990	abstract	29352709
compared	O	991	999	abstract	29352709
to	O	1000	1002	abstract	29352709
health	B-human	1003	1009	abstract	29352709
controls	I-human	1010	1018	abstract	29352709
.	O	1018	1019	abstract	29352709

The	O	1020	1023	abstract	29352709
receiver	B-statistical%technique	1024	1032	abstract	29352709
operating	I-statistical%technique	1033	1042	abstract	29352709
characteristic	I-statistical%technique	1043	1057	abstract	29352709
curve	I-statistical%technique	1058	1063	abstract	29352709
analysis	I-statistical%technique	1064	1072	abstract	29352709
demonstrated	O	1073	1085	abstract	29352709
that	O	1086	1090	abstract	29352709
12	O	1091	1093	abstract	29352709
significant	O	1094	1105	abstract	29352709
microbiota	O	1106	1116	abstract	29352709
biomarkers	O	1117	1127	abstract	29352709
were	O	1128	1132	abstract	29352709
capable	O	1133	1140	abstract	29352709
of	O	1141	1143	abstract	29352709
being	O	1144	1149	abstract	29352709
used	O	1150	1154	abstract	29352709
as	O	1155	1157	abstract	29352709
diagnostic	O	1158	1168	abstract	29352709
factors	O	1169	1176	abstract	29352709
for	O	1177	1180	abstract	29352709
distinguishing	O	1181	1195	abstract	29352709
the	O	1196	1199	abstract	29352709
schizophrenia	B-human	1200	1213	abstract	29352709
cohort	I-human	1214	1220	abstract	29352709
from	O	1221	1225	abstract	29352709
those	O	1226	1231	abstract	29352709
in	O	1232	1234	abstract	29352709
the	O	1235	1238	abstract	29352709
control	B-human	1239	1246	abstract	29352709
cohort	I-human	1247	1253	abstract	29352709
(	O	1254	1255	abstract	29352709
AUC	O	1255	1258	abstract	29352709
	O	1258	1259	abstract	29352709
=	O	1259	1260	abstract	29352709
	O	1260	1261	abstract	29352709
0.837	O	1261	1266	abstract	29352709
)	O	1266	1267	abstract	29352709
.	O	1267	1268	abstract	29352709

We	O	1269	1271	abstract	29352709
performed	O	1272	1281	abstract	29352709
PICRUSt	B-biomedical%technique	1282	1289	abstract	29352709
analysis	I-biomedical%technique	1290	1298	abstract	29352709
and	O	1299	1302	abstract	29352709
found	O	1303	1308	abstract	29352709
that	O	1309	1313	abstract	29352709
several	O	1314	1321	abstract	29352709
metabolic	O	1322	1331	abstract	29352709
pathways	O	1332	1340	abstract	29352709
differed	O	1341	1349	abstract	29352709
significantly	O	1350	1363	abstract	29352709
between	O	1364	1371	abstract	29352709
healthy	B-human	1372	1379	abstract	29352709
controls	I-human	1380	1388	abstract	29352709
and	O	1389	1392	abstract	29352709
schizophrenia	B-human	1393	1406	abstract	29352709
patients	I-human	1407	1415	abstract	29352709
,	O	1415	1416	abstract	29352709
including	O	1417	1426	abstract	29352709
vitamin	B-chemical	1427	1434	abstract	29352709
B6	I-chemical	1435	1437	abstract	29352709
and	O	1438	1441	abstract	29352709
fatty	B-chemical	1442	1447	abstract	29352709
acid	I-chemical	1448	1452	abstract	29352709
.	O	1452	1453	abstract	29352709

In	O	1454	1456	abstract	29352709
conclusion	O	1457	1467	abstract	29352709
,	O	1467	1468	abstract	29352709
there	O	1469	1474	abstract	29352709
are	O	1475	1478	abstract	29352709
some	O	1479	1483	abstract	29352709
difference	O	1484	1494	abstract	29352709
of	O	1495	1497	abstract	29352709
gut	B-microbiome	1498	1501	abstract	29352709
microbiota	I-microbiome	1502	1512	abstract	29352709
between	O	1513	1520	abstract	29352709
schizophrenia	B-human	1521	1534	abstract	29352709
patients	I-human	1535	1543	abstract	29352709
and	O	1544	1547	abstract	29352709
healthy	B-human	1548	1555	abstract	29352709
controls	I-human	1556	1564	abstract	29352709
and	O	1565	1568	abstract	29352709
the	O	1569	1572	abstract	29352709
insights	O	1573	1581	abstract	29352709
from	O	1582	1586	abstract	29352709
this	O	1587	1591	abstract	29352709
study	O	1592	1597	abstract	29352709
could	O	1598	1603	abstract	29352709
be	O	1604	1606	abstract	29352709
used	O	1607	1611	abstract	29352709
to	O	1612	1614	abstract	29352709
develop	O	1615	1622	abstract	29352709
microbiota-based	O	1623	1639	abstract	29352709
diagnosis	O	1640	1649	abstract	29352709
for	O	1650	1653	abstract	29352709
schizophrenia	B-DDF	1654	1667	abstract	29352709
.	O	1667	1668	abstract	29352709

Probiotic	B-dietary%supplement	0	9	title	33511258
consumption	I-dietary%supplement	10	21	title	33511258
relieved	O	22	30	title	33511258
human	B-DDF	31	36	title	33511258
stress	I-DDF	37	43	title	33511258
and	O	44	47	title	33511258
anxiety	B-DDF	48	55	title	33511258
symptoms	I-DDF	56	64	title	33511258
possibly	O	65	73	title	33511258
via	O	74	77	title	33511258
modulating	O	78	88	title	33511258
the	O	89	92	title	33511258
neuroactive	O	93	104	title	33511258
potential	O	105	114	title	33511258
of	O	115	117	title	33511258
the	O	118	121	title	33511258
gut	B-microbiome	122	125	title	33511258
microbiota	I-microbiome	126	136	title	33511258
.	O	136	137	title	33511258

Stress	B-DDF	0	6	abstract	33511258
has	O	7	10	abstract	33511258
been	O	11	15	abstract	33511258
shown	O	16	21	abstract	33511258
to	O	22	24	abstract	33511258
disturb	O	25	32	abstract	33511258
the	O	33	36	abstract	33511258
balance	O	37	44	abstract	33511258
of	O	45	47	abstract	33511258
human	B-microbiome	48	53	abstract	33511258
intestinal	I-microbiome	54	64	abstract	33511258
microbiota	I-microbiome	65	75	abstract	33511258
and	O	76	79	abstract	33511258
subsequently	O	80	92	abstract	33511258
causes	O	93	99	abstract	33511258
mental	B-DDF	100	106	abstract	33511258
health	I-DDF	107	113	abstract	33511258
problems	I-DDF	114	122	abstract	33511258
like	O	123	127	abstract	33511258
anxiety	B-DDF	128	135	abstract	33511258
and	O	136	139	abstract	33511258
depression	B-DDF	140	150	abstract	33511258
.	O	150	151	abstract	33511258

Our	O	152	155	abstract	33511258
previous	O	156	164	abstract	33511258
study	O	165	170	abstract	33511258
showed	O	171	177	abstract	33511258
that	O	178	182	abstract	33511258
ingesting	O	183	192	abstract	33511258
the	O	193	196	abstract	33511258
probiotic	B-dietary%supplement	197	206	abstract	33511258
strain	I-dietary%supplement	207	213	abstract	33511258
,	O	213	214	abstract	33511258
<	O	215	216	abstract	33511258
i	O	216	217	abstract	33511258
>	O	217	218	abstract	33511258
Lactobacillus</i	B-bacteria	218	234	abstract	33511258
>	O	234	235	abstract	33511258
(	O	236	237	abstract	33511258
<	O	237	238	abstract	33511258
i	O	238	239	abstract	33511258
>	O	239	240	abstract	33511258
L</i>.	B-bacteria	240	246	abstract	33511258
)	O	246	247	abstract	33511258
<	B-bacteria	248	249	abstract	33511258
i	I-bacteria	249	250	abstract	33511258
>	I-bacteria	250	251	abstract	33511258
plantarum</i	I-bacteria	251	263	abstract	33511258
>	I-bacteria	263	264	abstract	33511258
P-8	I-bacteria	265	268	abstract	33511258
,	O	268	269	abstract	33511258
for	O	270	273	abstract	33511258
12	O	274	276	abstract	33511258
weeks	O	277	282	abstract	33511258
could	O	283	288	abstract	33511258
alleviate	O	289	298	abstract	33511258
stress	B-DDF	299	305	abstract	33511258
and	O	306	309	abstract	33511258
anxiety	B-DDF	310	317	abstract	33511258
of	O	318	320	abstract	33511258
stressed	B-human	321	329	abstract	33511258
adults	I-human	330	336	abstract	33511258
.	O	336	337	abstract	33511258

The	O	338	341	abstract	33511258
current	O	342	349	abstract	33511258
study	O	350	355	abstract	33511258
was	O	356	359	abstract	33511258
a	O	360	361	abstract	33511258
follow-up	O	362	371	abstract	33511258
work	O	372	376	abstract	33511258
aiming	O	377	383	abstract	33511258
to	O	384	386	abstract	33511258
investigate	O	387	398	abstract	33511258
the	O	399	402	abstract	33511258
functional	O	403	413	abstract	33511258
role	O	414	418	abstract	33511258
of	O	419	421	abstract	33511258
the	O	422	425	abstract	33511258
gut	B-microbiome	426	429	abstract	33511258
metagenomes	I-microbiome	430	441	abstract	33511258
in	O	442	444	abstract	33511258
the	O	445	448	abstract	33511258
observed	O	449	457	abstract	33511258
beneficial	O	458	468	abstract	33511258
effects	O	469	476	abstract	33511258
.	O	476	477	abstract	33511258

The	O	478	481	abstract	33511258
fecal	B-microbiome	482	487	abstract	33511258
metagenomes	I-microbiome	488	499	abstract	33511258
of	O	500	502	abstract	33511258
the	O	503	506	abstract	33511258
probiotic	O	507	516	abstract	33511258
(	O	517	518	abstract	33511258
n	O	518	519	abstract	33511258
	O	519	520	abstract	33511258
=	O	520	521	abstract	33511258
	O	521	522	abstract	33511258
43	O	522	524	abstract	33511258
)	O	524	525	abstract	33511258
and	O	526	529	abstract	33511258
placebo	O	530	537	abstract	33511258
(	O	538	539	abstract	33511258
n	O	539	540	abstract	33511258
	O	540	541	abstract	33511258
=	O	541	542	abstract	33511258
	O	542	543	abstract	33511258
36	O	543	545	abstract	33511258
)	O	545	546	abstract	33511258
receivers	O	547	556	abstract	33511258
were	O	557	561	abstract	33511258
analyzed	O	562	570	abstract	33511258
in	O	571	573	abstract	33511258
depth	O	574	579	abstract	33511258
.	O	579	580	abstract	33511258

The	O	581	584	abstract	33511258
gut	B-microbiome	585	588	abstract	33511258
microbiomes	I-microbiome	589	600	abstract	33511258
of	O	601	603	abstract	33511258
the	O	604	607	abstract	33511258
placebo	B-human	608	615	abstract	33511258
group	I-human	616	621	abstract	33511258
at	O	622	624	abstract	33511258
weeks	O	625	630	abstract	33511258
0	O	631	632	abstract	33511258
and	O	633	636	abstract	33511258
12	O	637	639	abstract	33511258
showed	O	640	646	abstract	33511258
a	O	647	648	abstract	33511258
significantly	O	649	662	abstract	33511258
greater	O	663	670	abstract	33511258
Aitchison	O	671	680	abstract	33511258
distance	O	681	689	abstract	33511258
(	O	690	691	abstract	33511258
<	O	691	692	abstract	33511258
i	O	692	693	abstract	33511258
>	O	693	694	abstract	33511258
P</i	O	694	698	abstract	33511258
>	O	698	699	abstract	33511258
	O	699	700	abstract	33511258
<	O	700	701	abstract	33511258
	O	701	702	abstract	33511258
0.001	O	702	707	abstract	33511258
)	O	707	708	abstract	33511258
compared	O	709	717	abstract	33511258
with	O	718	722	abstract	33511258
the	O	723	726	abstract	33511258
probiotic	B-human	727	736	abstract	33511258
group	I-human	737	742	abstract	33511258
.	O	742	743	abstract	33511258

Meanwhile	O	744	753	abstract	33511258
,	O	753	754	abstract	33511258
the	O	755	758	abstract	33511258
Shannon	O	759	766	abstract	33511258
diversity	O	767	776	abstract	33511258
index	O	777	782	abstract	33511258
of	O	783	785	abstract	33511258
the	O	786	789	abstract	33511258
placebo	B-human	790	797	abstract	33511258
group	I-human	798	803	abstract	33511258
(	O	804	805	abstract	33511258
<	O	805	806	abstract	33511258
i	O	806	807	abstract	33511258
>	O	807	808	abstract	33511258
P</i	O	808	812	abstract	33511258
>	O	812	813	abstract	33511258
	O	813	814	abstract	33511258
<	O	814	815	abstract	33511258
	O	815	816	abstract	33511258
0.05	O	816	820	abstract	33511258
)	O	820	821	abstract	33511258
but	O	822	825	abstract	33511258
not	O	826	829	abstract	33511258
the	O	830	833	abstract	33511258
probiotic	B-human	834	843	abstract	33511258
group	I-human	844	849	abstract	33511258
decreased	O	850	859	abstract	33511258
significantly	O	860	873	abstract	33511258
at	O	874	876	abstract	33511258
week	O	877	881	abstract	33511258
12	O	882	884	abstract	33511258
.	O	884	885	abstract	33511258

Additionally	O	886	898	abstract	33511258
,	O	898	899	abstract	33511258
significantly	O	900	913	abstract	33511258
more	O	914	918	abstract	33511258
species-level	O	919	932	abstract	33511258
genome	O	933	939	abstract	33511258
bins	O	940	944	abstract	33511258
(	O	945	946	abstract	33511258
SGBs	O	946	950	abstract	33511258
)	O	950	951	abstract	33511258
of	O	952	954	abstract	33511258
<	O	955	956	abstract	33511258
i	O	956	957	abstract	33511258
>	O	957	958	abstract	33511258
Bifidobacterium	B-bacteria	958	973	abstract	33511258
adolescentis</i	I-bacteria	974	989	abstract	33511258
>	O	989	990	abstract	33511258
,	O	990	991	abstract	33511258
<	O	992	993	abstract	33511258
i	O	993	994	abstract	33511258
>	O	994	995	abstract	33511258
Bifidobacterium	B-bacteria	995	1010	abstract	33511258
longum</i	I-bacteria	1011	1020	abstract	33511258
>	O	1020	1021	abstract	33511258
,	O	1021	1022	abstract	33511258
and	O	1023	1026	abstract	33511258
<	O	1027	1028	abstract	33511258
i	O	1028	1029	abstract	33511258
>	O	1029	1030	abstract	33511258
Fecalibacterium	B-bacteria	1030	1045	abstract	33511258
prausnitzii</i	I-bacteria	1046	1060	abstract	33511258
>	O	1060	1061	abstract	33511258
(	O	1062	1063	abstract	33511258
<	O	1063	1064	abstract	33511258
i	O	1064	1065	abstract	33511258
>	O	1065	1066	abstract	33511258
P</i	O	1066	1070	abstract	33511258
>	O	1070	1071	abstract	33511258
	O	1071	1072	abstract	33511258
<	O	1072	1073	abstract	33511258
	O	1073	1074	abstract	33511258
0.01	O	1074	1078	abstract	33511258
)	O	1078	1079	abstract	33511258
were	O	1080	1084	abstract	33511258
identified	O	1085	1095	abstract	33511258
in	O	1096	1098	abstract	33511258
the	O	1099	1102	abstract	33511258
fecal	B-microbiome	1103	1108	abstract	33511258
metagenomes	I-microbiome	1109	1120	abstract	33511258
of	O	1121	1123	abstract	33511258
the	O	1124	1127	abstract	33511258
probiotic	B-human	1128	1137	abstract	33511258
group	I-human	1138	1143	abstract	33511258
,	O	1143	1144	abstract	33511258
while	O	1145	1150	abstract	33511258
the	O	1151	1154	abstract	33511258
abundances	O	1155	1165	abstract	33511258
of	O	1166	1168	abstract	33511258
SGBs	O	1169	1173	abstract	33511258
representing	O	1174	1186	abstract	33511258
the	O	1187	1190	abstract	33511258
species	O	1191	1198	abstract	33511258
<	O	1199	1200	abstract	33511258
i	O	1200	1201	abstract	33511258
>	O	1201	1202	abstract	33511258
Roseburia	B-bacteria	1202	1211	abstract	33511258
faecis</i	I-bacteria	1212	1221	abstract	33511258
>	O	1221	1222	abstract	33511258
and	O	1223	1226	abstract	33511258
<	O	1227	1228	abstract	33511258
i	O	1228	1229	abstract	33511258
>	O	1229	1230	abstract	33511258
Fusicatenibacter	B-bacteria	1230	1246	abstract	33511258
saccharivorans</i	I-bacteria	1247	1264	abstract	33511258
>	O	1264	1265	abstract	33511258
decreased	O	1266	1275	abstract	33511258
significantly	O	1276	1289	abstract	33511258
(	O	1290	1291	abstract	33511258
<	O	1291	1292	abstract	33511258
i	O	1292	1293	abstract	33511258
>	O	1293	1294	abstract	33511258
P</i	O	1294	1298	abstract	33511258
>	O	1298	1299	abstract	33511258
	O	1299	1300	abstract	33511258
<	O	1300	1301	abstract	33511258
	O	1301	1302	abstract	33511258
0.05	O	1302	1306	abstract	33511258
)	O	1306	1307	abstract	33511258
.	O	1307	1308	abstract	33511258

Furthermore	O	1309	1320	abstract	33511258
,	O	1320	1321	abstract	33511258
the	O	1322	1325	abstract	33511258
12-week	O	1326	1333	abstract	33511258
probiotic	B-dietary%supplement	1334	1343	abstract	33511258
supplementation	I-dietary%supplement	1344	1359	abstract	33511258
enhanced	O	1360	1368	abstract	33511258
the	O	1369	1372	abstract	33511258
diversity	O	1373	1382	abstract	33511258
of	O	1383	1385	abstract	33511258
neurotransmitter-synthesizing/consuming	O	1386	1425	abstract	33511258
SGBs	O	1426	1430	abstract	33511258
and	O	1431	1434	abstract	33511258
the	O	1435	1438	abstract	33511258
levels	O	1439	1445	abstract	33511258
of	O	1446	1448	abstract	33511258
some	O	1449	1453	abstract	33511258
predicted	O	1454	1463	abstract	33511258
microbial	B-chemical	1464	1473	abstract	33511258
neuroactive	I-chemical	1474	1485	abstract	33511258
metabolites	I-chemical	1486	1497	abstract	33511258
(	O	1498	1499	abstract	33511258
e.g.	O	1499	1503	abstract	33511258
,	O	1503	1504	abstract	33511258
short-chain	B-chemical	1505	1516	abstract	33511258
fatty	I-chemical	1517	1522	abstract	33511258
acids	I-chemical	1523	1528	abstract	33511258
,	O	1528	1529	abstract	33511258
gamma-aminobutyric	B-chemical	1530	1548	abstract	33511258
acid	I-chemical	1549	1553	abstract	33511258
,	O	1553	1554	abstract	33511258
arachidonic	B-chemical	1555	1566	abstract	33511258
acid	I-chemical	1567	1571	abstract	33511258
,	O	1571	1572	abstract	33511258
and	O	1573	1576	abstract	33511258
sphingomyelin	B-chemical	1577	1590	abstract	33511258
)	O	1590	1591	abstract	33511258
.	O	1591	1592	abstract	33511258

Our	O	1593	1596	abstract	33511258
results	O	1597	1604	abstract	33511258
showed	O	1605	1611	abstract	33511258
a	O	1612	1613	abstract	33511258
potential	O	1614	1623	abstract	33511258
link	O	1624	1628	abstract	33511258
between	O	1629	1636	abstract	33511258
probiotic-induced	O	1637	1654	abstract	33511258
gut	O	1655	1658	abstract	33511258
microbiota	O	1659	1669	abstract	33511258
modulation	O	1670	1680	abstract	33511258
and	O	1681	1684	abstract	33511258
stress/anxiety	O	1685	1699	abstract	33511258
alleviation	O	1700	1711	abstract	33511258
in	O	1712	1714	abstract	33511258
stressed	B-human	1715	1723	abstract	33511258
adults	I-human	1724	1730	abstract	33511258
,	O	1730	1731	abstract	33511258
supporting	O	1732	1742	abstract	33511258
that	O	1743	1747	abstract	33511258
the	O	1748	1751	abstract	33511258
gut-brain	O	1752	1761	abstract	33511258
axis	O	1762	1766	abstract	33511258
was	O	1767	1770	abstract	33511258
involved	O	1771	1779	abstract	33511258
in	O	1780	1782	abstract	33511258
relieving	O	1783	1792	abstract	33511258
stress-related	B-DDF	1793	1807	abstract	33511258
symptoms	I-DDF	1808	1816	abstract	33511258
.	O	1816	1817	abstract	33511258

The	O	1818	1821	abstract	33511258
beneficial	O	1822	1832	abstract	33511258
effect	O	1833	1839	abstract	33511258
relied	O	1840	1846	abstract	33511258
not	O	1847	1850	abstract	33511258
only	O	1851	1855	abstract	33511258
on	O	1856	1858	abstract	33511258
microbial	O	1859	1868	abstract	33511258
diversity	O	1869	1878	abstract	33511258
changes	O	1879	1886	abstract	33511258
but	O	1887	1890	abstract	33511258
more	O	1891	1895	abstract	33511258
importantly	O	1896	1907	abstract	33511258
gut	O	1908	1911	abstract	33511258
metagenome	O	1912	1922	abstract	33511258
modulations	O	1923	1934	abstract	33511258
at	O	1935	1937	abstract	33511258
the	O	1938	1941	abstract	33511258
SGB	O	1942	1945	abstract	33511258
and	O	1946	1949	abstract	33511258
functional	O	1950	1960	abstract	33511258
gene	O	1961	1965	abstract	33511258
levels	O	1966	1972	abstract	33511258
.	O	1972	1973	abstract	33511258

The	O	0	3	title	33422110
impact	O	4	10	title	33422110
of	O	11	13	title	33422110
dextran	B-chemical	14	21	title	33422110
sodium	I-chemical	22	28	title	33422110
sulphate	I-chemical	29	37	title	33422110
and	O	38	41	title	33422110
probiotic	B-dietary%supplement	42	51	title	33422110
pre-treatment	I-dietary%supplement	52	65	title	33422110
in	O	66	68	title	33422110
a	O	69	70	title	33422110
murine	O	71	77	title	33422110
model	O	78	83	title	33422110
of	O	84	86	title	33422110
Parkinson	B-DDF	87	96	title	33422110
's	I-DDF	96	98	title	33422110
disease	I-DDF	99	106	title	33422110
.	O	106	107	title	33422110

Recent	O	0	6	abstract	33422110
work	O	7	11	abstract	33422110
has	O	12	15	abstract	33422110
established	O	16	27	abstract	33422110
that	O	28	32	abstract	33422110
Parkinson	B-human	33	42	abstract	33422110
's	I-human	42	44	abstract	33422110
disease	I-human	45	52	abstract	33422110
(	I-human	53	54	abstract	33422110
PD	I-human	54	56	abstract	33422110
)	I-human	56	57	abstract	33422110
patients	I-human	58	66	abstract	33422110
have	O	67	71	abstract	33422110
an	O	72	74	abstract	33422110
altered	B-DDF	75	82	abstract	33422110
gut	I-DDF	83	86	abstract	33422110
microbiome	I-DDF	87	97	abstract	33422110
,	O	97	98	abstract	33422110
along	O	99	104	abstract	33422110
with	O	105	109	abstract	33422110
signs	O	110	115	abstract	33422110
of	O	116	118	abstract	33422110
intestinal	B-DDF	119	129	abstract	33422110
inflammation	I-DDF	130	142	abstract	33422110
.	O	142	143	abstract	33422110

This	O	144	148	abstract	33422110
could	O	149	154	abstract	33422110
help	O	155	159	abstract	33422110
explain	O	160	167	abstract	33422110
the	O	168	171	abstract	33422110
high	O	172	176	abstract	33422110
degree	O	177	183	abstract	33422110
of	O	184	186	abstract	33422110
gastric	B-DDF	187	194	abstract	33422110
disturbances	I-DDF	195	207	abstract	33422110
in	O	208	210	abstract	33422110
PD	B-human	211	213	abstract	33422110
patients	I-human	214	222	abstract	33422110
,	O	222	223	abstract	33422110
as	O	224	226	abstract	33422110
well	O	227	231	abstract	33422110
as	O	232	234	abstract	33422110
potentially	O	235	246	abstract	33422110
be	O	247	249	abstract	33422110
linked	O	250	256	abstract	33422110
to	O	257	259	abstract	33422110
the	O	260	263	abstract	33422110
migration	O	264	273	abstract	33422110
of	O	274	276	abstract	33422110
peripheral	O	277	287	abstract	33422110
inflammatory	O	288	300	abstract	33422110
factors	O	301	308	abstract	33422110
into	O	309	313	abstract	33422110
the	O	314	317	abstract	33422110
brain	B-anatomical%location	318	323	abstract	33422110
.	O	323	324	abstract	33422110

To	O	325	327	abstract	33422110
our	O	328	331	abstract	33422110
knowledge	O	332	341	abstract	33422110
,	O	341	342	abstract	33422110
this	O	343	347	abstract	33422110
is	O	348	350	abstract	33422110
the	O	351	354	abstract	33422110
first	O	355	360	abstract	33422110
study	O	361	366	abstract	33422110
to	O	367	369	abstract	33422110
examine	O	370	377	abstract	33422110
microbiome	B-DDF	378	388	abstract	33422110
alteration	I-DDF	389	399	abstract	33422110
prior	O	400	405	abstract	33422110
to	O	406	408	abstract	33422110
the	O	409	412	abstract	33422110
induction	O	413	422	abstract	33422110
of	O	423	425	abstract	33422110
a	O	426	427	abstract	33422110
PD	O	428	430	abstract	33422110
murine	O	431	437	abstract	33422110
model	O	438	443	abstract	33422110
.	O	443	444	abstract	33422110

We	O	445	447	abstract	33422110
presently	O	448	457	abstract	33422110
assessed	O	458	466	abstract	33422110
whether	O	467	474	abstract	33422110
pre-treatment	O	475	488	abstract	33422110
with	O	489	493	abstract	33422110
the	O	494	497	abstract	33422110
probiotic	B-dietary%supplement	498	507	abstract	33422110
,	O	507	508	abstract	33422110
VSL	B-dietary%supplement	509	512	abstract	33422110
#	I-dietary%supplement	513	514	abstract	33422110
3	I-dietary%supplement	514	515	abstract	33422110
,	O	515	516	abstract	33422110
or	O	517	519	abstract	33422110
the	O	520	523	abstract	33422110
inflammatory	O	524	536	abstract	33422110
inducer	O	537	544	abstract	33422110
,	O	544	545	abstract	33422110
dextran	B-chemical	546	553	abstract	33422110
sodium	I-chemical	554	560	abstract	33422110
sulphate	I-chemical	561	569	abstract	33422110
(	O	570	571	abstract	33422110
DSS	B-chemical	571	574	abstract	33422110
)	O	574	575	abstract	33422110
,	O	575	576	abstract	33422110
would	O	577	582	abstract	33422110
influence	O	583	592	abstract	33422110
the	O	593	596	abstract	33422110
PD-like	B-DDF	597	604	abstract	33422110
pathology	I-DDF	605	614	abstract	33422110
provoked	O	615	623	abstract	33422110
by	O	624	626	abstract	33422110
a	O	627	628	abstract	33422110
dual	B-biomedical%technique	629	633	abstract	33422110
hit	I-biomedical%technique	634	637	abstract	33422110
toxin	I-biomedical%technique	638	643	abstract	33422110
model	I-biomedical%technique	644	649	abstract	33422110
using	O	650	655	abstract	33422110
lipopolysaccharide	B-chemical	656	674	abstract	33422110
(	O	675	676	abstract	33422110
LPS	B-chemical	676	679	abstract	33422110
)	O	679	680	abstract	33422110
and	O	681	684	abstract	33422110
paraquat	O	685	693	abstract	33422110
exposure	O	694	702	abstract	33422110
.	O	702	703	abstract	33422110

While	O	704	709	abstract	33422110
VSL	B-dietary%supplement	710	713	abstract	33422110
#	I-dietary%supplement	714	715	abstract	33422110
3	I-dietary%supplement	715	716	abstract	33422110
has	O	717	720	abstract	33422110
been	O	721	725	abstract	33422110
reported	O	726	734	abstract	33422110
to	O	735	737	abstract	33422110
have	O	738	742	abstract	33422110
anti-inflammatory	O	743	760	abstract	33422110
effects	O	761	768	abstract	33422110
,	O	768	769	abstract	33422110
DSS	B-chemical	770	773	abstract	33422110
is	O	774	776	abstract	33422110
often	O	777	782	abstract	33422110
used	O	783	787	abstract	33422110
as	O	788	790	abstract	33422110
a	O	791	792	abstract	33422110
model	O	793	798	abstract	33422110
of	O	799	801	abstract	33422110
colitis	B-DDF	802	809	abstract	33422110
because	O	810	817	abstract	33422110
of	O	818	820	abstract	33422110
the	O	821	824	abstract	33422110
gut	B-DDF	825	828	abstract	33422110
inflammation	I-DDF	829	841	abstract	33422110
and	O	842	845	abstract	33422110
the	O	846	849	abstract	33422110
breach	O	850	856	abstract	33422110
of	O	857	859	abstract	33422110
the	O	860	863	abstract	33422110
intestinal	B-anatomical%location	864	874	abstract	33422110
barrier	I-anatomical%location	875	882	abstract	33422110
that	O	883	887	abstract	33422110
it	O	888	890	abstract	33422110
induces	O	891	898	abstract	33422110
.	O	898	899	abstract	33422110

We	O	900	902	abstract	33422110
found	O	903	908	abstract	33422110
that	O	909	913	abstract	33422110
VSL#3	B-dietary%supplement	914	919	abstract	33422110
did	O	920	923	abstract	33422110
not	O	924	927	abstract	33422110
have	O	928	932	abstract	33422110
any	O	933	936	abstract	33422110
significant	O	937	948	abstract	33422110
effects	O	949	956	abstract	33422110
(	O	957	958	abstract	33422110
beyond	O	958	964	abstract	33422110
a	O	965	966	abstract	33422110
blunting	O	967	975	abstract	33422110
of	O	976	978	abstract	33422110
LPS	B-DDF	979	982	abstract	33422110
paraquat-induced	I-DDF	983	999	abstract	33422110
weight	I-DDF	1000	1006	abstract	33422110
loss	I-DDF	1007	1011	abstract	33422110
)	O	1011	1012	abstract	33422110
.	O	1012	1013	abstract	33422110

However	O	1014	1021	abstract	33422110
,	O	1021	1022	abstract	33422110
the	O	1023	1026	abstract	33422110
DSS	O	1027	1030	abstract	33422110
treatment	O	1031	1040	abstract	33422110
caused	O	1041	1047	abstract	33422110
marked	O	1048	1054	abstract	33422110
changes	O	1055	1062	abstract	33422110
in	O	1063	1065	abstract	33422110
the	O	1066	1069	abstract	33422110
gut	B-microbiome	1070	1073	abstract	33422110
microbiome	I-microbiome	1074	1084	abstract	33422110
and	O	1085	1088	abstract	33422110
was	O	1089	1092	abstract	33422110
also	O	1093	1097	abstract	33422110
associated	O	1098	1108	abstract	33422110
with	O	1109	1113	abstract	33422110
augmented	O	1114	1123	abstract	33422110
behavioral	O	1124	1134	abstract	33422110
and	O	1135	1138	abstract	33422110
inflammatory	O	1139	1151	abstract	33422110
outcomes	O	1152	1160	abstract	33422110
.	O	1160	1161	abstract	33422110

In	O	1162	1164	abstract	33422110
fact	O	1165	1169	abstract	33422110
,	O	1169	1170	abstract	33422110
DSS	B-chemical	1171	1174	abstract	33422110
markedly	O	1175	1183	abstract	33422110
increased	O	1184	1193	abstract	33422110
taxa	O	1194	1198	abstract	33422110
belonging	O	1199	1208	abstract	33422110
to	O	1209	1211	abstract	33422110
the	O	1212	1215	abstract	33422110
Bacteroidaceae	B-bacteria	1216	1230	abstract	33422110
and	I-bacteria	1231	1234	abstract	33422110
Porphyromonadaceae	I-bacteria	1235	1253	abstract	33422110
families	I-bacteria	1254	1262	abstract	33422110
but	O	1263	1266	abstract	33422110
reduced	O	1267	1274	abstract	33422110
those	O	1275	1280	abstract	33422110
from	O	1281	1285	abstract	33422110
Rikencellaceae	B-bacteria	1286	1300	abstract	33422110
and	O	1301	1304	abstract	33422110
S24	B-bacteria	1305	1308	abstract	33422110
-	I-bacteria	1308	1309	abstract	33422110
7	I-bacteria	1309	1310	abstract	33422110
,	O	1310	1311	abstract	33422110
as	O	1312	1314	abstract	33422110
well	O	1315	1319	abstract	33422110
as	O	1320	1322	abstract	33422110
provoking	O	1323	1332	abstract	33422110
colonic	O	1333	1340	abstract	33422110
pro-inflammatory	O	1341	1357	abstract	33422110
cytokine	O	1358	1366	abstract	33422110
expression	O	1367	1377	abstract	33422110
,	O	1377	1378	abstract	33422110
consistent	O	1379	1389	abstract	33422110
with	O	1390	1394	abstract	33422110
an	O	1395	1397	abstract	33422110
inflamed	B-DDF	1398	1406	abstract	33422110
gut	I-DDF	1407	1410	abstract	33422110
.	O	1410	1411	abstract	33422110

The	O	1412	1415	abstract	33422110
DSS	B-chemical	1416	1419	abstract	33422110
also	O	1420	1424	abstract	33422110
increased	O	1425	1434	abstract	33422110
the	O	1435	1438	abstract	33422110
impact	O	1439	1445	abstract	33422110
of	O	1446	1448	abstract	33422110
LPS	B-chemical	1449	1452	abstract	33422110
plus	O	1453	1457	abstract	33422110
paraquat	B-chemical	1458	1466	abstract	33422110
upon	O	1467	1471	abstract	33422110
microglial	O	1472	1482	abstract	33422110
morphology	O	1483	1493	abstract	33422110
,	O	1493	1494	abstract	33422110
along	O	1495	1500	abstract	33422110
with	O	1501	1505	abstract	33422110
circulating	B-chemical	1506	1517	abstract	33422110
lipocalin-2	I-chemical	1518	1529	abstract	33422110
(	O	1530	1531	abstract	33422110
neutrophil	O	1531	1541	abstract	33422110
marker	O	1542	1548	abstract	33422110
)	O	1548	1549	abstract	33422110
and	O	1550	1553	abstract	33422110
IL-6	B-chemical	1554	1558	abstract	33422110
.	O	1558	1559	abstract	33422110

Yet	O	1560	1563	abstract	33422110
,	O	1563	1564	abstract	33422110
neither	O	1565	1572	abstract	33422110
DSS	B-chemical	1573	1576	abstract	33422110
nor	O	1577	1580	abstract	33422110
VSL#3	B-dietary%supplement	1581	1586	abstract	33422110
influenced	O	1587	1597	abstract	33422110
the	O	1598	1601	abstract	33422110
loss	O	1602	1606	abstract	33422110
of	O	1607	1609	abstract	33422110
substantia	O	1610	1620	abstract	33422110
nigra	O	1621	1626	abstract	33422110
dopamine	O	1627	1635	abstract	33422110
neurons	O	1636	1643	abstract	33422110
or	O	1644	1646	abstract	33422110
the	O	1647	1650	abstract	33422110
astrocytic	O	1651	1661	abstract	33422110
and	O	1662	1665	abstract	33422110
cytoskeleton	O	1666	1678	abstract	33422110
remodeling	O	1679	1689	abstract	33422110
protein	O	1690	1697	abstract	33422110
changes	O	1698	1705	abstract	33422110
that	O	1706	1710	abstract	33422110
were	O	1711	1715	abstract	33422110
provoked	O	1716	1724	abstract	33422110
by	O	1725	1727	abstract	33422110
the	O	1728	1731	abstract	33422110
LPS	O	1732	1735	abstract	33422110
followed	O	1736	1744	abstract	33422110
by	O	1745	1747	abstract	33422110
paraquat	O	1748	1756	abstract	33422110
treatment	O	1757	1766	abstract	33422110
.	O	1766	1767	abstract	33422110

These	O	1768	1773	abstract	33422110
data	O	1774	1778	abstract	33422110
suggest	O	1779	1786	abstract	33422110
that	O	1787	1791	abstract	33422110
disruption	O	1792	1802	abstract	33422110
of	O	1803	1805	abstract	33422110
the	O	1806	1809	abstract	33422110
intestinal	O	1810	1820	abstract	33422110
integrity	O	1821	1830	abstract	33422110
and	O	1831	1834	abstract	33422110
the	O	1835	1838	abstract	33422110
associated	O	1839	1849	abstract	33422110
microbiome	O	1850	1860	abstract	33422110
can	O	1861	1864	abstract	33422110
interact	O	1865	1873	abstract	33422110
with	O	1874	1878	abstract	33422110
systemic	O	1879	1887	abstract	33422110
inflammatory	O	1888	1900	abstract	33422110
events	O	1901	1907	abstract	33422110
to	O	1908	1910	abstract	33422110
promote	O	1911	1918	abstract	33422110
widespread	O	1919	1929	abstract	33422110
brain-gut	B-DDF	1930	1939	abstract	33422110
changes	I-DDF	1940	1947	abstract	33422110
that	O	1948	1952	abstract	33422110
could	O	1953	1958	abstract	33422110
be	O	1959	1961	abstract	33422110
relevant	O	1962	1970	abstract	33422110
for	O	1971	1974	abstract	33422110
PD	B-DDF	1975	1977	abstract	33422110
and	O	1978	1981	abstract	33422110
at	O	1982	1984	abstract	33422110
the	O	1985	1988	abstract	33422110
very	O	1989	1993	abstract	33422110
least	O	1994	1999	abstract	33422110
,	O	1999	2000	abstract	33422110
suggestive	O	2001	2011	abstract	33422110
of	O	2012	2014	abstract	33422110
novel	O	2015	2020	abstract	33422110
neuro-immune	O	2021	2033	abstract	33422110
communication	O	2034	2047	abstract	33422110
.	O	2047	2048	abstract	33422110

A	O	0	1	title	34985325
Comprehensive	O	2	15	title	34985325
Review	O	16	22	title	34985325
on	O	23	25	title	34985325
the	O	26	29	title	34985325
Role	O	30	34	title	34985325
of	O	35	37	title	34985325
the	O	38	41	title	34985325
Gut	B-microbiome	42	45	title	34985325
Microbiome	I-microbiome	46	56	title	34985325
in	O	57	59	title	34985325
Human	B-DDF	60	65	title	34985325
Neurological	I-DDF	66	78	title	34985325
Disorders	I-DDF	79	88	title	34985325
.	O	88	89	title	34985325

The	O	0	3	abstract	34985325
human	B-anatomical%location	4	9	abstract	34985325
body	I-anatomical%location	10	14	abstract	34985325
is	O	15	17	abstract	34985325
full	O	18	22	abstract	34985325
of	O	23	25	abstract	34985325
an	O	26	28	abstract	34985325
extensive	O	29	38	abstract	34985325
number	O	39	45	abstract	34985325
of	O	46	48	abstract	34985325
commensal	O	49	58	abstract	34985325
microbes	O	59	67	abstract	34985325
,	O	67	68	abstract	34985325
consisting	O	69	79	abstract	34985325
of	O	80	82	abstract	34985325
bacteria	B-bacteria	83	91	abstract	34985325
,	O	91	92	abstract	34985325
viruses	O	93	100	abstract	34985325
,	O	100	101	abstract	34985325
and	O	102	105	abstract	34985325
fungi	O	106	111	abstract	34985325
,	O	111	112	abstract	34985325
collectively	O	113	125	abstract	34985325
termed	O	126	132	abstract	34985325
the	O	133	136	abstract	34985325
human	B-microbiome	137	142	abstract	34985325
microbiome	I-microbiome	143	153	abstract	34985325
.	O	153	154	abstract	34985325

The	O	155	158	abstract	34985325
initial	O	159	166	abstract	34985325
acquisition	O	167	178	abstract	34985325
of	O	179	181	abstract	34985325
microbiota	O	182	192	abstract	34985325
occurs	O	193	199	abstract	34985325
from	O	200	204	abstract	34985325
both	O	205	209	abstract	34985325
the	O	210	213	abstract	34985325
external	O	214	222	abstract	34985325
and	O	223	226	abstract	34985325
maternal	O	227	235	abstract	34985325
environments	O	236	248	abstract	34985325
,	O	248	249	abstract	34985325
and	O	250	253	abstract	34985325
the	O	254	257	abstract	34985325
vast	O	258	262	abstract	34985325
majority	O	263	271	abstract	34985325
of	O	272	274	abstract	34985325
them	O	275	279	abstract	34985325
colonize	O	280	288	abstract	34985325
the	O	289	292	abstract	34985325
gastrointestinal	B-anatomical%location	293	309	abstract	34985325
tract	I-anatomical%location	310	315	abstract	34985325
(	O	316	317	abstract	34985325
GIT	B-anatomical%location	317	320	abstract	34985325
)	O	320	321	abstract	34985325
.	O	321	322	abstract	34985325

These	O	323	328	abstract	34985325
microbial	O	329	338	abstract	34985325
communities	O	339	350	abstract	34985325
play	O	351	355	abstract	34985325
a	O	356	357	abstract	34985325
central	O	358	365	abstract	34985325
role	O	366	370	abstract	34985325
in	O	371	373	abstract	34985325
the	O	374	377	abstract	34985325
maturation	O	378	388	abstract	34985325
and	O	389	392	abstract	34985325
development	O	393	404	abstract	34985325
of	O	405	407	abstract	34985325
the	O	408	411	abstract	34985325
immune	B-anatomical%location	412	418	abstract	34985325
system	I-anatomical%location	419	425	abstract	34985325
,	O	425	426	abstract	34985325
the	O	427	430	abstract	34985325
central	B-anatomical%location	431	438	abstract	34985325
nervous	I-anatomical%location	439	446	abstract	34985325
system	I-anatomical%location	447	453	abstract	34985325
,	O	453	454	abstract	34985325
and	O	455	458	abstract	34985325
the	O	459	462	abstract	34985325
GIT	O	463	466	abstract	34985325
system	O	467	473	abstract	34985325
and	O	474	477	abstract	34985325
are	O	478	481	abstract	34985325
also	O	482	486	abstract	34985325
responsible	O	487	498	abstract	34985325
for	O	499	502	abstract	34985325
essential	O	503	512	abstract	34985325
metabolic	O	513	522	abstract	34985325
pathways	O	523	531	abstract	34985325
.	O	531	532	abstract	34985325

Various	O	533	540	abstract	34985325
factors	O	541	548	abstract	34985325
,	O	548	549	abstract	34985325
including	O	550	559	abstract	34985325
host	O	560	564	abstract	34985325
genetic	O	565	572	abstract	34985325
predisposition	O	573	587	abstract	34985325
,	O	587	588	abstract	34985325
environmental	O	589	602	abstract	34985325
factors	O	603	610	abstract	34985325
,	O	610	611	abstract	34985325
lifestyle	O	612	621	abstract	34985325
,	O	621	622	abstract	34985325
diet	O	623	627	abstract	34985325
,	O	627	628	abstract	34985325
antibiotic	O	629	639	abstract	34985325
or	O	640	642	abstract	34985325
nonantibiotic	O	643	656	abstract	34985325
drug	O	657	661	abstract	34985325
use	O	662	665	abstract	34985325
,	O	665	666	abstract	34985325
etc	O	667	670	abstract	34985325
.	O	670	671	abstract	34985325
,	O	671	672	abstract	34985325
affect	O	673	679	abstract	34985325
the	O	680	683	abstract	34985325
composition	O	684	695	abstract	34985325
of	O	696	698	abstract	34985325
the	O	699	702	abstract	34985325
gut	B-microbiome	703	706	abstract	34985325
microbiota	I-microbiome	707	717	abstract	34985325
.	O	717	718	abstract	34985325

Recent	O	719	725	abstract	34985325
publications	O	726	738	abstract	34985325
have	O	739	743	abstract	34985325
highlighted	O	744	755	abstract	34985325
that	O	756	760	abstract	34985325
an	O	761	763	abstract	34985325
imbalance	B-DDF	764	773	abstract	34985325
in	I-DDF	774	776	abstract	34985325
the	I-DDF	777	780	abstract	34985325
gut	I-DDF	781	784	abstract	34985325
microflora	I-DDF	785	795	abstract	34985325
,	O	795	796	abstract	34985325
known	O	797	802	abstract	34985325
as	O	803	805	abstract	34985325
dysbiosis	B-DDF	806	815	abstract	34985325
,	O	815	816	abstract	34985325
is	O	817	819	abstract	34985325
associated	O	820	830	abstract	34985325
with	O	831	835	abstract	34985325
the	O	836	839	abstract	34985325
onset	O	840	845	abstract	34985325
and	O	846	849	abstract	34985325
progression	O	850	861	abstract	34985325
of	O	862	864	abstract	34985325
neurological	B-DDF	865	877	abstract	34985325
disorders	I-DDF	878	887	abstract	34985325
.	O	887	888	abstract	34985325

Moreover	O	889	897	abstract	34985325
,	O	897	898	abstract	34985325
characterization	O	899	915	abstract	34985325
of	O	916	918	abstract	34985325
the	O	919	922	abstract	34985325
microbiome-host	O	923	938	abstract	34985325
cross	O	939	944	abstract	34985325
talk	O	945	949	abstract	34985325
pathways	O	950	958	abstract	34985325
provides	O	959	967	abstract	34985325
insight	O	968	975	abstract	34985325
into	O	976	980	abstract	34985325
novel	O	981	986	abstract	34985325
therapeutic	O	987	998	abstract	34985325
strategies	O	999	1009	abstract	34985325
.	O	1009	1010	abstract	34985325

Novel	O	1011	1016	abstract	34985325
preclinical	O	1017	1028	abstract	34985325
and	O	1029	1032	abstract	34985325
clinical	O	1033	1041	abstract	34985325
research	O	1042	1050	abstract	34985325
on	O	1051	1053	abstract	34985325
interventions	O	1054	1067	abstract	34985325
related	O	1068	1075	abstract	34985325
to	O	1076	1078	abstract	34985325
the	O	1079	1082	abstract	34985325
gut	B-microbiome	1083	1086	abstract	34985325
microbiome	I-microbiome	1087	1097	abstract	34985325
for	O	1098	1101	abstract	34985325
treating	O	1102	1110	abstract	34985325
neurological	B-DDF	1111	1123	abstract	34985325
conditions	I-DDF	1124	1134	abstract	34985325
,	O	1134	1135	abstract	34985325
including	O	1136	1145	abstract	34985325
autism	B-DDF	1146	1152	abstract	34985325
spectrum	I-DDF	1153	1161	abstract	34985325
disorders	I-DDF	1162	1171	abstract	34985325
,	O	1171	1172	abstract	34985325
Parkinson	B-DDF	1173	1182	abstract	34985325
's	I-DDF	1182	1184	abstract	34985325
disease	I-DDF	1185	1192	abstract	34985325
,	O	1192	1193	abstract	34985325
schizophrenia	B-DDF	1194	1207	abstract	34985325
,	O	1207	1208	abstract	34985325
multiple	B-DDF	1209	1217	abstract	34985325
sclerosis	I-DDF	1218	1227	abstract	34985325
,	O	1227	1228	abstract	34985325
Alzheimer	B-DDF	1229	1238	abstract	34985325
's	I-DDF	1238	1240	abstract	34985325
disease	I-DDF	1241	1248	abstract	34985325
,	O	1248	1249	abstract	34985325
epilepsy	B-DDF	1250	1258	abstract	34985325
,	O	1258	1259	abstract	34985325
and	O	1260	1263	abstract	34985325
stroke	B-DDF	1264	1270	abstract	34985325
,	O	1270	1271	abstract	34985325
hold	O	1272	1276	abstract	34985325
significant	O	1277	1288	abstract	34985325
promise	O	1289	1296	abstract	34985325
.	O	1296	1297	abstract	34985325

This	O	1298	1302	abstract	34985325
review	O	1303	1309	abstract	34985325
aims	O	1310	1314	abstract	34985325
to	O	1315	1317	abstract	34985325
present	O	1318	1325	abstract	34985325
a	O	1326	1327	abstract	34985325
comprehensive	O	1328	1341	abstract	34985325
overview	O	1342	1350	abstract	34985325
of	O	1351	1353	abstract	34985325
the	O	1354	1357	abstract	34985325
potential	O	1358	1367	abstract	34985325
involvement	O	1368	1379	abstract	34985325
of	O	1380	1382	abstract	34985325
the	O	1383	1386	abstract	34985325
human	B-microbiome	1387	1392	abstract	34985325
gut	I-microbiome	1393	1396	abstract	34985325
microbiome	I-microbiome	1397	1407	abstract	34985325
in	O	1408	1410	abstract	34985325
the	O	1411	1414	abstract	34985325
pathogenesis	O	1415	1427	abstract	34985325
of	O	1428	1430	abstract	34985325
neurological	B-DDF	1431	1443	abstract	34985325
disorders	I-DDF	1444	1453	abstract	34985325
,	O	1453	1454	abstract	34985325
with	O	1455	1459	abstract	34985325
a	O	1460	1461	abstract	34985325
particular	O	1462	1472	abstract	34985325
emphasis	O	1473	1481	abstract	34985325
on	O	1482	1484	abstract	34985325
the	O	1485	1488	abstract	34985325
potential	O	1489	1498	abstract	34985325
of	O	1499	1501	abstract	34985325
microbe-based	O	1502	1515	abstract	34985325
therapies	O	1516	1525	abstract	34985325
and/or	O	1526	1532	abstract	34985325
diagnostic	O	1533	1543	abstract	34985325
microbial	O	1544	1553	abstract	34985325
biomarkers	O	1554	1564	abstract	34985325
.	O	1564	1565	abstract	34985325

This	O	1566	1570	abstract	34985325
review	O	1571	1577	abstract	34985325
also	O	1578	1582	abstract	34985325
discusses	O	1583	1592	abstract	34985325
the	O	1593	1596	abstract	34985325
potential	O	1597	1606	abstract	34985325
health	O	1607	1613	abstract	34985325
benefits	O	1614	1622	abstract	34985325
of	O	1623	1625	abstract	34985325
the	O	1626	1629	abstract	34985325
administration	O	1630	1644	abstract	34985325
of	O	1645	1647	abstract	34985325
probiotics	B-dietary%supplement	1648	1658	abstract	34985325
,	O	1658	1659	abstract	34985325
prebiotics	B-dietary%supplement	1660	1670	abstract	34985325
,	O	1670	1671	abstract	34985325
postbiotics	B-dietary%supplement	1672	1683	abstract	34985325
,	O	1683	1684	abstract	34985325
and	O	1685	1688	abstract	34985325
synbiotics	B-dietary%supplement	1689	1699	abstract	34985325
and	O	1700	1703	abstract	34985325
fecal	O	1704	1709	abstract	34985325
microbiota	O	1710	1720	abstract	34985325
transplantation	O	1721	1736	abstract	34985325
in	O	1737	1739	abstract	34985325
neurological	B-DDF	1740	1752	abstract	34985325
disorders	I-DDF	1753	1762	abstract	34985325
.	O	1762	1763	abstract	34985325

Antidepression	O	0	14	title	36550591
of	O	15	17	title	36550591
Xingpijieyu	B-chemical	18	29	title	36550591
formula	I-chemical	30	37	title	36550591
targets	O	38	45	title	36550591
gut	B-microbiome	46	49	title	36550591
microbiota	I-microbiome	50	60	title	36550591
derived	O	61	68	title	36550591
from	O	69	73	title	36550591
depressive	B-DDF	74	84	title	36550591
disorder	I-DDF	85	93	title	36550591
.	O	93	94	title	36550591

This	O	0	4	abstract	36550591
investigation	O	5	18	abstract	36550591
aims	O	19	23	abstract	36550591
to	O	24	26	abstract	36550591
determine	O	27	36	abstract	36550591
the	O	37	40	abstract	36550591
antidepressant	O	41	55	abstract	36550591
role	O	56	60	abstract	36550591
of	O	61	63	abstract	36550591
Xingpijieyu	B-chemical	64	75	abstract	36550591
formula	I-chemical	76	83	abstract	36550591
(	O	84	85	abstract	36550591
XPJYF	B-chemical	85	90	abstract	36550591
)	O	90	91	abstract	36550591
mediated	O	92	100	abstract	36550591
via	O	101	104	abstract	36550591
gut	O	105	108	abstract	36550591
microbiota	O	109	119	abstract	36550591
(GM)-brain	O	120	130	abstract	36550591
axis	O	131	135	abstract	36550591
.	O	135	136	abstract	36550591

We	O	137	139	abstract	36550591
collected	O	140	149	abstract	36550591
fecal	B-microbiome	150	155	abstract	36550591
microbiota	I-microbiome	156	166	abstract	36550591
from	O	167	171	abstract	36550591
patients	B-human	172	180	abstract	36550591
with	O	181	185	abstract	36550591
depressive	B-DDF	186	196	abstract	36550591
disorder	I-DDF	197	205	abstract	36550591
(	O	206	207	abstract	36550591
DD	B-DDF	207	209	abstract	36550591
)	O	209	210	abstract	36550591
and	O	211	214	abstract	36550591
cultured	O	215	223	abstract	36550591
microbiota	B-microbiome	224	234	abstract	36550591
in	O	235	237	abstract	36550591
vitro	O	238	243	abstract	36550591
.	O	243	244	abstract	36550591

Some	O	245	249	abstract	36550591
of	O	250	252	abstract	36550591
microbiota	B-microbiome	253	263	abstract	36550591
were	O	264	268	abstract	36550591
transplanted	O	269	281	abstract	36550591
into	O	282	286	abstract	36550591
germ-free	O	287	296	abstract	36550591
rats	B-animal	297	301	abstract	36550591
with	O	302	306	abstract	36550591
the	O	307	310	abstract	36550591
intragastric	O	311	323	abstract	36550591
administration	O	324	338	abstract	36550591
of	O	339	341	abstract	36550591
XPJYF	B-chemical	342	347	abstract	36550591
grain	O	348	353	abstract	36550591
at	O	354	356	abstract	36550591
the	O	357	360	abstract	36550591
dose	O	361	365	abstract	36550591
of	O	366	368	abstract	36550591
1.533	O	369	374	abstract	36550591
	O	374	375	abstract	36550591
g/kg/day	O	375	383	abstract	36550591
.	O	383	384	abstract	36550591

The	O	385	388	abstract	36550591
behaviors	O	389	398	abstract	36550591
were	O	399	403	abstract	36550591
studied	O	404	411	abstract	36550591
by	O	412	414	abstract	36550591
forced	B-biomedical%technique	415	421	abstract	36550591
swimming	I-biomedical%technique	422	430	abstract	36550591
test	I-biomedical%technique	431	435	abstract	36550591
,	O	435	436	abstract	36550591
open	B-biomedical%technique	437	441	abstract	36550591
field	I-biomedical%technique	442	447	abstract	36550591
test	I-biomedical%technique	448	452	abstract	36550591
,	O	452	453	abstract	36550591
sucrose	B-biomedical%technique	454	461	abstract	36550591
preference	I-biomedical%technique	462	472	abstract	36550591
test	I-biomedical%technique	473	477	abstract	36550591
,	O	477	478	abstract	36550591
and	O	479	482	abstract	36550591
body	B-biomedical%technique	483	487	abstract	36550591
weight	I-biomedical%technique	488	494	abstract	36550591
.	O	494	495	abstract	36550591

Products	O	496	504	abstract	36550591
of	O	505	507	abstract	36550591
hypothalamus-pituitary-adrenocortical	O	508	545	abstract	36550591
(	O	546	547	abstract	36550591
HPA	O	547	550	abstract	36550591
)	O	550	551	abstract	36550591
axis	O	552	556	abstract	36550591
,	O	556	557	abstract	36550591
neurotransmitter	O	558	574	abstract	36550591
,	O	574	575	abstract	36550591
and	O	576	579	abstract	36550591
serum	B-chemical	580	585	abstract	36550591
cytokines	I-chemical	586	595	abstract	36550591
were	O	596	600	abstract	36550591
investigated	O	601	613	abstract	36550591
by	O	614	616	abstract	36550591
enzyme	B-biomedical%technique	617	623	abstract	36550591
linked	I-biomedical%technique	624	630	abstract	36550591
immunosorbent	I-biomedical%technique	631	644	abstract	36550591
assay	I-biomedical%technique	645	650	abstract	36550591
.	O	650	651	abstract	36550591

Glial	B-chemical	652	657	abstract	36550591
fibrillary	I-chemical	658	668	abstract	36550591
acidic	I-chemical	669	675	abstract	36550591
protein	I-chemical	676	683	abstract	36550591
(	O	684	685	abstract	36550591
GFAP	B-chemical	685	689	abstract	36550591
)	O	689	690	abstract	36550591
,	O	690	691	abstract	36550591
a	O	692	693	abstract	36550591
biomarker	O	694	703	abstract	36550591
of	O	704	706	abstract	36550591
astrocyte	O	707	716	abstract	36550591
,	O	716	717	abstract	36550591
was	O	718	721	abstract	36550591
quantified	O	722	732	abstract	36550591
using	O	733	738	abstract	36550591
immunofluorescence	B-biomedical%technique	739	757	abstract	36550591
.	O	757	758	abstract	36550591

Microbiota	O	759	769	abstract	36550591
culturing	O	770	779	abstract	36550591
in	O	780	782	abstract	36550591
vitro	O	783	788	abstract	36550591
after	O	789	794	abstract	36550591
XPJYF	B-chemical	795	800	abstract	36550591
treatment	O	801	810	abstract	36550591
was	O	811	814	abstract	36550591
analyze	O	815	822	abstract	36550591
by	O	823	825	abstract	36550591
16	B-biomedical%technique	826	828	abstract	36550591
	I-biomedical%technique	828	829	abstract	36550591
s	I-biomedical%technique	829	830	abstract	36550591
RNA	I-biomedical%technique	831	834	abstract	36550591
sequencing	I-biomedical%technique	835	845	abstract	36550591
technology	O	846	856	abstract	36550591
.	O	856	857	abstract	36550591

We	O	858	860	abstract	36550591
used	O	861	865	abstract	36550591
lipopolysaccharide	B-chemical	866	884	abstract	36550591
(	O	885	886	abstract	36550591
LPS	B-chemical	886	889	abstract	36550591
)	O	889	890	abstract	36550591
to	O	891	893	abstract	36550591
mimic	O	894	899	abstract	36550591
activated	O	900	909	abstract	36550591
rat	O	910	913	abstract	36550591
primary	O	914	921	abstract	36550591
astrocyte	O	922	931	abstract	36550591
in	O	932	934	abstract	36550591
vitro	O	935	940	abstract	36550591
.	O	940	941	abstract	36550591

Brain-derived	O	942	955	abstract	36550591
neurotrophic	O	956	968	abstract	36550591
factor	O	969	975	abstract	36550591
(	O	976	977	abstract	36550591
BDNF	O	977	981	abstract	36550591
)	O	981	982	abstract	36550591
,	O	982	983	abstract	36550591
cytokines	B-chemical	984	993	abstract	36550591
,	O	993	994	abstract	36550591
and	O	995	998	abstract	36550591
oxidative	O	999	1008	abstract	36550591
stress	O	1009	1015	abstract	36550591
factors	O	1016	1023	abstract	36550591
were	O	1024	1028	abstract	36550591
determined	O	1029	1039	abstract	36550591
by	O	1040	1042	abstract	36550591
western	B-biomedical%technique	1043	1050	abstract	36550591
blotting	I-biomedical%technique	1051	1059	abstract	36550591
,	O	1059	1060	abstract	36550591
and	O	1061	1064	abstract	36550591
glycometabolism	O	1065	1080	abstract	36550591
in	O	1081	1083	abstract	36550591
astrocyte	O	1084	1093	abstract	36550591
was	O	1094	1097	abstract	36550591
investigated	O	1098	1110	abstract	36550591
by	O	1111	1113	abstract	36550591
2-deoxy-D-glucose	B-chemical	1114	1131	abstract	36550591
(	O	1132	1133	abstract	36550591
2-DG	B-chemical	1133	1137	abstract	36550591
)	O	1137	1138	abstract	36550591
uptake	O	1139	1145	abstract	36550591
,	O	1145	1146	abstract	36550591
adenosine	B-chemical	1147	1156	abstract	36550591
triphosphate	I-chemical	1157	1169	abstract	36550591
(	O	1170	1171	abstract	36550591
ATP	B-chemical	1171	1174	abstract	36550591
)	O	1174	1175	abstract	36550591
,	O	1175	1176	abstract	36550591
and	O	1177	1180	abstract	36550591
glucose-1-phosphate	B-chemical	1181	1200	abstract	36550591
(	O	1201	1202	abstract	36550591
G1P	B-chemical	1202	1205	abstract	36550591
)	O	1205	1206	abstract	36550591
kits	O	1207	1211	abstract	36550591
.	O	1211	1212	abstract	36550591

Microbiota	O	1213	1223	abstract	36550591
composition	O	1224	1235	abstract	36550591
during	O	1236	1242	abstract	36550591
8	O	1243	1244	abstract	36550591
	O	1244	1245	abstract	36550591
mg/ml	O	1245	1250	abstract	36550591
of	O	1251	1253	abstract	36550591
XPJYF	B-chemical	1254	1259	abstract	36550591
(	O	1260	1261	abstract	36550591
H12	O	1261	1264	abstract	36550591
-	O	1264	1265	abstract	36550591
8)	O	1265	1267	abstract	36550591
for	O	1268	1271	abstract	36550591
12	O	1272	1274	abstract	36550591
	O	1274	1275	abstract	36550591
h	O	1275	1276	abstract	36550591
showed	O	1277	1283	abstract	36550591
the	O	1284	1287	abstract	36550591
more	O	1288	1292	abstract	36550591
consistency	O	1293	1304	abstract	36550591
.	O	1304	1305	abstract	36550591

Lactococcus	B-bacteria	1306	1317	abstract	36550591
is	O	1318	1320	abstract	36550591
enriched	O	1321	1329	abstract	36550591
in	O	1330	1332	abstract	36550591
DD-derived	O	1333	1343	abstract	36550591
microbiota	O	1344	1354	abstract	36550591
composition	O	1355	1366	abstract	36550591
,	O	1366	1367	abstract	36550591
and	O	1368	1371	abstract	36550591
Biffdobacterium	B-bacteria	1372	1387	abstract	36550591
and	O	1388	1391	abstract	36550591
Lactobacillus	B-bacteria	1392	1405	abstract	36550591
in	O	1406	1408	abstract	36550591
H12	O	1409	1412	abstract	36550591
-	O	1412	1413	abstract	36550591
8	O	1413	1414	abstract	36550591
group	O	1415	1420	abstract	36550591
.	O	1420	1421	abstract	36550591

GLUCOSE1PMETAB-PWY	B-chemical	1422	1440	abstract	36550591
and	O	1441	1444	abstract	36550591
PWY-7328	B-gene	1445	1453	abstract	36550591
of	O	1454	1456	abstract	36550591
which	O	1457	1462	abstract	36550591
biofunctions	O	1463	1475	abstract	36550591
were	O	1476	1480	abstract	36550591
dominantly	O	1481	1491	abstract	36550591
encoded	O	1492	1499	abstract	36550591
by	O	1500	1502	abstract	36550591
Biffdobacterium	B-bacteria	1503	1518	abstract	36550591
were	O	1519	1523	abstract	36550591
the	O	1524	1527	abstract	36550591
top	O	1528	1531	abstract	36550591
two	O	1532	1535	abstract	36550591
of	O	1536	1538	abstract	36550591
altered	O	1539	1546	abstract	36550591
pathways	O	1547	1555	abstract	36550591
.	O	1555	1556	abstract	36550591

XPJYF	B-chemical	1557	1562	abstract	36550591
improved	O	1563	1571	abstract	36550591
behaviors	O	1572	1581	abstract	36550591
and	O	1582	1585	abstract	36550591
repressed	O	1586	1595	abstract	36550591
astrocyte	O	1596	1605	abstract	36550591
activation	O	1606	1616	abstract	36550591
in	O	1617	1619	abstract	36550591
depression	O	1620	1630	abstract	36550591
rats	O	1631	1635	abstract	36550591
.	O	1635	1636	abstract	36550591

XPJYF	B-chemical	1637	1642	abstract	36550591
elevated	O	1643	1651	abstract	36550591
2-DG	O	1652	1656	abstract	36550591
uptake	O	1657	1663	abstract	36550591
,	O	1663	1664	abstract	36550591
ATP	B-chemical	1665	1668	abstract	36550591
,	O	1668	1669	abstract	36550591
glucose-1-phosphate	B-chemical	1670	1689	abstract	36550591
,	O	1689	1690	abstract	36550591
and	O	1691	1694	abstract	36550591
brain-derived	O	1695	1708	abstract	36550591
neurotrophic	O	1709	1721	abstract	36550591
factor	O	1722	1728	abstract	36550591
(	O	1729	1730	abstract	36550591
BDNF	O	1730	1734	abstract	36550591
)	O	1734	1735	abstract	36550591
,	O	1735	1736	abstract	36550591
and	O	1737	1740	abstract	36550591
inhibited	O	1741	1750	abstract	36550591
cytokines	O	1751	1760	abstract	36550591
and	O	1761	1764	abstract	36550591
oxidative	O	1765	1774	abstract	36550591
stress	O	1775	1781	abstract	36550591
in	O	1782	1784	abstract	36550591
LPS-induced	O	1785	1796	abstract	36550591
astrocyte	O	1797	1806	abstract	36550591
.	O	1806	1807	abstract	36550591

XPJYF	B-chemical	1808	1813	abstract	36550591
treatment	O	1814	1823	abstract	36550591
targets	O	1824	1831	abstract	36550591
inflammation	O	1832	1844	abstract	36550591
,	O	1844	1845	abstract	36550591
activation	O	1846	1856	abstract	36550591
,	O	1856	1857	abstract	36550591
and	O	1858	1861	abstract	36550591
glycometabolim	O	1862	1876	abstract	36550591
in	O	1877	1879	abstract	36550591
astrocyte	O	1880	1889	abstract	36550591
via	O	1890	1893	abstract	36550591
gut	O	1894	1897	abstract	36550591
microbiota	O	1898	1908	abstract	36550591
modulation	O	1909	1919	abstract	36550591
,	O	1919	1920	abstract	36550591
thereby	O	1921	1928	abstract	36550591
improve	O	1929	1936	abstract	36550591
animal	O	1937	1943	abstract	36550591
behaviors	O	1944	1953	abstract	36550591
,	O	1953	1954	abstract	36550591
HPA	B-DDF	1955	1958	abstract	36550591
axis	I-DDF	1959	1963	abstract	36550591
dysfunction	I-DDF	1964	1975	abstract	36550591
,	O	1975	1976	abstract	36550591
and	O	1977	1980	abstract	36550591
neurotransmitter	O	1981	1997	abstract	36550591
synthesis	O	1998	2007	abstract	36550591
in	O	2008	2010	abstract	36550591
depression	O	2011	2021	abstract	36550591
rats	B-animal	2022	2026	abstract	36550591
.	O	2026	2027	abstract	36550591

Oral	B-dietary%supplement	0	4	title	30459574
Probiotics	I-dietary%supplement	5	15	title	30459574
Ameliorate	O	16	26	title	30459574
the	O	27	30	title	30459574
Behavioral	O	31	41	title	30459574
Deficits	O	42	50	title	30459574
Induced	O	51	58	title	30459574
by	O	59	61	title	30459574
Chronic	B-DDF	62	69	title	30459574
Mild	I-DDF	70	74	title	30459574
Stress	I-DDF	75	81	title	30459574
in	O	82	84	title	30459574
Mice	B-animal	85	89	title	30459574
via	O	90	93	title	30459574
the	O	94	97	title	30459574
Gut	O	98	101	title	30459574
Microbiota-Inflammation	O	102	125	title	30459574
Axis	O	126	130	title	30459574
.	O	130	131	title	30459574

In	O	0	2	abstract	30459574
recent	O	3	9	abstract	30459574
years	O	10	15	abstract	30459574
,	O	15	16	abstract	30459574
a	O	17	18	abstract	30459574
burgeoning	O	19	29	abstract	30459574
body	O	30	34	abstract	30459574
of	O	35	37	abstract	30459574
research	O	38	46	abstract	30459574
has	O	47	50	abstract	30459574
revealed	O	51	59	abstract	30459574
links	O	60	65	abstract	30459574
between	O	66	73	abstract	30459574
depression	B-DDF	74	84	abstract	30459574
and	O	85	88	abstract	30459574
the	O	89	92	abstract	30459574
gut	B-microbiome	93	96	abstract	30459574
microbiota	I-microbiome	97	107	abstract	30459574
,	O	107	108	abstract	30459574
leading	O	109	116	abstract	30459574
to	O	117	119	abstract	30459574
the	O	120	123	abstract	30459574
therapeutic	O	124	135	abstract	30459574
use	O	136	139	abstract	30459574
of	O	140	142	abstract	30459574
probiotics	B-dietary%supplement	143	153	abstract	30459574
for	O	154	157	abstract	30459574
stress-related	B-DDF	158	172	abstract	30459574
disorders	I-DDF	173	182	abstract	30459574
.	O	182	183	abstract	30459574

In	O	184	186	abstract	30459574
this	O	187	191	abstract	30459574
study	O	192	197	abstract	30459574
,	O	197	198	abstract	30459574
we	O	199	201	abstract	30459574
explored	O	202	210	abstract	30459574
the	O	211	214	abstract	30459574
potential	O	215	224	abstract	30459574
antidepressant	O	225	239	abstract	30459574
efficacy	O	240	248	abstract	30459574
of	O	249	251	abstract	30459574
a	O	252	253	abstract	30459574
multi-strain	O	254	266	abstract	30459574
probiotics	B-dietary%supplement	267	277	abstract	30459574
treatment	O	278	287	abstract	30459574
(	O	288	289	abstract	30459574
<	O	289	290	abstract	30459574
i	O	290	291	abstract	30459574
>	O	291	292	abstract	30459574
Lactobacillus	B-bacteria	292	305	abstract	30459574
helveticus	I-bacteria	306	316	abstract	30459574
R0052</i	I-bacteria	317	325	abstract	30459574
>	O	325	326	abstract	30459574
,	O	326	327	abstract	30459574
<	O	328	329	abstract	30459574
i	O	329	330	abstract	30459574
>	O	330	331	abstract	30459574
Lactobacillus	B-bacteria	331	344	abstract	30459574
plantarum	I-bacteria	345	354	abstract	30459574
R1012</i	I-bacteria	355	363	abstract	30459574
>	O	363	364	abstract	30459574
,	O	364	365	abstract	30459574
and	O	366	369	abstract	30459574
<	O	370	371	abstract	30459574
i	O	371	372	abstract	30459574
>	O	372	373	abstract	30459574
Bifidobacterium	B-bacteria	373	388	abstract	30459574
longum	I-bacteria	389	395	abstract	30459574
R0175</i	I-bacteria	396	404	abstract	30459574
>	O	404	405	abstract	30459574
)	O	405	406	abstract	30459574
in	O	407	409	abstract	30459574
a	O	410	411	abstract	30459574
chronic	O	412	419	abstract	30459574
mild	O	420	424	abstract	30459574
stress	O	425	431	abstract	30459574
(	O	432	433	abstract	30459574
CMS	O	433	436	abstract	30459574
)	O	436	437	abstract	30459574
mouse	O	438	443	abstract	30459574
model	O	444	449	abstract	30459574
of	O	450	452	abstract	30459574
depression	B-DDF	453	463	abstract	30459574
and	O	464	467	abstract	30459574
determined	O	468	478	abstract	30459574
its	O	479	482	abstract	30459574
probable	O	483	491	abstract	30459574
mechanism	O	492	501	abstract	30459574
of	O	502	504	abstract	30459574
action	O	505	511	abstract	30459574
.	O	511	512	abstract	30459574

Our	O	513	516	abstract	30459574
findings	O	517	525	abstract	30459574
revealed	O	526	534	abstract	30459574
that	O	535	539	abstract	30459574
mice	B-animal	540	544	abstract	30459574
subjected	O	545	554	abstract	30459574
to	O	555	557	abstract	30459574
CMS	B-DDF	558	561	abstract	30459574
exhibited	O	562	571	abstract	30459574
anxiety-	B-DDF	572	580	abstract	30459574
and	I-DDF	581	584	abstract	30459574
depressive-like	I-DDF	585	600	abstract	30459574
behaviors	I-DDF	601	610	abstract	30459574
in	O	611	613	abstract	30459574
the	O	614	617	abstract	30459574
sucrose	O	618	625	abstract	30459574
preference	O	626	636	abstract	30459574
test	O	637	641	abstract	30459574
,	O	641	642	abstract	30459574
elevated	O	643	651	abstract	30459574
plus	O	652	656	abstract	30459574
maze	O	657	661	abstract	30459574
,	O	661	662	abstract	30459574
and	O	663	666	abstract	30459574
forced	O	667	673	abstract	30459574
swim	O	674	678	abstract	30459574
test	O	679	683	abstract	30459574
,	O	683	684	abstract	30459574
along	O	685	690	abstract	30459574
with	O	691	695	abstract	30459574
increased	O	696	705	abstract	30459574
interferon-	B-chemical	706	718	abstract	30459574
,	O	718	719	abstract	30459574
tumor	B-chemical	720	725	abstract	30459574
necrosis	I-chemical	726	734	abstract	30459574
factor-	I-chemical	735	743	abstract	30459574
,	O	743	744	abstract	30459574
and	O	745	748	abstract	30459574
indoleamine	B-chemical	749	760	abstract	30459574
2,3-dioxygenase-1	I-chemical	761	778	abstract	30459574
levels	O	779	785	abstract	30459574
in	O	786	788	abstract	30459574
the	O	789	792	abstract	30459574
hippocampus	B-anatomical%location	793	804	abstract	30459574
.	O	804	805	abstract	30459574

Moreover	O	806	814	abstract	30459574
,	O	814	815	abstract	30459574
the	O	816	819	abstract	30459574
microbiota	O	820	830	abstract	30459574
distinctly	O	831	841	abstract	30459574
changed	O	842	849	abstract	30459574
from	O	850	854	abstract	30459574
the	O	855	858	abstract	30459574
non-stress	O	859	869	abstract	30459574
group	O	870	875	abstract	30459574
and	O	876	879	abstract	30459574
was	O	880	883	abstract	30459574
characterized	O	884	897	abstract	30459574
by	O	898	900	abstract	30459574
highly	O	901	907	abstract	30459574
diverse	O	908	915	abstract	30459574
bacterial	O	916	925	abstract	30459574
communities	O	926	937	abstract	30459574
associated	O	938	948	abstract	30459574
with	O	949	953	abstract	30459574
significant	O	954	965	abstract	30459574
reductions	O	966	976	abstract	30459574
in	O	977	979	abstract	30459574
<	O	980	981	abstract	30459574
i	O	981	982	abstract	30459574
>	O	982	983	abstract	30459574
Lactobacillus</i	B-bacteria	983	999	abstract	30459574
>	O	999	1000	abstract	30459574
species	O	1001	1008	abstract	30459574
.	O	1008	1009	abstract	30459574

Probiotics	B-dietary%supplement	1010	1020	abstract	30459574
attenuated	O	1021	1031	abstract	30459574
CMS-induced	B-DDF	1032	1043	abstract	30459574
anxiety-	I-DDF	1044	1052	abstract	30459574
and	I-DDF	1053	1056	abstract	30459574
depressive-like	I-DDF	1057	1072	abstract	30459574
behaviors	I-DDF	1073	1082	abstract	30459574
,	O	1082	1083	abstract	30459574
significantly	O	1084	1097	abstract	30459574
increased	O	1098	1107	abstract	30459574
<	O	1108	1109	abstract	30459574
i	O	1109	1110	abstract	30459574
>	O	1110	1111	abstract	30459574
Lactobacillus</i	O	1111	1127	abstract	30459574
>	O	1127	1128	abstract	30459574
abundance	O	1129	1138	abstract	30459574
,	O	1138	1139	abstract	30459574
and	O	1140	1143	abstract	30459574
reversed	O	1144	1152	abstract	30459574
the	O	1153	1156	abstract	30459574
CMS-induced	O	1157	1168	abstract	30459574
immune	O	1169	1175	abstract	30459574
changes	O	1176	1183	abstract	30459574
in	O	1184	1186	abstract	30459574
the	O	1187	1190	abstract	30459574
hippocampus	B-anatomical%location	1191	1202	abstract	30459574
.	O	1202	1203	abstract	30459574

Thus	O	1204	1208	abstract	30459574
,	O	1208	1209	abstract	30459574
the	O	1210	1213	abstract	30459574
possible	O	1214	1222	abstract	30459574
mechanism	O	1223	1232	abstract	30459574
involved	O	1233	1241	abstract	30459574
in	O	1242	1244	abstract	30459574
the	O	1245	1248	abstract	30459574
antidepressant-like	O	1249	1268	abstract	30459574
activity	O	1269	1277	abstract	30459574
of	O	1278	1280	abstract	30459574
probiotics	B-dietary%supplement	1281	1291	abstract	30459574
is	O	1292	1294	abstract	30459574
correlated	O	1295	1305	abstract	30459574
with	O	1306	1310	abstract	30459574
<	B-bacteria	1311	1312	abstract	30459574
i	I-bacteria	1312	1313	abstract	30459574
>	I-bacteria	1313	1314	abstract	30459574
Lactobacillus</i	I-bacteria	1314	1330	abstract	30459574
>	I-bacteria	1330	1331	abstract	30459574
species	I-bacteria	1332	1339	abstract	30459574
via	O	1340	1343	abstract	30459574
the	O	1344	1347	abstract	30459574
gut	O	1348	1351	abstract	30459574
microbiota-inflammation-brain	O	1352	1381	abstract	30459574
axis	O	1382	1386	abstract	30459574
.	O	1386	1387	abstract	30459574

The	O	0	3	title	38026003
importance	O	4	14	title	38026003
of	O	15	17	title	38026003
the	O	18	21	title	38026003
intestinal	B-microbiome	22	32	title	38026003
microbiota	I-microbiome	33	43	title	38026003
in	O	44	46	title	38026003
humans	B-human	47	53	title	38026003
and	O	54	57	title	38026003
dogs	B-animal	58	62	title	38026003
in	O	63	65	title	38026003
the	O	66	69	title	38026003
neonatal	O	70	78	title	38026003
period	O	79	85	title	38026003
.	O	85	86	title	38026003

The	O	0	3	abstract	38026003
neonatal	O	4	12	abstract	38026003
period	O	13	19	abstract	38026003
represents	O	20	30	abstract	38026003
a	O	31	32	abstract	38026003
critical	O	33	41	abstract	38026003
stage	O	42	47	abstract	38026003
for	O	48	51	abstract	38026003
the	O	52	55	abstract	38026003
establishment	O	56	69	abstract	38026003
and	O	70	73	abstract	38026003
development	O	74	85	abstract	38026003
of	O	86	88	abstract	38026003
the	O	89	92	abstract	38026003
gut	B-microbiome	93	96	abstract	38026003
microbiota	I-microbiome	97	107	abstract	38026003
,	O	107	108	abstract	38026003
which	O	109	114	abstract	38026003
profoundly	O	115	125	abstract	38026003
influences	O	126	136	abstract	38026003
the	O	137	140	abstract	38026003
future	O	141	147	abstract	38026003
health	O	148	154	abstract	38026003
trajectory	O	155	165	abstract	38026003
of	O	166	168	abstract	38026003
individuals	B-human	169	180	abstract	38026003
.	O	180	181	abstract	38026003

This	O	182	186	abstract	38026003
review	O	187	193	abstract	38026003
examines	O	194	202	abstract	38026003
the	O	203	206	abstract	38026003
importance	O	207	217	abstract	38026003
of	O	218	220	abstract	38026003
intestinal	B-microbiome	221	231	abstract	38026003
microbiota	I-microbiome	232	242	abstract	38026003
in	O	243	245	abstract	38026003
humans	B-human	246	252	abstract	38026003
and	O	253	256	abstract	38026003
dogs	B-animal	257	261	abstract	38026003
,	O	261	262	abstract	38026003
aiming	O	263	269	abstract	38026003
to	O	270	272	abstract	38026003
elucidate	O	273	282	abstract	38026003
the	O	283	286	abstract	38026003
distinct	O	287	295	abstract	38026003
characteristics	O	296	311	abstract	38026003
and	O	312	315	abstract	38026003
variations	O	316	326	abstract	38026003
in	O	327	329	abstract	38026003
the	O	330	333	abstract	38026003
composition	O	334	345	abstract	38026003
between	O	346	353	abstract	38026003
these	O	354	359	abstract	38026003
two	O	360	363	abstract	38026003
species	O	364	371	abstract	38026003
.	O	371	372	abstract	38026003

In	O	373	375	abstract	38026003
humans	B-human	376	382	abstract	38026003
,	O	382	383	abstract	38026003
the	O	384	387	abstract	38026003
intestinal	B-microbiome	388	398	abstract	38026003
microbiota	I-microbiome	399	409	abstract	38026003
contributes	O	410	421	abstract	38026003
to	O	422	424	abstract	38026003
several	O	425	432	abstract	38026003
crucial	O	433	440	abstract	38026003
physiological	O	441	454	abstract	38026003
processes	O	455	464	abstract	38026003
,	O	464	465	abstract	38026003
including	O	466	475	abstract	38026003
digestion	O	476	485	abstract	38026003
,	O	485	486	abstract	38026003
nutrient	O	487	495	abstract	38026003
absorption	O	496	506	abstract	38026003
,	O	506	507	abstract	38026003
immune	O	508	514	abstract	38026003
system	O	515	521	abstract	38026003
development	O	522	533	abstract	38026003
,	O	533	534	abstract	38026003
and	O	535	538	abstract	38026003
modulation	O	539	549	abstract	38026003
of	O	550	552	abstract	38026003
host	O	553	557	abstract	38026003
metabolism	O	558	568	abstract	38026003
.	O	568	569	abstract	38026003

Dysbiosis	B-DDF	570	579	abstract	38026003
,	O	579	580	abstract	38026003
an	O	581	583	abstract	38026003
imbalance	O	584	593	abstract	38026003
or	O	594	596	abstract	38026003
disruption	O	597	607	abstract	38026003
of	O	608	610	abstract	38026003
the	O	611	614	abstract	38026003
gut	B-microbiome	615	618	abstract	38026003
microbial	I-microbiome	619	628	abstract	38026003
community	I-microbiome	629	638	abstract	38026003
,	O	638	639	abstract	38026003
has	O	640	643	abstract	38026003
been	O	644	648	abstract	38026003
linked	O	649	655	abstract	38026003
to	O	656	658	abstract	38026003
various	O	659	666	abstract	38026003
disorders	O	667	676	abstract	38026003
,	O	676	677	abstract	38026003
such	O	678	682	abstract	38026003
as	O	683	685	abstract	38026003
inflammatory	B-DDF	686	698	abstract	38026003
bowel	I-DDF	699	704	abstract	38026003
disease	I-DDF	705	712	abstract	38026003
,	O	712	713	abstract	38026003
obesity	B-DDF	714	721	abstract	38026003
,	O	721	722	abstract	38026003
and	O	723	726	abstract	38026003
even	O	727	731	abstract	38026003
neurological	B-DDF	732	744	abstract	38026003
conditions	I-DDF	745	755	abstract	38026003
.	O	755	756	abstract	38026003

Furthermore	O	757	768	abstract	38026003
,	O	768	769	abstract	38026003
recent	O	770	776	abstract	38026003
research	O	777	785	abstract	38026003
has	O	786	789	abstract	38026003
unveiled	O	790	798	abstract	38026003
the	O	799	802	abstract	38026003
profound	O	803	811	abstract	38026003
influence	O	812	821	abstract	38026003
of	O	822	824	abstract	38026003
the	O	825	828	abstract	38026003
gut-brain	O	829	838	abstract	38026003
axis	O	839	843	abstract	38026003
,	O	843	844	abstract	38026003
emphasizing	O	845	856	abstract	38026003
the	O	857	860	abstract	38026003
bidirectional	O	861	874	abstract	38026003
communication	O	875	888	abstract	38026003
between	O	889	896	abstract	38026003
the	O	897	900	abstract	38026003
gut	B-microbiome	901	904	abstract	38026003
microbiota	I-microbiome	905	915	abstract	38026003
and	O	916	919	abstract	38026003
the	O	920	923	abstract	38026003
central	O	924	931	abstract	38026003
nervous	O	932	939	abstract	38026003
system	O	940	946	abstract	38026003
,	O	946	947	abstract	38026003
impacting	O	948	957	abstract	38026003
cognitive	O	958	967	abstract	38026003
function	O	968	976	abstract	38026003
and	O	977	980	abstract	38026003
mental	O	981	987	abstract	38026003
health	O	988	994	abstract	38026003
.	O	994	995	abstract	38026003

Similarly	O	996	1005	abstract	38026003
,	O	1005	1006	abstract	38026003
alterations	O	1007	1018	abstract	38026003
in	O	1019	1021	abstract	38026003
the	O	1022	1025	abstract	38026003
canine	B-microbiome	1026	1032	abstract	38026003
intestinal	I-microbiome	1033	1043	abstract	38026003
microbiota	I-microbiome	1044	1054	abstract	38026003
have	O	1055	1059	abstract	38026003
been	O	1060	1064	abstract	38026003
associated	O	1065	1075	abstract	38026003
with	O	1076	1080	abstract	38026003
gastrointestinal	B-DDF	1081	1097	abstract	38026003
disorders	I-DDF	1098	1107	abstract	38026003
,	O	1107	1108	abstract	38026003
including	O	1109	1118	abstract	38026003
chronic	B-DDF	1119	1126	abstract	38026003
enteropathy	I-DDF	1127	1138	abstract	38026003
,	O	1138	1139	abstract	38026003
such	O	1140	1144	abstract	38026003
as	O	1145	1147	abstract	38026003
inflammatory	B-DDF	1148	1160	abstract	38026003
bowel	I-DDF	1161	1166	abstract	38026003
disease	I-DDF	1167	1174	abstract	38026003
,	O	1174	1175	abstract	38026003
food	B-DDF	1176	1180	abstract	38026003
allergies	I-DDF	1181	1190	abstract	38026003
,	O	1190	1191	abstract	38026003
and	O	1192	1195	abstract	38026003
ulcerative	B-DDF	1196	1206	abstract	38026003
histiocytic	I-DDF	1207	1218	abstract	38026003
colitis	I-DDF	1219	1226	abstract	38026003
.	O	1226	1227	abstract	38026003

However	O	1228	1235	abstract	38026003
,	O	1235	1236	abstract	38026003
our	O	1237	1240	abstract	38026003
understanding	O	1241	1254	abstract	38026003
of	O	1255	1257	abstract	38026003
the	O	1258	1261	abstract	38026003
intricacies	O	1262	1273	abstract	38026003
and	O	1274	1277	abstract	38026003
functional	O	1278	1288	abstract	38026003
significance	O	1289	1301	abstract	38026003
of	O	1302	1304	abstract	38026003
the	O	1305	1308	abstract	38026003
intestinal	B-microbiome	1309	1319	abstract	38026003
microbiota	I-microbiome	1320	1330	abstract	38026003
in	O	1331	1333	abstract	38026003
dogs	B-animal	1334	1338	abstract	38026003
remains	O	1339	1346	abstract	38026003
limited	O	1347	1354	abstract	38026003
.	O	1354	1355	abstract	38026003

Understanding	O	1356	1369	abstract	38026003
the	O	1370	1373	abstract	38026003
complex	O	1374	1381	abstract	38026003
dynamics	O	1382	1390	abstract	38026003
of	O	1391	1393	abstract	38026003
the	O	1394	1397	abstract	38026003
intestinal	B-microbiome	1398	1408	abstract	38026003
microbiota	I-microbiome	1409	1419	abstract	38026003
in	O	1420	1422	abstract	38026003
both	O	1423	1427	abstract	38026003
humans	B-human	1428	1434	abstract	38026003
and	O	1435	1438	abstract	38026003
dogs	B-animal	1439	1443	abstract	38026003
is	O	1444	1446	abstract	38026003
crucial	O	1447	1454	abstract	38026003
for	O	1455	1458	abstract	38026003
devising	O	1459	1467	abstract	38026003
effective	O	1468	1477	abstract	38026003
strategies	O	1478	1488	abstract	38026003
to	O	1489	1491	abstract	38026003
promote	O	1492	1499	abstract	38026003
health	O	1500	1506	abstract	38026003
and	O	1507	1510	abstract	38026003
manage	O	1511	1517	abstract	38026003
disease	O	1518	1525	abstract	38026003
.	O	1525	1526	abstract	38026003

Moreover	O	1527	1535	abstract	38026003
,	O	1535	1536	abstract	38026003
exploring	O	1537	1546	abstract	38026003
the	O	1547	1550	abstract	38026003
similarities	O	1551	1563	abstract	38026003
and	O	1564	1567	abstract	38026003
differences	O	1568	1579	abstract	38026003
in	O	1580	1582	abstract	38026003
the	O	1583	1586	abstract	38026003
gut	O	1587	1590	abstract	38026003
microbial	O	1591	1600	abstract	38026003
composition	O	1601	1612	abstract	38026003
between	O	1613	1620	abstract	38026003
these	O	1621	1626	abstract	38026003
two	O	1627	1630	abstract	38026003
species	O	1631	1638	abstract	38026003
can	O	1639	1642	abstract	38026003
facilitate	O	1643	1653	abstract	38026003
translational	O	1654	1667	abstract	38026003
research	O	1668	1676	abstract	38026003
,	O	1676	1677	abstract	38026003
potentially	O	1678	1689	abstract	38026003
leading	O	1690	1697	abstract	38026003
to	O	1698	1700	abstract	38026003
innovative	O	1701	1711	abstract	38026003
therapeutic	O	1712	1723	abstract	38026003
interventions	O	1724	1737	abstract	38026003
and	O	1738	1741	abstract	38026003
strategies	O	1742	1752	abstract	38026003
to	O	1753	1755	abstract	38026003
enhance	O	1756	1763	abstract	38026003
the	O	1764	1767	abstract	38026003
well-being	O	1768	1778	abstract	38026003
of	O	1779	1781	abstract	38026003
both	O	1782	1786	abstract	38026003
humans	B-human	1787	1793	abstract	38026003
and	O	1794	1797	abstract	38026003
dogs	B-animal	1798	1802	abstract	38026003
.	O	1802	1803	abstract	38026003

Multiomics	B-biomedical%technique	0	10	title	33194817
Study	I-biomedical%technique	11	16	title	33194817
of	O	17	19	title	33194817
Gut	B-bacteria	20	23	title	33194817
Bacteria	I-bacteria	24	32	title	33194817
and	O	33	36	title	33194817
Host	O	37	41	title	33194817
Metabolism	O	42	52	title	33194817
in	O	53	55	title	33194817
Irritable	B-DDF	56	65	title	33194817
Bowel	I-DDF	66	71	title	33194817
Syndrome	I-DDF	72	80	title	33194817
and	O	81	84	title	33194817
Depression	B-DDF	85	95	title	33194817
Patients	I-DDF	96	104	title	33194817
.	O	104	105	title	33194817

Irritable	B-DDF	0	9	abstract	33194817
bowel	I-DDF	10	15	abstract	33194817
syndrome	I-DDF	16	24	abstract	33194817
(	O	25	26	abstract	33194817
IBS	B-DDF	26	29	abstract	33194817
)	O	29	30	abstract	33194817
and	O	31	34	abstract	33194817
depression	B-DDF	35	45	abstract	33194817
have	O	46	50	abstract	33194817
high	O	51	55	abstract	33194817
tendencies	O	56	66	abstract	33194817
of	O	67	69	abstract	33194817
comorbidity	O	70	81	abstract	33194817
.	O	81	82	abstract	33194817

In	O	83	85	abstract	33194817
particular	O	86	96	abstract	33194817
,	O	96	97	abstract	33194817
diarrhea-predominant	B-DDF	98	118	abstract	33194817
IBS	I-DDF	119	122	abstract	33194817
(	O	123	124	abstract	33194817
IBS-D	B-DDF	124	129	abstract	33194817
)	O	129	130	abstract	33194817
and	O	131	134	abstract	33194817
depression	B-DDF	135	145	abstract	33194817
exhibit	O	146	153	abstract	33194817
similar	O	154	161	abstract	33194817
fecal	O	162	167	abstract	33194817
microbiota	O	168	178	abstract	33194817
signatures	O	179	189	abstract	33194817
,	O	189	190	abstract	33194817
yet	O	191	194	abstract	33194817
little	O	195	201	abstract	33194817
is	O	202	204	abstract	33194817
known	O	205	210	abstract	33194817
about	O	211	216	abstract	33194817
their	O	217	222	abstract	33194817
pathogenic	O	223	233	abstract	33194817
mechanism	O	234	243	abstract	33194817
.	O	243	244	abstract	33194817

Here	O	245	249	abstract	33194817
,	O	249	250	abstract	33194817
we	O	251	253	abstract	33194817
propose	O	254	261	abstract	33194817
that	O	262	266	abstract	33194817
the	O	267	270	abstract	33194817
differences	O	271	282	abstract	33194817
in	O	283	285	abstract	33194817
structure	O	286	295	abstract	33194817
and	O	296	299	abstract	33194817
composition	O	300	311	abstract	33194817
of	O	312	314	abstract	33194817
IBS-D	B-DDF	315	320	abstract	33194817
and	O	321	324	abstract	33194817
depression	B-microbiome	325	335	abstract	33194817
gut	I-microbiome	336	339	abstract	33194817
microbiota	I-microbiome	340	350	abstract	33194817
give	O	351	355	abstract	33194817
rise	O	356	360	abstract	33194817
to	O	361	363	abstract	33194817
different	O	364	373	abstract	33194817
downstream	O	374	384	abstract	33194817
functions	O	385	394	abstract	33194817
,	O	394	395	abstract	33194817
which	O	396	401	abstract	33194817
lead	O	402	406	abstract	33194817
to	O	407	409	abstract	33194817
distinct	O	410	418	abstract	33194817
clinical	O	419	427	abstract	33194817
phenotypes	O	428	438	abstract	33194817
<	O	439	440	abstract	33194817
i	O	440	441	abstract	33194817
>	O	441	442	abstract	33194817
via</i	O	442	448	abstract	33194817
>	O	448	449	abstract	33194817
host	O	450	454	abstract	33194817
metabolism	O	455	465	abstract	33194817
and	O	466	469	abstract	33194817
further	O	470	477	abstract	33194817
influence	O	478	487	abstract	33194817
the	O	488	491	abstract	33194817
interaction	O	492	503	abstract	33194817
of	O	504	506	abstract	33194817
brain-gut	O	507	516	abstract	33194817
axis	O	517	521	abstract	33194817
.	O	521	522	abstract	33194817

We	O	523	525	abstract	33194817
performed	O	526	535	abstract	33194817
multiomics	B-biomedical%technique	536	546	abstract	33194817
study	I-biomedical%technique	547	552	abstract	33194817
,	O	552	553	abstract	33194817
including	O	554	563	abstract	33194817
fecal	B-biomedical%technique	564	569	abstract	33194817
metagenome-wide	I-biomedical%technique	570	585	abstract	33194817
sequencing	I-biomedical%technique	586	596	abstract	33194817
and	O	597	600	abstract	33194817
serum	B-biomedical%technique	601	606	abstract	33194817
metabolomics	I-biomedical%technique	607	619	abstract	33194817
profiling	I-biomedical%technique	620	629	abstract	33194817
in	O	630	632	abstract	33194817
65	O	633	635	abstract	33194817
individuals	B-human	636	647	abstract	33194817
with	O	648	652	abstract	33194817
IBS-D	B-DDF	653	658	abstract	33194817
(	O	659	660	abstract	33194817
n=22	O	660	664	abstract	33194817
)	O	664	665	abstract	33194817
,	O	665	666	abstract	33194817
depression	B-DDF	667	677	abstract	33194817
(	O	678	679	abstract	33194817
n=15	O	679	683	abstract	33194817
)	O	683	684	abstract	33194817
,	O	684	685	abstract	33194817
comorbid	B-human	686	694	abstract	33194817
patients	I-human	695	703	abstract	33194817
(	O	704	705	abstract	33194817
n=13	O	705	709	abstract	33194817
)	O	709	710	abstract	33194817
,	O	710	711	abstract	33194817
and	O	712	715	abstract	33194817
healthy	B-human	716	723	abstract	33194817
controls	I-human	724	732	abstract	33194817
(	O	733	734	abstract	33194817
n=15	O	734	738	abstract	33194817
)	O	738	739	abstract	33194817
.	O	739	740	abstract	33194817

We	O	741	743	abstract	33194817
analyzed	O	744	752	abstract	33194817
functional	O	753	763	abstract	33194817
genes	O	764	769	abstract	33194817
contributed	O	770	781	abstract	33194817
by	O	782	784	abstract	33194817
the	O	785	788	abstract	33194817
primary	O	789	796	abstract	33194817
genus	O	797	802	abstract	33194817
and	O	803	806	abstract	33194817
evaluated	O	807	816	abstract	33194817
their	O	817	822	abstract	33194817
correlations	O	823	835	abstract	33194817
with	O	836	840	abstract	33194817
clinical	O	841	849	abstract	33194817
indices	O	850	857	abstract	33194817
and	O	858	861	abstract	33194817
host	O	862	866	abstract	33194817
metabolites	O	867	878	abstract	33194817
.	O	878	879	abstract	33194817

Metagenomic	B-biomedical%technique	880	891	abstract	33194817
analysis	I-biomedical%technique	892	900	abstract	33194817
revealed	O	901	909	abstract	33194817
26	O	910	912	abstract	33194817
clusters	O	913	921	abstract	33194817
of	O	922	924	abstract	33194817
orthologous	O	925	936	abstract	33194817
groups	O	937	943	abstract	33194817
of	O	944	946	abstract	33194817
protein	O	947	954	abstract	33194817
(	O	955	956	abstract	33194817
COG	O	956	959	abstract	33194817
)	O	959	960	abstract	33194817
categories	O	961	971	abstract	33194817
consisting	O	972	982	abstract	33194817
of	O	983	985	abstract	33194817
a	O	986	987	abstract	33194817
total	O	988	993	abstract	33194817
of	O	994	996	abstract	33194817
4,631	O	997	1002	abstract	33194817
functional	O	1003	1013	abstract	33194817
genes	O	1014	1019	abstract	33194817
.	O	1019	1020	abstract	33194817

Trehalose	B-gene	1021	1030	abstract	33194817
and	O	1031	1034	abstract	33194817
maltose	B-gene	1035	1042	abstract	33194817
hydrolase	I-gene	1043	1052	abstract	33194817
(	O	1053	1054	abstract	33194817
COG1554	B-gene	1054	1061	abstract	33194817
)	O	1061	1062	abstract	33194817
and	O	1063	1066	abstract	33194817
fucose	B-gene	1067	1073	abstract	33194817
permease	I-gene	1074	1082	abstract	33194817
(	O	1083	1084	abstract	33194817
COG0738	B-gene	1084	1091	abstract	33194817
)	O	1091	1092	abstract	33194817
were	O	1093	1097	abstract	33194817
the	O	1098	1101	abstract	33194817
most	O	1102	1106	abstract	33194817
relevant	O	1107	1115	abstract	33194817
and	O	1116	1119	abstract	33194817
enriched	O	1120	1128	abstract	33194817
functional	O	1129	1139	abstract	33194817
genes	O	1140	1145	abstract	33194817
in	O	1146	1148	abstract	33194817
the	O	1149	1152	abstract	33194817
IBS-D	B-human	1153	1158	abstract	33194817
patients	I-human	1159	1167	abstract	33194817
;	O	1167	1168	abstract	33194817
urease	B-gene	1169	1175	abstract	33194817
accessory	I-gene	1176	1185	abstract	33194817
proteins	I-gene	1186	1194	abstract	33194817
UreE	I-gene	1195	1199	abstract	33194817
(	O	1200	1201	abstract	33194817
COG2371	B-gene	1201	1208	abstract	33194817
)	O	1208	1209	abstract	33194817
was	O	1210	1213	abstract	33194817
that	O	1214	1218	abstract	33194817
in	O	1219	1221	abstract	33194817
the	O	1222	1225	abstract	33194817
depression	B-human	1226	1236	abstract	33194817
patients	I-human	1237	1245	abstract	33194817
.	O	1245	1246	abstract	33194817

Context	O	1247	1254	abstract	33194817
based	O	1255	1260	abstract	33194817
genome	O	1261	1267	abstract	33194817
annotation	O	1268	1278	abstract	33194817
suggest	O	1279	1286	abstract	33194817
that	O	1287	1291	abstract	33194817
an	O	1292	1294	abstract	33194817
alteration	O	1295	1305	abstract	33194817
of	O	1306	1308	abstract	33194817
<	O	1309	1310	abstract	33194817
i	O	1310	1311	abstract	33194817
>	O	1311	1312	abstract	33194817
Escherichia	B-bacteria	1312	1323	abstract	33194817
coli</i	I-bacteria	1324	1331	abstract	33194817
>	O	1331	1332	abstract	33194817
and	O	1333	1336	abstract	33194817
<	O	1337	1338	abstract	33194817
i	O	1338	1339	abstract	33194817
>	O	1339	1340	abstract	33194817
Enterobacter	B-bacteria	1340	1352	abstract	33194817
cloacae</i	I-bacteria	1353	1363	abstract	33194817
>	O	1363	1364	abstract	33194817
in	O	1365	1367	abstract	33194817
IBS-D	B-DDF	1368	1373	abstract	33194817
and	O	1374	1377	abstract	33194817
depression	B-DDF	1378	1388	abstract	33194817
respectively	O	1389	1401	abstract	33194817
may	O	1402	1405	abstract	33194817
be	O	1406	1408	abstract	33194817
responsible	O	1409	1420	abstract	33194817
for	O	1421	1424	abstract	33194817
the	O	1425	1428	abstract	33194817
enrichment	O	1429	1439	abstract	33194817
described	O	1440	1449	abstract	33194817
above	O	1450	1455	abstract	33194817
.	O	1455	1456	abstract	33194817

Correlation	O	1457	1468	abstract	33194817
with	O	1469	1473	abstract	33194817
host	O	1474	1478	abstract	33194817
metabolites	O	1479	1490	abstract	33194817
,	O	1490	1491	abstract	33194817
such	O	1492	1496	abstract	33194817
as	O	1497	1499	abstract	33194817
maltotriose	B-chemical	1500	1511	abstract	33194817
and	O	1512	1515	abstract	33194817
isomaltose	B-chemical	1516	1526	abstract	33194817
in	O	1527	1529	abstract	33194817
carbohydrate	O	1530	1542	abstract	33194817
metabolism	O	1543	1553	abstract	33194817
and	O	1554	1557	abstract	33194817
anandamide	B-chemical	1558	1568	abstract	33194817
in	O	1569	1571	abstract	33194817
neuroactive	O	1572	1583	abstract	33194817
metabolism	O	1584	1594	abstract	33194817
,	O	1594	1595	abstract	33194817
drew	O	1596	1600	abstract	33194817
further	O	1601	1608	abstract	33194817
connections	O	1609	1620	abstract	33194817
between	O	1621	1628	abstract	33194817
these	O	1629	1634	abstract	33194817
findings	O	1635	1643	abstract	33194817
.	O	1643	1644	abstract	33194817

These	O	1645	1650	abstract	33194817
changes	O	1651	1658	abstract	33194817
led	O	1659	1662	abstract	33194817
us	O	1663	1665	abstract	33194817
to	O	1666	1668	abstract	33194817
propose	O	1669	1676	abstract	33194817
a	O	1677	1678	abstract	33194817
connection	O	1679	1689	abstract	33194817
between	O	1690	1697	abstract	33194817
genomic	O	1698	1705	abstract	33194817
signatures	O	1706	1716	abstract	33194817
and	O	1717	1720	abstract	33194817
clinical	O	1721	1729	abstract	33194817
differences	O	1730	1741	abstract	33194817
observed	O	1742	1750	abstract	33194817
in	O	1751	1753	abstract	33194817
IBS-D	B-DDF	1754	1759	abstract	33194817
and	O	1760	1763	abstract	33194817
depression	B-DDF	1764	1774	abstract	33194817
.	O	1774	1775	abstract	33194817

Our	O	1776	1779	abstract	33194817
findings	O	1780	1788	abstract	33194817
provide	O	1789	1796	abstract	33194817
further	O	1797	1804	abstract	33194817
insights	O	1805	1813	abstract	33194817
into	O	1814	1818	abstract	33194817
the	O	1819	1822	abstract	33194817
involvement	O	1823	1834	abstract	33194817
of	O	1835	1837	abstract	33194817
gut	B-microbiome	1838	1841	abstract	33194817
microbiota	I-microbiome	1842	1852	abstract	33194817
in	O	1853	1855	abstract	33194817
diseases	O	1856	1864	abstract	33194817
related	O	1865	1872	abstract	33194817
to	O	1873	1875	abstract	33194817
brain-gut	O	1876	1885	abstract	33194817
disorder	O	1886	1894	abstract	33194817
.	O	1894	1895	abstract	33194817

Does	O	0	4	title	29022384
the	O	5	8	title	29022384
maternal	B-microbiome	9	17	title	29022384
vaginal	I-microbiome	18	25	title	29022384
microbiota	I-microbiome	26	36	title	29022384
play	O	37	41	title	29022384
a	O	42	43	title	29022384
role	O	44	48	title	29022384
in	O	49	51	title	29022384
seeding	O	52	59	title	29022384
the	O	60	63	title	29022384
microbiota	B-microbiome	64	74	title	29022384
of	I-microbiome	75	77	title	29022384
neonatal	I-microbiome	78	86	title	29022384
gut	I-microbiome	87	90	title	29022384
and	I-microbiome	91	94	title	29022384
nose	I-microbiome	95	99	title	29022384
?	O	99	100	title	29022384

The	O	0	3	abstract	29022384
acquisition	O	4	15	abstract	29022384
and	O	16	19	abstract	29022384
early	O	20	25	abstract	29022384
maturation	O	26	36	abstract	29022384
of	O	37	39	abstract	29022384
infant	B-microbiome	40	46	abstract	29022384
microbiota	I-microbiome	47	57	abstract	29022384
is	O	58	60	abstract	29022384
not	O	61	64	abstract	29022384
well	O	65	69	abstract	29022384
understood	O	70	80	abstract	29022384
despite	O	81	88	abstract	29022384
its	O	89	92	abstract	29022384
likely	O	93	99	abstract	29022384
influence	O	100	109	abstract	29022384
on	O	110	112	abstract	29022384
later	O	113	118	abstract	29022384
health	O	119	125	abstract	29022384
.	O	125	126	abstract	29022384

We	O	127	129	abstract	29022384
investigated	O	130	142	abstract	29022384
the	O	143	146	abstract	29022384
contribution	O	147	159	abstract	29022384
of	O	160	162	abstract	29022384
the	O	163	166	abstract	29022384
maternal	B-microbiome	167	175	abstract	29022384
microbiota	I-microbiome	176	186	abstract	29022384
to	O	187	189	abstract	29022384
the	O	190	193	abstract	29022384
microbiota	B-microbiome	194	204	abstract	29022384
of	I-microbiome	205	207	abstract	29022384
infant	I-microbiome	208	214	abstract	29022384
gut	I-microbiome	215	218	abstract	29022384
and	I-microbiome	219	222	abstract	29022384
nose	I-microbiome	223	227	abstract	29022384
in	O	228	230	abstract	29022384
the	O	231	234	abstract	29022384
context	O	235	242	abstract	29022384
of	O	243	245	abstract	29022384
mode	O	246	250	abstract	29022384
of	O	251	253	abstract	29022384
delivery	O	254	262	abstract	29022384
and	O	263	266	abstract	29022384
feeding	O	267	274	abstract	29022384
.	O	274	275	abstract	29022384

Using	O	276	281	abstract	29022384
16S	B-biomedical%technique	282	285	abstract	29022384
rRNA	I-biomedical%technique	286	290	abstract	29022384
sequencing	I-biomedical%technique	291	301	abstract	29022384
and	O	302	305	abstract	29022384
specific	O	306	314	abstract	29022384
qPCR	B-biomedical%technique	315	319	abstract	29022384
,	O	319	320	abstract	29022384
we	O	321	323	abstract	29022384
profiled	O	324	332	abstract	29022384
microbiota	O	333	343	abstract	29022384
of	O	344	346	abstract	29022384
42	O	347	349	abstract	29022384
mother-infant	B-human	350	363	abstract	29022384
pairs	I-human	364	369	abstract	29022384
from	O	370	374	abstract	29022384
the	O	375	378	abstract	29022384
GUSTO	O	379	384	abstract	29022384
birth	O	385	390	abstract	29022384
cohort	O	391	397	abstract	29022384
,	O	397	398	abstract	29022384
at	O	399	401	abstract	29022384
body	O	402	406	abstract	29022384
sites	O	407	412	abstract	29022384
including	O	413	422	abstract	29022384
maternal	B-anatomical%location	423	431	abstract	29022384
vagina	I-anatomical%location	432	438	abstract	29022384
,	O	438	439	abstract	29022384
rectum	B-anatomical%location	440	446	abstract	29022384
and	O	447	450	abstract	29022384
skin	B-anatomical%location	451	455	abstract	29022384
;	O	455	456	abstract	29022384
and	O	457	460	abstract	29022384
infant	B-anatomical%location	461	467	abstract	29022384
stool	I-anatomical%location	468	473	abstract	29022384
and	I-anatomical%location	474	477	abstract	29022384
nose	I-anatomical%location	478	482	abstract	29022384
.	O	482	483	abstract	29022384

In	O	484	486	abstract	29022384
our	O	487	490	abstract	29022384
study	O	491	496	abstract	29022384
,	O	496	497	abstract	29022384
overlap	O	498	505	abstract	29022384
between	O	506	513	abstract	29022384
maternal	B-microbiome	514	522	abstract	29022384
vaginal	I-microbiome	523	530	abstract	29022384
microbiota	I-microbiome	531	541	abstract	29022384
and	O	542	545	abstract	29022384
infant	B-microbiome	546	552	abstract	29022384
faecal	I-microbiome	553	559	abstract	29022384
microbiota	I-microbiome	560	570	abstract	29022384
was	O	571	574	abstract	29022384
minimal	O	575	582	abstract	29022384
,	O	582	583	abstract	29022384
while	O	584	589	abstract	29022384
the	O	590	593	abstract	29022384
similarity	O	594	604	abstract	29022384
between	O	605	612	abstract	29022384
maternal	B-microbiome	613	621	abstract	29022384
rectal	I-microbiome	622	628	abstract	29022384
microbiota	I-microbiome	629	639	abstract	29022384
and	O	640	643	abstract	29022384
infant	B-microbiome	644	650	abstract	29022384
microbiota	I-microbiome	651	661	abstract	29022384
was	O	662	665	abstract	29022384
more	O	666	670	abstract	29022384
pronounced	O	671	681	abstract	29022384
.	O	681	682	abstract	29022384

However	O	683	690	abstract	29022384
,	O	690	691	abstract	29022384
an	O	692	694	abstract	29022384
infant	B-microbiome	695	701	abstract	29022384
's	I-microbiome	701	703	abstract	29022384
nasal	I-microbiome	704	709	abstract	29022384
and	I-microbiome	710	713	abstract	29022384
gut	I-microbiome	714	717	abstract	29022384
microbiota	I-microbiome	718	728	abstract	29022384
were	O	729	733	abstract	29022384
no	O	734	736	abstract	29022384
more	O	737	741	abstract	29022384
similar	O	742	749	abstract	29022384
to	O	750	752	abstract	29022384
that	O	753	757	abstract	29022384
of	O	758	760	abstract	29022384
its	O	761	764	abstract	29022384
own	O	765	768	abstract	29022384
mother	B-human	769	775	abstract	29022384
,	O	775	776	abstract	29022384
than	O	777	781	abstract	29022384
to	O	782	784	abstract	29022384
that	O	785	789	abstract	29022384
of	O	790	792	abstract	29022384
unrelated	O	793	802	abstract	29022384
mothers	O	803	810	abstract	29022384
.	O	810	811	abstract	29022384

These	O	812	817	abstract	29022384
findings	O	818	826	abstract	29022384
were	O	827	831	abstract	29022384
independent	O	832	843	abstract	29022384
of	O	844	846	abstract	29022384
delivery	O	847	855	abstract	29022384
mode	O	856	860	abstract	29022384
.	O	860	861	abstract	29022384

We	O	862	864	abstract	29022384
conclude	O	865	873	abstract	29022384
that	O	874	878	abstract	29022384
the	O	879	882	abstract	29022384
transfer	O	883	891	abstract	29022384
of	O	892	894	abstract	29022384
maternal	B-bacteria	895	903	abstract	29022384
vaginal	I-bacteria	904	911	abstract	29022384
microbes	I-bacteria	912	920	abstract	29022384
play	O	921	925	abstract	29022384
a	O	926	927	abstract	29022384
minor	O	928	933	abstract	29022384
role	O	934	938	abstract	29022384
in	O	939	941	abstract	29022384
seeding	O	942	949	abstract	29022384
infant	B-microbiome	950	956	abstract	29022384
stool	I-microbiome	957	962	abstract	29022384
microbiota	I-microbiome	963	973	abstract	29022384
.	O	973	974	abstract	29022384

Transfer	O	975	983	abstract	29022384
of	O	984	986	abstract	29022384
maternal	B-microbiome	987	995	abstract	29022384
rectal	I-microbiome	996	1002	abstract	29022384
microbiota	I-microbiome	1003	1013	abstract	29022384
could	O	1014	1019	abstract	29022384
play	O	1020	1024	abstract	29022384
a	O	1025	1026	abstract	29022384
larger	O	1027	1033	abstract	29022384
role	O	1034	1038	abstract	29022384
in	O	1039	1041	abstract	29022384
seeding	O	1042	1049	abstract	29022384
infant	B-microbiome	1050	1056	abstract	29022384
stool	I-microbiome	1057	1062	abstract	29022384
microbiota	I-microbiome	1063	1073	abstract	29022384
,	O	1073	1074	abstract	29022384
but	O	1075	1078	abstract	29022384
approaches	O	1079	1089	abstract	29022384
other	O	1090	1095	abstract	29022384
than	O	1096	1100	abstract	29022384
the	O	1101	1104	abstract	29022384
generally	O	1105	1114	abstract	29022384
used	O	1115	1119	abstract	29022384
analyses	O	1120	1128	abstract	29022384
of	O	1129	1131	abstract	29022384
community	O	1132	1141	abstract	29022384
similarity	O	1142	1152	abstract	29022384
measures	O	1153	1161	abstract	29022384
are	O	1162	1165	abstract	29022384
likely	O	1166	1172	abstract	29022384
to	O	1173	1175	abstract	29022384
be	O	1176	1178	abstract	29022384
needed	O	1179	1185	abstract	29022384
to	O	1186	1188	abstract	29022384
quantify	O	1189	1197	abstract	29022384
bacterial	O	1198	1207	abstract	29022384
transmission	O	1208	1220	abstract	29022384
.	O	1220	1221	abstract	29022384

We	O	1222	1224	abstract	29022384
confirmed	O	1225	1234	abstract	29022384
the	O	1235	1238	abstract	29022384
clear	O	1239	1244	abstract	29022384
difference	O	1245	1255	abstract	29022384
between	O	1256	1263	abstract	29022384
microbiota	B-microbiome	1264	1274	abstract	29022384
of	I-microbiome	1275	1277	abstract	29022384
infants	I-microbiome	1278	1285	abstract	29022384
born	O	1286	1290	abstract	29022384
by	O	1291	1293	abstract	29022384
Caesarean	O	1294	1303	abstract	29022384
section	O	1304	1311	abstract	29022384
compared	O	1312	1320	abstract	29022384
to	O	1321	1323	abstract	29022384
vaginally	B-human	1324	1333	abstract	29022384
delivered	I-human	1334	1343	abstract	29022384
infants	I-human	1344	1351	abstract	29022384
and	O	1352	1355	abstract	29022384
the	O	1356	1359	abstract	29022384
impact	O	1360	1366	abstract	29022384
of	O	1367	1369	abstract	29022384
feeding	O	1370	1377	abstract	29022384
mode	O	1378	1382	abstract	29022384
on	O	1383	1385	abstract	29022384
infant	B-microbiome	1386	1392	abstract	29022384
gut	I-microbiome	1393	1396	abstract	29022384
microbiota	I-microbiome	1397	1407	abstract	29022384
.	O	1407	1408	abstract	29022384

Only	O	1409	1413	abstract	29022384
vaginally	B-human	1414	1423	abstract	29022384
delivered	I-human	1424	1433	abstract	29022384
,	I-human	1433	1434	abstract	29022384
fully	I-human	1435	1440	abstract	29022384
breastfed	I-human	1441	1450	abstract	29022384
infants	I-human	1451	1458	abstract	29022384
had	O	1459	1462	abstract	29022384
gut	B-microbiome	1463	1466	abstract	29022384
microbiota	I-microbiome	1467	1477	abstract	29022384
dominated	O	1478	1487	abstract	29022384
by	O	1488	1490	abstract	29022384
Bifidobacteria	B-bacteria	1491	1505	abstract	29022384
.	O	1505	1506	abstract	29022384

Our	O	1507	1510	abstract	29022384
data	O	1511	1515	abstract	29022384
suggest	O	1516	1523	abstract	29022384
that	O	1524	1528	abstract	29022384
reduced	O	1529	1536	abstract	29022384
transfer	O	1537	1545	abstract	29022384
of	O	1546	1548	abstract	29022384
maternal	O	1549	1557	abstract	29022384
vaginal	O	1558	1565	abstract	29022384
microbial	O	1566	1575	abstract	29022384
is	O	1576	1578	abstract	29022384
not	O	1579	1582	abstract	29022384
the	O	1583	1586	abstract	29022384
main	O	1587	1591	abstract	29022384
mechanism	O	1592	1601	abstract	29022384
underlying	O	1602	1612	abstract	29022384
the	O	1613	1616	abstract	29022384
differential	O	1617	1629	abstract	29022384
infant	B-microbiome	1630	1636	abstract	29022384
microbiota	I-microbiome	1637	1647	abstract	29022384
composition	O	1648	1659	abstract	29022384
associated	O	1660	1670	abstract	29022384
with	O	1671	1675	abstract	29022384
Caesarean	O	1676	1685	abstract	29022384
delivery	O	1686	1694	abstract	29022384
.	O	1694	1695	abstract	29022384

The	O	1696	1699	abstract	29022384
sources	O	1700	1707	abstract	29022384
of	O	1708	1710	abstract	29022384
a	O	1711	1712	abstract	29022384
large	O	1713	1718	abstract	29022384
proportion	O	1719	1729	abstract	29022384
of	O	1730	1732	abstract	29022384
infant	B-microbiome	1733	1739	abstract	29022384
microbiota	I-microbiome	1740	1750	abstract	29022384
could	O	1751	1756	abstract	29022384
not	O	1757	1760	abstract	29022384
be	O	1761	1763	abstract	29022384
identified	O	1764	1774	abstract	29022384
in	O	1775	1777	abstract	29022384
maternal	B-microbiome	1778	1786	abstract	29022384
microbiota	I-microbiome	1787	1797	abstract	29022384
,	O	1797	1798	abstract	29022384
and	O	1799	1802	abstract	29022384
the	O	1803	1806	abstract	29022384
sources	O	1807	1814	abstract	29022384
of	O	1815	1817	abstract	29022384
seeding	O	1818	1825	abstract	29022384
of	O	1826	1828	abstract	29022384
infant	B-microbiome	1829	1835	abstract	29022384
gut	I-microbiome	1836	1839	abstract	29022384
and	I-microbiome	1840	1843	abstract	29022384
nasal	I-microbiome	1844	1849	abstract	29022384
microbiota	I-microbiome	1850	1860	abstract	29022384
remain	O	1861	1867	abstract	29022384
to	O	1868	1870	abstract	29022384
be	O	1871	1873	abstract	29022384
elucidated	O	1874	1884	abstract	29022384
.	O	1884	1885	abstract	29022384

Changes	O	0	7	title	29857583
of	O	8	10	title	29857583
Colonic	O	11	18	title	29857583
Bacterial	O	19	28	title	29857583
Composition	O	29	40	title	29857583
in	O	41	43	title	29857583
Parkinson	B-DDF	44	53	title	29857583
's	I-DDF	53	55	title	29857583
Disease	I-DDF	56	63	title	29857583
and	O	64	67	title	29857583
Other	O	68	73	title	29857583
Neurodegenerative	B-DDF	74	91	title	29857583
Diseases	I-DDF	92	100	title	29857583
.	O	100	101	title	29857583

In	O	0	2	abstract	29857583
recent	O	3	9	abstract	29857583
years	O	10	15	abstract	29857583
evidence	O	16	24	abstract	29857583
has	O	25	28	abstract	29857583
emerged	O	29	36	abstract	29857583
that	O	37	41	abstract	29857583
neurodegenerative	B-DDF	42	59	abstract	29857583
diseases	I-DDF	60	68	abstract	29857583
(	O	69	70	abstract	29857583
NDs	B-DDF	70	73	abstract	29857583
)	O	73	74	abstract	29857583
are	O	75	78	abstract	29857583
strongly	O	79	87	abstract	29857583
associated	O	88	98	abstract	29857583
with	O	99	103	abstract	29857583
the	O	104	107	abstract	29857583
microbiome	O	108	118	abstract	29857583
composition	O	119	130	abstract	29857583
in	O	131	133	abstract	29857583
the	O	134	137	abstract	29857583
gut	B-anatomical%location	138	141	abstract	29857583
.	O	141	142	abstract	29857583

Parkinson	B-DDF	143	152	abstract	29857583
's	I-DDF	152	154	abstract	29857583
disease	I-DDF	155	162	abstract	29857583
(	O	163	164	abstract	29857583
PD	B-DDF	164	166	abstract	29857583
)	O	166	167	abstract	29857583
is	O	168	170	abstract	29857583
the	O	171	174	abstract	29857583
most	O	175	179	abstract	29857583
intensively	O	180	191	abstract	29857583
studied	O	192	199	abstract	29857583
neurodegenerative	B-DDF	200	217	abstract	29857583
disease	I-DDF	218	225	abstract	29857583
in	O	226	228	abstract	29857583
this	O	229	233	abstract	29857583
context	O	234	241	abstract	29857583
.	O	241	242	abstract	29857583

In	O	243	245	abstract	29857583
this	O	246	250	abstract	29857583
review	O	251	257	abstract	29857583
,	O	257	258	abstract	29857583
we	O	259	261	abstract	29857583
performed	O	262	271	abstract	29857583
a	O	272	273	abstract	29857583
systematic	O	274	284	abstract	29857583
evaluation	O	285	295	abstract	29857583
of	O	296	298	abstract	29857583
the	O	299	302	abstract	29857583
published	O	303	312	abstract	29857583
literature	O	313	323	abstract	29857583
comparing	O	324	333	abstract	29857583
changes	O	334	341	abstract	29857583
in	O	342	344	abstract	29857583
colonic	B-microbiome	345	352	abstract	29857583
microbiome	I-microbiome	353	363	abstract	29857583
in	O	364	366	abstract	29857583
PD	B-DDF	367	369	abstract	29857583
to	O	370	372	abstract	29857583
the	O	373	376	abstract	29857583
ones	O	377	381	abstract	29857583
observed	O	382	390	abstract	29857583
in	O	391	393	abstract	29857583
other	O	394	399	abstract	29857583
NDs	B-DDF	400	403	abstract	29857583
including	O	404	413	abstract	29857583
Alzheimer	B-DDF	414	423	abstract	29857583
's	I-DDF	423	425	abstract	29857583
disease	I-DDF	426	433	abstract	29857583
(	O	434	435	abstract	29857583
AD	B-DDF	435	437	abstract	29857583
)	O	437	438	abstract	29857583
,	O	438	439	abstract	29857583
multiple	B-DDF	440	448	abstract	29857583
system	I-DDF	449	455	abstract	29857583
atrophy	I-DDF	456	463	abstract	29857583
(	O	464	465	abstract	29857583
MSA	B-DDF	465	468	abstract	29857583
)	O	468	469	abstract	29857583
,	O	469	470	abstract	29857583
multiple	B-DDF	471	479	abstract	29857583
sclerosis	I-DDF	480	489	abstract	29857583
(	O	490	491	abstract	29857583
MS	B-DDF	491	493	abstract	29857583
)	O	493	494	abstract	29857583
,	O	494	495	abstract	29857583
neuromyelitis	B-DDF	496	509	abstract	29857583
optica	I-DDF	510	516	abstract	29857583
(	O	517	518	abstract	29857583
NMO	B-DDF	518	521	abstract	29857583
)	O	521	522	abstract	29857583
and	O	523	526	abstract	29857583
amyotrophic	B-DDF	527	538	abstract	29857583
lateral	I-DDF	539	546	abstract	29857583
sclerosis	I-DDF	547	556	abstract	29857583
(	O	557	558	abstract	29857583
ALS	B-DDF	558	561	abstract	29857583
)	O	561	562	abstract	29857583
.	O	562	563	abstract	29857583

To	O	564	566	abstract	29857583
enhance	O	567	574	abstract	29857583
the	O	575	578	abstract	29857583
comparability	O	579	592	abstract	29857583
of	O	593	595	abstract	29857583
different	O	596	605	abstract	29857583
studies	O	606	613	abstract	29857583
,	O	613	614	abstract	29857583
only	O	615	619	abstract	29857583
human	O	620	625	abstract	29857583
case-control	O	626	638	abstract	29857583
studies	O	639	646	abstract	29857583
were	O	647	651	abstract	29857583
included	O	652	660	abstract	29857583
.	O	660	661	abstract	29857583

Several	O	662	669	abstract	29857583
studies	O	670	677	abstract	29857583
showed	O	678	684	abstract	29857583
an	O	685	687	abstract	29857583
increase	O	688	696	abstract	29857583
of	O	697	699	abstract	29857583
<	O	700	701	abstract	29857583
i	O	701	702	abstract	29857583
>	O	702	703	abstract	29857583
Lactobacillus</i	B-bacteria	703	719	abstract	29857583
>	O	719	720	abstract	29857583
,	O	720	721	abstract	29857583
<	O	722	723	abstract	29857583
i	O	723	724	abstract	29857583
>	O	724	725	abstract	29857583
Bifidobacterium</i	B-bacteria	725	743	abstract	29857583
>	O	743	744	abstract	29857583
,	O	744	745	abstract	29857583
Verrucomicrobiaceae	B-bacteria	746	765	abstract	29857583
and	O	766	769	abstract	29857583
<	O	770	771	abstract	29857583
i	O	771	772	abstract	29857583
>	O	772	773	abstract	29857583
Akkermansia</i	B-bacteria	773	787	abstract	29857583
>	O	787	788	abstract	29857583
in	O	789	791	abstract	29857583
PD	B-DDF	792	794	abstract	29857583
.	O	794	795	abstract	29857583

A	O	796	797	abstract	29857583
decrease	O	798	806	abstract	29857583
of	O	807	809	abstract	29857583
<	O	810	811	abstract	29857583
i	O	811	812	abstract	29857583
>	O	812	813	abstract	29857583
Faecalibacterium</i	B-bacteria	813	832	abstract	29857583
>	O	832	833	abstract	29857583
spp	O	834	837	abstract	29857583
.	O	837	838	abstract	29857583
,	O	838	839	abstract	29857583
<	O	840	841	abstract	29857583
i	O	841	842	abstract	29857583
>	O	842	843	abstract	29857583
Coprococcus</i	B-bacteria	843	857	abstract	29857583
>	O	857	858	abstract	29857583
spp	O	859	862	abstract	29857583
.	O	862	863	abstract	29857583
,	O	863	864	abstract	29857583
<	O	865	866	abstract	29857583
i	O	866	867	abstract	29857583
>	O	867	868	abstract	29857583
Blautia</i	B-bacteria	868	878	abstract	29857583
>	O	878	879	abstract	29857583
spp	O	880	883	abstract	29857583
.	O	883	884	abstract	29857583
,	O	884	885	abstract	29857583
<	O	886	887	abstract	29857583
i	O	887	888	abstract	29857583
>	O	888	889	abstract	29857583
Prevotella</i	B-bacteria	889	902	abstract	29857583
>	O	902	903	abstract	29857583
spp	O	904	907	abstract	29857583
.	O	907	908	abstract	29857583
and	O	909	912	abstract	29857583
Prevotellaceae	B-bacteria	913	927	abstract	29857583
was	O	928	931	abstract	29857583
observed	O	932	940	abstract	29857583
in	O	941	943	abstract	29857583
PD	B-DDF	944	946	abstract	29857583
.	O	946	947	abstract	29857583

On	O	948	950	abstract	29857583
a	O	951	952	abstract	29857583
low	O	953	956	abstract	29857583
taxonomic	O	957	966	abstract	29857583
resolution	O	967	977	abstract	29857583
,	O	977	978	abstract	29857583
like	O	979	983	abstract	29857583
the	O	984	987	abstract	29857583
phylum	O	988	994	abstract	29857583
level	O	995	1000	abstract	29857583
,	O	1000	1001	abstract	29857583
the	O	1002	1005	abstract	29857583
changes	O	1006	1013	abstract	29857583
are	O	1014	1017	abstract	29857583
not	O	1018	1021	abstract	29857583
disease-specific	O	1022	1038	abstract	29857583
and	O	1039	1042	abstract	29857583
are	O	1043	1046	abstract	29857583
inconsistent	O	1047	1059	abstract	29857583
.	O	1059	1060	abstract	29857583

However	O	1061	1068	abstract	29857583
,	O	1068	1069	abstract	29857583
on	O	1070	1072	abstract	29857583
a	O	1073	1074	abstract	29857583
higher	O	1075	1081	abstract	29857583
taxonomic	O	1082	1091	abstract	29857583
resolution	O	1092	1102	abstract	29857583
like	O	1103	1107	abstract	29857583
genus	O	1108	1113	abstract	29857583
or	O	1114	1116	abstract	29857583
species	O	1117	1124	abstract	29857583
level	O	1125	1130	abstract	29857583
,	O	1130	1131	abstract	29857583
a	O	1132	1133	abstract	29857583
minor	O	1134	1139	abstract	29857583
overlap	O	1140	1147	abstract	29857583
was	O	1148	1151	abstract	29857583
observed	O	1152	1160	abstract	29857583
between	O	1161	1168	abstract	29857583
PD	B-DDF	1169	1171	abstract	29857583
and	O	1172	1175	abstract	29857583
MSA	B-DDF	1176	1179	abstract	29857583
,	O	1179	1180	abstract	29857583
both	O	1181	1185	abstract	29857583
alpha	B-DDF	1186	1191	abstract	29857583
synucleinopathies	I-DDF	1192	1209	abstract	29857583
.	O	1209	1210	abstract	29857583

We	O	1211	1213	abstract	29857583
show	O	1214	1218	abstract	29857583
that	O	1219	1223	abstract	29857583
standardization	O	1224	1239	abstract	29857583
of	O	1240	1242	abstract	29857583
sample	O	1243	1249	abstract	29857583
collection	O	1250	1260	abstract	29857583
and	O	1261	1264	abstract	29857583
analysis	O	1265	1273	abstract	29857583
is	O	1274	1276	abstract	29857583
necessary	O	1277	1286	abstract	29857583
for	O	1287	1290	abstract	29857583
ensuring	O	1291	1299	abstract	29857583
the	O	1300	1303	abstract	29857583
reproducibility	O	1304	1319	abstract	29857583
and	O	1320	1323	abstract	29857583
comparability	O	1324	1337	abstract	29857583
of	O	1338	1340	abstract	29857583
data	O	1341	1345	abstract	29857583
.	O	1345	1346	abstract	29857583

We	O	1347	1349	abstract	29857583
also	O	1350	1354	abstract	29857583
provide	O	1355	1362	abstract	29857583
evidence	O	1363	1371	abstract	29857583
that	O	1372	1376	abstract	29857583
assessing	O	1377	1386	abstract	29857583
the	O	1387	1390	abstract	29857583
microbiota	O	1391	1401	abstract	29857583
composition	O	1402	1413	abstract	29857583
at	O	1414	1416	abstract	29857583
high	O	1417	1421	abstract	29857583
taxonomic	O	1422	1431	abstract	29857583
resolution	O	1432	1442	abstract	29857583
reveals	O	1443	1450	abstract	29857583
changes	O	1451	1458	abstract	29857583
in	O	1459	1461	abstract	29857583
relative	O	1462	1470	abstract	29857583
abundance	O	1471	1480	abstract	29857583
that	O	1481	1485	abstract	29857583
may	O	1486	1489	abstract	29857583
be	O	1490	1492	abstract	29857583
specific	O	1493	1501	abstract	29857583
to	O	1502	1504	abstract	29857583
or	O	1505	1507	abstract	29857583
characteristic	O	1508	1522	abstract	29857583
of	O	1523	1525	abstract	29857583
one	O	1526	1529	abstract	29857583
disease	O	1530	1537	abstract	29857583
or	O	1538	1540	abstract	29857583
disease	O	1541	1548	abstract	29857583
group	O	1549	1554	abstract	29857583
,	O	1554	1555	abstract	29857583
and	O	1556	1559	abstract	29857583
might	O	1560	1565	abstract	29857583
evolve	O	1566	1572	abstract	29857583
discriminative	O	1573	1587	abstract	29857583
power	O	1588	1593	abstract	29857583
.	O	1593	1594	abstract	29857583

The	O	1595	1598	abstract	29857583
interactions	O	1599	1611	abstract	29857583
between	O	1612	1619	abstract	29857583
bacterial	O	1620	1629	abstract	29857583
species	O	1630	1637	abstract	29857583
and	O	1638	1641	abstract	29857583
strains	O	1642	1649	abstract	29857583
and	O	1650	1653	abstract	29857583
the	O	1654	1657	abstract	29857583
co-abundances	O	1658	1671	abstract	29857583
must	O	1672	1676	abstract	29857583
be	O	1677	1679	abstract	29857583
investigated	O	1680	1692	abstract	29857583
before	O	1693	1699	abstract	29857583
assumptions	O	1700	1711	abstract	29857583
about	O	1712	1717	abstract	29857583
the	O	1718	1721	abstract	29857583
effects	O	1722	1729	abstract	29857583
of	O	1730	1732	abstract	29857583
specific	O	1733	1741	abstract	29857583
bacteria	O	1742	1750	abstract	29857583
on	O	1751	1753	abstract	29857583
the	O	1754	1757	abstract	29857583
host	O	1758	1762	abstract	29857583
can	O	1763	1766	abstract	29857583
be	O	1767	1769	abstract	29857583
made	O	1770	1774	abstract	29857583
with	O	1775	1779	abstract	29857583
certainty	O	1780	1789	abstract	29857583
.	O	1789	1790	abstract	29857583

A	O	0	1	title	34758889
fiber-deprived	O	2	16	title	34758889
diet	O	17	21	title	34758889
causes	O	22	28	title	34758889
cognitive	B-DDF	29	38	title	34758889
impairment	I-DDF	39	49	title	34758889
and	O	50	53	title	34758889
hippocampal	B-DDF	54	65	title	34758889
microglia-mediated	I-DDF	66	84	title	34758889
synaptic	I-DDF	85	93	title	34758889
loss	I-DDF	94	98	title	34758889
through	O	99	106	title	34758889
the	O	107	110	title	34758889
gut	B-microbiome	111	114	title	34758889
microbiota	I-microbiome	115	125	title	34758889
and	O	126	129	title	34758889
metabolites	O	130	141	title	34758889
.	O	141	142	title	34758889

Cognitive	B-DDF	0	9	abstract	34758889
impairment	I-DDF	10	20	abstract	34758889
,	O	20	21	abstract	34758889
an	O	22	24	abstract	34758889
increasing	O	25	35	abstract	34758889
mental	O	36	42	abstract	34758889
health	O	43	49	abstract	34758889
issue	O	50	55	abstract	34758889
,	O	55	56	abstract	34758889
is	O	57	59	abstract	34758889
a	O	60	61	abstract	34758889
core	O	62	66	abstract	34758889
feature	O	67	74	abstract	34758889
of	O	75	77	abstract	34758889
the	O	78	81	abstract	34758889
aging	O	82	87	abstract	34758889
brain	O	88	93	abstract	34758889
and	O	94	97	abstract	34758889
neurodegenerative	B-DDF	98	115	abstract	34758889
diseases	I-DDF	116	124	abstract	34758889
.	O	124	125	abstract	34758889

Industrialized	O	126	140	abstract	34758889
nations	O	141	148	abstract	34758889
especially	O	149	159	abstract	34758889
,	O	159	160	abstract	34758889
have	O	161	165	abstract	34758889
experienced	O	166	177	abstract	34758889
a	O	178	179	abstract	34758889
marked	O	180	186	abstract	34758889
decrease	O	187	195	abstract	34758889
in	O	196	198	abstract	34758889
dietary	O	199	206	abstract	34758889
fiber	O	207	212	abstract	34758889
intake	O	213	219	abstract	34758889
,	O	219	220	abstract	34758889
but	O	221	224	abstract	34758889
the	O	225	228	abstract	34758889
potential	O	229	238	abstract	34758889
mechanism	O	239	248	abstract	34758889
linking	O	249	256	abstract	34758889
low	O	257	260	abstract	34758889
fiber	O	261	266	abstract	34758889
intake	O	267	273	abstract	34758889
and	O	274	277	abstract	34758889
cognitive	B-DDF	278	287	abstract	34758889
impairment	I-DDF	288	298	abstract	34758889
is	O	299	301	abstract	34758889
poorly	O	302	308	abstract	34758889
understood	O	309	319	abstract	34758889
.	O	319	320	abstract	34758889

Emerging	O	321	329	abstract	34758889
research	O	330	338	abstract	34758889
reported	O	339	347	abstract	34758889
that	O	348	352	abstract	34758889
the	O	353	356	abstract	34758889
diversity	O	357	366	abstract	34758889
of	O	367	369	abstract	34758889
gut	B-microbiome	370	373	abstract	34758889
microbiota	I-microbiome	374	384	abstract	34758889
in	O	385	387	abstract	34758889
Western	O	388	395	abstract	34758889
populations	O	396	407	abstract	34758889
is	O	408	410	abstract	34758889
significantly	O	411	424	abstract	34758889
reduced	O	425	432	abstract	34758889
.	O	432	433	abstract	34758889

However	O	434	441	abstract	34758889
,	O	441	442	abstract	34758889
it	O	443	445	abstract	34758889
is	O	446	448	abstract	34758889
unknown	O	449	456	abstract	34758889
whether	O	457	464	abstract	34758889
a	O	465	466	abstract	34758889
fiber-deficient	O	467	482	abstract	34758889
diet	O	483	487	abstract	34758889
(	O	488	489	abstract	34758889
which	O	489	494	abstract	34758889
alters	O	495	501	abstract	34758889
gut	O	502	505	abstract	34758889
microbiota	O	506	516	abstract	34758889
)	O	516	517	abstract	34758889
could	O	518	523	abstract	34758889
impair	O	524	530	abstract	34758889
cognition	O	531	540	abstract	34758889
and	O	541	544	abstract	34758889
brain	O	545	550	abstract	34758889
functional	O	551	561	abstract	34758889
elements	O	562	570	abstract	34758889
through	O	571	578	abstract	34758889
the	O	579	582	abstract	34758889
gut-brain	O	583	592	abstract	34758889
axis	O	593	597	abstract	34758889
.	O	597	598	abstract	34758889

In	O	599	601	abstract	34758889
this	O	602	606	abstract	34758889
study	O	607	612	abstract	34758889
,	O	612	613	abstract	34758889
a	O	614	615	abstract	34758889
mouse	O	616	621	abstract	34758889
model	O	622	627	abstract	34758889
of	O	628	630	abstract	34758889
long-term	O	631	640	abstract	34758889
(	O	641	642	abstract	34758889
15	O	642	644	abstract	34758889
weeks	O	645	650	abstract	34758889
)	O	650	651	abstract	34758889
dietary	O	652	659	abstract	34758889
fiber	O	660	665	abstract	34758889
deficiency	O	666	676	abstract	34758889
(	O	677	678	abstract	34758889
FD	O	678	680	abstract	34758889
)	O	680	681	abstract	34758889
was	O	682	685	abstract	34758889
used	O	686	690	abstract	34758889
to	O	691	693	abstract	34758889
mimic	O	694	699	abstract	34758889
a	O	700	701	abstract	34758889
sustained	O	702	711	abstract	34758889
low	O	712	715	abstract	34758889
fiber	O	716	721	abstract	34758889
intake	O	722	728	abstract	34758889
in	O	729	731	abstract	34758889
humans	B-human	732	738	abstract	34758889
.	O	738	739	abstract	34758889

We	O	740	742	abstract	34758889
found	O	743	748	abstract	34758889
that	O	749	753	abstract	34758889
FD	B-animal	754	756	abstract	34758889
mice	I-animal	757	761	abstract	34758889
showed	O	762	768	abstract	34758889
impaired	B-DDF	769	777	abstract	34758889
cognition	I-DDF	778	787	abstract	34758889
,	O	787	788	abstract	34758889
including	O	789	798	abstract	34758889
deficits	O	799	807	abstract	34758889
in	O	808	810	abstract	34758889
object	O	811	817	abstract	34758889
location	O	818	826	abstract	34758889
memory	O	827	833	abstract	34758889
,	O	833	834	abstract	34758889
temporal	O	835	843	abstract	34758889
order	O	844	849	abstract	34758889
memory	O	850	856	abstract	34758889
,	O	856	857	abstract	34758889
and	O	858	861	abstract	34758889
the	O	862	865	abstract	34758889
ability	O	866	873	abstract	34758889
to	O	874	876	abstract	34758889
perform	O	877	884	abstract	34758889
daily	O	885	890	abstract	34758889
living	O	891	897	abstract	34758889
activities	O	898	908	abstract	34758889
.	O	908	909	abstract	34758889

The	O	910	913	abstract	34758889
hippocampal	B-anatomical%location	914	925	abstract	34758889
synaptic	I-anatomical%location	926	934	abstract	34758889
ultrastructure	I-anatomical%location	935	949	abstract	34758889
was	O	950	953	abstract	34758889
damaged	O	954	961	abstract	34758889
in	O	962	964	abstract	34758889
FD	B-animal	965	967	abstract	34758889
mice	I-animal	968	972	abstract	34758889
,	O	972	973	abstract	34758889
characterized	O	974	987	abstract	34758889
by	O	988	990	abstract	34758889
widened	O	991	998	abstract	34758889
synaptic	B-anatomical%location	999	1007	abstract	34758889
clefts	I-anatomical%location	1008	1014	abstract	34758889
and	O	1015	1018	abstract	34758889
thinned	O	1019	1026	abstract	34758889
postsynaptic	B-anatomical%location	1027	1039	abstract	34758889
densities	I-anatomical%location	1040	1049	abstract	34758889
.	O	1049	1050	abstract	34758889

A	O	1051	1052	abstract	34758889
hippocampal	B-biomedical%technique	1053	1064	abstract	34758889
proteomic	I-biomedical%technique	1065	1074	abstract	34758889
analysis	I-biomedical%technique	1075	1083	abstract	34758889
further	O	1084	1091	abstract	34758889
identified	O	1092	1102	abstract	34758889
a	O	1103	1104	abstract	34758889
deficit	O	1105	1112	abstract	34758889
of	O	1113	1115	abstract	34758889
CaMKIId	B-gene	1116	1123	abstract	34758889
and	O	1124	1127	abstract	34758889
its	O	1128	1131	abstract	34758889
associated	B-chemical	1132	1142	abstract	34758889
synaptic	I-chemical	1143	1151	abstract	34758889
proteins	I-chemical	1152	1160	abstract	34758889
(	O	1161	1162	abstract	34758889
including	O	1162	1171	abstract	34758889
GAP43	B-chemical	1172	1177	abstract	34758889
and	O	1178	1181	abstract	34758889
SV2C	B-chemical	1182	1186	abstract	34758889
)	O	1186	1187	abstract	34758889
in	O	1188	1190	abstract	34758889
the	O	1191	1194	abstract	34758889
FD	B-animal	1195	1197	abstract	34758889
mice	I-animal	1198	1202	abstract	34758889
,	O	1202	1203	abstract	34758889
along	O	1204	1209	abstract	34758889
with	O	1210	1214	abstract	34758889
neuroinflammation	O	1215	1232	abstract	34758889
and	O	1233	1236	abstract	34758889
microglial	O	1237	1247	abstract	34758889
engulfment	O	1248	1258	abstract	34758889
of	O	1259	1261	abstract	34758889
synapses	O	1262	1270	abstract	34758889
.	O	1270	1271	abstract	34758889

The	O	1272	1275	abstract	34758889
FD	B-animal	1276	1278	abstract	34758889
mice	I-animal	1279	1283	abstract	34758889
also	O	1284	1288	abstract	34758889
exhibited	O	1289	1298	abstract	34758889
gut	B-DDF	1299	1302	abstract	34758889
microbiota	I-DDF	1303	1313	abstract	34758889
dysbiosis	I-DDF	1314	1323	abstract	34758889
(	O	1324	1325	abstract	34758889
decreased	O	1325	1334	abstract	34758889
Bacteroidetes	B-bacteria	1335	1348	abstract	34758889
and	O	1349	1352	abstract	34758889
increased	O	1353	1362	abstract	34758889
Proteobacteria	B-bacteria	1363	1377	abstract	34758889
)	O	1377	1378	abstract	34758889
,	O	1378	1379	abstract	34758889
which	O	1380	1385	abstract	34758889
was	O	1386	1389	abstract	34758889
significantly	O	1390	1403	abstract	34758889
associated	O	1404	1414	abstract	34758889
with	O	1415	1419	abstract	34758889
the	O	1420	1423	abstract	34758889
cognitive	O	1424	1433	abstract	34758889
deficits	O	1434	1442	abstract	34758889
.	O	1442	1443	abstract	34758889

Of	O	1444	1446	abstract	34758889
note	O	1447	1451	abstract	34758889
,	O	1451	1452	abstract	34758889
a	O	1453	1454	abstract	34758889
rapid	O	1455	1460	abstract	34758889
differentiating	O	1461	1476	abstract	34758889
microbiota	O	1477	1487	abstract	34758889
change	O	1488	1494	abstract	34758889
was	O	1495	1498	abstract	34758889
observed	O	1499	1507	abstract	34758889
in	O	1508	1510	abstract	34758889
the	O	1511	1514	abstract	34758889
mice	B-animal	1515	1519	abstract	34758889
with	I-animal	1520	1524	abstract	34758889
a	I-animal	1525	1526	abstract	34758889
short-term	I-animal	1527	1537	abstract	34758889
FD	I-animal	1538	1540	abstract	34758889
diet	I-animal	1541	1545	abstract	34758889
(	I-animal	1546	1547	abstract	34758889
7	I-animal	1547	1548	abstract	34758889
days	I-animal	1549	1553	abstract	34758889
)	I-animal	1553	1554	abstract	34758889
before	O	1555	1561	abstract	34758889
cognitive	B-DDF	1562	1571	abstract	34758889
impairment	I-DDF	1572	1582	abstract	34758889
,	O	1582	1583	abstract	34758889
highlighting	O	1584	1596	abstract	34758889
a	O	1597	1598	abstract	34758889
possible	O	1599	1607	abstract	34758889
causal	O	1608	1614	abstract	34758889
impact	O	1615	1621	abstract	34758889
of	O	1622	1624	abstract	34758889
the	O	1625	1628	abstract	34758889
gut	O	1629	1632	abstract	34758889
microbiota	O	1633	1643	abstract	34758889
profile	O	1644	1651	abstract	34758889
on	O	1652	1654	abstract	34758889
cognitive	O	1655	1664	abstract	34758889
outcomes	O	1665	1673	abstract	34758889
.	O	1673	1674	abstract	34758889

Moreover	O	1675	1683	abstract	34758889
,	O	1683	1684	abstract	34758889
the	O	1685	1688	abstract	34758889
FD	O	1689	1691	abstract	34758889
diet	O	1692	1696	abstract	34758889
compromised	O	1697	1708	abstract	34758889
the	O	1709	1712	abstract	34758889
intestinal	O	1713	1723	abstract	34758889
barrier	O	1724	1731	abstract	34758889
and	O	1732	1735	abstract	34758889
reduced	O	1736	1743	abstract	34758889
short-chain	B-chemical	1744	1755	abstract	34758889
fatty	I-chemical	1756	1761	abstract	34758889
acid	I-chemical	1762	1766	abstract	34758889
(	O	1767	1768	abstract	34758889
SCFA	B-chemical	1768	1772	abstract	34758889
)	O	1772	1773	abstract	34758889
production	O	1774	1784	abstract	34758889
.	O	1784	1785	abstract	34758889

We	O	1786	1788	abstract	34758889
exploit	O	1789	1796	abstract	34758889
these	O	1797	1802	abstract	34758889
findings	O	1803	1811	abstract	34758889
for	O	1812	1815	abstract	34758889
SCFA	B-animal	1816	1820	abstract	34758889
receptor	I-animal	1821	1829	abstract	34758889
knockout	I-animal	1830	1838	abstract	34758889
mice	I-animal	1839	1843	abstract	34758889
and	O	1844	1847	abstract	34758889
oral	B-dietary%supplement	1848	1852	abstract	34758889
SCFA	I-dietary%supplement	1853	1857	abstract	34758889
supplementation	I-dietary%supplement	1858	1873	abstract	34758889
that	O	1874	1878	abstract	34758889
verified	O	1879	1887	abstract	34758889
SCFA	B-chemical	1888	1892	abstract	34758889
playing	O	1893	1900	abstract	34758889
a	O	1901	1902	abstract	34758889
critical	O	1903	1911	abstract	34758889
role	O	1912	1916	abstract	34758889
linking	O	1917	1924	abstract	34758889
the	O	1925	1928	abstract	34758889
altered	B-microbiome	1929	1936	abstract	34758889
gut	I-microbiome	1937	1940	abstract	34758889
microbiota	I-microbiome	1941	1951	abstract	34758889
and	O	1952	1955	abstract	34758889
cognitive	B-DDF	1956	1965	abstract	34758889
impairment	I-DDF	1966	1976	abstract	34758889
.	O	1976	1977	abstract	34758889

This	O	1978	1982	abstract	34758889
study	O	1983	1988	abstract	34758889
,	O	1988	1989	abstract	34758889
for	O	1990	1993	abstract	34758889
the	O	1994	1997	abstract	34758889
first	O	1998	2003	abstract	34758889
time	O	2004	2008	abstract	34758889
,	O	2008	2009	abstract	34758889
reports	O	2010	2017	abstract	34758889
that	O	2018	2022	abstract	34758889
a	O	2023	2024	abstract	34758889
fiber-deprived	O	2025	2039	abstract	34758889
diet	O	2040	2044	abstract	34758889
leads	O	2045	2050	abstract	34758889
to	O	2051	2053	abstract	34758889
cognitive	B-DDF	2054	2063	abstract	34758889
impairment	I-DDF	2064	2074	abstract	34758889
through	O	2075	2082	abstract	34758889
altering	O	2083	2091	abstract	34758889
the	O	2092	2095	abstract	34758889
gut	O	2096	2099	abstract	34758889
microbiota-hippocampal	O	2100	2122	abstract	34758889
axis	O	2123	2127	abstract	34758889
,	O	2127	2128	abstract	34758889
which	O	2129	2134	abstract	34758889
is	O	2135	2137	abstract	34758889
pathologically	O	2138	2152	abstract	34758889
distinct	O	2153	2161	abstract	34758889
from	O	2162	2166	abstract	34758889
normal	O	2167	2173	abstract	34758889
brain	O	2174	2179	abstract	34758889
aging	O	2180	2185	abstract	34758889
.	O	2185	2186	abstract	34758889

These	O	2187	2192	abstract	34758889
findings	O	2193	2201	abstract	34758889
alert	O	2202	2207	abstract	34758889
the	O	2208	2211	abstract	34758889
adverse	O	2212	2219	abstract	34758889
impact	O	2220	2226	abstract	34758889
of	O	2227	2229	abstract	34758889
dietary	O	2230	2237	abstract	34758889
fiber	O	2238	2243	abstract	34758889
deficiency	O	2244	2254	abstract	34758889
on	O	2255	2257	abstract	34758889
brain	O	2258	2263	abstract	34758889
function	O	2264	2272	abstract	34758889
,	O	2272	2273	abstract	34758889
and	O	2274	2277	abstract	34758889
highlight	O	2278	2287	abstract	34758889
an	O	2288	2290	abstract	34758889
increase	O	2291	2299	abstract	34758889
in	O	2300	2302	abstract	34758889
fiber	O	2303	2308	abstract	34758889
intake	O	2309	2315	abstract	34758889
as	O	2316	2318	abstract	34758889
a	O	2319	2320	abstract	34758889
nutritional	O	2321	2332	abstract	34758889
strategy	O	2333	2341	abstract	34758889
to	O	2342	2344	abstract	34758889
reduce	O	2345	2351	abstract	34758889
the	O	2352	2355	abstract	34758889
risk	O	2356	2360	abstract	34758889
of	O	2361	2363	abstract	34758889
developing	O	2364	2374	abstract	34758889
diet-associated	O	2375	2390	abstract	34758889
cognitive	O	2391	2400	abstract	34758889
decline	O	2401	2408	abstract	34758889
and	O	2409	2412	abstract	34758889
neurodegenerative	B-DDF	2413	2430	abstract	34758889
diseases	I-DDF	2431	2439	abstract	34758889
.	O	2439	2440	abstract	34758889

Video	O	2441	2446	abstract	34758889
Abstract	O	2447	2455	abstract	34758889
.	O	2455	2456	abstract	34758889

Repeated	B-biomedical%technique	0	8	title	37881577
Social	I-biomedical%technique	9	15	title	37881577
Defeat	I-biomedical%technique	16	22	title	37881577
Stress	I-biomedical%technique	23	29	title	37881577
Induces	O	30	37	title	37881577
an	O	38	40	title	37881577
Inflammatory	B-DDF	41	53	title	37881577
Gut	I-DDF	54	57	title	37881577
Milieu	I-DDF	58	64	title	37881577
by	O	65	67	title	37881577
Altering	O	68	76	title	37881577
the	O	77	80	title	37881577
Mucosal	O	81	88	title	37881577
Barrier	O	89	96	title	37881577
Integrity	O	97	106	title	37881577
and	O	107	110	title	37881577
Gut	O	111	114	title	37881577
Microbiota	O	115	125	title	37881577
Homeostasis	O	126	137	title	37881577
.	O	137	138	title	37881577

Posttraumatic	B-DDF	0	13	abstract	37881577
stress	I-DDF	14	20	abstract	37881577
disorder	I-DDF	21	29	abstract	37881577
(	O	30	31	abstract	37881577
PTSD	B-DDF	31	35	abstract	37881577
)	O	35	36	abstract	37881577
is	O	37	39	abstract	37881577
a	O	40	41	abstract	37881577
mental	O	42	48	abstract	37881577
health	O	49	55	abstract	37881577
condition	O	56	65	abstract	37881577
triggered	O	66	75	abstract	37881577
by	O	76	78	abstract	37881577
exposure	O	79	87	abstract	37881577
to	O	88	90	abstract	37881577
traumatic	O	91	100	abstract	37881577
events	O	101	107	abstract	37881577
in	O	108	110	abstract	37881577
an	O	111	113	abstract	37881577
individual	O	114	124	abstract	37881577
's	O	124	126	abstract	37881577
life	O	127	131	abstract	37881577
.	O	131	132	abstract	37881577

Patients	B-human	133	141	abstract	37881577
with	O	142	146	abstract	37881577
PTSD	B-DDF	147	151	abstract	37881577
are	O	152	155	abstract	37881577
also	O	156	160	abstract	37881577
at	O	161	163	abstract	37881577
a	O	164	165	abstract	37881577
higher	O	166	172	abstract	37881577
risk	O	173	177	abstract	37881577
for	O	178	181	abstract	37881577
comorbidities	O	182	195	abstract	37881577
.	O	195	196	abstract	37881577

However	O	197	204	abstract	37881577
,	O	204	205	abstract	37881577
it	O	206	208	abstract	37881577
is	O	209	211	abstract	37881577
not	O	212	215	abstract	37881577
well	O	216	220	abstract	37881577
understood	O	221	231	abstract	37881577
how	O	232	235	abstract	37881577
PTSD	B-DDF	236	240	abstract	37881577
affects	O	241	248	abstract	37881577
human	O	249	254	abstract	37881577
health	O	255	261	abstract	37881577
and/or	O	262	268	abstract	37881577
promotes	O	269	277	abstract	37881577
the	O	278	281	abstract	37881577
risk	O	282	286	abstract	37881577
for	O	287	290	abstract	37881577
comorbidities	O	291	304	abstract	37881577
.	O	304	305	abstract	37881577

Nevertheless	O	306	318	abstract	37881577
,	O	318	319	abstract	37881577
patients	O	320	328	abstract	37881577
with	O	329	333	abstract	37881577
PTSD	B-DDF	334	338	abstract	37881577
harbor	O	339	345	abstract	37881577
a	O	346	347	abstract	37881577
proinflammatory	O	348	363	abstract	37881577
milieu	O	364	370	abstract	37881577
and	O	371	374	abstract	37881577
dysbiotic	B-microbiome	375	384	abstract	37881577
gut	I-microbiome	385	388	abstract	37881577
microbiota	I-microbiome	389	399	abstract	37881577
.	O	399	400	abstract	37881577

Gut	O	401	404	abstract	37881577
barrier	O	405	412	abstract	37881577
integrity	O	413	422	abstract	37881577
helps	O	423	428	abstract	37881577
to	O	429	431	abstract	37881577
maintain	O	432	440	abstract	37881577
normal	O	441	447	abstract	37881577
gut	O	448	451	abstract	37881577
homeostasis	O	452	463	abstract	37881577
and	O	464	467	abstract	37881577
its	O	468	471	abstract	37881577
dysregulation	O	472	485	abstract	37881577
promotes	O	486	494	abstract	37881577
gut	B-DDF	495	498	abstract	37881577
dysbiosis	I-DDF	499	508	abstract	37881577
and	I-DDF	509	512	abstract	37881577
inflammation	I-DDF	513	525	abstract	37881577
.	O	525	526	abstract	37881577

We	O	527	529	abstract	37881577
used	O	530	534	abstract	37881577
a	O	535	536	abstract	37881577
mouse	B-animal	537	542	abstract	37881577
model	I-animal	543	548	abstract	37881577
of	O	549	551	abstract	37881577
repeated	B-biomedical%technique	552	560	abstract	37881577
social	I-biomedical%technique	561	567	abstract	37881577
defeat	I-biomedical%technique	568	574	abstract	37881577
stress	I-biomedical%technique	575	581	abstract	37881577
(	O	582	583	abstract	37881577
RSDS	B-biomedical%technique	583	587	abstract	37881577
)	O	587	588	abstract	37881577
,	O	588	589	abstract	37881577
a	O	590	591	abstract	37881577
preclinical	O	592	603	abstract	37881577
model	O	604	609	abstract	37881577
of	O	610	612	abstract	37881577
PTSD	B-DDF	613	617	abstract	37881577
.	O	617	618	abstract	37881577

Behavioral	O	619	629	abstract	37881577
studies	O	630	637	abstract	37881577
,	O	637	638	abstract	37881577
metagenomics	B-biomedical%technique	639	651	abstract	37881577
analysis	I-biomedical%technique	652	660	abstract	37881577
of	I-biomedical%technique	661	663	abstract	37881577
the	I-biomedical%technique	664	667	abstract	37881577
microbiome	I-biomedical%technique	668	678	abstract	37881577
,	O	678	679	abstract	37881577
gut	B-biomedical%technique	680	683	abstract	37881577
permeability	I-biomedical%technique	684	696	abstract	37881577
assay	I-biomedical%technique	697	702	abstract	37881577
(	O	703	704	abstract	37881577
on	O	704	706	abstract	37881577
mouse	B-anatomical%location	707	712	abstract	37881577
colon	I-anatomical%location	713	718	abstract	37881577
,	O	718	719	abstract	37881577
using	O	720	725	abstract	37881577
an	O	726	728	abstract	37881577
Ussing	B-biomedical%technique	729	735	abstract	37881577
chamber	I-biomedical%technique	736	743	abstract	37881577
)	O	743	744	abstract	37881577
,	O	744	745	abstract	37881577
immunoblotting	B-biomedical%technique	746	760	abstract	37881577
,	O	760	761	abstract	37881577
and	O	762	765	abstract	37881577
immunohistochemical	B-biomedical%technique	766	785	abstract	37881577
analyses	I-biomedical%technique	786	794	abstract	37881577
were	O	795	799	abstract	37881577
performed	O	800	809	abstract	37881577
.	O	809	810	abstract	37881577

Polarized	O	811	820	abstract	37881577
intestinal	O	821	831	abstract	37881577
epithelial	O	832	842	abstract	37881577
cells	O	843	848	abstract	37881577
and	O	849	852	abstract	37881577
3-dimensional	O	853	866	abstract	37881577
crypt	O	867	872	abstract	37881577
cultures	O	873	881	abstract	37881577
were	O	882	886	abstract	37881577
used	O	887	891	abstract	37881577
for	O	892	895	abstract	37881577
mechanistic	B-biomedical%technique	896	907	abstract	37881577
analysis	I-biomedical%technique	908	916	abstract	37881577
.	O	916	917	abstract	37881577

The	O	918	921	abstract	37881577
RSDS	B-animal	922	926	abstract	37881577
mice	I-animal	927	931	abstract	37881577
harbor	O	932	938	abstract	37881577
a	O	939	940	abstract	37881577
heightened	O	941	951	abstract	37881577
proinflammatory	O	952	967	abstract	37881577
gut	O	968	971	abstract	37881577
environment	O	972	983	abstract	37881577
and	O	984	987	abstract	37881577
microbiota	B-DDF	988	998	abstract	37881577
dysbiosis	I-DDF	999	1008	abstract	37881577
.	O	1008	1009	abstract	37881577

The	O	1010	1013	abstract	37881577
RSDS	B-animal	1014	1018	abstract	37881577
mice	I-animal	1019	1023	abstract	37881577
further	O	1024	1031	abstract	37881577
showed	O	1032	1038	abstract	37881577
significant	O	1039	1050	abstract	37881577
dysregulation	B-DDF	1051	1064	abstract	37881577
of	I-DDF	1065	1067	abstract	37881577
gut	I-DDF	1068	1071	abstract	37881577
barrier	I-DDF	1072	1079	abstract	37881577
functions	I-DDF	1080	1089	abstract	37881577
,	O	1089	1090	abstract	37881577
including	O	1091	1100	abstract	37881577
transepithelial	B-DDF	1101	1116	abstract	37881577
electrical	I-DDF	1117	1127	abstract	37881577
resistance	I-DDF	1128	1138	abstract	37881577
,	O	1138	1139	abstract	37881577
mucin	B-DDF	1140	1145	abstract	37881577
homeostasis	I-DDF	1146	1157	abstract	37881577
,	O	1157	1158	abstract	37881577
and	O	1159	1162	abstract	37881577
antimicrobial	B-DDF	1163	1176	abstract	37881577
responses	I-DDF	1177	1186	abstract	37881577
.	O	1186	1187	abstract	37881577

RSDS	B-animal	1188	1192	abstract	37881577
mice	I-animal	1193	1197	abstract	37881577
also	O	1198	1202	abstract	37881577
showed	O	1203	1209	abstract	37881577
a	O	1210	1211	abstract	37881577
specific	O	1212	1220	abstract	37881577
increase	O	1221	1229	abstract	37881577
in	O	1230	1232	abstract	37881577
intestinal	O	1233	1243	abstract	37881577
expression	O	1244	1254	abstract	37881577
of	O	1255	1257	abstract	37881577
claudin-2	B-chemical	1258	1267	abstract	37881577
,	O	1267	1268	abstract	37881577
a	O	1269	1270	abstract	37881577
tight	O	1271	1276	abstract	37881577
junction	O	1277	1285	abstract	37881577
protein	O	1286	1293	abstract	37881577
,	O	1293	1294	abstract	37881577
and	O	1295	1298	abstract	37881577
epinephrine	B-chemical	1299	1310	abstract	37881577
,	O	1310	1311	abstract	37881577
a	O	1312	1313	abstract	37881577
stress-induced	O	1314	1328	abstract	37881577
neurotransmitter	O	1329	1345	abstract	37881577
.	O	1345	1346	abstract	37881577

Treating	O	1347	1355	abstract	37881577
intestinal	O	1356	1366	abstract	37881577
epithelial	O	1367	1377	abstract	37881577
cells	O	1378	1383	abstract	37881577
or	O	1384	1386	abstract	37881577
3-dimensional	O	1387	1400	abstract	37881577
cultured	O	1401	1409	abstract	37881577
crypts	O	1410	1416	abstract	37881577
with	O	1417	1421	abstract	37881577
norepinephrine	B-chemical	1422	1436	abstract	37881577
or	O	1437	1439	abstract	37881577
intestinal	O	1440	1450	abstract	37881577
luminal	O	1451	1458	abstract	37881577
contents	O	1459	1467	abstract	37881577
(	O	1468	1469	abstract	37881577
fecal	O	1469	1474	abstract	37881577
contents	O	1475	1483	abstract	37881577
)	O	1483	1484	abstract	37881577
upregulated	O	1485	1496	abstract	37881577
claudin-2	O	1497	1506	abstract	37881577
expression	O	1507	1517	abstract	37881577
and	O	1518	1521	abstract	37881577
inhibited	O	1522	1531	abstract	37881577
transepithelial	O	1532	1547	abstract	37881577
electrical	O	1548	1558	abstract	37881577
resistance	O	1559	1569	abstract	37881577
.	O	1569	1570	abstract	37881577

Traumatic	B-DDF	1571	1580	abstract	37881577
stress	I-DDF	1581	1587	abstract	37881577
induces	O	1588	1595	abstract	37881577
dysregulation	B-DDF	1596	1609	abstract	37881577
of	I-DDF	1610	1612	abstract	37881577
gut	I-DDF	1613	1616	abstract	37881577
barrier	I-DDF	1617	1624	abstract	37881577
functions	I-DDF	1625	1634	abstract	37881577
,	O	1634	1635	abstract	37881577
which	O	1636	1641	abstract	37881577
may	O	1642	1645	abstract	37881577
underlie	O	1646	1654	abstract	37881577
the	O	1655	1658	abstract	37881577
observed	O	1659	1667	abstract	37881577
gut	B-microbiome	1668	1671	abstract	37881577
microbiota	I-microbiome	1672	1682	abstract	37881577
changes	O	1683	1690	abstract	37881577
and	O	1691	1694	abstract	37881577
proinflammatory	B-DDF	1695	1710	abstract	37881577
gut	I-DDF	1711	1714	abstract	37881577
milieu	I-DDF	1715	1721	abstract	37881577
,	O	1721	1722	abstract	37881577
all	O	1723	1726	abstract	37881577
of	O	1727	1729	abstract	37881577
which	O	1730	1735	abstract	37881577
may	O	1736	1739	abstract	37881577
have	O	1740	1744	abstract	37881577
an	O	1745	1747	abstract	37881577
interdependent	O	1748	1762	abstract	37881577
effect	O	1763	1769	abstract	37881577
on	O	1770	1772	abstract	37881577
the	O	1773	1776	abstract	37881577
health	O	1777	1783	abstract	37881577
and	O	1784	1787	abstract	37881577
increased	O	1788	1797	abstract	37881577
risk	O	1798	1802	abstract	37881577
of	O	1803	1805	abstract	37881577
comorbidities	O	1806	1819	abstract	37881577
in	O	1820	1822	abstract	37881577
patients	O	1823	1831	abstract	37881577
with	O	1832	1836	abstract	37881577
PTSD	B-DDF	1837	1841	abstract	37881577
.	O	1841	1842	abstract	37881577

Controlling	O	0	11	title	36984505
the	O	12	15	title	36984505
Impact	O	16	22	title	36984505
of	O	23	25	title	36984505
<	B-DDF	26	27	title	36984505
i	I-DDF	27	28	title	36984505
>	I-DDF	28	29	title	36984505
Helicobacter	I-DDF	29	41	title	36984505
pylori</i>-Related	I-DDF	42	60	title	36984505
Hyperhomocysteinemia	I-DDF	61	81	title	36984505
on	O	82	84	title	36984505
Neurodegeneration	B-DDF	85	102	title	36984505
.	O	102	103	title	36984505

<	B-DDF	0	1	abstract	36984505
i	I-DDF	1	2	abstract	36984505
>	I-DDF	2	3	abstract	36984505
Helicobacter	I-DDF	3	15	abstract	36984505
pylori</i	I-DDF	16	25	abstract	36984505
>	I-DDF	25	26	abstract	36984505
infection	I-DDF	27	36	abstract	36984505
consists	O	37	45	abstract	36984505
a	O	46	47	abstract	36984505
high	O	48	52	abstract	36984505
global	O	53	59	abstract	36984505
burden	O	60	66	abstract	36984505
affecting	O	67	76	abstract	36984505
more	O	77	81	abstract	36984505
than	O	82	86	abstract	36984505
50	O	87	89	abstract	36984505
%	O	89	90	abstract	36984505
of	O	91	93	abstract	36984505
the	O	94	97	abstract	36984505
world	B-human	98	103	abstract	36984505
's	I-human	103	105	abstract	36984505
population	I-human	106	116	abstract	36984505
.	O	116	117	abstract	36984505

It	O	118	120	abstract	36984505
is	O	121	123	abstract	36984505
implicated	O	124	134	abstract	36984505
,	O	134	135	abstract	36984505
beyond	O	136	142	abstract	36984505
substantiated	B-DDF	143	156	abstract	36984505
local	I-DDF	157	162	abstract	36984505
gastric	I-DDF	163	170	abstract	36984505
pathologies	I-DDF	171	182	abstract	36984505
,	O	182	183	abstract	36984505
i.e.	O	184	188	abstract	36984505
,	O	188	189	abstract	36984505
peptic	B-DDF	190	196	abstract	36984505
ulcers	I-DDF	197	203	abstract	36984505
and	O	204	207	abstract	36984505
gastric	B-DDF	208	215	abstract	36984505
cancer	I-DDF	216	222	abstract	36984505
,	O	222	223	abstract	36984505
in	O	224	226	abstract	36984505
the	O	227	230	abstract	36984505
pathophysiology	O	231	246	abstract	36984505
of	O	247	249	abstract	36984505
several	O	250	257	abstract	36984505
neurodegenerative	B-DDF	258	275	abstract	36984505
disorders	I-DDF	276	285	abstract	36984505
,	O	285	286	abstract	36984505
mainly	O	287	293	abstract	36984505
by	O	294	296	abstract	36984505
inducing	O	297	305	abstract	36984505
hyperhomocysteinemia-related	B-DDF	306	334	abstract	36984505
brain	I-DDF	335	340	abstract	36984505
cortical	I-DDF	341	349	abstract	36984505
thinning	I-DDF	350	358	abstract	36984505
(	O	359	360	abstract	36984505
BCT	B-DDF	360	363	abstract	36984505
)	O	363	364	abstract	36984505
.	O	364	365	abstract	36984505

BCT	B-DDF	366	369	abstract	36984505
has	O	370	373	abstract	36984505
been	O	374	378	abstract	36984505
advocated	O	379	388	abstract	36984505
as	O	389	391	abstract	36984505
a	O	392	393	abstract	36984505
possible	O	394	402	abstract	36984505
biomarker	O	403	412	abstract	36984505
associated	O	413	423	abstract	36984505
with	O	424	428	abstract	36984505
neurodegenerative	B-DDF	429	446	abstract	36984505
central	I-DDF	447	454	abstract	36984505
nervous	I-DDF	455	462	abstract	36984505
system	I-DDF	463	469	abstract	36984505
disorders	I-DDF	470	479	abstract	36984505
such	O	480	484	abstract	36984505
as	O	485	487	abstract	36984505
Alzheimer	B-DDF	488	497	abstract	36984505
's	I-DDF	497	499	abstract	36984505
disease	I-DDF	500	507	abstract	36984505
,	O	507	508	abstract	36984505
Parkinson	B-DDF	509	518	abstract	36984505
's	I-DDF	518	520	abstract	36984505
disease	I-DDF	521	528	abstract	36984505
,	O	528	529	abstract	36984505
multiple	B-DDF	530	538	abstract	36984505
sclerosis	I-DDF	539	548	abstract	36984505
,	O	548	549	abstract	36984505
and/or	O	550	556	abstract	36984505
glaucoma	B-DDF	557	565	abstract	36984505
,	O	565	566	abstract	36984505
termed	O	567	573	abstract	36984505
as	O	574	576	abstract	36984505
"	O	577	578	abstract	36984505
ocular	B-DDF	578	584	abstract	36984505
Alzheimer	I-DDF	585	594	abstract	36984505
's	I-DDF	594	596	abstract	36984505
disease	I-DDF	597	604	abstract	36984505
"	O	604	605	abstract	36984505
.	O	605	606	abstract	36984505

According	O	607	616	abstract	36984505
to	O	617	619	abstract	36984505
the	O	620	623	abstract	36984505
infection	O	624	633	abstract	36984505
hypothesis	O	634	644	abstract	36984505
in	O	645	647	abstract	36984505
relation	O	648	656	abstract	36984505
to	O	657	659	abstract	36984505
neurodegeneration	B-DDF	660	677	abstract	36984505
,	O	677	678	abstract	36984505
<	O	679	680	abstract	36984505
i	O	680	681	abstract	36984505
>	O	681	682	abstract	36984505
Helicobacter	B-bacteria	682	694	abstract	36984505
pylori</i	I-bacteria	695	704	abstract	36984505
>	O	704	705	abstract	36984505
as	O	706	708	abstract	36984505
non-commensal	B-microbiome	709	722	abstract	36984505
gut	I-microbiome	723	726	abstract	36984505
microbiome	I-microbiome	727	737	abstract	36984505
has	O	738	741	abstract	36984505
been	O	742	746	abstract	36984505
advocated	O	747	756	abstract	36984505
as	O	757	759	abstract	36984505
trigger	O	760	767	abstract	36984505
and/or	O	768	774	abstract	36984505
mediator	O	775	783	abstract	36984505
of	O	784	786	abstract	36984505
neurodegenerative	B-DDF	787	804	abstract	36984505
diseases	I-DDF	805	813	abstract	36984505
,	O	813	814	abstract	36984505
such	O	815	819	abstract	36984505
as	O	820	822	abstract	36984505
the	O	823	826	abstract	36984505
development	O	827	838	abstract	36984505
of	O	839	841	abstract	36984505
Alzheimer	B-DDF	842	851	abstract	36984505
's	I-DDF	851	853	abstract	36984505
disease	I-DDF	854	861	abstract	36984505
.	O	861	862	abstract	36984505

Among	O	863	868	abstract	36984505
others	O	869	875	abstract	36984505
,	O	875	876	abstract	36984505
<	B-chemical	877	878	abstract	36984505
i	I-chemical	878	879	abstract	36984505
>	I-chemical	879	880	abstract	36984505
Helicobacter	I-chemical	880	892	abstract	36984505
pylori</i>-related	I-chemical	893	911	abstract	36984505
inflammatory	I-chemical	912	924	abstract	36984505
mediators	I-chemical	925	934	abstract	36984505
,	O	934	935	abstract	36984505
defensins	B-chemical	936	945	abstract	36984505
,	O	945	946	abstract	36984505
autophagy	O	947	956	abstract	36984505
,	O	956	957	abstract	36984505
vitamin	B-chemical	958	965	abstract	36984505
D	I-chemical	966	967	abstract	36984505
,	O	967	968	abstract	36984505
dietary	O	969	976	abstract	36984505
factors	O	977	984	abstract	36984505
,	O	984	985	abstract	36984505
role	O	986	990	abstract	36984505
of	O	991	993	abstract	36984505
probiotics	B-dietary%supplement	994	1004	abstract	36984505
,	O	1004	1005	abstract	36984505
and	O	1006	1009	abstract	36984505
some	O	1010	1014	abstract	36984505
pathogenetic	O	1015	1027	abstract	36984505
considerations	O	1028	1042	abstract	36984505
including	O	1043	1052	abstract	36984505
relevant	O	1053	1061	abstract	36984505
involved	O	1062	1070	abstract	36984505
genes	O	1071	1076	abstract	36984505
are	O	1077	1080	abstract	36984505
discussed	O	1081	1090	abstract	36984505
within	O	1091	1097	abstract	36984505
this	O	1098	1102	abstract	36984505
opinion	O	1103	1110	abstract	36984505
article	O	1111	1118	abstract	36984505
.	O	1118	1119	abstract	36984505

In	O	1120	1122	abstract	36984505
conclusion	O	1123	1133	abstract	36984505
,	O	1133	1134	abstract	36984505
by	O	1135	1137	abstract	36984505
controlling	O	1138	1149	abstract	36984505
the	O	1150	1153	abstract	36984505
impact	O	1154	1160	abstract	36984505
of	O	1161	1163	abstract	36984505
<	B-DDF	1164	1165	abstract	36984505
i	I-DDF	1165	1166	abstract	36984505
>	I-DDF	1166	1167	abstract	36984505
Helicobacter	I-DDF	1167	1179	abstract	36984505
pylori</i>-related	I-DDF	1180	1198	abstract	36984505
hyperhomocysteinemia	I-DDF	1199	1219	abstract	36984505
on	O	1220	1222	abstract	36984505
neurodegenerative	B-DDF	1223	1240	abstract	36984505
disorders	I-DDF	1241	1250	abstract	36984505
might	O	1251	1256	abstract	36984505
offer	O	1257	1262	abstract	36984505
benefits	O	1263	1271	abstract	36984505
,	O	1271	1272	abstract	36984505
and	O	1273	1276	abstract	36984505
additional	O	1277	1287	abstract	36984505
research	O	1288	1296	abstract	36984505
is	O	1297	1299	abstract	36984505
warranted	O	1300	1309	abstract	36984505
to	O	1310	1312	abstract	36984505
clarify	O	1313	1320	abstract	36984505
this	O	1321	1325	abstract	36984505
crucial	O	1326	1333	abstract	36984505
topic	O	1334	1339	abstract	36984505
currently	O	1340	1349	abstract	36984505
representing	O	1350	1362	abstract	36984505
a	O	1363	1364	abstract	36984505
major	O	1365	1370	abstract	36984505
worldwide	O	1371	1380	abstract	36984505
burden	O	1381	1387	abstract	36984505
.	O	1387	1388	abstract	36984505

Shotgun	B-biomedical%technique	0	7	title	32979562
metagenomics	I-biomedical%technique	8	20	title	32979562
reveals	O	21	28	title	32979562
both	O	29	33	title	32979562
taxonomic	O	34	43	title	32979562
and	O	44	47	title	32979562
tryptophan	O	48	58	title	32979562
pathway	O	59	66	title	32979562
differences	O	67	78	title	32979562
of	O	79	81	title	32979562
gut	B-microbiome	82	85	title	32979562
microbiota	I-microbiome	86	96	title	32979562
in	O	97	99	title	32979562
bipolar	B-DDF	100	107	title	32979562
disorder	I-DDF	108	116	title	32979562
with	O	117	121	title	32979562
current	O	122	129	title	32979562
major	B-human	130	135	title	32979562
depressive	I-human	136	146	title	32979562
episode	I-human	147	154	title	32979562
patients	I-human	155	163	title	32979562
.	O	163	164	title	32979562

The	O	0	3	abstract	32979562
microbiome-gut-brain	O	4	24	abstract	32979562
axis	O	25	29	abstract	32979562
,	O	29	30	abstract	32979562
especially	O	31	41	abstract	32979562
the	O	42	45	abstract	32979562
microbial	B-chemical	46	55	abstract	32979562
tryptophan	I-chemical	56	66	abstract	32979562
biosynthesis	O	67	79	abstract	32979562
and	O	80	83	abstract	32979562
metabolism	O	84	94	abstract	32979562
pathway	O	95	102	abstract	32979562
(	O	103	104	abstract	32979562
MiTBamp	O	104	111	abstract	32979562
)	O	111	112	abstract	32979562
,	O	112	113	abstract	32979562
is	O	114	116	abstract	32979562
closely	O	117	124	abstract	32979562
connected	O	125	134	abstract	32979562
to	O	135	137	abstract	32979562
bipolar	B-DDF	138	145	abstract	32979562
disorder	I-DDF	146	154	abstract	32979562
with	O	155	159	abstract	32979562
current	O	160	167	abstract	32979562
major	B-DDF	168	173	abstract	32979562
depressive	I-DDF	174	184	abstract	32979562
episode	I-DDF	185	192	abstract	32979562
(	O	193	194	abstract	32979562
BPD	B-DDF	194	197	abstract	32979562
)	O	197	198	abstract	32979562
.	O	198	199	abstract	32979562

We	O	200	202	abstract	32979562
performed	O	203	212	abstract	32979562
shotgun	B-biomedical%technique	213	220	abstract	32979562
metagenomics	I-biomedical%technique	221	233	abstract	32979562
sequencing	I-biomedical%technique	234	244	abstract	32979562
(	O	245	246	abstract	32979562
SMS	B-biomedical%technique	246	249	abstract	32979562
)	O	249	250	abstract	32979562
of	O	251	253	abstract	32979562
faecal	O	254	260	abstract	32979562
samples	O	261	268	abstract	32979562
from	O	269	273	abstract	32979562
25	O	274	276	abstract	32979562
BPD	B-DDF	277	280	abstract	32979562
patients	B-human	281	289	abstract	32979562
and	O	290	293	abstract	32979562
28	O	294	296	abstract	32979562
healthy	B-human	297	304	abstract	32979562
controls	I-human	305	313	abstract	32979562
(	O	314	315	abstract	32979562
HCs	B-human	315	318	abstract	32979562
)	O	318	319	abstract	32979562
.	O	319	320	abstract	32979562

Except	O	321	327	abstract	32979562
for	O	328	331	abstract	32979562
the	O	332	335	abstract	32979562
microbiota	O	336	346	abstract	32979562
taxa	O	347	351	abstract	32979562
and	O	352	355	abstract	32979562
MiTBamp	O	356	363	abstract	32979562
analyses	O	364	372	abstract	32979562
,	O	372	373	abstract	32979562
we	O	374	376	abstract	32979562
also	O	377	381	abstract	32979562
built	O	382	387	abstract	32979562
a	O	388	389	abstract	32979562
classification	O	390	404	abstract	32979562
model	O	405	410	abstract	32979562
using	O	411	416	abstract	32979562
the	O	417	420	abstract	32979562
Random	B-statistical%technique	421	427	abstract	32979562
Forests	I-statistical%technique	428	435	abstract	32979562
(	O	436	437	abstract	32979562
RF	B-statistical%technique	437	439	abstract	32979562
)	O	439	440	abstract	32979562
and	O	441	444	abstract	32979562
Boruta	B-statistical%technique	445	451	abstract	32979562
algorithm	I-statistical%technique	452	461	abstract	32979562
to	O	462	464	abstract	32979562
find	O	465	469	abstract	32979562
the	O	470	473	abstract	32979562
microbial	O	474	483	abstract	32979562
biomarkers	O	484	494	abstract	32979562
for	O	495	498	abstract	32979562
BPD	B-DDF	499	502	abstract	32979562
.	O	502	503	abstract	32979562

Compared	O	504	512	abstract	32979562
to	O	513	515	abstract	32979562
HCs	B-human	516	519	abstract	32979562
,	O	519	520	abstract	32979562
the	O	521	524	abstract	32979562
phylum	O	525	531	abstract	32979562
Bacteroidetes	B-bacteria	532	545	abstract	32979562
abundance	O	546	555	abstract	32979562
was	O	556	559	abstract	32979562
significantly	O	560	573	abstract	32979562
reduced	O	574	581	abstract	32979562
,	O	581	582	abstract	32979562
whereas	O	583	590	abstract	32979562
that	O	591	595	abstract	32979562
of	O	596	598	abstract	32979562
the	O	599	602	abstract	32979562
Actinobacteria	B-bacteria	603	617	abstract	32979562
and	O	618	621	abstract	32979562
Firmicutes	B-bacteria	622	632	abstract	32979562
were	O	633	637	abstract	32979562
significantly	O	638	651	abstract	32979562
increased	O	652	661	abstract	32979562
in	O	662	664	abstract	32979562
BPD	B-DDF	665	668	abstract	32979562
patients	O	669	677	abstract	32979562
.	O	677	678	abstract	32979562

We	O	679	681	abstract	32979562
also	O	682	686	abstract	32979562
identified	O	687	697	abstract	32979562
38	O	698	700	abstract	32979562
species	O	701	708	abstract	32979562
increased	O	709	718	abstract	32979562
and	O	719	722	abstract	32979562
6	O	723	724	abstract	32979562
species	O	725	732	abstract	32979562
decreased	O	733	742	abstract	32979562
significantly	O	743	756	abstract	32979562
in	O	757	759	abstract	32979562
the	O	760	763	abstract	32979562
BPD	B-DDF	764	767	abstract	32979562
group	O	768	773	abstract	32979562
.	O	773	774	abstract	32979562

In	O	775	777	abstract	32979562
the	O	778	781	abstract	32979562
MiTBamp	O	782	789	abstract	32979562
,	O	789	790	abstract	32979562
we	O	791	793	abstract	32979562
identified	O	794	804	abstract	32979562
that	O	805	809	abstract	32979562
two	O	810	813	abstract	32979562
Kyoto	O	814	819	abstract	32979562
Encyclopedia	O	820	832	abstract	32979562
of	O	833	835	abstract	32979562
Genes	O	836	841	abstract	32979562
and	O	842	845	abstract	32979562
Genomes	O	846	853	abstract	32979562
(	O	854	855	abstract	32979562
KEGG	O	855	859	abstract	32979562
)	O	859	860	abstract	32979562
orthologies	O	861	872	abstract	32979562
(	O	873	874	abstract	32979562
KOs	O	874	877	abstract	32979562
)	O	877	878	abstract	32979562
(	O	879	880	abstract	32979562
K00658	B-gene	880	886	abstract	32979562
and	O	887	890	abstract	32979562
K00837	B-gene	891	897	abstract	32979562
)	O	897	898	abstract	32979562
were	O	899	903	abstract	32979562
significantly	O	904	917	abstract	32979562
lower	O	918	923	abstract	32979562
in	O	924	926	abstract	32979562
the	O	927	930	abstract	32979562
BPD	B-DDF	931	934	abstract	32979562
,	O	934	935	abstract	32979562
and	O	936	939	abstract	32979562
five	O	940	944	abstract	32979562
KOs	O	945	948	abstract	32979562
(	O	949	950	abstract	32979562
K01696	B-gene	950	956	abstract	32979562
,	O	956	957	abstract	32979562
K00382	B-gene	958	964	abstract	32979562
,	O	964	965	abstract	32979562
K00626	B-gene	966	972	abstract	32979562
,	O	972	973	abstract	32979562
K01667	B-gene	974	980	abstract	32979562
,	O	980	981	abstract	32979562
and	O	982	985	abstract	32979562
K03781	B-gene	986	992	abstract	32979562
)	O	992	993	abstract	32979562
were	O	994	998	abstract	32979562
significantly	O	999	1012	abstract	32979562
higher	O	1013	1019	abstract	32979562
in	O	1020	1022	abstract	32979562
the	O	1023	1026	abstract	32979562
BPD	B-DDF	1027	1030	abstract	32979562
group	O	1031	1036	abstract	32979562
.	O	1036	1037	abstract	32979562

We	O	1038	1040	abstract	32979562
also	O	1041	1045	abstract	32979562
identified	O	1046	1056	abstract	32979562
significant	O	1057	1068	abstract	32979562
genera	O	1069	1075	abstract	32979562
and	O	1076	1079	abstract	32979562
species	O	1080	1087	abstract	32979562
which	O	1088	1093	abstract	32979562
were	O	1094	1098	abstract	32979562
closely	O	1099	1106	abstract	32979562
related	O	1107	1114	abstract	32979562
to	O	1115	1117	abstract	32979562
these	O	1118	1123	abstract	32979562
KOs	O	1124	1127	abstract	32979562
.	O	1127	1128	abstract	32979562

Finally	O	1129	1136	abstract	32979562
,	O	1136	1137	abstract	32979562
RF	B-statistical%technique	1138	1140	abstract	32979562
classification	O	1141	1155	abstract	32979562
based	O	1156	1161	abstract	32979562
on	O	1162	1164	abstract	32979562
gut	B-microbiome	1165	1168	abstract	32979562
microbiota	I-microbiome	1169	1179	abstract	32979562
at	O	1180	1182	abstract	32979562
the	O	1183	1186	abstract	32979562
genus	O	1187	1192	abstract	32979562
level	O	1193	1198	abstract	32979562
can	O	1199	1202	abstract	32979562
achieve	O	1203	1210	abstract	32979562
an	O	1211	1213	abstract	32979562
area	O	1214	1218	abstract	32979562
under	O	1219	1224	abstract	32979562
the	O	1225	1228	abstract	32979562
receiver	O	1229	1237	abstract	32979562
operating	O	1238	1247	abstract	32979562
characteristic	O	1248	1262	abstract	32979562
curve	O	1263	1268	abstract	32979562
of	O	1269	1271	abstract	32979562
0.997	O	1272	1277	abstract	32979562
.	O	1277	1278	abstract	32979562

The	O	1279	1282	abstract	32979562
features	O	1283	1291	abstract	32979562
of	O	1292	1294	abstract	32979562
cross-sectional	O	1295	1310	abstract	32979562
design	O	1311	1317	abstract	32979562
,	O	1317	1318	abstract	32979562
limited	O	1319	1326	abstract	32979562
sample	O	1327	1333	abstract	32979562
size	O	1334	1338	abstract	32979562
,	O	1338	1339	abstract	32979562
the	O	1340	1343	abstract	32979562
heterogeneity	O	1344	1357	abstract	32979562
of	O	1358	1360	abstract	32979562
bipolar	B-DDF	1361	1368	abstract	32979562
disorders	I-DDF	1369	1378	abstract	32979562
,	O	1378	1379	abstract	32979562
and	O	1380	1383	abstract	32979562
a	O	1384	1385	abstract	32979562
lack	O	1386	1390	abstract	32979562
of	O	1391	1393	abstract	32979562
serum/plasma	O	1394	1406	abstract	32979562
tryptophan	B-biomedical%technique	1407	1417	abstract	32979562
concentration	I-biomedical%technique	1418	1431	abstract	32979562
measurements	I-biomedical%technique	1432	1444	abstract	32979562
.	O	1444	1445	abstract	32979562

The	O	1446	1449	abstract	32979562
present	O	1450	1457	abstract	32979562
findings	O	1458	1466	abstract	32979562
enable	O	1467	1473	abstract	32979562
a	O	1474	1475	abstract	32979562
better	O	1476	1482	abstract	32979562
understanding	O	1483	1496	abstract	32979562
of	O	1497	1499	abstract	32979562
changes	O	1500	1507	abstract	32979562
in	O	1508	1510	abstract	32979562
gastrointestinal	B-microbiome	1511	1527	abstract	32979562
microbiome	I-microbiome	1528	1538	abstract	32979562
and	O	1539	1542	abstract	32979562
MiTBamp	O	1543	1550	abstract	32979562
in	O	1551	1553	abstract	32979562
BPD	B-DDF	1554	1557	abstract	32979562
.	O	1557	1558	abstract	32979562

Alterations	O	1559	1570	abstract	32979562
of	O	1571	1573	abstract	32979562
microbes	B-bacteria	1574	1582	abstract	32979562
may	O	1583	1586	abstract	32979562
have	O	1587	1591	abstract	32979562
potential	O	1592	1601	abstract	32979562
as	O	1602	1604	abstract	32979562
biomarkers	O	1605	1615	abstract	32979562
for	O	1616	1619	abstract	32979562
distinguishing	O	1620	1634	abstract	32979562
the	O	1635	1638	abstract	32979562
BPD	B-DDF	1639	1642	abstract	32979562
patients	O	1643	1651	abstract	32979562
form	O	1652	1656	abstract	32979562
HCs	B-human	1657	1660	abstract	32979562
.	O	1660	1661	abstract	32979562

Effects	O	0	7	title	34961418
of	O	8	10	title	34961418
Berberine	B-dietary%supplement	11	20	title	34961418
on	O	21	23	title	34961418
Gut	B-microbiome	24	27	title	34961418
Microbiota	I-microbiome	28	38	title	34961418
in	O	39	41	title	34961418
Patients	B-human	42	50	title	34961418
with	O	51	55	title	34961418
Mild	B-DDF	56	60	title	34961418
Metabolic	I-DDF	61	70	title	34961418
Disorders	I-DDF	71	80	title	34961418
Induced	O	81	88	title	34961418
by	O	89	91	title	34961418
Olanzapine	B-drug	92	102	title	34961418
.	O	102	103	title	34961418

Secondary	B-DDF	0	9	abstract	34961418
metabolic	I-DDF	10	19	abstract	34961418
disturbances	I-DDF	20	32	abstract	34961418
in	O	33	35	abstract	34961418
patients	B-human	36	44	abstract	34961418
with	O	45	49	abstract	34961418
schizophrenia	B-DDF	50	63	abstract	34961418
or	O	64	66	abstract	34961418
bipolar	B-DDF	67	74	abstract	34961418
disorder	I-DDF	75	83	abstract	34961418
may	O	84	87	abstract	34961418
be	O	88	90	abstract	34961418
attributed	O	91	101	abstract	34961418
to	O	102	104	abstract	34961418
olanzapine	B-drug	105	115	abstract	34961418
.	O	115	116	abstract	34961418

It	O	117	119	abstract	34961418
is	O	120	122	abstract	34961418
important	O	123	132	abstract	34961418
to	O	133	135	abstract	34961418
prevent	O	136	143	abstract	34961418
mild	B-DDF	144	148	abstract	34961418
metabolic	I-DDF	149	158	abstract	34961418
disorders	I-DDF	159	168	abstract	34961418
progressing	O	169	180	abstract	34961418
to	O	181	183	abstract	34961418
metabolic	B-DDF	184	193	abstract	34961418
syndrome	I-DDF	194	202	abstract	34961418
.	O	202	203	abstract	34961418

This	O	204	208	abstract	34961418
study	O	209	214	abstract	34961418
aims	O	215	219	abstract	34961418
to	O	220	222	abstract	34961418
investigate	O	223	234	abstract	34961418
the	O	235	238	abstract	34961418
effects	O	239	246	abstract	34961418
of	O	247	249	abstract	34961418
berberine	B-dietary%supplement	250	259	abstract	34961418
on	O	260	262	abstract	34961418
intestinal	B-microbiome	263	273	abstract	34961418
flora	I-microbiome	274	279	abstract	34961418
in	O	280	282	abstract	34961418
patients	B-human	283	291	abstract	34961418
with	O	292	296	abstract	34961418
mild	B-DDF	297	301	abstract	34961418
metabolic	I-DDF	302	311	abstract	34961418
disorders	I-DDF	312	321	abstract	34961418
induced	O	322	329	abstract	34961418
by	O	330	332	abstract	34961418
olanzapine	B-drug	333	343	abstract	34961418
.	O	343	344	abstract	34961418

A	O	345	346	abstract	34961418
total	O	347	352	abstract	34961418
of	O	353	355	abstract	34961418
132	O	356	359	abstract	34961418
patients	B-human	360	368	abstract	34961418
with	O	369	373	abstract	34961418
schizophrenia	B-DDF	374	387	abstract	34961418
,	O	387	388	abstract	34961418
bipolar	B-DDF	389	396	abstract	34961418
disorder	I-DDF	397	405	abstract	34961418
,	O	405	406	abstract	34961418
or	O	407	409	abstract	34961418
schizoaffective	B-DDF	410	425	abstract	34961418
psychosis	I-DDF	426	435	abstract	34961418
that	O	436	440	abstract	34961418
had	O	441	444	abstract	34961418
been	O	445	449	abstract	34961418
treated	O	450	457	abstract	34961418
with	O	458	462	abstract	34961418
olanzapine	B-drug	463	473	abstract	34961418
for	O	474	477	abstract	34961418
at	O	478	480	abstract	34961418
least	O	481	486	abstract	34961418
9	O	487	488	abstract	34961418
months	O	489	495	abstract	34961418
were	O	496	500	abstract	34961418
randomly	O	501	509	abstract	34961418
assigned	O	510	518	abstract	34961418
(	O	519	520	abstract	34961418
[	O	520	521	abstract	34961418
Formula	O	521	528	abstract	34961418
:	O	528	529	abstract	34961418
see	O	530	533	abstract	34961418
text	O	534	538	abstract	34961418
]	O	538	539	abstract	34961418
=	O	540	541	abstract	34961418
66	O	542	544	abstract	34961418
each	O	545	549	abstract	34961418
)	O	549	550	abstract	34961418
to	O	551	553	abstract	34961418
receive	O	554	561	abstract	34961418
berberine	B-dietary%supplement	562	571	abstract	34961418
or	O	572	574	abstract	34961418
placebo	B-drug	575	582	abstract	34961418
tablets	I-drug	583	590	abstract	34961418
for	O	591	594	abstract	34961418
12	O	595	597	abstract	34961418
weeks	O	598	603	abstract	34961418
.	O	603	604	abstract	34961418

Metabolic	O	605	614	abstract	34961418
assessments	O	615	626	abstract	34961418
and	O	627	630	abstract	34961418
intestinal	B-microbiome	631	641	abstract	34961418
flora	I-microbiome	642	647	abstract	34961418
were	O	648	652	abstract	34961418
quantified	O	653	663	abstract	34961418
at	O	664	666	abstract	34961418
baseline	O	667	675	abstract	34961418
and	O	676	679	abstract	34961418
after	O	680	685	abstract	34961418
4	O	686	687	abstract	34961418
,	O	687	688	abstract	34961418
8	O	689	690	abstract	34961418
,	O	690	691	abstract	34961418
and	O	692	695	abstract	34961418
12	O	696	698	abstract	34961418
weeks	O	699	704	abstract	34961418
of	O	705	707	abstract	34961418
treatment	O	708	717	abstract	34961418
.	O	717	718	abstract	34961418

Incidence	O	719	728	abstract	34961418
rates	O	729	734	abstract	34961418
of	O	735	737	abstract	34961418
adverse	O	738	745	abstract	34961418
reactions	O	746	755	abstract	34961418
were	O	756	760	abstract	34961418
recorded	O	761	769	abstract	34961418
.	O	769	770	abstract	34961418

FPG	B-biomedical%technique	771	774	abstract	34961418
,	O	774	775	abstract	34961418
FPI	B-biomedical%technique	776	779	abstract	34961418
,	O	779	780	abstract	34961418
HOMA-IR	B-biomedical%technique	781	788	abstract	34961418
,	O	788	789	abstract	34961418
HbA1	B-gene	790	794	abstract	34961418
,	O	794	795	abstract	34961418
TG	O	796	798	abstract	34961418
,	O	798	799	abstract	34961418
BMI	O	800	803	abstract	34961418
,	O	803	804	abstract	34961418
and	O	805	808	abstract	34961418
WC	O	809	811	abstract	34961418
were	O	812	816	abstract	34961418
significantly	O	817	830	abstract	34961418
lower	O	831	836	abstract	34961418
in	O	837	839	abstract	34961418
patients	B-human	840	848	abstract	34961418
who	O	849	852	abstract	34961418
received	O	853	861	abstract	34961418
berberine	B-dietary%supplement	862	871	abstract	34961418
compared	O	872	880	abstract	34961418
to	O	881	883	abstract	34961418
placebo	B-drug	884	891	abstract	34961418
after	O	892	897	abstract	34961418
12	O	898	900	abstract	34961418
weeks	O	901	906	abstract	34961418
of	O	907	909	abstract	34961418
treatment	O	910	919	abstract	34961418
(	O	920	921	abstract	34961418
[	O	921	922	abstract	34961418
Formula	O	922	929	abstract	34961418
:	O	929	930	abstract	34961418
see	O	931	934	abstract	34961418
text	O	935	939	abstract	34961418
]	O	939	940	abstract	34961418
<	O	940	941	abstract	34961418
0.05	O	942	946	abstract	34961418
)	O	946	947	abstract	34961418
.	O	947	948	abstract	34961418

The	O	949	952	abstract	34961418
abundance	O	953	962	abstract	34961418
of	O	963	965	abstract	34961418
firmicutes	B-bacteria	966	976	abstract	34961418
and	O	977	980	abstract	34961418
coliform	B-bacteria	981	989	abstract	34961418
were	O	990	994	abstract	34961418
significantly	O	995	1008	abstract	34961418
lower	O	1009	1014	abstract	34961418
and	O	1015	1018	abstract	34961418
the	O	1019	1022	abstract	34961418
abundance	O	1023	1032	abstract	34961418
of	O	1033	1035	abstract	34961418
bacteroides	B-bacteria	1036	1047	abstract	34961418
significantly	O	1048	1061	abstract	34961418
higher	O	1062	1068	abstract	34961418
in	O	1069	1071	abstract	34961418
patients	B-human	1072	1080	abstract	34961418
who	O	1081	1084	abstract	34961418
received	O	1085	1093	abstract	34961418
berberine	B-dietary%supplement	1094	1103	abstract	34961418
compared	O	1104	1112	abstract	34961418
to	O	1113	1115	abstract	34961418
placebo	B-drug	1116	1123	abstract	34961418
after	O	1124	1129	abstract	34961418
12	O	1130	1132	abstract	34961418
weeks	O	1133	1138	abstract	34961418
of	O	1139	1141	abstract	34961418
treatment	O	1142	1151	abstract	34961418
(	O	1152	1153	abstract	34961418
[	O	1153	1154	abstract	34961418
Formula	O	1154	1161	abstract	34961418
:	O	1161	1162	abstract	34961418
see	O	1163	1166	abstract	34961418
text	O	1167	1171	abstract	34961418
]	O	1171	1172	abstract	34961418
<	O	1172	1173	abstract	34961418
0.05	O	1174	1178	abstract	34961418
)	O	1178	1179	abstract	34961418
.	O	1179	1180	abstract	34961418

In	O	1181	1183	abstract	34961418
patients	B-human	1184	1192	abstract	34961418
who	O	1193	1196	abstract	34961418
received	O	1197	1205	abstract	34961418
berberine	B-dietary%supplement	1206	1215	abstract	34961418
,	O	1215	1216	abstract	34961418
the	O	1217	1220	abstract	34961418
abundance	O	1221	1230	abstract	34961418
of	O	1231	1233	abstract	34961418
firmicutes	B-bacteria	1234	1244	abstract	34961418
was	O	1245	1248	abstract	34961418
significantly	O	1249	1262	abstract	34961418
decreased	O	1263	1272	abstract	34961418
,	O	1272	1273	abstract	34961418
and	O	1274	1277	abstract	34961418
the	O	1278	1281	abstract	34961418
abundance	O	1282	1291	abstract	34961418
of	O	1292	1294	abstract	34961418
bacteroides	B-bacteria	1295	1306	abstract	34961418
was	O	1307	1310	abstract	34961418
significantly	O	1311	1324	abstract	34961418
increased	O	1325	1334	abstract	34961418
,	O	1334	1335	abstract	34961418
and	O	1336	1339	abstract	34961418
in	O	1340	1342	abstract	34961418
patients	B-human	1343	1351	abstract	34961418
who	O	1352	1355	abstract	34961418
received	O	1356	1364	abstract	34961418
placebo	B-drug	1365	1372	abstract	34961418
,	O	1372	1373	abstract	34961418
the	O	1374	1377	abstract	34961418
abundance	O	1378	1387	abstract	34961418
of	O	1388	1390	abstract	34961418
firmicutes	B-bacteria	1391	1401	abstract	34961418
was	O	1402	1405	abstract	34961418
significantly	O	1406	1419	abstract	34961418
increased	O	1420	1429	abstract	34961418
post-treatment	O	1430	1444	abstract	34961418
,	O	1444	1445	abstract	34961418
compared	O	1446	1454	abstract	34961418
to	O	1455	1457	abstract	34961418
baseline	O	1458	1466	abstract	34961418
(	O	1467	1468	abstract	34961418
both	O	1468	1472	abstract	34961418
[	O	1473	1474	abstract	34961418
Formula	O	1474	1481	abstract	34961418
:	O	1481	1482	abstract	34961418
see	O	1483	1486	abstract	34961418
text	O	1487	1491	abstract	34961418
]	O	1491	1492	abstract	34961418
<	O	1492	1493	abstract	34961418
0.05	O	1494	1498	abstract	34961418
)	O	1498	1499	abstract	34961418
.	O	1499	1500	abstract	34961418

In	O	1501	1503	abstract	34961418
conclusions	O	1504	1515	abstract	34961418
,	O	1515	1516	abstract	34961418
berberine	B-dietary%supplement	1517	1526	abstract	34961418
may	O	1527	1530	abstract	34961418
regulate	O	1531	1539	abstract	34961418
intestinal	B-microbiome	1540	1550	abstract	34961418
flora	I-microbiome	1551	1556	abstract	34961418
and	O	1557	1560	abstract	34961418
metabolism	O	1561	1571	abstract	34961418
in	O	1572	1574	abstract	34961418
patients	B-human	1575	1583	abstract	34961418
with	O	1584	1588	abstract	34961418
schizophrenia	B-DDF	1589	1602	abstract	34961418
or	O	1603	1605	abstract	34961418
bipolar	B-DDF	1606	1613	abstract	34961418
disorder	I-DDF	1614	1622	abstract	34961418
and	O	1623	1626	abstract	34961418
mild	B-DDF	1627	1631	abstract	34961418
metabolic	I-DDF	1632	1641	abstract	34961418
disturbances	I-DDF	1642	1654	abstract	34961418
induced	O	1655	1662	abstract	34961418
by	O	1663	1665	abstract	34961418
olanzapine	B-drug	1666	1676	abstract	34961418
.	O	1676	1677	abstract	34961418

Autoimmune	B-DDF	0	10	title	25034760
diseases	I-DDF	11	19	title	25034760
,	O	19	20	title	25034760
gastrointestinal	B-DDF	21	37	title	25034760
disorders	I-DDF	38	47	title	25034760
and	O	48	51	title	25034760
the	O	52	55	title	25034760
microbiome	O	56	66	title	25034760
in	O	67	69	title	25034760
schizophrenia	B-DDF	70	83	title	25034760
:	O	83	84	title	25034760
more	O	85	89	title	25034760
than	O	90	94	title	25034760
a	O	95	96	title	25034760
gut	O	97	100	title	25034760
feeling	O	101	108	title	25034760
.	O	108	109	title	25034760

Autoimmunity	B-DDF	0	12	abstract	25034760
,	O	12	13	abstract	25034760
gastrointestinal	B-DDF	14	30	abstract	25034760
(	I-DDF	31	32	abstract	25034760
GI	I-DDF	32	34	abstract	25034760
)	I-DDF	34	35	abstract	25034760
disorders	I-DDF	36	45	abstract	25034760
and	O	46	49	abstract	25034760
schizophrenia	B-DDF	50	63	abstract	25034760
have	O	64	68	abstract	25034760
been	O	69	73	abstract	25034760
associated	O	74	84	abstract	25034760
with	O	85	89	abstract	25034760
one	O	90	93	abstract	25034760
another	O	94	101	abstract	25034760
for	O	102	105	abstract	25034760
a	O	106	107	abstract	25034760
long	O	108	112	abstract	25034760
time	O	113	117	abstract	25034760
.	O	117	118	abstract	25034760

This	O	119	123	abstract	25034760
paper	O	124	129	abstract	25034760
reviews	O	130	137	abstract	25034760
these	O	138	143	abstract	25034760
connections	O	144	155	abstract	25034760
and	O	156	159	abstract	25034760
provides	O	160	168	abstract	25034760
a	O	169	170	abstract	25034760
context	O	171	178	abstract	25034760
by	O	179	181	abstract	25034760
which	O	182	187	abstract	25034760
multiple	O	188	196	abstract	25034760
risk	O	197	201	abstract	25034760
factors	O	202	209	abstract	25034760
for	O	210	213	abstract	25034760
schizophrenia	B-DDF	214	227	abstract	25034760
may	O	228	231	abstract	25034760
be	O	232	234	abstract	25034760
related	O	235	242	abstract	25034760
.	O	242	243	abstract	25034760

Epidemiological	O	244	259	abstract	25034760
studies	O	260	267	abstract	25034760
strongly	O	268	276	abstract	25034760
link	O	277	281	abstract	25034760
schizophrenia	B-DDF	282	295	abstract	25034760
with	O	296	300	abstract	25034760
autoimmune	B-DDF	301	311	abstract	25034760
disorders	I-DDF	312	321	abstract	25034760
including	O	322	331	abstract	25034760
enteropathic	B-DDF	332	344	abstract	25034760
celiac	I-DDF	345	351	abstract	25034760
disease	I-DDF	352	359	abstract	25034760
.	O	359	360	abstract	25034760

Exposure	O	361	369	abstract	25034760
to	O	370	372	abstract	25034760
wheat	B-chemical	373	378	abstract	25034760
gluten	I-chemical	379	385	abstract	25034760
and	O	386	389	abstract	25034760
bovine	B-chemical	390	396	abstract	25034760
milk	I-chemical	397	401	abstract	25034760
casein	I-chemical	402	408	abstract	25034760
also	O	409	413	abstract	25034760
contribute	O	414	424	abstract	25034760
to	O	425	427	abstract	25034760
non-celiac	B-DDF	428	438	abstract	25034760
food	I-DDF	439	443	abstract	25034760
sensitivities	I-DDF	444	457	abstract	25034760
in	O	458	460	abstract	25034760
susceptible	O	461	472	abstract	25034760
individuals	B-human	473	484	abstract	25034760
.	O	484	485	abstract	25034760

Co-morbid	B-DDF	486	495	abstract	25034760
GI	I-DDF	496	498	abstract	25034760
inflammation	I-DDF	499	511	abstract	25034760
accompanies	O	512	523	abstract	25034760
humoral	B-DDF	524	531	abstract	25034760
immunity	I-DDF	532	540	abstract	25034760
to	O	541	543	abstract	25034760
food	B-chemical	544	548	abstract	25034760
antigens	I-chemical	549	557	abstract	25034760
,	O	557	558	abstract	25034760
occurs	O	559	565	abstract	25034760
early	O	566	571	abstract	25034760
during	O	572	578	abstract	25034760
the	O	579	582	abstract	25034760
course	O	583	589	abstract	25034760
of	O	590	592	abstract	25034760
schizophrenia	B-DDF	593	606	abstract	25034760
and	O	607	610	abstract	25034760
appears	O	611	618	abstract	25034760
to	O	619	621	abstract	25034760
be	O	622	624	abstract	25034760
independent	O	625	636	abstract	25034760
from	O	637	641	abstract	25034760
antipsychotic-generated	B-DDF	642	665	abstract	25034760
motility	I-DDF	666	674	abstract	25034760
effects	I-DDF	675	682	abstract	25034760
.	O	682	683	abstract	25034760

This	O	684	688	abstract	25034760
inflammation	B-DDF	689	701	abstract	25034760
impacts	O	702	709	abstract	25034760
endothelial	O	710	721	abstract	25034760
barrier	O	722	729	abstract	25034760
permeability	O	730	742	abstract	25034760
and	O	743	746	abstract	25034760
can	O	747	750	abstract	25034760
precipitate	O	751	762	abstract	25034760
translocation	O	763	776	abstract	25034760
of	O	777	779	abstract	25034760
gut	B-bacteria	780	783	abstract	25034760
bacteria	I-bacteria	784	792	abstract	25034760
into	O	793	797	abstract	25034760
systemic	B-anatomical%location	798	806	abstract	25034760
circulation	I-anatomical%location	807	818	abstract	25034760
.	O	818	819	abstract	25034760

Infection	B-DDF	820	829	abstract	25034760
by	O	830	832	abstract	25034760
the	O	833	836	abstract	25034760
neurotropic	O	837	848	abstract	25034760
gut	O	849	852	abstract	25034760
pathogen	O	853	861	abstract	25034760
,	O	861	862	abstract	25034760
Toxoplasma	B-bacteria	863	873	abstract	25034760
gondii	I-bacteria	874	880	abstract	25034760
,	O	880	881	abstract	25034760
will	O	882	886	abstract	25034760
elicit	O	887	893	abstract	25034760
an	O	894	896	abstract	25034760
inflammatory	O	897	909	abstract	25034760
GI	O	910	912	abstract	25034760
environment	O	913	924	abstract	25034760
.	O	924	925	abstract	25034760

Such	O	926	930	abstract	25034760
processes	O	931	940	abstract	25034760
trigger	O	941	948	abstract	25034760
innate	O	949	955	abstract	25034760
immunity	O	956	964	abstract	25034760
,	O	964	965	abstract	25034760
including	O	966	975	abstract	25034760
activation	O	976	986	abstract	25034760
of	O	987	989	abstract	25034760
complement	B-chemical	990	1000	abstract	25034760
C1q	I-chemical	1001	1004	abstract	25034760
,	O	1004	1005	abstract	25034760
which	O	1006	1011	abstract	25034760
also	O	1012	1016	abstract	25034760
functions	O	1017	1026	abstract	25034760
at	O	1027	1029	abstract	25034760
synapses	B-anatomical%location	1030	1038	abstract	25034760
in	O	1039	1041	abstract	25034760
the	O	1042	1045	abstract	25034760
brain	B-anatomical%location	1046	1051	abstract	25034760
.	O	1051	1052	abstract	25034760

The	O	1053	1056	abstract	25034760
emerging	O	1057	1065	abstract	25034760
field	O	1066	1071	abstract	25034760
of	O	1072	1074	abstract	25034760
microbiome	O	1075	1085	abstract	25034760
research	O	1086	1094	abstract	25034760
lies	O	1095	1099	abstract	25034760
at	O	1100	1102	abstract	25034760
the	O	1103	1106	abstract	25034760
center	O	1107	1113	abstract	25034760
of	O	1114	1116	abstract	25034760
these	O	1117	1122	abstract	25034760
interactions	O	1123	1135	abstract	25034760
with	O	1136	1140	abstract	25034760
evidence	O	1141	1149	abstract	25034760
that	O	1150	1154	abstract	25034760
the	O	1155	1158	abstract	25034760
abundance	O	1159	1168	abstract	25034760
and	O	1169	1172	abstract	25034760
diversity	O	1173	1182	abstract	25034760
of	O	1183	1185	abstract	25034760
resident	O	1186	1194	abstract	25034760
gut	B-microbiome	1195	1198	abstract	25034760
microbiota	I-microbiome	1199	1209	abstract	25034760
contribute	O	1210	1220	abstract	25034760
to	O	1221	1223	abstract	25034760
digestion	O	1224	1233	abstract	25034760
,	O	1233	1234	abstract	25034760
inflammation	B-DDF	1235	1247	abstract	25034760
,	O	1247	1248	abstract	25034760
gut	O	1249	1252	abstract	25034760
permeability	O	1253	1265	abstract	25034760
and	O	1266	1269	abstract	25034760
behavior	O	1270	1278	abstract	25034760
.	O	1278	1279	abstract	25034760

Dietary	O	1280	1287	abstract	25034760
modifications	O	1288	1301	abstract	25034760
of	O	1302	1304	abstract	25034760
core	O	1305	1309	abstract	25034760
bacterial	O	1310	1319	abstract	25034760
compositions	O	1320	1332	abstract	25034760
may	O	1333	1336	abstract	25034760
explain	O	1337	1344	abstract	25034760
inefficient	B-DDF	1345	1356	abstract	25034760
gluten	I-DDF	1357	1363	abstract	25034760
digestion	I-DDF	1364	1373	abstract	25034760
and	O	1374	1377	abstract	25034760
how	O	1378	1381	abstract	25034760
immigrant	O	1382	1391	abstract	25034760
status	O	1392	1398	abstract	25034760
in	O	1399	1401	abstract	25034760
certain	O	1402	1409	abstract	25034760
situations	O	1410	1420	abstract	25034760
is	O	1421	1423	abstract	25034760
a	O	1424	1425	abstract	25034760
risk	O	1426	1430	abstract	25034760
factor	O	1431	1437	abstract	25034760
for	O	1438	1441	abstract	25034760
schizophrenia	B-DDF	1442	1455	abstract	25034760
.	O	1455	1456	abstract	25034760

Gut	B-microbiome	1457	1460	abstract	25034760
microbiome	I-microbiome	1461	1471	abstract	25034760
research	O	1472	1480	abstract	25034760
in	O	1481	1483	abstract	25034760
schizophrenia	B-DDF	1484	1497	abstract	25034760
is	O	1498	1500	abstract	25034760
in	O	1501	1503	abstract	25034760
its	O	1504	1507	abstract	25034760
infancy	O	1508	1515	abstract	25034760
,	O	1515	1516	abstract	25034760
but	O	1517	1520	abstract	25034760
data	O	1521	1525	abstract	25034760
in	O	1526	1528	abstract	25034760
related	O	1529	1536	abstract	25034760
fields	O	1537	1543	abstract	25034760
suggest	O	1544	1551	abstract	25034760
disease-associated	O	1552	1570	abstract	25034760
altered	O	1571	1578	abstract	25034760
phylogenetic	O	1579	1591	abstract	25034760
compositions	O	1592	1604	abstract	25034760
.	O	1604	1605	abstract	25034760

In	O	1606	1608	abstract	25034760
summary	O	1609	1616	abstract	25034760
,	O	1616	1617	abstract	25034760
this	O	1618	1622	abstract	25034760
review	O	1623	1629	abstract	25034760
surveys	O	1630	1637	abstract	25034760
associative	O	1638	1649	abstract	25034760
and	O	1650	1653	abstract	25034760
experimental	O	1654	1666	abstract	25034760
data	O	1667	1671	abstract	25034760
linking	O	1672	1679	abstract	25034760
autoimmunity	B-DDF	1680	1692	abstract	25034760
,	O	1692	1693	abstract	25034760
GI	O	1694	1696	abstract	25034760
activity	O	1697	1705	abstract	25034760
and	O	1706	1709	abstract	25034760
schizophrenia	B-DDF	1710	1723	abstract	25034760
,	O	1723	1724	abstract	25034760
and	O	1725	1728	abstract	25034760
proposes	O	1729	1737	abstract	25034760
that	O	1738	1742	abstract	25034760
understanding	O	1743	1756	abstract	25034760
of	O	1757	1759	abstract	25034760
disrupted	O	1760	1769	abstract	25034760
biological	O	1770	1780	abstract	25034760
pathways	O	1781	1789	abstract	25034760
outside	O	1790	1797	abstract	25034760
of	O	1798	1800	abstract	25034760
the	O	1801	1804	abstract	25034760
brain	B-anatomical%location	1805	1810	abstract	25034760
can	O	1811	1814	abstract	25034760
lend	O	1815	1819	abstract	25034760
valuable	O	1820	1828	abstract	25034760
information	O	1829	1840	abstract	25034760
regarding	O	1841	1850	abstract	25034760
pathogeneses	O	1851	1863	abstract	25034760
of	O	1864	1866	abstract	25034760
complex	O	1867	1874	abstract	25034760
,	O	1874	1875	abstract	25034760
polygenic	B-DDF	1876	1885	abstract	25034760
brain	I-DDF	1886	1891	abstract	25034760
disorders	I-DDF	1892	1901	abstract	25034760
.	O	1901	1902	abstract	25034760

Interaction	O	0	11	title	33067915
between	O	12	19	title	33067915
Maternal	O	20	28	title	33067915
Immune	O	29	35	title	33067915
Activation	O	36	46	title	33067915
and	O	47	50	title	33067915
Antibiotic	O	51	61	title	33067915
Use	O	62	65	title	33067915
during	O	66	72	title	33067915
Pregnancy	O	73	82	title	33067915
and	O	83	86	title	33067915
Child	O	87	92	title	33067915
Risk	O	93	97	title	33067915
of	O	98	100	title	33067915
Autism	B-DDF	101	107	title	33067915
Spectrum	I-DDF	108	116	title	33067915
Disorder	I-DDF	117	125	title	33067915
.	O	125	126	title	33067915

Prenatal	O	0	8	abstract	33067915
exposure	O	9	17	abstract	33067915
to	O	18	20	abstract	33067915
maternal	B-DDF	21	29	abstract	33067915
immune	I-DDF	30	36	abstract	33067915
activation	I-DDF	37	47	abstract	33067915
(	O	48	49	abstract	33067915
MIA	B-DDF	49	52	abstract	33067915
)	O	52	53	abstract	33067915
has	O	54	57	abstract	33067915
been	O	58	62	abstract	33067915
implicated	O	63	73	abstract	33067915
as	O	74	76	abstract	33067915
a	O	77	78	abstract	33067915
risk	O	79	83	abstract	33067915
factor	O	84	90	abstract	33067915
for	O	91	94	abstract	33067915
the	O	95	98	abstract	33067915
development	O	99	110	abstract	33067915
of	O	111	113	abstract	33067915
autism	B-DDF	114	120	abstract	33067915
spectrum	I-DDF	121	129	abstract	33067915
disorder	I-DDF	130	138	abstract	33067915
(	O	139	140	abstract	33067915
ASD	B-DDF	140	143	abstract	33067915
)	O	143	144	abstract	33067915
,	O	144	145	abstract	33067915
though	O	146	152	abstract	33067915
the	O	153	156	abstract	33067915
conditions	O	157	167	abstract	33067915
under	O	168	173	abstract	33067915
which	O	174	179	abstract	33067915
this	O	180	184	abstract	33067915
elevated	O	185	193	abstract	33067915
risk	O	194	198	abstract	33067915
occurs	O	199	205	abstract	33067915
are	O	206	209	abstract	33067915
unclear	O	210	217	abstract	33067915
.	O	217	218	abstract	33067915

Animal	O	219	225	abstract	33067915
literature	O	226	236	abstract	33067915
demonstrates	O	237	249	abstract	33067915
that	O	250	254	abstract	33067915
antibiotic	O	255	265	abstract	33067915
use	O	266	269	abstract	33067915
,	O	269	270	abstract	33067915
which	O	271	276	abstract	33067915
affects	O	277	284	abstract	33067915
the	O	285	288	abstract	33067915
composition	O	289	300	abstract	33067915
of	O	301	303	abstract	33067915
the	O	304	307	abstract	33067915
maternal	B-microbiome	308	316	abstract	33067915
gut	I-microbiome	317	320	abstract	33067915
microbiota	I-microbiome	321	331	abstract	33067915
,	O	331	332	abstract	33067915
modifies	O	333	341	abstract	33067915
the	O	342	345	abstract	33067915
effect	O	346	352	abstract	33067915
of	O	353	355	abstract	33067915
MIA	B-DDF	356	359	abstract	33067915
on	O	360	362	abstract	33067915
neurodevelopmental	O	363	381	abstract	33067915
outcomes	O	382	390	abstract	33067915
in	O	391	393	abstract	33067915
the	O	394	397	abstract	33067915
offspring	B-human	398	407	abstract	33067915
.	O	407	408	abstract	33067915

The	O	409	412	abstract	33067915
aim	O	413	416	abstract	33067915
of	O	417	419	abstract	33067915
this	O	420	424	abstract	33067915
study	O	425	430	abstract	33067915
was	O	431	434	abstract	33067915
to	O	435	437	abstract	33067915
assess	O	438	444	abstract	33067915
whether	O	445	452	abstract	33067915
antibiotic	O	453	463	abstract	33067915
use	O	464	467	abstract	33067915
during	O	468	474	abstract	33067915
pregnancy	O	475	484	abstract	33067915
modifies	O	485	493	abstract	33067915
the	O	494	497	abstract	33067915
association	O	498	509	abstract	33067915
between	O	510	517	abstract	33067915
MIA	B-DDF	518	521	abstract	33067915
and	O	522	525	abstract	33067915
subsequent	O	526	536	abstract	33067915
risk	O	537	541	abstract	33067915
of	O	542	544	abstract	33067915
ASD	B-DDF	545	548	abstract	33067915
,	O	548	549	abstract	33067915
in	O	550	552	abstract	33067915
a	O	553	554	abstract	33067915
prospective	O	555	566	abstract	33067915
birth	O	567	572	abstract	33067915
cohort	O	573	579	abstract	33067915
with	O	580	584	abstract	33067915
116	O	585	588	abstract	33067915
ASD	O	589	592	abstract	33067915
cases	O	593	598	abstract	33067915
and	O	599	602	abstract	33067915
860	O	603	606	abstract	33067915
typically	O	607	616	abstract	33067915
developing	O	617	627	abstract	33067915
(	O	628	629	abstract	33067915
TD	O	629	631	abstract	33067915
)	O	631	632	abstract	33067915
child	O	633	638	abstract	33067915
controls	O	639	647	abstract	33067915
.	O	647	648	abstract	33067915

There	O	649	654	abstract	33067915
was	O	655	658	abstract	33067915
no	O	659	661	abstract	33067915
evidence	O	662	670	abstract	33067915
of	O	671	673	abstract	33067915
interaction	O	674	685	abstract	33067915
between	O	686	693	abstract	33067915
fever	B-DDF	694	699	abstract	33067915
or	O	700	702	abstract	33067915
genitourinary	B-DDF	703	716	abstract	33067915
infection	I-DDF	717	726	abstract	33067915
and	O	727	730	abstract	33067915
antibiotic	O	731	741	abstract	33067915
use	O	742	745	abstract	33067915
on	O	746	748	abstract	33067915
the	O	749	752	abstract	33067915
odds	O	753	757	abstract	33067915
of	O	758	760	abstract	33067915
ASD	B-DDF	761	764	abstract	33067915
in	O	765	767	abstract	33067915
unadjusted	O	768	778	abstract	33067915
or	O	779	781	abstract	33067915
adjusted	O	782	790	abstract	33067915
analyzes	O	791	799	abstract	33067915
.	O	799	800	abstract	33067915

However	O	801	808	abstract	33067915
,	O	808	809	abstract	33067915
we	O	810	812	abstract	33067915
found	O	813	818	abstract	33067915
evidence	O	819	827	abstract	33067915
of	O	828	830	abstract	33067915
an	O	831	833	abstract	33067915
interaction	O	834	845	abstract	33067915
between	O	846	853	abstract	33067915
flu	B-DDF	854	857	abstract	33067915
,	O	857	858	abstract	33067915
specifically	O	859	871	abstract	33067915
in	O	872	874	abstract	33067915
second	O	875	881	abstract	33067915
trimester	O	882	891	abstract	33067915
,	O	891	892	abstract	33067915
and	O	893	896	abstract	33067915
antibiotic	O	897	907	abstract	33067915
use	O	908	911	abstract	33067915
at	O	912	914	abstract	33067915
any	O	915	918	abstract	33067915
point	O	919	924	abstract	33067915
during	O	925	931	abstract	33067915
pregnancy	O	932	941	abstract	33067915
on	O	942	944	abstract	33067915
the	O	945	948	abstract	33067915
odds	O	949	953	abstract	33067915
of	O	954	956	abstract	33067915
ASD	B-DDF	957	960	abstract	33067915
in	O	961	963	abstract	33067915
the	O	964	967	abstract	33067915
child	B-human	968	973	abstract	33067915
.	O	973	974	abstract	33067915

Among	O	975	980	abstract	33067915
women	B-human	981	986	abstract	33067915
who	O	987	990	abstract	33067915
received	O	991	999	abstract	33067915
an	O	1000	1002	abstract	33067915
antibiotic	B-drug	1003	1013	abstract	33067915
during	O	1014	1020	abstract	33067915
pregnancy	O	1021	1030	abstract	33067915
,	O	1030	1031	abstract	33067915
flu	B-DDF	1032	1035	abstract	33067915
in	O	1036	1038	abstract	33067915
trimester	O	1039	1048	abstract	33067915
two	O	1049	1052	abstract	33067915
was	O	1053	1056	abstract	33067915
not	O	1057	1060	abstract	33067915
associated	O	1061	1071	abstract	33067915
with	O	1072	1076	abstract	33067915
ASD	B-DDF	1077	1080	abstract	33067915
(	O	1081	1082	abstract	33067915
adjusted	O	1082	1090	abstract	33067915
odds	O	1091	1095	abstract	33067915
ratio	O	1096	1101	abstract	33067915
[	O	1102	1103	abstract	33067915
aOR	O	1103	1106	abstract	33067915
]	O	1106	1107	abstract	33067915
=	O	1108	1109	abstract	33067915
0.99	O	1110	1114	abstract	33067915
[	O	1115	1116	abstract	33067915
0.43	O	1116	1120	abstract	33067915
-	O	1120	1121	abstract	33067915
2.28	O	1121	1125	abstract	33067915
]	O	1125	1126	abstract	33067915
)	O	1126	1127	abstract	33067915
.	O	1127	1128	abstract	33067915

Among	O	1129	1134	abstract	33067915
women	B-human	1135	1140	abstract	33067915
who	O	1141	1144	abstract	33067915
were	O	1145	1149	abstract	33067915
not	O	1150	1153	abstract	33067915
exposed	O	1154	1161	abstract	33067915
to	O	1162	1164	abstract	33067915
an	O	1165	1167	abstract	33067915
antibiotic	B-drug	1168	1178	abstract	33067915
at	O	1179	1181	abstract	33067915
any	O	1182	1185	abstract	33067915
point	O	1186	1191	abstract	33067915
during	O	1192	1198	abstract	33067915
pregnancy	O	1199	1208	abstract	33067915
,	O	1208	1209	abstract	33067915
flu	B-DDF	1210	1213	abstract	33067915
in	O	1214	1216	abstract	33067915
second	O	1217	1223	abstract	33067915
trimester	O	1224	1233	abstract	33067915
was	O	1234	1237	abstract	33067915
significantly	O	1238	1251	abstract	33067915
associated	O	1252	1262	abstract	33067915
with	O	1263	1267	abstract	33067915
increased	O	1268	1277	abstract	33067915
odds	O	1278	1282	abstract	33067915
of	O	1283	1285	abstract	33067915
ASD	B-DDF	1286	1289	abstract	33067915
(	O	1290	1291	abstract	33067915
aOR	O	1291	1294	abstract	33067915
=	O	1295	1296	abstract	33067915
4.05	O	1297	1301	abstract	33067915
[	O	1302	1303	abstract	33067915
1.14	O	1303	1307	abstract	33067915
-	O	1307	1308	abstract	33067915
14.38	O	1308	1313	abstract	33067915
]	O	1313	1314	abstract	33067915
,	O	1314	1315	abstract	33067915
P	O	1316	1317	abstract	33067915
=	O	1318	1319	abstract	33067915
.03	O	1320	1323	abstract	33067915
)	O	1323	1324	abstract	33067915
,	O	1324	1325	abstract	33067915
after	O	1326	1331	abstract	33067915
adjustment	O	1332	1342	abstract	33067915
for	O	1343	1346	abstract	33067915
child	O	1347	1352	abstract	33067915
sex	O	1353	1356	abstract	33067915
,	O	1356	1357	abstract	33067915
child	O	1358	1363	abstract	33067915
birth	O	1364	1369	abstract	33067915
year	O	1370	1374	abstract	33067915
,	O	1374	1375	abstract	33067915
maternal	O	1376	1384	abstract	33067915
age	O	1385	1388	abstract	33067915
,	O	1388	1389	abstract	33067915
gestational	O	1390	1401	abstract	33067915
age	O	1402	1405	abstract	33067915
,	O	1405	1406	abstract	33067915
C-section	O	1407	1416	abstract	33067915
delivery	O	1417	1425	abstract	33067915
,	O	1425	1426	abstract	33067915
and	O	1427	1430	abstract	33067915
low	O	1431	1434	abstract	33067915
birthweight	O	1435	1446	abstract	33067915
.	O	1446	1447	abstract	33067915

These	O	1448	1453	abstract	33067915
findings	O	1454	1462	abstract	33067915
should	O	1463	1469	abstract	33067915
be	O	1470	1472	abstract	33067915
treated	O	1473	1480	abstract	33067915
as	O	1481	1483	abstract	33067915
hypothesis-generating	O	1484	1505	abstract	33067915
and	O	1506	1509	abstract	33067915
suggest	O	1510	1517	abstract	33067915
that	O	1518	1522	abstract	33067915
antibiotic	O	1523	1533	abstract	33067915
use	O	1534	1537	abstract	33067915
may	O	1538	1541	abstract	33067915
modify	O	1542	1548	abstract	33067915
the	O	1549	1552	abstract	33067915
influence	O	1553	1562	abstract	33067915
that	O	1563	1567	abstract	33067915
MIA	B-DDF	1568	1571	abstract	33067915
has	O	1572	1575	abstract	33067915
on	O	1576	1578	abstract	33067915
autism	O	1579	1585	abstract	33067915
risk	O	1586	1590	abstract	33067915
in	O	1591	1593	abstract	33067915
the	O	1594	1597	abstract	33067915
child	B-human	1598	1603	abstract	33067915
.	O	1603	1604	abstract	33067915

LAY	O	1605	1608	abstract	33067915
SUMMARY	O	1609	1616	abstract	33067915
:	O	1616	1617	abstract	33067915
We	O	1618	1620	abstract	33067915
looked	O	1621	1627	abstract	33067915
at	O	1628	1630	abstract	33067915
whether	O	1631	1638	abstract	33067915
the	O	1639	1642	abstract	33067915
association	O	1643	1654	abstract	33067915
between	O	1655	1662	abstract	33067915
activation	O	1663	1673	abstract	33067915
of	O	1674	1676	abstract	33067915
the	O	1677	1680	abstract	33067915
immune	O	1681	1687	abstract	33067915
system	O	1688	1694	abstract	33067915
during	O	1695	1701	abstract	33067915
pregnancy	O	1702	1711	abstract	33067915
and	O	1712	1715	abstract	33067915
risk	O	1716	1720	abstract	33067915
of	O	1721	1723	abstract	33067915
the	O	1724	1727	abstract	33067915
child	B-human	1728	1733	abstract	33067915
developing	O	1734	1744	abstract	33067915
autism	B-DDF	1745	1751	abstract	33067915
spectrum	I-DDF	1752	1760	abstract	33067915
disorder	I-DDF	1761	1769	abstract	33067915
(	O	1770	1771	abstract	33067915
ASD	B-DDF	1771	1774	abstract	33067915
)	O	1774	1775	abstract	33067915
differed	O	1776	1784	abstract	33067915
among	O	1785	1790	abstract	33067915
women	B-human	1791	1796	abstract	33067915
who	O	1797	1800	abstract	33067915
did	O	1801	1804	abstract	33067915
or	O	1805	1807	abstract	33067915
did	O	1808	1811	abstract	33067915
not	O	1812	1815	abstract	33067915
take	O	1816	1820	abstract	33067915
an	O	1821	1823	abstract	33067915
antibiotic	B-drug	1824	1834	abstract	33067915
at	O	1835	1837	abstract	33067915
any	O	1838	1841	abstract	33067915
point	O	1842	1847	abstract	33067915
during	O	1848	1854	abstract	33067915
pregnancy	O	1855	1864	abstract	33067915
.	O	1864	1865	abstract	33067915

We	O	1866	1868	abstract	33067915
examined	O	1869	1877	abstract	33067915
116	O	1878	1881	abstract	33067915
children	B-human	1882	1890	abstract	33067915
with	O	1891	1895	abstract	33067915
ASD	B-DDF	1896	1899	abstract	33067915
and	O	1900	1903	abstract	33067915
860	O	1904	1907	abstract	33067915
without	O	1908	1915	abstract	33067915
ASD	B-DDF	1916	1919	abstract	33067915
and	O	1920	1923	abstract	33067915
found	O	1924	1929	abstract	33067915
that	O	1930	1934	abstract	33067915
flu	B-DDF	1935	1938	abstract	33067915
in	O	1939	1941	abstract	33067915
second	O	1942	1948	abstract	33067915
trimester	O	1949	1958	abstract	33067915
was	O	1959	1962	abstract	33067915
associated	O	1963	1973	abstract	33067915
with	O	1974	1978	abstract	33067915
increased	O	1979	1988	abstract	33067915
ASD	B-DDF	1989	1992	abstract	33067915
,	O	1992	1993	abstract	33067915
but	O	1994	1997	abstract	33067915
only	O	1998	2002	abstract	33067915
among	O	2003	2008	abstract	33067915
women	B-human	2009	2014	abstract	33067915
who	O	2015	2018	abstract	33067915
did	O	2019	2022	abstract	33067915
not	O	2023	2026	abstract	33067915
take	O	2027	2031	abstract	33067915
an	O	2032	2034	abstract	33067915
antibiotic	B-drug	2035	2045	abstract	33067915
during	O	2046	2052	abstract	33067915
pregnancy	O	2053	2062	abstract	33067915
.	O	2062	2063	abstract	33067915

No	O	2064	2066	abstract	33067915
other	O	2067	2072	abstract	33067915
immune	O	2073	2079	abstract	33067915
activation	O	2080	2090	abstract	33067915
exposures	O	2091	2100	abstract	33067915
seemed	O	2101	2107	abstract	33067915
to	O	2108	2110	abstract	33067915
interact	O	2111	2119	abstract	33067915
with	O	2120	2124	abstract	33067915
antibiotic	O	2125	2135	abstract	33067915
use	O	2136	2139	abstract	33067915
.	O	2139	2140	abstract	33067915

A	O	0	1	title	33271210
systematic	O	2	12	title	33271210
review	O	13	19	title	33271210
of	O	20	22	title	33271210
microbiome	O	23	33	title	33271210
changes	O	34	41	title	33271210
and	O	42	45	title	33271210
impact	O	46	52	title	33271210
of	O	53	55	title	33271210
probiotic	B-dietary%supplement	56	65	title	33271210
supplementation	I-dietary%supplement	66	81	title	33271210
in	O	82	84	title	33271210
children	B-human	85	93	title	33271210
and	O	94	97	title	33271210
adolescents	B-human	98	109	title	33271210
with	O	110	114	title	33271210
neuropsychiatric	B-DDF	115	131	title	33271210
disorders	I-DDF	132	141	title	33271210
.	O	141	142	title	33271210

In	O	0	2	abstract	33271210
recent	O	3	9	abstract	33271210
decades	O	10	17	abstract	33271210
,	O	17	18	abstract	33271210
the	O	19	22	abstract	33271210
diagnostic	O	23	33	abstract	33271210
and	O	34	37	abstract	33271210
therapeutic	O	38	49	abstract	33271210
implications	O	50	62	abstract	33271210
of	O	63	65	abstract	33271210
the	O	66	69	abstract	33271210
microbiome	O	70	80	abstract	33271210
changes	O	81	88	abstract	33271210
and	O	89	92	abstract	33271210
the	O	93	96	abstract	33271210
impact	O	97	103	abstract	33271210
of	O	104	106	abstract	33271210
probiotic	B-dietary%supplement	107	116	abstract	33271210
supplementation	I-dietary%supplement	117	132	abstract	33271210
have	O	133	137	abstract	33271210
increased	O	138	147	abstract	33271210
rapidly	O	148	155	abstract	33271210
.	O	155	156	abstract	33271210

However	O	157	164	abstract	33271210
,	O	164	165	abstract	33271210
the	O	166	169	abstract	33271210
potential	O	170	179	abstract	33271210
for	O	180	183	abstract	33271210
clinical	O	184	192	abstract	33271210
translation	O	193	204	abstract	33271210
of	O	205	207	abstract	33271210
microbiome	O	208	218	abstract	33271210
research	O	219	227	abstract	33271210
for	O	228	231	abstract	33271210
children	B-human	232	240	abstract	33271210
and	O	241	244	abstract	33271210
adolescents	B-human	245	256	abstract	33271210
with	O	257	261	abstract	33271210
psychiatric	B-DDF	262	273	abstract	33271210
disorders	I-DDF	274	283	abstract	33271210
is	O	284	286	abstract	33271210
unclear	O	287	294	abstract	33271210
.	O	294	295	abstract	33271210

This	O	296	300	abstract	33271210
review	O	301	307	abstract	33271210
examined	O	308	316	abstract	33271210
available	O	317	326	abstract	33271210
evidence	O	327	335	abstract	33271210
related	O	336	343	abstract	33271210
to	O	344	346	abstract	33271210
gut	B-microbiome	347	350	abstract	33271210
microbiota	I-microbiome	351	361	abstract	33271210
as	O	362	364	abstract	33271210
well	O	365	369	abstract	33271210
as	O	370	372	abstract	33271210
the	O	373	376	abstract	33271210
impact	O	377	383	abstract	33271210
of	O	384	386	abstract	33271210
probiotic	B-dietary%supplement	387	396	abstract	33271210
supplementation	I-dietary%supplement	397	412	abstract	33271210
on	O	413	415	abstract	33271210
psychiatric	B-DDF	416	427	abstract	33271210
disorders	I-DDF	428	437	abstract	33271210
in	O	438	440	abstract	33271210
the	O	441	444	abstract	33271210
pediatric	B-human	445	454	abstract	33271210
population	I-human	455	465	abstract	33271210
reported	O	466	474	abstract	33271210
to	O	475	477	abstract	33271210
date	O	478	482	abstract	33271210
.	O	482	483	abstract	33271210

We	O	484	486	abstract	33271210
performed	O	487	496	abstract	33271210
a	O	497	498	abstract	33271210
literature	O	499	509	abstract	33271210
search	O	510	516	abstract	33271210
for	O	517	520	abstract	33271210
the	O	521	524	abstract	33271210
gut	B-microbiome	525	528	abstract	33271210
microbiota	I-microbiome	529	539	abstract	33271210
in	O	540	542	abstract	33271210
child	B-human	543	548	abstract	33271210
and	I-human	549	552	abstract	33271210
adolescent	I-human	553	563	abstract	33271210
population	I-human	564	574	abstract	33271210
(	I-human	575	576	abstract	33271210
0	I-human	576	577	abstract	33271210
-	I-human	577	578	abstract	33271210
18	I-human	578	580	abstract	33271210
	I-human	580	581	abstract	33271210
years	I-human	581	586	abstract	33271210
old	I-human	587	590	abstract	33271210
)	I-human	590	591	abstract	33271210
with	O	592	596	abstract	33271210
mental	B-DDF	597	603	abstract	33271210
health	I-DDF	604	610	abstract	33271210
disorders	I-DDF	611	620	abstract	33271210
from	O	621	625	abstract	33271210
July	O	626	630	abstract	33271210
1999	O	631	635	abstract	33271210
through	O	636	643	abstract	33271210
July	O	644	648	abstract	33271210
2019	O	649	653	abstract	33271210
in	O	654	656	abstract	33271210
several	O	657	664	abstract	33271210
databases	O	665	674	abstract	33271210
:	O	674	675	abstract	33271210
ClinicalTrials.gov	O	676	694	abstract	33271210
,	O	694	695	abstract	33271210
Ovid	O	696	700	abstract	33271210
EBM	O	701	704	abstract	33271210
Reviews	O	705	712	abstract	33271210
,	O	712	713	abstract	33271210
Ovid	O	714	718	abstract	33271210
Embase	O	719	725	abstract	33271210
,	O	725	726	abstract	33271210
Ovid	O	727	731	abstract	33271210
Medline	O	732	739	abstract	33271210
,	O	739	740	abstract	33271210
Ovid	O	741	745	abstract	33271210
PsycINFO	O	746	754	abstract	33271210
,	O	754	755	abstract	33271210
Scopus	O	756	762	abstract	33271210
,	O	762	763	abstract	33271210
and	O	764	767	abstract	33271210
Web	O	768	771	abstract	33271210
of	O	772	774	abstract	33271210
Science	O	775	782	abstract	33271210
.	O	782	783	abstract	33271210

A	O	784	785	abstract	33271210
total	O	786	791	abstract	33271210
of	O	792	794	abstract	33271210
7	O	795	796	abstract	33271210
studies	O	797	804	abstract	33271210
met	O	805	808	abstract	33271210
inclusion	O	809	818	abstract	33271210
criteria	O	819	827	abstract	33271210
consisting	O	828	838	abstract	33271210
of	O	839	841	abstract	33271210
randomized	O	842	852	abstract	33271210
controlled	O	853	863	abstract	33271210
trials	O	864	870	abstract	33271210
and	O	871	874	abstract	33271210
cohort	O	875	881	abstract	33271210
studies	O	882	889	abstract	33271210
that	O	890	894	abstract	33271210
examined	O	895	903	abstract	33271210
various	O	904	911	abstract	33271210
associations	O	912	924	abstract	33271210
between	O	925	932	abstract	33271210
psychiatric	B-DDF	933	944	abstract	33271210
disorders	I-DDF	945	954	abstract	33271210
and	O	955	958	abstract	33271210
gut	B-microbiome	959	962	abstract	33271210
microbiota	I-microbiome	963	973	abstract	33271210
in	O	974	976	abstract	33271210
youth	B-human	977	982	abstract	33271210
.	O	982	983	abstract	33271210

Six	O	984	987	abstract	33271210
studies	O	988	995	abstract	33271210
examined	O	996	1004	abstract	33271210
the	O	1005	1008	abstract	33271210
effects	O	1009	1016	abstract	33271210
of	O	1017	1019	abstract	33271210
various	O	1020	1027	abstract	33271210
treatment	O	1028	1037	abstract	33271210
interventions	O	1038	1051	abstract	33271210
such	O	1052	1056	abstract	33271210
as	O	1057	1059	abstract	33271210
probiotic	B-dietary%supplement	1060	1069	abstract	33271210
supplementation	I-dietary%supplement	1070	1085	abstract	33271210
on	O	1086	1088	abstract	33271210
microbiota	O	1089	1099	abstract	33271210
composition	O	1100	1111	abstract	33271210
and	O	1112	1115	abstract	33271210
behaviors	O	1116	1125	abstract	33271210
.	O	1125	1126	abstract	33271210

One	O	1127	1130	abstract	33271210
study	O	1131	1136	abstract	33271210
showed	O	1137	1143	abstract	33271210
an	O	1144	1146	abstract	33271210
increase	O	1147	1155	abstract	33271210
in	O	1156	1158	abstract	33271210
prosocial	O	1159	1168	abstract	33271210
behavior	O	1169	1177	abstract	33271210
in	O	1178	1180	abstract	33271210
children	B-human	1181	1189	abstract	33271210
with	O	1190	1194	abstract	33271210
Autism	B-DDF	1195	1201	abstract	33271210
Spectrum	I-DDF	1202	1210	abstract	33271210
Disorder	I-DDF	1211	1219	abstract	33271210
(	O	1220	1221	abstract	33271210
ASD	B-DDF	1221	1224	abstract	33271210
)	O	1224	1225	abstract	33271210
and	O	1226	1229	abstract	33271210
an	O	1230	1232	abstract	33271210
increase	O	1233	1241	abstract	33271210
in	O	1242	1244	abstract	33271210
the	O	1245	1248	abstract	33271210
Lachnospiraceae	B-bacteria	1249	1264	abstract	33271210
family	I-bacteria	1265	1271	abstract	33271210
following	O	1272	1281	abstract	33271210
prebiotic	B-dietary%supplement	1282	1291	abstract	33271210
supplementation	I-dietary%supplement	1292	1307	abstract	33271210
.	O	1307	1308	abstract	33271210

Another	O	1309	1316	abstract	33271210
study	O	1317	1322	abstract	33271210
suggested	O	1323	1332	abstract	33271210
that	O	1333	1337	abstract	33271210
prebiotic	B-dietary%supplement	1338	1347	abstract	33271210
supplementation	I-dietary%supplement	1348	1363	abstract	33271210
increased	O	1364	1373	abstract	33271210
bifidobacterial	B-bacteria	1374	1389	abstract	33271210
populations	I-bacteria	1390	1401	abstract	33271210
for	O	1402	1405	abstract	33271210
ASD	B-human	1406	1409	abstract	33271210
and	I-human	1410	1413	abstract	33271210
healthy	I-human	1414	1421	abstract	33271210
controls	I-human	1422	1430	abstract	33271210
.	O	1430	1431	abstract	33271210

A	O	1432	1433	abstract	33271210
study	O	1434	1439	abstract	33271210
evaluating	O	1440	1450	abstract	33271210
infant	O	1451	1457	abstract	33271210
supplementation	O	1458	1473	abstract	33271210
of	O	1474	1476	abstract	33271210
prebiotics	B-dietary%supplement	1477	1487	abstract	33271210
showed	O	1488	1494	abstract	33271210
both	O	1495	1499	abstract	33271210
a	O	1500	1501	abstract	33271210
decreased	O	1502	1511	abstract	33271210
likelihood	O	1512	1522	abstract	33271210
of	O	1523	1525	abstract	33271210
developing	O	1526	1536	abstract	33271210
Attention	B-DDF	1537	1546	abstract	33271210
Deficit	I-DDF	1547	1554	abstract	33271210
Hyperactivity	I-DDF	1555	1568	abstract	33271210
Disorder	I-DDF	1569	1577	abstract	33271210
(	O	1578	1579	abstract	33271210
ADHD	B-DDF	1579	1583	abstract	33271210
)	O	1583	1584	abstract	33271210
or	O	1585	1587	abstract	33271210
ASD	B-DDF	1588	1591	abstract	33271210
and	O	1592	1595	abstract	33271210
decreased	O	1596	1605	abstract	33271210
gut	B-bacteria	1606	1609	abstract	33271210
Bifidobacterium	I-bacteria	1610	1625	abstract	33271210
.	O	1625	1626	abstract	33271210

One	O	1627	1630	abstract	33271210
study	O	1631	1636	abstract	33271210
did	O	1637	1640	abstract	33271210
not	O	1641	1644	abstract	33271210
find	O	1645	1649	abstract	33271210
significant	O	1650	1661	abstract	33271210
differences	O	1662	1673	abstract	33271210
in	O	1674	1676	abstract	33271210
microbiome	O	1677	1687	abstract	33271210
composition	O	1688	1699	abstract	33271210
after	O	1700	1705	abstract	33271210
micronutrient	B-dietary%supplement	1706	1719	abstract	33271210
treatment	I-dietary%supplement	1720	1729	abstract	33271210
.	O	1729	1730	abstract	33271210

The	O	1731	1734	abstract	33271210
main	O	1735	1739	abstract	33271210
goal	O	1740	1744	abstract	33271210
of	O	1745	1747	abstract	33271210
this	O	1748	1752	abstract	33271210
systematic	O	1753	1763	abstract	33271210
review	O	1764	1770	abstract	33271210
was	O	1771	1774	abstract	33271210
to	O	1775	1777	abstract	33271210
comprehensively	O	1778	1793	abstract	33271210
examine	O	1794	1801	abstract	33271210
and	O	1802	1805	abstract	33271210
summarize	O	1806	1815	abstract	33271210
the	O	1816	1819	abstract	33271210
current	O	1820	1827	abstract	33271210
evidence	O	1828	1836	abstract	33271210
focused	O	1837	1844	abstract	33271210
on	O	1845	1847	abstract	33271210
the	O	1848	1851	abstract	33271210
potential	O	1852	1861	abstract	33271210
effect	O	1862	1868	abstract	33271210
of	O	1869	1871	abstract	33271210
the	O	1872	1875	abstract	33271210
relationship	O	1876	1888	abstract	33271210
between	O	1889	1896	abstract	33271210
microbiota	O	1897	1907	abstract	33271210
gut	O	1908	1911	abstract	33271210
composition	O	1912	1923	abstract	33271210
as	O	1924	1926	abstract	33271210
well	O	1927	1931	abstract	33271210
as	O	1932	1934	abstract	33271210
the	O	1935	1938	abstract	33271210
effects	O	1939	1946	abstract	33271210
of	O	1947	1949	abstract	33271210
probiotic	B-dietary%supplement	1950	1959	abstract	33271210
supplementation	I-dietary%supplement	1960	1975	abstract	33271210
on	O	1976	1978	abstract	33271210
psychiatric	B-DDF	1979	1990	abstract	33271210
disorders	I-DDF	1991	2000	abstract	33271210
in	O	2001	2003	abstract	33271210
children	B-human	2004	2012	abstract	33271210
and	O	2013	2016	abstract	33271210
adolescents	B-human	2017	2028	abstract	33271210
.	O	2028	2029	abstract	33271210

This	O	2030	2034	abstract	33271210
is	O	2035	2037	abstract	33271210
a	O	2038	2039	abstract	33271210
relatively	O	2040	2050	abstract	33271210
new	O	2051	2054	abstract	33271210
area	O	2055	2059	abstract	33271210
of	O	2060	2062	abstract	33271210
research	O	2063	2071	abstract	33271210
and	O	2072	2075	abstract	33271210
the	O	2076	2079	abstract	33271210
number	O	2080	2086	abstract	33271210
of	O	2087	2089	abstract	33271210
included	O	2090	2098	abstract	33271210
studies	O	2099	2106	abstract	33271210
is	O	2107	2109	abstract	33271210
limited	O	2110	2117	abstract	33271210
.	O	2117	2118	abstract	33271210

More	O	2119	2123	abstract	33271210
studies	O	2124	2131	abstract	33271210
are	O	2132	2135	abstract	33271210
needed	O	2136	2142	abstract	33271210
to	O	2143	2145	abstract	33271210
determine	O	2146	2155	abstract	33271210
whether	O	2156	2163	abstract	33271210
gut	B-DDF	2164	2167	abstract	33271210
dysbiosis	I-DDF	2168	2177	abstract	33271210
leads	O	2178	2183	abstract	33271210
to	O	2184	2186	abstract	33271210
the	O	2187	2190	abstract	33271210
development	O	2191	2202	abstract	33271210
and/or	O	2203	2209	abstract	33271210
contributes	O	2210	2221	abstract	33271210
to	O	2222	2224	abstract	33271210
the	O	2225	2228	abstract	33271210
severity	O	2229	2237	abstract	33271210
of	O	2238	2240	abstract	33271210
mental	B-DDF	2241	2247	abstract	33271210
disorders	I-DDF	2248	2257	abstract	33271210
or	O	2258	2260	abstract	33271210
whether	O	2261	2268	abstract	33271210
gut	B-DDF	2269	2272	abstract	33271210
dysbiosis	I-DDF	2273	2282	abstract	33271210
is	O	2283	2285	abstract	33271210
a	O	2286	2287	abstract	33271210
result	O	2288	2294	abstract	33271210
of	O	2295	2297	abstract	33271210
other	O	2298	2303	abstract	33271210
processes	O	2304	2313	abstract	33271210
that	O	2314	2318	abstract	33271210
accompany	O	2319	2328	abstract	33271210
mental	B-DDF	2329	2335	abstract	33271210
disorders	I-DDF	2336	2345	abstract	33271210
.	O	2345	2346	abstract	33271210

A	O	2347	2348	abstract	33271210
better	O	2349	2355	abstract	33271210
understanding	O	2356	2369	abstract	33271210
of	O	2370	2372	abstract	33271210
the	O	2373	2376	abstract	33271210
specific	O	2377	2385	abstract	33271210
bacteria	O	2386	2394	abstract	33271210
contributions	O	2395	2408	abstract	33271210
,	O	2408	2409	abstract	33271210
gut-brain	O	2410	2419	abstract	33271210
pathways	O	2420	2428	abstract	33271210
,	O	2428	2429	abstract	33271210
and	O	2430	2433	abstract	33271210
role	O	2434	2438	abstract	33271210
in	O	2439	2441	abstract	33271210
pathophysiological	O	2442	2460	abstract	33271210
mechanisms	O	2461	2471	abstract	33271210
in	O	2472	2474	abstract	33271210
neuropsychiatric	B-DDF	2475	2491	abstract	33271210
disorders	I-DDF	2492	2501	abstract	33271210
in	O	2502	2504	abstract	33271210
the	O	2505	2508	abstract	33271210
child	B-human	2509	2514	abstract	33271210
and	I-human	2515	2518	abstract	33271210
adolescent	I-human	2519	2529	abstract	33271210
populations	I-human	2530	2541	abstract	33271210
can	O	2542	2545	abstract	33271210
possibly	O	2546	2554	abstract	33271210
provide	O	2555	2562	abstract	33271210
alternative	O	2563	2574	abstract	33271210
tools	O	2575	2580	abstract	33271210
for	O	2581	2584	abstract	33271210
a	O	2585	2586	abstract	33271210
clinical	O	2587	2595	abstract	33271210
psychiatrist	O	2596	2608	abstract	33271210
.	O	2608	2609	abstract	33271210

Moreover	O	2610	2618	abstract	33271210
,	O	2618	2619	abstract	33271210
it	O	2620	2622	abstract	33271210
may	O	2623	2626	abstract	33271210
ultimately	O	2627	2637	abstract	33271210
aid	O	2638	2641	abstract	33271210
the	O	2642	2645	abstract	33271210
clinician	O	2646	2655	abstract	33271210
with	O	2656	2660	abstract	33271210
intervention	O	2661	2673	abstract	33271210
strategies	O	2674	2684	abstract	33271210
,	O	2684	2685	abstract	33271210
or	O	2686	2688	abstract	33271210
detect	O	2689	2695	abstract	33271210
populations	O	2696	2707	abstract	33271210
at	O	2708	2710	abstract	33271210
risk	O	2711	2715	abstract	33271210
for	O	2716	2719	abstract	33271210
developing	O	2720	2730	abstract	33271210
neuropsychiatric	B-DDF	2731	2747	abstract	33271210
disorders	I-DDF	2748	2757	abstract	33271210
.	O	2757	2758	abstract	33271210

High-fiber	B-food	0	10	title	36794003
diet	I-food	11	15	title	36794003
ameliorates	O	16	27	title	36794003
gut	B-microbiome	28	31	title	36794003
microbiota	I-microbiome	32	42	title	36794003
,	O	42	43	title	36794003
serum	O	44	49	title	36794003
metabolism	O	50	60	title	36794003
and	O	61	64	title	36794003
emotional	O	65	74	title	36794003
mood	O	75	79	title	36794003
in	O	80	82	title	36794003
type	B-human	83	87	title	36794003
2	I-human	88	89	title	36794003
diabetes	I-human	90	98	title	36794003
patients	I-human	99	107	title	36794003
.	O	107	108	title	36794003

Previous	O	0	8	abstract	36794003
studies	O	9	16	abstract	36794003
have	O	17	21	abstract	36794003
demonstrated	O	22	34	abstract	36794003
that	O	35	39	abstract	36794003
patients	B-human	40	48	abstract	36794003
with	O	49	53	abstract	36794003
type	B-DDF	54	58	abstract	36794003
2	I-DDF	59	60	abstract	36794003
diabetes	I-DDF	61	69	abstract	36794003
mellitus	I-DDF	70	78	abstract	36794003
(	O	79	80	abstract	36794003
T2DM	B-DDF	80	84	abstract	36794003
)	O	84	85	abstract	36794003
often	O	86	91	abstract	36794003
had	O	92	95	abstract	36794003
the	O	96	99	abstract	36794003
problems	O	100	108	abstract	36794003
of	O	109	111	abstract	36794003
fecal	B-DDF	112	117	abstract	36794003
microbiota	I-DDF	118	128	abstract	36794003
dysbiosis	I-DDF	129	138	abstract	36794003
,	O	138	139	abstract	36794003
and	O	140	143	abstract	36794003
were	O	144	148	abstract	36794003
usually	O	149	156	abstract	36794003
accompanied	O	157	168	abstract	36794003
with	O	169	173	abstract	36794003
psychiatric	B-DDF	174	185	abstract	36794003
comorbidities	I-DDF	186	199	abstract	36794003
(	O	200	201	abstract	36794003
such	O	201	205	abstract	36794003
as	O	206	208	abstract	36794003
depression	B-DDF	209	219	abstract	36794003
and	O	220	223	abstract	36794003
anxiety	B-DDF	224	231	abstract	36794003
)	O	231	232	abstract	36794003
.	O	232	233	abstract	36794003

Here	O	234	238	abstract	36794003
,	O	238	239	abstract	36794003
we	O	240	242	abstract	36794003
conducted	O	243	252	abstract	36794003
a	O	253	254	abstract	36794003
randomized	O	255	265	abstract	36794003
clinical	O	266	274	abstract	36794003
study	O	275	280	abstract	36794003
to	O	281	283	abstract	36794003
analyze	O	284	291	abstract	36794003
the	O	292	295	abstract	36794003
changes	O	296	303	abstract	36794003
in	O	304	306	abstract	36794003
gut	B-microbiome	307	310	abstract	36794003
microbiota	I-microbiome	311	321	abstract	36794003
,	O	321	322	abstract	36794003
serum	O	323	328	abstract	36794003
metabolism	O	329	339	abstract	36794003
and	O	340	343	abstract	36794003
emotional	O	344	353	abstract	36794003
mood	O	354	358	abstract	36794003
of	O	359	361	abstract	36794003
patients	B-human	362	370	abstract	36794003
with	O	371	375	abstract	36794003
T2DM	B-DDF	376	380	abstract	36794003
after	O	381	386	abstract	36794003
consumption	O	387	398	abstract	36794003
of	O	399	401	abstract	36794003
a	O	402	403	abstract	36794003
high-fiber	B-food	404	414	abstract	36794003
diet	I-food	415	419	abstract	36794003
.	O	419	420	abstract	36794003

The	O	421	424	abstract	36794003
glucose	O	425	432	abstract	36794003
homeostasis	O	433	444	abstract	36794003
of	O	445	447	abstract	36794003
participants	B-human	448	460	abstract	36794003
with	O	461	465	abstract	36794003
T2DM	B-DDF	466	470	abstract	36794003
was	O	471	474	abstract	36794003
improved	O	475	483	abstract	36794003
by	O	484	486	abstract	36794003
the	O	487	490	abstract	36794003
high-fiber	B-food	491	501	abstract	36794003
diet	I-food	502	506	abstract	36794003
,	O	506	507	abstract	36794003
and	O	508	511	abstract	36794003
the	O	512	515	abstract	36794003
serum	B-chemical	516	521	abstract	36794003
metabolome	I-chemical	522	532	abstract	36794003
,	O	532	533	abstract	36794003
systemic	B-DDF	534	542	abstract	36794003
inflammation	I-DDF	543	555	abstract	36794003
and	O	556	559	abstract	36794003
psychiatric	B-DDF	560	571	abstract	36794003
comorbidities	I-DDF	572	585	abstract	36794003
were	O	586	590	abstract	36794003
also	O	591	595	abstract	36794003
altered	O	596	603	abstract	36794003
.	O	603	604	abstract	36794003

The	O	605	608	abstract	36794003
increased	O	609	618	abstract	36794003
abundances	O	619	629	abstract	36794003
of	O	630	632	abstract	36794003
<	O	633	634	abstract	36794003
i	O	634	635	abstract	36794003
>	O	635	636	abstract	36794003
Lactobacillus</i	B-bacteria	636	652	abstract	36794003
>	O	652	653	abstract	36794003
,	O	653	654	abstract	36794003
<	O	655	656	abstract	36794003
i	O	656	657	abstract	36794003
>	O	657	658	abstract	36794003
Bifidobacterium</i	B-bacteria	658	676	abstract	36794003
>	O	676	677	abstract	36794003
and	O	678	681	abstract	36794003
<	O	682	683	abstract	36794003
i	O	683	684	abstract	36794003
>	O	684	685	abstract	36794003
Akkermansias</i	B-bacteria	685	700	abstract	36794003
>	O	700	701	abstract	36794003
revealed	O	702	710	abstract	36794003
that	O	711	715	abstract	36794003
the	O	716	719	abstract	36794003
proportions	O	720	731	abstract	36794003
of	O	732	734	abstract	36794003
beneficial	O	735	745	abstract	36794003
gut	B-microbiome	746	749	abstract	36794003
microbes	I-microbiome	750	758	abstract	36794003
were	O	759	763	abstract	36794003
enriched	O	764	772	abstract	36794003
by	O	773	775	abstract	36794003
the	O	776	779	abstract	36794003
high-fiber	B-food	780	790	abstract	36794003
diet	I-food	791	795	abstract	36794003
,	O	795	796	abstract	36794003
while	O	797	802	abstract	36794003
the	O	803	806	abstract	36794003
abundances	O	807	817	abstract	36794003
of	O	818	820	abstract	36794003
<	O	821	822	abstract	36794003
i	O	822	823	abstract	36794003
>	O	823	824	abstract	36794003
Desulfovibrio</i	B-bacteria	824	840	abstract	36794003
>	O	840	841	abstract	36794003
,	O	841	842	abstract	36794003
<	O	843	844	abstract	36794003
i	O	844	845	abstract	36794003
>	O	845	846	abstract	36794003
Klebsiella</i	B-bacteria	846	859	abstract	36794003
>	O	859	860	abstract	36794003
and	O	861	864	abstract	36794003
other	O	865	870	abstract	36794003
opportunistic	O	871	884	abstract	36794003
pathogens	O	885	894	abstract	36794003
were	O	895	899	abstract	36794003
decreased	O	900	909	abstract	36794003
.	O	909	910	abstract	36794003

Therefore	O	911	920	abstract	36794003
,	O	920	921	abstract	36794003
the	O	922	925	abstract	36794003
current	O	926	933	abstract	36794003
study	O	934	939	abstract	36794003
demonstrated	O	940	952	abstract	36794003
that	O	953	957	abstract	36794003
the	O	958	961	abstract	36794003
intestinal	B-DDF	962	972	abstract	36794003
microbiota	I-DDF	973	983	abstract	36794003
alterations	I-DDF	984	995	abstract	36794003
which	O	996	1001	abstract	36794003
were	O	1002	1006	abstract	36794003
influenced	O	1007	1017	abstract	36794003
by	O	1018	1020	abstract	36794003
the	O	1021	1024	abstract	36794003
high-fiber	B-food	1025	1035	abstract	36794003
diet	I-food	1036	1040	abstract	36794003
could	O	1041	1046	abstract	36794003
improve	O	1047	1054	abstract	36794003
the	O	1055	1058	abstract	36794003
serum	O	1059	1064	abstract	36794003
metabolism	O	1065	1075	abstract	36794003
and	O	1076	1079	abstract	36794003
emotional	O	1080	1089	abstract	36794003
mood	O	1090	1094	abstract	36794003
of	O	1095	1097	abstract	36794003
patients	B-human	1098	1106	abstract	36794003
with	O	1107	1111	abstract	36794003
T2DM	B-DDF	1112	1116	abstract	36794003
.	O	1116	1117	abstract	36794003

Association	O	0	11	title	38132705
of	O	12	14	title	38132705
homelessness	O	15	27	title	38132705
and	O	28	31	title	38132705
diet	O	32	36	title	38132705
on	O	37	39	title	38132705
the	O	40	43	title	38132705
gut	B-microbiome	44	47	title	38132705
microbiome	I-microbiome	48	58	title	38132705
:	O	58	59	title	38132705
a	O	60	61	title	38132705
United	O	62	68	title	38132705
States-Veteran	O	69	83	title	38132705
Microbiome	O	84	94	title	38132705
Project	O	95	102	title	38132705
(	O	103	104	title	38132705
US-VMP	O	104	110	title	38132705
)	O	110	111	title	38132705
study	O	112	117	title	38132705
.	O	117	118	title	38132705

Military	B-human	0	8	abstract	38132705
veterans	I-human	9	17	abstract	38132705
account	O	18	25	abstract	38132705
for	O	26	29	abstract	38132705
8	O	30	31	abstract	38132705
%	O	31	32	abstract	38132705
of	O	33	35	abstract	38132705
homeless	B-human	36	44	abstract	38132705
individuals	I-human	45	56	abstract	38132705
living	O	57	63	abstract	38132705
in	O	64	66	abstract	38132705
the	O	67	70	abstract	38132705
United	O	71	77	abstract	38132705
States	O	78	84	abstract	38132705
.	O	84	85	abstract	38132705

To	O	86	88	abstract	38132705
highlight	O	89	98	abstract	38132705
associations	O	99	111	abstract	38132705
between	O	112	119	abstract	38132705
history	O	120	127	abstract	38132705
of	O	128	130	abstract	38132705
homelessness	O	131	143	abstract	38132705
and	O	144	147	abstract	38132705
the	O	148	151	abstract	38132705
gut	B-microbiome	152	155	abstract	38132705
microbiome	I-microbiome	156	166	abstract	38132705
,	O	166	167	abstract	38132705
we	O	168	170	abstract	38132705
compared	O	171	179	abstract	38132705
the	O	180	183	abstract	38132705
gut	B-microbiome	184	187	abstract	38132705
microbiome	I-microbiome	188	198	abstract	38132705
of	O	199	201	abstract	38132705
veterans	B-human	202	210	abstract	38132705
who	O	211	214	abstract	38132705
reported	O	215	223	abstract	38132705
having	O	224	230	abstract	38132705
a	O	231	232	abstract	38132705
previous	O	233	241	abstract	38132705
experience	O	242	252	abstract	38132705
of	O	253	255	abstract	38132705
homelessness	O	256	268	abstract	38132705
to	O	269	271	abstract	38132705
those	O	272	277	abstract	38132705
from	O	278	282	abstract	38132705
individuals	B-human	283	294	abstract	38132705
who	O	295	298	abstract	38132705
reported	O	299	307	abstract	38132705
never	O	308	313	abstract	38132705
having	O	314	320	abstract	38132705
experienced	O	321	332	abstract	38132705
a	O	333	334	abstract	38132705
period	O	335	341	abstract	38132705
of	O	342	344	abstract	38132705
homelessness	O	345	357	abstract	38132705
.	O	357	358	abstract	38132705

Moreover	O	359	367	abstract	38132705
,	O	367	368	abstract	38132705
we	O	369	371	abstract	38132705
examined	O	372	380	abstract	38132705
the	O	381	384	abstract	38132705
impact	O	385	391	abstract	38132705
of	O	392	394	abstract	38132705
the	O	395	398	abstract	38132705
cumulative	O	399	409	abstract	38132705
exposure	O	410	418	abstract	38132705
of	O	419	421	abstract	38132705
prior	O	422	427	abstract	38132705
and	O	428	431	abstract	38132705
current	O	432	439	abstract	38132705
homelessness	O	440	452	abstract	38132705
to	O	453	455	abstract	38132705
understand	O	456	466	abstract	38132705
possible	O	467	475	abstract	38132705
associations	O	476	488	abstract	38132705
between	O	489	496	abstract	38132705
these	O	497	502	abstract	38132705
experiences	O	503	514	abstract	38132705
and	O	515	518	abstract	38132705
the	O	519	522	abstract	38132705
gut	B-microbiome	523	526	abstract	38132705
microbiome	I-microbiome	527	537	abstract	38132705
.	O	537	538	abstract	38132705

Microbiome	O	539	549	abstract	38132705
samples	O	550	557	abstract	38132705
underwent	O	558	567	abstract	38132705
genomic	O	568	575	abstract	38132705
sequencing	O	576	586	abstract	38132705
and	O	587	590	abstract	38132705
were	O	591	595	abstract	38132705
analyzed	O	596	604	abstract	38132705
based	O	605	610	abstract	38132705
on	O	611	613	abstract	38132705
alpha	O	614	619	abstract	38132705
diversity	O	620	629	abstract	38132705
,	O	629	630	abstract	38132705
beta	O	631	635	abstract	38132705
diversity	O	636	645	abstract	38132705
,	O	645	646	abstract	38132705
and	O	647	650	abstract	38132705
taxonomic	O	651	660	abstract	38132705
differences	O	661	672	abstract	38132705
.	O	672	673	abstract	38132705

Additionally	O	674	686	abstract	38132705
,	O	686	687	abstract	38132705
demographic	O	688	699	abstract	38132705
information	O	700	711	abstract	38132705
,	O	711	712	abstract	38132705
dietary	O	713	720	abstract	38132705
data	O	721	725	abstract	38132705
,	O	725	726	abstract	38132705
and	O	727	730	abstract	38132705
mental	O	731	737	abstract	38132705
health	O	738	744	abstract	38132705
history	O	745	752	abstract	38132705
were	O	753	757	abstract	38132705
collected	O	758	767	abstract	38132705
.	O	767	768	abstract	38132705

A	O	769	770	abstract	38132705
lifetime	O	771	779	abstract	38132705
history	O	780	787	abstract	38132705
of	O	788	790	abstract	38132705
homelessness	O	791	803	abstract	38132705
was	O	804	807	abstract	38132705
found	O	808	813	abstract	38132705
to	O	814	816	abstract	38132705
be	O	817	819	abstract	38132705
associated	O	820	830	abstract	38132705
with	O	831	835	abstract	38132705
alcohol	B-DDF	836	843	abstract	38132705
use	I-DDF	844	847	abstract	38132705
disorder	I-DDF	848	856	abstract	38132705
,	O	856	857	abstract	38132705
substance	B-DDF	858	867	abstract	38132705
use	I-DDF	868	871	abstract	38132705
disorder	I-DDF	872	880	abstract	38132705
,	O	880	881	abstract	38132705
and	O	882	885	abstract	38132705
healthy	B-DDF	886	893	abstract	38132705
eating	I-DDF	894	900	abstract	38132705
index	I-DDF	901	906	abstract	38132705
compared	O	907	915	abstract	38132705
to	O	916	918	abstract	38132705
those	O	919	924	abstract	38132705
without	O	925	932	abstract	38132705
such	O	933	937	abstract	38132705
a	O	938	939	abstract	38132705
history	O	940	947	abstract	38132705
.	O	947	948	abstract	38132705

In	O	949	951	abstract	38132705
terms	O	952	957	abstract	38132705
of	O	958	960	abstract	38132705
differences	O	961	972	abstract	38132705
in	O	973	975	abstract	38132705
gut	B-microbiome	976	979	abstract	38132705
microbiota	I-microbiome	980	990	abstract	38132705
,	O	990	991	abstract	38132705
beta	O	992	996	abstract	38132705
diversity	O	997	1006	abstract	38132705
was	O	1007	1010	abstract	38132705
significantly	O	1011	1024	abstract	38132705
different	O	1025	1034	abstract	38132705
between	O	1035	1042	abstract	38132705
veterans	B-human	1043	1051	abstract	38132705
who	O	1052	1055	abstract	38132705
had	O	1056	1059	abstract	38132705
experienced	O	1060	1071	abstract	38132705
homelessness	O	1072	1084	abstract	38132705
and	O	1085	1088	abstract	38132705
veterans	B-human	1089	1097	abstract	38132705
who	O	1098	1101	abstract	38132705
had	O	1102	1105	abstract	38132705
never	O	1106	1111	abstract	38132705
been	O	1112	1116	abstract	38132705
homeless	O	1117	1125	abstract	38132705
(	O	1126	1127	abstract	38132705
<	O	1127	1128	abstract	38132705
i	O	1128	1129	abstract	38132705
>	O	1129	1130	abstract	38132705
P</i	O	1130	1134	abstract	38132705
>	O	1134	1135	abstract	38132705
=	O	1136	1137	abstract	38132705
0.047	O	1138	1143	abstract	38132705
,	O	1143	1144	abstract	38132705
weighted	O	1145	1153	abstract	38132705
UniFrac	O	1154	1161	abstract	38132705
)	O	1161	1162	abstract	38132705
,	O	1162	1163	abstract	38132705
while	O	1164	1169	abstract	38132705
alpha	O	1170	1175	abstract	38132705
diversity	O	1176	1185	abstract	38132705
was	O	1186	1189	abstract	38132705
similar	O	1190	1197	abstract	38132705
.	O	1197	1198	abstract	38132705

The	O	1199	1202	abstract	38132705
microbial	O	1203	1212	abstract	38132705
community	O	1213	1222	abstract	38132705
differences	O	1223	1234	abstract	38132705
were	O	1235	1239	abstract	38132705
,	O	1239	1240	abstract	38132705
in	O	1241	1243	abstract	38132705
part	O	1244	1248	abstract	38132705
,	O	1248	1249	abstract	38132705
driven	O	1250	1256	abstract	38132705
by	O	1257	1259	abstract	38132705
a	O	1260	1261	abstract	38132705
lower	O	1262	1267	abstract	38132705
relative	O	1268	1276	abstract	38132705
abundance	O	1277	1286	abstract	38132705
of	O	1287	1289	abstract	38132705
<	O	1290	1291	abstract	38132705
i	O	1291	1292	abstract	38132705
>	O	1292	1293	abstract	38132705
Akkermansia</i	B-bacteria	1293	1307	abstract	38132705
>	O	1307	1308	abstract	38132705
in	O	1309	1311	abstract	38132705
veterans	B-human	1312	1320	abstract	38132705
who	O	1321	1324	abstract	38132705
had	O	1325	1328	abstract	38132705
experienced	O	1329	1340	abstract	38132705
homelessness	O	1341	1353	abstract	38132705
(	O	1354	1355	abstract	38132705
mean	O	1355	1359	abstract	38132705
;	O	1359	1360	abstract	38132705
range	O	1361	1366	abstract	38132705
[	O	1367	1368	abstract	38132705
in	O	1368	1370	abstract	38132705
percentages	O	1371	1382	abstract	38132705
]	O	1382	1383	abstract	38132705
,	O	1383	1384	abstract	38132705
1.07	O	1385	1389	abstract	38132705
;	O	1389	1390	abstract	38132705
0	O	1391	1392	abstract	38132705
-	O	1392	1393	abstract	38132705
33.9	O	1393	1397	abstract	38132705
)	O	1397	1398	abstract	38132705
compared	O	1399	1407	abstract	38132705
to	O	1408	1410	abstract	38132705
veterans	B-human	1411	1419	abstract	38132705
who	O	1420	1423	abstract	38132705
had	O	1424	1427	abstract	38132705
never	O	1428	1433	abstract	38132705
been	O	1434	1438	abstract	38132705
homeless	O	1439	1447	abstract	38132705
(	O	1448	1449	abstract	38132705
2.02	O	1449	1453	abstract	38132705
;	O	1453	1454	abstract	38132705
0	O	1455	1456	abstract	38132705
-	O	1456	1457	abstract	38132705
36.8	O	1457	1461	abstract	38132705
)	O	1461	1462	abstract	38132705
(	O	1463	1464	abstract	38132705
<	O	1464	1465	abstract	38132705
i	O	1465	1466	abstract	38132705
>	O	1466	1467	abstract	38132705
P</i	O	1467	1471	abstract	38132705
>	O	1471	1472	abstract	38132705
=	O	1473	1474	abstract	38132705
0.014	O	1475	1480	abstract	38132705
,	O	1480	1481	abstract	38132705
ancom-bc2	B-biomedical%technique	1482	1491	abstract	38132705
)	O	1491	1492	abstract	38132705
.	O	1492	1493	abstract	38132705

Additional	O	1494	1504	abstract	38132705
research	O	1505	1513	abstract	38132705
is	O	1514	1516	abstract	38132705
required	O	1517	1525	abstract	38132705
to	O	1526	1528	abstract	38132705
facilitate	O	1529	1539	abstract	38132705
understanding	O	1540	1553	abstract	38132705
regarding	O	1554	1563	abstract	38132705
the	O	1564	1567	abstract	38132705
complex	O	1568	1575	abstract	38132705
associations	O	1576	1588	abstract	38132705
between	O	1589	1596	abstract	38132705
homelessness	O	1597	1609	abstract	38132705
,	O	1609	1610	abstract	38132705
the	O	1611	1614	abstract	38132705
gut	B-microbiome	1615	1618	abstract	38132705
microbiome	I-microbiome	1619	1629	abstract	38132705
,	O	1629	1630	abstract	38132705
and	O	1631	1634	abstract	38132705
mental	O	1635	1641	abstract	38132705
and	O	1642	1645	abstract	38132705
physical	O	1646	1654	abstract	38132705
health	O	1655	1661	abstract	38132705
conditions	O	1662	1672	abstract	38132705
,	O	1672	1673	abstract	38132705
with	O	1674	1678	abstract	38132705
a	O	1679	1680	abstract	38132705
focus	O	1681	1686	abstract	38132705
on	O	1687	1689	abstract	38132705
increasing	O	1690	1700	abstract	38132705
understanding	O	1701	1714	abstract	38132705
regarding	O	1715	1724	abstract	38132705
the	O	1725	1728	abstract	38132705
longitudinal	O	1729	1741	abstract	38132705
impact	O	1742	1748	abstract	38132705
of	O	1749	1751	abstract	38132705
housing	O	1752	1759	abstract	38132705
instability	O	1760	1771	abstract	38132705
throughout	O	1772	1782	abstract	38132705
the	O	1783	1786	abstract	38132705
lifespan	O	1787	1795	abstract	38132705
.	O	1795	1796	abstract	38132705

IMPORTANCEAlthough	O	1796	1814	abstract	38132705
there	O	1815	1820	abstract	38132705
are	O	1821	1824	abstract	38132705
known	O	1825	1830	abstract	38132705
stressors	O	1831	1840	abstract	38132705
related	O	1841	1848	abstract	38132705
to	O	1849	1851	abstract	38132705
homelessness	O	1852	1864	abstract	38132705
as	O	1865	1867	abstract	38132705
well	O	1868	1872	abstract	38132705
as	O	1873	1875	abstract	38132705
chronic	O	1876	1883	abstract	38132705
health	O	1884	1890	abstract	38132705
conditions	O	1891	1901	abstract	38132705
experienced	O	1902	1913	abstract	38132705
by	O	1914	1916	abstract	38132705
those	O	1917	1922	abstract	38132705
without	O	1923	1930	abstract	38132705
stable	O	1931	1937	abstract	38132705
housing	O	1938	1945	abstract	38132705
,	O	1945	1946	abstract	38132705
there	O	1947	1952	abstract	38132705
has	O	1953	1956	abstract	38132705
been	O	1957	1961	abstract	38132705
limited	O	1962	1969	abstract	38132705
work	O	1970	1974	abstract	38132705
evaluating	O	1975	1985	abstract	38132705
the	O	1986	1989	abstract	38132705
associations	O	1990	2002	abstract	38132705
between	O	2003	2010	abstract	38132705
microbial	O	2011	2020	abstract	38132705
community	O	2021	2030	abstract	38132705
composition	O	2031	2042	abstract	38132705
and	O	2043	2046	abstract	38132705
homelessness	O	2047	2059	abstract	38132705
.	O	2059	2060	abstract	38132705

We	O	2061	2063	abstract	38132705
analyzed	O	2064	2072	abstract	38132705
,	O	2072	2073	abstract	38132705
for	O	2074	2077	abstract	38132705
the	O	2078	2081	abstract	38132705
first	O	2082	2087	abstract	38132705
time	O	2088	2092	abstract	38132705
,	O	2092	2093	abstract	38132705
bacterial	O	2094	2103	abstract	38132705
gut	O	2104	2107	abstract	38132705
microbiome	O	2108	2118	abstract	38132705
associations	O	2119	2131	abstract	38132705
among	O	2132	2137	abstract	38132705
those	O	2138	2143	abstract	38132705
with	O	2144	2148	abstract	38132705
experiences	O	2149	2160	abstract	38132705
of	O	2161	2163	abstract	38132705
homelessness	O	2164	2176	abstract	38132705
on	O	2177	2179	abstract	38132705
alpha	O	2180	2185	abstract	38132705
diversity	O	2186	2195	abstract	38132705
,	O	2195	2196	abstract	38132705
beta	O	2197	2201	abstract	38132705
diversity	O	2202	2211	abstract	38132705
,	O	2211	2212	abstract	38132705
and	O	2213	2216	abstract	38132705
taxonomic	O	2217	2226	abstract	38132705
differences	O	2227	2238	abstract	38132705
.	O	2238	2239	abstract	38132705

Additionally	O	2240	2252	abstract	38132705
,	O	2252	2253	abstract	38132705
we	O	2254	2256	abstract	38132705
characterized	O	2257	2270	abstract	38132705
the	O	2271	2274	abstract	38132705
influences	O	2275	2285	abstract	38132705
of	O	2286	2288	abstract	38132705
diet	O	2289	2293	abstract	38132705
,	O	2293	2294	abstract	38132705
demographic	O	2295	2306	abstract	38132705
characteristics	O	2307	2322	abstract	38132705
,	O	2322	2323	abstract	38132705
military	O	2324	2332	abstract	38132705
service	O	2333	2340	abstract	38132705
history	O	2341	2348	abstract	38132705
,	O	2348	2349	abstract	38132705
and	O	2350	2353	abstract	38132705
mental	O	2354	2360	abstract	38132705
health	O	2361	2367	abstract	38132705
conditions	O	2368	2378	abstract	38132705
on	O	2379	2381	abstract	38132705
the	O	2382	2385	abstract	38132705
microbiome	O	2386	2396	abstract	38132705
of	O	2397	2399	abstract	38132705
veterans	O	2400	2408	abstract	38132705
with	O	2409	2413	abstract	38132705
and	O	2414	2417	abstract	38132705
without	O	2418	2425	abstract	38132705
any	O	2426	2429	abstract	38132705
lifetime	O	2430	2438	abstract	38132705
history	O	2439	2446	abstract	38132705
of	O	2447	2449	abstract	38132705
homelessness	O	2450	2462	abstract	38132705
.	O	2462	2463	abstract	38132705

Future	O	2464	2470	abstract	38132705
longitudinal	O	2471	2483	abstract	38132705
research	O	2484	2492	abstract	38132705
to	O	2493	2495	abstract	38132705
evaluate	O	2496	2504	abstract	38132705
the	O	2505	2508	abstract	38132705
complex	O	2509	2516	abstract	38132705
relationships	O	2517	2530	abstract	38132705
between	O	2531	2538	abstract	38132705
homelessness	O	2539	2551	abstract	38132705
,	O	2551	2552	abstract	38132705
the	O	2553	2556	abstract	38132705
gut	B-microbiome	2557	2560	abstract	38132705
microbiome	I-microbiome	2561	2571	abstract	38132705
,	O	2571	2572	abstract	38132705
and	O	2573	2576	abstract	38132705
mental	O	2577	2583	abstract	38132705
health	O	2584	2590	abstract	38132705
outcomes	O	2591	2599	abstract	38132705
is	O	2600	2602	abstract	38132705
recommended	O	2603	2614	abstract	38132705
.	O	2614	2615	abstract	38132705

Ultimately	O	2616	2626	abstract	38132705
,	O	2626	2627	abstract	38132705
differences	O	2628	2639	abstract	38132705
in	O	2640	2642	abstract	38132705
the	O	2643	2646	abstract	38132705
gut	B-microbiome	2647	2650	abstract	38132705
microbiome	I-microbiome	2651	2661	abstract	38132705
of	O	2662	2664	abstract	38132705
individuals	O	2665	2676	abstract	38132705
experiencing	O	2677	2689	abstract	38132705
and	O	2690	2693	abstract	38132705
not	O	2694	2697	abstract	38132705
experiencing	O	2698	2710	abstract	38132705
homelessness	O	2711	2723	abstract	38132705
could	O	2724	2729	abstract	38132705
assist	O	2730	2736	abstract	38132705
in	O	2737	2739	abstract	38132705
identification	O	2740	2754	abstract	38132705
of	O	2755	2757	abstract	38132705
treatment	O	2758	2767	abstract	38132705
targets	O	2768	2775	abstract	38132705
to	O	2776	2778	abstract	38132705
improve	O	2779	2786	abstract	38132705
health	O	2787	2793	abstract	38132705
outcomes	O	2794	2802	abstract	38132705
.	O	2802	2803	abstract	38132705

Fermented	B-dietary%supplement	0	9	title	36900437
Wheat	I-dietary%supplement	10	15	title	36900437
Germ	I-dietary%supplement	16	20	title	36900437
Alleviates	O	21	31	title	36900437
Depression-like	B-DDF	32	47	title	36900437
Behavior	I-DDF	48	56	title	36900437
in	O	57	59	title	36900437
Rats	B-animal	60	64	title	36900437
with	O	65	69	title	36900437
Chronic	B-DDF	70	77	title	36900437
and	I-DDF	78	81	title	36900437
Unpredictable	I-DDF	82	95	title	36900437
Mild	I-DDF	96	100	title	36900437
Stress	I-DDF	101	107	title	36900437
.	O	107	108	title	36900437

Depression	B-DDF	0	10	abstract	36900437
is	O	11	13	abstract	36900437
a	O	14	15	abstract	36900437
chronic	B-DDF	16	23	abstract	36900437
mental	I-DDF	24	30	abstract	36900437
illness	I-DDF	31	38	abstract	36900437
with	O	39	43	abstract	36900437
devastating	O	44	55	abstract	36900437
effects	O	56	63	abstract	36900437
on	O	64	66	abstract	36900437
a	O	67	68	abstract	36900437
person	O	69	75	abstract	36900437
's	O	75	77	abstract	36900437
physical	O	78	86	abstract	36900437
and	O	87	90	abstract	36900437
mental	O	91	97	abstract	36900437
health	O	98	104	abstract	36900437
.	O	104	105	abstract	36900437

Studies	O	106	113	abstract	36900437
have	O	114	118	abstract	36900437
reported	O	119	127	abstract	36900437
that	O	128	132	abstract	36900437
food	O	133	137	abstract	36900437
fermentation	O	138	150	abstract	36900437
with	O	151	155	abstract	36900437
probiotics	B-dietary%supplement	156	166	abstract	36900437
can	O	167	170	abstract	36900437
enrich	O	171	177	abstract	36900437
the	O	178	181	abstract	36900437
nutritional	O	182	193	abstract	36900437
values	O	194	200	abstract	36900437
of	O	201	203	abstract	36900437
food	O	204	208	abstract	36900437
and	O	209	212	abstract	36900437
produce	O	213	220	abstract	36900437
functional	O	221	231	abstract	36900437
microorganisms	O	232	246	abstract	36900437
that	O	247	251	abstract	36900437
can	O	252	255	abstract	36900437
alleviate	O	256	265	abstract	36900437
depression	B-DDF	266	276	abstract	36900437
and	O	277	280	abstract	36900437
anxiety	B-DDF	281	288	abstract	36900437
.	O	288	289	abstract	36900437

Wheat	B-food	290	295	abstract	36900437
germ	I-food	296	300	abstract	36900437
is	O	301	303	abstract	36900437
an	O	304	306	abstract	36900437
inexpensive	O	307	318	abstract	36900437
raw	O	319	322	abstract	36900437
material	O	323	331	abstract	36900437
that	O	332	336	abstract	36900437
is	O	337	339	abstract	36900437
rich	O	340	344	abstract	36900437
in	O	345	347	abstract	36900437
bioactive	O	348	357	abstract	36900437
ingredients	O	358	369	abstract	36900437
.	O	369	370	abstract	36900437

For	O	371	374	abstract	36900437
example	O	375	382	abstract	36900437
,	O	382	383	abstract	36900437
gamma-aminobutyric	B-chemical	384	402	abstract	36900437
acid	I-chemical	403	407	abstract	36900437
(	O	408	409	abstract	36900437
GABA	B-chemical	409	413	abstract	36900437
)	O	413	414	abstract	36900437
is	O	415	417	abstract	36900437
reported	O	418	426	abstract	36900437
to	O	427	429	abstract	36900437
have	O	430	434	abstract	36900437
antidepressant	O	435	449	abstract	36900437
effects	O	450	457	abstract	36900437
.	O	457	458	abstract	36900437

Several	O	459	466	abstract	36900437
studies	O	467	474	abstract	36900437
concluded	O	475	484	abstract	36900437
that	O	485	489	abstract	36900437
<	O	490	491	abstract	36900437
i	O	491	492	abstract	36900437
>	O	492	493	abstract	36900437
Lactobacillus	B-bacteria	493	506	abstract	36900437
plantarum</i	I-bacteria	507	519	abstract	36900437
>	O	519	520	abstract	36900437
is	O	521	523	abstract	36900437
a	O	524	525	abstract	36900437
GABA-producing	B-bacteria	526	540	abstract	36900437
bacteria	I-bacteria	541	549	abstract	36900437
and	O	550	553	abstract	36900437
can	O	554	557	abstract	36900437
alleviate	O	558	567	abstract	36900437
depression	B-DDF	568	578	abstract	36900437
.	O	578	579	abstract	36900437

Herein	O	580	586	abstract	36900437
,	O	586	587	abstract	36900437
fermented	B-dietary%supplement	588	597	abstract	36900437
wheat	I-dietary%supplement	598	603	abstract	36900437
germs	I-dietary%supplement	604	609	abstract	36900437
(	O	610	611	abstract	36900437
FWGs	B-dietary%supplement	611	615	abstract	36900437
)	O	615	616	abstract	36900437
were	O	617	621	abstract	36900437
used	O	622	626	abstract	36900437
to	O	627	629	abstract	36900437
treat	O	630	635	abstract	36900437
stress-induced	B-DDF	636	650	abstract	36900437
depression	I-DDF	651	661	abstract	36900437
.	O	661	662	abstract	36900437

FWG	B-dietary%supplement	663	666	abstract	36900437
was	O	667	670	abstract	36900437
prepared	O	671	679	abstract	36900437
by	O	680	682	abstract	36900437
fermenting	O	683	693	abstract	36900437
wheat	B-food	694	699	abstract	36900437
germs	I-food	700	705	abstract	36900437
with	O	706	710	abstract	36900437
<	O	711	712	abstract	36900437
i	O	712	713	abstract	36900437
>	O	713	714	abstract	36900437
Lactobacillus	B-bacteria	714	727	abstract	36900437
plantarum</i>.	I-bacteria	728	742	abstract	36900437
The	O	743	746	abstract	36900437
chronic	B-biomedical%technique	747	754	abstract	36900437
unpredictable	I-biomedical%technique	755	768	abstract	36900437
mild	I-biomedical%technique	769	773	abstract	36900437
stress	I-biomedical%technique	774	780	abstract	36900437
(	I-biomedical%technique	781	782	abstract	36900437
CUMS	I-biomedical%technique	782	786	abstract	36900437
)	I-biomedical%technique	786	787	abstract	36900437
model	I-biomedical%technique	788	793	abstract	36900437
was	O	794	797	abstract	36900437
established	O	798	809	abstract	36900437
in	O	810	812	abstract	36900437
rats	B-animal	813	817	abstract	36900437
,	O	817	818	abstract	36900437
and	O	819	822	abstract	36900437
these	O	823	828	abstract	36900437
rats	B-animal	829	833	abstract	36900437
were	O	834	838	abstract	36900437
treated	O	839	846	abstract	36900437
with	O	847	851	abstract	36900437
FWG	B-dietary%supplement	852	855	abstract	36900437
for	O	856	859	abstract	36900437
four	O	860	864	abstract	36900437
weeks	O	865	870	abstract	36900437
to	O	871	873	abstract	36900437
evaluate	O	874	882	abstract	36900437
the	O	883	886	abstract	36900437
effects	O	887	894	abstract	36900437
of	O	895	897	abstract	36900437
FWG	B-dietary%supplement	898	901	abstract	36900437
in	O	902	904	abstract	36900437
relieving	O	905	914	abstract	36900437
depression	B-DDF	915	925	abstract	36900437
.	O	925	926	abstract	36900437

In	O	927	929	abstract	36900437
addition	O	930	938	abstract	36900437
,	O	938	939	abstract	36900437
the	O	940	943	abstract	36900437
study	O	944	949	abstract	36900437
also	O	950	954	abstract	36900437
analyzed	O	955	963	abstract	36900437
the	O	964	967	abstract	36900437
potential	O	968	977	abstract	36900437
anti-depressive	O	978	993	abstract	36900437
mechanism	O	994	1003	abstract	36900437
of	O	1004	1006	abstract	36900437
FWG	B-dietary%supplement	1007	1010	abstract	36900437
based	O	1011	1016	abstract	36900437
on	O	1017	1019	abstract	36900437
behavioral	O	1020	1030	abstract	36900437
changes	O	1031	1038	abstract	36900437
,	O	1038	1039	abstract	36900437
physiological	O	1040	1053	abstract	36900437
and	O	1054	1057	abstract	36900437
biochemical	O	1058	1069	abstract	36900437
index	O	1070	1075	abstract	36900437
changes	O	1076	1083	abstract	36900437
,	O	1083	1084	abstract	36900437
and	O	1085	1088	abstract	36900437
intestinal	O	1089	1099	abstract	36900437
flora	O	1100	1105	abstract	36900437
changes	O	1106	1113	abstract	36900437
in	O	1114	1116	abstract	36900437
depressed	B-animal	1117	1126	abstract	36900437
rats	I-animal	1127	1131	abstract	36900437
.	O	1131	1132	abstract	36900437

The	O	1133	1136	abstract	36900437
results	O	1137	1144	abstract	36900437
demonstrated	O	1145	1157	abstract	36900437
that	O	1158	1162	abstract	36900437
FWG	B-dietary%supplement	1163	1166	abstract	36900437
improved	O	1167	1175	abstract	36900437
depression-like	B-DDF	1176	1191	abstract	36900437
behaviors	I-DDF	1192	1201	abstract	36900437
and	O	1202	1205	abstract	36900437
increased	O	1206	1215	abstract	36900437
neurotransmitter	O	1216	1232	abstract	36900437
levels	O	1233	1239	abstract	36900437
in	O	1240	1242	abstract	36900437
the	O	1243	1246	abstract	36900437
hippocampus	B-anatomical%location	1247	1258	abstract	36900437
of	O	1259	1261	abstract	36900437
CUMS	B-animal	1262	1266	abstract	36900437
model	I-animal	1267	1272	abstract	36900437
rats	I-animal	1273	1277	abstract	36900437
.	O	1277	1278	abstract	36900437

In	O	1279	1281	abstract	36900437
addition	O	1282	1290	abstract	36900437
,	O	1290	1291	abstract	36900437
FWG	B-dietary%supplement	1292	1295	abstract	36900437
effectively	O	1296	1307	abstract	36900437
altered	O	1308	1315	abstract	36900437
the	O	1316	1319	abstract	36900437
gut	O	1320	1323	abstract	36900437
microbiota	O	1324	1334	abstract	36900437
structure	O	1335	1344	abstract	36900437
and	O	1345	1348	abstract	36900437
remodeled	O	1349	1358	abstract	36900437
the	O	1359	1362	abstract	36900437
gut	B-microbiome	1363	1366	abstract	36900437
microbiota	I-microbiome	1367	1377	abstract	36900437
in	O	1378	1380	abstract	36900437
CUMS	B-animal	1381	1385	abstract	36900437
rats	I-animal	1386	1390	abstract	36900437
,	O	1390	1391	abstract	36900437
restored	O	1392	1400	abstract	36900437
neurotransmitter	O	1401	1417	abstract	36900437
levels	O	1418	1424	abstract	36900437
in	O	1425	1427	abstract	36900437
depressed	B-animal	1428	1437	abstract	36900437
rats	I-animal	1438	1442	abstract	36900437
through	O	1443	1450	abstract	36900437
the	O	1451	1454	abstract	36900437
brain-gut	O	1455	1464	abstract	36900437
axis	O	1465	1469	abstract	36900437
,	O	1469	1470	abstract	36900437
and	O	1471	1474	abstract	36900437
restored	O	1475	1483	abstract	36900437
amino	O	1484	1489	abstract	36900437
acid	O	1490	1494	abstract	36900437
metabolic	O	1495	1504	abstract	36900437
functions	O	1505	1514	abstract	36900437
.	O	1514	1515	abstract	36900437

In	O	1516	1518	abstract	36900437
conclusion	O	1519	1529	abstract	36900437
,	O	1529	1530	abstract	36900437
we	O	1531	1533	abstract	36900437
suggest	O	1534	1541	abstract	36900437
that	O	1542	1546	abstract	36900437
FWG	B-dietary%supplement	1547	1550	abstract	36900437
has	O	1551	1554	abstract	36900437
antidepressant	O	1555	1569	abstract	36900437
effects	O	1570	1577	abstract	36900437
,	O	1577	1578	abstract	36900437
and	O	1579	1582	abstract	36900437
its	O	1583	1586	abstract	36900437
potential	O	1587	1596	abstract	36900437
mechanism	O	1597	1606	abstract	36900437
may	O	1607	1610	abstract	36900437
act	O	1611	1614	abstract	36900437
by	O	1615	1617	abstract	36900437
restoring	O	1618	1627	abstract	36900437
the	O	1628	1631	abstract	36900437
disordered	O	1632	1642	abstract	36900437
brain-gut	O	1643	1652	abstract	36900437
axis	O	1653	1657	abstract	36900437
.	O	1657	1658	abstract	36900437

Consumption	O	0	11	title	34603341
of	O	12	14	title	34603341
Butylated	B-dietary%supplement	15	24	title	34603341
Starch	I-dietary%supplement	25	31	title	34603341
Alleviates	O	32	42	title	34603341
the	O	43	46	title	34603341
Chronic	B-DDF	47	54	title	34603341
Restraint	I-DDF	55	64	title	34603341
Stress-Induced	I-DDF	65	79	title	34603341
Neurobehavioral	I-DDF	80	95	title	34603341
and	I-DDF	96	99	title	34603341
Gut	I-DDF	100	103	title	34603341
Barrier	I-DDF	104	111	title	34603341
Deficits	I-DDF	112	120	title	34603341
Through	O	121	128	title	34603341
Reshaping	O	129	138	title	34603341
the	O	139	142	title	34603341
Gut	B-microbiome	143	146	title	34603341
Microbiota	I-microbiome	147	157	title	34603341
.	O	157	158	title	34603341

The	O	0	3	abstract	34603341
beneficial	O	4	14	abstract	34603341
effect	O	15	21	abstract	34603341
of	O	22	24	abstract	34603341
short-chain	B-chemical	25	36	abstract	34603341
fatty	I-chemical	37	42	abstract	34603341
acids	I-chemical	43	48	abstract	34603341
(	O	49	50	abstract	34603341
SCFAs	B-chemical	50	55	abstract	34603341
)	O	55	56	abstract	34603341
on	O	57	59	abstract	34603341
host	O	60	64	abstract	34603341
health	O	65	71	abstract	34603341
has	O	72	75	abstract	34603341
been	O	76	80	abstract	34603341
well	O	81	85	abstract	34603341
recognized	O	86	96	abstract	34603341
based	O	97	102	abstract	34603341
on	O	103	105	abstract	34603341
the	O	106	109	abstract	34603341
booming	O	110	117	abstract	34603341
knowledge	O	118	127	abstract	34603341
from	O	128	132	abstract	34603341
gut	O	133	136	abstract	34603341
microbiome	O	137	147	abstract	34603341
research	O	148	156	abstract	34603341
.	O	156	157	abstract	34603341

The	O	158	161	abstract	34603341
role	O	162	166	abstract	34603341
of	O	167	169	abstract	34603341
SCFA	B-chemical	170	174	abstract	34603341
in	O	175	177	abstract	34603341
influencing	O	178	189	abstract	34603341
psychological	O	190	203	abstract	34603341
function	O	204	212	abstract	34603341
is	O	213	215	abstract	34603341
highlighted	O	216	227	abstract	34603341
in	O	228	230	abstract	34603341
recent	O	231	237	abstract	34603341
years	O	238	243	abstract	34603341
but	O	244	247	abstract	34603341
has	O	248	251	abstract	34603341
not	O	252	255	abstract	34603341
been	O	256	260	abstract	34603341
fully	O	261	266	abstract	34603341
elucidated	O	267	277	abstract	34603341
.	O	277	278	abstract	34603341

In	O	279	281	abstract	34603341
this	O	282	286	abstract	34603341
study	O	287	292	abstract	34603341
,	O	292	293	abstract	34603341
the	O	294	297	abstract	34603341
SCFA-acylated	B-dietary%supplement	298	311	abstract	34603341
starches	I-dietary%supplement	312	320	abstract	34603341
were	O	321	325	abstract	34603341
used	O	326	330	abstract	34603341
to	O	331	333	abstract	34603341
accomplish	O	334	344	abstract	34603341
a	O	345	346	abstract	34603341
sizeable	O	347	355	abstract	34603341
intestine-targeted	O	356	374	abstract	34603341
release	O	375	382	abstract	34603341
of	O	383	385	abstract	34603341
the	O	386	389	abstract	34603341
SCFAs	B-chemical	390	395	abstract	34603341
,	O	395	396	abstract	34603341
and	O	397	400	abstract	34603341
the	O	401	404	abstract	34603341
neurobehavioral	O	405	420	abstract	34603341
,	O	420	421	abstract	34603341
immunological	O	422	435	abstract	34603341
,	O	435	436	abstract	34603341
and	O	437	440	abstract	34603341
microbial	O	441	450	abstract	34603341
effects	O	451	458	abstract	34603341
were	O	459	463	abstract	34603341
further	O	464	471	abstract	34603341
investigated	O	472	484	abstract	34603341
.	O	484	485	abstract	34603341

Acetylated-	B-dietary%supplement	486	497	abstract	34603341
,	I-dietary%supplement	497	498	abstract	34603341
butylated-	I-dietary%supplement	499	509	abstract	34603341
,	I-dietary%supplement	509	510	abstract	34603341
and	I-dietary%supplement	511	514	abstract	34603341
isobutylated-starch	I-dietary%supplement	515	534	abstract	34603341
could	O	535	540	abstract	34603341
attenuate	O	541	550	abstract	34603341
the	O	551	554	abstract	34603341
depression-like	B-DDF	555	570	abstract	34603341
behaviors	I-DDF	571	580	abstract	34603341
and	O	581	584	abstract	34603341
excessive	O	585	594	abstract	34603341
corticosterone	O	595	609	abstract	34603341
production	O	610	620	abstract	34603341
in	O	621	623	abstract	34603341
chronically	O	624	635	abstract	34603341
stressed	O	636	644	abstract	34603341
mice	B-animal	645	649	abstract	34603341
.	O	649	650	abstract	34603341

Butylated-	B-dietary%supplement	651	661	abstract	34603341
starch	I-dietary%supplement	662	668	abstract	34603341
significantly	O	669	682	abstract	34603341
reduced	O	683	690	abstract	34603341
the	O	691	694	abstract	34603341
colonic	O	695	702	abstract	34603341
permeability	O	703	715	abstract	34603341
<	O	716	717	abstract	34603341
i	O	717	718	abstract	34603341
>	O	718	719	abstract	34603341
via</i	O	719	725	abstract	34603341
>	O	725	726	abstract	34603341
increasing	O	727	737	abstract	34603341
the	O	738	741	abstract	34603341
tight	B-chemical	742	747	abstract	34603341
junction	I-chemical	748	756	abstract	34603341
proteins	I-chemical	757	765	abstract	34603341
(	O	766	767	abstract	34603341
including	O	767	776	abstract	34603341
ZO-1	B-chemical	777	781	abstract	34603341
,	O	781	782	abstract	34603341
Claudin	B-chemical	783	790	abstract	34603341
,	O	790	791	abstract	34603341
and	O	792	795	abstract	34603341
Occludin	B-chemical	796	804	abstract	34603341
)	O	804	805	abstract	34603341
gene	O	806	810	abstract	34603341
expression	O	811	821	abstract	34603341
and	O	822	825	abstract	34603341
reduced	O	826	833	abstract	34603341
the	O	834	837	abstract	34603341
level	O	838	843	abstract	34603341
of	O	844	846	abstract	34603341
the	O	847	850	abstract	34603341
inflammatory	B-chemical	851	863	abstract	34603341
cytokines	I-chemical	864	873	abstract	34603341
(	O	874	875	abstract	34603341
including	O	875	884	abstract	34603341
IL-1	B-chemical	885	890	abstract	34603341
and	O	891	894	abstract	34603341
IL-6	B-chemical	895	899	abstract	34603341
)	O	899	900	abstract	34603341
.	O	900	901	abstract	34603341

The	O	902	905	abstract	34603341
butylated	O	906	915	abstract	34603341
starch	O	916	922	abstract	34603341
's	O	922	924	abstract	34603341
neurological	O	925	937	abstract	34603341
and	O	938	941	abstract	34603341
immunological	O	942	955	abstract	34603341
benefits	O	956	964	abstract	34603341
may	O	965	968	abstract	34603341
be	O	969	971	abstract	34603341
derived	O	972	979	abstract	34603341
from	O	980	984	abstract	34603341
the	O	985	988	abstract	34603341
gut	O	989	992	abstract	34603341
microbiome	O	993	1003	abstract	34603341
modifications	O	1004	1017	abstract	34603341
,	O	1017	1018	abstract	34603341
including	O	1019	1028	abstract	34603341
normalizing	O	1029	1040	abstract	34603341
the	O	1041	1044	abstract	34603341
abundance	O	1045	1054	abstract	34603341
of	O	1055	1057	abstract	34603341
certain	O	1058	1065	abstract	34603341
beneficial	O	1066	1076	abstract	34603341
microbes	O	1077	1085	abstract	34603341
(	O	1086	1087	abstract	34603341
<	O	1087	1088	abstract	34603341
i	O	1088	1089	abstract	34603341
>	O	1089	1090	abstract	34603341
Odoribacter</i	B-bacteria	1090	1104	abstract	34603341
>	O	1104	1105	abstract	34603341
and	O	1106	1109	abstract	34603341
<	O	1110	1111	abstract	34603341
i	O	1111	1112	abstract	34603341
>	O	1112	1113	abstract	34603341
Oscillibacter</i	B-bacteria	1113	1129	abstract	34603341
>	O	1129	1130	abstract	34603341
)	O	1130	1131	abstract	34603341
and	O	1132	1135	abstract	34603341
metabolomic	O	1136	1147	abstract	34603341
pathways	O	1148	1156	abstract	34603341
(	O	1157	1158	abstract	34603341
<	O	1158	1159	abstract	34603341
i	O	1159	1160	abstract	34603341
>	O	1160	1161	abstract	34603341
Tryptophan	O	1161	1171	abstract	34603341
synthesis</i	O	1172	1184	abstract	34603341
>	O	1184	1185	abstract	34603341
and	O	1186	1189	abstract	34603341
<	O	1190	1191	abstract	34603341
i	O	1191	1192	abstract	34603341
>	O	1192	1193	abstract	34603341
Inositol	O	1193	1201	abstract	34603341
degradation</i	O	1202	1216	abstract	34603341
>	O	1216	1217	abstract	34603341
)	O	1217	1218	abstract	34603341
.	O	1218	1219	abstract	34603341

The	O	1220	1223	abstract	34603341
present	O	1224	1231	abstract	34603341
findings	O	1232	1240	abstract	34603341
further	O	1241	1248	abstract	34603341
validate	O	1249	1257	abstract	34603341
the	O	1258	1261	abstract	34603341
brain-beneficial	O	1262	1278	abstract	34603341
effect	O	1279	1285	abstract	34603341
of	O	1286	1288	abstract	34603341
butyrate	B-chemical	1289	1297	abstract	34603341
and	O	1298	1301	abstract	34603341
offer	O	1302	1307	abstract	34603341
novel	O	1308	1313	abstract	34603341
guidance	O	1314	1322	abstract	34603341
for	O	1323	1326	abstract	34603341
developing	O	1327	1337	abstract	34603341
novel	O	1338	1343	abstract	34603341
food	O	1344	1348	abstract	34603341
or	O	1349	1351	abstract	34603341
dietary	O	1352	1359	abstract	34603341
supplements	O	1360	1371	abstract	34603341
for	O	1372	1375	abstract	34603341
improving	O	1376	1385	abstract	34603341
mental	O	1386	1392	abstract	34603341
health	O	1393	1399	abstract	34603341
.	O	1399	1400	abstract	34603341

A	O	0	1	title	34422393
discussion	O	2	12	title	34422393
of	O	13	15	title	34422393
the	O	16	19	title	34422393
gut	O	20	23	title	34422393
microbiome	O	24	34	title	34422393
's	O	34	36	title	34422393
development	O	37	48	title	34422393
,	O	48	49	title	34422393
determinants	O	50	62	title	34422393
,	O	62	63	title	34422393
and	O	64	67	title	34422393
dysbiosis	B-DDF	68	77	title	34422393
in	O	78	80	title	34422393
cancers	B-DDF	81	88	title	34422393
of	I-DDF	89	91	title	34422393
the	I-DDF	92	95	title	34422393
esophagus	I-DDF	96	105	title	34422393
and	I-DDF	106	109	title	34422393
stomach	I-DDF	110	117	title	34422393
.	O	117	118	title	34422393

The	O	0	3	abstract	34422393
microbiome	O	4	14	abstract	34422393
refers	O	15	21	abstract	34422393
to	O	22	24	abstract	34422393
a	O	25	26	abstract	34422393
population	O	27	37	abstract	34422393
of	O	38	40	abstract	34422393
microbes	O	41	49	abstract	34422393
that	O	50	54	abstract	34422393
colonize	O	55	63	abstract	34422393
the	O	64	67	abstract	34422393
skin	B-anatomical%location	68	72	abstract	34422393
,	O	72	73	abstract	34422393
nasopharynx	B-anatomical%location	74	85	abstract	34422393
,	O	85	86	abstract	34422393
oral	B-anatomical%location	87	91	abstract	34422393
cavity	I-anatomical%location	92	98	abstract	34422393
,	O	98	99	abstract	34422393
gastrointestinal	B-anatomical%location	100	116	abstract	34422393
tract	I-anatomical%location	117	122	abstract	34422393
,	O	122	123	abstract	34422393
and	O	124	127	abstract	34422393
urogenital	B-anatomical%location	128	138	abstract	34422393
tract	I-anatomical%location	139	144	abstract	34422393
.	O	144	145	abstract	34422393

The	O	146	149	abstract	34422393
human	O	150	155	abstract	34422393
microbiome	O	156	166	abstract	34422393
consists	O	167	175	abstract	34422393
of	O	176	178	abstract	34422393
bacteria	O	179	187	abstract	34422393
,	O	187	188	abstract	34422393
archaea	O	189	196	abstract	34422393
,	O	196	197	abstract	34422393
fungi	O	198	203	abstract	34422393
,	O	203	204	abstract	34422393
viruses	O	205	212	abstract	34422393
,	O	212	213	abstract	34422393
and	O	214	217	abstract	34422393
phages	O	218	224	abstract	34422393
.	O	224	225	abstract	34422393

Recent	O	226	232	abstract	34422393
advances	O	233	241	abstract	34422393
in	O	242	244	abstract	34422393
genomic	B-biomedical%technique	245	252	abstract	34422393
sequencing	I-biomedical%technique	253	263	abstract	34422393
have	O	264	268	abstract	34422393
catalyzed	O	269	278	abstract	34422393
a	O	279	280	abstract	34422393
deeper	O	281	287	abstract	34422393
understanding	O	288	301	abstract	34422393
of	O	302	304	abstract	34422393
complex	O	305	312	abstract	34422393
microbe-microbe	O	313	328	abstract	34422393
and	O	329	332	abstract	34422393
host-microbe	O	333	345	abstract	34422393
interactions	O	346	358	abstract	34422393
.	O	358	359	abstract	34422393

Dysregulation	O	360	373	abstract	34422393
of	O	374	376	abstract	34422393
these	O	377	382	abstract	34422393
interactions	O	383	395	abstract	34422393
,	O	395	396	abstract	34422393
or	O	397	399	abstract	34422393
dysbiosis	B-DDF	400	409	abstract	34422393
of	I-DDF	410	412	abstract	34422393
the	I-DDF	413	416	abstract	34422393
gastrointestinal	I-DDF	417	433	abstract	34422393
tract	I-DDF	434	439	abstract	34422393
,	O	439	440	abstract	34422393
has	O	441	444	abstract	34422393
been	O	445	449	abstract	34422393
implicated	O	450	460	abstract	34422393
in	O	461	463	abstract	34422393
a	O	464	465	abstract	34422393
growing	O	466	473	abstract	34422393
list	O	474	478	abstract	34422393
of	O	479	481	abstract	34422393
pathologies	O	482	493	abstract	34422393
including	O	494	503	abstract	34422393
nonalcoholic	B-DDF	504	516	abstract	34422393
fatty	I-DDF	517	522	abstract	34422393
liver	I-DDF	523	528	abstract	34422393
disease	I-DDF	529	536	abstract	34422393
,	O	536	537	abstract	34422393
cardiovascular	B-DDF	538	552	abstract	34422393
disease	I-DDF	553	560	abstract	34422393
,	O	560	561	abstract	34422393
obesity	B-DDF	562	569	abstract	34422393
,	O	569	570	abstract	34422393
diabetes	B-DDF	571	579	abstract	34422393
,	O	579	580	abstract	34422393
depression	B-DDF	581	591	abstract	34422393
,	O	591	592	abstract	34422393
Parkinson	B-DDF	593	602	abstract	34422393
's	I-DDF	602	604	abstract	34422393
disease	I-DDF	605	612	abstract	34422393
,	O	612	613	abstract	34422393
autism	B-DDF	614	620	abstract	34422393
,	O	620	621	abstract	34422393
and	O	622	625	abstract	34422393
various	O	626	633	abstract	34422393
gastrointestinal	B-DDF	634	650	abstract	34422393
cancers	I-DDF	651	658	abstract	34422393
.	O	658	659	abstract	34422393

Gastric	B-DDF	660	667	abstract	34422393
and	I-DDF	668	671	abstract	34422393
esophageal	I-DDF	672	682	abstract	34422393
cancer	I-DDF	683	689	abstract	34422393
,	O	689	690	abstract	34422393
for	O	691	694	abstract	34422393
example	O	695	702	abstract	34422393
,	O	702	703	abstract	34422393
continue	O	704	712	abstract	34422393
to	O	713	715	abstract	34422393
remain	O	716	722	abstract	34422393
as	O	723	725	abstract	34422393
two	O	726	729	abstract	34422393
of	O	730	732	abstract	34422393
the	O	733	736	abstract	34422393
most	O	737	741	abstract	34422393
common	O	742	748	abstract	34422393
causes	O	749	755	abstract	34422393
of	O	756	758	abstract	34422393
cancer-related	O	759	773	abstract	34422393
deaths	O	774	780	abstract	34422393
worldwide	O	781	790	abstract	34422393
,	O	790	791	abstract	34422393
therefore	O	792	801	abstract	34422393
there	O	802	807	abstract	34422393
is	O	808	810	abstract	34422393
an	O	811	813	abstract	34422393
increased	O	814	823	abstract	34422393
emphasis	O	824	832	abstract	34422393
on	O	833	835	abstract	34422393
investigating	O	836	849	abstract	34422393
the	O	850	853	abstract	34422393
role	O	854	858	abstract	34422393
of	O	859	861	abstract	34422393
dysbiosis	B-DDF	862	871	abstract	34422393
on	O	872	874	abstract	34422393
these	O	875	880	abstract	34422393
cancers	B-DDF	881	888	abstract	34422393
.	O	888	889	abstract	34422393

In	O	890	892	abstract	34422393
this	O	893	897	abstract	34422393
review	O	898	904	abstract	34422393
,	O	904	905	abstract	34422393
we	O	906	908	abstract	34422393
discuss	O	909	916	abstract	34422393
the	O	917	920	abstract	34422393
development	O	921	932	abstract	34422393
and	O	933	936	abstract	34422393
structure	O	937	946	abstract	34422393
of	O	947	949	abstract	34422393
the	O	950	953	abstract	34422393
gut	B-microbiome	954	957	abstract	34422393
microbiome	I-microbiome	958	968	abstract	34422393
,	O	968	969	abstract	34422393
its	O	970	973	abstract	34422393
homeostatic	O	974	985	abstract	34422393
and	O	986	989	abstract	34422393
dysbiotic	O	990	999	abstract	34422393
mechanisms	O	1000	1010	abstract	34422393
,	O	1010	1011	abstract	34422393
and	O	1012	1015	abstract	34422393
the	O	1016	1019	abstract	34422393
key	O	1020	1023	abstract	34422393
microbes	O	1024	1032	abstract	34422393
in	O	1033	1035	abstract	34422393
esophageal	O	1036	1046	abstract	34422393
and	O	1047	1050	abstract	34422393
gastric	O	1051	1058	abstract	34422393
carcinogenesis	O	1059	1073	abstract	34422393
with	O	1074	1078	abstract	34422393
a	O	1079	1080	abstract	34422393
focus	O	1081	1086	abstract	34422393
on	O	1087	1089	abstract	34422393
bacterial	O	1090	1099	abstract	34422393
biology	O	1100	1107	abstract	34422393
.	O	1107	1108	abstract	34422393

Further	O	1109	1116	abstract	34422393
clarification	O	1117	1130	abstract	34422393
of	O	1131	1133	abstract	34422393
these	O	1134	1139	abstract	34422393
pathways	O	1140	1148	abstract	34422393
and	O	1149	1152	abstract	34422393
discovery	O	1153	1162	abstract	34422393
of	O	1163	1165	abstract	34422393
diagnostic	O	1166	1176	abstract	34422393
or	O	1177	1179	abstract	34422393
therapeutic	O	1180	1191	abstract	34422393
targets	O	1192	1199	abstract	34422393
could	O	1200	1205	abstract	34422393
have	O	1206	1210	abstract	34422393
broad	O	1211	1216	abstract	34422393
impacts	O	1217	1224	abstract	34422393
on	O	1225	1227	abstract	34422393
global	O	1228	1234	abstract	34422393
subpopulations	O	1235	1249	abstract	34422393
.	O	1249	1250	abstract	34422393

It	O	1251	1253	abstract	34422393
is	O	1254	1256	abstract	34422393
important	O	1257	1266	abstract	34422393
to	O	1267	1269	abstract	34422393
understand	O	1270	1280	abstract	34422393
the	O	1281	1284	abstract	34422393
nature	O	1285	1291	abstract	34422393
of	O	1292	1294	abstract	34422393
the	O	1295	1298	abstract	34422393
gastrointestinal	B-microbiome	1299	1315	abstract	34422393
tract	I-microbiome	1316	1321	abstract	34422393
microbiome	I-microbiome	1322	1332	abstract	34422393
and	O	1333	1336	abstract	34422393
its	O	1337	1340	abstract	34422393
potentional	O	1341	1352	abstract	34422393
risk	O	1353	1357	abstract	34422393
factors	O	1358	1365	abstract	34422393
for	O	1366	1369	abstract	34422393
dysbiosis	B-DDF	1370	1379	abstract	34422393
in	O	1380	1382	abstract	34422393
order	O	1383	1388	abstract	34422393
to	O	1389	1391	abstract	34422393
tailor	O	1392	1398	abstract	34422393
its	O	1399	1402	abstract	34422393
application	O	1403	1414	abstract	34422393
to	O	1415	1417	abstract	34422393
the	O	1418	1421	abstract	34422393
individual	B-human	1422	1432	abstract	34422393
patient	I-human	1433	1440	abstract	34422393
and	O	1441	1444	abstract	34422393
create	O	1445	1451	abstract	34422393
an	O	1452	1454	abstract	34422393
era	O	1455	1458	abstract	34422393
of	O	1459	1461	abstract	34422393
highly	O	1462	1468	abstract	34422393
personalized	O	1469	1481	abstract	34422393
,	O	1481	1482	abstract	34422393
precision	O	1483	1492	abstract	34422393
medicine	O	1493	1501	abstract	34422393
.	O	1501	1502	abstract	34422393

Oral	O	0	4	title	35914559
ingestion	O	5	14	title	35914559
of	O	15	17	title	35914559
the	O	18	21	title	35914559
environmental	O	22	35	title	35914559
toxicant	O	36	44	title	35914559
trichloroethylene	B-chemical	45	62	title	35914559
in	O	63	65	title	35914559
rats	B-animal	66	70	title	35914559
induces	O	71	78	title	35914559
alterations	O	79	90	title	35914559
in	O	91	93	title	35914559
the	O	94	97	title	35914559
gut	B-microbiome	98	101	title	35914559
microbiome	I-microbiome	102	112	title	35914559
:	O	112	113	title	35914559
Relevance	O	114	123	title	35914559
to	O	124	126	title	35914559
idiopathic	B-DDF	127	137	title	35914559
Parkinson	I-DDF	138	147	title	35914559
's	I-DDF	147	149	title	35914559
disease	I-DDF	150	157	title	35914559
.	O	157	158	title	35914559

Microbial	O	0	9	abstract	35914559
alterations	O	10	21	abstract	35914559
within	O	22	28	abstract	35914559
the	O	29	32	abstract	35914559
gut	B-microbiome	33	36	abstract	35914559
microbiome	I-microbiome	37	47	abstract	35914559
appear	O	48	54	abstract	35914559
to	O	55	57	abstract	35914559
be	O	58	60	abstract	35914559
a	O	61	62	abstract	35914559
common	O	63	69	abstract	35914559
feature	O	70	77	abstract	35914559
of	O	78	80	abstract	35914559
individuals	B-human	81	92	abstract	35914559
with	O	93	97	abstract	35914559
Parkinson	B-DDF	98	107	abstract	35914559
's	I-DDF	107	109	abstract	35914559
disease	I-DDF	110	117	abstract	35914559
(	O	118	119	abstract	35914559
PD	B-DDF	119	121	abstract	35914559
)	O	121	122	abstract	35914559
,	O	122	123	abstract	35914559
providing	O	124	133	abstract	35914559
further	O	134	141	abstract	35914559
evidence	O	142	150	abstract	35914559
for	O	151	154	abstract	35914559
the	O	155	158	abstract	35914559
role	O	159	163	abstract	35914559
of	O	164	166	abstract	35914559
the	O	167	170	abstract	35914559
gut-brain	O	171	180	abstract	35914559
axis	O	181	185	abstract	35914559
in	O	186	188	abstract	35914559
PD	B-DDF	189	191	abstract	35914559
development	O	192	203	abstract	35914559
.	O	203	204	abstract	35914559

As	O	205	207	abstract	35914559
a	O	208	209	abstract	35914559
major	O	210	215	abstract	35914559
site	O	216	220	abstract	35914559
of	O	221	223	abstract	35914559
contact	O	224	231	abstract	35914559
with	O	232	236	abstract	35914559
the	O	237	240	abstract	35914559
environment	O	241	252	abstract	35914559
,	O	252	253	abstract	35914559
questions	O	254	263	abstract	35914559
have	O	264	268	abstract	35914559
emerged	O	269	276	abstract	35914559
surrounding	O	277	288	abstract	35914559
the	O	289	292	abstract	35914559
cause	O	293	298	abstract	35914559
and	O	299	302	abstract	35914559
effect	O	303	309	abstract	35914559
of	O	310	312	abstract	35914559
alterations	O	313	324	abstract	35914559
to	O	325	327	abstract	35914559
the	O	328	331	abstract	35914559
gut	B-microbiome	332	335	abstract	35914559
microbiome	I-microbiome	336	346	abstract	35914559
by	O	347	349	abstract	35914559
environmental	O	350	363	abstract	35914559
contaminants	O	364	376	abstract	35914559
associated	O	377	387	abstract	35914559
with	O	388	392	abstract	35914559
PD	O	393	395	abstract	35914559
risk	O	396	400	abstract	35914559
,	O	400	401	abstract	35914559
such	O	402	406	abstract	35914559
as	O	407	409	abstract	35914559
pesticides	B-chemical	410	420	abstract	35914559
,	O	420	421	abstract	35914559
metals	B-chemical	422	428	abstract	35914559
,	O	428	429	abstract	35914559
and	O	430	433	abstract	35914559
organic	B-chemical	434	441	abstract	35914559
solvents	I-chemical	442	450	abstract	35914559
.	O	450	451	abstract	35914559

Recent	O	452	458	abstract	35914559
data	O	459	463	abstract	35914559
from	O	464	468	abstract	35914559
our	O	469	472	abstract	35914559
lab	O	473	476	abstract	35914559
shows	O	477	482	abstract	35914559
that	O	483	487	abstract	35914559
ingestion	O	488	497	abstract	35914559
of	O	498	500	abstract	35914559
the	O	501	504	abstract	35914559
industrial	O	505	515	abstract	35914559
byproduct	O	516	525	abstract	35914559
and	O	526	529	abstract	35914559
environmental	O	530	543	abstract	35914559
pollutant	O	544	553	abstract	35914559
trichloroethylene	B-chemical	554	571	abstract	35914559
(	O	572	573	abstract	35914559
TCE	B-chemical	573	576	abstract	35914559
)	O	576	577	abstract	35914559
induces	O	578	585	abstract	35914559
key	O	586	589	abstract	35914559
Parkinsonian	B-DDF	590	602	abstract	35914559
pathology	I-DDF	603	612	abstract	35914559
within	O	613	619	abstract	35914559
aged	B-animal	620	624	abstract	35914559
rats	I-animal	625	629	abstract	35914559
,	O	629	630	abstract	35914559
including	O	631	640	abstract	35914559
the	O	641	644	abstract	35914559
degeneration	O	645	657	abstract	35914559
of	O	658	660	abstract	35914559
dopaminergic	O	661	673	abstract	35914559
neurons	O	674	681	abstract	35914559
,	O	681	682	abstract	35914559
-synuclein	O	683	694	abstract	35914559
accumulation	O	695	707	abstract	35914559
,	O	707	708	abstract	35914559
neuroinflammation	B-DDF	709	726	abstract	35914559
,	O	726	727	abstract	35914559
and	O	728	731	abstract	35914559
endolysosomal	B-DDF	732	745	abstract	35914559
deficits	I-DDF	746	754	abstract	35914559
.	O	754	755	abstract	35914559

As	O	756	758	abstract	35914559
TCE	B-chemical	759	762	abstract	35914559
is	O	763	765	abstract	35914559
the	O	766	769	abstract	35914559
most	O	770	774	abstract	35914559
common	O	775	781	abstract	35914559
organic	O	782	789	abstract	35914559
contaminant	O	790	801	abstract	35914559
within	O	802	808	abstract	35914559
drinking	O	809	817	abstract	35914559
water	O	818	823	abstract	35914559
,	O	823	824	abstract	35914559
we	O	825	827	abstract	35914559
postulated	O	828	838	abstract	35914559
that	O	839	843	abstract	35914559
ingestion	O	844	853	abstract	35914559
of	O	854	856	abstract	35914559
TCE	B-chemical	857	860	abstract	35914559
associated	O	861	871	abstract	35914559
with	O	872	876	abstract	35914559
PD-related	B-DDF	877	887	abstract	35914559
neurodegeneration	I-DDF	888	905	abstract	35914559
may	O	906	909	abstract	35914559
alter	O	910	915	abstract	35914559
the	O	916	919	abstract	35914559
gut	B-microbiome	920	923	abstract	35914559
microbiome	I-microbiome	924	934	abstract	35914559
to	O	935	937	abstract	35914559
a	O	938	939	abstract	35914559
similar	O	940	947	abstract	35914559
extent	O	948	954	abstract	35914559
as	O	955	957	abstract	35914559
observed	O	958	966	abstract	35914559
in	O	967	969	abstract	35914559
persons	B-human	970	977	abstract	35914559
with	O	978	982	abstract	35914559
PD	B-DDF	983	985	abstract	35914559
.	O	985	986	abstract	35914559

To	O	987	989	abstract	35914559
assess	O	990	996	abstract	35914559
this	O	997	1001	abstract	35914559
,	O	1001	1002	abstract	35914559
we	O	1003	1005	abstract	35914559
collected	O	1006	1015	abstract	35914559
fecal	O	1016	1021	abstract	35914559
samples	O	1022	1029	abstract	35914559
from	O	1030	1034	abstract	35914559
adult	B-animal	1035	1040	abstract	35914559
rats	I-animal	1041	1045	abstract	35914559
treated	O	1046	1053	abstract	35914559
with	O	1054	1058	abstract	35914559
200	O	1059	1062	abstract	35914559
	O	1062	1063	abstract	35914559
mg/kg	O	1063	1068	abstract	35914559
TCE	B-chemical	1069	1072	abstract	35914559
over	O	1073	1077	abstract	35914559
6	O	1078	1079	abstract	35914559
	O	1079	1080	abstract	35914559
weeks	O	1080	1085	abstract	35914559
via	O	1086	1089	abstract	35914559
oral	O	1090	1094	abstract	35914559
gavage	O	1095	1101	abstract	35914559
-	O	1102	1103	abstract	35914559
the	O	1104	1107	abstract	35914559
dose	O	1108	1112	abstract	35914559
that	O	1113	1117	abstract	35914559
produced	O	1118	1126	abstract	35914559
nigrostriatal	B-DDF	1127	1140	abstract	35914559
neurodegeneration	I-DDF	1141	1158	abstract	35914559
-	O	1159	1160	abstract	35914559
and	O	1161	1164	abstract	35914559
analyzed	O	1165	1173	abstract	35914559
the	O	1174	1177	abstract	35914559
gut	B-microbiome	1178	1181	abstract	35914559
microbiome	I-microbiome	1182	1192	abstract	35914559
via	O	1193	1196	abstract	35914559
whole	B-biomedical%technique	1197	1202	abstract	35914559
genome	I-biomedical%technique	1203	1209	abstract	35914559
shotgun	I-biomedical%technique	1210	1217	abstract	35914559
sequencing	I-biomedical%technique	1218	1228	abstract	35914559
.	O	1228	1229	abstract	35914559

Our	O	1230	1233	abstract	35914559
results	O	1234	1241	abstract	35914559
showed	O	1242	1248	abstract	35914559
changes	O	1249	1256	abstract	35914559
in	O	1257	1259	abstract	35914559
gut	O	1260	1263	abstract	35914559
microorganisms	O	1264	1278	abstract	35914559
reflective	O	1279	1289	abstract	35914559
of	O	1290	1292	abstract	35914559
the	O	1293	1296	abstract	35914559
microbial	O	1297	1306	abstract	35914559
signatures	O	1307	1317	abstract	35914559
observed	O	1318	1326	abstract	35914559
in	O	1327	1329	abstract	35914559
individuals	B-human	1330	1341	abstract	35914559
with	O	1342	1346	abstract	35914559
idiopathic	B-DDF	1347	1357	abstract	35914559
PD	I-DDF	1358	1360	abstract	35914559
,	O	1360	1361	abstract	35914559
such	O	1362	1366	abstract	35914559
as	O	1367	1369	abstract	35914559
decreased	O	1370	1379	abstract	35914559
abundance	O	1380	1389	abstract	35914559
of	O	1390	1392	abstract	35914559
short-chain	B-chemical	1393	1404	abstract	35914559
fatty	I-chemical	1405	1410	abstract	35914559
acid	I-chemical	1411	1415	abstract	35914559
producing	O	1416	1425	abstract	35914559
Blautia	B-bacteria	1426	1433	abstract	35914559
and	O	1434	1437	abstract	35914559
elevated	O	1438	1446	abstract	35914559
lactic-acid	B-chemical	1447	1458	abstract	35914559
producing	O	1459	1468	abstract	35914559
Bifidobacteria	B-bacteria	1469	1483	abstract	35914559
,	O	1483	1484	abstract	35914559
as	O	1485	1487	abstract	35914559
well	O	1488	1492	abstract	35914559
as	O	1493	1495	abstract	35914559
genera	O	1496	1502	abstract	35914559
who	O	1503	1506	abstract	35914559
contain	O	1507	1514	abstract	35914559
species	O	1515	1522	abstract	35914559
previously	O	1523	1533	abstract	35914559
reported	O	1534	1542	abstract	35914559
as	O	1543	1545	abstract	35914559
opportunistic	O	1546	1559	abstract	35914559
pathogens	O	1560	1569	abstract	35914559
such	O	1570	1574	abstract	35914559
as	O	1575	1577	abstract	35914559
Clostridium	B-bacteria	1578	1589	abstract	35914559
.	O	1589	1590	abstract	35914559

From	O	1591	1595	abstract	35914559
these	O	1596	1601	abstract	35914559
experimental	O	1602	1614	abstract	35914559
data	O	1615	1619	abstract	35914559
,	O	1619	1620	abstract	35914559
we	O	1621	1623	abstract	35914559
postulate	O	1624	1633	abstract	35914559
that	O	1634	1638	abstract	35914559
TCE	O	1639	1642	abstract	35914559
exposure	O	1643	1651	abstract	35914559
within	O	1652	1658	abstract	35914559
contaminated	O	1659	1671	abstract	35914559
drinking	O	1672	1680	abstract	35914559
water	O	1681	1686	abstract	35914559
could	O	1687	1692	abstract	35914559
induce	O	1693	1699	abstract	35914559
alterations	O	1700	1711	abstract	35914559
of	O	1712	1714	abstract	35914559
the	O	1715	1718	abstract	35914559
gut	B-microbiome	1719	1722	abstract	35914559
microbiome	I-microbiome	1723	1733	abstract	35914559
that	O	1734	1738	abstract	35914559
contributes	O	1739	1750	abstract	35914559
to	O	1751	1753	abstract	35914559
chronic	O	1754	1761	abstract	35914559
disease	O	1762	1769	abstract	35914559
risk	O	1770	1774	abstract	35914559
,	O	1774	1775	abstract	35914559
including	O	1776	1785	abstract	35914559
idiopathic	B-DDF	1786	1796	abstract	35914559
PD	I-DDF	1797	1799	abstract	35914559
.	O	1799	1800	abstract	35914559

Gut	O	0	3	title	38422755
microbiota	O	4	14	title	38422755
disturbances	O	15	27	title	38422755
in	O	28	30	title	38422755
hospitalized	B-human	31	43	title	38422755
older	I-human	44	49	title	38422755
adults	I-human	50	56	title	38422755
with	O	57	61	title	38422755
malnutrition	B-DDF	62	74	title	38422755
and	O	75	78	title	38422755
clinical	O	79	87	title	38422755
outcomes	O	88	96	title	38422755
.	O	96	97	title	38422755

Malnutrition	B-DDF	0	12	abstract	38422755
is	O	13	15	abstract	38422755
one	O	16	19	abstract	38422755
of	O	20	22	abstract	38422755
the	O	23	26	abstract	38422755
most	O	27	31	abstract	38422755
threatening	O	32	43	abstract	38422755
conditions	O	44	54	abstract	38422755
in	O	55	57	abstract	38422755
geriatric	B-human	58	67	abstract	38422755
populations	I-human	68	79	abstract	38422755
.	O	79	80	abstract	38422755

The	O	81	84	abstract	38422755
gut	B-microbiome	85	88	abstract	38422755
microbiota	I-microbiome	89	99	abstract	38422755
has	O	100	103	abstract	38422755
an	O	104	106	abstract	38422755
important	O	107	116	abstract	38422755
role	O	117	121	abstract	38422755
in	O	122	124	abstract	38422755
the	O	125	128	abstract	38422755
host	O	129	133	abstract	38422755
's	O	133	135	abstract	38422755
metabolic	O	136	145	abstract	38422755
and	O	146	149	abstract	38422755
muscular	O	150	158	abstract	38422755
health	O	159	165	abstract	38422755
:	O	165	166	abstract	38422755
however	O	167	174	abstract	38422755
,	O	174	175	abstract	38422755
its	O	176	179	abstract	38422755
interplay	O	180	189	abstract	38422755
with	O	190	194	abstract	38422755
disease-related	B-DDF	195	210	abstract	38422755
malnutrition	I-DDF	211	223	abstract	38422755
is	O	224	226	abstract	38422755
not	O	227	230	abstract	38422755
well	O	231	235	abstract	38422755
understood	O	236	246	abstract	38422755
.	O	246	247	abstract	38422755

We	O	248	250	abstract	38422755
aimed	O	251	256	abstract	38422755
to	O	257	259	abstract	38422755
identify	O	260	268	abstract	38422755
the	O	269	272	abstract	38422755
association	O	273	284	abstract	38422755
of	O	285	287	abstract	38422755
malnutrition	B-DDF	288	300	abstract	38422755
with	O	301	305	abstract	38422755
the	O	306	309	abstract	38422755
gut	B-microbiome	310	313	abstract	38422755
microbiota	I-microbiome	314	324	abstract	38422755
and	O	325	328	abstract	38422755
predict	O	329	336	abstract	38422755
clinical	O	337	345	abstract	38422755
outcomes	O	346	354	abstract	38422755
in	O	355	357	abstract	38422755
hospitalized	B-human	358	370	abstract	38422755
acutely	I-human	371	378	abstract	38422755
ill	I-human	379	382	abstract	38422755
older	I-human	383	388	abstract	38422755
adults	I-human	389	395	abstract	38422755
.	O	395	396	abstract	38422755

We	O	397	399	abstract	38422755
performed	O	400	409	abstract	38422755
a	O	410	411	abstract	38422755
secondary	O	412	421	abstract	38422755
longitudinal	O	422	434	abstract	38422755
analysis	O	435	443	abstract	38422755
in	O	444	446	abstract	38422755
108	O	447	450	abstract	38422755
geriatric	B-human	451	460	abstract	38422755
patients	I-human	461	469	abstract	38422755
from	O	470	474	abstract	38422755
a	O	475	476	abstract	38422755
prospective	O	477	488	abstract	38422755
cohort	O	489	495	abstract	38422755
evaluated	O	496	505	abstract	38422755
at	O	506	508	abstract	38422755
admission	O	509	518	abstract	38422755
and	O	519	522	abstract	38422755
72	O	523	525	abstract	38422755
h	O	526	527	abstract	38422755
of	O	528	530	abstract	38422755
hospitalization	O	531	546	abstract	38422755
.	O	546	547	abstract	38422755

We	O	548	550	abstract	38422755
collected	O	551	560	abstract	38422755
clinical	O	561	569	abstract	38422755
,	O	569	570	abstract	38422755
demographic	O	571	582	abstract	38422755
,	O	582	583	abstract	38422755
nutritional	O	584	595	abstract	38422755
,	O	595	596	abstract	38422755
and	O	597	600	abstract	38422755
16S	B-biomedical%technique	601	604	abstract	38422755
rRNA	I-biomedical%technique	605	609	abstract	38422755
gene-sequenced	I-biomedical%technique	610	624	abstract	38422755
gut	I-biomedical%technique	625	628	abstract	38422755
microbiota	I-biomedical%technique	629	639	abstract	38422755
data	I-biomedical%technique	640	644	abstract	38422755
.	O	644	645	abstract	38422755

Microbiota	O	646	656	abstract	38422755
diversity	O	657	666	abstract	38422755
,	O	666	667	abstract	38422755
overall	O	668	675	abstract	38422755
composition	O	676	687	abstract	38422755
,	O	687	688	abstract	38422755
and	O	689	692	abstract	38422755
differential	O	693	705	abstract	38422755
abundance	O	706	715	abstract	38422755
were	O	716	720	abstract	38422755
calculated	O	721	731	abstract	38422755
and	O	732	735	abstract	38422755
compared	O	736	744	abstract	38422755
between	O	745	752	abstract	38422755
patients	B-human	753	761	abstract	38422755
with	O	762	766	abstract	38422755
and	O	767	770	abstract	38422755
without	O	771	778	abstract	38422755
malnutrition	B-DDF	779	791	abstract	38422755
.	O	791	792	abstract	38422755

Microbiota	O	793	803	abstract	38422755
features	O	804	812	abstract	38422755
associated	O	813	823	abstract	38422755
with	O	824	828	abstract	38422755
malnutrition	B-DDF	829	841	abstract	38422755
were	O	842	846	abstract	38422755
used	O	847	851	abstract	38422755
to	O	852	854	abstract	38422755
predict	O	855	862	abstract	38422755
clinical	O	863	871	abstract	38422755
outcomes	O	872	880	abstract	38422755
.	O	880	881	abstract	38422755

Patients	B-human	882	890	abstract	38422755
with	O	891	895	abstract	38422755
malnutrition	B-DDF	896	908	abstract	38422755
(	O	909	910	abstract	38422755
51	O	910	912	abstract	38422755
%	O	912	913	abstract	38422755
)	O	913	914	abstract	38422755
had	O	915	918	abstract	38422755
a	O	919	920	abstract	38422755
different	O	921	930	abstract	38422755
microbiota	O	931	941	abstract	38422755
composition	O	942	953	abstract	38422755
compared	O	954	962	abstract	38422755
to	O	963	965	abstract	38422755
those	O	966	971	abstract	38422755
who	O	972	975	abstract	38422755
were	O	976	980	abstract	38422755
well-nourished	O	981	995	abstract	38422755
during	O	996	1002	abstract	38422755
hospitalization	O	1003	1018	abstract	38422755
(	O	1019	1020	abstract	38422755
ANOSIM	O	1020	1026	abstract	38422755
R	O	1027	1028	abstract	38422755
=	O	1029	1030	abstract	38422755
0.079	O	1031	1036	abstract	38422755
,	O	1036	1037	abstract	38422755
P	O	1038	1039	abstract	38422755
=	O	1040	1041	abstract	38422755
0.003	O	1042	1047	abstract	38422755
)	O	1047	1048	abstract	38422755
.	O	1048	1049	abstract	38422755

Patients	B-human	1050	1058	abstract	38422755
with	O	1059	1063	abstract	38422755
severe	O	1064	1070	abstract	38422755
malnutrition	B-DDF	1071	1083	abstract	38422755
showed	O	1084	1090	abstract	38422755
poorer	O	1091	1097	abstract	38422755
-diversity	O	1098	1109	abstract	38422755
at	O	1110	1112	abstract	38422755
admission	O	1113	1122	abstract	38422755
(	O	1123	1124	abstract	38422755
Shannon	O	1124	1131	abstract	38422755
P	O	1132	1133	abstract	38422755
=	O	1134	1135	abstract	38422755
0.012	O	1136	1141	abstract	38422755
,	O	1141	1142	abstract	38422755
Simpson	O	1143	1150	abstract	38422755
P	O	1151	1152	abstract	38422755
=	O	1153	1154	abstract	38422755
0.018	O	1155	1160	abstract	38422755
)	O	1160	1161	abstract	38422755
and	O	1162	1165	abstract	38422755
follow-up	O	1166	1175	abstract	38422755
(	O	1176	1177	abstract	38422755
Shannon	O	1177	1184	abstract	38422755
P	O	1185	1186	abstract	38422755
=	O	1187	1188	abstract	38422755
0.023	O	1189	1194	abstract	38422755
,	O	1194	1195	abstract	38422755
Chao1	O	1196	1201	abstract	38422755
P	O	1202	1203	abstract	38422755
=	O	1204	1205	abstract	38422755
0.008	O	1206	1211	abstract	38422755
)	O	1211	1212	abstract	38422755
.	O	1212	1213	abstract	38422755

Differential	O	1214	1226	abstract	38422755
abundance	O	1227	1236	abstract	38422755
of	O	1237	1239	abstract	38422755
Lachnospiraceae	B-bacteria	1240	1255	abstract	38422755
NK4A136	I-bacteria	1256	1263	abstract	38422755
group	I-bacteria	1264	1269	abstract	38422755
,	O	1269	1270	abstract	38422755
Subdoligranulum	B-bacteria	1271	1286	abstract	38422755
,	O	1286	1287	abstract	38422755
and	O	1288	1291	abstract	38422755
Faecalibacterium	B-bacteria	1292	1308	abstract	38422755
prausnitzii	I-bacteria	1309	1320	abstract	38422755
were	O	1321	1325	abstract	38422755
significantly	O	1326	1339	abstract	38422755
lower	O	1340	1345	abstract	38422755
and	O	1346	1349	abstract	38422755
inversely	O	1350	1359	abstract	38422755
associated	O	1360	1370	abstract	38422755
with	O	1371	1375	abstract	38422755
malnutrition	B-DDF	1376	1388	abstract	38422755
,	O	1388	1389	abstract	38422755
while	O	1390	1395	abstract	38422755
Corynebacterium	B-bacteria	1396	1411	abstract	38422755
,	O	1411	1412	abstract	38422755
Ruminococcaceae	B-bacteria	1413	1428	abstract	38422755
Incertae	I-bacteria	1429	1437	abstract	38422755
Sedis	I-bacteria	1438	1443	abstract	38422755
,	O	1443	1444	abstract	38422755
and	O	1445	1448	abstract	38422755
Fusobacterium	B-bacteria	1449	1462	abstract	38422755
were	O	1463	1467	abstract	38422755
significantly	O	1468	1481	abstract	38422755
increased	O	1482	1491	abstract	38422755
and	O	1492	1495	abstract	38422755
positively	O	1496	1506	abstract	38422755
associated	O	1507	1517	abstract	38422755
with	O	1518	1522	abstract	38422755
malnutrition	B-DDF	1523	1535	abstract	38422755
.	O	1535	1536	abstract	38422755

Corynebacterium	B-bacteria	1537	1552	abstract	38422755
,	O	1552	1553	abstract	38422755
Ruminococcaceae	B-bacteria	1554	1569	abstract	38422755
Incertae	I-bacteria	1570	1578	abstract	38422755
Sedis	I-bacteria	1579	1584	abstract	38422755
,	O	1584	1585	abstract	38422755
and	O	1586	1589	abstract	38422755
the	O	1590	1593	abstract	38422755
overall	O	1594	1601	abstract	38422755
composition	O	1602	1613	abstract	38422755
were	O	1614	1618	abstract	38422755
important	O	1619	1628	abstract	38422755
predictors	O	1629	1639	abstract	38422755
of	O	1640	1642	abstract	38422755
critical	O	1643	1651	abstract	38422755
care	O	1652	1656	abstract	38422755
in	O	1657	1659	abstract	38422755
patients	B-human	1660	1668	abstract	38422755
with	O	1669	1673	abstract	38422755
malnutrition	B-DDF	1674	1686	abstract	38422755
during	O	1687	1693	abstract	38422755
hospitalization	O	1694	1709	abstract	38422755
.	O	1709	1710	abstract	38422755

Older	B-human	1711	1716	abstract	38422755
adults	I-human	1717	1723	abstract	38422755
with	O	1724	1728	abstract	38422755
malnutrition	B-DDF	1729	1741	abstract	38422755
,	O	1741	1742	abstract	38422755
especially	O	1743	1753	abstract	38422755
in	O	1754	1756	abstract	38422755
a	O	1757	1758	abstract	38422755
severe	O	1759	1765	abstract	38422755
stage	O	1766	1771	abstract	38422755
,	O	1771	1772	abstract	38422755
may	O	1773	1776	abstract	38422755
be	O	1777	1779	abstract	38422755
subject	O	1780	1787	abstract	38422755
to	O	1788	1790	abstract	38422755
substantial	O	1791	1802	abstract	38422755
gut	O	1803	1806	abstract	38422755
microbial	O	1807	1816	abstract	38422755
disturbances	O	1817	1829	abstract	38422755
during	O	1830	1836	abstract	38422755
hospitalization	O	1837	1852	abstract	38422755
.	O	1852	1853	abstract	38422755

The	O	1854	1857	abstract	38422755
gut	O	1858	1861	abstract	38422755
microbiota	O	1862	1872	abstract	38422755
profile	O	1873	1880	abstract	38422755
of	O	1881	1883	abstract	38422755
patients	B-human	1884	1892	abstract	38422755
with	O	1893	1897	abstract	38422755
malnutrition	B-DDF	1898	1910	abstract	38422755
might	O	1911	1916	abstract	38422755
help	O	1917	1921	abstract	38422755
us	O	1922	1924	abstract	38422755
to	O	1925	1927	abstract	38422755
predict	O	1928	1935	abstract	38422755
worse	O	1936	1941	abstract	38422755
clinical	O	1942	1950	abstract	38422755
outcomes	O	1951	1959	abstract	38422755
.	O	1959	1960	abstract	38422755

The	O	0	3	title	37228957
microbiota-gut-brain	O	4	24	title	37228957
axis	O	25	29	title	37228957
and	O	30	33	title	37228957
three	O	34	39	title	37228957
common	O	40	46	title	37228957
neurological	B-DDF	47	59	title	37228957
disorders	I-DDF	60	69	title	37228957
:	O	69	70	title	37228957
a	O	71	72	title	37228957
mini-review	O	73	84	title	37228957
.	O	84	85	title	37228957

Neurological	B-DDF	0	12	abstract	37228957
disorders	I-DDF	13	22	abstract	37228957
are	O	23	26	abstract	37228957
an	O	27	29	abstract	37228957
important	O	30	39	abstract	37228957
cause	O	40	45	abstract	37228957
of	O	46	48	abstract	37228957
disability	B-DDF	49	59	abstract	37228957
and	O	60	63	abstract	37228957
death	O	64	69	abstract	37228957
globally	O	70	78	abstract	37228957
.	O	78	79	abstract	37228957

Recently	O	80	88	abstract	37228957
,	O	88	89	abstract	37228957
a	O	90	91	abstract	37228957
large	O	92	97	abstract	37228957
body	O	98	102	abstract	37228957
of	O	103	105	abstract	37228957
research	O	106	114	abstract	37228957
shows	O	115	120	abstract	37228957
that	O	121	125	abstract	37228957
the	O	126	129	abstract	37228957
gut	B-microbiome	130	133	abstract	37228957
microbiome	I-microbiome	134	144	abstract	37228957
affects	O	145	152	abstract	37228957
the	O	153	156	abstract	37228957
brain	B-anatomical%location	157	162	abstract	37228957
and	O	163	166	abstract	37228957
its	O	167	170	abstract	37228957
conditions	O	171	181	abstract	37228957
,	O	181	182	abstract	37228957
through	O	183	190	abstract	37228957
the	O	191	194	abstract	37228957
gut-brain	O	195	204	abstract	37228957
axis	O	205	209	abstract	37228957
.	O	209	210	abstract	37228957

The	O	211	214	abstract	37228957
purpose	O	215	222	abstract	37228957
of	O	223	225	abstract	37228957
this	O	226	230	abstract	37228957
mini-review	O	231	242	abstract	37228957
is	O	243	245	abstract	37228957
to	O	246	248	abstract	37228957
provide	O	249	256	abstract	37228957
a	O	257	258	abstract	37228957
brief	O	259	264	abstract	37228957
overview	O	265	273	abstract	37228957
of	O	274	276	abstract	37228957
the	O	277	280	abstract	37228957
relationship	O	281	293	abstract	37228957
between	O	294	301	abstract	37228957
the	O	302	305	abstract	37228957
microbiota-gut-brain	O	306	326	abstract	37228957
axis	O	327	331	abstract	37228957
in	O	332	334	abstract	37228957
three	O	335	340	abstract	37228957
neurological	O	341	353	abstract	37228957
disorders	O	354	363	abstract	37228957
:	O	363	364	abstract	37228957
epilepsy	B-DDF	365	373	abstract	37228957
,	O	373	374	abstract	37228957
Parkinson	B-DDF	375	384	abstract	37228957
's	I-DDF	384	386	abstract	37228957
disease	I-DDF	387	394	abstract	37228957
,	O	394	395	abstract	37228957
and	O	396	399	abstract	37228957
migraine	B-DDF	400	408	abstract	37228957
.	O	408	409	abstract	37228957

The	O	410	413	abstract	37228957
authors	O	414	421	abstract	37228957
chose	O	422	427	abstract	37228957
these	O	428	433	abstract	37228957
three	O	434	439	abstract	37228957
disorders	O	440	449	abstract	37228957
because	O	450	457	abstract	37228957
of	O	458	460	abstract	37228957
their	O	461	466	abstract	37228957
burdensome	O	467	477	abstract	37228957
and	O	478	481	abstract	37228957
great	O	482	487	abstract	37228957
effect	O	488	494	abstract	37228957
on	O	495	497	abstract	37228957
health	O	498	504	abstract	37228957
care	O	505	509	abstract	37228957
.	O	509	510	abstract	37228957

We	O	511	513	abstract	37228957
live	O	514	518	abstract	37228957
on	O	519	521	abstract	37228957
a	O	522	523	abstract	37228957
microbial	O	524	533	abstract	37228957
planet	O	534	540	abstract	37228957
.	O	540	541	abstract	37228957

Before	O	542	548	abstract	37228957
humans	B-human	549	555	abstract	37228957
,	O	555	556	abstract	37228957
microorganisms	B-bacteria	557	571	abstract	37228957
existed	O	572	579	abstract	37228957
for	O	580	583	abstract	37228957
a	O	584	585	abstract	37228957
hundred	O	586	593	abstract	37228957
million	O	594	601	abstract	37228957
years	O	602	607	abstract	37228957
.	O	607	608	abstract	37228957

Today	O	609	614	abstract	37228957
,	O	614	615	abstract	37228957
there	O	616	621	abstract	37228957
are	O	622	625	abstract	37228957
trillions	O	626	635	abstract	37228957
of	O	636	638	abstract	37228957
these	O	639	644	abstract	37228957
microbes	O	645	653	abstract	37228957
living	O	654	660	abstract	37228957
in	O	661	663	abstract	37228957
our	O	664	667	abstract	37228957
bodies	O	668	674	abstract	37228957
,	O	674	675	abstract	37228957
it	O	676	678	abstract	37228957
is	O	679	681	abstract	37228957
called	O	682	688	abstract	37228957
human	B-microbiome	689	694	abstract	37228957
microbiota	I-microbiome	695	705	abstract	37228957
.	O	705	706	abstract	37228957

These	O	707	712	abstract	37228957
organisms	O	713	722	abstract	37228957
have	O	723	727	abstract	37228957
a	O	728	729	abstract	37228957
crucial	O	730	737	abstract	37228957
role	O	738	742	abstract	37228957
in	O	743	745	abstract	37228957
our	O	746	749	abstract	37228957
homeostasis	O	750	761	abstract	37228957
and	O	762	765	abstract	37228957
survival	O	766	774	abstract	37228957
.	O	774	775	abstract	37228957

Most	O	776	780	abstract	37228957
of	O	781	783	abstract	37228957
the	O	784	787	abstract	37228957
human	B-microbiome	788	793	abstract	37228957
microbiota	I-microbiome	794	804	abstract	37228957
live	O	805	809	abstract	37228957
in	O	810	812	abstract	37228957
the	O	813	816	abstract	37228957
gut	B-anatomical%location	817	820	abstract	37228957
.	O	820	821	abstract	37228957

The	O	822	825	abstract	37228957
number	O	826	832	abstract	37228957
of	O	833	835	abstract	37228957
gut	B-microbiome	836	839	abstract	37228957
microbiota	I-microbiome	840	850	abstract	37228957
is	O	851	853	abstract	37228957
much	O	854	858	abstract	37228957
more	O	859	863	abstract	37228957
than	O	864	868	abstract	37228957
the	O	869	872	abstract	37228957
number	O	873	879	abstract	37228957
of	O	880	882	abstract	37228957
body	O	883	887	abstract	37228957
cells	O	888	893	abstract	37228957
.	O	893	894	abstract	37228957

Gut	B-microbiome	895	898	abstract	37228957
microbiota	I-microbiome	899	909	abstract	37228957
has	O	910	913	abstract	37228957
been	O	914	918	abstract	37228957
regarded	O	919	927	abstract	37228957
as	O	928	930	abstract	37228957
a	O	931	932	abstract	37228957
crucial	O	933	940	abstract	37228957
regulator	O	941	950	abstract	37228957
of	O	951	953	abstract	37228957
the	O	954	957	abstract	37228957
gut-brain	O	958	967	abstract	37228957
axis	O	968	972	abstract	37228957
.	O	972	973	abstract	37228957

The	O	974	977	abstract	37228957
discovery	O	978	987	abstract	37228957
of	O	988	990	abstract	37228957
the	O	991	994	abstract	37228957
microbiota-gut-brain	O	995	1015	abstract	37228957
axis	O	1016	1020	abstract	37228957
is	O	1021	1023	abstract	37228957
described	O	1024	1033	abstract	37228957
as	O	1034	1036	abstract	37228957
a	O	1037	1038	abstract	37228957
major	O	1039	1044	abstract	37228957
advancement	O	1045	1056	abstract	37228957
in	O	1057	1059	abstract	37228957
neuroscience	O	1060	1072	abstract	37228957
because	O	1073	1080	abstract	37228957
it	O	1081	1083	abstract	37228957
influences	O	1084	1094	abstract	37228957
the	O	1095	1098	abstract	37228957
pathophysiology	O	1099	1114	abstract	37228957
of	O	1115	1117	abstract	37228957
several	O	1118	1125	abstract	37228957
neurological	B-DDF	1126	1138	abstract	37228957
and	I-DDF	1139	1142	abstract	37228957
psychiatric	I-DDF	1143	1154	abstract	37228957
disorders	I-DDF	1155	1164	abstract	37228957
.	O	1164	1165	abstract	37228957

From	O	1166	1170	abstract	37228957
this	O	1171	1175	abstract	37228957
,	O	1175	1176	abstract	37228957
more	O	1177	1181	abstract	37228957
studies	O	1182	1189	abstract	37228957
of	O	1190	1192	abstract	37228957
the	O	1193	1196	abstract	37228957
microbiota-gut-brain	O	1197	1217	abstract	37228957
axis	O	1218	1222	abstract	37228957
are	O	1223	1226	abstract	37228957
needed	O	1227	1233	abstract	37228957
in	O	1234	1236	abstract	37228957
the	O	1237	1240	abstract	37228957
future	O	1241	1247	abstract	37228957
,	O	1247	1248	abstract	37228957
to	O	1249	1251	abstract	37228957
provide	O	1252	1259	abstract	37228957
a	O	1260	1261	abstract	37228957
better	O	1262	1268	abstract	37228957
understanding	O	1269	1282	abstract	37228957
of	O	1283	1285	abstract	37228957
brain	B-DDF	1286	1291	abstract	37228957
disorders	I-DDF	1292	1301	abstract	37228957
and	O	1302	1305	abstract	37228957
so	O	1306	1308	abstract	37228957
that	O	1309	1313	abstract	37228957
better	O	1314	1320	abstract	37228957
treatment	O	1321	1330	abstract	37228957
and	O	1331	1334	abstract	37228957
prognosis	O	1335	1344	abstract	37228957
.	O	1344	1345	abstract	37228957

Fecal	B-microbiome	0	5	title	30717162
Microbiota	I-microbiome	6	16	title	30717162
Analysis	O	17	25	title	30717162
in	O	26	28	title	30717162
Patients	B-human	29	37	title	30717162
Going	O	38	43	title	30717162
through	O	44	51	title	30717162
a	O	52	53	title	30717162
Depressive	B-DDF	54	64	title	30717162
Episode	I-DDF	65	72	title	30717162
during	O	73	79	title	30717162
Treatment	O	80	89	title	30717162
in	O	90	92	title	30717162
a	O	93	94	title	30717162
Psychiatric	O	95	106	title	30717162
Hospital	O	107	115	title	30717162
Setting	O	116	123	title	30717162
.	O	123	124	title	30717162

There	O	0	5	abstract	30717162
is	O	6	8	abstract	30717162
a	O	9	10	abstract	30717162
worldwide	O	11	20	abstract	30717162
prevalence	O	21	31	abstract	30717162
of	O	32	34	abstract	30717162
generalized	B-DDF	35	46	abstract	30717162
anxiety	I-DDF	47	54	abstract	30717162
and	O	55	58	abstract	30717162
major	B-DDF	59	64	abstract	30717162
depressive	I-DDF	65	75	abstract	30717162
disorders	I-DDF	76	85	abstract	30717162
(	O	86	87	abstract	30717162
MDD	B-DDF	87	90	abstract	30717162
)	O	90	91	abstract	30717162
.	O	91	92	abstract	30717162

Gutbrain	B-DDF	93	102	abstract	30717162
axis	I-DDF	103	107	abstract	30717162
dysfunction	I-DDF	108	119	abstract	30717162
,	O	119	120	abstract	30717162
antibacterial	O	121	134	abstract	30717162
activity	O	135	143	abstract	30717162
,	O	143	144	abstract	30717162
and	O	145	148	abstract	30717162
modulatory	O	149	159	abstract	30717162
effects	O	160	167	abstract	30717162
of	O	168	170	abstract	30717162
antidepressants	B-drug	171	186	abstract	30717162
toward	O	187	193	abstract	30717162
intestinal	B-bacteria	194	204	abstract	30717162
bacteria	I-bacteria	205	213	abstract	30717162
have	O	214	218	abstract	30717162
been	O	219	223	abstract	30717162
shown	O	224	229	abstract	30717162
both	O	230	234	abstract	30717162
in	O	235	237	abstract	30717162
vitro	O	238	243	abstract	30717162
and	O	244	247	abstract	30717162
in	O	248	250	abstract	30717162
vivo	O	251	255	abstract	30717162
.	O	255	256	abstract	30717162

In	O	257	259	abstract	30717162
this	O	260	264	abstract	30717162
study	O	265	270	abstract	30717162
,	O	270	271	abstract	30717162
we	O	272	274	abstract	30717162
aimed	O	275	280	abstract	30717162
to	O	281	283	abstract	30717162
investigate	O	284	295	abstract	30717162
the	O	296	299	abstract	30717162
effects	O	300	307	abstract	30717162
of	O	308	310	abstract	30717162
hospital	O	311	319	abstract	30717162
stay	O	320	324	abstract	30717162
,	O	324	325	abstract	30717162
including	O	326	335	abstract	30717162
escitalopram	O	336	348	abstract	30717162
administration	O	349	363	abstract	30717162
,	O	363	364	abstract	30717162
on	O	365	367	abstract	30717162
gut	B-microbiome	368	371	abstract	30717162
microbiota	I-microbiome	372	382	abstract	30717162
in	O	383	385	abstract	30717162
patients	B-human	386	394	abstract	30717162
with	O	395	399	abstract	30717162
depressive	B-DDF	400	410	abstract	30717162
episodes	I-DDF	411	419	abstract	30717162
.	O	419	420	abstract	30717162

After	O	421	426	abstract	30717162
admission	O	427	436	abstract	30717162
to	O	437	439	abstract	30717162
the	O	440	443	abstract	30717162
hospital	O	444	452	abstract	30717162
and	O	453	456	abstract	30717162
7-days	O	457	463	abstract	30717162
washout	O	464	471	abstract	30717162
from	O	472	476	abstract	30717162
all	O	477	480	abstract	30717162
medications	O	481	492	abstract	30717162
the	O	493	496	abstract	30717162
composition	O	497	508	abstract	30717162
of	O	509	511	abstract	30717162
fecal	B-microbiome	512	517	abstract	30717162
microbiota	I-microbiome	518	528	abstract	30717162
samples	O	529	536	abstract	30717162
was	O	537	540	abstract	30717162
evaluated	O	541	550	abstract	30717162
at	O	551	553	abstract	30717162
baseline	O	554	562	abstract	30717162
(	O	563	564	abstract	30717162
W0	O	564	566	abstract	30717162
)	O	566	567	abstract	30717162
and	O	568	571	abstract	30717162
after	O	572	577	abstract	30717162
6	O	578	579	abstract	30717162
weeks	O	580	585	abstract	30717162
(	O	586	587	abstract	30717162
W6	O	587	589	abstract	30717162
)	O	589	590	abstract	30717162
,	O	590	591	abstract	30717162
using	O	592	597	abstract	30717162
16S	B-biomedical%technique	598	601	abstract	30717162
rRNA	I-biomedical%technique	602	606	abstract	30717162
sequencing	I-biomedical%technique	607	617	abstract	30717162
.	O	617	618	abstract	30717162

The	O	619	622	abstract	30717162
study	O	623	628	abstract	30717162
was	O	629	632	abstract	30717162
conducted	O	633	642	abstract	30717162
on	O	643	645	abstract	30717162
17	O	646	648	abstract	30717162
inpatients	B-human	649	659	abstract	30717162
(	O	660	661	abstract	30717162
52.9	O	661	665	abstract	30717162
%	O	665	666	abstract	30717162
females	B-human	667	674	abstract	30717162
)	O	674	675	abstract	30717162
,	O	675	676	abstract	30717162
who	O	677	680	abstract	30717162
followed	O	681	689	abstract	30717162
the	O	690	693	abstract	30717162
same	O	694	698	abstract	30717162
daily	O	699	704	abstract	30717162
hospital	O	705	713	abstract	30717162
routine	O	714	721	abstract	30717162
,	O	721	722	abstract	30717162
including	O	723	732	abstract	30717162
a	O	733	734	abstract	30717162
standard	B-dietary%supplement	735	743	abstract	30717162
diet	I-dietary%supplement	744	748	abstract	30717162
and	O	749	752	abstract	30717162
received	O	753	761	abstract	30717162
520	O	762	766	abstract	30717162
mg	O	767	769	abstract	30717162
daily	O	770	775	abstract	30717162
doses	O	776	781	abstract	30717162
of	O	782	784	abstract	30717162
escitalopram	B-drug	785	797	abstract	30717162
.	O	797	798	abstract	30717162

At	O	799	801	abstract	30717162
the	O	802	805	abstract	30717162
end	O	806	809	abstract	30717162
of	O	810	812	abstract	30717162
treatment	O	813	822	abstract	30717162
(	O	823	824	abstract	30717162
W6	O	824	826	abstract	30717162
)	O	826	827	abstract	30717162
,	O	827	828	abstract	30717162
no	O	829	831	abstract	30717162
change	O	832	838	abstract	30717162
was	O	839	842	abstract	30717162
observed	O	843	851	abstract	30717162
in	O	852	854	abstract	30717162
the	O	855	858	abstract	30717162
Chao1	B-statistical%technique	859	864	abstract	30717162
index	I-statistical%technique	865	870	abstract	30717162
.	O	870	871	abstract	30717162

However	O	872	879	abstract	30717162
,	O	879	880	abstract	30717162
Shannon	B-statistical%technique	881	888	abstract	30717162
(	O	889	890	abstract	30717162
median	O	890	896	abstract	30717162
(	O	897	898	abstract	30717162
Q1Q3	O	898	903	abstract	30717162
):	O	903	905	abstract	30717162
W0	O	906	908	abstract	30717162
2.78	O	909	913	abstract	30717162
(	O	914	915	abstract	30717162
2.673.02	O	915	924	abstract	30717162
)	O	924	925	abstract	30717162
vs.	O	926	929	abstract	30717162
W6	O	930	932	abstract	30717162
3.11	O	933	937	abstract	30717162
(	O	938	939	abstract	30717162
2.803.30	O	939	948	abstract	30717162
)	O	948	949	abstract	30717162
)	O	949	950	abstract	30717162
,	O	950	951	abstract	30717162
and	O	952	955	abstract	30717162
inverse	B-statistical%technique	956	963	abstract	30717162
Simpson	I-statistical%technique	964	971	abstract	30717162
(	O	972	973	abstract	30717162
median	O	973	979	abstract	30717162
(	O	980	981	abstract	30717162
Q1Q3	O	981	986	abstract	30717162
):	O	986	988	abstract	30717162
W0	O	989	991	abstract	30717162
9.26	O	992	996	abstract	30717162
(	O	997	998	abstract	30717162
7.2613.76	O	998	1008	abstract	30717162
)	O	1008	1009	abstract	30717162
vs.	O	1010	1013	abstract	30717162
W6	O	1014	1016	abstract	30717162
12.13	O	1017	1022	abstract	30717162
(	O	1023	1024	abstract	30717162
9.1715.73	O	1024	1034	abstract	30717162
)	O	1034	1035	abstract	30717162
)	O	1035	1036	abstract	30717162
indices	O	1037	1044	abstract	30717162
increased	O	1045	1054	abstract	30717162
significantly	O	1055	1068	abstract	30717162
compared	O	1069	1077	abstract	30717162
to	O	1078	1080	abstract	30717162
baseline	O	1081	1089	abstract	30717162
values	O	1090	1096	abstract	30717162
(	O	1097	1098	abstract	30717162
False	O	1098	1103	abstract	30717162
Discovery	O	1104	1113	abstract	30717162
Rate	O	1114	1118	abstract	30717162
<	O	1119	1120	abstract	30717162
i	O	1120	1121	abstract	30717162
>	O	1121	1122	abstract	30717162
p</i	O	1122	1126	abstract	30717162
>	O	1126	1127	abstract	30717162
(	O	1128	1129	abstract	30717162
<	O	1129	1130	abstract	30717162
i	O	1130	1131	abstract	30717162
>	O	1131	1132	abstract	30717162
q</i	O	1132	1136	abstract	30717162
>	O	1136	1137	abstract	30717162
)	O	1137	1138	abstract	30717162
=	O	1139	1140	abstract	30717162
0.031	O	1141	1146	abstract	30717162
and	O	1147	1150	abstract	30717162
<	O	1151	1152	abstract	30717162
i	O	1152	1153	abstract	30717162
>	O	1153	1154	abstract	30717162
q</i	O	1154	1158	abstract	30717162
>	O	1158	1159	abstract	30717162
=	O	1160	1161	abstract	30717162
0.011	O	1162	1167	abstract	30717162
,	O	1167	1168	abstract	30717162
respectively	O	1169	1181	abstract	30717162
)	O	1181	1182	abstract	30717162
.	O	1182	1183	abstract	30717162

We	O	1184	1186	abstract	30717162
also	O	1187	1191	abstract	30717162
found	O	1192	1197	abstract	30717162
that	O	1198	1202	abstract	30717162
between-subject	O	1203	1218	abstract	30717162
W0	O	1219	1221	abstract	30717162
BrayCurtis	B-statistical%technique	1222	1233	abstract	30717162
dissimilarities	I-statistical%technique	1234	1249	abstract	30717162
were	O	1250	1254	abstract	30717162
significantly	O	1255	1268	abstract	30717162
higher	O	1269	1275	abstract	30717162
than	O	1276	1280	abstract	30717162
W0W6	O	1281	1286	abstract	30717162
within-subject	O	1287	1301	abstract	30717162
dissimilarities	O	1302	1317	abstract	30717162
(	O	1318	1319	abstract	30717162
median	O	1319	1325	abstract	30717162
(	O	1326	1327	abstract	30717162
Q1Q3	O	1327	1332	abstract	30717162
):	O	1332	1334	abstract	30717162
0.68	O	1335	1339	abstract	30717162
(	O	1340	1341	abstract	30717162
0.560.77	O	1341	1350	abstract	30717162
)	O	1350	1351	abstract	30717162
vs.	O	1352	1355	abstract	30717162
0.38	O	1356	1360	abstract	30717162
(	O	1361	1362	abstract	30717162
0.350.52	O	1362	1371	abstract	30717162
)	O	1371	1372	abstract	30717162
,	O	1372	1373	abstract	30717162
two	B-statistical%technique	1374	1377	abstract	30717162
sided	I-statistical%technique	1378	1383	abstract	30717162
MannWhitney	I-statistical%technique	1384	1396	abstract	30717162
test	I-statistical%technique	1397	1401	abstract	30717162
<	O	1402	1403	abstract	30717162
i	O	1403	1404	abstract	30717162
>	O	1404	1405	abstract	30717162
p</i	O	1405	1409	abstract	30717162
>	O	1409	1410	abstract	30717162
<	O	1411	1412	abstract	30717162
0.00001	O	1413	1420	abstract	30717162
.	O	1420	1421	abstract	30717162

The	O	1422	1425	abstract	30717162
within-subject	O	1426	1440	abstract	30717162
dissimilarities	O	1441	1456	abstract	30717162
did	O	1457	1460	abstract	30717162
not	O	1461	1464	abstract	30717162
depend	O	1465	1471	abstract	30717162
on	O	1472	1474	abstract	30717162
sex	O	1475	1478	abstract	30717162
,	O	1478	1479	abstract	30717162
age	O	1480	1483	abstract	30717162
,	O	1483	1484	abstract	30717162
BMI	O	1485	1488	abstract	30717162
,	O	1488	1489	abstract	30717162
illness	O	1490	1497	abstract	30717162
duration	O	1498	1506	abstract	30717162
and	O	1507	1510	abstract	30717162
a	O	1511	1512	abstract	30717162
daily	O	1513	1518	abstract	30717162
dose	O	1519	1523	abstract	30717162
of	O	1524	1526	abstract	30717162
escitalopram	B-drug	1527	1539	abstract	30717162
.	O	1539	1540	abstract	30717162

No	O	1541	1543	abstract	30717162
significant	O	1544	1555	abstract	30717162
differences	O	1556	1567	abstract	30717162
between	O	1568	1575	abstract	30717162
taxa	O	1576	1580	abstract	30717162
levels	O	1581	1587	abstract	30717162
,	O	1587	1588	abstract	30717162
at	O	1589	1591	abstract	30717162
the	O	1592	1595	abstract	30717162
studied	O	1596	1603	abstract	30717162
time	O	1604	1608	abstract	30717162
points	O	1609	1615	abstract	30717162
,	O	1615	1616	abstract	30717162
were	O	1617	1621	abstract	30717162
observed	O	1622	1630	abstract	30717162
when	O	1631	1635	abstract	30717162
adjusted	O	1636	1644	abstract	30717162
for	O	1645	1648	abstract	30717162
multiple	O	1649	1657	abstract	30717162
hypotheses	O	1658	1668	abstract	30717162
testing	O	1669	1676	abstract	30717162
procedures	O	1677	1687	abstract	30717162
.	O	1687	1688	abstract	30717162

We	O	1689	1691	abstract	30717162
conclude	O	1692	1700	abstract	30717162
that	O	1701	1705	abstract	30717162
a	O	1706	1707	abstract	30717162
six-week	O	1708	1716	abstract	30717162
treatment	O	1717	1726	abstract	30717162
in	O	1727	1729	abstract	30717162
a	O	1730	1731	abstract	30717162
psychiatric	O	1732	1743	abstract	30717162
hospital	O	1744	1752	abstract	30717162
setting	O	1753	1760	abstract	30717162
resulted	O	1761	1769	abstract	30717162
in	O	1770	1772	abstract	30717162
increased	O	1773	1782	abstract	30717162
alpha	O	1783	1788	abstract	30717162
biodiversity	O	1789	1801	abstract	30717162
in	O	1802	1804	abstract	30717162
fecal	B-microbiome	1805	1810	abstract	30717162
microbiota	I-microbiome	1811	1821	abstract	30717162
,	O	1821	1822	abstract	30717162
however	O	1823	1830	abstract	30717162
its	O	1831	1834	abstract	30717162
causal	O	1835	1841	abstract	30717162
relationship	O	1842	1854	abstract	30717162
with	O	1855	1859	abstract	30717162
patients	O	1860	1868	abstract	30717162
'	O	1868	1869	abstract	30717162
mental	O	1870	1876	abstract	30717162
health	O	1877	1883	abstract	30717162
was	O	1884	1887	abstract	30717162
not	O	1888	1891	abstract	30717162
proved	O	1892	1898	abstract	30717162
.	O	1898	1899	abstract	30717162

We	O	1900	1902	abstract	30717162
have	O	1903	1907	abstract	30717162
also	O	1908	1912	abstract	30717162
found	O	1913	1918	abstract	30717162
that	O	1919	1923	abstract	30717162
individual	O	1924	1934	abstract	30717162
microbiome	O	1935	1945	abstract	30717162
stability	O	1946	1955	abstract	30717162
was	O	1956	1959	abstract	30717162
not	O	1960	1963	abstract	30717162
affected	O	1964	1972	abstract	30717162
by	O	1973	1975	abstract	30717162
hospitalization	O	1976	1991	abstract	30717162
.	O	1991	1992	abstract	30717162

Altered	B-DDF	0	7	title	31248424
gut	I-DDF	8	11	title	31248424
microbiota	I-DDF	12	22	title	31248424
and	O	23	26	title	31248424
inflammatory	O	27	39	title	31248424
cytokine	O	40	48	title	31248424
responses	O	49	58	title	31248424
in	O	59	61	title	31248424
patients	B-human	62	70	title	31248424
with	O	71	75	title	31248424
Parkinson	B-DDF	76	85	title	31248424
's	I-DDF	85	87	title	31248424
disease	I-DDF	88	95	title	31248424
.	O	95	96	title	31248424

Emerging	O	0	8	abstract	31248424
evidence	O	9	17	abstract	31248424
suggests	O	18	26	abstract	31248424
that	O	27	31	abstract	31248424
gut	B-DDF	32	35	abstract	31248424
microbiome	I-DDF	36	46	abstract	31248424
composition	I-DDF	47	58	abstract	31248424
alterations	I-DDF	59	70	abstract	31248424
affect	O	71	77	abstract	31248424
neurodegeneration	B-DDF	78	95	abstract	31248424
through	O	96	103	abstract	31248424
neuroinflammation	B-DDF	104	121	abstract	31248424
in	O	122	124	abstract	31248424
the	O	125	128	abstract	31248424
pathogenesis	O	129	141	abstract	31248424
of	O	142	144	abstract	31248424
Parkinson	B-DDF	145	154	abstract	31248424
's	I-DDF	154	156	abstract	31248424
disease	I-DDF	157	164	abstract	31248424
(	O	165	166	abstract	31248424
PD	B-DDF	166	168	abstract	31248424
)	O	168	169	abstract	31248424
.	O	169	170	abstract	31248424

Here	O	171	175	abstract	31248424
,	O	175	176	abstract	31248424
we	O	177	179	abstract	31248424
evaluate	O	180	188	abstract	31248424
gut	B-DDF	189	192	abstract	31248424
microbiota	I-DDF	193	203	abstract	31248424
alterations	I-DDF	204	215	abstract	31248424
and	O	216	219	abstract	31248424
host	O	220	224	abstract	31248424
cytokine	O	225	233	abstract	31248424
responses	O	234	243	abstract	31248424
in	O	244	246	abstract	31248424
a	O	247	248	abstract	31248424
population	O	249	259	abstract	31248424
of	O	260	262	abstract	31248424
Taiwanese	B-human	263	272	abstract	31248424
patients	I-human	273	281	abstract	31248424
with	O	282	286	abstract	31248424
PD	B-DDF	287	289	abstract	31248424
.	O	289	290	abstract	31248424

Fecal	B-microbiome	291	296	abstract	31248424
microbiota	I-microbiome	297	307	abstract	31248424
communities	O	308	319	abstract	31248424
from	O	320	324	abstract	31248424
80	O	325	327	abstract	31248424
patients	B-human	328	336	abstract	31248424
with	O	337	341	abstract	31248424
PD	B-DDF	342	344	abstract	31248424
and	O	345	348	abstract	31248424
77	O	349	351	abstract	31248424
age	O	352	355	abstract	31248424
and	O	356	359	abstract	31248424
gender-matched	B-human	360	374	abstract	31248424
controls	I-human	375	383	abstract	31248424
were	O	384	388	abstract	31248424
assessed	O	389	397	abstract	31248424
by	O	398	400	abstract	31248424
sequencing	O	401	411	abstract	31248424
the	O	412	415	abstract	31248424
V3-V4	O	416	421	abstract	31248424
region	O	422	428	abstract	31248424
of	O	429	431	abstract	31248424
the	O	432	435	abstract	31248424
16S	B-gene	436	439	abstract	31248424
ribosomal	I-gene	440	449	abstract	31248424
RNA	I-gene	450	453	abstract	31248424
gene	I-gene	454	458	abstract	31248424
.	O	458	459	abstract	31248424

Diet	O	460	464	abstract	31248424
and	O	465	468	abstract	31248424
comorbidities	O	469	482	abstract	31248424
were	O	483	487	abstract	31248424
controlled	O	488	498	abstract	31248424
in	O	499	501	abstract	31248424
the	O	502	505	abstract	31248424
analyses	O	506	514	abstract	31248424
.	O	514	515	abstract	31248424

Plasma	O	516	522	abstract	31248424
concentrations	O	523	537	abstract	31248424
of	O	538	540	abstract	31248424
IL-1	B-chemical	541	546	abstract	31248424
,	O	546	547	abstract	31248424
IL-2	B-chemical	548	552	abstract	31248424
,	O	552	553	abstract	31248424
IL-4	B-chemical	554	558	abstract	31248424
,	O	558	559	abstract	31248424
IL-6	B-chemical	560	564	abstract	31248424
,	O	564	565	abstract	31248424
IL-13	B-chemical	566	571	abstract	31248424
,	O	571	572	abstract	31248424
IL-18	B-chemical	573	578	abstract	31248424
,	O	578	579	abstract	31248424
GM-CSF	B-chemical	580	586	abstract	31248424
,	O	586	587	abstract	31248424
IFN	B-chemical	588	592	abstract	31248424
,	O	592	593	abstract	31248424
and	O	594	597	abstract	31248424
TNF	B-chemical	598	602	abstract	31248424
were	O	603	607	abstract	31248424
measured	O	608	616	abstract	31248424
by	O	617	619	abstract	31248424
a	O	620	621	abstract	31248424
multiplex	B-biomedical%technique	622	631	abstract	31248424
immunoassay	I-biomedical%technique	632	643	abstract	31248424
and	O	644	647	abstract	31248424
relationships	O	648	661	abstract	31248424
between	O	662	669	abstract	31248424
microbiota	B-microbiome	670	680	abstract	31248424
,	O	680	681	abstract	31248424
clinical	O	682	690	abstract	31248424
characteristics	O	691	706	abstract	31248424
,	O	706	707	abstract	31248424
and	O	708	711	abstract	31248424
cytokine	O	712	720	abstract	31248424
levels	O	721	727	abstract	31248424
were	O	728	732	abstract	31248424
analyzed	O	733	741	abstract	31248424
in	O	742	744	abstract	31248424
the	O	745	748	abstract	31248424
PD	B-DDF	749	751	abstract	31248424
group	O	752	757	abstract	31248424
.	O	757	758	abstract	31248424

We	O	759	761	abstract	31248424
further	O	762	769	abstract	31248424
examined	O	770	778	abstract	31248424
the	O	779	782	abstract	31248424
cytokine	O	783	791	abstract	31248424
changes	O	792	799	abstract	31248424
associated	O	800	810	abstract	31248424
with	O	811	815	abstract	31248424
the	O	816	819	abstract	31248424
altered	B-DDF	820	827	abstract	31248424
gut	I-DDF	828	831	abstract	31248424
microbiota	I-DDF	832	842	abstract	31248424
seen	O	843	847	abstract	31248424
in	O	848	850	abstract	31248424
patients	B-human	851	859	abstract	31248424
with	O	860	864	abstract	31248424
PD	B-DDF	865	867	abstract	31248424
in	O	868	870	abstract	31248424
another	O	871	878	abstract	31248424
independent	O	879	890	abstract	31248424
cohort	O	891	897	abstract	31248424
of	O	898	900	abstract	31248424
120	O	901	904	abstract	31248424
PD	B-human	905	907	abstract	31248424
patients	I-human	908	916	abstract	31248424
and	O	917	920	abstract	31248424
120	O	921	924	abstract	31248424
controls	O	925	933	abstract	31248424
.	O	933	934	abstract	31248424

Microbiota	B-microbiome	935	945	abstract	31248424
from	O	946	950	abstract	31248424
patients	B-human	951	959	abstract	31248424
with	O	960	964	abstract	31248424
PD	B-DDF	965	967	abstract	31248424
was	O	968	971	abstract	31248424
altered	O	972	979	abstract	31248424
relative	O	980	988	abstract	31248424
to	O	989	991	abstract	31248424
controls	O	992	1000	abstract	31248424
and	O	1001	1004	abstract	31248424
dominated	O	1005	1014	abstract	31248424
by	O	1015	1017	abstract	31248424
Verrucomicrobia	B-bacteria	1018	1033	abstract	31248424
,	O	1033	1034	abstract	31248424
Mucispirillum	B-bacteria	1035	1048	abstract	31248424
,	O	1048	1049	abstract	31248424
Porphyromonas	B-bacteria	1050	1063	abstract	31248424
,	O	1063	1064	abstract	31248424
Lactobacillus	B-bacteria	1065	1078	abstract	31248424
,	O	1078	1079	abstract	31248424
and	O	1080	1083	abstract	31248424
Parabacteroides	B-bacteria	1084	1099	abstract	31248424
.	O	1099	1100	abstract	31248424

In	O	1101	1103	abstract	31248424
contrast	O	1104	1112	abstract	31248424
,	O	1112	1113	abstract	31248424
Prevotella	B-bacteria	1114	1124	abstract	31248424
was	O	1125	1128	abstract	31248424
more	O	1129	1133	abstract	31248424
abundant	O	1134	1142	abstract	31248424
in	O	1143	1145	abstract	31248424
controls	O	1146	1154	abstract	31248424
.	O	1154	1155	abstract	31248424

The	O	1156	1159	abstract	31248424
abundances	O	1160	1170	abstract	31248424
of	O	1171	1173	abstract	31248424
Bacteroides	B-bacteria	1174	1185	abstract	31248424
were	O	1186	1190	abstract	31248424
more	O	1191	1195	abstract	31248424
increased	O	1196	1205	abstract	31248424
in	O	1206	1208	abstract	31248424
patients	B-human	1209	1217	abstract	31248424
with	O	1218	1222	abstract	31248424
non-tremor	B-DDF	1223	1233	abstract	31248424
PD	I-DDF	1234	1236	abstract	31248424
subtype	I-DDF	1237	1244	abstract	31248424
than	O	1245	1249	abstract	31248424
patients	B-human	1250	1258	abstract	31248424
with	O	1259	1263	abstract	31248424
tremor	O	1264	1270	abstract	31248424
subtype	O	1271	1278	abstract	31248424
.	O	1278	1279	abstract	31248424

Bacteroides	B-bacteria	1280	1291	abstract	31248424
abundance	O	1292	1301	abstract	31248424
was	O	1302	1305	abstract	31248424
correlated	O	1306	1316	abstract	31248424
with	O	1317	1321	abstract	31248424
motor	O	1322	1327	abstract	31248424
symptom	O	1328	1335	abstract	31248424
severity	O	1336	1344	abstract	31248424
defined	O	1345	1352	abstract	31248424
by	O	1353	1355	abstract	31248424
UPDRS	B-biomedical%technique	1356	1361	abstract	31248424
part	I-biomedical%technique	1362	1366	abstract	31248424
III	I-biomedical%technique	1367	1370	abstract	31248424
motor	I-biomedical%technique	1371	1376	abstract	31248424
scores	I-biomedical%technique	1377	1383	abstract	31248424
(	O	1384	1385	abstract	31248424
rho	O	1385	1388	abstract	31248424
	O	1388	1389	abstract	31248424
=	O	1389	1390	abstract	31248424
	O	1390	1391	abstract	31248424
0.637	O	1391	1396	abstract	31248424
[	O	1397	1398	abstract	31248424
95	O	1398	1400	abstract	31248424
%	O	1400	1401	abstract	31248424
confidence	O	1402	1412	abstract	31248424
interval	O	1413	1421	abstract	31248424
0.474	O	1422	1427	abstract	31248424
to	O	1428	1430	abstract	31248424
0.758	O	1431	1436	abstract	31248424
]	O	1436	1437	abstract	31248424
,	O	1437	1438	abstract	31248424
P	O	1439	1440	abstract	31248424
	O	1440	1441	abstract	31248424
<	O	1441	1442	abstract	31248424
	O	1442	1443	abstract	31248424
0.01	O	1443	1447	abstract	31248424
)	O	1447	1448	abstract	31248424
.	O	1448	1449	abstract	31248424

Altered	B-DDF	1450	1457	abstract	31248424
microbiota	I-DDF	1458	1468	abstract	31248424
was	O	1469	1472	abstract	31248424
correlated	O	1473	1483	abstract	31248424
with	O	1484	1488	abstract	31248424
plasma	O	1489	1495	abstract	31248424
concentrations	O	1496	1510	abstract	31248424
of	O	1511	1513	abstract	31248424
IFN	B-chemical	1514	1518	abstract	31248424
and	O	1519	1522	abstract	31248424
TNF	B-chemical	1523	1527	abstract	31248424
.	O	1527	1528	abstract	31248424

There	O	1529	1534	abstract	31248424
was	O	1535	1538	abstract	31248424
a	O	1539	1540	abstract	31248424
correlation	O	1541	1552	abstract	31248424
between	O	1553	1560	abstract	31248424
Bacteroides	B-bacteria	1561	1572	abstract	31248424
and	O	1573	1576	abstract	31248424
plasma	O	1577	1583	abstract	31248424
level	O	1584	1589	abstract	31248424
of	O	1590	1592	abstract	31248424
TNF	B-chemical	1593	1597	abstract	31248424
(	O	1598	1599	abstract	31248424
rho	O	1599	1602	abstract	31248424
	O	1602	1603	abstract	31248424
=	O	1603	1604	abstract	31248424
	O	1604	1605	abstract	31248424
0.638	O	1605	1610	abstract	31248424
[	O	1611	1612	abstract	31248424
95	O	1612	1614	abstract	31248424
%	O	1614	1615	abstract	31248424
CI	O	1616	1618	abstract	31248424
:	O	1618	1619	abstract	31248424
0.102	O	1620	1625	abstract	31248424
-	O	1625	1626	abstract	31248424
0.887	O	1626	1631	abstract	31248424
]	O	1631	1632	abstract	31248424
,	O	1632	1633	abstract	31248424
P	O	1634	1635	abstract	31248424
	O	1635	1636	abstract	31248424
=	O	1636	1637	abstract	31248424
	O	1637	1638	abstract	31248424
0.02	O	1638	1642	abstract	31248424
)	O	1642	1643	abstract	31248424
;	O	1643	1644	abstract	31248424
and	O	1645	1648	abstract	31248424
a	O	1649	1650	abstract	31248424
correlation	O	1651	1662	abstract	31248424
between	O	1663	1670	abstract	31248424
Verrucomicrobia	B-bacteria	1671	1686	abstract	31248424
abundance	O	1687	1696	abstract	31248424
and	O	1697	1700	abstract	31248424
plasma	O	1701	1707	abstract	31248424
concentrations	O	1708	1722	abstract	31248424
of	O	1723	1725	abstract	31248424
IFN	B-chemical	1726	1730	abstract	31248424
(	O	1731	1732	abstract	31248424
rho	O	1732	1735	abstract	31248424
	O	1735	1736	abstract	31248424
=	O	1736	1737	abstract	31248424
	O	1737	1738	abstract	31248424
0.545	O	1738	1743	abstract	31248424
[	O	1744	1745	abstract	31248424
95	O	1745	1747	abstract	31248424
%	O	1747	1748	abstract	31248424
CI	O	1749	1751	abstract	31248424
-	O	1752	1753	abstract	31248424
	O	1753	1754	abstract	31248424
0.043	O	1754	1759	abstract	31248424
-	O	1759	1760	abstract	31248424
0.852	O	1760	1765	abstract	31248424
]	O	1765	1766	abstract	31248424
,	O	1766	1767	abstract	31248424
P	O	1768	1769	abstract	31248424
	O	1769	1770	abstract	31248424
=	O	1770	1771	abstract	31248424
	O	1771	1772	abstract	31248424
0.05	O	1772	1776	abstract	31248424
)	O	1776	1777	abstract	31248424
.	O	1777	1778	abstract	31248424

The	O	1779	1782	abstract	31248424
elevated	O	1783	1791	abstract	31248424
plasma	O	1792	1798	abstract	31248424
cytokine	O	1799	1807	abstract	31248424
responses	O	1808	1817	abstract	31248424
were	O	1818	1822	abstract	31248424
confirmed	O	1823	1832	abstract	31248424
in	O	1833	1835	abstract	31248424
an	O	1836	1838	abstract	31248424
additional	O	1839	1849	abstract	31248424
independent	O	1850	1861	abstract	31248424
120	O	1862	1865	abstract	31248424
patients	B-human	1866	1874	abstract	31248424
with	O	1875	1879	abstract	31248424
PD	B-DDF	1880	1882	abstract	31248424
and	O	1883	1886	abstract	31248424
120	O	1887	1890	abstract	31248424
controls	O	1891	1899	abstract	31248424
(	O	1900	1901	abstract	31248424
TNF	B-chemical	1901	1905	abstract	31248424
:	O	1905	1906	abstract	31248424
PD	B-DDF	1907	1909	abstract	31248424
vs.	O	1910	1913	abstract	31248424
control	O	1914	1921	abstract	31248424
8.51	O	1922	1926	abstract	31248424
	O	1926	1927	abstract	31248424
	O	1927	1928	abstract	31248424
	O	1928	1929	abstract	31248424
4.63	O	1929	1933	abstract	31248424
	O	1933	1934	abstract	31248424
pg/ml	O	1934	1939	abstract	31248424
vs.	O	1940	1943	abstract	31248424
4.82	O	1944	1948	abstract	31248424
	O	1948	1949	abstract	31248424
	O	1949	1950	abstract	31248424
	O	1950	1951	abstract	31248424
2.23	O	1951	1955	abstract	31248424
	O	1955	1956	abstract	31248424
pg/ml	O	1956	1961	abstract	31248424
,	O	1961	1962	abstract	31248424
P	O	1963	1964	abstract	31248424
	O	1964	1965	abstract	31248424
<	O	1965	1966	abstract	31248424
	O	1966	1967	abstract	31248424
0.01	O	1967	1971	abstract	31248424
;	O	1971	1972	abstract	31248424
and	O	1973	1976	abstract	31248424
IFN	B-chemical	1977	1981	abstract	31248424
:	O	1981	1982	abstract	31248424
PD	B-DDF	1983	1985	abstract	31248424
vs.	O	1986	1989	abstract	31248424
control	O	1990	1997	abstract	31248424
:	O	1997	1998	abstract	31248424
38.45	O	1999	2004	abstract	31248424
	O	2004	2005	abstract	31248424
	O	2005	2006	abstract	31248424
	O	2006	2007	abstract	31248424
7.12	O	2007	2011	abstract	31248424
	O	2011	2012	abstract	31248424
pg/ml	O	2012	2017	abstract	31248424
vs.	O	2018	2021	abstract	31248424
32.79	O	2022	2027	abstract	31248424
	O	2027	2028	abstract	31248424
	O	2028	2029	abstract	31248424
	O	2029	2030	abstract	31248424
8.03	O	2030	2034	abstract	31248424
	O	2034	2035	abstract	31248424
pg/ml	O	2035	2040	abstract	31248424
,	O	2040	2041	abstract	31248424
P	O	2042	2043	abstract	31248424
	O	2043	2044	abstract	31248424
=	O	2044	2045	abstract	31248424
	O	2045	2046	abstract	31248424
0.03	O	2046	2050	abstract	31248424
)	O	2050	2051	abstract	31248424
.	O	2051	2052	abstract	31248424

This	O	2053	2057	abstract	31248424
study	O	2058	2063	abstract	31248424
reveals	O	2064	2071	abstract	31248424
altered	B-DDF	2072	2079	abstract	31248424
gut	I-DDF	2080	2083	abstract	31248424
microbiota	I-DDF	2084	2094	abstract	31248424
in	O	2095	2097	abstract	31248424
PD	B-DDF	2098	2100	abstract	31248424
and	O	2101	2104	abstract	31248424
its	O	2105	2108	abstract	31248424
correlation	O	2109	2120	abstract	31248424
with	O	2121	2125	abstract	31248424
clinical	O	2126	2134	abstract	31248424
phenotypes	O	2135	2145	abstract	31248424
and	O	2146	2149	abstract	31248424
severity	O	2150	2158	abstract	31248424
in	O	2159	2161	abstract	31248424
our	O	2162	2165	abstract	31248424
population	B-human	2166	2176	abstract	31248424
.	O	2176	2177	abstract	31248424

The	O	2178	2181	abstract	31248424
altered	O	2182	2189	abstract	31248424
plasma	O	2190	2196	abstract	31248424
cytokine	O	2197	2205	abstract	31248424
profiles	O	2206	2214	abstract	31248424
associated	O	2215	2225	abstract	31248424
with	O	2226	2230	abstract	31248424
gut	O	2231	2234	abstract	31248424
microbiome	O	2235	2245	abstract	31248424
composition	O	2246	2257	abstract	31248424
alterations	O	2258	2269	abstract	31248424
suggest	O	2270	2277	abstract	31248424
aberrant	O	2278	2286	abstract	31248424
immune	O	2287	2293	abstract	31248424
responses	O	2294	2303	abstract	31248424
may	O	2304	2307	abstract	31248424
contribute	O	2308	2318	abstract	31248424
to	O	2319	2321	abstract	31248424
inflammatory	B-DDF	2322	2334	abstract	31248424
processes	I-DDF	2335	2344	abstract	31248424
in	O	2345	2347	abstract	31248424
PD	B-DDF	2348	2350	abstract	31248424
.	O	2350	2351	abstract	31248424

Exopolysaccharide	B-chemical	0	17	title	37469436
is	O	18	20	title	37469436
the	O	21	24	title	37469436
potential	O	25	34	title	37469436
effector	O	35	43	title	37469436
of	O	44	46	title	37469436
<	B-bacteria	47	48	title	37469436
i	I-bacteria	48	49	title	37469436
>	I-bacteria	49	50	title	37469436
Lactobacillus	I-bacteria	50	63	title	37469436
fermentum</i	I-bacteria	64	76	title	37469436
>	I-bacteria	76	77	title	37469436
PS150	I-bacteria	78	83	title	37469436
,	O	83	84	title	37469436
a	O	85	86	title	37469436
hypnotic	B-bacteria	87	95	title	37469436
psychobiotic	I-bacteria	96	108	title	37469436
strain	I-bacteria	109	115	title	37469436
.	O	115	116	title	37469436

Psychobiotics	B-bacteria	0	13	abstract	37469436
are	O	14	17	abstract	37469436
a	O	18	19	abstract	37469436
class	O	20	25	abstract	37469436
of	O	26	28	abstract	37469436
probiotics	B-bacteria	29	39	abstract	37469436
that	O	40	44	abstract	37469436
confer	O	45	51	abstract	37469436
beneficial	O	52	62	abstract	37469436
effects	O	63	70	abstract	37469436
on	O	71	73	abstract	37469436
the	O	74	77	abstract	37469436
mental	O	78	84	abstract	37469436
health	O	85	91	abstract	37469436
of	O	92	94	abstract	37469436
the	O	95	98	abstract	37469436
host	O	99	103	abstract	37469436
.	O	103	104	abstract	37469436

We	O	105	107	abstract	37469436
have	O	108	112	abstract	37469436
previously	O	113	123	abstract	37469436
reported	O	124	132	abstract	37469436
hypnotic	B-DDF	133	141	abstract	37469436
effects	I-DDF	142	149	abstract	37469436
of	O	150	152	abstract	37469436
a	O	153	154	abstract	37469436
psychobiotic	B-bacteria	155	167	abstract	37469436
strain	I-bacteria	168	174	abstract	37469436
,	O	174	175	abstract	37469436
<	B-bacteria	176	177	abstract	37469436
i	I-bacteria	177	178	abstract	37469436
>	I-bacteria	178	179	abstract	37469436
Lactobacillus	I-bacteria	179	192	abstract	37469436
fermentum</i	I-bacteria	193	205	abstract	37469436
>	I-bacteria	205	206	abstract	37469436
PS150	I-bacteria	207	212	abstract	37469436
(	O	213	214	abstract	37469436
PS150	B-bacteria	214	219	abstract	37469436
)	O	219	220	abstract	37469436
,	O	220	221	abstract	37469436
which	O	222	227	abstract	37469436
significantly	O	228	241	abstract	37469436
shortens	O	242	250	abstract	37469436
sleep	O	251	256	abstract	37469436
latency	O	257	264	abstract	37469436
in	O	265	267	abstract	37469436
experimental	B-animal	268	280	abstract	37469436
mice	I-animal	281	285	abstract	37469436
,	O	285	286	abstract	37469436
and	O	287	290	abstract	37469436
effectively	O	291	302	abstract	37469436
ameliorate	O	303	313	abstract	37469436
sleep	B-DDF	314	319	abstract	37469436
disturbances	I-DDF	320	332	abstract	37469436
caused	O	333	339	abstract	37469436
by	O	340	342	abstract	37469436
either	O	343	349	abstract	37469436
caffeine	O	350	358	abstract	37469436
consumption	O	359	370	abstract	37469436
or	O	371	373	abstract	37469436
a	O	374	375	abstract	37469436
novel	O	376	381	abstract	37469436
environment	O	382	393	abstract	37469436
.	O	393	394	abstract	37469436

In	O	395	397	abstract	37469436
the	O	398	401	abstract	37469436
present	O	402	409	abstract	37469436
study	O	410	415	abstract	37469436
,	O	415	416	abstract	37469436
we	O	417	419	abstract	37469436
discovered	O	420	430	abstract	37469436
a	O	431	432	abstract	37469436
<	B-bacteria	433	434	abstract	37469436
i	I-bacteria	434	435	abstract	37469436
>	I-bacteria	435	436	abstract	37469436
L.	I-bacteria	436	438	abstract	37469436
fermentum</i	I-bacteria	439	451	abstract	37469436
>	I-bacteria	451	452	abstract	37469436
strain	I-bacteria	453	459	abstract	37469436
,	O	459	460	abstract	37469436
GR1009	B-bacteria	461	467	abstract	37469436
,	O	467	468	abstract	37469436
isolated	O	469	477	abstract	37469436
from	O	478	482	abstract	37469436
the	O	483	486	abstract	37469436
same	O	487	491	abstract	37469436
source	O	492	498	abstract	37469436
of	O	499	501	abstract	37469436
PS150	B-bacteria	502	507	abstract	37469436
,	O	507	508	abstract	37469436
and	O	509	512	abstract	37469436
found	O	513	518	abstract	37469436
that	O	519	523	abstract	37469436
GR1009	B-bacteria	524	530	abstract	37469436
is	O	531	533	abstract	37469436
phenotypically	O	534	548	abstract	37469436
distinct	O	549	557	abstract	37469436
but	O	558	561	abstract	37469436
genetically	O	562	573	abstract	37469436
similar	O	574	581	abstract	37469436
to	O	582	584	abstract	37469436
PS150	B-bacteria	585	590	abstract	37469436
.	O	590	591	abstract	37469436

Compared	O	592	600	abstract	37469436
with	O	601	605	abstract	37469436
PS150	B-bacteria	606	611	abstract	37469436
,	O	611	612	abstract	37469436
GR1009	B-bacteria	613	619	abstract	37469436
have	O	620	624	abstract	37469436
no	O	625	627	abstract	37469436
significant	O	628	639	abstract	37469436
hypnotic	B-DDF	640	648	abstract	37469436
effects	I-DDF	649	656	abstract	37469436
in	O	657	659	abstract	37469436
the	O	660	663	abstract	37469436
pentobarbital-induced	B-biomedical%technique	664	685	abstract	37469436
sleep	I-biomedical%technique	686	691	abstract	37469436
test	I-biomedical%technique	692	696	abstract	37469436
in	O	697	699	abstract	37469436
mice	B-animal	700	704	abstract	37469436
.	O	704	705	abstract	37469436

In	O	706	708	abstract	37469436
addition	O	709	717	abstract	37469436
,	O	717	718	abstract	37469436
we	O	719	721	abstract	37469436
found	O	722	727	abstract	37469436
that	O	728	732	abstract	37469436
heat-killed	B-bacteria	733	744	abstract	37469436
PS150	I-bacteria	745	750	abstract	37469436
exhibited	O	751	760	abstract	37469436
hypnotic	B-DDF	761	769	abstract	37469436
effects	I-DDF	770	777	abstract	37469436
and	O	778	781	abstract	37469436
altered	O	782	789	abstract	37469436
the	O	790	793	abstract	37469436
gut	B-microbiome	794	797	abstract	37469436
microbiota	I-microbiome	798	808	abstract	37469436
in	O	809	811	abstract	37469436
a	O	812	813	abstract	37469436
manner	O	814	820	abstract	37469436
similar	O	821	828	abstract	37469436
to	O	829	831	abstract	37469436
live	O	832	836	abstract	37469436
bacteria	O	837	845	abstract	37469436
,	O	845	846	abstract	37469436
suggesting	O	847	857	abstract	37469436
that	O	858	862	abstract	37469436
a	O	863	864	abstract	37469436
heat-stable	O	865	876	abstract	37469436
effector	O	877	885	abstract	37469436
,	O	885	886	abstract	37469436
such	O	887	891	abstract	37469436
as	O	892	894	abstract	37469436
exopolysaccharide	B-chemical	895	912	abstract	37469436
(	O	913	914	abstract	37469436
EPS	B-chemical	914	917	abstract	37469436
)	O	917	918	abstract	37469436
,	O	918	919	abstract	37469436
could	O	920	925	abstract	37469436
be	O	926	928	abstract	37469436
responsible	O	929	940	abstract	37469436
for	O	941	944	abstract	37469436
these	O	945	950	abstract	37469436
effects	O	951	958	abstract	37469436
.	O	958	959	abstract	37469436

Our	O	960	963	abstract	37469436
comparative	B-biomedical%technique	964	975	abstract	37469436
genomics	I-biomedical%technique	976	984	abstract	37469436
analysis	I-biomedical%technique	985	993	abstract	37469436
also	O	994	998	abstract	37469436
revealed	O	999	1007	abstract	37469436
distinct	O	1008	1016	abstract	37469436
genetic	O	1017	1024	abstract	37469436
characteristics	O	1025	1040	abstract	37469436
in	O	1041	1043	abstract	37469436
EPS	B-chemical	1044	1047	abstract	37469436
biosynthesis	O	1048	1060	abstract	37469436
between	O	1061	1068	abstract	37469436
GR1009	B-bacteria	1069	1075	abstract	37469436
and	O	1076	1079	abstract	37469436
PS150	B-bacteria	1080	1085	abstract	37469436
.	O	1085	1086	abstract	37469436

Furthermore	O	1087	1098	abstract	37469436
,	O	1098	1099	abstract	37469436
scanning	O	1100	1108	abstract	37469436
electron	O	1109	1117	abstract	37469436
microscopy	O	1118	1128	abstract	37469436
imaging	O	1129	1136	abstract	37469436
showed	O	1137	1143	abstract	37469436
a	O	1144	1145	abstract	37469436
sheet-like	O	1146	1156	abstract	37469436
EPS	O	1157	1160	abstract	37469436
structure	O	1161	1170	abstract	37469436
in	O	1171	1173	abstract	37469436
PS150	B-bacteria	1174	1179	abstract	37469436
,	O	1179	1180	abstract	37469436
while	O	1181	1186	abstract	37469436
GR1009	B-bacteria	1187	1193	abstract	37469436
displayed	O	1194	1203	abstract	37469436
no	O	1204	1206	abstract	37469436
apparent	O	1207	1215	abstract	37469436
EPS	O	1216	1219	abstract	37469436
structure	O	1220	1229	abstract	37469436
.	O	1229	1230	abstract	37469436

Using	O	1231	1236	abstract	37469436
the	O	1237	1240	abstract	37469436
phenol-sulfate	B-biomedical%technique	1241	1255	abstract	37469436
assay	I-biomedical%technique	1256	1261	abstract	37469436
,	O	1261	1262	abstract	37469436
we	O	1263	1265	abstract	37469436
found	O	1266	1271	abstract	37469436
that	O	1272	1276	abstract	37469436
the	O	1277	1280	abstract	37469436
sugar	O	1281	1286	abstract	37469436
content	O	1287	1294	abstract	37469436
value	O	1295	1300	abstract	37469436
of	O	1301	1303	abstract	37469436
the	O	1304	1307	abstract	37469436
crude	O	1308	1313	abstract	37469436
extract	O	1314	1321	abstract	37469436
containing	O	1322	1332	abstract	37469436
EPS	B-chemical	1333	1336	abstract	37469436
(	O	1337	1338	abstract	37469436
C-EPS	B-chemical	1338	1343	abstract	37469436
)	O	1343	1344	abstract	37469436
from	O	1345	1349	abstract	37469436
PS150	B-bacteria	1350	1355	abstract	37469436
was	O	1356	1359	abstract	37469436
approximately	O	1360	1373	abstract	37469436
five	O	1374	1378	abstract	37469436
times	O	1379	1384	abstract	37469436
higher	O	1385	1391	abstract	37469436
than	O	1392	1396	abstract	37469436
that	O	1397	1401	abstract	37469436
of	O	1402	1404	abstract	37469436
GR1009	B-bacteria	1405	1411	abstract	37469436
,	O	1411	1412	abstract	37469436
indicating	O	1413	1423	abstract	37469436
that	O	1424	1428	abstract	37469436
GR1009	B-bacteria	1429	1435	abstract	37469436
has	O	1436	1439	abstract	37469436
a	O	1440	1441	abstract	37469436
lower	O	1442	1447	abstract	37469436
EPS	O	1448	1451	abstract	37469436
production	O	1452	1462	abstract	37469436
activity	O	1463	1471	abstract	37469436
than	O	1472	1476	abstract	37469436
PS150	B-bacteria	1477	1482	abstract	37469436
.	O	1482	1483	abstract	37469436

Through	O	1484	1491	abstract	37469436
the	O	1492	1495	abstract	37469436
pentobarbital-induced	B-biomedical%technique	1496	1517	abstract	37469436
sleep	I-biomedical%technique	1518	1523	abstract	37469436
test	I-biomedical%technique	1524	1528	abstract	37469436
,	O	1528	1529	abstract	37469436
we	O	1530	1532	abstract	37469436
confirmed	O	1533	1542	abstract	37469436
the	O	1543	1546	abstract	37469436
hypnotic	B-DDF	1547	1555	abstract	37469436
effects	I-DDF	1556	1563	abstract	37469436
of	O	1564	1566	abstract	37469436
the	O	1567	1570	abstract	37469436
C-EPS	B-chemical	1571	1576	abstract	37469436
isolated	O	1577	1585	abstract	37469436
from	O	1586	1590	abstract	37469436
PS150	B-bacteria	1591	1596	abstract	37469436
,	O	1596	1597	abstract	37469436
as	O	1598	1600	abstract	37469436
evidenced	O	1601	1610	abstract	37469436
by	O	1611	1613	abstract	37469436
a	O	1614	1615	abstract	37469436
significant	O	1616	1627	abstract	37469436
reduction	O	1628	1637	abstract	37469436
in	O	1638	1640	abstract	37469436
sleep	O	1641	1646	abstract	37469436
latency	O	1647	1654	abstract	37469436
and	O	1655	1658	abstract	37469436
recovery	O	1659	1667	abstract	37469436
time	O	1668	1672	abstract	37469436
following	O	1673	1682	abstract	37469436
oral	O	1683	1687	abstract	37469436
administration	O	1688	1702	abstract	37469436
in	O	1703	1705	abstract	37469436
mice	B-animal	1706	1710	abstract	37469436
.	O	1710	1711	abstract	37469436

In	O	1712	1714	abstract	37469436
summary	O	1715	1722	abstract	37469436
,	O	1722	1723	abstract	37469436
we	O	1724	1726	abstract	37469436
utilized	O	1727	1735	abstract	37469436
a	O	1736	1737	abstract	37469436
comparative	O	1738	1749	abstract	37469436
approach	O	1750	1758	abstract	37469436
to	O	1759	1761	abstract	37469436
delineate	O	1762	1771	abstract	37469436
differences	O	1772	1783	abstract	37469436
between	O	1784	1791	abstract	37469436
PS150	B-bacteria	1792	1797	abstract	37469436
and	O	1798	1801	abstract	37469436
GR1009	B-bacteria	1802	1808	abstract	37469436
and	O	1809	1812	abstract	37469436
proposed	O	1813	1821	abstract	37469436
that	O	1822	1826	abstract	37469436
EPS	B-chemical	1827	1830	abstract	37469436
may	O	1831	1834	abstract	37469436
serve	O	1835	1840	abstract	37469436
as	O	1841	1843	abstract	37469436
a	O	1844	1845	abstract	37469436
key	O	1846	1849	abstract	37469436
factor	O	1850	1856	abstract	37469436
that	O	1857	1861	abstract	37469436
mediates	O	1862	1870	abstract	37469436
the	O	1871	1874	abstract	37469436
observed	O	1875	1883	abstract	37469436
hypnotic	B-DDF	1884	1892	abstract	37469436
effect	I-DDF	1893	1899	abstract	37469436
.	O	1899	1900	abstract	37469436

Effects	O	0	7	title	31179435
of	O	8	10	title	31179435
regulating	O	11	21	title	31179435
intestinal	B-microbiome	22	32	title	31179435
microbiota	I-microbiome	33	43	title	31179435
on	O	44	46	title	31179435
anxiety	B-DDF	47	54	title	31179435
symptoms	I-DDF	55	63	title	31179435
:	O	63	64	title	31179435
A	O	65	66	title	31179435
systematic	O	67	77	title	31179435
review	O	78	84	title	31179435
.	O	84	85	title	31179435

Anxiety	B-DDF	0	7	abstract	31179435
symptoms	I-DDF	8	16	abstract	31179435
are	O	17	20	abstract	31179435
common	O	21	27	abstract	31179435
in	O	28	30	abstract	31179435
mental	B-DDF	31	37	abstract	31179435
diseases	I-DDF	38	46	abstract	31179435
and	O	47	50	abstract	31179435
a	O	51	52	abstract	31179435
variety	O	53	60	abstract	31179435
of	O	61	63	abstract	31179435
physical	B-DDF	64	72	abstract	31179435
disorders	I-DDF	73	82	abstract	31179435
,	O	82	83	abstract	31179435
especially	O	84	94	abstract	31179435
in	O	95	97	abstract	31179435
disorders	O	98	107	abstract	31179435
related	O	108	115	abstract	31179435
to	O	116	118	abstract	31179435
stress	B-DDF	119	125	abstract	31179435
.	O	125	126	abstract	31179435

More	O	127	131	abstract	31179435
and	O	132	135	abstract	31179435
more	O	136	140	abstract	31179435
basic	O	141	146	abstract	31179435
studies	O	147	154	abstract	31179435
have	O	155	159	abstract	31179435
indicated	O	160	169	abstract	31179435
that	O	170	174	abstract	31179435
gut	B-microbiome	175	178	abstract	31179435
microbiota	I-microbiome	179	189	abstract	31179435
can	O	190	193	abstract	31179435
regulate	O	194	202	abstract	31179435
brain	O	203	208	abstract	31179435
function	O	209	217	abstract	31179435
through	O	218	225	abstract	31179435
the	O	226	229	abstract	31179435
gut-brain	O	230	239	abstract	31179435
axis	O	240	244	abstract	31179435
,	O	244	245	abstract	31179435
and	O	246	249	abstract	31179435
dysbiosis	B-DDF	250	259	abstract	31179435
of	I-DDF	260	262	abstract	31179435
intestinal	I-DDF	263	273	abstract	31179435
microbiota	I-DDF	274	284	abstract	31179435
was	O	285	288	abstract	31179435
related	O	289	296	abstract	31179435
to	O	297	299	abstract	31179435
anxiety	B-DDF	300	307	abstract	31179435
.	O	307	308	abstract	31179435

However	O	309	316	abstract	31179435
,	O	316	317	abstract	31179435
there	O	318	323	abstract	31179435
is	O	324	326	abstract	31179435
no	O	327	329	abstract	31179435
specific	O	330	338	abstract	31179435
evidence	O	339	347	abstract	31179435
to	O	348	350	abstract	31179435
support	O	351	358	abstract	31179435
treatment	O	359	368	abstract	31179435
of	O	369	371	abstract	31179435
anxiety	B-DDF	372	379	abstract	31179435
by	O	380	382	abstract	31179435
regulating	O	383	393	abstract	31179435
intestinal	B-microbiome	394	404	abstract	31179435
microbiota	I-microbiome	405	415	abstract	31179435
.	O	415	416	abstract	31179435

To	O	417	419	abstract	31179435
find	O	420	424	abstract	31179435
evidence	O	425	433	abstract	31179435
supporting	O	434	444	abstract	31179435
improvement	O	445	456	abstract	31179435
of	O	457	459	abstract	31179435
anxiety	B-DDF	460	467	abstract	31179435
symptoms	I-DDF	468	476	abstract	31179435
by	O	477	479	abstract	31179435
regulation	O	480	490	abstract	31179435
of	O	491	493	abstract	31179435
intestinal	B-microbiome	494	504	abstract	31179435
microbiota	I-microbiome	505	515	abstract	31179435
.	O	515	516	abstract	31179435

This	O	517	521	abstract	31179435
systematic	O	522	532	abstract	31179435
review	O	533	539	abstract	31179435
of	O	540	542	abstract	31179435
randomised	O	543	553	abstract	31179435
controlled	O	554	564	abstract	31179435
trials	O	565	571	abstract	31179435
was	O	572	575	abstract	31179435
searched	O	576	584	abstract	31179435
based	O	585	590	abstract	31179435
on	O	591	593	abstract	31179435
the	O	594	597	abstract	31179435
following	O	598	607	abstract	31179435
databases	O	608	617	abstract	31179435
:	O	617	618	abstract	31179435
PubMed	O	619	625	abstract	31179435
,	O	625	626	abstract	31179435
EMBASE	O	627	633	abstract	31179435
,	O	633	634	abstract	31179435
the	O	635	638	abstract	31179435
Cochrane	O	639	647	abstract	31179435
Library	O	648	655	abstract	31179435
,	O	655	656	abstract	31179435
OVID	O	657	661	abstract	31179435
,	O	661	662	abstract	31179435
Web	O	663	666	abstract	31179435
of	O	667	669	abstract	31179435
Knowledge	O	670	679	abstract	31179435
,	O	679	680	abstract	31179435
China	O	681	686	abstract	31179435
National	O	687	695	abstract	31179435
Knowledge	O	696	705	abstract	31179435
Infrastructure	O	706	720	abstract	31179435
(	O	721	722	abstract	31179435
CNKI	O	722	726	abstract	31179435
)	O	726	727	abstract	31179435
,	O	727	728	abstract	31179435
Wanfang	O	729	736	abstract	31179435
Data	O	737	741	abstract	31179435
,	O	741	742	abstract	31179435
VIP	O	743	746	abstract	31179435
databases	O	747	756	abstract	31179435
and	O	757	760	abstract	31179435
SinoMed	O	761	768	abstract	31179435
.	O	768	769	abstract	31179435

The	O	770	773	abstract	31179435
retrieval	O	774	783	abstract	31179435
time	O	784	788	abstract	31179435
dated	O	789	794	abstract	31179435
back	O	795	799	abstract	31179435
to	O	800	802	abstract	31179435
25	O	803	805	abstract	31179435
July	O	806	810	abstract	31179435
2018	O	811	815	abstract	31179435
.	O	815	816	abstract	31179435

Then	O	817	821	abstract	31179435
we	O	822	824	abstract	31179435
screened	O	825	833	abstract	31179435
research	O	834	842	abstract	31179435
literatures	O	843	854	abstract	31179435
based	O	855	860	abstract	31179435
on	O	861	863	abstract	31179435
established	O	864	875	abstract	31179435
inclusion	O	876	885	abstract	31179435
and	O	886	889	abstract	31179435
exclusion	O	890	899	abstract	31179435
criteria	O	900	908	abstract	31179435
.	O	908	909	abstract	31179435

Quality	O	910	917	abstract	31179435
evaluation	O	918	928	abstract	31179435
for	O	929	932	abstract	31179435
each	O	933	937	abstract	31179435
included	O	938	946	abstract	31179435
study	O	947	952	abstract	31179435
was	O	953	956	abstract	31179435
done	O	957	961	abstract	31179435
using	O	962	967	abstract	31179435
the	O	968	971	abstract	31179435
Cochrane	B-statistical%technique	972	980	abstract	31179435
risk	I-statistical%technique	981	985	abstract	31179435
of	I-statistical%technique	986	988	abstract	31179435
bias	I-statistical%technique	989	993	abstract	31179435
and	O	994	997	abstract	31179435
the	O	998	1001	abstract	31179435
Jadad	O	1002	1007	abstract	31179435
scale	O	1008	1013	abstract	31179435
.	O	1013	1014	abstract	31179435

A	O	1015	1016	abstract	31179435
total	O	1017	1022	abstract	31179435
of	O	1023	1025	abstract	31179435
3334	O	1026	1030	abstract	31179435
articles	O	1031	1039	abstract	31179435
were	O	1040	1044	abstract	31179435
retrieved	O	1045	1054	abstract	31179435
and	O	1055	1058	abstract	31179435
21	O	1059	1061	abstract	31179435
studies	O	1062	1069	abstract	31179435
were	O	1070	1074	abstract	31179435
included	O	1075	1083	abstract	31179435
which	O	1084	1089	abstract	31179435
contained	O	1090	1099	abstract	31179435
1503	O	1100	1104	abstract	31179435
subjects	O	1105	1113	abstract	31179435
.	O	1113	1114	abstract	31179435

In	O	1115	1117	abstract	31179435
the	O	1118	1121	abstract	31179435
21	O	1122	1124	abstract	31179435
studies	O	1125	1132	abstract	31179435
,	O	1132	1133	abstract	31179435
15	O	1134	1136	abstract	31179435
chose	O	1137	1142	abstract	31179435
probiotics	B-dietary%supplement	1143	1153	abstract	31179435
as	O	1154	1156	abstract	31179435
interventions	O	1157	1170	abstract	31179435
to	O	1171	1173	abstract	31179435
regulate	O	1174	1182	abstract	31179435
intestinal	B-microbiome	1183	1193	abstract	31179435
microbiota	I-microbiome	1194	1204	abstract	31179435
and	O	1205	1208	abstract	31179435
six	O	1209	1212	abstract	31179435
chose	O	1213	1218	abstract	31179435
non-probiotic	O	1219	1232	abstract	31179435
ways	O	1233	1237	abstract	31179435
such	O	1238	1242	abstract	31179435
as	O	1243	1245	abstract	31179435
adjusting	O	1246	1255	abstract	31179435
daily	O	1256	1261	abstract	31179435
diets	O	1262	1267	abstract	31179435
.	O	1267	1268	abstract	31179435

Probiotic	B-dietary%supplement	1269	1278	abstract	31179435
supplements	I-dietary%supplement	1279	1290	abstract	31179435
in	O	1291	1293	abstract	31179435
seven	O	1294	1299	abstract	31179435
studies	O	1300	1307	abstract	31179435
contained	O	1308	1317	abstract	31179435
only	O	1318	1322	abstract	31179435
one	O	1323	1326	abstract	31179435
kind	O	1327	1331	abstract	31179435
of	O	1332	1334	abstract	31179435
probiotic	B-dietary%supplement	1335	1344	abstract	31179435
,	O	1344	1345	abstract	31179435
two	O	1346	1349	abstract	31179435
studies	O	1350	1357	abstract	31179435
used	O	1358	1362	abstract	31179435
a	O	1363	1364	abstract	31179435
product	O	1365	1372	abstract	31179435
that	O	1373	1377	abstract	31179435
contained	O	1378	1387	abstract	31179435
two	O	1388	1391	abstract	31179435
kinds	O	1392	1397	abstract	31179435
of	O	1398	1400	abstract	31179435
probiotics	B-dietary%supplement	1401	1411	abstract	31179435
and	O	1412	1415	abstract	31179435
the	O	1416	1419	abstract	31179435
supplements	O	1420	1431	abstract	31179435
used	O	1432	1436	abstract	31179435
in	O	1437	1439	abstract	31179435
the	O	1440	1443	abstract	31179435
other	O	1444	1449	abstract	31179435
five	O	1450	1454	abstract	31179435
studies	O	1455	1462	abstract	31179435
included	O	1463	1471	abstract	31179435
at	O	1472	1474	abstract	31179435
least	O	1475	1480	abstract	31179435
three	O	1481	1486	abstract	31179435
kinds	O	1487	1492	abstract	31179435
of	O	1493	1495	abstract	31179435
probiotics	B-dietary%supplement	1496	1506	abstract	31179435
.	O	1506	1507	abstract	31179435

In	O	1508	1510	abstract	31179435
the	O	1511	1514	abstract	31179435
studies	O	1515	1522	abstract	31179435
that	O	1523	1527	abstract	31179435
used	O	1528	1532	abstract	31179435
treatment	O	1533	1542	abstract	31179435
as	O	1543	1545	abstract	31179435
usual	O	1546	1551	abstract	31179435
plus	O	1552	1556	abstract	31179435
interventions	O	1557	1570	abstract	31179435
regulating	O	1571	1581	abstract	31179435
intestinal	B-microbiome	1582	1592	abstract	31179435
flora	I-microbiome	1593	1598	abstract	31179435
(	O	1599	1600	abstract	31179435
IRIF	B-microbiome	1600	1604	abstract	31179435
)	O	1604	1605	abstract	31179435
as	O	1606	1608	abstract	31179435
interventions	O	1609	1622	abstract	31179435
(	O	1623	1624	abstract	31179435
five	O	1624	1628	abstract	31179435
studies	O	1629	1636	abstract	31179435
)	O	1636	1637	abstract	31179435
,	O	1637	1638	abstract	31179435
only	O	1639	1643	abstract	31179435
non-probiotic	O	1644	1657	abstract	31179435
ways	O	1658	1662	abstract	31179435
were	O	1663	1667	abstract	31179435
effective	O	1668	1677	abstract	31179435
(	O	1678	1679	abstract	31179435
two	O	1679	1682	abstract	31179435
studies	O	1683	1690	abstract	31179435
)	O	1690	1691	abstract	31179435
,	O	1691	1692	abstract	31179435
which	O	1693	1698	abstract	31179435
means	O	1699	1704	abstract	31179435
40	O	1705	1707	abstract	31179435
%	O	1707	1708	abstract	31179435
of	O	1709	1711	abstract	31179435
studies	O	1712	1719	abstract	31179435
were	O	1720	1724	abstract	31179435
effective	O	1725	1734	abstract	31179435
;	O	1734	1735	abstract	31179435
in	O	1736	1738	abstract	31179435
the	O	1739	1742	abstract	31179435
studies	O	1743	1750	abstract	31179435
that	O	1751	1755	abstract	31179435
used	O	1756	1760	abstract	31179435
IRIF	B-microbiome	1761	1765	abstract	31179435
alone	O	1766	1771	abstract	31179435
(	O	1772	1773	abstract	31179435
16	O	1773	1775	abstract	31179435
studies	O	1776	1783	abstract	31179435
,	O	1783	1784	abstract	31179435
11	O	1785	1787	abstract	31179435
studies	O	1788	1795	abstract	31179435
used	O	1796	1800	abstract	31179435
probiotic	O	1801	1810	abstract	31179435
ways	O	1811	1815	abstract	31179435
and	O	1816	1819	abstract	31179435
5	O	1820	1821	abstract	31179435
studies	O	1822	1829	abstract	31179435
used	O	1830	1834	abstract	31179435
non-probiotic	O	1835	1848	abstract	31179435
ways	O	1849	1853	abstract	31179435
)	O	1853	1854	abstract	31179435
,	O	1854	1855	abstract	31179435
56	O	1856	1858	abstract	31179435
%	O	1858	1859	abstract	31179435
of	O	1860	1862	abstract	31179435
studies	O	1863	1870	abstract	31179435
could	O	1871	1876	abstract	31179435
improve	O	1877	1884	abstract	31179435
anxiety	B-DDF	1885	1892	abstract	31179435
symptoms	I-DDF	1893	1901	abstract	31179435
,	O	1901	1902	abstract	31179435
and	O	1903	1906	abstract	31179435
80	O	1907	1909	abstract	31179435
%	O	1909	1910	abstract	31179435
of	O	1911	1913	abstract	31179435
studies	O	1914	1921	abstract	31179435
that	O	1922	1926	abstract	31179435
conducted	O	1927	1936	abstract	31179435
the	O	1937	1940	abstract	31179435
non-probiotic	O	1941	1954	abstract	31179435
interventions	O	1955	1968	abstract	31179435
were	O	1969	1973	abstract	31179435
effective	O	1974	1983	abstract	31179435
,	O	1983	1984	abstract	31179435
while	O	1985	1990	abstract	31179435
45	O	1991	1993	abstract	31179435
%	O	1993	1994	abstract	31179435
of	O	1995	1997	abstract	31179435
studies	O	1998	2005	abstract	31179435
that	O	2006	2010	abstract	31179435
used	O	2011	2015	abstract	31179435
probiotic	B-dietary%supplement	2016	2025	abstract	31179435
supplementations	I-dietary%supplement	2026	2042	abstract	31179435
had	O	2043	2046	abstract	31179435
positive	O	2047	2055	abstract	31179435
effects	O	2056	2063	abstract	31179435
on	O	2064	2066	abstract	31179435
anxiety	B-DDF	2067	2074	abstract	31179435
symptoms	I-DDF	2075	2083	abstract	31179435
.	O	2083	2084	abstract	31179435

Overall	O	2085	2092	abstract	31179435
,	O	2092	2093	abstract	31179435
11	O	2094	2096	abstract	31179435
studies	O	2097	2104	abstract	31179435
showed	O	2105	2111	abstract	31179435
a	O	2112	2113	abstract	31179435
positive	O	2114	2122	abstract	31179435
effect	O	2123	2129	abstract	31179435
on	O	2130	2132	abstract	31179435
anxiety	B-DDF	2133	2140	abstract	31179435
symptoms	I-DDF	2141	2149	abstract	31179435
by	O	2150	2152	abstract	31179435
regulating	O	2153	2163	abstract	31179435
intestinal	B-microbiome	2164	2174	abstract	31179435
microbiota	I-microbiome	2175	2185	abstract	31179435
,	O	2185	2186	abstract	31179435
which	O	2187	2192	abstract	31179435
indicated	O	2193	2202	abstract	31179435
52	O	2203	2205	abstract	31179435
%	O	2205	2206	abstract	31179435
of	O	2207	2209	abstract	31179435
the	O	2210	2213	abstract	31179435
21	O	2214	2216	abstract	31179435
studies	O	2217	2224	abstract	31179435
were	O	2225	2229	abstract	31179435
effective	O	2230	2239	abstract	31179435
,	O	2239	2240	abstract	31179435
and	O	2241	2244	abstract	31179435
there	O	2245	2250	abstract	31179435
were	O	2251	2255	abstract	31179435
five	O	2256	2260	abstract	31179435
studies	O	2261	2268	abstract	31179435
that	O	2269	2273	abstract	31179435
used	O	2274	2278	abstract	31179435
probiotic	B-dietary%supplement	2279	2288	abstract	31179435
supplements	I-dietary%supplement	2289	2300	abstract	31179435
as	O	2301	2303	abstract	31179435
interventions	O	2304	2317	abstract	31179435
and	O	2318	2321	abstract	31179435
six	O	2322	2325	abstract	31179435
used	O	2326	2330	abstract	31179435
non-probiotic	O	2331	2344	abstract	31179435
interventions	O	2345	2358	abstract	31179435
.	O	2358	2359	abstract	31179435

In	O	2360	2362	abstract	31179435
addition	O	2363	2371	abstract	31179435
,	O	2371	2372	abstract	31179435
it	O	2373	2375	abstract	31179435
should	O	2376	2382	abstract	31179435
be	O	2383	2385	abstract	31179435
noted	O	2386	2391	abstract	31179435
that	O	2392	2396	abstract	31179435
six	O	2397	2400	abstract	31179435
of	O	2401	2403	abstract	31179435
seven	O	2404	2409	abstract	31179435
studies	O	2410	2417	abstract	31179435
showed	O	2418	2424	abstract	31179435
that	O	2425	2429	abstract	31179435
regulation	O	2430	2440	abstract	31179435
of	O	2441	2443	abstract	31179435
intestinal	B-microbiome	2444	2454	abstract	31179435
microbiota	I-microbiome	2455	2465	abstract	31179435
could	O	2466	2471	abstract	31179435
treat	O	2472	2477	abstract	31179435
anxiety	B-DDF	2478	2485	abstract	31179435
symptoms	I-DDF	2486	2494	abstract	31179435
,	O	2494	2495	abstract	31179435
the	O	2496	2499	abstract	31179435
rate	O	2500	2504	abstract	31179435
of	O	2505	2507	abstract	31179435
efficacy	O	2508	2516	abstract	31179435
was	O	2517	2520	abstract	31179435
86	O	2521	2523	abstract	31179435
%	O	2523	2524	abstract	31179435
.	O	2524	2525	abstract	31179435

We	O	2526	2528	abstract	31179435
find	O	2529	2533	abstract	31179435
that	O	2534	2538	abstract	31179435
more	O	2539	2543	abstract	31179435
than	O	2544	2548	abstract	31179435
half	O	2549	2553	abstract	31179435
of	O	2554	2556	abstract	31179435
the	O	2557	2560	abstract	31179435
studies	O	2561	2568	abstract	31179435
included	O	2569	2577	abstract	31179435
showed	O	2578	2584	abstract	31179435
it	O	2585	2587	abstract	31179435
was	O	2588	2591	abstract	31179435
positive	O	2592	2600	abstract	31179435
to	O	2601	2603	abstract	31179435
treat	O	2604	2609	abstract	31179435
anxiety	B-DDF	2610	2617	abstract	31179435
symptoms	I-DDF	2618	2626	abstract	31179435
by	O	2627	2629	abstract	31179435
regulation	O	2630	2640	abstract	31179435
of	O	2641	2643	abstract	31179435
intestinal	B-microbiome	2644	2654	abstract	31179435
microbiota	I-microbiome	2655	2665	abstract	31179435
.	O	2665	2666	abstract	31179435

There	O	2667	2672	abstract	31179435
are	O	2673	2676	abstract	31179435
two	O	2677	2680	abstract	31179435
kinds	O	2681	2686	abstract	31179435
of	O	2687	2689	abstract	31179435
interventions	O	2690	2703	abstract	31179435
(	O	2704	2705	abstract	31179435
probiotic	O	2705	2714	abstract	31179435
and	O	2715	2718	abstract	31179435
non-probiotic	O	2719	2732	abstract	31179435
interventions	O	2733	2746	abstract	31179435
)	O	2746	2747	abstract	31179435
to	O	2748	2750	abstract	31179435
regulate	O	2751	2759	abstract	31179435
intestinal	B-microbiome	2760	2770	abstract	31179435
microbiota	I-microbiome	2771	2781	abstract	31179435
,	O	2781	2782	abstract	31179435
and	O	2783	2786	abstract	31179435
it	O	2787	2789	abstract	31179435
should	O	2790	2796	abstract	31179435
be	O	2797	2799	abstract	31179435
highlighted	O	2800	2811	abstract	31179435
that	O	2812	2816	abstract	31179435
the	O	2817	2820	abstract	31179435
non-probiotic	O	2821	2834	abstract	31179435
interventions	O	2835	2848	abstract	31179435
were	O	2849	2853	abstract	31179435
more	O	2854	2858	abstract	31179435
effective	O	2859	2868	abstract	31179435
than	O	2869	2873	abstract	31179435
the	O	2874	2877	abstract	31179435
probiotic	O	2878	2887	abstract	31179435
interventions	O	2888	2901	abstract	31179435
.	O	2901	2902	abstract	31179435

More	O	2903	2907	abstract	31179435
studies	O	2908	2915	abstract	31179435
are	O	2916	2919	abstract	31179435
needed	O	2920	2926	abstract	31179435
to	O	2927	2929	abstract	31179435
clarify	O	2930	2937	abstract	31179435
this	O	2938	2942	abstract	31179435
conclusion	O	2943	2953	abstract	31179435
since	O	2954	2959	abstract	31179435
we	O	2960	2962	abstract	31179435
still	O	2963	2968	abstract	31179435
can	O	2969	2972	abstract	31179435
not	O	2972	2975	abstract	31179435
run	O	2976	2979	abstract	31179435
meta-analysis	O	2980	2993	abstract	31179435
so	O	2994	2996	abstract	31179435
far	O	2997	3000	abstract	31179435
.	O	3000	3001	abstract	31179435

Microbiota	O	0	10	title	37995075
Alters	O	11	17	title	37995075
and	O	18	21	title	37995075
Its	O	22	25	title	37995075
Correlation	O	26	37	title	37995075
with	O	38	42	title	37995075
Molecular	O	43	52	title	37995075
Regulation	O	53	63	title	37995075
Underlying	O	64	74	title	37995075
Depression	B-DDF	75	85	title	37995075
in	O	86	88	title	37995075
PCOS	B-human	89	93	title	37995075
Patients	I-human	94	102	title	37995075
.	O	102	103	title	37995075

Depression	B-DDF	0	10	abstract	37995075
is	O	11	13	abstract	37995075
one	O	14	17	abstract	37995075
of	O	18	20	abstract	37995075
the	O	21	24	abstract	37995075
complications	O	25	38	abstract	37995075
in	O	39	41	abstract	37995075
patients	O	42	50	abstract	37995075
with	O	51	55	abstract	37995075
polycystic	B-DDF	56	66	abstract	37995075
ovary	I-DDF	67	72	abstract	37995075
syndrome	I-DDF	73	81	abstract	37995075
(	O	82	83	abstract	37995075
PCOS	B-DDF	83	87	abstract	37995075
)	O	87	88	abstract	37995075
that	O	89	93	abstract	37995075
leads	O	94	99	abstract	37995075
to	O	100	102	abstract	37995075
considerable	O	103	115	abstract	37995075
mental	O	116	122	abstract	37995075
health	O	123	129	abstract	37995075
.	O	129	130	abstract	37995075

Accumulating	O	131	143	abstract	37995075
evidence	O	144	152	abstract	37995075
suggests	O	153	161	abstract	37995075
that	O	162	166	abstract	37995075
human	B-microbiome	167	172	abstract	37995075
gut	I-microbiome	173	176	abstract	37995075
microbiomes	I-microbiome	177	188	abstract	37995075
are	O	189	192	abstract	37995075
associated	O	193	203	abstract	37995075
with	O	204	208	abstract	37995075
the	O	209	212	abstract	37995075
progression	O	213	224	abstract	37995075
of	O	225	227	abstract	37995075
PCOS	B-DDF	228	232	abstract	37995075
and	O	233	236	abstract	37995075
depression	B-DDF	237	247	abstract	37995075
.	O	247	248	abstract	37995075

However	O	249	256	abstract	37995075
,	O	256	257	abstract	37995075
whether	O	258	265	abstract	37995075
microbiota	O	266	276	abstract	37995075
influences	O	277	287	abstract	37995075
depression	O	288	298	abstract	37995075
development	O	299	310	abstract	37995075
in	O	311	313	abstract	37995075
PCOS	B-human	314	318	abstract	37995075
patients	I-human	319	327	abstract	37995075
is	O	328	330	abstract	37995075
still	O	331	336	abstract	37995075
uncharacterized	O	337	352	abstract	37995075
.	O	352	353	abstract	37995075

In	O	354	356	abstract	37995075
this	O	357	361	abstract	37995075
study	O	362	367	abstract	37995075
,	O	367	368	abstract	37995075
we	O	369	371	abstract	37995075
employed	O	372	380	abstract	37995075
metagenomic	B-biomedical%technique	381	392	abstract	37995075
sequencing	I-biomedical%technique	393	403	abstract	37995075
and	O	404	407	abstract	37995075
transcriptome	B-biomedical%technique	408	421	abstract	37995075
sequencing	I-biomedical%technique	422	432	abstract	37995075
(	O	433	434	abstract	37995075
RNA-seq	B-biomedical%technique	434	441	abstract	37995075
)	O	441	442	abstract	37995075
to	O	443	445	abstract	37995075
profile	O	446	453	abstract	37995075
the	O	454	457	abstract	37995075
composition	O	458	469	abstract	37995075
of	O	470	472	abstract	37995075
the	O	473	476	abstract	37995075
fecal	B-microbiome	477	482	abstract	37995075
microbiota	I-microbiome	483	493	abstract	37995075
and	O	494	497	abstract	37995075
gene	O	498	502	abstract	37995075
expression	O	503	513	abstract	37995075
of	O	514	516	abstract	37995075
peripheral	O	517	527	abstract	37995075
blood	O	528	533	abstract	37995075
mononuclear	O	534	545	abstract	37995075
cells	O	546	551	abstract	37995075
in	O	552	554	abstract	37995075
depressed	B-human	555	564	abstract	37995075
women	I-human	565	570	abstract	37995075
with	O	571	575	abstract	37995075
PCOS	B-DDF	576	580	abstract	37995075
(	O	581	582	abstract	37995075
PCOS-DP	B-human	582	589	abstract	37995075
,	O	589	590	abstract	37995075
n	O	591	592	abstract	37995075
	O	592	593	abstract	37995075
=	O	593	594	abstract	37995075
	O	594	595	abstract	37995075
27	O	595	597	abstract	37995075
)	O	597	598	abstract	37995075
in	O	599	601	abstract	37995075
comparison	O	602	612	abstract	37995075
to	O	613	615	abstract	37995075
mentally	B-human	616	624	abstract	37995075
healthy	I-human	625	632	abstract	37995075
women	I-human	633	638	abstract	37995075
with	O	639	643	abstract	37995075
PCOS	B-DDF	644	648	abstract	37995075
(	O	649	650	abstract	37995075
PCOS	B-DDF	650	654	abstract	37995075
,	O	654	655	abstract	37995075
n	O	656	657	abstract	37995075
	O	657	658	abstract	37995075
=	O	658	659	abstract	37995075
	O	659	660	abstract	37995075
18	O	660	662	abstract	37995075
)	O	662	663	abstract	37995075
and	O	664	667	abstract	37995075
compared	O	668	676	abstract	37995075
with	O	677	681	abstract	37995075
healthy	B-human	682	689	abstract	37995075
control	I-human	690	697	abstract	37995075
(	O	698	699	abstract	37995075
HC	O	699	701	abstract	37995075
,	O	701	702	abstract	37995075
n	O	703	704	abstract	37995075
	O	704	705	abstract	37995075
=	O	705	706	abstract	37995075
	O	706	707	abstract	37995075
27	O	707	709	abstract	37995075
)	O	709	710	abstract	37995075
and	O	711	714	abstract	37995075
patients	B-human	715	723	abstract	37995075
with	O	724	728	abstract	37995075
major	B-DDF	729	734	abstract	37995075
depressive	I-DDF	735	745	abstract	37995075
disorder	I-DDF	746	754	abstract	37995075
(	O	755	756	abstract	37995075
MDD	B-DDF	756	759	abstract	37995075
,	O	759	760	abstract	37995075
n	O	761	762	abstract	37995075
	O	762	763	abstract	37995075
=	O	763	764	abstract	37995075
	O	764	765	abstract	37995075
29	O	765	767	abstract	37995075
)	O	767	768	abstract	37995075
.	O	768	769	abstract	37995075

Gut	O	770	773	abstract	37995075
microbiota	O	774	784	abstract	37995075
assessment	O	785	795	abstract	37995075
revealed	O	796	804	abstract	37995075
distinct	O	805	813	abstract	37995075
patterns	O	814	822	abstract	37995075
in	O	823	825	abstract	37995075
the	O	826	829	abstract	37995075
relative	O	830	838	abstract	37995075
abundance	O	839	848	abstract	37995075
in	O	849	851	abstract	37995075
the	O	852	855	abstract	37995075
PCOS-DP	B-human	856	863	abstract	37995075
compared	O	864	872	abstract	37995075
to	O	873	875	abstract	37995075
HC	B-human	876	878	abstract	37995075
,	I-human	878	879	abstract	37995075
MDD	I-human	880	883	abstract	37995075
,	I-human	883	884	abstract	37995075
and	I-human	885	888	abstract	37995075
PCOS	I-human	889	893	abstract	37995075
groups	I-human	894	900	abstract	37995075
.	O	900	901	abstract	37995075

Several	O	902	909	abstract	37995075
gut	O	910	913	abstract	37995075
microbes	O	914	922	abstract	37995075
exhibited	O	923	932	abstract	37995075
uniquely	O	933	941	abstract	37995075
and	O	942	945	abstract	37995075
significantly	O	946	959	abstract	37995075
higher	O	960	966	abstract	37995075
abundance	O	967	976	abstract	37995075
in	O	977	979	abstract	37995075
the	O	980	983	abstract	37995075
PCOS-DP	B-human	984	991	abstract	37995075
compared	O	992	1000	abstract	37995075
to	O	1001	1003	abstract	37995075
PCOS	B-human	1004	1008	abstract	37995075
patients	I-human	1009	1017	abstract	37995075
,	O	1017	1018	abstract	37995075
inducing	O	1019	1027	abstract	37995075
EC	B-bacteria	1028	1030	abstract	37995075
Ruminococcus	I-bacteria	1031	1043	abstract	37995075
torques	I-bacteria	1044	1051	abstract	37995075
,	O	1051	1052	abstract	37995075
Coprococcus	B-bacteria	1053	1064	abstract	37995075
comes	I-bacteria	1065	1070	abstract	37995075
,	O	1070	1071	abstract	37995075
Megasphaera	B-bacteria	1072	1083	abstract	37995075
elsdenii	I-bacteria	1084	1092	abstract	37995075
,	O	1092	1093	abstract	37995075
Acidaminococcus	B-bacteria	1094	1109	abstract	37995075
intestini	I-bacteria	1110	1119	abstract	37995075
,	O	1119	1120	abstract	37995075
and	O	1121	1124	abstract	37995075
Barnesiella	B-bacteria	1125	1136	abstract	37995075
viscericola	I-bacteria	1137	1148	abstract	37995075
.	O	1148	1149	abstract	37995075

Bacteroides	B-bacteria	1150	1161	abstract	37995075
eggerthii	I-bacteria	1162	1171	abstract	37995075
was	O	1172	1175	abstract	37995075
a	O	1176	1177	abstract	37995075
potential	O	1178	1187	abstract	37995075
gut	O	1188	1191	abstract	37995075
microbial	O	1192	1201	abstract	37995075
biomarker	O	1202	1211	abstract	37995075
for	O	1212	1215	abstract	37995075
the	O	1216	1219	abstract	37995075
PCOS-DP	B-human	1220	1227	abstract	37995075
.	O	1227	1228	abstract	37995075

RNA-seq	B-biomedical%technique	1229	1236	abstract	37995075
profiling	I-biomedical%technique	1237	1246	abstract	37995075
identified	O	1247	1257	abstract	37995075
that	O	1258	1262	abstract	37995075
35	O	1263	1265	abstract	37995075
and	O	1266	1269	abstract	37995075
37	O	1270	1272	abstract	37995075
genes	O	1273	1278	abstract	37995075
were	O	1279	1283	abstract	37995075
significantly	O	1284	1297	abstract	37995075
elevated	O	1298	1306	abstract	37995075
and	O	1307	1310	abstract	37995075
downregulated	O	1311	1324	abstract	37995075
in	O	1325	1327	abstract	37995075
the	O	1328	1331	abstract	37995075
PCOS-DP	B-human	1332	1339	abstract	37995075
,	O	1339	1340	abstract	37995075
respectively	O	1341	1353	abstract	37995075
.	O	1353	1354	abstract	37995075

The	O	1355	1358	abstract	37995075
enhanced	O	1359	1367	abstract	37995075
differential	B-gene	1368	1380	abstract	37995075
expressed	I-gene	1381	1390	abstract	37995075
genes	I-gene	1391	1396	abstract	37995075
(	O	1397	1398	abstract	37995075
DEGs	B-gene	1398	1402	abstract	37995075
)	O	1402	1403	abstract	37995075
in	O	1404	1406	abstract	37995075
the	O	1407	1410	abstract	37995075
PCOS-DP	B-human	1411	1418	abstract	37995075
were	O	1419	1423	abstract	37995075
enriched	O	1424	1432	abstract	37995075
in	O	1433	1435	abstract	37995075
pathways	O	1436	1444	abstract	37995075
involved	O	1445	1453	abstract	37995075
in	O	1454	1456	abstract	37995075
signal	O	1457	1463	abstract	37995075
transduction	O	1464	1476	abstract	37995075
and	O	1477	1480	abstract	37995075
endocrine	B-DDF	1481	1490	abstract	37995075
and	I-DDF	1491	1494	abstract	37995075
metabolic	I-DDF	1495	1504	abstract	37995075
diseases	I-DDF	1505	1513	abstract	37995075
,	O	1513	1514	abstract	37995075
whereas	O	1515	1522	abstract	37995075
several	O	1523	1530	abstract	37995075
lipid	O	1531	1536	abstract	37995075
metabolism	O	1537	1547	abstract	37995075
pathways	O	1548	1556	abstract	37995075
were	O	1557	1561	abstract	37995075
downregulated	O	1562	1575	abstract	37995075
.	O	1575	1576	abstract	37995075

Intriguingly	O	1577	1589	abstract	37995075
,	O	1589	1590	abstract	37995075
genes	O	1591	1596	abstract	37995075
correlated	O	1597	1607	abstract	37995075
with	O	1608	1612	abstract	37995075
the	O	1613	1616	abstract	37995075
gut	B-microbiome	1617	1620	abstract	37995075
microbiota	I-microbiome	1621	1631	abstract	37995075
were	O	1632	1636	abstract	37995075
found	O	1637	1642	abstract	37995075
to	O	1643	1645	abstract	37995075
be	O	1646	1648	abstract	37995075
significantly	O	1649	1662	abstract	37995075
enriched	O	1663	1671	abstract	37995075
in	O	1672	1674	abstract	37995075
pathways	O	1675	1683	abstract	37995075
of	O	1684	1686	abstract	37995075
neurodegenerative	B-DDF	1687	1704	abstract	37995075
diseases	I-DDF	1705	1713	abstract	37995075
and	O	1714	1717	abstract	37995075
the	O	1718	1721	abstract	37995075
immune	O	1722	1728	abstract	37995075
system	O	1729	1735	abstract	37995075
,	O	1735	1736	abstract	37995075
suggesting	O	1737	1747	abstract	37995075
that	O	1748	1752	abstract	37995075
changes	O	1753	1760	abstract	37995075
in	O	1761	1763	abstract	37995075
the	O	1764	1767	abstract	37995075
microbiota	O	1768	1778	abstract	37995075
may	O	1779	1782	abstract	37995075
have	O	1783	1787	abstract	37995075
a	O	1788	1789	abstract	37995075
systemic	O	1790	1798	abstract	37995075
impact	O	1799	1805	abstract	37995075
on	O	1806	1808	abstract	37995075
the	O	1809	1812	abstract	37995075
expression	O	1813	1823	abstract	37995075
of	O	1824	1826	abstract	37995075
neurodegenerative	B-DDF	1827	1844	abstract	37995075
diseases	I-DDF	1845	1853	abstract	37995075
and	O	1854	1857	abstract	37995075
immune	O	1858	1864	abstract	37995075
genes	O	1865	1870	abstract	37995075
.	O	1870	1871	abstract	37995075

Gut	B-gene	1872	1875	abstract	37995075
microbe-related	I-gene	1876	1891	abstract	37995075
DEGs	I-gene	1892	1896	abstract	37995075
of	O	1897	1899	abstract	37995075
CREB3L3	B-gene	1900	1907	abstract	37995075
and	O	1908	1911	abstract	37995075
CCDC173	B-gene	1912	1919	abstract	37995075
were	O	1920	1924	abstract	37995075
possible	O	1925	1933	abstract	37995075
molecular	O	1934	1943	abstract	37995075
biomarkers	O	1944	1954	abstract	37995075
and	O	1955	1958	abstract	37995075
therapeutic	O	1959	1970	abstract	37995075
targets	O	1971	1978	abstract	37995075
of	O	1979	1981	abstract	37995075
women	O	1982	1987	abstract	37995075
with	O	1988	1992	abstract	37995075
PCOS-DP	O	1993	2000	abstract	37995075
.	O	2000	2001	abstract	37995075

Our	O	2002	2005	abstract	37995075
multi-omics	O	2006	2017	abstract	37995075
data	O	2018	2022	abstract	37995075
indicate	O	2023	2031	abstract	37995075
shifts	O	2032	2038	abstract	37995075
in	O	2039	2041	abstract	37995075
the	O	2042	2045	abstract	37995075
gut	O	2046	2049	abstract	37995075
microbiome	O	2050	2060	abstract	37995075
and	O	2061	2064	abstract	37995075
host	O	2065	2069	abstract	37995075
gene	O	2070	2074	abstract	37995075
regulation	O	2075	2085	abstract	37995075
in	O	2086	2088	abstract	37995075
PCOS	B-human	2089	2093	abstract	37995075
patients	I-human	2094	2102	abstract	37995075
with	O	2103	2107	abstract	37995075
depression	B-DDF	2108	2118	abstract	37995075
,	O	2118	2119	abstract	37995075
which	O	2120	2125	abstract	37995075
is	O	2126	2128	abstract	37995075
of	O	2129	2131	abstract	37995075
possible	O	2132	2140	abstract	37995075
etiological	O	2141	2152	abstract	37995075
and	O	2153	2156	abstract	37995075
diagnostic	O	2157	2167	abstract	37995075
importance	O	2168	2178	abstract	37995075
.	O	2178	2179	abstract	37995075

Hydrogen	B-chemical	0	8	title	35326429
Sulfide	I-chemical	9	16	title	35326429
Produced	O	17	25	title	35326429
by	O	26	28	title	35326429
Gut	B-bacteria	29	32	title	35326429
Bacteria	I-bacteria	33	41	title	35326429
May	O	42	45	title	35326429
Induce	O	46	52	title	35326429
Parkinson	B-DDF	53	62	title	35326429
's	I-DDF	62	64	title	35326429
Disease	I-DDF	65	72	title	35326429
.	O	72	73	title	35326429

Several	O	0	7	abstract	35326429
bacterial	O	8	17	abstract	35326429
species	O	18	25	abstract	35326429
can	O	26	29	abstract	35326429
generate	O	30	38	abstract	35326429
hydrogen	B-chemical	39	47	abstract	35326429
sulfide	I-chemical	48	55	abstract	35326429
(	O	56	57	abstract	35326429
H	B-chemical	57	58	abstract	35326429
<	I-chemical	58	59	abstract	35326429
sub>2</sub	I-chemical	59	69	abstract	35326429
>	I-chemical	69	70	abstract	35326429
S	I-chemical	70	71	abstract	35326429
)	O	71	72	abstract	35326429
.	O	72	73	abstract	35326429

Study	O	74	79	abstract	35326429
evidence	O	80	88	abstract	35326429
favors	O	89	95	abstract	35326429
the	O	96	99	abstract	35326429
view	O	100	104	abstract	35326429
that	O	105	109	abstract	35326429
the	O	110	113	abstract	35326429
microbiome	O	114	124	abstract	35326429
of	O	125	127	abstract	35326429
the	O	128	131	abstract	35326429
colon	B-anatomical%location	132	137	abstract	35326429
harbors	O	138	145	abstract	35326429
increased	O	146	155	abstract	35326429
amounts	O	156	163	abstract	35326429
of	O	164	166	abstract	35326429
H	B-chemical	167	168	abstract	35326429
<	I-chemical	168	169	abstract	35326429
sub>2</sub	I-chemical	169	179	abstract	35326429
>	I-chemical	179	180	abstract	35326429
S	I-chemical	180	181	abstract	35326429
producing	O	182	191	abstract	35326429
bacteria	O	192	200	abstract	35326429
in	O	201	203	abstract	35326429
Parkinson	B-DDF	204	213	abstract	35326429
's	I-DDF	213	215	abstract	35326429
disease	I-DDF	216	223	abstract	35326429
.	O	223	224	abstract	35326429

Additionally	O	225	237	abstract	35326429
,	O	237	238	abstract	35326429
H	B-chemical	239	240	abstract	35326429
<	I-chemical	240	241	abstract	35326429
sub>2</sub	I-chemical	241	251	abstract	35326429
>	I-chemical	251	252	abstract	35326429
S	I-chemical	252	253	abstract	35326429
can	O	254	257	abstract	35326429
easily	O	258	264	abstract	35326429
penetrate	O	265	274	abstract	35326429
cell	O	275	279	abstract	35326429
membranes	O	280	289	abstract	35326429
and	O	290	293	abstract	35326429
enter	O	294	299	abstract	35326429
the	O	300	303	abstract	35326429
cell	O	304	308	abstract	35326429
interior	O	309	317	abstract	35326429
.	O	317	318	abstract	35326429

In	O	319	321	abstract	35326429
the	O	322	325	abstract	35326429
cells	O	326	331	abstract	35326429
,	O	331	332	abstract	35326429
excessive	O	333	342	abstract	35326429
amounts	O	343	350	abstract	35326429
of	O	351	353	abstract	35326429
H	B-chemical	354	355	abstract	35326429
<	I-chemical	355	356	abstract	35326429
sub>2</sub	I-chemical	356	366	abstract	35326429
>	I-chemical	366	367	abstract	35326429
S	I-chemical	367	368	abstract	35326429
can	O	369	372	abstract	35326429
potentially	O	373	384	abstract	35326429
release	O	385	392	abstract	35326429
cytochrome	B-chemical	393	403	abstract	35326429
c	I-chemical	404	405	abstract	35326429
protein	I-chemical	406	413	abstract	35326429
from	O	414	418	abstract	35326429
the	O	419	422	abstract	35326429
mitochondria	O	423	435	abstract	35326429
,	O	435	436	abstract	35326429
increase	O	437	445	abstract	35326429
the	O	446	449	abstract	35326429
iron	O	450	454	abstract	35326429
content	O	455	462	abstract	35326429
of	O	463	465	abstract	35326429
the	O	466	469	abstract	35326429
cytosolic	O	470	479	abstract	35326429
iron	O	480	484	abstract	35326429
pool	O	485	489	abstract	35326429
,	O	489	490	abstract	35326429
and	O	491	494	abstract	35326429
increase	O	495	503	abstract	35326429
the	O	504	507	abstract	35326429
amount	O	508	514	abstract	35326429
of	O	515	517	abstract	35326429
reactive	B-chemical	518	526	abstract	35326429
oxygen	I-chemical	527	533	abstract	35326429
species	I-chemical	534	541	abstract	35326429
.	O	541	542	abstract	35326429

These	O	543	548	abstract	35326429
events	O	549	555	abstract	35326429
can	O	556	559	abstract	35326429
lead	O	560	564	abstract	35326429
to	O	565	567	abstract	35326429
the	O	568	571	abstract	35326429
formation	O	572	581	abstract	35326429
of	O	582	584	abstract	35326429
alpha-synuclein	B-chemical	585	600	abstract	35326429
oligomers	I-chemical	601	610	abstract	35326429
and	O	611	614	abstract	35326429
fibrils	O	615	622	abstract	35326429
in	O	623	625	abstract	35326429
cells	O	626	631	abstract	35326429
containing	O	632	642	abstract	35326429
the	O	643	646	abstract	35326429
alpha-synuclein	B-chemical	647	662	abstract	35326429
protein	I-chemical	663	670	abstract	35326429
.	O	670	671	abstract	35326429

In	O	672	674	abstract	35326429
addition	O	675	683	abstract	35326429
,	O	683	684	abstract	35326429
bacterially	O	685	696	abstract	35326429
produced	O	697	705	abstract	35326429
H	B-chemical	706	707	abstract	35326429
<	I-chemical	707	708	abstract	35326429
sub>2</sub	I-chemical	708	718	abstract	35326429
>	I-chemical	718	719	abstract	35326429
S	I-chemical	719	720	abstract	35326429
can	O	721	724	abstract	35326429
interfere	O	725	734	abstract	35326429
with	O	735	739	abstract	35326429
the	O	740	743	abstract	35326429
body	O	744	748	abstract	35326429
urate	O	749	754	abstract	35326429
metabolism	O	755	765	abstract	35326429
and	O	766	769	abstract	35326429
affect	O	770	776	abstract	35326429
the	O	777	780	abstract	35326429
blood	B-chemical	781	786	abstract	35326429
erythrocytes	I-chemical	787	799	abstract	35326429
and	I-chemical	800	803	abstract	35326429
lymphocytes	I-chemical	804	815	abstract	35326429
.	O	815	816	abstract	35326429

Gut	B-bacteria	817	820	abstract	35326429
bacteria	I-bacteria	821	829	abstract	35326429
responsible	O	830	841	abstract	35326429
for	O	842	845	abstract	35326429
increased	O	846	855	abstract	35326429
H	O	856	857	abstract	35326429
<	O	857	858	abstract	35326429
sub>2</sub	O	858	868	abstract	35326429
>	O	868	869	abstract	35326429
S	O	869	870	abstract	35326429
production	O	871	881	abstract	35326429
,	O	881	882	abstract	35326429
especially	O	883	893	abstract	35326429
the	O	894	897	abstract	35326429
mucus-associated	B-bacteria	898	914	abstract	35326429
species	I-bacteria	915	922	abstract	35326429
of	O	923	925	abstract	35326429
the	O	926	929	abstract	35326429
bacterial	O	930	939	abstract	35326429
genera	O	940	946	abstract	35326429
belonging	O	947	956	abstract	35326429
to	O	957	959	abstract	35326429
the	O	960	963	abstract	35326429
Desulfovibrionaceae	B-bacteria	964	983	abstract	35326429
and	O	984	987	abstract	35326429
Enterobacteriaceae	B-bacteria	988	1006	abstract	35326429
families	O	1007	1015	abstract	35326429
,	O	1015	1016	abstract	35326429
are	O	1017	1020	abstract	35326429
likely	O	1021	1027	abstract	35326429
play	O	1028	1032	abstract	35326429
a	O	1033	1034	abstract	35326429
role	O	1035	1039	abstract	35326429
in	O	1040	1042	abstract	35326429
the	O	1043	1046	abstract	35326429
pathogenesis	O	1047	1059	abstract	35326429
of	O	1060	1062	abstract	35326429
Parkinson	B-DDF	1063	1072	abstract	35326429
's	I-DDF	1072	1074	abstract	35326429
disease	I-DDF	1075	1082	abstract	35326429
.	O	1082	1083	abstract	35326429

Special	O	1084	1091	abstract	35326429
attention	O	1092	1101	abstract	35326429
should	O	1102	1108	abstract	35326429
be	O	1109	1111	abstract	35326429
devoted	O	1112	1119	abstract	35326429
to	O	1120	1122	abstract	35326429
changes	O	1123	1130	abstract	35326429
not	O	1131	1134	abstract	35326429
only	O	1135	1139	abstract	35326429
in	O	1140	1142	abstract	35326429
the	O	1143	1146	abstract	35326429
colonic	O	1147	1154	abstract	35326429
but	O	1155	1158	abstract	35326429
also	O	1159	1163	abstract	35326429
in	O	1164	1166	abstract	35326429
the	O	1167	1170	abstract	35326429
duodenal	B-microbiome	1171	1179	abstract	35326429
microbiome	I-microbiome	1180	1190	abstract	35326429
composition	O	1191	1202	abstract	35326429
with	O	1203	1207	abstract	35326429
regard	O	1208	1214	abstract	35326429
to	O	1215	1217	abstract	35326429
the	O	1218	1221	abstract	35326429
pathogenesis	O	1222	1234	abstract	35326429
of	O	1235	1237	abstract	35326429
Parkinson	B-DDF	1238	1247	abstract	35326429
's	I-DDF	1247	1249	abstract	35326429
disease	I-DDF	1250	1257	abstract	35326429
.	O	1257	1258	abstract	35326429

Influenza	B-DDF	1259	1268	abstract	35326429
infections	I-DDF	1269	1279	abstract	35326429
may	O	1280	1283	abstract	35326429
increase	O	1284	1292	abstract	35326429
the	O	1293	1296	abstract	35326429
risk	O	1297	1301	abstract	35326429
of	O	1302	1304	abstract	35326429
Parkinson	B-DDF	1305	1314	abstract	35326429
's	I-DDF	1314	1316	abstract	35326429
disease	I-DDF	1317	1324	abstract	35326429
by	O	1325	1327	abstract	35326429
causing	O	1328	1335	abstract	35326429
the	O	1336	1339	abstract	35326429
overgrowth	O	1340	1350	abstract	35326429
of	O	1351	1353	abstract	35326429
H	O	1354	1355	abstract	35326429
<	O	1355	1356	abstract	35326429
sub>2</sub	O	1356	1366	abstract	35326429
>	O	1366	1367	abstract	35326429
S-producing	O	1367	1378	abstract	35326429
bacteria	O	1379	1387	abstract	35326429
both	O	1388	1392	abstract	35326429
in	O	1393	1395	abstract	35326429
the	O	1396	1399	abstract	35326429
colon	B-anatomical%location	1400	1405	abstract	35326429
and	O	1406	1409	abstract	35326429
duodenum	B-anatomical%location	1410	1418	abstract	35326429
.	O	1418	1419	abstract	35326429

A	O	0	1	title	31083360
Systematic	O	2	12	title	31083360
Review	O	13	19	title	31083360
of	O	20	22	title	31083360
the	O	23	26	title	31083360
Role	O	27	31	title	31083360
of	O	32	34	title	31083360
Prebiotics	B-dietary%supplement	35	45	title	31083360
and	O	46	49	title	31083360
Probiotics	B-dietary%supplement	50	60	title	31083360
in	O	61	63	title	31083360
Autism	B-DDF	64	70	title	31083360
Spectrum	I-DDF	71	79	title	31083360
Disorders	I-DDF	80	89	title	31083360
.	O	89	90	title	31083360

<	O	0	1	abstract	31083360
i	O	1	2	abstract	31083360
>	O	2	3	abstract	31083360
Background</i	O	3	16	abstract	31083360
>	O	16	17	abstract	31083360
:	O	17	18	abstract	31083360
Autism	B-DDF	19	25	abstract	31083360
spectrum	I-DDF	26	34	abstract	31083360
disorder	I-DDF	35	43	abstract	31083360
(	O	44	45	abstract	31083360
ASD	B-DDF	45	48	abstract	31083360
)	O	48	49	abstract	31083360
is	O	50	52	abstract	31083360
a	O	53	54	abstract	31083360
complex	O	55	62	abstract	31083360
developmental	O	63	76	abstract	31083360
condition	O	77	86	abstract	31083360
typically	O	87	96	abstract	31083360
characterized	O	97	110	abstract	31083360
by	O	111	113	abstract	31083360
deficits	O	114	122	abstract	31083360
in	O	123	125	abstract	31083360
social	O	126	132	abstract	31083360
and	O	133	136	abstract	31083360
communicative	O	137	150	abstract	31083360
behaviors	O	151	160	abstract	31083360
as	O	161	163	abstract	31083360
well	O	164	168	abstract	31083360
as	O	169	171	abstract	31083360
repetitive	O	172	182	abstract	31083360
patterns	O	183	191	abstract	31083360
of	O	192	194	abstract	31083360
behaviors	O	195	204	abstract	31083360
.	O	204	205	abstract	31083360

Despite	O	206	213	abstract	31083360
its	O	214	217	abstract	31083360
prevalence	O	218	228	abstract	31083360
(	O	229	230	abstract	31083360
affecting	O	230	239	abstract	31083360
0.1	O	240	243	abstract	31083360
%	O	243	244	abstract	31083360
to	O	245	247	abstract	31083360
1.8	O	248	251	abstract	31083360
%	O	251	252	abstract	31083360
of	O	253	255	abstract	31083360
the	O	256	259	abstract	31083360
global	O	260	266	abstract	31083360
population	O	267	277	abstract	31083360
)	O	277	278	abstract	31083360
,	O	278	279	abstract	31083360
the	O	280	283	abstract	31083360
pathogenesis	O	284	296	abstract	31083360
of	O	297	299	abstract	31083360
ASD	B-DDF	300	303	abstract	31083360
remains	O	304	311	abstract	31083360
incompletely	O	312	324	abstract	31083360
understood	O	325	335	abstract	31083360
.	O	335	336	abstract	31083360

Patients	B-human	337	345	abstract	31083360
with	O	346	350	abstract	31083360
ASD	B-DDF	351	354	abstract	31083360
are	O	355	358	abstract	31083360
reported	O	359	367	abstract	31083360
to	O	368	370	abstract	31083360
have	O	371	375	abstract	31083360
more	O	376	380	abstract	31083360
frequent	O	381	389	abstract	31083360
gastrointestinal	O	390	406	abstract	31083360
(	O	407	408	abstract	31083360
GI	O	408	410	abstract	31083360
)	O	410	411	abstract	31083360
complaints	O	412	422	abstract	31083360
.	O	422	423	abstract	31083360

There	O	424	429	abstract	31083360
is	O	430	432	abstract	31083360
some	O	433	437	abstract	31083360
anecdotal	O	438	447	abstract	31083360
evidence	O	448	456	abstract	31083360
that	O	457	461	abstract	31083360
probiotics	B-dietary%supplement	462	472	abstract	31083360
are	O	473	476	abstract	31083360
able	O	477	481	abstract	31083360
to	O	482	484	abstract	31083360
alleviate	O	485	494	abstract	31083360
GI	B-DDF	495	497	abstract	31083360
symptoms	I-DDF	498	506	abstract	31083360
as	O	507	509	abstract	31083360
well	O	510	514	abstract	31083360
as	O	515	517	abstract	31083360
improve	O	518	525	abstract	31083360
behavioral	O	526	536	abstract	31083360
issues	O	537	543	abstract	31083360
in	O	544	546	abstract	31083360
children	B-human	547	555	abstract	31083360
with	O	556	560	abstract	31083360
ASD	B-DDF	561	564	abstract	31083360
.	O	564	565	abstract	31083360

However	O	566	573	abstract	31083360
,	O	573	574	abstract	31083360
systematic	O	575	585	abstract	31083360
reviews	O	586	593	abstract	31083360
of	O	594	596	abstract	31083360
the	O	597	600	abstract	31083360
effect	O	601	607	abstract	31083360
of	O	608	610	abstract	31083360
prebiotics/probiotics	B-dietary%supplement	611	632	abstract	31083360
on	O	633	635	abstract	31083360
ASD	B-DDF	636	639	abstract	31083360
and	O	640	643	abstract	31083360
its	O	644	647	abstract	31083360
associated	O	648	658	abstract	31083360
symptoms	O	659	667	abstract	31083360
are	O	668	671	abstract	31083360
lacking	O	672	679	abstract	31083360
.	O	679	680	abstract	31083360
<	O	681	682	abstract	31083360
i	O	682	683	abstract	31083360
>	O	683	684	abstract	31083360
Methods</i	O	684	694	abstract	31083360
>	O	694	695	abstract	31083360
:	O	695	696	abstract	31083360
Using	O	697	702	abstract	31083360
the	O	703	706	abstract	31083360
keywords	O	707	715	abstract	31083360
(	O	716	717	abstract	31083360
prebiotics	B-dietary%supplement	717	727	abstract	31083360
OR	O	728	730	abstract	31083360
probiotics	B-dietary%supplement	731	741	abstract	31083360
OR	O	742	744	abstract	31083360
microbiota	B-microbiome	745	755	abstract	31083360
OR	O	756	758	abstract	31083360
gut	B-anatomical%location	759	762	abstract	31083360
)	O	762	763	abstract	31083360
AND	O	764	767	abstract	31083360
(	O	768	769	abstract	31083360
autism	B-DDF	769	775	abstract	31083360
OR	O	776	778	abstract	31083360
social	O	779	785	abstract	31083360
OR	O	786	788	abstract	31083360
ASD	B-DDF	789	792	abstract	31083360
)	O	792	793	abstract	31083360
,	O	793	794	abstract	31083360
a	O	795	796	abstract	31083360
systematic	O	797	807	abstract	31083360
literature	O	808	818	abstract	31083360
search	O	819	825	abstract	31083360
was	O	826	829	abstract	31083360
conducted	O	830	839	abstract	31083360
on	O	840	842	abstract	31083360
PubMed	O	843	849	abstract	31083360
,	O	849	850	abstract	31083360
EMBASE	O	851	857	abstract	31083360
,	O	857	858	abstract	31083360
Medline	O	859	866	abstract	31083360
,	O	866	867	abstract	31083360
Clinicaltrials.gov	O	868	886	abstract	31083360
and	O	887	890	abstract	31083360
Google	O	891	897	abstract	31083360
Scholar	O	898	905	abstract	31083360
databases	O	906	915	abstract	31083360
.	O	915	916	abstract	31083360

The	O	917	920	abstract	31083360
inclusion	O	921	930	abstract	31083360
criteria	O	931	939	abstract	31083360
were	O	940	944	abstract	31083360
original	O	945	953	abstract	31083360
clinical	O	954	962	abstract	31083360
trials	O	963	969	abstract	31083360
,	O	969	970	abstract	31083360
published	O	971	980	abstract	31083360
in	O	981	983	abstract	31083360
English	O	984	991	abstract	31083360
between	O	992	999	abstract	31083360
the	O	1000	1003	abstract	31083360
period	O	1004	1010	abstract	31083360
1st	O	1011	1014	abstract	31083360
January	O	1015	1022	abstract	31083360
1988	O	1023	1027	abstract	31083360
and	O	1028	1031	abstract	31083360
1st	O	1032	1035	abstract	31083360
February	O	1036	1044	abstract	31083360
2019	O	1045	1049	abstract	31083360
.	O	1049	1050	abstract	31083360
<	O	1051	1052	abstract	31083360
i	O	1052	1053	abstract	31083360
>	O	1053	1054	abstract	31083360
Results</i	O	1054	1064	abstract	31083360
>	O	1064	1065	abstract	31083360
:	O	1065	1066	abstract	31083360
A	O	1067	1068	abstract	31083360
total	O	1069	1074	abstract	31083360
of	O	1075	1077	abstract	31083360
eight	O	1078	1083	abstract	31083360
clinical	O	1084	1092	abstract	31083360
trials	O	1093	1099	abstract	31083360
were	O	1100	1104	abstract	31083360
systematically	O	1105	1119	abstract	31083360
reviewed	O	1120	1128	abstract	31083360
.	O	1128	1129	abstract	31083360

Two	O	1130	1133	abstract	31083360
clinical	O	1134	1142	abstract	31083360
trials	O	1143	1149	abstract	31083360
examined	O	1150	1158	abstract	31083360
the	O	1159	1162	abstract	31083360
use	O	1163	1166	abstract	31083360
of	O	1167	1169	abstract	31083360
prebiotic	O	1170	1179	abstract	31083360
and/or	O	1180	1186	abstract	31083360
diet	O	1187	1191	abstract	31083360
exclusion	O	1192	1201	abstract	31083360
while	O	1202	1207	abstract	31083360
six	O	1208	1211	abstract	31083360
involved	O	1212	1220	abstract	31083360
the	O	1221	1224	abstract	31083360
use	O	1225	1228	abstract	31083360
of	O	1229	1231	abstract	31083360
probiotic	O	1232	1241	abstract	31083360
supplementation	O	1242	1257	abstract	31083360
in	O	1258	1260	abstract	31083360
children	B-human	1261	1269	abstract	31083360
with	O	1270	1274	abstract	31083360
ASD	B-DDF	1275	1278	abstract	31083360
.	O	1278	1279	abstract	31083360

Most	O	1280	1284	abstract	31083360
of	O	1285	1287	abstract	31083360
these	O	1288	1293	abstract	31083360
were	O	1294	1298	abstract	31083360
prospective	O	1299	1310	abstract	31083360
,	O	1310	1311	abstract	31083360
open-label	O	1312	1322	abstract	31083360
studies	O	1323	1330	abstract	31083360
.	O	1330	1331	abstract	31083360

Prebiotics	B-dietary%supplement	1332	1342	abstract	31083360
only	O	1343	1347	abstract	31083360
improved	O	1348	1356	abstract	31083360
certain	O	1357	1364	abstract	31083360
GI	B-DDF	1365	1367	abstract	31083360
symptoms	I-DDF	1368	1376	abstract	31083360
;	O	1376	1377	abstract	31083360
however	O	1378	1385	abstract	31083360
,	O	1385	1386	abstract	31083360
when	O	1387	1391	abstract	31083360
combined	O	1392	1400	abstract	31083360
with	O	1401	1405	abstract	31083360
an	O	1406	1408	abstract	31083360
exclusion	O	1409	1418	abstract	31083360
diet	O	1419	1423	abstract	31083360
(	O	1424	1425	abstract	31083360
gluten	B-dietary%supplement	1425	1431	abstract	31083360
and	O	1432	1435	abstract	31083360
casein	B-dietary%supplement	1436	1442	abstract	31083360
free	O	1443	1447	abstract	31083360
)	O	1447	1448	abstract	31083360
showed	O	1449	1455	abstract	31083360
a	O	1456	1457	abstract	31083360
significant	O	1458	1469	abstract	31083360
reduction	O	1470	1479	abstract	31083360
in	O	1480	1482	abstract	31083360
anti-sociability	O	1483	1499	abstract	31083360
scores	O	1500	1506	abstract	31083360
.	O	1506	1507	abstract	31083360

As	O	1508	1510	abstract	31083360
for	O	1511	1514	abstract	31083360
probiotics	B-dietary%supplement	1515	1525	abstract	31083360
,	O	1525	1526	abstract	31083360
there	O	1527	1532	abstract	31083360
is	O	1533	1535	abstract	31083360
limited	O	1536	1543	abstract	31083360
evidence	O	1544	1552	abstract	31083360
to	O	1553	1555	abstract	31083360
support	O	1556	1563	abstract	31083360
the	O	1564	1567	abstract	31083360
role	O	1568	1572	abstract	31083360
of	O	1573	1575	abstract	31083360
probiotics	B-dietary%supplement	1576	1586	abstract	31083360
in	O	1587	1589	abstract	31083360
alleviating	O	1590	1601	abstract	31083360
the	O	1602	1605	abstract	31083360
GI	O	1606	1608	abstract	31083360
or	O	1609	1611	abstract	31083360
behavioral	O	1612	1622	abstract	31083360
symptoms	O	1623	1631	abstract	31083360
in	O	1632	1634	abstract	31083360
children	B-human	1635	1643	abstract	31083360
with	O	1644	1648	abstract	31083360
ASD	B-DDF	1649	1652	abstract	31083360
.	O	1652	1653	abstract	31083360

The	O	1654	1657	abstract	31083360
two	O	1658	1661	abstract	31083360
available	O	1662	1671	abstract	31083360
double-blind	B-biomedical%technique	1672	1684	abstract	31083360
,	I-biomedical%technique	1684	1685	abstract	31083360
randomized	I-biomedical%technique	1686	1696	abstract	31083360
,	I-biomedical%technique	1696	1697	abstract	31083360
placebo-controlled	I-biomedical%technique	1698	1716	abstract	31083360
trials	I-biomedical%technique	1717	1723	abstract	31083360
found	O	1724	1729	abstract	31083360
no	O	1730	1732	abstract	31083360
significant	O	1733	1744	abstract	31083360
difference	O	1745	1755	abstract	31083360
in	O	1756	1758	abstract	31083360
GI	B-DDF	1759	1761	abstract	31083360
symptoms	I-DDF	1762	1770	abstract	31083360
and	O	1771	1774	abstract	31083360
behavior	O	1775	1783	abstract	31083360
.	O	1783	1784	abstract	31083360

<	O	1785	1786	abstract	31083360
i	O	1786	1787	abstract	31083360
>	O	1787	1788	abstract	31083360
Conclusion</i	O	1788	1801	abstract	31083360
>	O	1801	1802	abstract	31083360
:	O	1802	1803	abstract	31083360
Despite	O	1804	1811	abstract	31083360
promising	O	1812	1821	abstract	31083360
preclinical	O	1822	1833	abstract	31083360
findings	O	1834	1842	abstract	31083360
,	O	1842	1843	abstract	31083360
prebiotics	B-dietary%supplement	1844	1854	abstract	31083360
and	O	1855	1858	abstract	31083360
probiotics	B-dietary%supplement	1859	1869	abstract	31083360
have	O	1870	1874	abstract	31083360
demonstrated	O	1875	1887	abstract	31083360
an	O	1888	1890	abstract	31083360
overall	O	1891	1898	abstract	31083360
limited	O	1899	1906	abstract	31083360
efficacy	O	1907	1915	abstract	31083360
in	O	1916	1918	abstract	31083360
the	O	1919	1922	abstract	31083360
management	O	1923	1933	abstract	31083360
of	O	1934	1936	abstract	31083360
GI	O	1937	1939	abstract	31083360
or	O	1940	1942	abstract	31083360
behavioral	O	1943	1953	abstract	31083360
symptoms	O	1954	1962	abstract	31083360
in	O	1963	1965	abstract	31083360
children	B-human	1966	1974	abstract	31083360
with	O	1975	1979	abstract	31083360
ASD	B-DDF	1980	1983	abstract	31083360
.	O	1983	1984	abstract	31083360

In	O	1985	1987	abstract	31083360
addition	O	1988	1996	abstract	31083360
,	O	1996	1997	abstract	31083360
there	O	1998	2003	abstract	31083360
was	O	2004	2007	abstract	31083360
no	O	2008	2010	abstract	31083360
standardized	O	2011	2023	abstract	31083360
probiotics	B-dietary%supplement	2024	2034	abstract	31083360
regimen	O	2035	2042	abstract	31083360
,	O	2042	2043	abstract	31083360
with	O	2044	2048	abstract	31083360
multiple	O	2049	2057	abstract	31083360
different	O	2058	2067	abstract	31083360
strains	O	2068	2075	abstract	31083360
and	O	2076	2079	abstract	31083360
concentrations	O	2080	2094	abstract	31083360
of	O	2095	2097	abstract	31083360
probiotics	B-dietary%supplement	2098	2108	abstract	31083360
,	O	2108	2109	abstract	31083360
and	O	2110	2113	abstract	31083360
variable	O	2114	2122	abstract	31083360
duration	O	2123	2131	abstract	31083360
of	O	2132	2134	abstract	31083360
treatments	O	2135	2145	abstract	31083360
.	O	2145	2146	abstract	31083360

Multi-omics	B-biomedical%technique	0	11	title	38010793
analyses	I-biomedical%technique	12	20	title	38010793
demonstrate	O	21	32	title	38010793
the	O	33	36	title	38010793
modulating	O	37	47	title	38010793
role	O	48	52	title	38010793
of	O	53	55	title	38010793
gut	B-microbiome	56	59	title	38010793
microbiota	I-microbiome	60	70	title	38010793
on	O	71	73	title	38010793
the	O	74	77	title	38010793
associations	O	78	90	title	38010793
of	O	91	93	title	38010793
unbalanced	O	94	104	title	38010793
dietary	O	105	112	title	38010793
intake	O	113	119	title	38010793
with	O	120	124	title	38010793
gastrointestinal	B-DDF	125	141	title	38010793
symptoms	I-DDF	142	150	title	38010793
in	O	151	153	title	38010793
children	B-human	154	162	title	38010793
with	O	163	167	title	38010793
autism	B-DDF	168	174	title	38010793
spectrum	I-DDF	175	183	title	38010793
disorder	I-DDF	184	192	title	38010793
.	O	192	193	title	38010793

Our	O	0	3	abstract	38010793
previous	O	4	12	abstract	38010793
work	O	13	17	abstract	38010793
revealed	O	18	26	abstract	38010793
that	O	27	31	abstract	38010793
unbalanced	O	32	42	abstract	38010793
dietary	O	43	50	abstract	38010793
intake	O	51	57	abstract	38010793
was	O	58	61	abstract	38010793
an	O	62	64	abstract	38010793
important	O	65	74	abstract	38010793
independent	O	75	86	abstract	38010793
factor	O	87	93	abstract	38010793
associated	O	94	104	abstract	38010793
with	O	105	109	abstract	38010793
constipation	B-DDF	110	122	abstract	38010793
and	O	123	126	abstract	38010793
gastrointestinal	B-DDF	127	143	abstract	38010793
(	I-DDF	144	145	abstract	38010793
GI	I-DDF	145	147	abstract	38010793
)	I-DDF	147	148	abstract	38010793
symptoms	I-DDF	149	157	abstract	38010793
in	O	158	160	abstract	38010793
children	B-human	161	169	abstract	38010793
with	O	170	174	abstract	38010793
autism	B-DDF	175	181	abstract	38010793
spectrum	I-DDF	182	190	abstract	38010793
disorder	I-DDF	191	199	abstract	38010793
(	O	200	201	abstract	38010793
ASD	B-DDF	201	204	abstract	38010793
)	O	204	205	abstract	38010793
.	O	205	206	abstract	38010793

Growing	O	207	214	abstract	38010793
evidence	O	215	223	abstract	38010793
has	O	224	227	abstract	38010793
shown	O	228	233	abstract	38010793
the	O	234	237	abstract	38010793
alterations	O	238	249	abstract	38010793
in	O	250	252	abstract	38010793
the	O	253	256	abstract	38010793
gut	B-microbiome	257	260	abstract	38010793
microbiota	I-microbiome	261	271	abstract	38010793
and	O	272	275	abstract	38010793
gut	B-chemical	276	279	abstract	38010793
microbiota-derived	I-chemical	280	298	abstract	38010793
metabolites	I-chemical	299	310	abstract	38010793
in	O	311	313	abstract	38010793
ASD	B-DDF	314	317	abstract	38010793
.	O	317	318	abstract	38010793

However	O	319	326	abstract	38010793
,	O	326	327	abstract	38010793
how	O	328	331	abstract	38010793
the	O	332	335	abstract	38010793
altered	O	336	343	abstract	38010793
microbiota	O	344	354	abstract	38010793
might	O	355	360	abstract	38010793
affect	O	361	367	abstract	38010793
the	O	368	371	abstract	38010793
associations	O	372	384	abstract	38010793
between	O	385	392	abstract	38010793
unbalanced	O	393	403	abstract	38010793
diets	O	404	409	abstract	38010793
and	O	410	413	abstract	38010793
GI	B-DDF	414	416	abstract	38010793
symptoms	I-DDF	417	425	abstract	38010793
in	O	426	428	abstract	38010793
ASD	B-DDF	429	432	abstract	38010793
remains	O	433	440	abstract	38010793
unknown	O	441	448	abstract	38010793
.	O	448	449	abstract	38010793

We	O	450	452	abstract	38010793
analyzed	O	453	461	abstract	38010793
microbiome	O	462	472	abstract	38010793
and	O	473	476	abstract	38010793
metabolomics	B-biomedical%technique	477	489	abstract	38010793
data	O	490	494	abstract	38010793
in	O	495	497	abstract	38010793
90	O	498	500	abstract	38010793
ASD	B-DDF	501	504	abstract	38010793
and	O	505	508	abstract	38010793
90	O	509	511	abstract	38010793
typically	B-human	512	521	abstract	38010793
developing	I-human	522	532	abstract	38010793
(	I-human	533	534	abstract	38010793
TD	I-human	534	536	abstract	38010793
)	I-human	536	537	abstract	38010793
children	I-human	538	546	abstract	38010793
based	O	547	552	abstract	38010793
on	O	553	555	abstract	38010793
16S	B-biomedical%technique	556	559	abstract	38010793
rRNA	I-biomedical%technique	560	564	abstract	38010793
and	O	565	568	abstract	38010793
untargeted	B-biomedical%technique	569	579	abstract	38010793
metabolomics	I-biomedical%technique	580	592	abstract	38010793
,	O	592	593	abstract	38010793
together	O	594	602	abstract	38010793
with	O	603	607	abstract	38010793
dietary	O	608	615	abstract	38010793
intake	O	616	622	abstract	38010793
and	O	623	626	abstract	38010793
GI	B-DDF	627	629	abstract	38010793
symptoms	I-DDF	630	638	abstract	38010793
assessment	O	639	649	abstract	38010793
.	O	649	650	abstract	38010793

We	O	651	653	abstract	38010793
found	O	654	659	abstract	38010793
that	O	660	664	abstract	38010793
there	O	665	670	abstract	38010793
existed	O	671	678	abstract	38010793
11	O	679	681	abstract	38010793
altered	B-DDF	682	689	abstract	38010793
gut	I-DDF	690	693	abstract	38010793
microbiota	I-DDF	694	704	abstract	38010793
(	O	705	706	abstract	38010793
FDR-corrected	O	706	719	abstract	38010793
P-value	O	720	727	abstract	38010793
<	O	728	729	abstract	38010793
0.05	O	729	733	abstract	38010793
)	O	733	734	abstract	38010793
and	O	735	738	abstract	38010793
397	O	739	742	abstract	38010793
altered	O	743	750	abstract	38010793
metabolites	O	751	762	abstract	38010793
(	O	763	764	abstract	38010793
P-value	O	764	771	abstract	38010793
<	O	772	773	abstract	38010793
0.05	O	773	777	abstract	38010793
)	O	777	778	abstract	38010793
in	O	779	781	abstract	38010793
children	B-human	782	790	abstract	38010793
with	O	791	795	abstract	38010793
ASD	B-DDF	796	799	abstract	38010793
compared	O	800	808	abstract	38010793
with	O	809	813	abstract	38010793
TD	B-human	814	816	abstract	38010793
children	I-human	817	825	abstract	38010793
.	O	825	826	abstract	38010793

Among	O	827	832	abstract	38010793
the	O	833	836	abstract	38010793
11	O	837	839	abstract	38010793
altered	B-DDF	840	847	abstract	38010793
microbiota	I-DDF	848	858	abstract	38010793
,	O	858	859	abstract	38010793
the	O	860	863	abstract	38010793
<	O	864	865	abstract	38010793
i	O	865	866	abstract	38010793
>	O	866	867	abstract	38010793
Turicibacter</i	B-bacteria	867	882	abstract	38010793
>	O	882	883	abstract	38010793
,	O	883	884	abstract	38010793
<	O	885	886	abstract	38010793
i	O	886	887	abstract	38010793
>	O	887	888	abstract	38010793
Coprococcus	B-bacteria	888	899	abstract	38010793
1</i	I-bacteria	900	904	abstract	38010793
>	O	904	905	abstract	38010793
,	O	905	906	abstract	38010793
and	O	907	910	abstract	38010793
<	O	911	912	abstract	38010793
i	O	912	913	abstract	38010793
>	O	913	914	abstract	38010793
Lachnospiraceae	B-bacteria	914	929	abstract	38010793
FCS020	I-bacteria	930	936	abstract	38010793
group</i	I-bacteria	937	945	abstract	38010793
>	O	945	946	abstract	38010793
were	O	947	951	abstract	38010793
positively	O	952	962	abstract	38010793
correlated	O	963	973	abstract	38010793
with	O	974	978	abstract	38010793
constipation	O	979	991	abstract	38010793
(	O	992	993	abstract	38010793
FDR-corrected	O	993	1006	abstract	38010793
P-value	O	1007	1014	abstract	38010793
<	O	1015	1016	abstract	38010793
0.25	O	1016	1020	abstract	38010793
)	O	1020	1021	abstract	38010793
.	O	1021	1022	abstract	38010793

The	O	1023	1026	abstract	38010793
Eggerthellaceae	B-bacteria	1027	1042	abstract	38010793
was	O	1043	1046	abstract	38010793
positively	O	1047	1057	abstract	38010793
correlated	O	1058	1068	abstract	38010793
with	O	1069	1073	abstract	38010793
total	O	1074	1079	abstract	38010793
GI	B-DDF	1080	1082	abstract	38010793
symptoms	I-DDF	1083	1091	abstract	38010793
(	O	1092	1093	abstract	38010793
FDR-corrected	O	1093	1106	abstract	38010793
P-value	O	1107	1114	abstract	38010793
<	O	1115	1116	abstract	38010793
0.25	O	1116	1120	abstract	38010793
)	O	1120	1121	abstract	38010793
.	O	1121	1122	abstract	38010793

More	O	1123	1127	abstract	38010793
importantly	O	1128	1139	abstract	38010793
,	O	1139	1140	abstract	38010793
three	O	1141	1146	abstract	38010793
increased	O	1147	1156	abstract	38010793
microbiota	O	1157	1167	abstract	38010793
including	O	1168	1177	abstract	38010793
<	O	1178	1179	abstract	38010793
i	O	1179	1180	abstract	38010793
>	O	1180	1181	abstract	38010793
Turicibacter</i	B-bacteria	1181	1196	abstract	38010793
>	O	1196	1197	abstract	38010793
,	O	1197	1198	abstract	38010793
<	O	1199	1200	abstract	38010793
i	O	1200	1201	abstract	38010793
>	O	1201	1202	abstract	38010793
Coprococcus	B-bacteria	1202	1213	abstract	38010793
1</i	I-bacteria	1214	1218	abstract	38010793
>	O	1218	1219	abstract	38010793
,	O	1219	1220	abstract	38010793
and	O	1221	1224	abstract	38010793
Eggerthellaceae	B-bacteria	1225	1240	abstract	38010793
positively	O	1241	1251	abstract	38010793
modulated	O	1252	1261	abstract	38010793
the	O	1262	1265	abstract	38010793
associations	O	1266	1278	abstract	38010793
of	O	1279	1281	abstract	38010793
unbalanced	O	1282	1292	abstract	38010793
dietary	O	1293	1300	abstract	38010793
intake	O	1301	1307	abstract	38010793
with	O	1308	1312	abstract	38010793
constipation	O	1313	1325	abstract	38010793
and	O	1326	1329	abstract	38010793
total	O	1330	1335	abstract	38010793
GI	B-DDF	1336	1338	abstract	38010793
symptoms	I-DDF	1339	1347	abstract	38010793
,	O	1347	1348	abstract	38010793
and	O	1349	1352	abstract	38010793
the	O	1353	1356	abstract	38010793
decreased	O	1357	1366	abstract	38010793
<	O	1367	1368	abstract	38010793
i	O	1368	1369	abstract	38010793
>	O	1369	1370	abstract	38010793
Clostridium	B-bacteria	1370	1381	abstract	38010793
sp.	I-bacteria	1382	1385	abstract	38010793
BR31</i	I-bacteria	1386	1393	abstract	38010793
>	O	1393	1394	abstract	38010793
negatively	O	1395	1405	abstract	38010793
modulated	O	1406	1415	abstract	38010793
their	O	1416	1421	abstract	38010793
associations	O	1422	1434	abstract	38010793
in	O	1435	1437	abstract	38010793
ASD	B-human	1438	1441	abstract	38010793
children	I-human	1442	1450	abstract	38010793
(	O	1451	1452	abstract	38010793
P-value	O	1452	1459	abstract	38010793
<	O	1460	1461	abstract	38010793
0.05	O	1461	1465	abstract	38010793
)	O	1465	1466	abstract	38010793
.	O	1466	1467	abstract	38010793

Together	O	1468	1476	abstract	38010793
,	O	1476	1477	abstract	38010793
the	O	1478	1481	abstract	38010793
altered	B-DDF	1482	1489	abstract	38010793
microbiota	I-DDF	1490	1500	abstract	38010793
strengthens	O	1501	1512	abstract	38010793
the	O	1513	1516	abstract	38010793
relationship	O	1517	1529	abstract	38010793
between	O	1530	1537	abstract	38010793
unbalanced	O	1538	1548	abstract	38010793
dietary	O	1549	1556	abstract	38010793
intake	O	1557	1563	abstract	38010793
and	O	1564	1567	abstract	38010793
GI	B-DDF	1568	1570	abstract	38010793
symptoms	I-DDF	1571	1579	abstract	38010793
.	O	1579	1580	abstract	38010793

Among	O	1581	1586	abstract	38010793
the	O	1587	1590	abstract	38010793
altered	O	1591	1598	abstract	38010793
metabolites	O	1599	1610	abstract	38010793
,	O	1610	1611	abstract	38010793
ten	O	1612	1615	abstract	38010793
metabolites	O	1616	1627	abstract	38010793
derived	O	1628	1635	abstract	38010793
from	O	1636	1640	abstract	38010793
microbiota	O	1641	1651	abstract	38010793
(	O	1652	1653	abstract	38010793
<	O	1653	1654	abstract	38010793
i	O	1654	1655	abstract	38010793
>	O	1655	1656	abstract	38010793
Turicibacter</i	B-bacteria	1656	1671	abstract	38010793
>	O	1671	1672	abstract	38010793
,	O	1672	1673	abstract	38010793
<	O	1674	1675	abstract	38010793
i	O	1675	1676	abstract	38010793
>	O	1676	1677	abstract	38010793
Coprococcus	B-bacteria	1677	1688	abstract	38010793
1</i	I-bacteria	1689	1693	abstract	38010793
>	O	1693	1694	abstract	38010793
,	O	1694	1695	abstract	38010793
Eggerthellaceae	B-bacteria	1696	1711	abstract	38010793
,	O	1711	1712	abstract	38010793
and	O	1713	1716	abstract	38010793
<	O	1717	1718	abstract	38010793
i	O	1718	1719	abstract	38010793
>	O	1719	1720	abstract	38010793
Clostridium	B-bacteria	1720	1731	abstract	38010793
sp.	I-bacteria	1732	1735	abstract	38010793
BR31</i	I-bacteria	1736	1743	abstract	38010793
>	O	1743	1744	abstract	38010793
)	O	1744	1745	abstract	38010793
were	O	1746	1750	abstract	38010793
screened	O	1751	1759	abstract	38010793
out	O	1760	1763	abstract	38010793
,	O	1763	1764	abstract	38010793
enriched	O	1765	1773	abstract	38010793
in	O	1774	1776	abstract	38010793
eight	O	1777	1782	abstract	38010793
metabolic	O	1783	1792	abstract	38010793
pathways	O	1793	1801	abstract	38010793
,	O	1801	1802	abstract	38010793
and	O	1803	1806	abstract	38010793
were	O	1807	1811	abstract	38010793
identified	O	1812	1822	abstract	38010793
to	O	1823	1825	abstract	38010793
correlate	O	1826	1835	abstract	38010793
with	O	1836	1840	abstract	38010793
constipation	O	1841	1853	abstract	38010793
and	O	1854	1857	abstract	38010793
total	O	1858	1863	abstract	38010793
GI	B-DDF	1864	1866	abstract	38010793
symptoms	I-DDF	1867	1875	abstract	38010793
in	O	1876	1878	abstract	38010793
ASD	B-human	1879	1882	abstract	38010793
children	I-human	1883	1891	abstract	38010793
(	O	1892	1893	abstract	38010793
FDR-corrected	O	1893	1906	abstract	38010793
P-value	O	1907	1914	abstract	38010793
<	O	1915	1916	abstract	38010793
0.25	O	1916	1920	abstract	38010793
)	O	1920	1921	abstract	38010793
.	O	1921	1922	abstract	38010793

These	O	1923	1928	abstract	38010793
metabolomics	O	1929	1941	abstract	38010793
findings	O	1942	1950	abstract	38010793
further	O	1951	1958	abstract	38010793
support	O	1959	1966	abstract	38010793
the	O	1967	1970	abstract	38010793
modulating	O	1971	1981	abstract	38010793
role	O	1982	1986	abstract	38010793
of	O	1987	1989	abstract	38010793
gut	B-microbiome	1990	1993	abstract	38010793
microbiota	I-microbiome	1994	2004	abstract	38010793
on	O	2005	2007	abstract	38010793
the	O	2008	2011	abstract	38010793
associations	O	2012	2024	abstract	38010793
of	O	2025	2027	abstract	38010793
unbalanced	O	2028	2038	abstract	38010793
dietary	O	2039	2046	abstract	38010793
intake	O	2047	2053	abstract	38010793
with	O	2054	2058	abstract	38010793
GI	B-DDF	2059	2061	abstract	38010793
symptoms	I-DDF	2062	2070	abstract	38010793
.	O	2070	2071	abstract	38010793

Collectively	O	2072	2084	abstract	38010793
,	O	2084	2085	abstract	38010793
our	O	2086	2089	abstract	38010793
research	O	2090	2098	abstract	38010793
provides	O	2099	2107	abstract	38010793
insights	O	2108	2116	abstract	38010793
into	O	2117	2121	abstract	38010793
the	O	2122	2125	abstract	38010793
relationship	O	2126	2138	abstract	38010793
between	O	2139	2146	abstract	38010793
diet	O	2147	2151	abstract	38010793
,	O	2151	2152	abstract	38010793
the	O	2153	2156	abstract	38010793
gut	B-microbiome	2157	2160	abstract	38010793
microbiota	I-microbiome	2161	2171	abstract	38010793
,	O	2171	2172	abstract	38010793
and	O	2173	2176	abstract	38010793
GI	B-DDF	2177	2179	abstract	38010793
symptoms	I-DDF	2180	2188	abstract	38010793
in	O	2189	2191	abstract	38010793
children	B-human	2192	2200	abstract	38010793
with	O	2201	2205	abstract	38010793
ASD	B-DDF	2206	2209	abstract	38010793
.	O	2209	2210	abstract	38010793

Shotgun	B-biomedical%technique	0	7	title	31685046
metagenomics	I-biomedical%technique	8	20	title	31685046
reveals	O	21	28	title	31685046
both	O	29	33	title	31685046
taxonomic	O	34	43	title	31685046
and	O	44	47	title	31685046
tryptophan	O	48	58	title	31685046
pathway	O	59	66	title	31685046
differences	O	67	78	title	31685046
of	O	79	81	title	31685046
gut	B-microbiome	82	85	title	31685046
microbiota	I-microbiome	86	96	title	31685046
in	O	97	99	title	31685046
major	B-human	100	105	title	31685046
depressive	I-human	106	116	title	31685046
disorder	I-human	117	125	title	31685046
patients	I-human	126	134	title	31685046
.	O	134	135	title	31685046

The	O	0	3	abstract	31685046
microbiota-gut-brain	O	4	24	abstract	31685046
axis	O	25	29	abstract	31685046
,	O	29	30	abstract	31685046
especially	O	31	41	abstract	31685046
the	O	42	45	abstract	31685046
microbial	O	46	55	abstract	31685046
tryptophan	O	56	66	abstract	31685046
(	O	67	68	abstract	31685046
Trp	B-chemical	68	71	abstract	31685046
)	O	71	72	abstract	31685046
biosynthesis	O	73	85	abstract	31685046
and	O	86	89	abstract	31685046
metabolism	O	90	100	abstract	31685046
pathway	O	101	108	abstract	31685046
(	O	109	110	abstract	31685046
MiTBamp	O	110	117	abstract	31685046
)	O	117	118	abstract	31685046
,	O	118	119	abstract	31685046
may	O	120	123	abstract	31685046
play	O	124	128	abstract	31685046
a	O	129	130	abstract	31685046
critical	O	131	139	abstract	31685046
role	O	140	144	abstract	31685046
in	O	145	147	abstract	31685046
the	O	148	151	abstract	31685046
pathogenesis	O	152	164	abstract	31685046
of	O	165	167	abstract	31685046
major	B-DDF	168	173	abstract	31685046
depressive	I-DDF	174	184	abstract	31685046
disorder	I-DDF	185	193	abstract	31685046
(	O	194	195	abstract	31685046
MDD	B-DDF	195	198	abstract	31685046
)	O	198	199	abstract	31685046
.	O	199	200	abstract	31685046

However	O	201	208	abstract	31685046
,	O	208	209	abstract	31685046
studies	O	210	217	abstract	31685046
on	O	218	220	abstract	31685046
the	O	221	224	abstract	31685046
MiTBamp	O	225	232	abstract	31685046
in	O	233	235	abstract	31685046
MDD	B-DDF	236	239	abstract	31685046
are	O	240	243	abstract	31685046
lacking	O	244	251	abstract	31685046
.	O	251	252	abstract	31685046

The	O	253	256	abstract	31685046
aim	O	257	260	abstract	31685046
of	O	261	263	abstract	31685046
the	O	264	267	abstract	31685046
present	O	268	275	abstract	31685046
study	O	276	281	abstract	31685046
was	O	282	285	abstract	31685046
to	O	286	288	abstract	31685046
analyze	O	289	296	abstract	31685046
the	O	297	300	abstract	31685046
gut	O	301	304	abstract	31685046
microbiota	O	305	315	abstract	31685046
composition	O	316	327	abstract	31685046
and	O	328	331	abstract	31685046
the	O	332	335	abstract	31685046
MiTBamp	O	336	343	abstract	31685046
in	O	344	346	abstract	31685046
MDD	B-human	347	350	abstract	31685046
patients	I-human	351	359	abstract	31685046
.	O	359	360	abstract	31685046

We	O	361	363	abstract	31685046
performed	O	364	373	abstract	31685046
shotgun	B-biomedical%technique	374	381	abstract	31685046
metagenomic	I-biomedical%technique	382	393	abstract	31685046
sequencing	I-biomedical%technique	394	404	abstract	31685046
of	O	405	407	abstract	31685046
stool	O	408	413	abstract	31685046
samples	O	414	421	abstract	31685046
from	O	422	426	abstract	31685046
26	O	427	429	abstract	31685046
MDD	B-human	430	433	abstract	31685046
patients	I-human	434	442	abstract	31685046
and	O	443	446	abstract	31685046
29	O	447	449	abstract	31685046
healthy	B-human	450	457	abstract	31685046
controls	I-human	458	466	abstract	31685046
(	O	467	468	abstract	31685046
HCs	B-human	468	471	abstract	31685046
)	O	471	472	abstract	31685046
.	O	472	473	abstract	31685046

In	O	474	476	abstract	31685046
addition	O	477	485	abstract	31685046
to	O	486	488	abstract	31685046
the	O	489	492	abstract	31685046
microbiota	O	493	503	abstract	31685046
community	O	504	513	abstract	31685046
and	O	514	517	abstract	31685046
the	O	518	521	abstract	31685046
MiTBamp	B-biomedical%technique	522	529	abstract	31685046
analyses	I-biomedical%technique	530	538	abstract	31685046
,	O	538	539	abstract	31685046
we	O	540	542	abstract	31685046
also	O	543	547	abstract	31685046
built	O	548	553	abstract	31685046
a	O	554	555	abstract	31685046
classification	O	556	570	abstract	31685046
based	O	571	576	abstract	31685046
on	O	577	579	abstract	31685046
the	O	580	583	abstract	31685046
Random	B-statistical%technique	584	590	abstract	31685046
Forests	I-statistical%technique	591	598	abstract	31685046
(	I-statistical%technique	599	600	abstract	31685046
RF	I-statistical%technique	600	602	abstract	31685046
)	I-statistical%technique	602	603	abstract	31685046
and	O	604	607	abstract	31685046
Boruta	B-statistical%technique	608	614	abstract	31685046
algorithm	I-statistical%technique	615	624	abstract	31685046
to	O	625	627	abstract	31685046
identify	O	628	636	abstract	31685046
the	O	637	640	abstract	31685046
gut	B-microbiome	641	644	abstract	31685046
microbiota	I-microbiome	645	655	abstract	31685046
as	O	656	658	abstract	31685046
biomarkers	O	659	669	abstract	31685046
for	O	670	673	abstract	31685046
MDD	B-DDF	674	677	abstract	31685046
.	O	677	678	abstract	31685046

The	O	679	682	abstract	31685046
Bacteroidetes	B-bacteria	683	696	abstract	31685046
abundance	O	697	706	abstract	31685046
was	O	707	710	abstract	31685046
strongly	O	711	719	abstract	31685046
reduced	O	720	727	abstract	31685046
whereas	O	728	735	abstract	31685046
that	O	736	740	abstract	31685046
of	O	741	743	abstract	31685046
Actinobacteria	B-bacteria	744	758	abstract	31685046
was	O	759	762	abstract	31685046
significantly	O	763	776	abstract	31685046
increased	O	777	786	abstract	31685046
in	O	787	789	abstract	31685046
the	O	790	793	abstract	31685046
MDD	B-human	794	797	abstract	31685046
patients	I-human	798	806	abstract	31685046
compared	O	807	815	abstract	31685046
with	O	816	820	abstract	31685046
the	O	821	824	abstract	31685046
abundance	O	825	834	abstract	31685046
in	O	835	837	abstract	31685046
the	O	838	841	abstract	31685046
HCs	B-human	842	845	abstract	31685046
.	O	845	846	abstract	31685046

Most	O	847	851	abstract	31685046
noteworthy	O	852	862	abstract	31685046
,	O	862	863	abstract	31685046
the	O	864	867	abstract	31685046
MDD	B-human	868	871	abstract	31685046
patients	I-human	872	880	abstract	31685046
had	O	881	884	abstract	31685046
increased	O	885	894	abstract	31685046
levels	O	895	901	abstract	31685046
of	O	902	904	abstract	31685046
Bifidobacterium	B-bacteria	905	920	abstract	31685046
,	O	920	921	abstract	31685046
which	O	922	927	abstract	31685046
is	O	928	930	abstract	31685046
commonly	O	931	939	abstract	31685046
used	O	940	944	abstract	31685046
as	O	945	947	abstract	31685046
a	O	948	949	abstract	31685046
probiotic	B-dietary%supplement	950	959	abstract	31685046
.	O	959	960	abstract	31685046

Four	O	961	965	abstract	31685046
Kyoto	O	966	971	abstract	31685046
Encyclopedia	O	972	984	abstract	31685046
of	O	985	987	abstract	31685046
Genes	O	988	993	abstract	31685046
and	O	994	997	abstract	31685046
Genomes	O	998	1005	abstract	31685046
(	O	1006	1007	abstract	31685046
KEGG	O	1007	1011	abstract	31685046
)	O	1011	1012	abstract	31685046
orthologies	O	1013	1024	abstract	31685046
(	O	1025	1026	abstract	31685046
KOs	O	1026	1029	abstract	31685046
)	O	1029	1030	abstract	31685046
(	O	1031	1032	abstract	31685046
K01817	B-chemical	1032	1038	abstract	31685046
,	O	1038	1039	abstract	31685046
K11358	B-chemical	1040	1046	abstract	31685046
,	O	1046	1047	abstract	31685046
K01626	B-chemical	1048	1054	abstract	31685046
,	O	1054	1055	abstract	31685046
K01667	B-chemical	1056	1062	abstract	31685046
)	O	1062	1063	abstract	31685046
abundances	O	1064	1074	abstract	31685046
in	O	1075	1077	abstract	31685046
the	O	1078	1081	abstract	31685046
MiTBamp	O	1082	1089	abstract	31685046
were	O	1090	1094	abstract	31685046
significantly	O	1095	1108	abstract	31685046
lower	O	1109	1114	abstract	31685046
in	O	1115	1117	abstract	31685046
the	O	1118	1121	abstract	31685046
MDD	B-human	1122	1125	abstract	31685046
group	I-human	1126	1131	abstract	31685046
.	O	1131	1132	abstract	31685046

Furthermore	O	1133	1144	abstract	31685046
,	O	1144	1145	abstract	31685046
we	O	1146	1148	abstract	31685046
found	O	1149	1154	abstract	31685046
a	O	1155	1156	abstract	31685046
negative	O	1157	1165	abstract	31685046
correlation	O	1166	1177	abstract	31685046
between	O	1178	1185	abstract	31685046
the	O	1186	1189	abstract	31685046
K01626	B-chemical	1190	1196	abstract	31685046
abundance	O	1197	1206	abstract	31685046
and	O	1207	1210	abstract	31685046
the	O	1211	1214	abstract	31685046
HAMD	O	1215	1219	abstract	31685046
scores	O	1220	1226	abstract	31685046
in	O	1227	1229	abstract	31685046
the	O	1230	1233	abstract	31685046
MDD	B-human	1234	1237	abstract	31685046
group	I-human	1238	1243	abstract	31685046
.	O	1243	1244	abstract	31685046

Finally	O	1245	1252	abstract	31685046
,	O	1252	1253	abstract	31685046
RF	O	1254	1256	abstract	31685046
classification	O	1257	1271	abstract	31685046
at	O	1272	1274	abstract	31685046
the	O	1275	1278	abstract	31685046
genus	O	1279	1284	abstract	31685046
level	O	1285	1290	abstract	31685046
can	O	1291	1294	abstract	31685046
achieve	O	1295	1302	abstract	31685046
an	O	1303	1305	abstract	31685046
area	O	1306	1310	abstract	31685046
under	O	1311	1316	abstract	31685046
the	O	1317	1320	abstract	31685046
receiver	O	1321	1329	abstract	31685046
operating	O	1330	1339	abstract	31685046
characteristic	O	1340	1354	abstract	31685046
curve	O	1355	1360	abstract	31685046
of	O	1361	1363	abstract	31685046
0.890	O	1364	1369	abstract	31685046
.	O	1369	1370	abstract	31685046

The	O	1371	1374	abstract	31685046
present	O	1375	1382	abstract	31685046
findings	O	1383	1391	abstract	31685046
enabled	O	1392	1399	abstract	31685046
a	O	1400	1401	abstract	31685046
better	O	1402	1408	abstract	31685046
understanding	O	1409	1422	abstract	31685046
of	O	1423	1425	abstract	31685046
the	O	1426	1429	abstract	31685046
changes	O	1430	1437	abstract	31685046
in	O	1438	1440	abstract	31685046
gut	B-microbiome	1441	1444	abstract	31685046
microbiota	I-microbiome	1445	1455	abstract	31685046
and	O	1456	1459	abstract	31685046
the	O	1460	1463	abstract	31685046
related	O	1464	1471	abstract	31685046
Trp	O	1472	1475	abstract	31685046
pathway	O	1476	1483	abstract	31685046
in	O	1484	1486	abstract	31685046
MDD	B-DDF	1487	1490	abstract	31685046
.	O	1490	1491	abstract	31685046

Alterations	O	1492	1503	abstract	31685046
of	O	1504	1506	abstract	31685046
the	O	1507	1510	abstract	31685046
gut	B-microbiome	1511	1514	abstract	31685046
microbiota	I-microbiome	1515	1525	abstract	31685046
may	O	1526	1529	abstract	31685046
have	O	1530	1534	abstract	31685046
the	O	1535	1538	abstract	31685046
potential	O	1539	1548	abstract	31685046
as	O	1549	1551	abstract	31685046
biomarkers	O	1552	1562	abstract	31685046
for	O	1563	1566	abstract	31685046
distinguishing	O	1567	1581	abstract	31685046
MDD	B-human	1582	1585	abstract	31685046
patients	I-human	1586	1594	abstract	31685046
form	O	1595	1599	abstract	31685046
HCs	B-human	1600	1603	abstract	31685046
.	O	1603	1604	abstract	31685046

Effects	O	0	7	title	34444820
of	O	8	10	title	34444820
Probiotic	B-dietary%supplement	11	20	title	34444820
NVP-1704	I-dietary%supplement	21	29	title	34444820
on	O	30	32	title	34444820
Mental	O	33	39	title	34444820
Health	O	40	46	title	34444820
and	O	47	50	title	34444820
Sleep	O	51	56	title	34444820
in	O	57	59	title	34444820
Healthy	B-human	60	67	title	34444820
Adults	I-human	68	74	title	34444820
:	O	74	75	title	34444820
An	O	76	78	title	34444820
8-Week	O	79	85	title	34444820
Randomized	O	86	96	title	34444820
,	O	96	97	title	34444820
Double-Blind	O	98	110	title	34444820
,	O	110	111	title	34444820
Placebo-Controlled	O	112	130	title	34444820
Trial	O	131	136	title	34444820
.	O	136	137	title	34444820

The	O	0	3	abstract	34444820
human	B-microbiome	4	9	abstract	34444820
gut	I-microbiome	10	13	abstract	34444820
microbiome	I-microbiome	14	24	abstract	34444820
is	O	25	27	abstract	34444820
closely	O	28	35	abstract	34444820
linked	O	36	42	abstract	34444820
to	O	43	45	abstract	34444820
mental	O	46	52	abstract	34444820
health	O	53	59	abstract	34444820
and	O	60	63	abstract	34444820
sleep	O	64	69	abstract	34444820
.	O	69	70	abstract	34444820

We	O	71	73	abstract	34444820
aimed	O	74	79	abstract	34444820
to	O	80	82	abstract	34444820
verify	O	83	89	abstract	34444820
the	O	90	93	abstract	34444820
efficacy	O	94	102	abstract	34444820
and	O	103	106	abstract	34444820
safety	O	107	113	abstract	34444820
of	O	114	116	abstract	34444820
probiotic	B-dietary%supplement	117	126	abstract	34444820
NVP-1704	I-dietary%supplement	127	135	abstract	34444820
,	O	135	136	abstract	34444820
a	O	137	138	abstract	34444820
mixture	O	139	146	abstract	34444820
of	O	147	149	abstract	34444820
<	B-bacteria	150	151	abstract	34444820
i	I-bacteria	151	152	abstract	34444820
>	I-bacteria	152	153	abstract	34444820
Lactobacillus	I-bacteria	153	166	abstract	34444820
reuteri</i	I-bacteria	167	177	abstract	34444820
>	I-bacteria	177	178	abstract	34444820
NK33	I-bacteria	179	183	abstract	34444820
and	O	184	187	abstract	34444820
<	B-bacteria	188	189	abstract	34444820
i	I-bacteria	189	190	abstract	34444820
>	I-bacteria	190	191	abstract	34444820
Bifidobacterium	I-bacteria	191	206	abstract	34444820
adolescentis</i	I-bacteria	207	222	abstract	34444820
>	I-bacteria	222	223	abstract	34444820
NK98	I-bacteria	224	228	abstract	34444820
,	O	228	229	abstract	34444820
in	O	230	232	abstract	34444820
improving	O	233	242	abstract	34444820
stress	B-DDF	243	249	abstract	34444820
,	O	249	250	abstract	34444820
depression	B-DDF	251	261	abstract	34444820
,	O	261	262	abstract	34444820
anxiety	B-DDF	263	270	abstract	34444820
,	O	270	271	abstract	34444820
and	O	272	275	abstract	34444820
sleep	B-DDF	276	281	abstract	34444820
disturbances	I-DDF	282	294	abstract	34444820
,	O	294	295	abstract	34444820
along	O	296	301	abstract	34444820
with	O	302	306	abstract	34444820
the	O	307	310	abstract	34444820
measurement	O	311	322	abstract	34444820
of	O	323	325	abstract	34444820
some	O	326	330	abstract	34444820
blood	O	331	336	abstract	34444820
biomarkers	O	337	347	abstract	34444820
.	O	347	348	abstract	34444820

A	O	349	350	abstract	34444820
total	O	351	356	abstract	34444820
of	O	357	359	abstract	34444820
156	O	360	363	abstract	34444820
healthy	B-human	364	371	abstract	34444820
adults	I-human	372	378	abstract	34444820
with	O	379	383	abstract	34444820
subclinical	O	384	395	abstract	34444820
symptoms	O	396	404	abstract	34444820
of	O	405	407	abstract	34444820
depression	B-DDF	408	418	abstract	34444820
,	O	418	419	abstract	34444820
anxiety	B-DDF	420	427	abstract	34444820
,	O	427	428	abstract	34444820
and	O	429	432	abstract	34444820
insomnia	B-DDF	433	441	abstract	34444820
were	O	442	446	abstract	34444820
retrospectively	O	447	462	abstract	34444820
registered	O	463	473	abstract	34444820
and	O	474	477	abstract	34444820
randomly	O	478	486	abstract	34444820
assigned	O	487	495	abstract	34444820
to	O	496	498	abstract	34444820
receive	O	499	506	abstract	34444820
either	O	507	513	abstract	34444820
NVP-1704	B-dietary%supplement	514	522	abstract	34444820
(	O	523	524	abstract	34444820
<	O	524	525	abstract	34444820
i	O	525	526	abstract	34444820
>	O	526	527	abstract	34444820
n</i	O	527	531	abstract	34444820
>	O	531	532	abstract	34444820
=	O	533	534	abstract	34444820
78	O	535	537	abstract	34444820
)	O	537	538	abstract	34444820
or	O	539	541	abstract	34444820
a	O	542	543	abstract	34444820
placebo	O	544	551	abstract	34444820
(	O	552	553	abstract	34444820
<	O	553	554	abstract	34444820
i	O	554	555	abstract	34444820
>	O	555	556	abstract	34444820
n</i	O	556	560	abstract	34444820
>	O	560	561	abstract	34444820
=	O	562	563	abstract	34444820
78	O	564	566	abstract	34444820
)	O	566	567	abstract	34444820
for	O	568	571	abstract	34444820
eight	O	572	577	abstract	34444820
weeks	O	578	583	abstract	34444820
.	O	583	584	abstract	34444820

Participants	O	585	597	abstract	34444820
completed	O	598	607	abstract	34444820
the	O	608	611	abstract	34444820
Stress	O	612	618	abstract	34444820
Response	O	619	627	abstract	34444820
Inventory	O	628	637	abstract	34444820
,	O	637	638	abstract	34444820
Beck	O	639	643	abstract	34444820
's	O	643	645	abstract	34444820
Depression	O	646	656	abstract	34444820
and	O	657	660	abstract	34444820
Anxiety	O	661	668	abstract	34444820
Inventory	O	669	678	abstract	34444820
,	O	678	679	abstract	34444820
Pittsburg	O	680	689	abstract	34444820
Sleep	O	690	695	abstract	34444820
Quality	O	696	703	abstract	34444820
Index	O	704	709	abstract	34444820
,	O	709	710	abstract	34444820
and	O	711	714	abstract	34444820
Insomnia	O	715	723	abstract	34444820
Severity	O	724	732	abstract	34444820
Index	O	733	738	abstract	34444820
at	O	739	741	abstract	34444820
baseline	O	742	750	abstract	34444820
,	O	750	751	abstract	34444820
at	O	752	754	abstract	34444820
four	O	755	759	abstract	34444820
and	O	760	763	abstract	34444820
eight	O	764	769	abstract	34444820
weeks	O	770	775	abstract	34444820
of	O	776	778	abstract	34444820
treatment	O	779	788	abstract	34444820
.	O	788	789	abstract	34444820

Pre-	O	790	794	abstract	34444820
and	O	795	798	abstract	34444820
post-treatment	O	799	813	abstract	34444820
blood	O	814	819	abstract	34444820
tests	O	820	825	abstract	34444820
for	O	826	829	abstract	34444820
biomarkers	O	830	840	abstract	34444820
were	O	841	845	abstract	34444820
conducted	O	846	855	abstract	34444820
.	O	855	856	abstract	34444820

After	O	857	862	abstract	34444820
intervention	O	863	875	abstract	34444820
,	O	875	876	abstract	34444820
gut	O	877	880	abstract	34444820
microbiota	O	881	891	abstract	34444820
composition	O	892	903	abstract	34444820
was	O	904	907	abstract	34444820
quantified	O	908	918	abstract	34444820
by	O	919	921	abstract	34444820
pyrosequencing	O	922	936	abstract	34444820
the	O	937	940	abstract	34444820
bacterial	B-gene	941	950	abstract	34444820
16S	I-gene	951	954	abstract	34444820
rRNA	I-gene	955	959	abstract	34444820
gene	I-gene	960	964	abstract	34444820
.	O	964	965	abstract	34444820

The	O	966	969	abstract	34444820
NVP-1704	B-human	970	978	abstract	34444820
group	I-human	979	984	abstract	34444820
had	O	985	988	abstract	34444820
a	O	989	990	abstract	34444820
more	O	991	995	abstract	34444820
significant	O	996	1007	abstract	34444820
reduction	O	1008	1017	abstract	34444820
in	O	1018	1020	abstract	34444820
depressive	B-DDF	1021	1031	abstract	34444820
symptoms	I-DDF	1032	1040	abstract	34444820
at	O	1041	1043	abstract	34444820
four	O	1044	1048	abstract	34444820
and	O	1049	1052	abstract	34444820
eight	O	1053	1058	abstract	34444820
weeks	O	1059	1064	abstract	34444820
of	O	1065	1067	abstract	34444820
treatment	O	1068	1077	abstract	34444820
,	O	1077	1078	abstract	34444820
and	O	1079	1082	abstract	34444820
anxiety	B-DDF	1083	1090	abstract	34444820
symptoms	I-DDF	1091	1099	abstract	34444820
at	O	1100	1102	abstract	34444820
four	O	1103	1107	abstract	34444820
weeks	O	1108	1113	abstract	34444820
compared	O	1114	1122	abstract	34444820
to	O	1123	1125	abstract	34444820
the	O	1126	1129	abstract	34444820
placebo	B-human	1130	1137	abstract	34444820
group	I-human	1138	1143	abstract	34444820
.	O	1143	1144	abstract	34444820

Those	O	1145	1150	abstract	34444820
receiving	O	1151	1160	abstract	34444820
NVP-1704	B-dietary%supplement	1161	1169	abstract	34444820
also	O	1170	1174	abstract	34444820
experienced	O	1175	1186	abstract	34444820
an	O	1187	1189	abstract	34444820
improvement	O	1190	1201	abstract	34444820
in	O	1202	1204	abstract	34444820
sleep	O	1205	1210	abstract	34444820
quality	O	1211	1218	abstract	34444820
.	O	1218	1219	abstract	34444820

NVP-1704	B-dietary%supplement	1220	1228	abstract	34444820
treatment	I-dietary%supplement	1229	1238	abstract	34444820
led	O	1239	1242	abstract	34444820
to	O	1243	1245	abstract	34444820
a	O	1246	1247	abstract	34444820
decrease	O	1248	1256	abstract	34444820
in	O	1257	1259	abstract	34444820
serum	O	1260	1265	abstract	34444820
interleukin-6	O	1266	1279	abstract	34444820
levels	O	1280	1286	abstract	34444820
.	O	1286	1287	abstract	34444820

Furthermore	O	1288	1299	abstract	34444820
,	O	1299	1300	abstract	34444820
NVP-1704	B-dietary%supplement	1301	1309	abstract	34444820
increased	O	1310	1319	abstract	34444820
<	O	1320	1321	abstract	34444820
i	O	1321	1322	abstract	34444820
>	O	1322	1323	abstract	34444820
Bifidobacteriaceae</i	B-bacteria	1323	1344	abstract	34444820
>	O	1344	1345	abstract	34444820
and	O	1346	1349	abstract	34444820
<	O	1350	1351	abstract	34444820
i	O	1351	1352	abstract	34444820
>	O	1352	1353	abstract	34444820
Lactobacillacea</i	B-bacteria	1353	1371	abstract	34444820
>	O	1371	1372	abstract	34444820
,	O	1372	1373	abstract	34444820
whereas	O	1374	1381	abstract	34444820
it	O	1382	1384	abstract	34444820
decreased	O	1385	1394	abstract	34444820
<	O	1395	1396	abstract	34444820
i	O	1396	1397	abstract	34444820
>	O	1397	1398	abstract	34444820
Enterobacteriaceae</i	B-bacteria	1398	1419	abstract	34444820
>	O	1419	1420	abstract	34444820
in	O	1421	1423	abstract	34444820
the	O	1424	1427	abstract	34444820
gut	O	1428	1431	abstract	34444820
microbiota	O	1432	1442	abstract	34444820
composition	O	1443	1454	abstract	34444820
.	O	1454	1455	abstract	34444820

Our	O	1456	1459	abstract	34444820
findings	O	1460	1468	abstract	34444820
suggest	O	1469	1476	abstract	34444820
that	O	1477	1481	abstract	34444820
probiotic	B-dietary%supplement	1482	1491	abstract	34444820
NVP-1704	I-dietary%supplement	1492	1500	abstract	34444820
could	O	1501	1506	abstract	34444820
be	O	1507	1509	abstract	34444820
beneficial	O	1510	1520	abstract	34444820
for	O	1521	1524	abstract	34444820
mental	O	1525	1531	abstract	34444820
health	O	1532	1538	abstract	34444820
and	O	1539	1542	abstract	34444820
sleep	O	1543	1548	abstract	34444820
.	O	1548	1549	abstract	34444820

Studies	O	0	7	title	34092293
on	O	8	10	title	34092293
blood	O	11	16	title	34092293
enrichment	O	17	27	title	34092293
and	O	28	31	title	34092293
anti-tumor	O	32	42	title	34092293
effects	O	43	50	title	34092293
of	O	51	53	title	34092293
combined	O	54	62	title	34092293
Danggui	B-dietary%supplement	63	70	title	34092293
Buxue	I-dietary%supplement	71	76	title	34092293
Decoction	I-dietary%supplement	77	86	title	34092293
,	O	86	87	title	34092293
Fe	B-chemical	88	90	title	34092293
and	O	91	94	title	34092293
rhEPO	B-chemical	95	100	title	34092293
based	O	101	106	title	34092293
on	O	107	109	title	34092293
colon	O	110	115	title	34092293
cancer-related	O	116	130	title	34092293
anemia	O	131	137	title	34092293
model	O	138	143	title	34092293
and	O	144	147	title	34092293
gut	O	148	151	title	34092293
microbiota	O	152	162	title	34092293
modulation	O	163	173	title	34092293
.	O	173	174	title	34092293

Colon	B-DDF	0	5	abstract	34092293
cancer-related	I-DDF	6	20	abstract	34092293
anemia	I-DDF	21	27	abstract	34092293
(	O	28	29	abstract	34092293
CCRA	B-DDF	29	33	abstract	34092293
)	O	33	34	abstract	34092293
is	O	35	37	abstract	34092293
mainly	O	38	44	abstract	34092293
caused	O	45	51	abstract	34092293
by	O	52	54	abstract	34092293
systemic	B-DDF	55	63	abstract	34092293
inflammation	I-DDF	64	76	abstract	34092293
,	O	76	77	abstract	34092293
intestinal	B-DDF	78	88	abstract	34092293
bleeding	I-DDF	89	97	abstract	34092293
,	O	97	98	abstract	34092293
iron	B-DDF	99	103	abstract	34092293
deficiency	I-DDF	104	114	abstract	34092293
and	O	115	118	abstract	34092293
chemotherapy-induced	B-DDF	119	139	abstract	34092293
myelosuppression	I-DDF	140	156	abstract	34092293
in	O	157	159	abstract	34092293
colon	B-DDF	160	165	abstract	34092293
cancer	I-DDF	166	172	abstract	34092293
.	O	172	173	abstract	34092293

However	O	174	181	abstract	34092293
,	O	181	182	abstract	34092293
the	O	183	186	abstract	34092293
best	O	187	191	abstract	34092293
therapeutic	O	192	203	abstract	34092293
schedule	O	204	212	abstract	34092293
and	O	213	216	abstract	34092293
related	O	217	224	abstract	34092293
mechanism	O	225	234	abstract	34092293
on	O	235	237	abstract	34092293
CCRA	B-DDF	238	242	abstract	34092293
were	O	243	247	abstract	34092293
still	O	248	253	abstract	34092293
uncertain	O	254	263	abstract	34092293
.	O	263	264	abstract	34092293

Studies	O	265	272	abstract	34092293
on	O	273	275	abstract	34092293
blood	O	276	281	abstract	34092293
enrichment	O	282	292	abstract	34092293
and	O	293	296	abstract	34092293
anti-tumor	O	297	307	abstract	34092293
effects	O	308	315	abstract	34092293
of	O	316	318	abstract	34092293
combined	O	319	327	abstract	34092293
Danggui	B-dietary%supplement	328	335	abstract	34092293
Buxue	I-dietary%supplement	336	341	abstract	34092293
Decoction	I-dietary%supplement	342	351	abstract	34092293
(	O	352	353	abstract	34092293
DBD	B-dietary%supplement	353	356	abstract	34092293
)	O	356	357	abstract	34092293
,	O	357	358	abstract	34092293
Fe	B-chemical	359	361	abstract	34092293
and	O	362	365	abstract	34092293
rhEPO	B-chemical	366	371	abstract	34092293
based	O	372	377	abstract	34092293
on	O	378	380	abstract	34092293
CCRA	B-DDF	381	385	abstract	34092293
and	O	386	389	abstract	34092293
gut	O	390	393	abstract	34092293
microbiota	O	394	404	abstract	34092293
modulation	O	405	415	abstract	34092293
were	O	416	420	abstract	34092293
conducted	O	421	430	abstract	34092293
in	O	431	433	abstract	34092293
this	O	434	438	abstract	34092293
paper	O	439	444	abstract	34092293
.	O	444	445	abstract	34092293

Here	O	446	450	abstract	34092293
,	O	450	451	abstract	34092293
CCRA	B-DDF	452	456	abstract	34092293
model	O	457	462	abstract	34092293
was	O	463	466	abstract	34092293
successfully	O	467	479	abstract	34092293
induced	O	480	487	abstract	34092293
by	O	488	490	abstract	34092293
subcutaneous	O	491	503	abstract	34092293
inoculation	O	504	515	abstract	34092293
of	O	516	518	abstract	34092293
CT-26	B-drug	519	524	abstract	34092293
and	O	525	528	abstract	34092293
i.p	O	529	532	abstract	34092293
.	O	532	533	abstract	34092293

oxaliplatin	B-drug	534	545	abstract	34092293
,	O	545	546	abstract	34092293
rhEPO	B-drug	547	552	abstract	34092293
+	O	553	554	abstract	34092293
DBD	B-dietary%supplement	555	558	abstract	34092293
high	I-dietary%supplement	559	563	abstract	34092293
dosage	I-dietary%supplement	564	570	abstract	34092293
+	O	571	572	abstract	34092293
Fe	B-chemical	573	575	abstract	34092293
(	O	576	577	abstract	34092293
EDF	O	577	580	abstract	34092293
)	O	580	581	abstract	34092293
and	O	582	585	abstract	34092293
rhEPO	B-chemical	586	591	abstract	34092293
+	O	592	593	abstract	34092293
DBD	B-dietary%supplement	594	597	abstract	34092293
high	I-dietary%supplement	598	602	abstract	34092293
dosage	I-dietary%supplement	603	609	abstract	34092293
(	O	610	611	abstract	34092293
ED	O	611	613	abstract	34092293
)	O	613	614	abstract	34092293
groups	O	615	621	abstract	34092293
had	O	622	625	abstract	34092293
the	O	626	629	abstract	34092293
best	O	630	634	abstract	34092293
blood	O	635	640	abstract	34092293
enrichment	O	641	651	abstract	34092293
effect	O	652	658	abstract	34092293
.	O	658	659	abstract	34092293

Attractively	O	660	672	abstract	34092293
,	O	672	673	abstract	34092293
EDF	B-human	674	677	abstract	34092293
group	I-human	678	683	abstract	34092293
also	O	684	688	abstract	34092293
showed	O	689	695	abstract	34092293
antitumor	O	696	705	abstract	34092293
activity	O	706	714	abstract	34092293
.	O	714	715	abstract	34092293

The	O	716	719	abstract	34092293
sequencing	O	720	730	abstract	34092293
results	O	731	738	abstract	34092293
of	O	739	741	abstract	34092293
gut	B-microbiome	742	745	abstract	34092293
microbiota	I-microbiome	746	756	abstract	34092293
showed	O	757	763	abstract	34092293
that	O	764	768	abstract	34092293
compared	O	769	777	abstract	34092293
to	O	778	780	abstract	34092293
P	B-human	781	782	abstract	34092293
group	I-human	783	788	abstract	34092293
,	O	788	789	abstract	34092293
the	O	790	793	abstract	34092293
relative	O	794	802	abstract	34092293
abundances	O	803	813	abstract	34092293
of	O	814	816	abstract	34092293
Lachnospiraceae	B-bacteria	817	832	abstract	34092293
and	O	833	836	abstract	34092293
opportunistic	O	837	850	abstract	34092293
pathogen	O	851	859	abstract	34092293
(	O	860	861	abstract	34092293
Odoribacter	B-bacteria	861	872	abstract	34092293
)	O	872	873	abstract	34092293
in	O	874	876	abstract	34092293
ED	B-human	877	879	abstract	34092293
and	I-human	880	883	abstract	34092293
EDF	I-human	884	887	abstract	34092293
groups	I-human	888	894	abstract	34092293
were	O	895	899	abstract	34092293
decreased	O	900	909	abstract	34092293
.	O	909	910	abstract	34092293

Interestingly	O	911	924	abstract	34092293
,	O	924	925	abstract	34092293
EDF	O	926	929	abstract	34092293
also	O	930	934	abstract	34092293
decreased	O	935	944	abstract	34092293
the	O	945	948	abstract	34092293
relative	O	949	957	abstract	34092293
abundances	O	958	968	abstract	34092293
of	O	969	971	abstract	34092293
cancer-related	B-bacteria	972	986	abstract	34092293
bacteria	I-bacteria	987	995	abstract	34092293
(	O	996	997	abstract	34092293
Helicobacter	B-bacteria	997	1009	abstract	34092293
,	O	1009	1010	abstract	34092293
Lactococcus	B-bacteria	1011	1022	abstract	34092293
,	O	1022	1023	abstract	34092293
Alloprevotella	B-bacteria	1024	1038	abstract	34092293
)	O	1038	1039	abstract	34092293
and	O	1040	1043	abstract	34092293
imbalance-inducing	B-bacteria	1044	1062	abstract	34092293
bacteria	I-bacteria	1063	1071	abstract	34092293
(	O	1072	1073	abstract	34092293
Escherichia-Shigella	B-bacteria	1073	1093	abstract	34092293
and	O	1094	1097	abstract	34092293
Parabacteroides	B-bacteria	1098	1113	abstract	34092293
)	O	1113	1114	abstract	34092293
and	O	1115	1118	abstract	34092293
increased	O	1119	1128	abstract	34092293
the	O	1129	1132	abstract	34092293
relative	O	1133	1141	abstract	34092293
abundances	O	1142	1152	abstract	34092293
of	O	1153	1155	abstract	34092293
butyrate-producing	B-bacteria	1156	1174	abstract	34092293
bacteria	I-bacteria	1175	1183	abstract	34092293
(	O	1184	1185	abstract	34092293
Ruminococcaceae_UCG-014	B-bacteria	1185	1208	abstract	34092293
)	O	1208	1209	abstract	34092293
,	O	1209	1210	abstract	34092293
however	O	1211	1218	abstract	34092293
,	O	1218	1219	abstract	34092293
ED	O	1220	1222	abstract	34092293
showed	O	1223	1229	abstract	34092293
the	O	1230	1233	abstract	34092293
opposite	O	1234	1242	abstract	34092293
effects	O	1243	1250	abstract	34092293
to	O	1251	1253	abstract	34092293
EDF	O	1254	1257	abstract	34092293
,	O	1257	1258	abstract	34092293
this	O	1259	1263	abstract	34092293
might	O	1264	1269	abstract	34092293
be	O	1270	1272	abstract	34092293
the	O	1273	1276	abstract	34092293
reason	O	1277	1283	abstract	34092293
of	O	1284	1286	abstract	34092293
the	O	1287	1290	abstract	34092293
smaller	O	1291	1298	abstract	34092293
tumor	O	1299	1304	abstract	34092293
volume	O	1305	1311	abstract	34092293
in	O	1312	1314	abstract	34092293
EDF	O	1315	1318	abstract	34092293
group	O	1319	1324	abstract	34092293
.	O	1324	1325	abstract	34092293

Our	O	1326	1329	abstract	34092293
findings	O	1330	1338	abstract	34092293
proposed	O	1339	1347	abstract	34092293
the	O	1348	1351	abstract	34092293
best	O	1352	1356	abstract	34092293
treatment	O	1357	1366	abstract	34092293
combination	O	1367	1378	abstract	34092293
of	O	1379	1381	abstract	34092293
DBD	B-dietary%supplement	1382	1385	abstract	34092293
,	O	1385	1386	abstract	34092293
rhEPO	B-chemical	1387	1392	abstract	34092293
and	O	1393	1396	abstract	34092293
Fe	B-chemical	1397	1399	abstract	34092293
in	O	1400	1402	abstract	34092293
CCRA	B-DDF	1403	1407	abstract	34092293
and	O	1408	1411	abstract	34092293
provided	O	1412	1420	abstract	34092293
theoretical	O	1421	1432	abstract	34092293
basis	O	1433	1438	abstract	34092293
and	O	1439	1442	abstract	34092293
literature	O	1443	1453	abstract	34092293
reference	O	1454	1463	abstract	34092293
for	O	1464	1467	abstract	34092293
CCRA-induced	B-DDF	1468	1480	abstract	34092293
intestinal	I-DDF	1481	1491	abstract	34092293
flora	I-DDF	1492	1497	abstract	34092293
disorder	I-DDF	1498	1506	abstract	34092293
and	O	1507	1510	abstract	34092293
the	O	1511	1514	abstract	34092293
regulatory	O	1515	1525	abstract	34092293
mechanism	O	1526	1535	abstract	34092293
of	O	1536	1538	abstract	34092293
EDF	O	1539	1542	abstract	34092293
.	O	1542	1543	abstract	34092293

<	B-bacteria	0	1	title	37927130
i	I-bacteria	1	2	title	37927130
>	I-bacteria	2	3	title	37927130
Lactobacillus	I-bacteria	3	16	title	37927130
reuteri</i	I-bacteria	17	27	title	37927130
>	I-bacteria	27	28	title	37927130
ATG-F4	I-bacteria	29	35	title	37927130
Alleviates	O	36	46	title	37927130
Chronic	B-DDF	47	54	title	37927130
Stress-induced	I-DDF	55	69	title	37927130
Anhedonia	I-DDF	70	79	title	37927130
by	O	80	82	title	37927130
Modulating	O	83	93	title	37927130
the	O	94	97	title	37927130
Prefrontal	O	98	108	title	37927130
Serotonergic	O	109	121	title	37927130
System	O	122	128	title	37927130
.	O	128	129	title	37927130

Mental	O	0	6	abstract	37927130
health	O	7	13	abstract	37927130
is	O	14	16	abstract	37927130
influenced	O	17	27	abstract	37927130
by	O	28	30	abstract	37927130
the	O	31	34	abstract	37927130
gut-brain	O	35	44	abstract	37927130
axis	O	45	49	abstract	37927130
;	O	49	50	abstract	37927130
for	O	51	54	abstract	37927130
example	O	55	62	abstract	37927130
,	O	62	63	abstract	37927130
gut	B-DDF	64	67	abstract	37927130
dysbiosis	I-DDF	68	77	abstract	37927130
has	O	78	81	abstract	37927130
been	O	82	86	abstract	37927130
observed	O	87	95	abstract	37927130
in	O	96	98	abstract	37927130
patients	B-human	99	107	abstract	37927130
with	O	108	112	abstract	37927130
major	B-DDF	113	118	abstract	37927130
depressive	I-DDF	119	129	abstract	37927130
disorder	I-DDF	130	138	abstract	37927130
(	O	139	140	abstract	37927130
MDD	B-DDF	140	143	abstract	37927130
)	O	143	144	abstract	37927130
.	O	144	145	abstract	37927130

Gut	O	146	149	abstract	37927130
microbial	O	150	159	abstract	37927130
changes	O	160	167	abstract	37927130
by	O	168	170	abstract	37927130
fecal	O	171	176	abstract	37927130
microbiota	O	177	187	abstract	37927130
transplantation	O	188	203	abstract	37927130
or	O	204	206	abstract	37927130
probiotics	O	207	217	abstract	37927130
treatment	O	218	227	abstract	37927130
reportedly	O	228	238	abstract	37927130
modulates	O	239	248	abstract	37927130
depressive	B-DDF	249	259	abstract	37927130
symptoms	I-DDF	260	268	abstract	37927130
.	O	268	269	abstract	37927130

However	O	270	277	abstract	37927130
,	O	277	278	abstract	37927130
it	O	279	281	abstract	37927130
remains	O	282	289	abstract	37927130
unclear	O	290	297	abstract	37927130
how	O	298	301	abstract	37927130
gut	B-DDF	302	305	abstract	37927130
dysbiosis	I-DDF	306	315	abstract	37927130
contributes	O	316	327	abstract	37927130
to	O	328	330	abstract	37927130
mental	B-DDF	331	337	abstract	37927130
dysfunction	I-DDF	338	349	abstract	37927130
,	O	349	350	abstract	37927130
and	O	351	354	abstract	37927130
how	O	355	358	abstract	37927130
correction	O	359	369	abstract	37927130
of	O	370	372	abstract	37927130
the	O	373	376	abstract	37927130
gut	B-microbiome	377	380	abstract	37927130
microbiota	I-microbiome	381	391	abstract	37927130
alleviates	O	392	402	abstract	37927130
neuropsychiatric	B-DDF	403	419	abstract	37927130
disorders	I-DDF	420	429	abstract	37927130
.	O	429	430	abstract	37927130

Our	O	431	434	abstract	37927130
previous	O	435	443	abstract	37927130
study	O	444	449	abstract	37927130
showed	O	450	456	abstract	37927130
that	O	457	461	abstract	37927130
chronic	O	462	469	abstract	37927130
consumption	O	470	481	abstract	37927130
of	O	482	484	abstract	37927130
<	B-bacteria	485	486	abstract	37927130
i	I-bacteria	486	487	abstract	37927130
>	I-bacteria	487	488	abstract	37927130
Lactobacillus	I-bacteria	488	501	abstract	37927130
reuteri</i	I-bacteria	502	512	abstract	37927130
>	I-bacteria	512	513	abstract	37927130
ATG-F4	I-bacteria	514	520	abstract	37927130
(	O	521	522	abstract	37927130
F4	B-bacteria	522	524	abstract	37927130
)	O	524	525	abstract	37927130
induced	O	526	533	abstract	37927130
neurometabolic	B-DDF	534	548	abstract	37927130
alterations	I-DDF	549	560	abstract	37927130
in	O	561	563	abstract	37927130
healthy	B-animal	564	571	abstract	37927130
mice	I-animal	572	576	abstract	37927130
.	O	576	577	abstract	37927130

Here	O	578	582	abstract	37927130
,	O	582	583	abstract	37927130
we	O	584	586	abstract	37927130
investigated	O	587	599	abstract	37927130
whether	O	600	607	abstract	37927130
F4	B-bacteria	608	610	abstract	37927130
exerted	O	611	618	abstract	37927130
therapeutic	O	619	630	abstract	37927130
effects	O	631	638	abstract	37927130
on	O	639	641	abstract	37927130
depressive-like	B-DDF	642	657	abstract	37927130
behavior	I-DDF	658	666	abstract	37927130
by	O	667	669	abstract	37927130
influencing	O	670	681	abstract	37927130
the	O	682	685	abstract	37927130
central	O	686	693	abstract	37927130
nervous	O	694	701	abstract	37927130
system	O	702	708	abstract	37927130
.	O	708	709	abstract	37927130

Using	O	710	715	abstract	37927130
chronic	B-DDF	716	723	abstract	37927130
unpredictable	I-DDF	724	737	abstract	37927130
stress	I-DDF	738	744	abstract	37927130
(	O	745	746	abstract	37927130
CUS	B-DDF	746	749	abstract	37927130
)	O	749	750	abstract	37927130
to	O	751	753	abstract	37927130
induce	O	754	760	abstract	37927130
anhedonia	B-DDF	761	770	abstract	37927130
,	O	770	771	abstract	37927130
a	O	772	773	abstract	37927130
key	O	774	777	abstract	37927130
symptom	O	778	785	abstract	37927130
of	O	786	788	abstract	37927130
MDD	B-DDF	789	792	abstract	37927130
,	O	792	793	abstract	37927130
we	O	794	796	abstract	37927130
found	O	797	802	abstract	37927130
that	O	803	807	abstract	37927130
chronic	O	808	815	abstract	37927130
F4	B-dietary%supplement	816	818	abstract	37927130
consumption	I-dietary%supplement	819	830	abstract	37927130
alleviated	O	831	841	abstract	37927130
CUS-induced	B-DDF	842	853	abstract	37927130
anhedonic	I-DDF	854	863	abstract	37927130
behaviors	I-DDF	864	873	abstract	37927130
,	O	873	874	abstract	37927130
accompanied	O	875	886	abstract	37927130
by	O	887	889	abstract	37927130
biochemical	O	890	901	abstract	37927130
changes	O	902	909	abstract	37927130
in	O	910	912	abstract	37927130
the	O	913	916	abstract	37927130
gut	B-anatomical%location	917	920	abstract	37927130
,	O	920	921	abstract	37927130
serum	B-anatomical%location	922	927	abstract	37927130
,	O	927	928	abstract	37927130
and	O	929	932	abstract	37927130
brain	B-anatomical%location	933	938	abstract	37927130
.	O	938	939	abstract	37927130

Serum	O	940	945	abstract	37927130
and	O	946	949	abstract	37927130
brain	O	950	955	abstract	37927130
metabolite	O	956	966	abstract	37927130
concentrations	O	967	981	abstract	37927130
involved	O	982	990	abstract	37927130
in	O	991	993	abstract	37927130
tryptophan	O	994	1004	abstract	37927130
metabolism	O	1005	1015	abstract	37927130
were	O	1016	1020	abstract	37927130
regulated	O	1021	1030	abstract	37927130
by	O	1031	1033	abstract	37927130
CUS	B-DDF	1034	1037	abstract	37927130
and	O	1038	1041	abstract	37927130
F4	B-bacteria	1042	1044	abstract	37927130
.	O	1044	1045	abstract	37927130

F4	B-dietary%supplement	1046	1048	abstract	37927130
consumption	I-dietary%supplement	1049	1060	abstract	37927130
reduced	O	1061	1068	abstract	37927130
the	O	1069	1072	abstract	37927130
elevated	O	1073	1081	abstract	37927130
levels	O	1082	1088	abstract	37927130
of	O	1089	1091	abstract	37927130
serotonin	B-chemical	1092	1101	abstract	37927130
(	O	1102	1103	abstract	37927130
5-HT	B-chemical	1103	1107	abstract	37927130
)	O	1107	1108	abstract	37927130
in	O	1109	1111	abstract	37927130
the	O	1112	1115	abstract	37927130
brain	B-anatomical%location	1116	1121	abstract	37927130
observed	O	1122	1130	abstract	37927130
in	O	1131	1133	abstract	37927130
the	O	1134	1137	abstract	37927130
CUS	O	1138	1141	abstract	37927130
group	O	1142	1147	abstract	37927130
.	O	1147	1148	abstract	37927130

Additionally	O	1149	1161	abstract	37927130
,	O	1161	1162	abstract	37927130
the	O	1163	1166	abstract	37927130
increased	O	1167	1176	abstract	37927130
expression	O	1177	1187	abstract	37927130
of	O	1188	1190	abstract	37927130
<	O	1191	1192	abstract	37927130
i	O	1192	1193	abstract	37927130
>	O	1193	1194	abstract	37927130
Htr1a</i	B-gene	1194	1202	abstract	37927130
>	O	1202	1203	abstract	37927130
,	O	1203	1204	abstract	37927130
a	O	1205	1206	abstract	37927130
subtype	O	1207	1214	abstract	37927130
of	O	1215	1217	abstract	37927130
the	O	1218	1221	abstract	37927130
5-HT	B-chemical	1222	1226	abstract	37927130
receptor	I-chemical	1227	1235	abstract	37927130
,	O	1235	1236	abstract	37927130
in	O	1237	1239	abstract	37927130
the	O	1240	1243	abstract	37927130
medial	B-anatomical%location	1244	1250	abstract	37927130
prefrontal	I-anatomical%location	1251	1261	abstract	37927130
cortex	I-anatomical%location	1262	1268	abstract	37927130
(	O	1269	1270	abstract	37927130
mPFC	B-anatomical%location	1270	1274	abstract	37927130
)	O	1274	1275	abstract	37927130
of	O	1276	1278	abstract	37927130
stressed	B-animal	1279	1287	abstract	37927130
mice	I-animal	1288	1292	abstract	37927130
was	O	1293	1296	abstract	37927130
restored	O	1297	1305	abstract	37927130
to	O	1306	1308	abstract	37927130
levels	O	1309	1315	abstract	37927130
observed	O	1316	1324	abstract	37927130
in	O	1325	1327	abstract	37927130
stress-nave	B-animal	1328	1340	abstract	37927130
mice	I-animal	1341	1345	abstract	37927130
following	O	1346	1355	abstract	37927130
F4	B-dietary%supplement	1356	1358	abstract	37927130
supplementation	I-dietary%supplement	1359	1374	abstract	37927130
.	O	1374	1375	abstract	37927130

We	O	1376	1378	abstract	37927130
further	O	1379	1386	abstract	37927130
demonstrated	O	1387	1399	abstract	37927130
the	O	1400	1403	abstract	37927130
role	O	1404	1408	abstract	37927130
of	O	1409	1411	abstract	37927130
<	O	1412	1413	abstract	37927130
i	O	1413	1414	abstract	37927130
>	O	1414	1415	abstract	37927130
Htr1a</i	B-gene	1415	1423	abstract	37927130
>	O	1423	1424	abstract	37927130
using	O	1425	1430	abstract	37927130
AAV-shRNA	B-biomedical%technique	1431	1440	abstract	37927130
to	O	1441	1443	abstract	37927130
downregulate	O	1444	1456	abstract	37927130
<	O	1457	1458	abstract	37927130
i	O	1458	1459	abstract	37927130
>	O	1459	1460	abstract	37927130
Htr1a</i	B-gene	1460	1468	abstract	37927130
>	O	1468	1469	abstract	37927130
in	O	1470	1472	abstract	37927130
the	O	1473	1476	abstract	37927130
mPFC	B-anatomical%location	1477	1481	abstract	37927130
of	O	1482	1484	abstract	37927130
CUS	B-animal	1485	1488	abstract	37927130
mice	I-animal	1489	1493	abstract	37927130
,	O	1493	1494	abstract	37927130
effectively	O	1495	1506	abstract	37927130
reversing	O	1507	1516	abstract	37927130
CUS-induced	B-DDF	1517	1528	abstract	37927130
anhedonic	I-DDF	1529	1538	abstract	37927130
behavior	I-DDF	1539	1547	abstract	37927130
.	O	1547	1548	abstract	37927130

Together	O	1549	1557	abstract	37927130
,	O	1557	1558	abstract	37927130
our	O	1559	1562	abstract	37927130
findings	O	1563	1571	abstract	37927130
suggest	O	1572	1579	abstract	37927130
F4	B-bacteria	1580	1582	abstract	37927130
as	O	1583	1585	abstract	37927130
a	O	1586	1587	abstract	37927130
potential	O	1588	1597	abstract	37927130
therapeutic	O	1598	1609	abstract	37927130
approach	O	1610	1618	abstract	37927130
for	O	1619	1622	abstract	37927130
relieving	O	1623	1632	abstract	37927130
some	O	1633	1637	abstract	37927130
depressive	B-DDF	1638	1648	abstract	37927130
symptoms	I-DDF	1649	1657	abstract	37927130
and	O	1658	1661	abstract	37927130
highlight	O	1662	1671	abstract	37927130
the	O	1672	1675	abstract	37927130
involvement	O	1676	1687	abstract	37927130
of	O	1688	1690	abstract	37927130
the	O	1691	1694	abstract	37927130
tryptophan	O	1695	1705	abstract	37927130
metabolism	O	1706	1716	abstract	37927130
in	O	1717	1719	abstract	37927130
mitigating	O	1720	1730	abstract	37927130
CUS-induced	B-DDF	1731	1742	abstract	37927130
depressive-like	I-DDF	1743	1758	abstract	37927130
behaviors	I-DDF	1759	1768	abstract	37927130
through	O	1769	1776	abstract	37927130
the	O	1777	1780	abstract	37927130
action	O	1781	1787	abstract	37927130
of	O	1788	1790	abstract	37927130
this	O	1791	1795	abstract	37927130
bacterium	O	1796	1805	abstract	37927130
.	O	1805	1806	abstract	37927130

To	O	0	2	title	35432226
the	O	3	6	title	35432226
Gut	B-microbiome	7	10	title	35432226
Microbiome	I-microbiome	11	21	title	35432226
and	O	22	25	title	35432226
Beyond	O	26	32	title	35432226
:	O	32	33	title	35432226
The	O	34	37	title	35432226
Brain-First	O	38	49	title	35432226
or	O	50	52	title	35432226
Body-First	O	53	63	title	35432226
Hypothesis	O	64	74	title	35432226
in	O	75	77	title	35432226
Parkinson	B-DDF	78	87	title	35432226
's	I-DDF	87	89	title	35432226
Disease	I-DDF	90	97	title	35432226
.	O	97	98	title	35432226

There	O	0	5	abstract	35432226
is	O	6	8	abstract	35432226
continued	O	9	18	abstract	35432226
debate	O	19	25	abstract	35432226
regarding	O	26	35	abstract	35432226
Parkinson	B-DDF	36	45	abstract	35432226
's	I-DDF	45	47	abstract	35432226
disease	I-DDF	48	55	abstract	35432226
etiology	O	56	64	abstract	35432226
and	O	65	68	abstract	35432226
whether	O	69	76	abstract	35432226
it	O	77	79	abstract	35432226
originates	O	80	90	abstract	35432226
in	O	91	93	abstract	35432226
the	O	94	97	abstract	35432226
brain	B-anatomical%location	98	103	abstract	35432226
or	O	104	106	abstract	35432226
begins	O	107	113	abstract	35432226
in	O	114	116	abstract	35432226
the	O	117	120	abstract	35432226
gut	B-anatomical%location	121	124	abstract	35432226
.	O	124	125	abstract	35432226

Recently	O	126	134	abstract	35432226
,	O	134	135	abstract	35432226
evidence	O	136	144	abstract	35432226
has	O	145	148	abstract	35432226
been	O	149	153	abstract	35432226
provided	O	154	162	abstract	35432226
for	O	163	166	abstract	35432226
both	O	167	171	abstract	35432226
,	O	171	172	abstract	35432226
with	O	173	177	abstract	35432226
Parkinson	B-DDF	178	187	abstract	35432226
's	I-DDF	187	189	abstract	35432226
disease	I-DDF	190	197	abstract	35432226
onset	O	198	203	abstract	35432226
presenting	O	204	214	abstract	35432226
as	O	215	217	abstract	35432226
either	O	218	224	abstract	35432226
a	O	225	226	abstract	35432226
"	O	227	228	abstract	35432226
body-first	O	228	238	abstract	35432226
"	O	238	239	abstract	35432226
or	O	240	242	abstract	35432226
"	O	243	244	abstract	35432226
brain-first	O	244	255	abstract	35432226
"	O	255	256	abstract	35432226
progression	O	257	268	abstract	35432226
.	O	268	269	abstract	35432226

Most	O	270	274	abstract	35432226
research	O	275	283	abstract	35432226
indicates	O	284	293	abstract	35432226
those	O	294	299	abstract	35432226
with	O	300	304	abstract	35432226
Parkinson	B-DDF	305	314	abstract	35432226
's	I-DDF	314	316	abstract	35432226
disease	I-DDF	317	324	abstract	35432226
have	O	325	329	abstract	35432226
an	O	330	332	abstract	35432226
altered	O	333	340	abstract	35432226
gut	B-microbiome	341	344	abstract	35432226
microbiome	I-microbiome	345	355	abstract	35432226
compared	O	356	364	abstract	35432226
to	O	365	367	abstract	35432226
controls	O	368	376	abstract	35432226
.	O	376	377	abstract	35432226

However	O	378	385	abstract	35432226
,	O	385	386	abstract	35432226
some	O	387	391	abstract	35432226
studies	O	392	399	abstract	35432226
do	O	400	402	abstract	35432226
not	O	403	406	abstract	35432226
report	O	407	413	abstract	35432226
gut	O	414	417	abstract	35432226
microbiome	O	418	428	abstract	35432226
differences	O	429	440	abstract	35432226
,	O	440	441	abstract	35432226
potentially	O	442	453	abstract	35432226
due	O	454	457	abstract	35432226
to	O	458	460	abstract	35432226
the	O	461	464	abstract	35432226
brain	O	465	470	abstract	35432226
or	O	471	473	abstract	35432226
body-first	O	474	484	abstract	35432226
progression	O	485	496	abstract	35432226
type	O	497	501	abstract	35432226
.	O	501	502	abstract	35432226

Based	O	503	508	abstract	35432226
on	O	509	511	abstract	35432226
the	O	512	515	abstract	35432226
etiology	O	516	524	abstract	35432226
of	O	525	527	abstract	35432226
each	O	528	532	abstract	35432226
proposed	O	533	541	abstract	35432226
progression	O	542	553	abstract	35432226
,	O	553	554	abstract	35432226
individuals	B-human	555	566	abstract	35432226
with	O	567	571	abstract	35432226
the	O	572	575	abstract	35432226
body-first	O	576	586	abstract	35432226
progression	O	587	598	abstract	35432226
may	O	599	602	abstract	35432226
exhibit	O	603	610	abstract	35432226
altered	B-DDF	611	618	abstract	35432226
gut	I-DDF	619	622	abstract	35432226
microbiomes	I-DDF	623	634	abstract	35432226
,	O	634	635	abstract	35432226
i.e.	O	636	640	abstract	35432226
,	O	640	641	abstract	35432226
where	O	642	647	abstract	35432226
short-chain	B-bacteria	648	659	abstract	35432226
fatty	I-bacteria	660	665	abstract	35432226
acid	I-bacteria	666	670	abstract	35432226
producing	I-bacteria	671	680	abstract	35432226
bacteria	I-bacteria	681	689	abstract	35432226
are	O	690	693	abstract	35432226
reduced	O	694	701	abstract	35432226
,	O	701	702	abstract	35432226
while	O	703	708	abstract	35432226
the	O	709	712	abstract	35432226
brain-first	O	713	724	abstract	35432226
progression	O	725	736	abstract	35432226
may	O	737	740	abstract	35432226
not	O	741	744	abstract	35432226
.	O	744	745	abstract	35432226

Future	O	746	752	abstract	35432226
microbiome	O	753	763	abstract	35432226
research	O	764	772	abstract	35432226
should	O	773	779	abstract	35432226
consider	O	780	788	abstract	35432226
this	O	789	793	abstract	35432226
hypothesis	O	794	804	abstract	35432226
and	O	805	808	abstract	35432226
investigate	O	809	820	abstract	35432226
whether	O	821	828	abstract	35432226
gut	O	829	832	abstract	35432226
microbiome	O	833	843	abstract	35432226
differences	O	844	855	abstract	35432226
exist	O	856	861	abstract	35432226
between	O	862	869	abstract	35432226
each	O	870	874	abstract	35432226
type	O	875	879	abstract	35432226
of	O	880	882	abstract	35432226
progression	O	883	894	abstract	35432226
.	O	894	895	abstract	35432226

This	O	896	900	abstract	35432226
may	O	901	904	abstract	35432226
further	O	905	912	abstract	35432226
elucidate	O	913	922	abstract	35432226
the	O	923	926	abstract	35432226
impact	O	927	933	abstract	35432226
of	O	934	936	abstract	35432226
the	O	937	940	abstract	35432226
gut	B-microbiome	941	944	abstract	35432226
microbiome	I-microbiome	945	955	abstract	35432226
in	O	956	958	abstract	35432226
Parkinson	B-DDF	959	968	abstract	35432226
's	I-DDF	968	970	abstract	35432226
disease	I-DDF	971	978	abstract	35432226
and	O	979	982	abstract	35432226
show	O	983	987	abstract	35432226
how	O	988	991	abstract	35432226
it	O	992	994	abstract	35432226
may	O	995	998	abstract	35432226
not	O	999	1002	abstract	35432226
be	O	1003	1005	abstract	35432226
homogenous	O	1006	1016	abstract	35432226
across	O	1017	1023	abstract	35432226
individuals	O	1024	1035	abstract	35432226
with	O	1036	1040	abstract	35432226
Parkinson	B-DDF	1041	1050	abstract	35432226
's	I-DDF	1050	1052	abstract	35432226
disease	I-DDF	1053	1060	abstract	35432226
.	O	1060	1061	abstract	35432226

Targeting	O	0	9	title	36757367
the	O	10	13	title	36757367
gut-microbiota-brain	O	14	34	title	36757367
axis	O	35	39	title	36757367
in	O	40	42	title	36757367
irritable	B-DDF	43	52	title	36757367
bowel	I-DDF	53	58	title	36757367
disease	I-DDF	59	66	title	36757367
to	O	67	69	title	36757367
improve	O	70	77	title	36757367
cognitive	O	78	87	title	36757367
function	O	88	96	title	36757367
	O	96	97	title	36757367
-	O	97	98	title	36757367
recent	O	99	105	title	36757367
knowledge	O	106	115	title	36757367
and	O	116	119	title	36757367
emerging	O	120	128	title	36757367
therapeutic	O	129	140	title	36757367
opportunities	O	141	154	title	36757367
.	O	154	155	title	36757367

The	O	0	3	abstract	36757367
brain-gut	O	4	13	abstract	36757367
axis	O	14	18	abstract	36757367
forms	O	19	24	abstract	36757367
a	O	25	26	abstract	36757367
bidirectional	O	27	40	abstract	36757367
communication	O	41	54	abstract	36757367
system	O	55	61	abstract	36757367
between	O	62	69	abstract	36757367
the	O	70	73	abstract	36757367
gastrointestinal	B-animal	74	90	abstract	36757367
(	I-animal	91	92	abstract	36757367
GI	I-animal	92	94	abstract	36757367
)	I-animal	94	95	abstract	36757367
tract	I-animal	96	101	abstract	36757367
and	O	102	105	abstract	36757367
cognitive	B-anatomical%location	106	115	abstract	36757367
brain	I-anatomical%location	116	121	abstract	36757367
areas	I-anatomical%location	122	127	abstract	36757367
.	O	127	128	abstract	36757367

Disturbances	O	129	141	abstract	36757367
to	O	142	144	abstract	36757367
this	O	145	149	abstract	36757367
system	O	150	156	abstract	36757367
in	O	157	159	abstract	36757367
disease	O	160	167	abstract	36757367
states	O	168	174	abstract	36757367
such	O	175	179	abstract	36757367
as	O	180	182	abstract	36757367
inflammatory	B-DDF	183	195	abstract	36757367
bowel	I-DDF	196	201	abstract	36757367
disease	I-DDF	202	209	abstract	36757367
have	O	210	214	abstract	36757367
	O	214	215	abstract	36757367
consequences	O	215	227	abstract	36757367
for	O	228	231	abstract	36757367
neuronal	O	232	240	abstract	36757367
activity	O	241	249	abstract	36757367
and	O	250	253	abstract	36757367
subsequent	O	254	264	abstract	36757367
cognitive	O	265	274	abstract	36757367
function	O	275	283	abstract	36757367
.	O	283	284	abstract	36757367

The	O	285	288	abstract	36757367
gut-microbiota-brain	O	289	309	abstract	36757367
axis	O	310	314	abstract	36757367
refers	O	315	321	abstract	36757367
to	O	322	324	abstract	36757367
the	O	325	328	abstract	36757367
communication	O	329	342	abstract	36757367
between	O	343	350	abstract	36757367
gut-resident	B-bacteria	351	363	abstract	36757367
bacteria	I-bacteria	364	372	abstract	36757367
and	O	373	376	abstract	36757367
the	O	377	380	abstract	36757367
brain	B-anatomical%location	381	386	abstract	36757367
.	O	386	387	abstract	36757367

This	O	388	392	abstract	36757367
circuits	O	393	401	abstract	36757367
exists	O	402	408	abstract	36757367
to	O	409	411	abstract	36757367
detect	O	412	418	abstract	36757367
gut	B-microbiome	419	422	abstract	36757367
microorganisms	I-microbiome	423	437	abstract	36757367
and	O	438	441	abstract	36757367
	O	441	442	abstract	36757367
relay	O	442	447	abstract	36757367
information	O	448	459	abstract	36757367
to	O	460	462	abstract	36757367
specific	O	463	471	abstract	36757367
areas	O	472	477	abstract	36757367
of	O	478	480	abstract	36757367
the	O	481	484	abstract	36757367
central	O	485	492	abstract	36757367
nervous	O	493	500	abstract	36757367
system	O	501	507	abstract	36757367
(	O	508	509	abstract	36757367
CNS	O	509	512	abstract	36757367
)	O	512	513	abstract	36757367
that	O	514	518	abstract	36757367
in	O	519	521	abstract	36757367
turn	O	522	526	abstract	36757367
,	O	526	527	abstract	36757367
regulate	O	528	536	abstract	36757367
gut	O	537	540	abstract	36757367
physiology	O	541	551	abstract	36757367
.	O	551	552	abstract	36757367

Changes	O	553	560	abstract	36757367
in	O	561	563	abstract	36757367
both	O	564	568	abstract	36757367
the	O	569	572	abstract	36757367
stability	O	573	582	abstract	36757367
and	O	583	586	abstract	36757367
diversity	O	587	596	abstract	36757367
of	O	597	599	abstract	36757367
the	O	600	603	abstract	36757367
gut	B-microbiome	604	607	abstract	36757367
microbiota	I-microbiome	608	618	abstract	36757367
have	O	619	623	abstract	36757367
been	O	624	628	abstract	36757367
implicated	O	629	639	abstract	36757367
in	O	640	642	abstract	36757367
several	O	643	650	abstract	36757367
neuronal	B-DDF	651	659	abstract	36757367
disorders	I-DDF	660	669	abstract	36757367
,	O	669	670	abstract	36757367
including	O	671	680	abstract	36757367
depression	B-DDF	681	691	abstract	36757367
,	O	691	692	abstract	36757367
autism	B-DDF	693	699	abstract	36757367
spectrum	I-DDF	700	708	abstract	36757367
disorder	I-DDF	709	717	abstract	36757367
Parkinson	B-DDF	718	727	abstract	36757367
's	I-DDF	727	729	abstract	36757367
disease	I-DDF	730	737	abstract	36757367
,	O	737	738	abstract	36757367
Alzheimer	B-DDF	739	748	abstract	36757367
's	I-DDF	748	750	abstract	36757367
disease	I-DDF	751	758	abstract	36757367
and	O	759	762	abstract	36757367
multiple	B-DDF	763	771	abstract	36757367
sclerosis	I-DDF	772	781	abstract	36757367
.	O	781	782	abstract	36757367

Correcting	O	783	793	abstract	36757367
this	O	794	798	abstract	36757367
imbalance	O	799	808	abstract	36757367
with	O	809	813	abstract	36757367
medicinal	B-dietary%supplement	814	823	abstract	36757367
herbs	I-dietary%supplement	824	829	abstract	36757367
,	O	829	830	abstract	36757367
the	O	831	834	abstract	36757367
metabolic	O	835	844	abstract	36757367
products	O	845	853	abstract	36757367
of	O	854	856	abstract	36757367
dysregulated	B-bacteria	857	869	abstract	36757367
bacteria	I-bacteria	870	878	abstract	36757367
and	O	879	882	abstract	36757367
probiotics	B-dietary%supplement	883	893	abstract	36757367
have	O	894	898	abstract	36757367
shown	O	899	904	abstract	36757367
hope	O	905	909	abstract	36757367
for	O	910	913	abstract	36757367
the	O	914	917	abstract	36757367
treatment	O	918	927	abstract	36757367
of	O	928	930	abstract	36757367
these	O	931	936	abstract	36757367
neuronal	O	937	945	abstract	36757367
disorders	O	946	955	abstract	36757367
.	O	955	956	abstract	36757367

In	O	957	959	abstract	36757367
this	O	960	964	abstract	36757367
review	O	965	971	abstract	36757367
,	O	971	972	abstract	36757367
we	O	973	975	abstract	36757367
focus	O	976	981	abstract	36757367
on	O	982	984	abstract	36757367
recent	O	985	991	abstract	36757367
advances	O	992	1000	abstract	36757367
in	O	1001	1003	abstract	36757367
our	O	1004	1007	abstract	36757367
understanding	O	1008	1021	abstract	36757367
of	O	1022	1024	abstract	36757367
the	O	1025	1028	abstract	36757367
intricate	O	1029	1038	abstract	36757367
connections	O	1039	1050	abstract	36757367
between	O	1051	1058	abstract	36757367
the	O	1059	1062	abstract	36757367
gut-microbiota	B-microbiome	1063	1077	abstract	36757367
and	O	1078	1081	abstract	36757367
the	O	1082	1085	abstract	36757367
brain	B-anatomical%location	1086	1091	abstract	36757367
.	O	1091	1092	abstract	36757367

We	O	1093	1095	abstract	36757367
discuss	O	1096	1103	abstract	36757367
the	O	1104	1107	abstract	36757367
contribution	O	1108	1120	abstract	36757367
of	O	1121	1123	abstract	36757367
gut	B-microbiome	1124	1127	abstract	36757367
microbiota	I-microbiome	1128	1138	abstract	36757367
to	O	1139	1141	abstract	36757367
neuronal	B-DDF	1142	1150	abstract	36757367
disorders	I-DDF	1151	1160	abstract	36757367
and	O	1161	1164	abstract	36757367
the	O	1165	1168	abstract	36757367
tangible	O	1169	1177	abstract	36757367
links	O	1178	1183	abstract	36757367
between	O	1184	1191	abstract	36757367
diseases	B-DDF	1192	1200	abstract	36757367
of	I-DDF	1201	1203	abstract	36757367
the	I-DDF	1204	1207	abstract	36757367
GI	I-DDF	1208	1210	abstract	36757367
tract	I-DDF	1211	1216	abstract	36757367
with	O	1217	1221	abstract	36757367
cognitive	O	1222	1231	abstract	36757367
function	O	1232	1240	abstract	36757367
and	O	1241	1244	abstract	36757367
behaviour	O	1245	1254	abstract	36757367
.	O	1254	1255	abstract	36757367

In	O	1256	1258	abstract	36757367
this	O	1259	1263	abstract	36757367
regard	O	1264	1270	abstract	36757367
,	O	1270	1271	abstract	36757367
we	O	1272	1274	abstract	36757367
focus	O	1275	1280	abstract	36757367
on	O	1281	1283	abstract	36757367
irritable	B-DDF	1284	1293	abstract	36757367
bowel	I-DDF	1294	1299	abstract	36757367
syndrome	I-DDF	1300	1308	abstract	36757367
(	O	1309	1310	abstract	36757367
IBS	B-DDF	1310	1313	abstract	36757367
)	O	1313	1314	abstract	36757367
given	O	1315	1320	abstract	36757367
its	O	1321	1324	abstract	36757367
strong	O	1325	1331	abstract	36757367
links	O	1332	1337	abstract	36757367
to	O	1338	1340	abstract	36757367
	O	1340	1341	abstract	36757367
brain	O	1341	1346	abstract	36757367
function	O	1347	1355	abstract	36757367
and	O	1356	1359	abstract	36757367
anxiety	B-DDF	1360	1367	abstract	36757367
disorders	I-DDF	1368	1377	abstract	36757367
.	O	1377	1378	abstract	36757367

This	O	1379	1383	abstract	36757367
adds	O	1384	1388	abstract	36757367
to	O	1389	1391	abstract	36757367
the	O	1392	1395	abstract	36757367
growing	O	1396	1403	abstract	36757367
body	O	1404	1408	abstract	36757367
of	O	1409	1411	abstract	36757367
evidence	O	1412	1420	abstract	36757367
supporting	O	1421	1431	abstract	36757367
targeted	O	1432	1440	abstract	36757367
therapeutic	O	1441	1452	abstract	36757367
strategies	O	1453	1463	abstract	36757367
to	O	1464	1466	abstract	36757367
modulate	O	1467	1475	abstract	36757367
the	O	1476	1479	abstract	36757367
gut	B-microbiome	1480	1483	abstract	36757367
microbiota	I-microbiome	1484	1494	abstract	36757367
for	O	1495	1498	abstract	36757367
the	O	1499	1502	abstract	36757367
treatment	O	1503	1512	abstract	36757367
of	O	1513	1515	abstract	36757367
brain/mental-health-related	B-DDF	1516	1543	abstract	36757367
disease	I-DDF	1544	1551	abstract	36757367
.	O	1551	1552	abstract	36757367

Key	O	0	3	title	36493975
role	O	4	8	title	36493975
of	O	9	11	title	36493975
the	O	12	15	title	36493975
gut-microbiota-brain	O	16	36	title	36493975
axis	O	37	41	title	36493975
via	O	42	45	title	36493975
the	O	46	49	title	36493975
subdiaphragmatic	B-anatomical%location	50	66	title	36493975
vagus	I-anatomical%location	67	72	title	36493975
nerve	I-anatomical%location	73	78	title	36493975
in	O	79	81	title	36493975
demyelination	B-DDF	82	95	title	36493975
of	O	96	98	title	36493975
the	O	99	102	title	36493975
cuprizone-treated	B-anatomical%location	103	120	title	36493975
mouse	I-anatomical%location	121	126	title	36493975
brain	I-anatomical%location	127	132	title	36493975
.	O	132	133	title	36493975

Multiple	B-DDF	0	8	abstract	36493975
sclerosis	I-DDF	9	18	abstract	36493975
(	O	19	20	abstract	36493975
MS	B-DDF	20	22	abstract	36493975
)	O	22	23	abstract	36493975
is	O	24	26	abstract	36493975
the	O	27	30	abstract	36493975
most	O	31	35	abstract	36493975
common	O	36	42	abstract	36493975
demyelinating	B-DDF	43	56	abstract	36493975
disease	I-DDF	57	64	abstract	36493975
that	O	65	69	abstract	36493975
attacks	O	70	77	abstract	36493975
the	O	78	81	abstract	36493975
central	O	82	89	abstract	36493975
nervous	O	90	97	abstract	36493975
system	O	98	104	abstract	36493975
.	O	104	105	abstract	36493975

Dietary	O	106	113	abstract	36493975
intake	O	114	120	abstract	36493975
of	O	121	123	abstract	36493975
cuprizone	B-drug	124	133	abstract	36493975
(	O	134	135	abstract	36493975
CPZ	B-drug	135	138	abstract	36493975
)	O	138	139	abstract	36493975
produces	O	140	148	abstract	36493975
demyelination	B-DDF	149	162	abstract	36493975
resembling	O	163	173	abstract	36493975
that	O	174	178	abstract	36493975
of	O	179	181	abstract	36493975
patients	B-human	182	190	abstract	36493975
with	O	191	195	abstract	36493975
MS	B-DDF	196	198	abstract	36493975
.	O	198	199	abstract	36493975

Given	O	200	205	abstract	36493975
the	O	206	209	abstract	36493975
role	O	210	214	abstract	36493975
of	O	215	217	abstract	36493975
the	O	218	221	abstract	36493975
vagus	B-anatomical%location	222	227	abstract	36493975
nerve	I-anatomical%location	228	233	abstract	36493975
in	O	234	236	abstract	36493975
gut-microbiota-brain	O	237	257	abstract	36493975
axis	O	258	262	abstract	36493975
in	O	263	265	abstract	36493975
development	O	266	277	abstract	36493975
of	O	278	280	abstract	36493975
MS	B-DDF	281	283	abstract	36493975
,	O	283	284	abstract	36493975
we	O	285	287	abstract	36493975
performed	O	288	297	abstract	36493975
this	O	298	302	abstract	36493975
study	O	303	308	abstract	36493975
to	O	309	311	abstract	36493975
investigate	O	312	323	abstract	36493975
whether	O	324	331	abstract	36493975
subdiaphragmatic	B-DDF	332	348	abstract	36493975
vagotomy	I-DDF	349	357	abstract	36493975
(	O	358	359	abstract	36493975
SDV	B-DDF	359	362	abstract	36493975
)	O	362	363	abstract	36493975
affects	O	364	371	abstract	36493975
demyelination	B-DDF	372	385	abstract	36493975
in	O	386	388	abstract	36493975
CPZ-treated	B-animal	389	400	abstract	36493975
mice	I-animal	401	405	abstract	36493975
.	O	405	406	abstract	36493975

SDV	B-DDF	407	410	abstract	36493975
significantly	O	411	424	abstract	36493975
ameliorated	O	425	436	abstract	36493975
demyelination	B-DDF	437	450	abstract	36493975
and	O	451	454	abstract	36493975
microglial	O	455	465	abstract	36493975
activation	O	466	476	abstract	36493975
in	O	477	479	abstract	36493975
the	O	480	483	abstract	36493975
brain	B-anatomical%location	484	489	abstract	36493975
compared	O	490	498	abstract	36493975
with	O	499	503	abstract	36493975
sham-operated	O	504	517	abstract	36493975
CPZ-treated	B-animal	518	529	abstract	36493975
mice	I-animal	530	534	abstract	36493975
.	O	534	535	abstract	36493975

Furthermore	O	536	547	abstract	36493975
,	O	547	548	abstract	36493975
16S	B-biomedical%technique	549	552	abstract	36493975
ribosomal	I-biomedical%technique	553	562	abstract	36493975
RNA	I-biomedical%technique	563	566	abstract	36493975
analysis	I-biomedical%technique	567	575	abstract	36493975
revealed	O	576	584	abstract	36493975
that	O	585	589	abstract	36493975
SDV	B-DDF	590	593	abstract	36493975
significantly	O	594	607	abstract	36493975
improved	O	608	616	abstract	36493975
the	O	617	620	abstract	36493975
abnormal	O	621	629	abstract	36493975
gut	O	630	633	abstract	36493975
microbiota	O	634	644	abstract	36493975
composition	O	645	656	abstract	36493975
of	O	657	659	abstract	36493975
CPZ-treated	B-animal	660	671	abstract	36493975
mice	I-animal	672	676	abstract	36493975
.	O	676	677	abstract	36493975

An	O	678	680	abstract	36493975
untargeted	B-biomedical%technique	681	691	abstract	36493975
metabolomic	I-biomedical%technique	692	703	abstract	36493975
analysis	I-biomedical%technique	704	712	abstract	36493975
demonstrated	O	713	725	abstract	36493975
that	O	726	730	abstract	36493975
SDV	B-DDF	731	734	abstract	36493975
significantly	O	735	748	abstract	36493975
improved	O	749	757	abstract	36493975
abnormal	B-DDF	758	766	abstract	36493975
blood	I-DDF	767	772	abstract	36493975
levels	I-DDF	773	779	abstract	36493975
of	O	780	782	abstract	36493975
metabolites	O	783	794	abstract	36493975
in	O	795	797	abstract	36493975
CPZ-treated	B-animal	798	809	abstract	36493975
mice	I-animal	810	814	abstract	36493975
compared	O	815	823	abstract	36493975
with	O	824	828	abstract	36493975
sham-operated	O	829	842	abstract	36493975
CPZ-treated	B-animal	843	854	abstract	36493975
mice	I-animal	855	859	abstract	36493975
.	O	859	860	abstract	36493975

Notably	O	861	868	abstract	36493975
,	O	868	869	abstract	36493975
there	O	870	875	abstract	36493975
were	O	876	880	abstract	36493975
correlations	O	881	893	abstract	36493975
between	O	894	901	abstract	36493975
demyelination	B-DDF	902	915	abstract	36493975
or	O	916	918	abstract	36493975
microglial	O	919	929	abstract	36493975
activation	O	930	940	abstract	36493975
in	O	941	943	abstract	36493975
the	O	944	947	abstract	36493975
brain	B-anatomical%location	948	953	abstract	36493975
and	O	954	957	abstract	36493975
the	O	958	961	abstract	36493975
relative	O	962	970	abstract	36493975
abundance	O	971	980	abstract	36493975
of	O	981	983	abstract	36493975
several	O	984	991	abstract	36493975
microbiome	B-microbiome	992	1002	abstract	36493975
populations	I-microbiome	1003	1014	abstract	36493975
,	O	1014	1015	abstract	36493975
suggesting	O	1016	1026	abstract	36493975
a	O	1027	1028	abstract	36493975
link	O	1029	1033	abstract	36493975
between	O	1034	1041	abstract	36493975
gut	B-microbiome	1042	1045	abstract	36493975
microbiota	I-microbiome	1046	1056	abstract	36493975
and	O	1057	1060	abstract	36493975
the	O	1061	1064	abstract	36493975
brain	B-anatomical%location	1065	1070	abstract	36493975
.	O	1070	1071	abstract	36493975

There	O	1072	1077	abstract	36493975
were	O	1078	1082	abstract	36493975
also	O	1083	1087	abstract	36493975
correlations	O	1088	1100	abstract	36493975
between	O	1101	1108	abstract	36493975
demyelination	B-DDF	1109	1122	abstract	36493975
or	O	1123	1125	abstract	36493975
microglial	O	1126	1136	abstract	36493975
activation	O	1137	1147	abstract	36493975
in	O	1148	1150	abstract	36493975
the	O	1151	1154	abstract	36493975
brain	B-anatomical%location	1155	1160	abstract	36493975
and	O	1161	1164	abstract	36493975
blood	O	1165	1170	abstract	36493975
levels	O	1171	1177	abstract	36493975
of	O	1178	1180	abstract	36493975
metabolites	O	1181	1192	abstract	36493975
.	O	1192	1193	abstract	36493975

Together	O	1194	1202	abstract	36493975
,	O	1202	1203	abstract	36493975
these	O	1204	1209	abstract	36493975
data	O	1210	1214	abstract	36493975
suggest	O	1215	1222	abstract	36493975
that	O	1223	1227	abstract	36493975
CPZ	B-drug	1228	1231	abstract	36493975
produces	O	1232	1240	abstract	36493975
demyelination	B-DDF	1241	1254	abstract	36493975
in	O	1255	1257	abstract	36493975
the	O	1258	1261	abstract	36493975
brain	B-anatomical%location	1262	1267	abstract	36493975
through	O	1268	1275	abstract	36493975
the	O	1276	1279	abstract	36493975
gut-microbiota-brain	O	1280	1300	abstract	36493975
axis	O	1301	1305	abstract	36493975
via	O	1306	1309	abstract	36493975
the	O	1310	1313	abstract	36493975
subdiaphragmatic	B-anatomical%location	1314	1330	abstract	36493975
vagus	I-anatomical%location	1331	1336	abstract	36493975
nerve	I-anatomical%location	1337	1342	abstract	36493975
.	O	1342	1343	abstract	36493975

Global	O	0	6	title	37213508
research	O	7	15	title	37213508
trends	O	16	22	title	37213508
and	O	23	26	title	37213508
focus	O	27	32	title	37213508
on	O	33	35	title	37213508
the	O	36	39	title	37213508
link	O	40	44	title	37213508
between	O	45	52	title	37213508
colorectal	B-DDF	53	63	title	37213508
cancer	I-DDF	64	70	title	37213508
and	O	71	74	title	37213508
gut	B-microbiome	75	78	title	37213508
flora	I-microbiome	79	84	title	37213508
:	O	84	85	title	37213508
a	O	86	87	title	37213508
bibliometric	O	88	100	title	37213508
analysis	O	101	109	title	37213508
from	O	110	114	title	37213508
2001	O	115	119	title	37213508
to	O	120	122	title	37213508
2021	O	123	127	title	37213508
.	O	127	128	title	37213508

Colorectal	B-DDF	0	10	abstract	37213508
cancer	I-DDF	11	17	abstract	37213508
(	O	18	19	abstract	37213508
CRC	B-DDF	19	22	abstract	37213508
)	O	22	23	abstract	37213508
is	O	24	26	abstract	37213508
a	O	27	28	abstract	37213508
highly	O	29	35	abstract	37213508
prevalent	O	36	45	abstract	37213508
cancer	B-DDF	46	52	abstract	37213508
,	O	52	53	abstract	37213508
and	O	54	57	abstract	37213508
the	O	58	61	abstract	37213508
global	O	62	68	abstract	37213508
healthcare	O	69	79	abstract	37213508
system	O	80	86	abstract	37213508
bears	O	87	92	abstract	37213508
a	O	93	94	abstract	37213508
significant	O	95	106	abstract	37213508
burden	O	107	113	abstract	37213508
due	O	114	117	abstract	37213508
to	O	118	120	abstract	37213508
its	O	121	124	abstract	37213508
incidence	O	125	134	abstract	37213508
.	O	134	135	abstract	37213508

Modulating	O	136	146	abstract	37213508
the	O	147	150	abstract	37213508
gut	B-microbiome	151	154	abstract	37213508
microbiota	I-microbiome	155	165	abstract	37213508
is	O	166	168	abstract	37213508
a	O	169	170	abstract	37213508
promising	O	171	180	abstract	37213508
approach	O	181	189	abstract	37213508
to	O	190	192	abstract	37213508
enhance	O	193	200	abstract	37213508
the	O	201	204	abstract	37213508
efficacy	O	205	213	abstract	37213508
of	O	214	216	abstract	37213508
CRC	O	217	220	abstract	37213508
treatment	O	221	230	abstract	37213508
and	O	231	234	abstract	37213508
reduce	O	235	241	abstract	37213508
its	O	242	245	abstract	37213508
adverse	O	246	253	abstract	37213508
effects	O	254	261	abstract	37213508
.	O	261	262	abstract	37213508

The	O	263	266	abstract	37213508
causal	O	267	273	abstract	37213508
relationship	O	274	286	abstract	37213508
between	O	287	294	abstract	37213508
specific	O	295	303	abstract	37213508
microorganisms	O	304	318	abstract	37213508
'	O	318	319	abstract	37213508
presence	O	320	328	abstract	37213508
and	O	329	332	abstract	37213508
CRC	O	333	336	abstract	37213508
development	O	337	348	abstract	37213508
has	O	349	352	abstract	37213508
been	O	353	357	abstract	37213508
widely	O	358	364	abstract	37213508
validated	O	365	374	abstract	37213508
.	O	374	375	abstract	37213508

However	O	376	383	abstract	37213508
,	O	383	384	abstract	37213508
few	O	385	388	abstract	37213508
studies	O	389	396	abstract	37213508
have	O	397	401	abstract	37213508
investigated	O	402	414	abstract	37213508
this	O	415	419	abstract	37213508
relationship	O	420	432	abstract	37213508
using	O	433	438	abstract	37213508
bibliometric	O	439	451	abstract	37213508
methods	O	452	459	abstract	37213508
.	O	459	460	abstract	37213508

Therefore	O	461	470	abstract	37213508
,	O	470	471	abstract	37213508
this	O	472	476	abstract	37213508
study	O	477	482	abstract	37213508
analyzed	O	483	491	abstract	37213508
the	O	492	495	abstract	37213508
research	O	496	504	abstract	37213508
hotspots	O	505	513	abstract	37213508
and	O	514	517	abstract	37213508
trends	O	518	524	abstract	37213508
in	O	525	527	abstract	37213508
human	O	528	533	abstract	37213508
gut	O	534	537	abstract	37213508
microbiology	O	538	550	abstract	37213508
and	O	551	554	abstract	37213508
CRC	B-DDF	555	558	abstract	37213508
over	O	559	563	abstract	37213508
the	O	564	567	abstract	37213508
last	O	568	572	abstract	37213508
two	O	573	576	abstract	37213508
decades	O	577	584	abstract	37213508
from	O	585	589	abstract	37213508
a	O	590	591	abstract	37213508
bibliometric	O	592	604	abstract	37213508
perspective	O	605	616	abstract	37213508
.	O	616	617	abstract	37213508

The	O	618	621	abstract	37213508
study	O	622	627	abstract	37213508
aims	O	628	632	abstract	37213508
to	O	633	635	abstract	37213508
provide	O	636	643	abstract	37213508
novel	O	644	649	abstract	37213508
insights	O	650	658	abstract	37213508
into	O	659	663	abstract	37213508
basic	O	664	669	abstract	37213508
and	O	670	673	abstract	37213508
clinical	O	674	682	abstract	37213508
research	O	683	691	abstract	37213508
in	O	692	694	abstract	37213508
this	O	695	699	abstract	37213508
field	O	700	705	abstract	37213508
.	O	705	706	abstract	37213508

The	O	707	710	abstract	37213508
articles	O	711	719	abstract	37213508
and	O	720	723	abstract	37213508
reviews	O	724	731	abstract	37213508
on	O	732	734	abstract	37213508
gut	B-microbiome	735	738	abstract	37213508
microbiota	I-microbiome	739	749	abstract	37213508
in	O	750	752	abstract	37213508
CRC	B-DDF	753	756	abstract	37213508
were	O	757	761	abstract	37213508
obtained	O	762	770	abstract	37213508
from	O	771	775	abstract	37213508
the	O	776	779	abstract	37213508
Web	O	780	783	abstract	37213508
of	O	784	786	abstract	37213508
Science	O	787	794	abstract	37213508
Core	O	795	799	abstract	37213508
Collection	O	800	810	abstract	37213508
(	O	811	812	abstract	37213508
WOSCC	O	812	817	abstract	37213508
)	O	817	818	abstract	37213508
on	O	819	821	abstract	37213508
November	O	822	830	abstract	37213508
2	O	831	832	abstract	37213508
,	O	832	833	abstract	37213508
2022	O	834	838	abstract	37213508
.	O	838	839	abstract	37213508

CiteSpace	O	840	849	abstract	37213508
and	O	850	853	abstract	37213508
VOSviewer	O	854	863	abstract	37213508
were	O	864	868	abstract	37213508
used	O	869	873	abstract	37213508
to	O	874	876	abstract	37213508
conduct	O	877	884	abstract	37213508
the	O	885	888	abstract	37213508
bibliometric	O	889	901	abstract	37213508
and	O	902	905	abstract	37213508
knowledge-map	O	906	919	abstract	37213508
analysis	O	920	928	abstract	37213508
.	O	928	929	abstract	37213508

A	O	930	931	abstract	37213508
total	O	932	937	abstract	37213508
of	O	938	940	abstract	37213508
2,707	O	941	946	abstract	37213508
publications	O	947	959	abstract	37213508
were	O	960	964	abstract	37213508
obtained	O	965	973	abstract	37213508
,	O	973	974	abstract	37213508
with	O	975	979	abstract	37213508
a	O	980	981	abstract	37213508
rapid	O	982	987	abstract	37213508
increase	O	988	996	abstract	37213508
in	O	997	999	abstract	37213508
the	O	1000	1003	abstract	37213508
number	O	1004	1010	abstract	37213508
of	O	1011	1013	abstract	37213508
publications	O	1014	1026	abstract	37213508
since	O	1027	1032	abstract	37213508
2015	O	1033	1037	abstract	37213508
.	O	1037	1038	abstract	37213508

The	O	1039	1042	abstract	37213508
United	O	1043	1049	abstract	37213508
States	O	1050	1056	abstract	37213508
and	O	1057	1060	abstract	37213508
China	O	1061	1066	abstract	37213508
are	O	1067	1070	abstract	37213508
the	O	1071	1074	abstract	37213508
main	O	1075	1079	abstract	37213508
contributors	O	1080	1092	abstract	37213508
in	O	1093	1095	abstract	37213508
this	O	1096	1100	abstract	37213508
field	O	1101	1106	abstract	37213508
and	O	1107	1110	abstract	37213508
have	O	1111	1115	abstract	37213508
established	O	1116	1127	abstract	37213508
a	O	1128	1129	abstract	37213508
network	O	1130	1137	abstract	37213508
of	O	1138	1140	abstract	37213508
partnerships	O	1141	1153	abstract	37213508
in	O	1154	1156	abstract	37213508
several	O	1157	1164	abstract	37213508
countries	O	1165	1174	abstract	37213508
.	O	1174	1175	abstract	37213508

414	O	1176	1179	abstract	37213508
academic	O	1180	1188	abstract	37213508
journals	O	1189	1197	abstract	37213508
have	O	1198	1202	abstract	37213508
published	O	1203	1212	abstract	37213508
articles	O	1213	1221	abstract	37213508
on	O	1222	1224	abstract	37213508
this	O	1225	1229	abstract	37213508
topic	O	1230	1235	abstract	37213508
.	O	1235	1236	abstract	37213508

The	O	1237	1240	abstract	37213508
author	O	1241	1247	abstract	37213508
with	O	1248	1252	abstract	37213508
the	O	1253	1256	abstract	37213508
highest	O	1257	1264	abstract	37213508
number	O	1265	1271	abstract	37213508
of	O	1272	1274	abstract	37213508
publications	O	1275	1287	abstract	37213508
is	O	1288	1290	abstract	37213508
Jun	O	1291	1294	abstract	37213508
Yu	O	1295	1297	abstract	37213508
from	O	1298	1302	abstract	37213508
the	O	1303	1306	abstract	37213508
Chinese	O	1307	1314	abstract	37213508
University	O	1315	1325	abstract	37213508
of	O	1326	1328	abstract	37213508
Hong	O	1329	1333	abstract	37213508
Kong	O	1334	1338	abstract	37213508
.	O	1338	1339	abstract	37213508

In	O	1340	1342	abstract	37213508
addition	O	1343	1351	abstract	37213508
to	O	1352	1354	abstract	37213508
"	O	1355	1356	abstract	37213508
intestinal	B-microbiome	1356	1366	abstract	37213508
flora	I-microbiome	1367	1372	abstract	37213508
"	O	1372	1373	abstract	37213508
and	O	1374	1377	abstract	37213508
"	O	1378	1379	abstract	37213508
colorectal	B-DDF	1379	1389	abstract	37213508
cancer	I-DDF	1390	1396	abstract	37213508
,	O	1396	1397	abstract	37213508
"	O	1397	1398	abstract	37213508
high	O	1399	1403	abstract	37213508
frequency	O	1404	1413	abstract	37213508
terms	O	1414	1419	abstract	37213508
in	O	1420	1422	abstract	37213508
the	O	1423	1426	abstract	37213508
keyword	O	1427	1434	abstract	37213508
co-occurrence	O	1435	1448	abstract	37213508
network	O	1449	1456	abstract	37213508
analysis	O	1457	1465	abstract	37213508
included	O	1466	1474	abstract	37213508
inflammatory	B-DDF	1475	1487	abstract	37213508
bowel	I-DDF	1488	1493	abstract	37213508
disease	I-DDF	1494	1501	abstract	37213508
,	O	1501	1502	abstract	37213508
<	O	1503	1504	abstract	37213508
i	O	1504	1505	abstract	37213508
>	O	1505	1506	abstract	37213508
Fusobacterium	B-bacteria	1506	1519	abstract	37213508
nucleatum</i	I-bacteria	1520	1532	abstract	37213508
>	O	1532	1533	abstract	37213508
,	O	1533	1534	abstract	37213508
inflammation	O	1535	1547	abstract	37213508
,	O	1547	1548	abstract	37213508
long-chain	B-chemical	1549	1559	abstract	37213508
fatty	I-chemical	1560	1565	abstract	37213508
acids	I-chemical	1566	1571	abstract	37213508
,	O	1571	1572	abstract	37213508
ulcerative	B-DDF	1573	1583	abstract	37213508
colitis	I-DDF	1584	1591	abstract	37213508
,	O	1591	1592	abstract	37213508
bile	B-chemical	1593	1597	abstract	37213508
acids	I-chemical	1598	1603	abstract	37213508
,	O	1603	1604	abstract	37213508
and	O	1605	1608	abstract	37213508
resistant	B-chemical	1609	1618	abstract	37213508
starch	I-chemical	1619	1625	abstract	37213508
.	O	1625	1626	abstract	37213508

Analysis	O	1627	1635	abstract	37213508
of	O	1636	1638	abstract	37213508
keyword	O	1639	1646	abstract	37213508
trends	O	1647	1653	abstract	37213508
using	O	1654	1659	abstract	37213508
burst	B-biomedical%technique	1660	1665	abstract	37213508
testing	I-biomedical%technique	1666	1673	abstract	37213508
revealed	O	1674	1682	abstract	37213508
that	O	1683	1687	abstract	37213508
biomarkers	O	1688	1698	abstract	37213508
,	O	1698	1699	abstract	37213508
abnormal	B-DDF	1700	1708	abstract	37213508
crypt	I-DDF	1709	1714	abstract	37213508
foci	I-DDF	1715	1719	abstract	37213508
,	O	1719	1720	abstract	37213508
bifidobacteria	B-bacteria	1721	1735	abstract	37213508
,	O	1735	1736	abstract	37213508
-glucuronidase	B-chemical	1737	1752	abstract	37213508
,	O	1752	1753	abstract	37213508
short-chain	B-chemical	1754	1765	abstract	37213508
fatty	I-chemical	1766	1771	abstract	37213508
acids	I-chemical	1772	1777	abstract	37213508
,	O	1777	1778	abstract	37213508
bile	B-chemical	1779	1783	abstract	37213508
acids	I-chemical	1784	1789	abstract	37213508
,	O	1789	1790	abstract	37213508
and	O	1791	1794	abstract	37213508
DNA	B-chemical	1795	1798	abstract	37213508
methylation	I-chemical	1799	1810	abstract	37213508
are	O	1811	1814	abstract	37213508
at	O	1815	1817	abstract	37213508
the	O	1818	1821	abstract	37213508
forefront	O	1822	1831	abstract	37213508
of	O	1832	1834	abstract	37213508
research	O	1835	1843	abstract	37213508
in	O	1844	1846	abstract	37213508
this	O	1847	1851	abstract	37213508
area	O	1852	1856	abstract	37213508
.	O	1856	1857	abstract	37213508

The	O	1858	1861	abstract	37213508
findings	O	1862	1870	abstract	37213508
of	O	1871	1873	abstract	37213508
this	O	1874	1878	abstract	37213508
study	O	1879	1884	abstract	37213508
provide	O	1885	1892	abstract	37213508
a	O	1893	1894	abstract	37213508
bibliometric	O	1895	1907	abstract	37213508
analysis	O	1908	1916	abstract	37213508
and	O	1917	1920	abstract	37213508
visualization	O	1921	1934	abstract	37213508
of	O	1935	1937	abstract	37213508
the	O	1938	1941	abstract	37213508
key	O	1942	1945	abstract	37213508
research	O	1946	1954	abstract	37213508
areas	O	1955	1960	abstract	37213508
in	O	1961	1963	abstract	37213508
gut	B-microbiome	1964	1967	abstract	37213508
microbiota	I-microbiome	1968	1978	abstract	37213508
and	O	1979	1982	abstract	37213508
CRC	B-DDF	1983	1986	abstract	37213508
over	O	1987	1991	abstract	37213508
the	O	1992	1995	abstract	37213508
past	O	1996	2000	abstract	37213508
20	O	2001	2003	abstract	37213508
	O	2003	2004	abstract	37213508
years	O	2004	2009	abstract	37213508
.	O	2009	2010	abstract	37213508

The	O	2011	2014	abstract	37213508
results	O	2015	2022	abstract	37213508
suggest	O	2023	2030	abstract	37213508
that	O	2031	2035	abstract	37213508
the	O	2036	2039	abstract	37213508
role	O	2040	2044	abstract	37213508
of	O	2045	2047	abstract	37213508
gut	B-microbiome	2048	2051	abstract	37213508
microbiota	I-microbiome	2052	2062	abstract	37213508
in	O	2063	2065	abstract	37213508
CRC	B-DDF	2066	2069	abstract	37213508
and	O	2070	2073	abstract	37213508
its	O	2074	2077	abstract	37213508
underlying	O	2078	2088	abstract	37213508
mechanisms	O	2089	2099	abstract	37213508
should	O	2100	2106	abstract	37213508
be	O	2107	2109	abstract	37213508
closely	O	2110	2117	abstract	37213508
monitored	O	2118	2127	abstract	37213508
,	O	2127	2128	abstract	37213508
particularly	O	2129	2141	abstract	37213508
in	O	2142	2144	abstract	37213508
the	O	2145	2148	abstract	37213508
areas	O	2149	2154	abstract	37213508
of	O	2155	2157	abstract	37213508
biomarkers	O	2158	2168	abstract	37213508
,	O	2168	2169	abstract	37213508
metabolic	O	2170	2179	abstract	37213508
pathways	O	2180	2188	abstract	37213508
,	O	2188	2189	abstract	37213508
and	O	2190	2193	abstract	37213508
DNA	O	2194	2197	abstract	37213508
methylation	O	2198	2209	abstract	37213508
,	O	2209	2210	abstract	37213508
which	O	2211	2216	abstract	37213508
may	O	2217	2220	abstract	37213508
emerge	O	2221	2227	abstract	37213508
as	O	2228	2230	abstract	37213508
hot	O	2231	2234	abstract	37213508
topics	O	2235	2241	abstract	37213508
in	O	2242	2244	abstract	37213508
this	O	2245	2249	abstract	37213508
field	O	2250	2255	abstract	37213508
.	O	2255	2256	abstract	37213508

Using	O	0	5	title	33046051
data	O	6	10	title	33046051
science	O	11	18	title	33046051
for	O	19	22	title	33046051
medical	O	23	30	title	33046051
decision	O	31	39	title	33046051
making	O	40	46	title	33046051
case	O	47	51	title	33046051
:	O	51	52	title	33046051
role	O	53	57	title	33046051
of	O	58	60	title	33046051
gut	B-microbiome	61	64	title	33046051
microbiome	I-microbiome	65	75	title	33046051
in	O	76	78	title	33046051
multiple	B-DDF	79	87	title	33046051
sclerosis	I-DDF	88	97	title	33046051
.	O	97	98	title	33046051

A	O	0	1	abstract	33046051
decade	O	2	8	abstract	33046051
ago	O	9	12	abstract	33046051
,	O	12	13	abstract	33046051
the	O	14	17	abstract	33046051
advancements	O	18	30	abstract	33046051
in	O	31	33	abstract	33046051
the	O	34	37	abstract	33046051
microbiome	O	38	48	abstract	33046051
data	O	49	53	abstract	33046051
sequencing	O	54	64	abstract	33046051
techniques	O	65	75	abstract	33046051
initiated	O	76	85	abstract	33046051
the	O	86	89	abstract	33046051
development	O	90	101	abstract	33046051
of	O	102	104	abstract	33046051
research	O	105	113	abstract	33046051
of	O	114	116	abstract	33046051
the	O	117	120	abstract	33046051
microbiome	O	121	131	abstract	33046051
and	O	132	135	abstract	33046051
its	O	136	139	abstract	33046051
relationship	O	140	152	abstract	33046051
with	O	153	157	abstract	33046051
the	O	158	161	abstract	33046051
host	O	162	166	abstract	33046051
organism	O	167	175	abstract	33046051
.	O	175	176	abstract	33046051

The	O	177	180	abstract	33046051
development	O	181	192	abstract	33046051
of	O	193	195	abstract	33046051
sophisticated	O	196	209	abstract	33046051
bioinformatics	O	210	224	abstract	33046051
and	O	225	228	abstract	33046051
data	O	229	233	abstract	33046051
science	O	234	241	abstract	33046051
tools	O	242	247	abstract	33046051
for	O	248	251	abstract	33046051
the	O	252	255	abstract	33046051
analysis	O	256	264	abstract	33046051
of	O	265	267	abstract	33046051
large	O	268	273	abstract	33046051
amounts	O	274	281	abstract	33046051
of	O	282	284	abstract	33046051
data	O	285	289	abstract	33046051
followed	O	290	298	abstract	33046051
.	O	298	299	abstract	33046051

Since	O	300	305	abstract	33046051
then	O	306	310	abstract	33046051
,	O	310	311	abstract	33046051
the	O	312	315	abstract	33046051
analyzed	O	316	324	abstract	33046051
gut	O	325	328	abstract	33046051
microbiome	O	329	339	abstract	33046051
data	O	340	344	abstract	33046051
,	O	344	345	abstract	33046051
where	O	346	351	abstract	33046051
microbiome	O	352	362	abstract	33046051
is	O	363	365	abstract	33046051
defined	O	366	373	abstract	33046051
as	O	374	376	abstract	33046051
a	O	377	378	abstract	33046051
network	O	379	386	abstract	33046051
of	O	387	389	abstract	33046051
microorganisms	O	390	404	abstract	33046051
inhabiting	O	405	415	abstract	33046051
the	O	416	419	abstract	33046051
human	O	420	425	abstract	33046051
intestinal	O	426	436	abstract	33046051
system	O	437	443	abstract	33046051
,	O	443	444	abstract	33046051
has	O	445	448	abstract	33046051
been	O	449	453	abstract	33046051
associated	O	454	464	abstract	33046051
with	O	465	469	abstract	33046051
several	O	470	477	abstract	33046051
conditions	O	478	488	abstract	33046051
such	O	489	493	abstract	33046051
as	O	494	496	abstract	33046051
irritable	B-DDF	497	506	abstract	33046051
bowel	I-DDF	507	512	abstract	33046051
syndrome	I-DDF	513	521	abstract	33046051
-	O	522	523	abstract	33046051
IBS	B-DDF	524	527	abstract	33046051
,	O	527	528	abstract	33046051
colorectal	B-DDF	529	539	abstract	33046051
cancer	I-DDF	540	546	abstract	33046051
,	O	546	547	abstract	33046051
diabetes	B-DDF	548	556	abstract	33046051
,	O	556	557	abstract	33046051
obesity	B-DDF	558	565	abstract	33046051
,	O	565	566	abstract	33046051
and	O	567	570	abstract	33046051
metabolic	B-DDF	571	580	abstract	33046051
syndrome	I-DDF	581	589	abstract	33046051
,	O	589	590	abstract	33046051
and	O	591	594	abstract	33046051
lately	O	595	601	abstract	33046051
in	O	602	604	abstract	33046051
the	O	605	608	abstract	33046051
study	O	609	614	abstract	33046051
of	O	615	617	abstract	33046051
Parkinson	B-DDF	618	627	abstract	33046051
's	I-DDF	627	629	abstract	33046051
and	I-DDF	630	633	abstract	33046051
Alzheimer	I-DDF	634	643	abstract	33046051
's	I-DDF	643	645	abstract	33046051
diseases	I-DDF	646	654	abstract	33046051
as	O	655	657	abstract	33046051
well	O	658	662	abstract	33046051
.	O	662	663	abstract	33046051

This	O	664	668	abstract	33046051
paper	O	669	674	abstract	33046051
aims	O	675	679	abstract	33046051
to	O	680	682	abstract	33046051
provide	O	683	690	abstract	33046051
an	O	691	693	abstract	33046051
understanding	O	694	707	abstract	33046051
of	O	708	710	abstract	33046051
differences	O	711	722	abstract	33046051
between	O	723	730	abstract	33046051
microbial	O	731	740	abstract	33046051
data	O	741	745	abstract	33046051
of	O	746	748	abstract	33046051
individuals	B-human	749	760	abstract	33046051
who	O	761	764	abstract	33046051
have	O	765	769	abstract	33046051
been	O	770	774	abstract	33046051
diagnosed	O	775	784	abstract	33046051
with	O	785	789	abstract	33046051
multiple	B-DDF	790	798	abstract	33046051
sclerosis	I-DDF	799	808	abstract	33046051
and	O	809	812	abstract	33046051
those	O	813	818	abstract	33046051
who	O	819	822	abstract	33046051
were	O	823	827	abstract	33046051
not	O	828	831	abstract	33046051
by	O	832	834	abstract	33046051
exploiting	O	835	845	abstract	33046051
data	O	846	850	abstract	33046051
science	O	851	858	abstract	33046051
techniques	O	859	869	abstract	33046051
on	O	870	872	abstract	33046051
publicly	O	873	881	abstract	33046051
available	O	882	891	abstract	33046051
data	O	892	896	abstract	33046051
.	O	896	897	abstract	33046051

This	O	898	902	abstract	33046051
study	O	903	908	abstract	33046051
examines	O	909	917	abstract	33046051
the	O	918	921	abstract	33046051
relationship	O	922	934	abstract	33046051
between	O	935	942	abstract	33046051
multiple	B-DDF	943	951	abstract	33046051
sclerosis	I-DDF	952	961	abstract	33046051
(	O	962	963	abstract	33046051
MS	B-DDF	963	965	abstract	33046051
)	O	965	966	abstract	33046051
,	O	966	967	abstract	33046051
an	O	968	970	abstract	33046051
autoimmune	B-DDF	971	981	abstract	33046051
central	I-DDF	982	989	abstract	33046051
nervous	I-DDF	990	997	abstract	33046051
system	I-DDF	998	1004	abstract	33046051
disease	I-DDF	1005	1012	abstract	33046051
,	O	1012	1013	abstract	33046051
and	O	1014	1017	abstract	33046051
gut	O	1018	1021	abstract	33046051
microbial	O	1022	1031	abstract	33046051
community	O	1032	1041	abstract	33046051
composition	O	1042	1053	abstract	33046051
,	O	1053	1054	abstract	33046051
using	O	1055	1060	abstract	33046051
the	O	1061	1064	abstract	33046051
samples	O	1065	1072	abstract	33046051
acquired	O	1073	1081	abstract	33046051
by	O	1082	1084	abstract	33046051
16s	B-biomedical%technique	1085	1088	abstract	33046051
rRNA	I-biomedical%technique	1089	1093	abstract	33046051
sequencing	I-biomedical%technique	1094	1104	abstract	33046051
technique	I-biomedical%technique	1105	1114	abstract	33046051
.	O	1114	1115	abstract	33046051

We	O	1116	1118	abstract	33046051
have	O	1119	1123	abstract	33046051
used	O	1124	1128	abstract	33046051
three	O	1129	1134	abstract	33046051
different	O	1135	1144	abstract	33046051
sets	O	1145	1149	abstract	33046051
of	O	1150	1152	abstract	33046051
MS	O	1153	1155	abstract	33046051
samples	O	1156	1163	abstract	33046051
sequenced	O	1164	1173	abstract	33046051
during	O	1174	1180	abstract	33046051
three	O	1181	1186	abstract	33046051
independent	O	1187	1198	abstract	33046051
studies	O	1199	1206	abstract	33046051
(	O	1207	1208	abstract	33046051
Jangi	O	1208	1213	abstract	33046051
et	O	1214	1216	abstract	33046051
al	O	1217	1219	abstract	33046051
,	O	1219	1220	abstract	33046051
Nat	O	1221	1224	abstract	33046051
Commun	O	1225	1231	abstract	33046051
7:1	O	1232	1235	abstract	33046051
-	O	1235	1236	abstract	33046051
11	O	1236	1238	abstract	33046051
,	O	1238	1239	abstract	33046051
2016	O	1240	1244	abstract	33046051
)	O	1244	1245	abstract	33046051
,	O	1245	1246	abstract	33046051
(	O	1247	1248	abstract	33046051
Miyake	O	1248	1254	abstract	33046051
et	O	1255	1257	abstract	33046051
al	O	1258	1260	abstract	33046051
,	O	1260	1261	abstract	33046051
PLoS	O	1262	1266	abstract	33046051
ONE	O	1267	1270	abstract	33046051
10:0137429	O	1271	1281	abstract	33046051
,	O	1281	1282	abstract	33046051
2015	O	1283	1287	abstract	33046051
)	O	1287	1288	abstract	33046051
,	O	1288	1289	abstract	33046051
(	O	1290	1291	abstract	33046051
McDonald	O	1291	1299	abstract	33046051
et	O	1300	1302	abstract	33046051
al	O	1303	1305	abstract	33046051
,	O	1305	1306	abstract	33046051
Msystems	O	1307	1315	abstract	33046051
3:00031	O	1316	1323	abstract	33046051
-	O	1323	1324	abstract	33046051
18	O	1324	1326	abstract	33046051
,	O	1326	1327	abstract	33046051
2018	O	1328	1332	abstract	33046051
)	O	1332	1333	abstract	33046051
and	O	1334	1337	abstract	33046051
this	O	1338	1342	abstract	33046051
approach	O	1343	1351	abstract	33046051
strengthens	O	1352	1363	abstract	33046051
our	O	1364	1367	abstract	33046051
results	O	1368	1375	abstract	33046051
.	O	1375	1376	abstract	33046051

Analyzed	O	1377	1385	abstract	33046051
sequences	O	1386	1395	abstract	33046051
were	O	1396	1400	abstract	33046051
from	O	1401	1405	abstract	33046051
healthy	O	1406	1413	abstract	33046051
control	O	1414	1421	abstract	33046051
and	O	1422	1425	abstract	33046051
MS	O	1426	1428	abstract	33046051
groups	O	1429	1435	abstract	33046051
of	O	1436	1438	abstract	33046051
sequences	O	1439	1448	abstract	33046051
.	O	1448	1449	abstract	33046051

The	O	1450	1453	abstract	33046051
extracted	O	1454	1463	abstract	33046051
set	O	1464	1467	abstract	33046051
of	O	1468	1470	abstract	33046051
statistically	O	1471	1484	abstract	33046051
significant	O	1485	1496	abstract	33046051
bacteria	O	1497	1505	abstract	33046051
from	O	1506	1510	abstract	33046051
the	O	1511	1514	abstract	33046051
(	O	1515	1516	abstract	33046051
Jangi	O	1516	1521	abstract	33046051
et	O	1522	1524	abstract	33046051
al	O	1525	1527	abstract	33046051
,	O	1527	1528	abstract	33046051
Nat	O	1529	1532	abstract	33046051
Commun	O	1533	1539	abstract	33046051
7:1	O	1540	1543	abstract	33046051
-	O	1543	1544	abstract	33046051
11	O	1544	1546	abstract	33046051
,	O	1546	1547	abstract	33046051
2016	O	1548	1552	abstract	33046051
)	O	1552	1553	abstract	33046051
dataset	O	1554	1561	abstract	33046051
samples	O	1562	1569	abstract	33046051
and	O	1570	1573	abstract	33046051
their	O	1574	1579	abstract	33046051
statistically	O	1580	1593	abstract	33046051
significant	O	1594	1605	abstract	33046051
predictive	O	1606	1616	abstract	33046051
functions	O	1617	1626	abstract	33046051
were	O	1627	1631	abstract	33046051
used	O	1632	1636	abstract	33046051
to	O	1637	1639	abstract	33046051
develop	O	1640	1647	abstract	33046051
a	O	1648	1649	abstract	33046051
Random	O	1650	1656	abstract	33046051
Forest	O	1657	1663	abstract	33046051
classifier	O	1664	1674	abstract	33046051
.	O	1674	1675	abstract	33046051

In	O	1676	1678	abstract	33046051
total	O	1679	1684	abstract	33046051
,	O	1684	1685	abstract	33046051
8	O	1686	1687	abstract	33046051
models	O	1688	1694	abstract	33046051
based	O	1695	1700	abstract	33046051
on	O	1701	1703	abstract	33046051
two	O	1704	1707	abstract	33046051
criteria	O	1708	1716	abstract	33046051
:	O	1716	1717	abstract	33046051
bacteria	O	1718	1726	abstract	33046051
abundance	O	1727	1736	abstract	33046051
(	O	1737	1738	abstract	33046051
at	O	1738	1740	abstract	33046051
six	O	1741	1744	abstract	33046051
taxonomic	O	1745	1754	abstract	33046051
levels	O	1755	1761	abstract	33046051
)	O	1761	1762	abstract	33046051
and	O	1763	1766	abstract	33046051
predictive	O	1767	1777	abstract	33046051
functions	O	1778	1787	abstract	33046051
(	O	1788	1789	abstract	33046051
at	O	1789	1791	abstract	33046051
two	O	1792	1795	abstract	33046051
levels	O	1796	1802	abstract	33046051
)	O	1802	1803	abstract	33046051
,	O	1803	1804	abstract	33046051
were	O	1805	1809	abstract	33046051
constructed	O	1810	1821	abstract	33046051
and	O	1822	1825	abstract	33046051
evaluated	O	1826	1835	abstract	33046051
.	O	1835	1836	abstract	33046051

These	O	1837	1842	abstract	33046051
include	O	1843	1850	abstract	33046051
using	O	1851	1856	abstract	33046051
taxa	O	1857	1861	abstract	33046051
abundances	O	1862	1872	abstract	33046051
at	O	1873	1875	abstract	33046051
different	O	1876	1885	abstract	33046051
taxonomy	O	1886	1894	abstract	33046051
levels	O	1895	1901	abstract	33046051
as	O	1902	1904	abstract	33046051
well	O	1905	1909	abstract	33046051
as	O	1910	1912	abstract	33046051
predictive	O	1913	1923	abstract	33046051
function	O	1924	1932	abstract	33046051
analysis	O	1933	1941	abstract	33046051
at	O	1942	1944	abstract	33046051
different	O	1945	1954	abstract	33046051
hierarchical	O	1955	1967	abstract	33046051
levels	O	1968	1974	abstract	33046051
of	O	1975	1977	abstract	33046051
KEGG	O	1978	1982	abstract	33046051
pathways	O	1983	1991	abstract	33046051
.	O	1991	1992	abstract	33046051

The	O	1993	1996	abstract	33046051
highest	O	1997	2004	abstract	33046051
accuracy	O	2005	2013	abstract	33046051
of	O	2014	2016	abstract	33046051
the	O	2017	2020	abstract	33046051
classification	O	2021	2035	abstract	33046051
model	O	2036	2041	abstract	33046051
was	O	2042	2045	abstract	33046051
obtained	O	2046	2054	abstract	33046051
at	O	2055	2057	abstract	33046051
the	O	2058	2061	abstract	33046051
genus	O	2062	2067	abstract	33046051
level	O	2068	2073	abstract	33046051
of	O	2074	2076	abstract	33046051
taxonomy	O	2077	2085	abstract	33046051
(	O	2086	2087	abstract	33046051
76.82	O	2087	2092	abstract	33046051
%	O	2092	2093	abstract	33046051
)	O	2093	2094	abstract	33046051
and	O	2095	2098	abstract	33046051
the	O	2099	2102	abstract	33046051
third	O	2103	2108	abstract	33046051
hierarchical	O	2109	2121	abstract	33046051
level	O	2122	2127	abstract	33046051
of	O	2128	2130	abstract	33046051
KEGG	O	2131	2135	abstract	33046051
pathways	O	2136	2144	abstract	33046051
(	O	2145	2146	abstract	33046051
70.95	O	2146	2151	abstract	33046051
%	O	2151	2152	abstract	33046051
)	O	2152	2153	abstract	33046051
.	O	2153	2154	abstract	33046051

The	O	2155	2158	abstract	33046051
second	O	2159	2165	abstract	33046051
dataset	O	2166	2173	abstract	33046051
's	O	2173	2175	abstract	33046051
18	O	2176	2178	abstract	33046051
MS	O	2179	2181	abstract	33046051
samples	O	2182	2189	abstract	33046051
(	O	2190	2191	abstract	33046051
Miyake	O	2191	2197	abstract	33046051
et	O	2198	2200	abstract	33046051
al	O	2201	2203	abstract	33046051
,	O	2203	2204	abstract	33046051
PLoS	O	2205	2209	abstract	33046051
ONE	O	2210	2213	abstract	33046051
10:0137429	O	2214	2224	abstract	33046051
,	O	2224	2225	abstract	33046051
2015	O	2226	2230	abstract	33046051
)	O	2230	2231	abstract	33046051
and	O	2232	2235	abstract	33046051
18	O	2236	2238	abstract	33046051
self-reported	O	2239	2252	abstract	33046051
healthy	O	2253	2260	abstract	33046051
samples	O	2261	2268	abstract	33046051
from	O	2269	2273	abstract	33046051
the	O	2274	2277	abstract	33046051
(	O	2278	2279	abstract	33046051
McDonald	O	2279	2287	abstract	33046051
et	O	2288	2290	abstract	33046051
al	O	2291	2293	abstract	33046051
,	O	2293	2294	abstract	33046051
Msystems	O	2295	2303	abstract	33046051
3:00031	O	2304	2311	abstract	33046051
-	O	2311	2312	abstract	33046051
18	O	2312	2314	abstract	33046051
,	O	2314	2315	abstract	33046051
2018	O	2316	2320	abstract	33046051
)	O	2320	2321	abstract	33046051
dataset	O	2322	2329	abstract	33046051
were	O	2330	2334	abstract	33046051
used	O	2335	2339	abstract	33046051
to	O	2340	2342	abstract	33046051
validate	O	2343	2351	abstract	33046051
the	O	2352	2355	abstract	33046051
developed	O	2356	2365	abstract	33046051
classification	O	2366	2380	abstract	33046051
model	O	2381	2386	abstract	33046051
.	O	2386	2387	abstract	33046051

The	O	2388	2391	abstract	33046051
significance	O	2392	2404	abstract	33046051
of	O	2405	2407	abstract	33046051
this	O	2408	2412	abstract	33046051
step	O	2413	2417	abstract	33046051
is	O	2418	2420	abstract	33046051
to	O	2421	2423	abstract	33046051
show	O	2424	2428	abstract	33046051
that	O	2429	2433	abstract	33046051
the	O	2434	2437	abstract	33046051
model	O	2438	2443	abstract	33046051
is	O	2444	2446	abstract	33046051
not	O	2447	2450	abstract	33046051
overtrained	O	2451	2462	abstract	33046051
for	O	2463	2466	abstract	33046051
a	O	2467	2468	abstract	33046051
specific	O	2469	2477	abstract	33046051
dataset	O	2478	2485	abstract	33046051
but	O	2486	2489	abstract	33046051
can	O	2490	2493	abstract	33046051
also	O	2494	2498	abstract	33046051
be	O	2499	2501	abstract	33046051
used	O	2502	2506	abstract	33046051
on	O	2507	2509	abstract	33046051
other	O	2510	2515	abstract	33046051
independent	O	2516	2527	abstract	33046051
datasets	O	2528	2536	abstract	33046051
.	O	2536	2537	abstract	33046051

Again	O	2538	2543	abstract	33046051
,	O	2543	2544	abstract	33046051
the	O	2545	2548	abstract	33046051
highest	O	2549	2556	abstract	33046051
classification	O	2557	2571	abstract	33046051
model	O	2572	2577	abstract	33046051
accuracy	O	2578	2586	abstract	33046051
for	O	2587	2590	abstract	33046051
both	O	2591	2595	abstract	33046051
validating	O	2596	2606	abstract	33046051
datasets	O	2607	2615	abstract	33046051
combined	O	2616	2624	abstract	33046051
was	O	2625	2628	abstract	33046051
obtained	O	2629	2637	abstract	33046051
at	O	2638	2640	abstract	33046051
the	O	2641	2644	abstract	33046051
genus	O	2645	2650	abstract	33046051
level	O	2651	2656	abstract	33046051
of	O	2657	2659	abstract	33046051
taxonomy	O	2660	2668	abstract	33046051
(	O	2669	2670	abstract	33046051
70.98	O	2670	2675	abstract	33046051
%	O	2675	2676	abstract	33046051
)	O	2676	2677	abstract	33046051
and	O	2678	2681	abstract	33046051
third	O	2682	2687	abstract	33046051
hierarchical	O	2688	2700	abstract	33046051
level	O	2701	2706	abstract	33046051
of	O	2707	2709	abstract	33046051
KEGG	O	2710	2714	abstract	33046051
pathways	O	2715	2723	abstract	33046051
(	O	2724	2725	abstract	33046051
67.24	O	2725	2730	abstract	33046051
%	O	2730	2731	abstract	33046051
)	O	2731	2732	abstract	33046051
.	O	2732	2733	abstract	33046051

The	O	2734	2737	abstract	33046051
accuracy	O	2738	2746	abstract	33046051
of	O	2747	2749	abstract	33046051
the	O	2750	2753	abstract	33046051
independent	O	2754	2765	abstract	33046051
set	O	2766	2769	abstract	33046051
remained	O	2770	2778	abstract	33046051
very	O	2779	2783	abstract	33046051
relevant	O	2784	2792	abstract	33046051
.	O	2792	2793	abstract	33046051

Our	O	2794	2797	abstract	33046051
results	O	2798	2805	abstract	33046051
demonstrate	O	2806	2817	abstract	33046051
that	O	2818	2822	abstract	33046051
the	O	2823	2826	abstract	33046051
developed	O	2827	2836	abstract	33046051
classification	O	2837	2851	abstract	33046051
model	O	2852	2857	abstract	33046051
provides	O	2858	2866	abstract	33046051
a	O	2867	2868	abstract	33046051
good	O	2869	2873	abstract	33046051
tool	O	2874	2878	abstract	33046051
that	O	2879	2883	abstract	33046051
can	O	2884	2887	abstract	33046051
be	O	2888	2890	abstract	33046051
used	O	2891	2895	abstract	33046051
to	O	2896	2898	abstract	33046051
suggest	O	2899	2906	abstract	33046051
the	O	2907	2910	abstract	33046051
presence	O	2911	2919	abstract	33046051
or	O	2920	2922	abstract	33046051
absence	O	2923	2930	abstract	33046051
of	O	2931	2933	abstract	33046051
MS	B-DDF	2934	2936	abstract	33046051
condition	I-DDF	2937	2946	abstract	33046051
by	O	2947	2949	abstract	33046051
collecting	O	2950	2960	abstract	33046051
and	O	2961	2964	abstract	33046051
analyzing	O	2965	2974	abstract	33046051
gut	O	2975	2978	abstract	33046051
microbiome	O	2979	2989	abstract	33046051
samples	O	2990	2997	abstract	33046051
.	O	2997	2998	abstract	33046051

The	O	2999	3002	abstract	33046051
accuracy	O	3003	3011	abstract	33046051
of	O	3012	3014	abstract	33046051
the	O	3015	3018	abstract	33046051
model	O	3019	3024	abstract	33046051
can	O	3025	3028	abstract	33046051
be	O	3029	3031	abstract	33046051
further	O	3032	3039	abstract	33046051
increased	O	3040	3049	abstract	33046051
by	O	3050	3052	abstract	33046051
using	O	3053	3058	abstract	33046051
sequencing	O	3059	3069	abstract	33046051
methods	O	3070	3077	abstract	33046051
that	O	3078	3082	abstract	33046051
allow	O	3083	3088	abstract	33046051
higher	O	3089	3095	abstract	33046051
taxa	O	3096	3100	abstract	33046051
resolution	O	3101	3111	abstract	33046051
(	O	3112	3113	abstract	33046051
i.e.	O	3113	3117	abstract	33046051
shotgun	B-biomedical%technique	3118	3125	abstract	33046051
metagenomic	I-biomedical%technique	3126	3137	abstract	33046051
sequencing	I-biomedical%technique	3138	3148	abstract	33046051
)	O	3148	3149	abstract	33046051
.	O	3149	3150	abstract	33046051

Neuroendocrine	O	0	14	title	38204948
,	O	14	15	title	38204948
neurotransmitter	O	16	32	title	38204948
,	O	32	33	title	38204948
and	O	34	37	title	38204948
gut	O	38	41	title	38204948
microbiota	O	42	52	title	38204948
imbalance	O	53	62	title	38204948
contributing	O	63	75	title	38204948
to	O	76	78	title	38204948
potential	O	79	88	title	38204948
psychiatric	O	89	100	title	38204948
disorder	O	101	109	title	38204948
prevalence	O	110	120	title	38204948
in	O	121	123	title	38204948
polycystic	B-DDF	124	134	title	38204948
ovarian	I-DDF	135	142	title	38204948
syndrome	I-DDF	143	151	title	38204948
.	O	151	152	title	38204948

Polycystic	B-DDF	0	10	abstract	38204948
ovarian	I-DDF	11	18	abstract	38204948
syndrome	I-DDF	19	27	abstract	38204948
(	O	28	29	abstract	38204948
PCOS	B-DDF	29	33	abstract	38204948
)	O	33	34	abstract	38204948
is	O	35	37	abstract	38204948
the	O	38	41	abstract	38204948
most	O	42	46	abstract	38204948
common	O	47	53	abstract	38204948
endocrine	B-DDF	54	63	abstract	38204948
disorder	I-DDF	64	72	abstract	38204948
in	O	73	75	abstract	38204948
women	B-human	76	81	abstract	38204948
,	O	81	82	abstract	38204948
affecting	O	83	92	abstract	38204948
up	O	93	95	abstract	38204948
to	O	96	98	abstract	38204948
15	O	99	101	abstract	38204948
%	O	101	102	abstract	38204948
of	O	103	105	abstract	38204948
reproductive-aged	B-human	106	123	abstract	38204948
women	I-human	124	129	abstract	38204948
.	O	129	130	abstract	38204948

Polycystic	B-DDF	131	141	abstract	38204948
ovarian	I-DDF	142	149	abstract	38204948
syndrome	I-DDF	150	158	abstract	38204948
is	O	159	161	abstract	38204948
a	O	162	163	abstract	38204948
heterogeneous	O	164	177	abstract	38204948
disorder	O	178	186	abstract	38204948
,	O	186	187	abstract	38204948
both	O	188	192	abstract	38204948
in	O	193	195	abstract	38204948
the	O	196	199	abstract	38204948
sense	O	200	205	abstract	38204948
that	O	206	210	abstract	38204948
many	O	211	215	abstract	38204948
different	O	216	225	abstract	38204948
factors	O	226	233	abstract	38204948
may	O	234	237	abstract	38204948
play	O	238	242	abstract	38204948
a	O	243	244	abstract	38204948
role	O	245	249	abstract	38204948
in	O	250	252	abstract	38204948
its	O	253	256	abstract	38204948
manifestation	O	257	270	abstract	38204948
and	O	271	274	abstract	38204948
that	O	275	279	abstract	38204948
multiple	O	280	288	abstract	38204948
systems	O	289	296	abstract	38204948
throughout	O	297	307	abstract	38204948
the	O	308	311	abstract	38204948
body	O	312	316	abstract	38204948
can	O	317	320	abstract	38204948
be	O	321	323	abstract	38204948
affected	O	324	332	abstract	38204948
.	O	332	333	abstract	38204948

Polycystic	B-DDF	334	344	abstract	38204948
ovarian	I-DDF	345	352	abstract	38204948
syndrome	I-DDF	353	361	abstract	38204948
has	O	362	365	abstract	38204948
been	O	366	370	abstract	38204948
linked	O	371	377	abstract	38204948
to	O	378	380	abstract	38204948
an	O	381	383	abstract	38204948
increased	O	384	393	abstract	38204948
prevalence	O	394	404	abstract	38204948
of	O	405	407	abstract	38204948
various	O	408	415	abstract	38204948
psychiatric	B-DDF	416	427	abstract	38204948
disorders	I-DDF	428	437	abstract	38204948
,	O	437	438	abstract	38204948
including	O	439	448	abstract	38204948
depression	B-DDF	449	459	abstract	38204948
and	O	460	463	abstract	38204948
anxiety	B-DDF	464	471	abstract	38204948
.	O	471	472	abstract	38204948

Despite	O	473	480	abstract	38204948
the	O	481	484	abstract	38204948
socioeconomic	O	485	498	abstract	38204948
effect	O	499	505	abstract	38204948
that	O	506	510	abstract	38204948
these	O	511	516	abstract	38204948
disorders	O	517	526	abstract	38204948
may	O	527	530	abstract	38204948
have	O	531	535	abstract	38204948
on	O	536	538	abstract	38204948
patients	B-human	539	547	abstract	38204948
with	O	548	552	abstract	38204948
PCOS	B-DDF	553	557	abstract	38204948
and	O	558	561	abstract	38204948
society	O	562	569	abstract	38204948
as	O	570	572	abstract	38204948
a	O	573	574	abstract	38204948
whole	O	575	580	abstract	38204948
,	O	580	581	abstract	38204948
this	O	582	586	abstract	38204948
association	O	587	598	abstract	38204948
is	O	599	601	abstract	38204948
largely	O	602	609	abstract	38204948
lacking	O	610	617	abstract	38204948
in	O	618	620	abstract	38204948
research	O	621	629	abstract	38204948
.	O	629	630	abstract	38204948

There	O	631	636	abstract	38204948
are	O	637	640	abstract	38204948
currently	O	641	650	abstract	38204948
several	O	651	658	abstract	38204948
theories	O	659	667	abstract	38204948
regarding	O	668	677	abstract	38204948
the	O	678	681	abstract	38204948
link	O	682	686	abstract	38204948
between	O	687	694	abstract	38204948
PCOS	B-DDF	695	699	abstract	38204948
and	O	700	703	abstract	38204948
mental	O	704	710	abstract	38204948
health	O	711	717	abstract	38204948
.	O	717	718	abstract	38204948

Some	O	719	723	abstract	38204948
suggest	O	724	731	abstract	38204948
that	O	732	736	abstract	38204948
the	O	737	740	abstract	38204948
overactive	O	741	751	abstract	38204948
hypothalamic-pituitary-ovarian	O	752	782	abstract	38204948
and	O	783	786	abstract	38204948
hypothalamic-pituitary-adrenal	O	787	817	abstract	38204948
axes	O	818	822	abstract	38204948
in	O	823	825	abstract	38204948
PCOS	B-human	826	830	abstract	38204948
patients	I-human	831	839	abstract	38204948
may	O	840	843	abstract	38204948
alter	O	844	849	abstract	38204948
the	O	850	853	abstract	38204948
hormonal	O	854	862	abstract	38204948
profile	O	863	870	abstract	38204948
and	O	871	874	abstract	38204948
contribute	O	875	885	abstract	38204948
to	O	886	888	abstract	38204948
the	O	889	892	abstract	38204948
development	O	893	904	abstract	38204948
of	O	905	907	abstract	38204948
psychiatric	B-DDF	908	919	abstract	38204948
disorders	I-DDF	920	929	abstract	38204948
.	O	929	930	abstract	38204948

Other	O	931	936	abstract	38204948
studies	O	937	944	abstract	38204948
speculate	O	945	954	abstract	38204948
that	O	955	959	abstract	38204948
abnormal	O	960	968	abstract	38204948
levels	O	969	975	abstract	38204948
of	O	976	978	abstract	38204948
neurotransmitters	O	979	996	abstract	38204948
and	O	997	1000	abstract	38204948
neuronal	O	1001	1009	abstract	38204948
signaling	O	1010	1019	abstract	38204948
may	O	1020	1023	abstract	38204948
play	O	1024	1028	abstract	38204948
a	O	1029	1030	abstract	38204948
role	O	1031	1035	abstract	38204948
.	O	1035	1036	abstract	38204948

Recently	O	1037	1045	abstract	38204948
,	O	1045	1046	abstract	38204948
more	O	1047	1051	abstract	38204948
research	O	1052	1060	abstract	38204948
has	O	1061	1064	abstract	38204948
begun	O	1065	1070	abstract	38204948
to	O	1071	1073	abstract	38204948
focus	O	1074	1079	abstract	38204948
on	O	1080	1082	abstract	38204948
the	O	1083	1086	abstract	38204948
gut-brain	O	1087	1096	abstract	38204948
axis	O	1097	1101	abstract	38204948
,	O	1101	1102	abstract	38204948
addressing	O	1103	1113	abstract	38204948
the	O	1114	1117	abstract	38204948
nutritional	O	1118	1129	abstract	38204948
needs	O	1130	1135	abstract	38204948
of	O	1136	1138	abstract	38204948
PCOS	B-human	1139	1143	abstract	38204948
patients	I-human	1144	1152	abstract	38204948
.	O	1152	1153	abstract	38204948

Studies	O	1154	1161	abstract	38204948
show	O	1162	1166	abstract	38204948
that	O	1167	1171	abstract	38204948
dietary	O	1172	1179	abstract	38204948
factors	O	1180	1187	abstract	38204948
such	O	1188	1192	abstract	38204948
as	O	1193	1195	abstract	38204948
probiotics	B-dietary%supplement	1196	1206	abstract	38204948
and	O	1207	1210	abstract	38204948
micronutrient	B-dietary%supplement	1211	1224	abstract	38204948
supplementation	I-dietary%supplement	1225	1240	abstract	38204948
may	O	1241	1244	abstract	38204948
significantly	O	1245	1258	abstract	38204948
improve	O	1259	1266	abstract	38204948
psychiatric	B-DDF	1267	1278	abstract	38204948
symptoms	I-DDF	1279	1287	abstract	38204948
in	O	1288	1290	abstract	38204948
PCOS	B-human	1291	1295	abstract	38204948
patients	I-human	1296	1304	abstract	38204948
while	O	1305	1310	abstract	38204948
helping	O	1311	1318	abstract	38204948
regulate	O	1319	1327	abstract	38204948
neurotransmitter	O	1328	1344	abstract	38204948
levels	O	1345	1351	abstract	38204948
in	O	1352	1354	abstract	38204948
the	O	1355	1358	abstract	38204948
body	O	1359	1363	abstract	38204948
.	O	1363	1364	abstract	38204948

In	O	1365	1367	abstract	38204948
this	O	1368	1372	abstract	38204948
review	O	1373	1379	abstract	38204948
,	O	1379	1380	abstract	38204948
we	O	1381	1383	abstract	38204948
examine	O	1384	1391	abstract	38204948
different	O	1392	1401	abstract	38204948
theories	O	1402	1410	abstract	38204948
regarding	O	1411	1420	abstract	38204948
the	O	1421	1424	abstract	38204948
association	O	1425	1436	abstract	38204948
between	O	1437	1444	abstract	38204948
PCOS	B-DDF	1445	1449	abstract	38204948
and	O	1450	1453	abstract	38204948
psychiatric	B-DDF	1454	1465	abstract	38204948
disorders	I-DDF	1466	1475	abstract	38204948
and	O	1476	1479	abstract	38204948
point	O	1480	1485	abstract	38204948
out	O	1486	1489	abstract	38204948
different	O	1490	1499	abstract	38204948
areas	O	1500	1505	abstract	38204948
of	O	1506	1508	abstract	38204948
research	O	1509	1517	abstract	38204948
that	O	1518	1522	abstract	38204948
are	O	1523	1526	abstract	38204948
needed	O	1527	1533	abstract	38204948
to	O	1534	1536	abstract	38204948
broaden	O	1537	1544	abstract	38204948
our	O	1545	1548	abstract	38204948
understanding	O	1549	1562	abstract	38204948
of	O	1563	1565	abstract	38204948
this	O	1566	1570	abstract	38204948
association	O	1571	1582	abstract	38204948
.	O	1582	1583	abstract	38204948

Gut	O	0	3	title	31952911
microbial	O	4	13	title	31952911
changes	O	14	21	title	31952911
of	O	22	24	title	31952911
patients	B-human	25	33	title	31952911
with	O	34	38	title	31952911
psychotic	B-DDF	39	48	title	31952911
and	I-DDF	49	52	title	31952911
affective	I-DDF	53	62	title	31952911
disorders	I-DDF	63	72	title	31952911
:	O	72	73	title	31952911
A	O	74	75	title	31952911
systematic	O	76	86	title	31952911
review	O	87	93	title	31952911
.	O	93	94	title	31952911

Many	O	0	4	abstract	31952911
diverse	O	5	12	abstract	31952911
inflammatory	O	13	25	abstract	31952911
pathophysiologic	O	26	42	abstract	31952911
mechanisms	O	43	53	abstract	31952911
have	O	54	58	abstract	31952911
been	O	59	63	abstract	31952911
linked	O	64	70	abstract	31952911
to	O	71	73	abstract	31952911
mental	B-DDF	74	80	abstract	31952911
disorders	I-DDF	81	90	abstract	31952911
,	O	90	91	abstract	31952911
and	O	92	95	abstract	31952911
through	O	96	103	abstract	31952911
the	O	104	107	abstract	31952911
past	O	108	112	abstract	31952911
decade	O	113	119	abstract	31952911
an	O	120	122	abstract	31952911
increasing	O	123	133	abstract	31952911
interest	O	134	142	abstract	31952911
in	O	143	145	abstract	31952911
the	O	146	149	abstract	31952911
gut	B-microbiome	150	153	abstract	31952911
microbiota	I-microbiome	154	164	abstract	31952911
and	O	165	168	abstract	31952911
its	O	169	172	abstract	31952911
relation	O	173	181	abstract	31952911
to	O	182	184	abstract	31952911
mental	O	185	191	abstract	31952911
health	O	192	198	abstract	31952911
has	O	199	202	abstract	31952911
been	O	203	207	abstract	31952911
arising	O	208	215	abstract	31952911
.	O	215	216	abstract	31952911

We	O	217	219	abstract	31952911
aimed	O	220	225	abstract	31952911
to	O	226	228	abstract	31952911
systematically	O	229	243	abstract	31952911
review	O	244	250	abstract	31952911
studies	O	251	258	abstract	31952911
of	O	259	261	abstract	31952911
alterations	O	262	273	abstract	31952911
in	O	274	276	abstract	31952911
gut	B-microbiome	277	280	abstract	31952911
microbiota	I-microbiome	281	291	abstract	31952911
of	O	292	294	abstract	31952911
patients	B-human	295	303	abstract	31952911
suffering	O	304	313	abstract	31952911
from	O	314	318	abstract	31952911
psychotic	B-DDF	319	328	abstract	31952911
disorders	I-DDF	329	338	abstract	31952911
,	O	338	339	abstract	31952911
bipolar	B-DDF	340	347	abstract	31952911
disorder	I-DDF	348	356	abstract	31952911
or	O	357	359	abstract	31952911
depression	B-DDF	360	370	abstract	31952911
compared	O	371	379	abstract	31952911
to	O	380	382	abstract	31952911
healthy	B-human	383	390	abstract	31952911
controls	I-human	391	399	abstract	31952911
.	O	399	400	abstract	31952911

We	O	401	403	abstract	31952911
systematically	O	404	418	abstract	31952911
searched	O	419	427	abstract	31952911
the	O	428	431	abstract	31952911
databases	O	432	441	abstract	31952911
CENTRAL	O	442	449	abstract	31952911
,	O	449	450	abstract	31952911
PubMed	O	451	457	abstract	31952911
,	O	457	458	abstract	31952911
EMBASE	O	459	465	abstract	31952911
,	O	465	466	abstract	31952911
PsycINFO	O	467	475	abstract	31952911
and	O	476	479	abstract	31952911
LILACS	O	480	486	abstract	31952911
.	O	486	487	abstract	31952911

Primary	O	488	495	abstract	31952911
outcome	O	496	503	abstract	31952911
was	O	504	507	abstract	31952911
to	O	508	510	abstract	31952911
compare	O	511	518	abstract	31952911
the	O	519	522	abstract	31952911
gut	B-microbiome	523	526	abstract	31952911
microbiota	I-microbiome	527	537	abstract	31952911
of	O	538	540	abstract	31952911
patients	B-human	541	549	abstract	31952911
suffering	O	550	559	abstract	31952911
from	O	560	564	abstract	31952911
psychotic	B-DDF	565	574	abstract	31952911
disorders	I-DDF	575	584	abstract	31952911
,	O	584	585	abstract	31952911
bipolar	B-DDF	586	593	abstract	31952911
disorder	I-DDF	594	602	abstract	31952911
or	O	603	605	abstract	31952911
depression	B-DDF	606	616	abstract	31952911
with	O	617	621	abstract	31952911
healthy	B-human	622	629	abstract	31952911
controls	I-human	630	638	abstract	31952911
.	O	638	639	abstract	31952911

We	O	640	642	abstract	31952911
identified	O	643	653	abstract	31952911
17	O	654	656	abstract	31952911
studies	O	657	664	abstract	31952911
,	O	664	665	abstract	31952911
covering	O	666	674	abstract	31952911
744	O	675	678	abstract	31952911
patients	B-human	679	687	abstract	31952911
and	O	688	691	abstract	31952911
620	O	692	695	abstract	31952911
healthy	B-human	696	703	abstract	31952911
controls	I-human	704	712	abstract	31952911
.	O	712	713	abstract	31952911

The	O	714	717	abstract	31952911
most	O	718	722	abstract	31952911
consistent	O	723	733	abstract	31952911
microbiota	O	734	744	abstract	31952911
changes	O	745	752	abstract	31952911
were	O	753	757	abstract	31952911
a	O	758	759	abstract	31952911
tendency	O	760	768	abstract	31952911
towards	O	769	776	abstract	31952911
higher	O	777	783	abstract	31952911
abundance	O	784	793	abstract	31952911
of	O	794	796	abstract	31952911
Actinobacteria	B-bacteria	797	811	abstract	31952911
and	O	812	815	abstract	31952911
lower	O	816	821	abstract	31952911
abundance	O	822	831	abstract	31952911
of	O	832	834	abstract	31952911
Firmicutes	B-bacteria	835	845	abstract	31952911
at	O	846	848	abstract	31952911
the	O	849	852	abstract	31952911
phylum	O	853	859	abstract	31952911
level	O	860	865	abstract	31952911
,	O	865	866	abstract	31952911
lower	O	867	872	abstract	31952911
abundance	O	873	882	abstract	31952911
of	O	883	885	abstract	31952911
Lachnospiraceae	B-bacteria	886	901	abstract	31952911
at	O	902	904	abstract	31952911
family	O	905	911	abstract	31952911
level	O	912	917	abstract	31952911
and	O	918	921	abstract	31952911
lower	O	922	927	abstract	31952911
abundance	O	928	937	abstract	31952911
of	O	938	940	abstract	31952911
Faecalibacterium	B-bacteria	941	957	abstract	31952911
at	O	958	960	abstract	31952911
genus	O	961	966	abstract	31952911
level	O	967	972	abstract	31952911
for	O	973	976	abstract	31952911
the	O	977	980	abstract	31952911
mental	B-DDF	981	987	abstract	31952911
disorders	I-DDF	988	997	abstract	31952911
overall	O	998	1005	abstract	31952911
.	O	1005	1006	abstract	31952911

However	O	1007	1014	abstract	31952911
,	O	1014	1015	abstract	31952911
we	O	1016	1018	abstract	31952911
found	O	1019	1024	abstract	31952911
that	O	1025	1029	abstract	31952911
all	O	1030	1033	abstract	31952911
studies	O	1034	1041	abstract	31952911
had	O	1042	1045	abstract	31952911
risk	O	1046	1050	abstract	31952911
of	O	1051	1053	abstract	31952911
bias	O	1054	1058	abstract	31952911
and	O	1059	1062	abstract	31952911
that	O	1063	1067	abstract	31952911
the	O	1068	1071	abstract	31952911
included	O	1072	1080	abstract	31952911
studies	O	1081	1088	abstract	31952911
displayed	O	1089	1098	abstract	31952911
great	O	1099	1104	abstract	31952911
variability	O	1105	1116	abstract	31952911
in	O	1117	1119	abstract	31952911
methods	O	1120	1127	abstract	31952911
of	O	1128	1130	abstract	31952911
storage	O	1131	1138	abstract	31952911
,	O	1138	1139	abstract	31952911
analysis	B-biomedical%technique	1140	1148	abstract	31952911
of	I-biomedical%technique	1149	1151	abstract	31952911
the	I-biomedical%technique	1152	1155	abstract	31952911
fecal	I-biomedical%technique	1156	1161	abstract	31952911
samples	I-biomedical%technique	1162	1169	abstract	31952911
,	O	1169	1170	abstract	31952911
reporting	O	1171	1180	abstract	31952911
of	O	1181	1183	abstract	31952911
results	O	1184	1191	abstract	31952911
and	O	1192	1195	abstract	31952911
statistics	O	1196	1206	abstract	31952911
used	O	1207	1211	abstract	31952911
.	O	1211	1212	abstract	31952911

Due	O	1213	1216	abstract	31952911
to	O	1217	1219	abstract	31952911
the	O	1220	1223	abstract	31952911
many	O	1224	1228	abstract	31952911
limitations	O	1229	1240	abstract	31952911
of	O	1241	1243	abstract	31952911
the	O	1244	1247	abstract	31952911
included	O	1248	1256	abstract	31952911
studies	O	1257	1264	abstract	31952911
the	O	1265	1268	abstract	31952911
findings	O	1269	1277	abstract	31952911
should	O	1278	1284	abstract	31952911
be	O	1285	1287	abstract	31952911
interpreted	O	1288	1299	abstract	31952911
with	O	1300	1304	abstract	31952911
caution	O	1305	1312	abstract	31952911
.	O	1312	1313	abstract	31952911

Larger	O	1314	1320	abstract	31952911
studies	O	1321	1328	abstract	31952911
(	O	1329	1330	abstract	31952911
especially	O	1330	1340	abstract	31952911
of	O	1341	1343	abstract	31952911
schizophrenia	B-DDF	1344	1357	abstract	31952911
and	O	1358	1361	abstract	31952911
major	B-DDF	1362	1367	abstract	31952911
depressive	I-DDF	1368	1378	abstract	31952911
disorder	I-DDF	1379	1387	abstract	31952911
)	O	1387	1388	abstract	31952911
are	O	1389	1392	abstract	31952911
needed	O	1393	1399	abstract	31952911
,	O	1399	1400	abstract	31952911
but	O	1401	1404	abstract	31952911
it	O	1405	1407	abstract	31952911
is	O	1408	1410	abstract	31952911
also	O	1411	1415	abstract	31952911
of	O	1416	1418	abstract	31952911
great	O	1419	1424	abstract	31952911
importance	O	1425	1435	abstract	31952911
to	O	1436	1438	abstract	31952911
gather	O	1439	1445	abstract	31952911
information	O	1446	1457	abstract	31952911
of	O	1458	1460	abstract	31952911
and	O	1461	1464	abstract	31952911
control	O	1465	1472	abstract	31952911
for	O	1473	1476	abstract	31952911
factors	O	1477	1484	abstract	31952911
that	O	1485	1489	abstract	31952911
influence	O	1490	1499	abstract	31952911
the	O	1500	1503	abstract	31952911
result	O	1504	1510	abstract	31952911
of	O	1511	1513	abstract	31952911
a	O	1514	1515	abstract	31952911
microbiota	O	1516	1526	abstract	31952911
analysis	O	1527	1535	abstract	31952911
including	O	1536	1545	abstract	31952911
body	O	1546	1550	abstract	31952911
mass	O	1551	1555	abstract	31952911
index	O	1556	1561	abstract	31952911
(	O	1562	1563	abstract	31952911
BMI	O	1563	1566	abstract	31952911
)	O	1566	1567	abstract	31952911
,	O	1567	1568	abstract	31952911
smoking	O	1569	1576	abstract	31952911
,	O	1576	1577	abstract	31952911
alcohol	O	1578	1585	abstract	31952911
consumption	O	1586	1597	abstract	31952911
,	O	1597	1598	abstract	31952911
diet	O	1599	1603	abstract	31952911
habits	O	1604	1610	abstract	31952911
,	O	1610	1611	abstract	31952911
antibiotics	B-drug	1612	1623	abstract	31952911
,	O	1623	1624	abstract	31952911
sample	O	1625	1631	abstract	31952911
handling	O	1632	1640	abstract	31952911
,	O	1640	1641	abstract	31952911
wet	B-biomedical%technique	1642	1645	abstract	31952911
laboratory	I-biomedical%technique	1646	1656	abstract	31952911
methods	I-biomedical%technique	1657	1664	abstract	31952911
and	O	1665	1668	abstract	31952911
statistics	O	1669	1679	abstract	31952911
.	O	1679	1680	abstract	31952911

The	O	0	3	title	29023380
Gut	O	4	7	title	29023380
Microbiome	O	8	18	title	29023380
Feelings	O	19	27	title	29023380
of	O	28	30	title	29023380
the	O	31	34	title	29023380
Brain	B-anatomical%location	35	40	title	29023380
:	O	40	41	title	29023380
A	O	42	43	title	29023380
Perspective	O	44	55	title	29023380
for	O	56	59	title	29023380
Non-Microbiologists	O	60	79	title	29023380
.	O	79	80	title	29023380

<	O	0	1	abstract	29023380
b	O	1	2	abstract	29023380
>	O	2	3	abstract	29023380
Objectives:</b	O	3	17	abstract	29023380
>	O	17	18	abstract	29023380
To	O	19	21	abstract	29023380
comprehensively	O	22	37	abstract	29023380
review	O	38	44	abstract	29023380
the	O	45	48	abstract	29023380
scientific	O	49	59	abstract	29023380
knowledge	O	60	69	abstract	29023380
on	O	70	72	abstract	29023380
the	O	73	76	abstract	29023380
gut-brain	O	77	86	abstract	29023380
axis	O	87	91	abstract	29023380
.	O	91	92	abstract	29023380

<	O	93	94	abstract	29023380
b	O	94	95	abstract	29023380
>	O	95	96	abstract	29023380
Methods:</b	O	96	107	abstract	29023380
>	O	107	108	abstract	29023380
Various	O	109	116	abstract	29023380
publications	O	117	129	abstract	29023380
on	O	130	132	abstract	29023380
the	O	133	136	abstract	29023380
gut-brain	O	137	146	abstract	29023380
axis	O	147	151	abstract	29023380
,	O	151	152	abstract	29023380
until	O	153	158	abstract	29023380
31	O	159	161	abstract	29023380
July	O	162	166	abstract	29023380
2017	O	167	171	abstract	29023380
,	O	171	172	abstract	29023380
were	O	173	177	abstract	29023380
screened	O	178	186	abstract	29023380
using	O	187	192	abstract	29023380
the	O	193	196	abstract	29023380
Medline	O	197	204	abstract	29023380
,	O	204	205	abstract	29023380
Google	O	206	212	abstract	29023380
,	O	212	213	abstract	29023380
and	O	214	217	abstract	29023380
Cochrane	O	218	226	abstract	29023380
Library	O	227	234	abstract	29023380
databases	O	235	244	abstract	29023380
.	O	244	245	abstract	29023380

The	O	246	249	abstract	29023380
search	O	250	256	abstract	29023380
was	O	257	260	abstract	29023380
performed	O	261	270	abstract	29023380
using	O	271	276	abstract	29023380
the	O	277	280	abstract	29023380
following	O	281	290	abstract	29023380
keywords	O	291	299	abstract	29023380
:	O	299	300	abstract	29023380
"	O	301	302	abstract	29023380
gut-brain	O	302	311	abstract	29023380
axis	O	312	316	abstract	29023380
"	O	316	317	abstract	29023380
,	O	317	318	abstract	29023380
"	O	319	320	abstract	29023380
gut-microbiota-brain	O	320	340	abstract	29023380
axis	O	341	345	abstract	29023380
"	O	345	346	abstract	29023380
,	O	346	347	abstract	29023380
"	O	348	349	abstract	29023380
nutrition	O	349	358	abstract	29023380
microbiome/microbiota	O	359	380	abstract	29023380
"	O	380	381	abstract	29023380
,	O	381	382	abstract	29023380
"	O	383	384	abstract	29023380
enteric	O	384	391	abstract	29023380
nervous	O	392	399	abstract	29023380
system	O	400	406	abstract	29023380
"	O	406	407	abstract	29023380
,	O	407	408	abstract	29023380
"	O	409	410	abstract	29023380
enteric	B-chemical	410	417	abstract	29023380
glial	I-chemical	418	423	abstract	29023380
cells/network	I-chemical	424	437	abstract	29023380
"	O	437	438	abstract	29023380
,	O	438	439	abstract	29023380
"	O	440	441	abstract	29023380
gut-brain	O	441	450	abstract	29023380
pathways	O	451	459	abstract	29023380
"	O	459	460	abstract	29023380
,	O	460	461	abstract	29023380
"	O	462	463	abstract	29023380
microbiome	O	463	473	abstract	29023380
immune	O	474	480	abstract	29023380
system	O	481	487	abstract	29023380
"	O	487	488	abstract	29023380
,	O	488	489	abstract	29023380
"	O	490	491	abstract	29023380
microbiome	O	491	501	abstract	29023380
neuroendocrine	O	502	516	abstract	29023380
system	O	517	523	abstract	29023380
"	O	523	524	abstract	29023380
and	O	525	528	abstract	29023380
"	O	529	530	abstract	29023380
intestinal/gut/enteric	B-chemical	530	552	abstract	29023380
neuropeptides	I-chemical	553	566	abstract	29023380
"	O	566	567	abstract	29023380
.	O	567	568	abstract	29023380

Relevant	O	569	577	abstract	29023380
articles	O	578	586	abstract	29023380
were	O	587	591	abstract	29023380
selected	O	592	600	abstract	29023380
and	O	601	604	abstract	29023380
reviewed	O	605	613	abstract	29023380
.	O	613	614	abstract	29023380

<	O	615	616	abstract	29023380
b	O	616	617	abstract	29023380
>	O	617	618	abstract	29023380
Results:</b	O	618	629	abstract	29023380
>	O	629	630	abstract	29023380
Tremendous	O	631	641	abstract	29023380
progress	O	642	650	abstract	29023380
has	O	651	654	abstract	29023380
been	O	655	659	abstract	29023380
made	O	660	664	abstract	29023380
in	O	665	667	abstract	29023380
exploring	O	668	677	abstract	29023380
the	O	678	681	abstract	29023380
interactions	O	682	694	abstract	29023380
between	O	695	702	abstract	29023380
nutrients	O	703	712	abstract	29023380
,	O	712	713	abstract	29023380
the	O	714	717	abstract	29023380
microbiome	O	718	728	abstract	29023380
,	O	728	729	abstract	29023380
and	O	730	733	abstract	29023380
the	O	734	737	abstract	29023380
intestinal	O	738	748	abstract	29023380
,	O	748	749	abstract	29023380
epithelium-enteric	O	750	768	abstract	29023380
nervous	O	769	776	abstract	29023380
,	O	776	777	abstract	29023380
endocrine	O	778	787	abstract	29023380
and	O	788	791	abstract	29023380
immune	O	792	798	abstract	29023380
systems	O	799	806	abstract	29023380
and	O	807	810	abstract	29023380
the	O	811	814	abstract	29023380
brain	B-anatomical%location	815	820	abstract	29023380
.	O	820	821	abstract	29023380

The	O	822	825	abstract	29023380
basis	O	826	831	abstract	29023380
of	O	832	834	abstract	29023380
the	O	835	838	abstract	29023380
gut-brain	O	839	848	abstract	29023380
axis	O	849	853	abstract	29023380
comprises	O	854	863	abstract	29023380
of	O	864	866	abstract	29023380
an	O	867	869	abstract	29023380
array	O	870	875	abstract	29023380
of	O	876	878	abstract	29023380
multichannel	O	879	891	abstract	29023380
sensing	O	892	899	abstract	29023380
and	O	900	903	abstract	29023380
trafficking	O	904	915	abstract	29023380
pathways	O	916	924	abstract	29023380
that	O	925	929	abstract	29023380
are	O	930	933	abstract	29023380
suggested	O	934	943	abstract	29023380
to	O	944	946	abstract	29023380
convey	O	947	953	abstract	29023380
the	O	954	957	abstract	29023380
enteric	O	958	965	abstract	29023380
signals	O	966	973	abstract	29023380
to	O	974	976	abstract	29023380
the	O	977	980	abstract	29023380
brain	B-anatomical%location	981	986	abstract	29023380
.	O	986	987	abstract	29023380

These	O	988	993	abstract	29023380
are	O	994	997	abstract	29023380
mediated	O	998	1006	abstract	29023380
by	O	1007	1009	abstract	29023380
neuroanatomy	O	1010	1022	abstract	29023380
(	O	1023	1024	abstract	29023380
represented	O	1024	1035	abstract	29023380
by	O	1036	1038	abstract	29023380
the	O	1039	1042	abstract	29023380
vagal	B-chemical	1043	1048	abstract	29023380
and	I-chemical	1049	1052	abstract	29023380
spinal	I-chemical	1053	1059	abstract	29023380
afferent	I-chemical	1060	1068	abstract	29023380
neurons	I-chemical	1069	1076	abstract	29023380
)	O	1076	1077	abstract	29023380
,	O	1077	1078	abstract	29023380
the	O	1079	1082	abstract	29023380
neuroendocrine-hypothalamic-pituitary-adrenal	O	1083	1128	abstract	29023380
(	O	1129	1130	abstract	29023380
HPA	O	1130	1133	abstract	29023380
)	O	1133	1134	abstract	29023380
axis	O	1135	1139	abstract	29023380
(	O	1140	1141	abstract	29023380
represented	O	1141	1152	abstract	29023380
by	O	1153	1155	abstract	29023380
the	O	1156	1159	abstract	29023380
gut	B-chemical	1160	1163	abstract	29023380
hormones	I-chemical	1164	1172	abstract	29023380
)	O	1172	1173	abstract	29023380
,	O	1173	1174	abstract	29023380
immune	O	1175	1181	abstract	29023380
routes	O	1182	1188	abstract	29023380
(	O	1189	1190	abstract	29023380
represented	O	1190	1201	abstract	29023380
by	O	1202	1204	abstract	29023380
multiple	O	1205	1213	abstract	29023380
cytokines	B-chemical	1214	1223	abstract	29023380
)	O	1223	1224	abstract	29023380
,	O	1224	1225	abstract	29023380
microbially-derived	B-chemical	1226	1245	abstract	29023380
neurotransmitters	I-chemical	1246	1263	abstract	29023380
,	O	1263	1264	abstract	29023380
and	O	1265	1268	abstract	29023380
finally	O	1269	1276	abstract	29023380
the	O	1277	1280	abstract	29023380
gate	O	1281	1285	abstract	29023380
keepers	O	1286	1293	abstract	29023380
of	O	1294	1296	abstract	29023380
the	O	1297	1300	abstract	29023380
intestinal	O	1301	1311	abstract	29023380
and	O	1312	1315	abstract	29023380
brain	O	1316	1321	abstract	29023380
barriers	O	1322	1330	abstract	29023380
.	O	1330	1331	abstract	29023380

Their	O	1332	1337	abstract	29023380
mutual	O	1338	1344	abstract	29023380
and	O	1345	1348	abstract	29023380
harmonious	O	1349	1359	abstract	29023380
but	O	1360	1363	abstract	29023380
intricate	O	1364	1373	abstract	29023380
interaction	O	1374	1385	abstract	29023380
is	O	1386	1388	abstract	29023380
essential	O	1389	1398	abstract	29023380
for	O	1399	1402	abstract	29023380
human	O	1403	1408	abstract	29023380
life	O	1409	1413	abstract	29023380
and	O	1414	1417	abstract	29023380
brain	O	1418	1423	abstract	29023380
performance	O	1424	1435	abstract	29023380
.	O	1435	1436	abstract	29023380

However	O	1437	1444	abstract	29023380
,	O	1444	1445	abstract	29023380
a	O	1446	1447	abstract	29023380
failure	O	1448	1455	abstract	29023380
in	O	1456	1458	abstract	29023380
the	O	1459	1462	abstract	29023380
interaction	O	1463	1474	abstract	29023380
leads	O	1475	1480	abstract	29023380
to	O	1481	1483	abstract	29023380
a	O	1484	1485	abstract	29023380
number	O	1486	1492	abstract	29023380
of	O	1493	1495	abstract	29023380
inflammatory-	B-DDF	1496	1509	abstract	29023380
,	I-DDF	1509	1510	abstract	29023380
autoimmune-	I-DDF	1511	1522	abstract	29023380
,	I-DDF	1522	1523	abstract	29023380
neurodegenerative-	I-DDF	1524	1542	abstract	29023380
,	I-DDF	1542	1543	abstract	29023380
metabolic-	I-DDF	1544	1554	abstract	29023380
,	I-DDF	1554	1555	abstract	29023380
mood-	I-DDF	1556	1561	abstract	29023380
,	I-DDF	1561	1562	abstract	29023380
behavioral-	I-DDF	1563	1574	abstract	29023380
,	I-DDF	1574	1575	abstract	29023380
cognitive-	I-DDF	1576	1586	abstract	29023380
,	I-DDF	1586	1587	abstract	29023380
autism-spectrum-	I-DDF	1588	1604	abstract	29023380
,	I-DDF	1604	1605	abstract	29023380
stress-	I-DDF	1606	1613	abstract	29023380
and	I-DDF	1614	1617	abstract	29023380
pain-related	I-DDF	1618	1630	abstract	29023380
disorders	I-DDF	1631	1640	abstract	29023380
.	O	1640	1641	abstract	29023380

The	O	1642	1645	abstract	29023380
limited	O	1646	1653	abstract	29023380
availability	O	1654	1666	abstract	29023380
of	O	1667	1669	abstract	29023380
information	O	1670	1681	abstract	29023380
on	O	1682	1684	abstract	29023380
the	O	1685	1688	abstract	29023380
mechanisms	O	1689	1699	abstract	29023380
,	O	1699	1700	abstract	29023380
pathways	O	1701	1709	abstract	29023380
and	O	1710	1713	abstract	29023380
cause-and-effect	O	1714	1730	abstract	29023380
relationships	O	1731	1744	abstract	29023380
hinders	O	1745	1752	abstract	29023380
us	O	1753	1755	abstract	29023380
from	O	1756	1760	abstract	29023380
translating	O	1761	1772	abstract	29023380
and	O	1773	1776	abstract	29023380
implementing	O	1777	1789	abstract	29023380
the	O	1790	1793	abstract	29023380
knowledge	O	1794	1803	abstract	29023380
from	O	1804	1808	abstract	29023380
the	O	1809	1812	abstract	29023380
bench	O	1813	1818	abstract	29023380
to	O	1819	1821	abstract	29023380
the	O	1822	1825	abstract	29023380
clinic	O	1826	1832	abstract	29023380
.	O	1832	1833	abstract	29023380

<	O	1834	1835	abstract	29023380
b	O	1835	1836	abstract	29023380
>	O	1836	1837	abstract	29023380
Implications:</b	O	1837	1853	abstract	29023380
>	O	1853	1854	abstract	29023380
Further	O	1855	1862	abstract	29023380
understanding	O	1863	1876	abstract	29023380
of	O	1877	1879	abstract	29023380
this	O	1880	1884	abstract	29023380
intricate	O	1885	1894	abstract	29023380
field	O	1895	1900	abstract	29023380
might	O	1901	1906	abstract	29023380
potentially	O	1907	1918	abstract	29023380
shed	O	1919	1923	abstract	29023380
light	O	1924	1929	abstract	29023380
on	O	1930	1932	abstract	29023380
novel	O	1933	1938	abstract	29023380
preventive	O	1939	1949	abstract	29023380
and	O	1950	1953	abstract	29023380
therapeutic	O	1954	1965	abstract	29023380
strategies	O	1966	1976	abstract	29023380
to	O	1977	1979	abstract	29023380
combat	O	1980	1986	abstract	29023380
these	O	1987	1992	abstract	29023380
disorders	O	1993	2002	abstract	29023380
.	O	2002	2003	abstract	29023380

Nutritional	O	2004	2015	abstract	29023380
approaches	O	2016	2026	abstract	29023380
,	O	2026	2027	abstract	29023380
microbiome	O	2028	2038	abstract	29023380
manipulations	O	2039	2052	abstract	29023380
,	O	2052	2053	abstract	29023380
enteric	O	2054	2061	abstract	29023380
and	O	2062	2065	abstract	29023380
brain	O	2066	2071	abstract	29023380
barrier	O	2072	2079	abstract	29023380
reinforcement	O	2080	2093	abstract	29023380
and	O	2094	2097	abstract	29023380
sensing	O	2098	2105	abstract	29023380
and	O	2106	2109	abstract	29023380
trafficking	O	2110	2121	abstract	29023380
modulation	O	2122	2132	abstract	29023380
might	O	2133	2138	abstract	29023380
improve	O	2139	2146	abstract	29023380
physical	O	2147	2155	abstract	29023380
and	O	2156	2159	abstract	29023380
mental	O	2160	2166	abstract	29023380
health	O	2167	2173	abstract	29023380
outcomes	O	2174	2182	abstract	29023380
.	O	2182	2183	abstract	29023380

Chronic	B-DDF	0	7	title	28572752
alcohol	I-DDF	8	15	title	28572752
overconsumption	I-DDF	16	31	title	28572752
may	O	32	35	title	28572752
alter	O	36	41	title	28572752
gut	O	42	45	title	28572752
microbial	O	46	55	title	28572752
metabolism	O	56	66	title	28572752
:	O	66	67	title	28572752
a	O	68	69	title	28572752
retrospective	O	70	83	title	28572752
study	O	84	89	title	28572752
of	O	90	92	title	28572752
719	O	93	96	title	28572752
<	O	97	98	title	28572752
sup>13</sup	O	98	109	title	28572752
>	O	109	110	title	28572752
C-D-xylose	O	110	120	title	28572752
breath	O	121	127	title	28572752
test	O	128	132	title	28572752
results	O	133	140	title	28572752
.	O	140	141	title	28572752

<	O	0	1	abstract	28572752
b	O	1	2	abstract	28572752
>	O	2	3	abstract	28572752
Objective</b	O	3	15	abstract	28572752
>	O	15	16	abstract	28572752
:	O	16	17	abstract	28572752
Alterations	O	18	29	abstract	28572752
of	O	30	32	abstract	28572752
gut	O	33	36	abstract	28572752
microbiota	O	37	47	abstract	28572752
composition	O	48	59	abstract	28572752
or	O	60	62	abstract	28572752
function	O	63	71	abstract	28572752
may	O	72	75	abstract	28572752
participate	O	76	87	abstract	28572752
in	O	88	90	abstract	28572752
the	O	91	94	abstract	28572752
pathophysiology	O	95	110	abstract	28572752
of	O	111	113	abstract	28572752
several	O	114	121	abstract	28572752
diseases	O	122	130	abstract	28572752
.	O	130	131	abstract	28572752

We	O	132	134	abstract	28572752
aimed	O	135	140	abstract	28572752
to	O	141	143	abstract	28572752
explore	O	144	151	abstract	28572752
the	O	152	155	abstract	28572752
effect	O	156	162	abstract	28572752
of	O	163	165	abstract	28572752
chronic	B-DDF	166	173	abstract	28572752
alcohol	I-DDF	174	181	abstract	28572752
overconsumption	I-DDF	182	197	abstract	28572752
on	O	198	200	abstract	28572752
gut	O	201	204	abstract	28572752
microbial	O	205	214	abstract	28572752
metabolism	O	215	225	abstract	28572752
,	O	225	226	abstract	28572752
as	O	227	229	abstract	28572752
assessed	O	230	238	abstract	28572752
by	O	239	241	abstract	28572752
evaluating	O	242	252	abstract	28572752
<	O	253	254	abstract	28572752
sup>13</sup	O	254	265	abstract	28572752
>	O	265	266	abstract	28572752
C-D-xylose	O	266	276	abstract	28572752
breath	O	277	283	abstract	28572752
test	O	284	288	abstract	28572752
results	O	289	296	abstract	28572752
.	O	296	297	abstract	28572752

<	O	298	299	abstract	28572752
b	O	299	300	abstract	28572752
>	O	300	301	abstract	28572752
Materials	O	301	310	abstract	28572752
and	O	311	314	abstract	28572752
methods</b	O	315	325	abstract	28572752
>	O	325	326	abstract	28572752
:	O	326	327	abstract	28572752
We	O	328	330	abstract	28572752
investigated	O	331	343	abstract	28572752
all	O	344	347	abstract	28572752
<	B-biomedical%technique	348	349	abstract	28572752
sup>13</sup	I-biomedical%technique	349	360	abstract	28572752
>	I-biomedical%technique	360	361	abstract	28572752
C-D-xylose	I-biomedical%technique	361	371	abstract	28572752
breath	I-biomedical%technique	372	378	abstract	28572752
tests	I-biomedical%technique	379	384	abstract	28572752
performed	O	385	394	abstract	28572752
at	O	395	397	abstract	28572752
Lovisenberg	O	398	409	abstract	28572752
Diaconal	O	410	418	abstract	28572752
Hospital	O	419	427	abstract	28572752
during	O	428	434	abstract	28572752
the	O	435	438	abstract	28572752
years	O	439	444	abstract	28572752
2005	O	445	449	abstract	28572752
to	O	450	452	abstract	28572752
2011	O	453	457	abstract	28572752
,	O	457	458	abstract	28572752
using	O	459	464	abstract	28572752
patient	O	465	472	abstract	28572752
files	O	473	478	abstract	28572752
for	O	479	482	abstract	28572752
diagnosing	O	483	493	abstract	28572752
the	O	494	497	abstract	28572752
patients	B-human	498	506	abstract	28572752
into	O	507	511	abstract	28572752
one	O	512	515	abstract	28572752
of	O	516	518	abstract	28572752
three	O	519	524	abstract	28572752
patient	O	525	532	abstract	28572752
categories	O	533	543	abstract	28572752
:	O	543	544	abstract	28572752
alcohol	B-DDF	545	552	abstract	28572752
overconsumption	I-DDF	553	568	abstract	28572752
,	O	568	569	abstract	28572752
coeliac	B-DDF	570	577	abstract	28572752
disease	I-DDF	578	585	abstract	28572752
and	O	586	589	abstract	28572752
functional	B-DDF	590	600	abstract	28572752
bowel	I-DDF	601	606	abstract	28572752
disorder	I-DDF	607	615	abstract	28572752
.	O	615	616	abstract	28572752

In	O	617	619	abstract	28572752
addition	O	620	628	abstract	28572752
,	O	628	629	abstract	28572752
a	O	630	631	abstract	28572752
group	O	632	637	abstract	28572752
of	O	638	640	abstract	28572752
healthy	B-human	641	648	abstract	28572752
controls	I-human	649	657	abstract	28572752
was	O	658	661	abstract	28572752
included	O	662	670	abstract	28572752
.	O	670	671	abstract	28572752

The	O	672	675	abstract	28572752
time	O	676	680	abstract	28572752
curves	O	681	687	abstract	28572752
of	O	688	690	abstract	28572752
<	O	691	692	abstract	28572752
sup>13</sup	O	692	703	abstract	28572752
>	O	703	704	abstract	28572752
CO	O	704	706	abstract	28572752
<	O	706	707	abstract	28572752
sub>2</sub	O	707	717	abstract	28572752
>	O	717	718	abstract	28572752
excretion	O	719	728	abstract	28572752
in	O	729	731	abstract	28572752
breath	O	732	738	abstract	28572752
samples	O	739	746	abstract	28572752
were	O	747	751	abstract	28572752
divided	O	752	759	abstract	28572752
into	O	760	764	abstract	28572752
two	O	765	768	abstract	28572752
phases	O	769	775	abstract	28572752
,	O	775	776	abstract	28572752
evaluating	O	777	787	abstract	28572752
small	O	788	793	abstract	28572752
intestinal	O	794	804	abstract	28572752
absorption	O	805	815	abstract	28572752
(	O	816	817	abstract	28572752
0	O	817	818	abstract	28572752
-	O	818	819	abstract	28572752
60	O	819	821	abstract	28572752
	O	821	822	abstract	28572752
min	O	822	825	abstract	28572752
)	O	825	826	abstract	28572752
and	O	827	830	abstract	28572752
colonic	O	831	838	abstract	28572752
microbial	O	839	848	abstract	28572752
metabolism	O	849	859	abstract	28572752
(	O	860	861	abstract	28572752
90	O	861	863	abstract	28572752
-	O	863	864	abstract	28572752
240	O	864	867	abstract	28572752
	O	867	868	abstract	28572752
min	O	868	871	abstract	28572752
)	O	871	872	abstract	28572752
,	O	872	873	abstract	28572752
respectively	O	874	886	abstract	28572752
.	O	886	887	abstract	28572752

<	O	888	889	abstract	28572752
b	O	889	890	abstract	28572752
>	O	890	891	abstract	28572752
Results</b	O	891	901	abstract	28572752
>	O	901	902	abstract	28572752
:	O	902	903	abstract	28572752
A	O	904	905	abstract	28572752
total	O	906	911	abstract	28572752
of	O	912	914	abstract	28572752
719	O	915	918	abstract	28572752
patients	B-human	919	927	abstract	28572752
underwent	O	928	937	abstract	28572752
<	B-biomedical%technique	938	939	abstract	28572752
sup>13</sup	I-biomedical%technique	939	950	abstract	28572752
>	I-biomedical%technique	950	951	abstract	28572752
C-D-xylose	I-biomedical%technique	951	961	abstract	28572752
breath	I-biomedical%technique	962	968	abstract	28572752
testing	I-biomedical%technique	969	976	abstract	28572752
during	O	977	983	abstract	28572752
the	O	984	987	abstract	28572752
inclusion	O	988	997	abstract	28572752
period	O	998	1004	abstract	28572752
.	O	1004	1005	abstract	28572752

Thirty-five	O	1006	1017	abstract	28572752
had	O	1018	1021	abstract	28572752
a	O	1022	1023	abstract	28572752
history	O	1024	1031	abstract	28572752
of	O	1032	1034	abstract	28572752
alcohol	B-DDF	1035	1042	abstract	28572752
overconsumption	I-DDF	1043	1058	abstract	28572752
,	O	1058	1059	abstract	28572752
66	O	1060	1062	abstract	28572752
had	O	1063	1066	abstract	28572752
coeliac	B-DDF	1067	1074	abstract	28572752
disease	I-DDF	1075	1082	abstract	28572752
,	O	1082	1083	abstract	28572752
and	O	1084	1087	abstract	28572752
216	O	1088	1091	abstract	28572752
had	O	1092	1095	abstract	28572752
a	O	1096	1097	abstract	28572752
functional	B-DDF	1098	1108	abstract	28572752
bowel	I-DDF	1109	1114	abstract	28572752
disorder	I-DDF	1115	1123	abstract	28572752
,	O	1123	1124	abstract	28572752
while	O	1125	1130	abstract	28572752
44	O	1131	1133	abstract	28572752
healthy	B-human	1134	1141	abstract	28572752
controls	I-human	1142	1150	abstract	28572752
were	O	1151	1155	abstract	28572752
included	O	1156	1164	abstract	28572752
for	O	1165	1168	abstract	28572752
comparison	O	1169	1179	abstract	28572752
.	O	1179	1180	abstract	28572752

The	O	1181	1184	abstract	28572752
alcohol	B-human	1185	1192	abstract	28572752
overconsumption	I-human	1193	1208	abstract	28572752
group	I-human	1209	1214	abstract	28572752
had	O	1215	1218	abstract	28572752
similar	O	1219	1226	abstract	28572752
small	O	1227	1232	abstract	28572752
intestinal	O	1233	1243	abstract	28572752
phase	O	1244	1249	abstract	28572752
results	O	1250	1257	abstract	28572752
as	O	1258	1260	abstract	28572752
the	O	1261	1264	abstract	28572752
group	O	1265	1270	abstract	28572752
of	O	1271	1273	abstract	28572752
patients	B-human	1274	1282	abstract	28572752
with	O	1283	1287	abstract	28572752
untreated	O	1288	1297	abstract	28572752
coeliac	B-DDF	1298	1305	abstract	28572752
disease	I-DDF	1306	1313	abstract	28572752
.	O	1313	1314	abstract	28572752

During	O	1315	1321	abstract	28572752
the	O	1322	1325	abstract	28572752
colonic	O	1326	1333	abstract	28572752
phase	O	1334	1339	abstract	28572752
,	O	1339	1340	abstract	28572752
the	O	1341	1344	abstract	28572752
group	O	1345	1350	abstract	28572752
of	O	1351	1353	abstract	28572752
patients	B-human	1354	1362	abstract	28572752
with	O	1363	1367	abstract	28572752
alcohol	B-DDF	1368	1375	abstract	28572752
overconsumption	I-DDF	1376	1391	abstract	28572752
differed	O	1392	1400	abstract	28572752
from	O	1401	1405	abstract	28572752
all	O	1406	1409	abstract	28572752
the	O	1410	1413	abstract	28572752
other	O	1414	1419	abstract	28572752
groups	O	1420	1426	abstract	28572752
in	O	1427	1429	abstract	28572752
terms	O	1430	1435	abstract	28572752
of	O	1436	1438	abstract	28572752
<	O	1439	1440	abstract	28572752
sup>13</sup	O	1440	1451	abstract	28572752
>	O	1451	1452	abstract	28572752
C-xylose	O	1452	1460	abstract	28572752
recovery	O	1461	1469	abstract	28572752
,	O	1469	1470	abstract	28572752
with	O	1471	1475	abstract	28572752
significantly	O	1476	1489	abstract	28572752
less	O	1490	1494	abstract	28572752
<	O	1495	1496	abstract	28572752
sup>13</sup	O	1496	1507	abstract	28572752
>	O	1507	1508	abstract	28572752
CO	O	1508	1510	abstract	28572752
<	O	1510	1511	abstract	28572752
sub>2</sub	O	1511	1521	abstract	28572752
>	O	1521	1522	abstract	28572752
excretion	O	1523	1532	abstract	28572752
compared	O	1533	1541	abstract	28572752
to	O	1542	1544	abstract	28572752
the	O	1545	1548	abstract	28572752
other	O	1549	1554	abstract	28572752
groups	O	1555	1561	abstract	28572752
.	O	1561	1562	abstract	28572752

<	O	1563	1564	abstract	28572752
b	O	1564	1565	abstract	28572752
>	O	1565	1566	abstract	28572752
Conclusion</b	O	1566	1579	abstract	28572752
>	O	1579	1580	abstract	28572752
:	O	1580	1581	abstract	28572752
The	O	1582	1585	abstract	28572752
results	O	1586	1593	abstract	28572752
suggest	O	1594	1601	abstract	28572752
that	O	1602	1606	abstract	28572752
patients	B-human	1607	1615	abstract	28572752
with	O	1616	1620	abstract	28572752
a	O	1621	1622	abstract	28572752
history	O	1623	1630	abstract	28572752
of	O	1631	1633	abstract	28572752
alcohol	B-DDF	1634	1641	abstract	28572752
overconsumption	I-DDF	1642	1657	abstract	28572752
suffer	O	1658	1664	abstract	28572752
from	O	1665	1669	abstract	28572752
both	O	1670	1674	abstract	28572752
small	B-DDF	1675	1680	abstract	28572752
intestinal	I-DDF	1681	1691	abstract	28572752
malabsorption	I-DDF	1692	1705	abstract	28572752
and	O	1706	1709	abstract	28572752
impaired	B-DDF	1710	1718	abstract	28572752
colonic	I-DDF	1719	1726	abstract	28572752
microbial	I-DDF	1727	1736	abstract	28572752
metabolism	I-DDF	1737	1747	abstract	28572752
.	O	1747	1748	abstract	28572752

The	O	1749	1752	abstract	28572752
role	O	1753	1757	abstract	28572752
of	O	1758	1760	abstract	28572752
gut	B-microbiome	1761	1764	abstract	28572752
microbiota	I-microbiome	1765	1775	abstract	28572752
in	O	1776	1778	abstract	28572752
chronic	B-DDF	1779	1786	abstract	28572752
alcohol	I-DDF	1787	1794	abstract	28572752
overconsumption	I-DDF	1795	1810	abstract	28572752
should	O	1811	1817	abstract	28572752
be	O	1818	1820	abstract	28572752
investigated	O	1821	1833	abstract	28572752
further	O	1834	1841	abstract	28572752
.	O	1841	1842	abstract	28572752

A	O	0	1	title	36346385
prebiotic	O	2	11	title	36346385
diet	O	12	16	title	36346385
modulates	O	17	26	title	36346385
microglial	O	27	37	title	36346385
states	O	38	44	title	36346385
and	O	45	48	title	36346385
motor	B-DDF	49	54	title	36346385
deficits	I-DDF	55	63	title	36346385
in	O	64	66	title	36346385
-synuclein	B-animal	67	78	title	36346385
overexpressing	I-animal	79	93	title	36346385
mice	I-animal	94	98	title	36346385
.	O	98	99	title	36346385

Parkinson	B-DDF	0	9	abstract	36346385
's	I-DDF	9	11	abstract	36346385
disease	I-DDF	12	19	abstract	36346385
(	O	20	21	abstract	36346385
PD	B-DDF	21	23	abstract	36346385
)	O	23	24	abstract	36346385
is	O	25	27	abstract	36346385
a	O	28	29	abstract	36346385
movement	B-DDF	30	38	abstract	36346385
disorder	I-DDF	39	47	abstract	36346385
characterized	O	48	61	abstract	36346385
by	O	62	64	abstract	36346385
neuroinflammation	B-DDF	65	82	abstract	36346385
,	O	82	83	abstract	36346385
-synuclein	B-DDF	84	95	abstract	36346385
pathology	I-DDF	96	105	abstract	36346385
,	O	105	106	abstract	36346385
and	O	107	110	abstract	36346385
neurodegeneration	B-DDF	111	128	abstract	36346385
.	O	128	129	abstract	36346385

Most	O	130	134	abstract	36346385
cases	O	135	140	abstract	36346385
of	O	141	143	abstract	36346385
PD	B-DDF	144	146	abstract	36346385
are	O	147	150	abstract	36346385
non-hereditary	O	151	165	abstract	36346385
,	O	165	166	abstract	36346385
suggesting	O	167	177	abstract	36346385
a	O	178	179	abstract	36346385
strong	O	180	186	abstract	36346385
role	O	187	191	abstract	36346385
for	O	192	195	abstract	36346385
environmental	O	196	209	abstract	36346385
factors	O	210	217	abstract	36346385
,	O	217	218	abstract	36346385
and	O	219	222	abstract	36346385
it	O	223	225	abstract	36346385
has	O	226	229	abstract	36346385
been	O	230	234	abstract	36346385
speculated	O	235	245	abstract	36346385
that	O	246	250	abstract	36346385
disease	O	251	258	abstract	36346385
may	O	259	262	abstract	36346385
originate	O	263	272	abstract	36346385
in	O	273	275	abstract	36346385
peripheral	B-anatomical%location	276	286	abstract	36346385
tissues	I-anatomical%location	287	294	abstract	36346385
such	O	295	299	abstract	36346385
as	O	300	302	abstract	36346385
the	O	303	306	abstract	36346385
gastrointestinal	B-anatomical%location	307	323	abstract	36346385
(	I-anatomical%location	324	325	abstract	36346385
GI	I-anatomical%location	325	327	abstract	36346385
)	I-anatomical%location	327	328	abstract	36346385
tract	I-anatomical%location	329	334	abstract	36346385
before	O	335	341	abstract	36346385
affecting	O	342	351	abstract	36346385
the	O	352	355	abstract	36346385
brain	B-anatomical%location	356	361	abstract	36346385
.	O	361	362	abstract	36346385

The	O	363	366	abstract	36346385
gut	B-microbiome	367	370	abstract	36346385
microbiome	I-microbiome	371	381	abstract	36346385
is	O	382	384	abstract	36346385
altered	O	385	392	abstract	36346385
in	O	393	395	abstract	36346385
PD	B-DDF	396	398	abstract	36346385
and	O	399	402	abstract	36346385
may	O	403	406	abstract	36346385
impact	O	407	413	abstract	36346385
motor	B-DDF	414	419	abstract	36346385
and	I-DDF	420	423	abstract	36346385
GI	I-DDF	424	426	abstract	36346385
symptoms	I-DDF	427	435	abstract	36346385
as	O	436	438	abstract	36346385
indicated	O	439	448	abstract	36346385
by	O	449	451	abstract	36346385
animal	O	452	458	abstract	36346385
studies	O	459	466	abstract	36346385
,	O	466	467	abstract	36346385
although	O	468	476	abstract	36346385
mechanisms	O	477	487	abstract	36346385
of	O	488	490	abstract	36346385
gut-brain	O	491	500	abstract	36346385
interactions	O	501	513	abstract	36346385
remain	O	514	520	abstract	36346385
incompletely	O	521	533	abstract	36346385
defined	O	534	541	abstract	36346385
.	O	541	542	abstract	36346385

Intestinal	B-bacteria	543	553	abstract	36346385
bacteria	I-bacteria	554	562	abstract	36346385
ferment	O	563	570	abstract	36346385
dietary	B-food	571	578	abstract	36346385
fibers	I-food	579	585	abstract	36346385
into	O	586	590	abstract	36346385
short-chain	B-chemical	591	602	abstract	36346385
fatty	I-chemical	603	608	abstract	36346385
acids	I-chemical	609	614	abstract	36346385
,	O	614	615	abstract	36346385
with	O	616	620	abstract	36346385
fecal	O	621	626	abstract	36346385
levels	O	627	633	abstract	36346385
of	O	634	636	abstract	36346385
these	O	637	642	abstract	36346385
molecules	O	643	652	abstract	36346385
differing	O	653	662	abstract	36346385
between	O	663	670	abstract	36346385
PD	B-human	671	673	abstract	36346385
and	I-human	674	677	abstract	36346385
healthy	I-human	678	685	abstract	36346385
controls	I-human	686	694	abstract	36346385
and	O	695	698	abstract	36346385
in	O	699	701	abstract	36346385
mouse	O	702	707	abstract	36346385
models	O	708	714	abstract	36346385
.	O	714	715	abstract	36346385

Among	O	716	721	abstract	36346385
other	O	722	727	abstract	36346385
effects	O	728	735	abstract	36346385
,	O	735	736	abstract	36346385
dietary	B-chemical	737	744	abstract	36346385
microbial	I-chemical	745	754	abstract	36346385
metabolites	I-chemical	755	766	abstract	36346385
can	O	767	770	abstract	36346385
modulate	O	771	779	abstract	36346385
activation	O	780	790	abstract	36346385
of	O	791	793	abstract	36346385
microglia	O	794	803	abstract	36346385
,	O	803	804	abstract	36346385
brain-resident	O	805	819	abstract	36346385
immune	O	820	826	abstract	36346385
cells	O	827	832	abstract	36346385
implicated	O	833	843	abstract	36346385
in	O	844	846	abstract	36346385
PD	B-DDF	847	849	abstract	36346385
.	O	849	850	abstract	36346385

We	O	851	853	abstract	36346385
therefore	O	854	863	abstract	36346385
investigated	O	864	876	abstract	36346385
whether	O	877	884	abstract	36346385
a	O	885	886	abstract	36346385
fiber-rich	O	887	897	abstract	36346385
diet	O	898	902	abstract	36346385
influences	O	903	913	abstract	36346385
microglial	O	914	924	abstract	36346385
function	O	925	933	abstract	36346385
in	O	934	936	abstract	36346385
-synuclein	B-animal	937	948	abstract	36346385
overexpressing	I-animal	949	963	abstract	36346385
(	I-animal	964	965	abstract	36346385
ASO	I-animal	965	968	abstract	36346385
)	I-animal	968	969	abstract	36346385
mice	I-animal	970	974	abstract	36346385
,	O	974	975	abstract	36346385
a	O	976	977	abstract	36346385
preclinical	O	978	989	abstract	36346385
model	O	990	995	abstract	36346385
with	O	996	1000	abstract	36346385
PD-like	B-DDF	1001	1008	abstract	36346385
symptoms	I-DDF	1009	1017	abstract	36346385
and	I-DDF	1018	1021	abstract	36346385
pathology	I-DDF	1022	1031	abstract	36346385
.	O	1031	1032	abstract	36346385

Feeding	O	1033	1040	abstract	36346385
a	O	1041	1042	abstract	36346385
prebiotic	O	1043	1052	abstract	36346385
high-fiber	O	1053	1063	abstract	36346385
diet	O	1064	1068	abstract	36346385
attenuates	O	1069	1079	abstract	36346385
motor	B-DDF	1080	1085	abstract	36346385
deficits	I-DDF	1086	1094	abstract	36346385
and	O	1095	1098	abstract	36346385
reduces	O	1099	1106	abstract	36346385
-synuclein	B-DDF	1107	1118	abstract	36346385
aggregation	I-DDF	1119	1130	abstract	36346385
in	O	1131	1133	abstract	36346385
the	O	1134	1137	abstract	36346385
substantia	B-anatomical%location	1138	1148	abstract	36346385
nigra	I-anatomical%location	1149	1154	abstract	36346385
of	O	1155	1157	abstract	36346385
mice	B-animal	1158	1162	abstract	36346385
.	O	1162	1163	abstract	36346385

Concomitantly	O	1164	1177	abstract	36346385
,	O	1177	1178	abstract	36346385
the	O	1179	1182	abstract	36346385
gut	B-microbiome	1183	1186	abstract	36346385
microbiome	I-microbiome	1187	1197	abstract	36346385
of	O	1198	1200	abstract	36346385
ASO	B-animal	1201	1204	abstract	36346385
mice	I-animal	1205	1209	abstract	36346385
adopts	O	1210	1216	abstract	36346385
a	O	1217	1218	abstract	36346385
profile	O	1219	1226	abstract	36346385
correlated	O	1227	1237	abstract	36346385
with	O	1238	1242	abstract	36346385
health	O	1243	1249	abstract	36346385
upon	O	1250	1254	abstract	36346385
prebiotic	B-dietary%supplement	1255	1264	abstract	36346385
treatment	I-dietary%supplement	1265	1274	abstract	36346385
,	O	1274	1275	abstract	36346385
which	O	1276	1281	abstract	36346385
also	O	1282	1286	abstract	36346385
reduces	O	1287	1294	abstract	36346385
microglial	B-DDF	1295	1305	abstract	36346385
activation	I-DDF	1306	1316	abstract	36346385
.	O	1316	1317	abstract	36346385

Single-cell	B-biomedical%technique	1318	1329	abstract	36346385
RNA-seq	I-biomedical%technique	1330	1337	abstract	36346385
analysis	I-biomedical%technique	1338	1346	abstract	36346385
of	O	1347	1349	abstract	36346385
microglia	O	1350	1359	abstract	36346385
from	O	1360	1364	abstract	36346385
the	O	1365	1368	abstract	36346385
substantia	B-anatomical%location	1369	1379	abstract	36346385
nigra	I-anatomical%location	1380	1385	abstract	36346385
and	O	1386	1389	abstract	36346385
striatum	B-anatomical%location	1390	1398	abstract	36346385
uncovers	O	1399	1407	abstract	36346385
increased	O	1408	1417	abstract	36346385
pro-inflammatory	O	1418	1434	abstract	36346385
signaling	O	1435	1444	abstract	36346385
and	O	1445	1448	abstract	36346385
reduced	O	1449	1456	abstract	36346385
homeostatic	O	1457	1468	abstract	36346385
responses	O	1469	1478	abstract	36346385
in	O	1479	1481	abstract	36346385
ASO	B-animal	1482	1485	abstract	36346385
mice	I-animal	1486	1490	abstract	36346385
compared	O	1491	1499	abstract	36346385
to	O	1500	1502	abstract	36346385
wild-type	O	1503	1512	abstract	36346385
counterparts	O	1513	1525	abstract	36346385
on	O	1526	1528	abstract	36346385
standard	O	1529	1537	abstract	36346385
diets	O	1538	1543	abstract	36346385
.	O	1543	1544	abstract	36346385

However	O	1545	1552	abstract	36346385
,	O	1552	1553	abstract	36346385
prebiotic	O	1554	1563	abstract	36346385
feeding	O	1564	1571	abstract	36346385
reverses	O	1572	1580	abstract	36346385
pathogenic	O	1581	1591	abstract	36346385
microglial	O	1592	1602	abstract	36346385
states	O	1603	1609	abstract	36346385
in	O	1610	1612	abstract	36346385
ASO	B-animal	1613	1616	abstract	36346385
mice	I-animal	1617	1621	abstract	36346385
and	O	1622	1625	abstract	36346385
promotes	O	1626	1634	abstract	36346385
expansion	O	1635	1644	abstract	36346385
of	O	1645	1647	abstract	36346385
protective	O	1648	1658	abstract	36346385
disease-associated	O	1659	1677	abstract	36346385
macrophage	O	1678	1688	abstract	36346385
(	O	1689	1690	abstract	36346385
DAM	O	1690	1693	abstract	36346385
)	O	1693	1694	abstract	36346385
subsets	O	1695	1702	abstract	36346385
of	O	1703	1705	abstract	36346385
microglia	O	1706	1715	abstract	36346385
.	O	1715	1716	abstract	36346385

Notably	O	1717	1724	abstract	36346385
,	O	1724	1725	abstract	36346385
depletion	O	1726	1735	abstract	36346385
of	O	1736	1738	abstract	36346385
microglia	O	1739	1748	abstract	36346385
using	O	1749	1754	abstract	36346385
a	O	1755	1756	abstract	36346385
CSF1R	B-drug	1757	1762	abstract	36346385
inhibitor	I-drug	1763	1772	abstract	36346385
eliminates	O	1773	1783	abstract	36346385
the	O	1784	1787	abstract	36346385
beneficial	O	1788	1798	abstract	36346385
effects	O	1799	1806	abstract	36346385
of	O	1807	1809	abstract	36346385
prebiotics	B-dietary%supplement	1810	1820	abstract	36346385
by	O	1821	1823	abstract	36346385
restoring	O	1824	1833	abstract	36346385
motor	B-DDF	1834	1839	abstract	36346385
deficits	I-DDF	1840	1848	abstract	36346385
to	O	1849	1851	abstract	36346385
ASO	B-animal	1852	1855	abstract	36346385
mice	I-animal	1856	1860	abstract	36346385
despite	O	1861	1868	abstract	36346385
feeding	O	1869	1876	abstract	36346385
a	O	1877	1878	abstract	36346385
prebiotic	O	1879	1888	abstract	36346385
diet	O	1889	1893	abstract	36346385
.	O	1893	1894	abstract	36346385

These	O	1895	1900	abstract	36346385
studies	O	1901	1908	abstract	36346385
uncover	O	1909	1916	abstract	36346385
a	O	1917	1918	abstract	36346385
novel	O	1919	1924	abstract	36346385
microglia-dependent	O	1925	1944	abstract	36346385
interaction	O	1945	1956	abstract	36346385
between	O	1957	1964	abstract	36346385
diet	O	1965	1969	abstract	36346385
and	O	1970	1973	abstract	36346385
motor	B-DDF	1974	1979	abstract	36346385
symptoms	I-DDF	1980	1988	abstract	36346385
in	O	1989	1991	abstract	36346385
mice	B-animal	1992	1996	abstract	36346385
,	O	1996	1997	abstract	36346385
findings	O	1998	2006	abstract	36346385
that	O	2007	2011	abstract	36346385
may	O	2012	2015	abstract	36346385
have	O	2016	2020	abstract	36346385
implications	O	2021	2033	abstract	36346385
for	O	2034	2037	abstract	36346385
neuroinflammation	B-DDF	2038	2055	abstract	36346385
and	O	2056	2059	abstract	36346385
PD	B-DDF	2060	2062	abstract	36346385
.	O	2062	2063	abstract	36346385

The	O	0	3	title	32459708
role	O	4	8	title	32459708
of	O	9	11	title	32459708
the	O	12	15	title	32459708
gut	B-microbiome	16	19	title	32459708
microbiota	I-microbiome	20	30	title	32459708
in	O	31	33	title	32459708
the	O	34	37	title	32459708
pathophysiology	O	38	53	title	32459708
of	O	54	56	title	32459708
mental	B-DDF	57	63	title	32459708
and	I-DDF	64	67	title	32459708
neurological	I-DDF	68	80	title	32459708
disorders	I-DDF	81	90	title	32459708
.	O	90	91	title	32459708

In	O	0	2	abstract	32459708
recent	O	3	9	abstract	32459708
decades	O	10	17	abstract	32459708
,	O	17	18	abstract	32459708
the	O	19	22	abstract	32459708
concept	O	23	30	abstract	32459708
of	O	31	33	abstract	32459708
the	O	34	37	abstract	32459708
gut	B-microbiome	38	41	abstract	32459708
microbiota	I-microbiome	42	52	abstract	32459708
as	O	53	55	abstract	32459708
a	O	56	57	abstract	32459708
potential	O	58	67	abstract	32459708
novel	O	68	73	abstract	32459708
therapeutic	O	74	85	abstract	32459708
strategy	O	86	94	abstract	32459708
for	O	95	98	abstract	32459708
mental	O	99	105	abstract	32459708
health	O	106	112	abstract	32459708
has	O	113	116	abstract	32459708
emerged	O	117	124	abstract	32459708
.	O	124	125	abstract	32459708

The	O	126	129	abstract	32459708
tiny	O	130	134	abstract	32459708
microbes	O	135	143	abstract	32459708
inhabiting	O	144	154	abstract	32459708
our	O	155	158	abstract	32459708
gut	B-anatomical%location	159	162	abstract	32459708
communicate	O	163	174	abstract	32459708
through	O	175	182	abstract	32459708
a	O	183	184	abstract	32459708
bidirectional	O	185	198	abstract	32459708
communication	O	199	212	abstract	32459708
signaling	O	213	222	abstract	32459708
with	O	223	227	abstract	32459708
the	O	228	231	abstract	32459708
brain	B-anatomical%location	232	237	abstract	32459708
that	O	238	242	abstract	32459708
influences	O	243	253	abstract	32459708
gut	O	254	257	abstract	32459708
physiology	O	258	268	abstract	32459708
,	O	268	269	abstract	32459708
brain	O	270	275	abstract	32459708
function	O	276	284	abstract	32459708
and	O	285	288	abstract	32459708
behavior	O	289	297	abstract	32459708
.	O	297	298	abstract	32459708

Accumulating	O	299	311	abstract	32459708
evidence	O	312	320	abstract	32459708
suggests	O	321	329	abstract	32459708
that	O	330	334	abstract	32459708
perturbation	O	335	347	abstract	32459708
of	O	348	350	abstract	32459708
the	O	351	354	abstract	32459708
gut	B-microbiome	355	358	abstract	32459708
microbiota	I-microbiome	359	369	abstract	32459708
contributes	O	370	381	abstract	32459708
to	O	382	384	abstract	32459708
the	O	385	388	abstract	32459708
pathophysiology	O	389	404	abstract	32459708
of	O	405	407	abstract	32459708
mental	B-DDF	408	414	abstract	32459708
illnesses	I-DDF	415	424	abstract	32459708
including	O	425	434	abstract	32459708
autism	B-DDF	435	441	abstract	32459708
,	O	441	442	abstract	32459708
depression	B-DDF	443	453	abstract	32459708
and	O	454	457	abstract	32459708
anxiety	B-DDF	458	465	abstract	32459708
as	O	466	468	abstract	32459708
well	O	469	473	abstract	32459708
as	O	474	476	abstract	32459708
neurodegenerative	B-DDF	477	494	abstract	32459708
disorders	I-DDF	495	504	abstract	32459708
such	O	505	509	abstract	32459708
as	O	510	512	abstract	32459708
Alzheimer	B-DDF	513	522	abstract	32459708
's	I-DDF	522	524	abstract	32459708
and	I-DDF	525	528	abstract	32459708
Parkinson	I-DDF	529	538	abstract	32459708
's	I-DDF	538	540	abstract	32459708
diseases	I-DDF	541	549	abstract	32459708
.	O	549	550	abstract	32459708

This	O	551	555	abstract	32459708
review	O	556	562	abstract	32459708
will	O	563	567	abstract	32459708
highlight	O	568	577	abstract	32459708
recent	O	578	584	abstract	32459708
findings	O	585	593	abstract	32459708
in	O	594	596	abstract	32459708
both	O	597	601	abstract	32459708
human	O	602	607	abstract	32459708
and	O	608	611	abstract	32459708
animal	O	612	618	abstract	32459708
studies	O	619	626	abstract	32459708
indicating	O	627	637	abstract	32459708
how	O	638	641	abstract	32459708
changes	O	642	649	abstract	32459708
in	O	650	652	abstract	32459708
the	O	653	656	abstract	32459708
gut	B-microbiome	657	660	abstract	32459708
microbiota	I-microbiome	661	671	abstract	32459708
can	O	672	675	abstract	32459708
impact	O	676	682	abstract	32459708
the	O	683	686	abstract	32459708
pathophysiology	O	687	702	abstract	32459708
of	O	703	705	abstract	32459708
such	O	706	710	abstract	32459708
diseases	O	711	719	abstract	32459708
.	O	719	720	abstract	32459708

The	O	721	724	abstract	32459708
current	O	725	732	abstract	32459708
work	O	733	737	abstract	32459708
will	O	738	742	abstract	32459708
also	O	743	747	abstract	32459708
provide	O	748	755	abstract	32459708
an	O	756	758	abstract	32459708
understanding	O	759	772	abstract	32459708
of	O	773	775	abstract	32459708
the	O	776	779	abstract	32459708
efficacy	O	780	788	abstract	32459708
of	O	789	791	abstract	32459708
microbiota-targeted	B-biomedical%technique	792	811	abstract	32459708
therapies	I-biomedical%technique	812	821	abstract	32459708
on	O	822	824	abstract	32459708
psychiatric	B-DDF	825	836	abstract	32459708
disorders	I-DDF	837	846	abstract	32459708
.	O	846	847	abstract	32459708

Gut	O	0	3	title	33177907
Microbiota	O	4	14	title	33177907
Changes	O	15	22	title	33177907
and	O	23	26	title	33177907
Their	O	27	32	title	33177907
Relationship	O	33	45	title	33177907
with	O	46	50	title	33177907
Inflammation	B-DDF	51	63	title	33177907
in	O	64	66	title	33177907
Patients	B-human	67	75	title	33177907
with	O	76	80	title	33177907
Acute	B-DDF	81	86	title	33177907
and	I-DDF	87	90	title	33177907
Chronic	I-DDF	91	98	title	33177907
Insomnia	I-DDF	99	107	title	33177907
.	O	107	108	title	33177907

The	O	0	3	abstract	33177907
major	O	4	9	abstract	33177907
purpose	O	10	17	abstract	33177907
of	O	18	20	abstract	33177907
this	O	21	25	abstract	33177907
study	O	26	31	abstract	33177907
was	O	32	35	abstract	33177907
to	O	36	38	abstract	33177907
detect	O	39	45	abstract	33177907
the	O	46	49	abstract	33177907
changes	O	50	57	abstract	33177907
in	O	58	60	abstract	33177907
gut	O	61	64	abstract	33177907
microbiota	O	65	75	abstract	33177907
composition	O	76	87	abstract	33177907
and	O	88	91	abstract	33177907
inflammatory	O	92	104	abstract	33177907
cytokines	O	105	114	abstract	33177907
production	O	115	125	abstract	33177907
associated	O	126	136	abstract	33177907
with	O	137	141	abstract	33177907
acute	B-DDF	142	147	abstract	33177907
and	I-DDF	148	151	abstract	33177907
chronic	I-DDF	152	159	abstract	33177907
insomnia	I-DDF	160	168	abstract	33177907
.	O	168	169	abstract	33177907

This	O	170	174	abstract	33177907
study	O	175	180	abstract	33177907
also	O	181	185	abstract	33177907
evaluated	O	186	195	abstract	33177907
the	O	196	199	abstract	33177907
relationship	O	200	212	abstract	33177907
between	O	213	220	abstract	33177907
gut	O	221	224	abstract	33177907
microbiota	O	225	235	abstract	33177907
changes	O	236	243	abstract	33177907
and	O	244	247	abstract	33177907
increased	O	248	257	abstract	33177907
inflammatory	O	258	270	abstract	33177907
cytokines	O	271	280	abstract	33177907
in	O	281	283	abstract	33177907
insomnia	O	284	292	abstract	33177907
patients	O	293	301	abstract	33177907
.	O	301	302	abstract	33177907

Outpatients	O	303	314	abstract	33177907
with	O	315	319	abstract	33177907
acute	B-DDF	320	325	abstract	33177907
and	I-DDF	326	329	abstract	33177907
chronic	I-DDF	330	337	abstract	33177907
insomnia	I-DDF	338	346	abstract	33177907
(	O	347	348	abstract	33177907
aged	O	348	352	abstract	33177907
26	O	353	355	abstract	33177907
-	O	355	356	abstract	33177907
55	O	356	358	abstract	33177907
years	O	359	364	abstract	33177907
;	O	364	365	abstract	33177907
n=20	O	366	370	abstract	33177907
and	O	371	374	abstract	33177907
38	O	375	377	abstract	33177907
,	O	377	378	abstract	33177907
respectively	O	379	391	abstract	33177907
)	O	391	392	abstract	33177907
and	O	393	396	abstract	33177907
age/gender-matched	O	397	415	abstract	33177907
healthy	B-human	416	423	abstract	33177907
controls	I-human	424	432	abstract	33177907
(	O	433	434	abstract	33177907
n=38	O	434	438	abstract	33177907
)	O	438	439	abstract	33177907
were	O	440	444	abstract	33177907
recruited	O	445	454	abstract	33177907
from	O	455	459	abstract	33177907
a	O	460	461	abstract	33177907
southern	O	462	470	abstract	33177907
China	O	471	476	abstract	33177907
region	O	477	483	abstract	33177907
.	O	483	484	abstract	33177907

Participants	O	485	497	abstract	33177907
'	O	497	498	abstract	33177907
gut	O	499	502	abstract	33177907
microbiome	O	503	513	abstract	33177907
,	O	513	514	abstract	33177907
plasma	O	515	521	abstract	33177907
cytokines	O	522	531	abstract	33177907
,	O	531	532	abstract	33177907
and	O	533	536	abstract	33177907
self-reported	O	537	550	abstract	33177907
sleep	O	551	556	abstract	33177907
quality	O	557	564	abstract	33177907
and	O	565	568	abstract	33177907
psychopathological	O	569	587	abstract	33177907
symptoms	O	588	596	abstract	33177907
were	O	597	601	abstract	33177907
measured	O	602	610	abstract	33177907
.	O	610	611	abstract	33177907

The	O	612	615	abstract	33177907
gut	O	616	619	abstract	33177907
microbiomes	O	620	631	abstract	33177907
of	O	632	634	abstract	33177907
insomnia	B-human	635	643	abstract	33177907
patients	I-human	644	652	abstract	33177907
compared	O	653	661	abstract	33177907
with	O	662	666	abstract	33177907
healthy	B-human	667	674	abstract	33177907
controls	I-human	675	683	abstract	33177907
were	O	684	688	abstract	33177907
characterized	O	689	702	abstract	33177907
by	O	703	705	abstract	33177907
lower	O	706	711	abstract	33177907
microbial	O	712	721	abstract	33177907
richness	O	722	730	abstract	33177907
and	O	731	734	abstract	33177907
diversity	O	735	744	abstract	33177907
,	O	744	745	abstract	33177907
depletion	O	746	755	abstract	33177907
of	O	756	758	abstract	33177907
anaerobes	O	759	768	abstract	33177907
,	O	768	769	abstract	33177907
and	O	770	773	abstract	33177907
short-chain	B-bacteria	774	785	abstract	33177907
fatty	I-bacteria	786	791	abstract	33177907
acid	I-bacteria	792	796	abstract	33177907
(SCFA)-producing	I-bacteria	797	813	abstract	33177907
bacteria	I-bacteria	814	822	abstract	33177907
,	O	822	823	abstract	33177907
and	O	824	827	abstract	33177907
an	O	828	830	abstract	33177907
expansion	O	831	840	abstract	33177907
of	O	841	843	abstract	33177907
potential	O	844	853	abstract	33177907
pathobionts	O	854	865	abstract	33177907
.	O	865	866	abstract	33177907

<	O	867	868	abstract	33177907
i	O	868	869	abstract	33177907
>	O	869	870	abstract	33177907
Lachnospira</i	B-bacteria	870	884	abstract	33177907
>	O	884	885	abstract	33177907
and	O	886	889	abstract	33177907
<	O	890	891	abstract	33177907
i	O	891	892	abstract	33177907
>	O	892	893	abstract	33177907
Bacteroides</i	B-bacteria	893	907	abstract	33177907
>	O	907	908	abstract	33177907
were	O	909	913	abstract	33177907
signature	O	914	923	abstract	33177907
bacteria	O	924	932	abstract	33177907
for	O	933	936	abstract	33177907
distinguishing	O	937	951	abstract	33177907
acute	B-human	952	957	abstract	33177907
insomnia	I-human	958	966	abstract	33177907
patients	I-human	967	975	abstract	33177907
from	O	976	980	abstract	33177907
healthy	B-human	981	988	abstract	33177907
controls	I-human	989	997	abstract	33177907
,	O	997	998	abstract	33177907
while	O	999	1004	abstract	33177907
<	O	1005	1006	abstract	33177907
i	O	1006	1007	abstract	33177907
>	O	1007	1008	abstract	33177907
Faecalibacterium</i	B-bacteria	1008	1027	abstract	33177907
>	O	1027	1028	abstract	33177907
and	O	1029	1032	abstract	33177907
<	O	1033	1034	abstract	33177907
i	O	1034	1035	abstract	33177907
>	O	1035	1036	abstract	33177907
Blautia</i	B-bacteria	1036	1046	abstract	33177907
>	O	1046	1047	abstract	33177907
were	O	1048	1052	abstract	33177907
signature	O	1053	1062	abstract	33177907
bacteria	O	1063	1071	abstract	33177907
for	O	1072	1075	abstract	33177907
distinguishing	O	1076	1090	abstract	33177907
chronic	B-human	1091	1098	abstract	33177907
insomnia	I-human	1099	1107	abstract	33177907
patients	I-human	1108	1116	abstract	33177907
from	O	1117	1121	abstract	33177907
healthy	B-human	1122	1129	abstract	33177907
controls	I-human	1130	1138	abstract	33177907
.	O	1138	1139	abstract	33177907

Acute/chronic	B-bacteria	1140	1153	abstract	33177907
insomnia-related	I-bacteria	1154	1170	abstract	33177907
signature	I-bacteria	1171	1180	abstract	33177907
bacteria	I-bacteria	1181	1189	abstract	33177907
also	O	1190	1194	abstract	33177907
showed	O	1195	1201	abstract	33177907
correlations	O	1202	1214	abstract	33177907
with	O	1215	1219	abstract	33177907
these	O	1220	1225	abstract	33177907
patients	O	1226	1234	abstract	33177907
'	O	1234	1235	abstract	33177907
self-reported	O	1236	1249	abstract	33177907
sleep	O	1250	1255	abstract	33177907
quality	O	1256	1263	abstract	33177907
and	O	1264	1267	abstract	33177907
plasma	O	1268	1274	abstract	33177907
IL-1	O	1275	1280	abstract	33177907
.	O	1280	1281	abstract	33177907

These	O	1282	1287	abstract	33177907
ndings	O	1288	1295	abstract	33177907
suggest	O	1296	1303	abstract	33177907
that	O	1304	1308	abstract	33177907
insomnia	O	1309	1317	abstract	33177907
symptomology	O	1318	1330	abstract	33177907
,	O	1330	1331	abstract	33177907
gut	B-microbiome	1332	1335	abstract	33177907
microbiota	I-microbiome	1336	1346	abstract	33177907
,	O	1346	1347	abstract	33177907
and	O	1348	1351	abstract	33177907
inflammation	B-DDF	1352	1364	abstract	33177907
may	O	1365	1368	abstract	33177907
be	O	1369	1371	abstract	33177907
interrelated	O	1372	1384	abstract	33177907
in	O	1385	1387	abstract	33177907
complex	O	1388	1395	abstract	33177907
ways	O	1396	1400	abstract	33177907
.	O	1400	1401	abstract	33177907

Gut	B-microbiome	1402	1405	abstract	33177907
microbiota	I-microbiome	1406	1416	abstract	33177907
may	O	1417	1420	abstract	33177907
serve	O	1421	1426	abstract	33177907
as	O	1427	1429	abstract	33177907
an	O	1430	1432	abstract	33177907
important	O	1433	1442	abstract	33177907
indicator	O	1443	1452	abstract	33177907
for	O	1453	1456	abstract	33177907
auxiliary	O	1457	1466	abstract	33177907
diagnosis	O	1467	1476	abstract	33177907
of	O	1477	1479	abstract	33177907
insomnia	B-DDF	1480	1488	abstract	33177907
and	O	1489	1492	abstract	33177907
provide	O	1493	1500	abstract	33177907
possible	O	1501	1509	abstract	33177907
new	O	1510	1513	abstract	33177907
therapeutic	O	1514	1525	abstract	33177907
targets	O	1526	1533	abstract	33177907
in	O	1534	1536	abstract	33177907
the	O	1537	1540	abstract	33177907
eld	O	1541	1545	abstract	33177907
of	O	1546	1548	abstract	33177907
sleep	B-DDF	1549	1554	abstract	33177907
disorders	I-DDF	1555	1564	abstract	33177907
.	O	1564	1565	abstract	33177907

The	O	0	3	title	38089822
relationship	O	4	16	title	38089822
between	O	17	24	title	38089822
gut	B-microbiome	25	28	title	38089822
microbiota	I-microbiome	29	39	title	38089822
and	O	40	43	title	38089822
insomnia	B-DDF	44	52	title	38089822
:	O	52	53	title	38089822
a	O	54	55	title	38089822
bi-directional	O	56	70	title	38089822
two-sample	O	71	81	title	38089822
Mendelian	O	82	91	title	38089822
randomization	O	92	105	title	38089822
research	O	106	114	title	38089822
.	O	114	115	title	38089822

Insomnia	B-DDF	0	8	abstract	38089822
is	O	9	11	abstract	38089822
the	O	12	15	abstract	38089822
second	O	16	22	abstract	38089822
most	O	23	27	abstract	38089822
common	O	28	34	abstract	38089822
mental	B-DDF	35	41	abstract	38089822
health	I-DDF	42	48	abstract	38089822
issue	I-DDF	49	54	abstract	38089822
,	O	54	55	abstract	38089822
also	O	56	60	abstract	38089822
is	O	61	63	abstract	38089822
a	O	64	65	abstract	38089822
social	O	66	72	abstract	38089822
and	O	73	76	abstract	38089822
financial	O	77	86	abstract	38089822
burden	O	87	93	abstract	38089822
.	O	93	94	abstract	38089822

Insomnia	B-DDF	95	103	abstract	38089822
affects	O	104	111	abstract	38089822
the	O	112	115	abstract	38089822
balance	O	116	123	abstract	38089822
between	O	124	131	abstract	38089822
sleep	O	132	137	abstract	38089822
,	O	137	138	abstract	38089822
the	O	139	142	abstract	38089822
immune	O	143	149	abstract	38089822
system	O	150	156	abstract	38089822
,	O	156	157	abstract	38089822
and	O	158	161	abstract	38089822
the	O	162	165	abstract	38089822
central	O	166	173	abstract	38089822
nervous	O	174	181	abstract	38089822
system	O	182	188	abstract	38089822
,	O	188	189	abstract	38089822
which	O	190	195	abstract	38089822
may	O	196	199	abstract	38089822
raise	O	200	205	abstract	38089822
the	O	206	209	abstract	38089822
risk	O	210	214	abstract	38089822
of	O	215	217	abstract	38089822
different	O	218	227	abstract	38089822
systemic	B-DDF	228	236	abstract	38089822
disorders	I-DDF	237	246	abstract	38089822
.	O	246	247	abstract	38089822

The	O	248	251	abstract	38089822
gut	B-microbiome	252	255	abstract	38089822
microbiota	I-microbiome	256	266	abstract	38089822
,	O	266	267	abstract	38089822
referred	O	268	276	abstract	38089822
to	O	277	279	abstract	38089822
as	O	280	282	abstract	38089822
the	O	283	286	abstract	38089822
"	O	287	288	abstract	38089822
second	O	288	294	abstract	38089822
genome	O	295	301	abstract	38089822
,	O	301	302	abstract	38089822
"	O	302	303	abstract	38089822
has	O	304	307	abstract	38089822
the	O	308	311	abstract	38089822
ability	O	312	319	abstract	38089822
to	O	320	322	abstract	38089822
control	O	323	330	abstract	38089822
host	O	331	335	abstract	38089822
homeostasis	O	336	347	abstract	38089822
.	O	347	348	abstract	38089822

It	O	349	351	abstract	38089822
has	O	352	355	abstract	38089822
been	O	356	360	abstract	38089822
discovered	O	361	371	abstract	38089822
that	O	372	376	abstract	38089822
disruption	O	377	387	abstract	38089822
of	O	388	390	abstract	38089822
the	O	391	394	abstract	38089822
gut-brain	O	395	404	abstract	38089822
axis	O	405	409	abstract	38089822
is	O	410	412	abstract	38089822
linked	O	413	419	abstract	38089822
to	O	420	422	abstract	38089822
insomnia	B-DDF	423	431	abstract	38089822
.	O	431	432	abstract	38089822

In	O	433	435	abstract	38089822
this	O	436	440	abstract	38089822
study	O	441	446	abstract	38089822
,	O	446	447	abstract	38089822
we	O	448	450	abstract	38089822
conducted	O	451	460	abstract	38089822
MR	B-statistical%technique	461	463	abstract	38089822
analysis	I-statistical%technique	464	472	abstract	38089822
between	O	473	480	abstract	38089822
large-scale	O	481	492	abstract	38089822
GWAS	O	493	497	abstract	38089822
data	O	498	502	abstract	38089822
of	O	503	505	abstract	38089822
GMs	B-microbiome	506	509	abstract	38089822
and	O	510	513	abstract	38089822
insomnia	B-DDF	514	522	abstract	38089822
to	O	523	525	abstract	38089822
uncover	O	526	533	abstract	38089822
potential	O	534	543	abstract	38089822
associations	O	544	556	abstract	38089822
.	O	556	557	abstract	38089822

Ten	O	558	561	abstract	38089822
GM	O	562	564	abstract	38089822
taxa	O	565	569	abstract	38089822
were	O	570	574	abstract	38089822
detected	O	575	583	abstract	38089822
to	O	584	586	abstract	38089822
have	O	587	591	abstract	38089822
causal	O	592	598	abstract	38089822
associations	O	599	611	abstract	38089822
with	O	612	616	abstract	38089822
insomnia	B-DDF	617	625	abstract	38089822
.	O	625	626	abstract	38089822

Among	O	627	632	abstract	38089822
them	O	633	637	abstract	38089822
,	O	637	638	abstract	38089822
class	O	639	644	abstract	38089822
<	O	645	646	abstract	38089822
i	O	646	647	abstract	38089822
>	O	647	648	abstract	38089822
Negativicutes</i	B-bacteria	648	664	abstract	38089822
>	O	664	665	abstract	38089822
,	O	665	666	abstract	38089822
genus	O	667	672	abstract	38089822
<	O	673	674	abstract	38089822
i	O	674	675	abstract	38089822
>	O	675	676	abstract	38089822
Clostridiuminnocuumgroup</i	B-bacteria	676	703	abstract	38089822
>	O	703	704	abstract	38089822
,	O	704	705	abstract	38089822
genus	O	706	711	abstract	38089822
<	O	712	713	abstract	38089822
i	O	713	714	abstract	38089822
>	O	714	715	abstract	38089822
Dorea</i	B-bacteria	715	723	abstract	38089822
>	O	723	724	abstract	38089822
,	O	724	725	abstract	38089822
genus	O	726	731	abstract	38089822
<	O	732	733	abstract	38089822
i	O	733	734	abstract	38089822
>	O	734	735	abstract	38089822
Lachnoclostridium</i	B-bacteria	735	755	abstract	38089822
>	O	755	756	abstract	38089822
,	O	756	757	abstract	38089822
genus	O	758	763	abstract	38089822
<	O	764	765	abstract	38089822
i	O	765	766	abstract	38089822
>	O	766	767	abstract	38089822
Prevotella7</i	B-bacteria	767	781	abstract	38089822
>	O	781	782	abstract	38089822
,	O	782	783	abstract	38089822
and	O	784	787	abstract	38089822
order	O	788	793	abstract	38089822
<	O	794	795	abstract	38089822
i	O	795	796	abstract	38089822
>	O	796	797	abstract	38089822
Selenomonadalesare</i	B-bacteria	797	818	abstract	38089822
>	O	818	819	abstract	38089822
were	O	820	824	abstract	38089822
linked	O	825	831	abstract	38089822
to	O	832	834	abstract	38089822
a	O	835	836	abstract	38089822
higher	O	837	843	abstract	38089822
risk	O	844	848	abstract	38089822
of	O	849	851	abstract	38089822
insomnia	B-DDF	852	860	abstract	38089822
.	O	860	861	abstract	38089822

In	O	862	864	abstract	38089822
reverse	B-statistical%technique	865	872	abstract	38089822
MR	I-statistical%technique	873	875	abstract	38089822
analysis	I-statistical%technique	876	884	abstract	38089822
,	O	884	885	abstract	38089822
we	O	886	888	abstract	38089822
discovered	O	889	899	abstract	38089822
a	O	900	901	abstract	38089822
causal	O	902	908	abstract	38089822
link	O	909	913	abstract	38089822
between	O	914	921	abstract	38089822
insomnia	B-DDF	922	930	abstract	38089822
and	O	931	934	abstract	38089822
six	O	935	938	abstract	38089822
other	O	939	944	abstract	38089822
GM	O	945	947	abstract	38089822
taxa	O	948	952	abstract	38089822
.	O	952	953	abstract	38089822

It	O	954	956	abstract	38089822
suggested	O	957	966	abstract	38089822
that	O	967	971	abstract	38089822
the	O	972	975	abstract	38089822
relationship	O	976	988	abstract	38089822
between	O	989	996	abstract	38089822
insomnia	B-DDF	997	1005	abstract	38089822
and	O	1006	1009	abstract	38089822
intestinal	B-microbiome	1010	1020	abstract	38089822
flora	I-microbiome	1021	1026	abstract	38089822
was	O	1027	1030	abstract	38089822
convoluted	O	1031	1041	abstract	38089822
.	O	1041	1042	abstract	38089822

Our	O	1043	1046	abstract	38089822
findings	O	1047	1055	abstract	38089822
may	O	1056	1059	abstract	38089822
offer	O	1060	1065	abstract	38089822
beneficial	O	1066	1076	abstract	38089822
biomarkers	O	1077	1087	abstract	38089822
for	O	1088	1091	abstract	38089822
disease	O	1092	1099	abstract	38089822
development	O	1100	1111	abstract	38089822
and	O	1112	1115	abstract	38089822
prospective	O	1116	1127	abstract	38089822
candidate	O	1128	1137	abstract	38089822
treatment	O	1138	1147	abstract	38089822
targets	O	1148	1155	abstract	38089822
for	O	1156	1159	abstract	38089822
insomnia	B-DDF	1160	1168	abstract	38089822
.	O	1168	1169	abstract	38089822

Gut	O	0	3	title	31646148
microbial	O	4	13	title	31646148
metabolites	O	14	25	title	31646148
in	O	26	28	title	31646148
depression	B-DDF	29	39	title	31646148
:	O	39	40	title	31646148
understanding	O	41	54	title	31646148
the	O	55	58	title	31646148
biochemical	O	59	70	title	31646148
mechanisms	O	71	81	title	31646148
.	O	81	82	title	31646148

Gastrointestinal	O	0	16	abstract	31646148
and	O	17	20	abstract	31646148
central	O	21	28	abstract	31646148
function	O	29	37	abstract	31646148
are	O	38	41	abstract	31646148
intrinsically	O	42	55	abstract	31646148
connected	O	56	65	abstract	31646148
by	O	66	68	abstract	31646148
the	O	69	72	abstract	31646148
gut	B-microbiome	73	76	abstract	31646148
microbiota	I-microbiome	77	87	abstract	31646148
,	O	87	88	abstract	31646148
an	O	89	91	abstract	31646148
ecosystem	O	92	101	abstract	31646148
that	O	102	106	abstract	31646148
has	O	107	110	abstract	31646148
co-evolved	O	111	121	abstract	31646148
with	O	122	126	abstract	31646148
the	O	127	130	abstract	31646148
host	O	131	135	abstract	31646148
to	O	136	138	abstract	31646148
expand	O	139	145	abstract	31646148
its	O	146	149	abstract	31646148
biotransformational	O	150	169	abstract	31646148
capabilities	O	170	182	abstract	31646148
and	O	183	186	abstract	31646148
interact	O	187	195	abstract	31646148
with	O	196	200	abstract	31646148
host	O	201	205	abstract	31646148
physiological	O	206	219	abstract	31646148
processes	O	220	229	abstract	31646148
by	O	230	232	abstract	31646148
means	O	233	238	abstract	31646148
of	O	239	241	abstract	31646148
its	O	242	245	abstract	31646148
metabolic	O	246	255	abstract	31646148
products	O	256	264	abstract	31646148
.	O	264	265	abstract	31646148

Abnormalities	O	266	279	abstract	31646148
in	O	280	282	abstract	31646148
this	O	283	287	abstract	31646148
microbiota-gut-brain	O	288	308	abstract	31646148
axis	O	309	313	abstract	31646148
have	O	314	318	abstract	31646148
emerged	O	319	326	abstract	31646148
as	O	327	329	abstract	31646148
a	O	330	331	abstract	31646148
key	O	332	335	abstract	31646148
component	O	336	345	abstract	31646148
in	O	346	348	abstract	31646148
the	O	349	352	abstract	31646148
pathophysiology	O	353	368	abstract	31646148
of	O	369	371	abstract	31646148
depression	B-DDF	372	382	abstract	31646148
,	O	382	383	abstract	31646148
leading	O	384	391	abstract	31646148
to	O	392	394	abstract	31646148
more	O	395	399	abstract	31646148
research	O	400	408	abstract	31646148
attempting	O	409	419	abstract	31646148
to	O	420	422	abstract	31646148
understand	O	423	433	abstract	31646148
the	O	434	437	abstract	31646148
neuroactive	O	438	449	abstract	31646148
potential	O	450	459	abstract	31646148
of	O	460	462	abstract	31646148
the	O	463	466	abstract	31646148
products	O	467	475	abstract	31646148
of	O	476	478	abstract	31646148
gut	O	479	482	abstract	31646148
microbial	O	483	492	abstract	31646148
metabolism	O	493	503	abstract	31646148
.	O	503	504	abstract	31646148

This	O	505	509	abstract	31646148
review	O	510	516	abstract	31646148
explores	O	517	525	abstract	31646148
the	O	526	529	abstract	31646148
potential	O	530	539	abstract	31646148
for	O	540	543	abstract	31646148
the	O	544	547	abstract	31646148
gut	B-microbiome	548	551	abstract	31646148
microbiota	I-microbiome	552	562	abstract	31646148
to	O	563	565	abstract	31646148
contribute	O	566	576	abstract	31646148
to	O	577	579	abstract	31646148
depression	B-DDF	580	590	abstract	31646148
and	O	591	594	abstract	31646148
focuses	O	595	602	abstract	31646148
on	O	603	605	abstract	31646148
the	O	606	609	abstract	31646148
role	O	610	614	abstract	31646148
that	O	615	619	abstract	31646148
microbially-derived	O	620	639	abstract	31646148
molecules	O	640	649	abstract	31646148
-	O	650	651	abstract	31646148
neurotransmitters	O	652	669	abstract	31646148
,	O	669	670	abstract	31646148
short-chain	B-chemical	671	682	abstract	31646148
fatty	I-chemical	683	688	abstract	31646148
acids	I-chemical	689	694	abstract	31646148
,	O	694	695	abstract	31646148
indoles	B-chemical	696	703	abstract	31646148
,	O	703	704	abstract	31646148
bile	B-chemical	705	709	abstract	31646148
acids	I-chemical	710	715	abstract	31646148
,	O	715	716	abstract	31646148
choline	B-chemical	717	724	abstract	31646148
metabolites	I-chemical	725	736	abstract	31646148
,	O	736	737	abstract	31646148
lactate	B-chemical	738	745	abstract	31646148
and	O	746	749	abstract	31646148
vitamins	B-chemical	750	758	abstract	31646148
-	O	759	760	abstract	31646148
play	O	761	765	abstract	31646148
in	O	766	768	abstract	31646148
the	O	769	772	abstract	31646148
context	O	773	780	abstract	31646148
of	O	781	783	abstract	31646148
emotional	O	784	793	abstract	31646148
behavior	O	794	802	abstract	31646148
.	O	802	803	abstract	31646148

The	O	804	807	abstract	31646148
future	O	808	814	abstract	31646148
of	O	815	817	abstract	31646148
gut-brain	O	818	827	abstract	31646148
axis	O	828	832	abstract	31646148
research	O	833	841	abstract	31646148
lies	O	842	846	abstract	31646148
is	O	847	849	abstract	31646148
moving	O	850	856	abstract	31646148
away	O	857	861	abstract	31646148
from	O	862	866	abstract	31646148
association	O	867	878	abstract	31646148
,	O	878	879	abstract	31646148
towards	O	880	887	abstract	31646148
the	O	888	891	abstract	31646148
mechanisms	O	892	902	abstract	31646148
underlying	O	903	913	abstract	31646148
the	O	914	917	abstract	31646148
relationship	O	918	930	abstract	31646148
between	O	931	938	abstract	31646148
the	O	939	942	abstract	31646148
gut	B-bacteria	943	946	abstract	31646148
bacteria	I-bacteria	947	955	abstract	31646148
and	O	956	959	abstract	31646148
depressive	B-DDF	960	970	abstract	31646148
behavior	I-DDF	971	979	abstract	31646148
.	O	979	980	abstract	31646148

We	O	981	983	abstract	31646148
propose	O	984	991	abstract	31646148
that	O	992	996	abstract	31646148
direct	O	997	1003	abstract	31646148
and	O	1004	1007	abstract	31646148
indirect	O	1008	1016	abstract	31646148
mechanisms	O	1017	1027	abstract	31646148
exist	O	1028	1033	abstract	31646148
through	O	1034	1041	abstract	31646148
which	O	1042	1047	abstract	31646148
gut	O	1048	1051	abstract	31646148
microbial	O	1052	1061	abstract	31646148
metabolites	O	1062	1073	abstract	31646148
affect	O	1074	1080	abstract	31646148
depressive	B-DDF	1081	1091	abstract	31646148
behavior	I-DDF	1092	1100	abstract	31646148
:	O	1100	1101	abstract	31646148
these	O	1102	1107	abstract	31646148
include	O	1108	1115	abstract	31646148
(	O	1116	1117	abstract	31646148
i	O	1117	1118	abstract	31646148
)	O	1118	1119	abstract	31646148
direct	O	1120	1126	abstract	31646148
stimulation	O	1127	1138	abstract	31646148
of	O	1139	1141	abstract	31646148
central	O	1142	1149	abstract	31646148
receptors	O	1150	1159	abstract	31646148
,	O	1159	1160	abstract	31646148
(	O	1161	1162	abstract	31646148
ii	O	1162	1164	abstract	31646148
)	O	1164	1165	abstract	31646148
peripheral	O	1166	1176	abstract	31646148
stimulation	O	1177	1188	abstract	31646148
of	O	1189	1191	abstract	31646148
neural	O	1192	1198	abstract	31646148
,	O	1198	1199	abstract	31646148
endocrine	O	1200	1209	abstract	31646148
,	O	1209	1210	abstract	31646148
and	O	1211	1214	abstract	31646148
immune	O	1215	1221	abstract	31646148
mediators	O	1222	1231	abstract	31646148
,	O	1231	1232	abstract	31646148
and	O	1233	1236	abstract	31646148
(	O	1237	1238	abstract	31646148
iii	O	1238	1241	abstract	31646148
)	O	1241	1242	abstract	31646148
epigenetic	O	1243	1253	abstract	31646148
regulation	O	1254	1264	abstract	31646148
of	O	1265	1267	abstract	31646148
histone	O	1268	1275	abstract	31646148
acetylation	O	1276	1287	abstract	31646148
and	O	1288	1291	abstract	31646148
DNA	O	1292	1295	abstract	31646148
methylation	O	1296	1307	abstract	31646148
.	O	1307	1308	abstract	31646148

Elucidating	O	1309	1320	abstract	31646148
these	O	1321	1326	abstract	31646148
mechanisms	O	1327	1337	abstract	31646148
is	O	1338	1340	abstract	31646148
essential	O	1341	1350	abstract	31646148
to	O	1351	1353	abstract	31646148
expand	O	1354	1360	abstract	31646148
our	O	1361	1364	abstract	31646148
understanding	O	1365	1378	abstract	31646148
of	O	1379	1381	abstract	31646148
the	O	1382	1385	abstract	31646148
etiology	O	1386	1394	abstract	31646148
of	O	1395	1397	abstract	31646148
depression	B-DDF	1398	1408	abstract	31646148
,	O	1408	1409	abstract	31646148
and	O	1410	1413	abstract	31646148
to	O	1414	1416	abstract	31646148
develop	O	1417	1424	abstract	31646148
new	O	1425	1428	abstract	31646148
strategies	O	1429	1439	abstract	31646148
to	O	1440	1442	abstract	31646148
harness	O	1443	1450	abstract	31646148
the	O	1451	1454	abstract	31646148
beneficial	O	1455	1465	abstract	31646148
psychotropic	O	1466	1478	abstract	31646148
effects	O	1479	1486	abstract	31646148
of	O	1487	1489	abstract	31646148
these	O	1490	1495	abstract	31646148
molecules	O	1496	1505	abstract	31646148
.	O	1505	1506	abstract	31646148

Overall	O	1507	1514	abstract	31646148
,	O	1514	1515	abstract	31646148
the	O	1516	1519	abstract	31646148
review	O	1520	1526	abstract	31646148
highlights	O	1527	1537	abstract	31646148
the	O	1538	1541	abstract	31646148
potential	O	1542	1551	abstract	31646148
for	O	1552	1555	abstract	31646148
dietary	O	1556	1563	abstract	31646148
interventions	O	1564	1577	abstract	31646148
to	O	1578	1580	abstract	31646148
represent	O	1581	1590	abstract	31646148
such	O	1591	1595	abstract	31646148
novel	O	1596	1601	abstract	31646148
therapeutic	O	1602	1613	abstract	31646148
strategies	O	1614	1624	abstract	31646148
for	O	1625	1628	abstract	31646148
major	B-DDF	1629	1634	abstract	31646148
depressive	I-DDF	1635	1645	abstract	31646148
disorder	I-DDF	1646	1654	abstract	31646148
.	O	1654	1655	abstract	31646148

Metabolic	O	0	9	title	23981537
features	O	10	18	title	23981537
of	O	19	21	title	23981537
the	O	22	25	title	23981537
cell	O	26	30	title	23981537
danger	O	31	37	title	23981537
response	O	38	46	title	23981537
.	O	46	47	title	23981537

The	O	0	3	abstract	23981537
cell	B-DDF	4	8	abstract	23981537
danger	I-DDF	9	15	abstract	23981537
response	I-DDF	16	24	abstract	23981537
(	O	25	26	abstract	23981537
CDR	B-DDF	26	29	abstract	23981537
)	O	29	30	abstract	23981537
is	O	31	33	abstract	23981537
the	O	34	37	abstract	23981537
evolutionarily	O	38	52	abstract	23981537
conserved	O	53	62	abstract	23981537
metabolic	O	63	72	abstract	23981537
response	O	73	81	abstract	23981537
that	O	82	86	abstract	23981537
protects	O	87	95	abstract	23981537
cells	O	96	101	abstract	23981537
and	O	102	105	abstract	23981537
hosts	O	106	111	abstract	23981537
from	O	112	116	abstract	23981537
harm	O	117	121	abstract	23981537
.	O	121	122	abstract	23981537

It	O	123	125	abstract	23981537
is	O	126	128	abstract	23981537
triggered	O	129	138	abstract	23981537
by	O	139	141	abstract	23981537
encounters	O	142	152	abstract	23981537
with	O	153	157	abstract	23981537
chemical	O	158	166	abstract	23981537
,	O	166	167	abstract	23981537
physical	O	168	176	abstract	23981537
,	O	176	177	abstract	23981537
or	O	178	180	abstract	23981537
biological	O	181	191	abstract	23981537
threats	O	192	199	abstract	23981537
that	O	200	204	abstract	23981537
exceed	O	205	211	abstract	23981537
the	O	212	215	abstract	23981537
cellular	O	216	224	abstract	23981537
capacity	O	225	233	abstract	23981537
for	O	234	237	abstract	23981537
homeostasis	O	238	249	abstract	23981537
.	O	249	250	abstract	23981537

The	O	251	254	abstract	23981537
resulting	O	255	264	abstract	23981537
metabolic	O	265	274	abstract	23981537
mismatch	O	275	283	abstract	23981537
between	O	284	291	abstract	23981537
available	O	292	301	abstract	23981537
resources	O	302	311	abstract	23981537
and	O	312	315	abstract	23981537
functional	O	316	326	abstract	23981537
capacity	O	327	335	abstract	23981537
produces	O	336	344	abstract	23981537
a	O	345	346	abstract	23981537
cascade	O	347	354	abstract	23981537
of	O	355	357	abstract	23981537
changes	O	358	365	abstract	23981537
in	O	366	368	abstract	23981537
cellular	O	369	377	abstract	23981537
electron	O	378	386	abstract	23981537
flow	O	387	391	abstract	23981537
,	O	391	392	abstract	23981537
oxygen	O	393	399	abstract	23981537
consumption	O	400	411	abstract	23981537
,	O	411	412	abstract	23981537
redox	O	413	418	abstract	23981537
,	O	418	419	abstract	23981537
membrane	O	420	428	abstract	23981537
fluidity	O	429	437	abstract	23981537
,	O	437	438	abstract	23981537
lipid	O	439	444	abstract	23981537
dynamics	O	445	453	abstract	23981537
,	O	453	454	abstract	23981537
bioenergetics	O	455	468	abstract	23981537
,	O	468	469	abstract	23981537
carbon	O	470	476	abstract	23981537
and	O	477	480	abstract	23981537
sulfur	O	481	487	abstract	23981537
resource	O	488	496	abstract	23981537
allocation	O	497	507	abstract	23981537
,	O	507	508	abstract	23981537
protein	O	509	516	abstract	23981537
folding	O	517	524	abstract	23981537
and	O	525	528	abstract	23981537
aggregation	O	529	540	abstract	23981537
,	O	540	541	abstract	23981537
vitamin	O	542	549	abstract	23981537
availability	O	550	562	abstract	23981537
,	O	562	563	abstract	23981537
metal	O	564	569	abstract	23981537
homeostasis	O	570	581	abstract	23981537
,	O	581	582	abstract	23981537
indole	O	583	589	abstract	23981537
,	O	589	590	abstract	23981537
pterin	O	591	597	abstract	23981537
,	O	597	598	abstract	23981537
1-carbon	O	599	607	abstract	23981537
and	O	608	611	abstract	23981537
polyamine	O	612	621	abstract	23981537
metabolism	O	622	632	abstract	23981537
,	O	632	633	abstract	23981537
and	O	634	637	abstract	23981537
polymer	O	638	645	abstract	23981537
formation	O	646	655	abstract	23981537
.	O	655	656	abstract	23981537

The	O	657	660	abstract	23981537
first	O	661	666	abstract	23981537
wave	O	667	671	abstract	23981537
of	O	672	674	abstract	23981537
danger	O	675	681	abstract	23981537
signals	O	682	689	abstract	23981537
consists	O	690	698	abstract	23981537
of	O	699	701	abstract	23981537
the	O	702	705	abstract	23981537
release	O	706	713	abstract	23981537
of	O	714	716	abstract	23981537
metabolic	O	717	726	abstract	23981537
intermediates	O	727	740	abstract	23981537
like	O	741	745	abstract	23981537
ATP	B-chemical	746	749	abstract	23981537
and	O	750	753	abstract	23981537
ADP	B-chemical	754	757	abstract	23981537
,	O	757	758	abstract	23981537
Krebs	B-chemical	759	764	abstract	23981537
cycle	I-chemical	765	770	abstract	23981537
intermediates	I-chemical	771	784	abstract	23981537
,	O	784	785	abstract	23981537
oxygen	B-chemical	786	792	abstract	23981537
,	O	792	793	abstract	23981537
and	O	794	797	abstract	23981537
reactive	B-chemical	798	806	abstract	23981537
oxygen	I-chemical	807	813	abstract	23981537
species	I-chemical	814	821	abstract	23981537
(	O	822	823	abstract	23981537
ROS	B-chemical	823	826	abstract	23981537
)	O	826	827	abstract	23981537
,	O	827	828	abstract	23981537
and	O	829	832	abstract	23981537
is	O	833	835	abstract	23981537
sustained	O	836	845	abstract	23981537
by	O	846	848	abstract	23981537
purinergic	O	849	859	abstract	23981537
signaling	O	860	869	abstract	23981537
.	O	869	870	abstract	23981537

After	O	871	876	abstract	23981537
the	O	877	880	abstract	23981537
danger	O	881	887	abstract	23981537
has	O	888	891	abstract	23981537
been	O	892	896	abstract	23981537
eliminated	O	897	907	abstract	23981537
or	O	908	910	abstract	23981537
neutralized	O	911	922	abstract	23981537
,	O	922	923	abstract	23981537
a	O	924	925	abstract	23981537
choreographed	O	926	939	abstract	23981537
sequence	O	940	948	abstract	23981537
of	O	949	951	abstract	23981537
anti-inflammatory	O	952	969	abstract	23981537
and	O	970	973	abstract	23981537
regenerative	O	974	986	abstract	23981537
pathways	O	987	995	abstract	23981537
is	O	996	998	abstract	23981537
activated	O	999	1008	abstract	23981537
to	O	1009	1011	abstract	23981537
reverse	O	1012	1019	abstract	23981537
the	O	1020	1023	abstract	23981537
CDR	B-DDF	1024	1027	abstract	23981537
and	O	1028	1031	abstract	23981537
to	O	1032	1034	abstract	23981537
heal	O	1035	1039	abstract	23981537
.	O	1039	1040	abstract	23981537

When	O	1041	1045	abstract	23981537
the	O	1046	1049	abstract	23981537
CDR	B-DDF	1050	1053	abstract	23981537
persists	O	1054	1062	abstract	23981537
abnormally	O	1063	1073	abstract	23981537
,	O	1073	1074	abstract	23981537
whole	O	1075	1080	abstract	23981537
body	O	1081	1085	abstract	23981537
metabolism	O	1086	1096	abstract	23981537
and	O	1097	1100	abstract	23981537
the	O	1101	1104	abstract	23981537
gut	B-microbiome	1105	1108	abstract	23981537
microbiome	I-microbiome	1109	1119	abstract	23981537
are	O	1120	1123	abstract	23981537
disturbed	O	1124	1133	abstract	23981537
,	O	1133	1134	abstract	23981537
the	O	1135	1138	abstract	23981537
collective	O	1139	1149	abstract	23981537
performance	O	1150	1161	abstract	23981537
of	O	1162	1164	abstract	23981537
multiple	O	1165	1173	abstract	23981537
organ	O	1174	1179	abstract	23981537
systems	O	1180	1187	abstract	23981537
is	O	1188	1190	abstract	23981537
impaired	O	1191	1199	abstract	23981537
,	O	1199	1200	abstract	23981537
behavior	O	1201	1209	abstract	23981537
is	O	1210	1212	abstract	23981537
changed	O	1213	1220	abstract	23981537
,	O	1220	1221	abstract	23981537
and	O	1222	1225	abstract	23981537
chronic	O	1226	1233	abstract	23981537
disease	O	1234	1241	abstract	23981537
results	O	1242	1249	abstract	23981537
.	O	1249	1250	abstract	23981537

Metabolic	O	1251	1260	abstract	23981537
memory	O	1261	1267	abstract	23981537
of	O	1268	1270	abstract	23981537
past	O	1271	1275	abstract	23981537
stress	O	1276	1282	abstract	23981537
encounters	O	1283	1293	abstract	23981537
is	O	1294	1296	abstract	23981537
stored	O	1297	1303	abstract	23981537
in	O	1304	1306	abstract	23981537
the	O	1307	1310	abstract	23981537
form	O	1311	1315	abstract	23981537
of	O	1316	1318	abstract	23981537
altered	O	1319	1326	abstract	23981537
mitochondrial	O	1327	1340	abstract	23981537
and	O	1341	1344	abstract	23981537
cellular	O	1345	1353	abstract	23981537
macromolecule	O	1354	1367	abstract	23981537
content	O	1368	1375	abstract	23981537
,	O	1375	1376	abstract	23981537
resulting	O	1377	1386	abstract	23981537
in	O	1387	1389	abstract	23981537
an	O	1390	1392	abstract	23981537
increase	O	1393	1401	abstract	23981537
in	O	1402	1404	abstract	23981537
functional	O	1405	1415	abstract	23981537
reserve	O	1416	1423	abstract	23981537
capacity	O	1424	1432	abstract	23981537
through	O	1433	1440	abstract	23981537
a	O	1441	1442	abstract	23981537
process	O	1443	1450	abstract	23981537
known	O	1451	1456	abstract	23981537
as	O	1457	1459	abstract	23981537
mitocellular	O	1460	1472	abstract	23981537
hormesis	O	1473	1481	abstract	23981537
.	O	1481	1482	abstract	23981537

The	O	1483	1486	abstract	23981537
systemic	O	1487	1495	abstract	23981537
form	O	1496	1500	abstract	23981537
of	O	1501	1503	abstract	23981537
the	O	1504	1507	abstract	23981537
CDR	B-DDF	1508	1511	abstract	23981537
,	O	1511	1512	abstract	23981537
and	O	1513	1516	abstract	23981537
its	O	1517	1520	abstract	23981537
magnified	O	1521	1530	abstract	23981537
form	O	1531	1535	abstract	23981537
,	O	1535	1536	abstract	23981537
the	O	1537	1540	abstract	23981537
purinergic	O	1541	1551	abstract	23981537
life-threat	O	1552	1563	abstract	23981537
response	O	1564	1572	abstract	23981537
(	O	1573	1574	abstract	23981537
PLTR	O	1574	1578	abstract	23981537
)	O	1578	1579	abstract	23981537
,	O	1579	1580	abstract	23981537
are	O	1581	1584	abstract	23981537
under	O	1585	1590	abstract	23981537
direct	O	1591	1597	abstract	23981537
control	O	1598	1605	abstract	23981537
by	O	1606	1608	abstract	23981537
ancient	O	1609	1616	abstract	23981537
pathways	O	1617	1625	abstract	23981537
in	O	1626	1628	abstract	23981537
the	O	1629	1632	abstract	23981537
brain	O	1633	1638	abstract	23981537
that	O	1639	1643	abstract	23981537
are	O	1644	1647	abstract	23981537
ultimately	O	1648	1658	abstract	23981537
coordinated	O	1659	1670	abstract	23981537
by	O	1671	1673	abstract	23981537
centers	O	1674	1681	abstract	23981537
in	O	1682	1684	abstract	23981537
the	O	1685	1688	abstract	23981537
brainstem	O	1689	1698	abstract	23981537
.	O	1698	1699	abstract	23981537

Chemosensory	O	1700	1712	abstract	23981537
integration	O	1713	1724	abstract	23981537
of	O	1725	1727	abstract	23981537
whole	O	1728	1733	abstract	23981537
body	O	1734	1738	abstract	23981537
metabolism	O	1739	1749	abstract	23981537
occurs	O	1750	1756	abstract	23981537
in	O	1757	1759	abstract	23981537
the	O	1760	1763	abstract	23981537
brainstem	O	1764	1773	abstract	23981537
and	O	1774	1777	abstract	23981537
is	O	1778	1780	abstract	23981537
a	O	1781	1782	abstract	23981537
prerequisite	O	1783	1795	abstract	23981537
for	O	1796	1799	abstract	23981537
normal	O	1800	1806	abstract	23981537
brain	O	1807	1812	abstract	23981537
,	O	1812	1813	abstract	23981537
motor	O	1814	1819	abstract	23981537
,	O	1819	1820	abstract	23981537
vestibular	O	1821	1831	abstract	23981537
,	O	1831	1832	abstract	23981537
sensory	O	1833	1840	abstract	23981537
,	O	1840	1841	abstract	23981537
social	O	1842	1848	abstract	23981537
,	O	1848	1849	abstract	23981537
and	O	1850	1853	abstract	23981537
speech	O	1854	1860	abstract	23981537
development	O	1861	1872	abstract	23981537
.	O	1872	1873	abstract	23981537

An	O	1874	1876	abstract	23981537
understanding	O	1877	1890	abstract	23981537
of	O	1891	1893	abstract	23981537
the	O	1894	1897	abstract	23981537
CDR	B-DDF	1898	1901	abstract	23981537
permits	O	1902	1909	abstract	23981537
us	O	1910	1912	abstract	23981537
to	O	1913	1915	abstract	23981537
reframe	O	1916	1923	abstract	23981537
old	O	1924	1927	abstract	23981537
concepts	O	1928	1936	abstract	23981537
of	O	1937	1939	abstract	23981537
pathogenesis	O	1940	1952	abstract	23981537
for	O	1953	1956	abstract	23981537
a	O	1957	1958	abstract	23981537
broad	O	1959	1964	abstract	23981537
array	O	1965	1970	abstract	23981537
of	O	1971	1973	abstract	23981537
chronic	B-DDF	1974	1981	abstract	23981537
,	I-DDF	1981	1982	abstract	23981537
developmental	I-DDF	1983	1996	abstract	23981537
,	I-DDF	1996	1997	abstract	23981537
autoimmune	I-DDF	1998	2008	abstract	23981537
,	I-DDF	2008	2009	abstract	23981537
and	I-DDF	2010	2013	abstract	23981537
degenerative	I-DDF	2014	2026	abstract	23981537
disorders	I-DDF	2027	2036	abstract	23981537
.	O	2036	2037	abstract	23981537

These	O	2038	2043	abstract	23981537
disorders	O	2044	2053	abstract	23981537
include	O	2054	2061	abstract	23981537
autism	B-DDF	2062	2068	abstract	23981537
spectrum	I-DDF	2069	2077	abstract	23981537
disorders	I-DDF	2078	2087	abstract	23981537
(	O	2088	2089	abstract	23981537
ASD	B-DDF	2089	2092	abstract	23981537
)	O	2092	2093	abstract	23981537
,	O	2093	2094	abstract	23981537
attention	B-DDF	2095	2104	abstract	23981537
deficit	I-DDF	2105	2112	abstract	23981537
hyperactivity	I-DDF	2113	2126	abstract	23981537
disorder	I-DDF	2127	2135	abstract	23981537
(	O	2136	2137	abstract	23981537
ADHD	B-DDF	2137	2141	abstract	23981537
)	O	2141	2142	abstract	23981537
,	O	2142	2143	abstract	23981537
asthma	B-DDF	2144	2150	abstract	23981537
,	O	2150	2151	abstract	23981537
atopy	B-DDF	2152	2157	abstract	23981537
,	O	2157	2158	abstract	23981537
gluten	O	2159	2165	abstract	23981537
and	O	2166	2169	abstract	23981537
many	O	2170	2174	abstract	23981537
other	O	2175	2180	abstract	23981537
food	O	2181	2185	abstract	23981537
and	O	2186	2189	abstract	23981537
chemical	O	2190	2198	abstract	23981537
sensitivity	O	2199	2210	abstract	23981537
syndromes	O	2211	2220	abstract	23981537
,	O	2220	2221	abstract	23981537
emphysema	B-DDF	2222	2231	abstract	23981537
,	O	2231	2232	abstract	23981537
Tourette	B-DDF	2233	2241	abstract	23981537
's	I-DDF	2241	2243	abstract	23981537
syndrome	I-DDF	2244	2252	abstract	23981537
,	O	2252	2253	abstract	23981537
bipolar	B-DDF	2254	2261	abstract	23981537
disorder	I-DDF	2262	2270	abstract	23981537
,	O	2270	2271	abstract	23981537
schizophrenia	B-DDF	2272	2285	abstract	23981537
,	O	2285	2286	abstract	23981537
post-traumatic	B-DDF	2287	2301	abstract	23981537
stress	I-DDF	2302	2308	abstract	23981537
disorder	I-DDF	2309	2317	abstract	23981537
(	O	2318	2319	abstract	23981537
PTSD	B-DDF	2319	2323	abstract	23981537
)	O	2323	2324	abstract	23981537
,	O	2324	2325	abstract	23981537
chronic	B-DDF	2326	2333	abstract	23981537
traumatic	I-DDF	2334	2343	abstract	23981537
encephalopathy	I-DDF	2344	2358	abstract	23981537
(	O	2359	2360	abstract	23981537
CTE	B-DDF	2360	2363	abstract	23981537
)	O	2363	2364	abstract	23981537
,	O	2364	2365	abstract	23981537
traumatic	B-DDF	2366	2375	abstract	23981537
brain	I-DDF	2376	2381	abstract	23981537
injury	I-DDF	2382	2388	abstract	23981537
(	O	2389	2390	abstract	23981537
TBI	B-DDF	2390	2393	abstract	23981537
)	O	2393	2394	abstract	23981537
,	O	2394	2395	abstract	23981537
epilepsy	B-DDF	2396	2404	abstract	23981537
,	O	2404	2405	abstract	23981537
suicidal	O	2406	2414	abstract	23981537
ideation	O	2415	2423	abstract	23981537
,	O	2423	2424	abstract	23981537
organ	O	2425	2430	abstract	23981537
transplant	O	2431	2441	abstract	23981537
biology	O	2442	2449	abstract	23981537
,	O	2449	2450	abstract	23981537
diabetes	B-DDF	2451	2459	abstract	23981537
,	O	2459	2460	abstract	23981537
kidney	B-DDF	2461	2467	abstract	23981537
,	I-DDF	2467	2468	abstract	23981537
liver	I-DDF	2469	2474	abstract	23981537
,	I-DDF	2474	2475	abstract	23981537
and	I-DDF	2476	2479	abstract	23981537
heart	I-DDF	2480	2485	abstract	23981537
disease	I-DDF	2486	2493	abstract	23981537
,	O	2493	2494	abstract	23981537
cancer	B-DDF	2495	2501	abstract	23981537
,	O	2501	2502	abstract	23981537
Alzheimer	B-DDF	2503	2512	abstract	23981537
and	I-DDF	2513	2516	abstract	23981537
Parkinson	I-DDF	2517	2526	abstract	23981537
disease	I-DDF	2527	2534	abstract	23981537
,	O	2534	2535	abstract	23981537
and	O	2536	2539	abstract	23981537
autoimmune	B-DDF	2540	2550	abstract	23981537
disorders	I-DDF	2551	2560	abstract	23981537
like	O	2561	2565	abstract	23981537
lupus	B-DDF	2566	2571	abstract	23981537
,	O	2571	2572	abstract	23981537
rheumatoid	B-DDF	2573	2583	abstract	23981537
arthritis	I-DDF	2584	2593	abstract	23981537
,	O	2593	2594	abstract	23981537
multiple	B-DDF	2595	2603	abstract	23981537
sclerosis	I-DDF	2604	2613	abstract	23981537
,	O	2613	2614	abstract	23981537
and	O	2615	2618	abstract	23981537
primary	B-DDF	2619	2626	abstract	23981537
sclerosing	I-DDF	2627	2637	abstract	23981537
cholangitis	I-DDF	2638	2649	abstract	23981537
.	O	2649	2650	abstract	23981537

Strain-level	O	0	12	title	37657622
structure	O	13	22	title	37657622
of	O	23	25	title	37657622
gut	B-microbiome	26	29	title	37657622
microbiome	I-microbiome	30	40	title	37657622
showed	O	41	47	title	37657622
potential	O	48	57	title	37657622
association	O	58	69	title	37657622
with	O	70	74	title	37657622
cognitive	O	75	84	title	37657622
function	O	85	93	title	37657622
in	O	94	96	title	37657622
major	B-DDF	97	102	title	37657622
depressive	I-DDF	103	113	title	37657622
disorder	I-DDF	114	122	title	37657622
:	O	122	123	title	37657622
A	O	124	125	title	37657622
pilot	O	126	131	title	37657622
study	O	132	137	title	37657622
.	O	137	138	title	37657622

Although	O	0	8	abstract	37657622
the	O	9	12	abstract	37657622
association	O	13	24	abstract	37657622
between	O	25	32	abstract	37657622
gut	B-microbiome	33	36	abstract	37657622
microbiota	I-microbiome	37	47	abstract	37657622
and	O	48	51	abstract	37657622
the	O	52	55	abstract	37657622
pathogenesis	O	56	68	abstract	37657622
of	O	69	71	abstract	37657622
major	B-DDF	72	77	abstract	37657622
depressive	I-DDF	78	88	abstract	37657622
disorder	I-DDF	89	97	abstract	37657622
(	O	98	99	abstract	37657622
MDD	B-DDF	99	102	abstract	37657622
)	O	102	103	abstract	37657622
has	O	104	107	abstract	37657622
been	O	108	112	abstract	37657622
well	O	113	117	abstract	37657622
studied	O	118	125	abstract	37657622
,	O	125	126	abstract	37657622
it	O	127	129	abstract	37657622
is	O	130	132	abstract	37657622
unclear	O	133	140	abstract	37657622
whether	O	141	148	abstract	37657622
gut	B-microbiome	149	152	abstract	37657622
microbiota	I-microbiome	153	163	abstract	37657622
affects	O	164	171	abstract	37657622
cognitive	O	172	181	abstract	37657622
function	O	182	190	abstract	37657622
in	O	191	193	abstract	37657622
patients	B-human	194	202	abstract	37657622
with	O	203	207	abstract	37657622
MDD	B-DDF	208	211	abstract	37657622
.	O	211	212	abstract	37657622

In	O	213	215	abstract	37657622
this	O	216	220	abstract	37657622
study	O	221	226	abstract	37657622
,	O	226	227	abstract	37657622
we	O	228	230	abstract	37657622
explored	O	231	239	abstract	37657622
the	O	240	243	abstract	37657622
association	O	244	255	abstract	37657622
between	O	256	263	abstract	37657622
gut	B-microbiome	264	267	abstract	37657622
microbiota	I-microbiome	268	278	abstract	37657622
and	O	279	282	abstract	37657622
cognitive	O	283	292	abstract	37657622
function	O	293	301	abstract	37657622
in	O	302	304	abstract	37657622
MDD	B-DDF	305	308	abstract	37657622
and	O	309	312	abstract	37657622
its	O	313	316	abstract	37657622
possible	O	317	325	abstract	37657622
mechanisms	O	326	336	abstract	37657622
.	O	336	337	abstract	37657622

We	O	338	340	abstract	37657622
enrolled	O	341	349	abstract	37657622
57	O	350	352	abstract	37657622
patients	B-human	353	361	abstract	37657622
with	O	362	366	abstract	37657622
MDD	B-DDF	367	370	abstract	37657622
and	O	371	374	abstract	37657622
30	O	375	377	abstract	37657622
healthy	B-human	378	385	abstract	37657622
controls	I-human	386	394	abstract	37657622
(	O	395	396	abstract	37657622
HCs	B-human	396	399	abstract	37657622
)	O	399	400	abstract	37657622
and	O	401	404	abstract	37657622
used	O	405	409	abstract	37657622
16S	B-biomedical%technique	410	413	abstract	37657622
rRNA	I-biomedical%technique	414	418	abstract	37657622
gene	I-biomedical%technique	419	423	abstract	37657622
sequencing	I-biomedical%technique	424	434	abstract	37657622
analysis	O	435	443	abstract	37657622
and	O	444	447	abstract	37657622
shotgun	B-biomedical%technique	448	455	abstract	37657622
metagenomic	I-biomedical%technique	456	467	abstract	37657622
sequencing	I-biomedical%technique	468	478	abstract	37657622
analysis	O	479	487	abstract	37657622
to	O	488	490	abstract	37657622
determine	O	491	500	abstract	37657622
gut	O	501	504	abstract	37657622
microbial	O	505	514	abstract	37657622
composition	O	515	526	abstract	37657622
.	O	526	527	abstract	37657622

The	O	528	531	abstract	37657622
richness	O	532	540	abstract	37657622
and	O	541	544	abstract	37657622
diversity	O	545	554	abstract	37657622
of	O	555	557	abstract	37657622
gut	B-microbiome	558	561	abstract	37657622
microbiota	I-microbiome	562	572	abstract	37657622
in	O	573	575	abstract	37657622
patients	B-human	576	584	abstract	37657622
with	O	585	589	abstract	37657622
MDD	B-DDF	590	593	abstract	37657622
were	O	594	598	abstract	37657622
the	O	599	602	abstract	37657622
same	O	603	607	abstract	37657622
as	O	608	610	abstract	37657622
those	O	611	616	abstract	37657622
in	O	617	619	abstract	37657622
HCs	B-human	620	623	abstract	37657622
,	O	623	624	abstract	37657622
but	O	625	628	abstract	37657622
there	O	629	634	abstract	37657622
were	O	635	639	abstract	37657622
differences	O	640	651	abstract	37657622
in	O	652	654	abstract	37657622
the	O	655	658	abstract	37657622
abundance	O	659	668	abstract	37657622
of	O	669	671	abstract	37657622
Bifidobacterium	B-bacteria	672	687	abstract	37657622
and	O	688	691	abstract	37657622
Blautia	B-bacteria	692	699	abstract	37657622
.	O	699	700	abstract	37657622

Compared	O	701	709	abstract	37657622
with	O	710	714	abstract	37657622
HCs	B-human	715	718	abstract	37657622
,	O	718	719	abstract	37657622
two	O	720	723	abstract	37657622
strains	O	724	731	abstract	37657622
(	O	732	733	abstract	37657622
bin_32	O	733	739	abstract	37657622
and	O	740	743	abstract	37657622
bin_55	O	744	750	abstract	37657622
)	O	750	751	abstract	37657622
were	O	752	756	abstract	37657622
significantly	O	757	770	abstract	37657622
increased	O	771	780	abstract	37657622
,	O	780	781	abstract	37657622
and	O	782	785	abstract	37657622
one	O	786	789	abstract	37657622
strain	O	790	796	abstract	37657622
(	O	797	798	abstract	37657622
bin_31	O	798	804	abstract	37657622
)	O	804	805	abstract	37657622
was	O	806	809	abstract	37657622
significantly	O	810	823	abstract	37657622
decreased	O	824	833	abstract	37657622
in	O	834	836	abstract	37657622
patients	B-human	837	845	abstract	37657622
with	O	846	850	abstract	37657622
MDD	B-DDF	851	854	abstract	37657622
based	O	855	860	abstract	37657622
on	O	861	863	abstract	37657622
the	O	864	867	abstract	37657622
strain-level	B-biomedical%technique	868	880	abstract	37657622
meta-analysis	I-biomedical%technique	881	894	abstract	37657622
.	O	894	895	abstract	37657622

Time	O	896	900	abstract	37657622
to	O	901	903	abstract	37657622
complete	O	904	912	abstract	37657622
the	O	913	916	abstract	37657622
Stroop-C	O	917	925	abstract	37657622
had	O	926	929	abstract	37657622
significant	O	930	941	abstract	37657622
negative	O	942	950	abstract	37657622
correlations	O	951	963	abstract	37657622
with	O	964	968	abstract	37657622
bin_31	O	969	975	abstract	37657622
and	O	976	979	abstract	37657622
bin_32	O	980	986	abstract	37657622
.	O	986	987	abstract	37657622

Bin_55	O	988	994	abstract	37657622
had	O	995	998	abstract	37657622
significant	O	999	1010	abstract	37657622
negative	O	1011	1019	abstract	37657622
correlations	O	1020	1032	abstract	37657622
with	O	1033	1037	abstract	37657622
time	O	1038	1042	abstract	37657622
to	O	1043	1045	abstract	37657622
complete	O	1046	1054	abstract	37657622
the	O	1055	1058	abstract	37657622
Stroop-C	O	1059	1067	abstract	37657622
,	O	1067	1068	abstract	37657622
time	O	1069	1073	abstract	37657622
to	O	1074	1076	abstract	37657622
complete	O	1077	1085	abstract	37657622
the	O	1086	1089	abstract	37657622
Stroop-CW	O	1090	1099	abstract	37657622
,	O	1099	1100	abstract	37657622
and	O	1101	1104	abstract	37657622
repeated	O	1105	1113	abstract	37657622
animal	O	1114	1120	abstract	37657622
words	O	1121	1126	abstract	37657622
in	O	1127	1129	abstract	37657622
60	O	1130	1132	abstract	37657622
	O	1132	1133	abstract	37657622
s	O	1133	1134	abstract	37657622
but	O	1135	1138	abstract	37657622
significant	O	1139	1150	abstract	37657622
positive	O	1151	1159	abstract	37657622
correlations	O	1160	1172	abstract	37657622
with	O	1173	1177	abstract	37657622
correct	O	1178	1185	abstract	37657622
answers	O	1186	1193	abstract	37657622
in	O	1194	1196	abstract	37657622
120	O	1197	1200	abstract	37657622
	O	1200	1201	abstract	37657622
s	O	1201	1202	abstract	37657622
on	O	1203	1205	abstract	37657622
the	O	1206	1209	abstract	37657622
Stroop-CW	O	1210	1219	abstract	37657622
.	O	1219	1220	abstract	37657622

This	O	1221	1225	abstract	37657622
study	O	1226	1231	abstract	37657622
only	O	1232	1236	abstract	37657622
tested	O	1237	1243	abstract	37657622
the	O	1244	1247	abstract	37657622
cognitive	O	1248	1257	abstract	37657622
function	O	1258	1266	abstract	37657622
of	O	1267	1269	abstract	37657622
MDD	B-DDF	1270	1273	abstract	37657622
in	O	1274	1276	abstract	37657622
a	O	1277	1278	abstract	37657622
small	O	1279	1284	abstract	37657622
sample	O	1285	1291	abstract	37657622
,	O	1291	1292	abstract	37657622
which	O	1293	1298	abstract	37657622
may	O	1299	1302	abstract	37657622
have	O	1303	1307	abstract	37657622
caused	O	1308	1314	abstract	37657622
some	O	1315	1319	abstract	37657622
bias	O	1320	1324	abstract	37657622
.	O	1324	1325	abstract	37657622

Based	O	1326	1331	abstract	37657622
on	O	1332	1334	abstract	37657622
our	O	1335	1338	abstract	37657622
strain-level	O	1339	1351	abstract	37657622
analysis	O	1352	1360	abstract	37657622
,	O	1360	1361	abstract	37657622
we	O	1362	1364	abstract	37657622
found	O	1365	1370	abstract	37657622
that	O	1371	1375	abstract	37657622
gut	B-microbiome	1376	1379	abstract	37657622
microbiota	I-microbiome	1380	1390	abstract	37657622
may	O	1391	1394	abstract	37657622
be	O	1395	1397	abstract	37657622
associated	O	1398	1408	abstract	37657622
with	O	1409	1413	abstract	37657622
the	O	1414	1417	abstract	37657622
pathogenesis	O	1418	1430	abstract	37657622
of	O	1431	1433	abstract	37657622
MDD	B-DDF	1434	1437	abstract	37657622
and	O	1438	1441	abstract	37657622
may	O	1442	1445	abstract	37657622
have	O	1446	1450	abstract	37657622
potential	O	1451	1460	abstract	37657622
effects	O	1461	1468	abstract	37657622
on	O	1469	1471	abstract	37657622
cognitive	O	1472	1481	abstract	37657622
function	O	1482	1490	abstract	37657622
.	O	1490	1491	abstract	37657622

Alteration	B-DDF	0	10	title	36760344
of	I-DDF	11	13	title	36760344
faecal	I-DDF	14	20	title	36760344
microbiota	I-DDF	21	31	title	36760344
balance	I-DDF	32	39	title	36760344
related	O	40	47	title	36760344
to	O	48	50	title	36760344
long-term	O	51	60	title	36760344
deep	O	61	65	title	36760344
meditation	O	66	76	title	36760344
.	O	76	77	title	36760344

Advancements	O	0	12	abstract	36760344
in	O	13	15	abstract	36760344
research	O	16	24	abstract	36760344
have	O	25	29	abstract	36760344
confirmed	O	30	39	abstract	36760344
that	O	40	44	abstract	36760344
gut	B-microbiome	45	48	abstract	36760344
microbiota	I-microbiome	49	59	abstract	36760344
can	O	60	63	abstract	36760344
influence	O	64	73	abstract	36760344
health	O	74	80	abstract	36760344
through	O	81	88	abstract	36760344
the	O	89	92	abstract	36760344
microbiota-gut-brain	O	93	113	abstract	36760344
axis	O	114	118	abstract	36760344
.	O	118	119	abstract	36760344

Meditation	O	120	130	abstract	36760344
,	O	130	131	abstract	36760344
as	O	132	134	abstract	36760344
an	O	135	137	abstract	36760344
inner	O	138	143	abstract	36760344
mental	O	144	150	abstract	36760344
exercise	O	151	159	abstract	36760344
,	O	159	160	abstract	36760344
can	O	161	164	abstract	36760344
positively	O	165	175	abstract	36760344
impact	O	176	182	abstract	36760344
the	O	183	186	abstract	36760344
regulation	O	187	197	abstract	36760344
of	O	198	200	abstract	36760344
an	O	201	203	abstract	36760344
individual	O	204	214	abstract	36760344
's	O	214	216	abstract	36760344
physical	O	217	225	abstract	36760344
and	O	226	229	abstract	36760344
mental	O	230	236	abstract	36760344
health	O	237	243	abstract	36760344
.	O	243	244	abstract	36760344

However	O	245	252	abstract	36760344
,	O	252	253	abstract	36760344
few	O	254	257	abstract	36760344
studies	O	258	265	abstract	36760344
have	O	266	270	abstract	36760344
comprehensively	O	271	286	abstract	36760344
investigated	O	287	299	abstract	36760344
faecal	B-microbiome	300	306	abstract	36760344
microbiota	I-microbiome	307	317	abstract	36760344
following	O	318	327	abstract	36760344
long-term	O	328	337	abstract	36760344
(	O	338	339	abstract	36760344
several	O	339	346	abstract	36760344
years	O	347	352	abstract	36760344
)	O	352	353	abstract	36760344
deep	O	354	358	abstract	36760344
meditation	O	359	369	abstract	36760344
.	O	369	370	abstract	36760344

Therefore	O	371	380	abstract	36760344
,	O	380	381	abstract	36760344
we	O	382	384	abstract	36760344
propose	O	385	392	abstract	36760344
that	O	393	397	abstract	36760344
long-term	O	398	407	abstract	36760344
meditation	O	408	418	abstract	36760344
may	O	419	422	abstract	36760344
regulate	O	423	431	abstract	36760344
gut	O	432	435	abstract	36760344
microbiota	O	436	446	abstract	36760344
homeostasis	O	447	458	abstract	36760344
and	O	459	462	abstract	36760344
,	O	462	463	abstract	36760344
in	O	464	466	abstract	36760344
turn	O	467	471	abstract	36760344
,	O	471	472	abstract	36760344
affect	O	473	479	abstract	36760344
physical	O	480	488	abstract	36760344
and	O	489	492	abstract	36760344
mental	O	493	499	abstract	36760344
health	O	500	506	abstract	36760344
.	O	506	507	abstract	36760344

To	O	508	510	abstract	36760344
investigate	O	511	522	abstract	36760344
the	O	523	526	abstract	36760344
effects	O	527	534	abstract	36760344
of	O	535	537	abstract	36760344
long-term	O	538	547	abstract	36760344
deep	O	548	552	abstract	36760344
meditation	O	553	563	abstract	36760344
on	O	564	566	abstract	36760344
the	O	567	570	abstract	36760344
gut	B-microbiome	571	574	abstract	36760344
microbiome	I-microbiome	575	585	abstract	36760344
structure	O	586	595	abstract	36760344
.	O	595	596	abstract	36760344

To	O	597	599	abstract	36760344
examine	O	600	607	abstract	36760344
the	O	608	611	abstract	36760344
intestinal	B-microbiome	612	622	abstract	36760344
flora	I-microbiome	623	628	abstract	36760344
,	O	628	629	abstract	36760344
16S	B-biomedical%technique	630	633	abstract	36760344
rRNA	I-biomedical%technique	634	638	abstract	36760344
gene	I-biomedical%technique	639	643	abstract	36760344
sequencing	I-biomedical%technique	644	654	abstract	36760344
was	O	655	658	abstract	36760344
performed	O	659	668	abstract	36760344
on	O	669	671	abstract	36760344
faecal	O	672	678	abstract	36760344
samples	O	679	686	abstract	36760344
of	O	687	689	abstract	36760344
56	O	690	692	abstract	36760344
Tibetan	B-human	693	700	abstract	36760344
Buddhist	I-human	701	709	abstract	36760344
monks	I-human	710	715	abstract	36760344
and	O	716	719	abstract	36760344
neighbouring	B-human	720	732	abstract	36760344
residents	I-human	733	742	abstract	36760344
.	O	742	743	abstract	36760344

Based	O	744	749	abstract	36760344
on	O	750	752	abstract	36760344
the	O	753	756	abstract	36760344
sequencing	O	757	767	abstract	36760344
data	O	768	772	abstract	36760344
,	O	772	773	abstract	36760344
linear	B-statistical%technique	774	780	abstract	36760344
discriminant	I-statistical%technique	781	793	abstract	36760344
analysis	I-statistical%technique	794	802	abstract	36760344
effect	I-statistical%technique	803	809	abstract	36760344
size	I-statistical%technique	810	814	abstract	36760344
(	O	815	816	abstract	36760344
LEfSe	B-statistical%technique	816	821	abstract	36760344
)	O	821	822	abstract	36760344
was	O	823	826	abstract	36760344
employed	O	827	835	abstract	36760344
to	O	836	838	abstract	36760344
identify	O	839	847	abstract	36760344
differential	O	848	860	abstract	36760344
intestinal	O	861	871	abstract	36760344
microbial	O	872	881	abstract	36760344
communities	O	882	893	abstract	36760344
between	O	894	901	abstract	36760344
the	O	902	905	abstract	36760344
two	O	906	909	abstract	36760344
groups	O	910	916	abstract	36760344
.	O	916	917	abstract	36760344

Phylogenetic	B-biomedical%technique	918	930	abstract	36760344
Investigation	I-biomedical%technique	931	944	abstract	36760344
of	I-biomedical%technique	945	947	abstract	36760344
Communities	I-biomedical%technique	948	959	abstract	36760344
by	I-biomedical%technique	960	962	abstract	36760344
Reconstruction	I-biomedical%technique	963	977	abstract	36760344
of	I-biomedical%technique	978	980	abstract	36760344
Unobserved	I-biomedical%technique	981	991	abstract	36760344
States	I-biomedical%technique	992	998	abstract	36760344
(	I-biomedical%technique	999	1000	abstract	36760344
PICRUSt	I-biomedical%technique	1000	1007	abstract	36760344
)	I-biomedical%technique	1007	1008	abstract	36760344
analysis	I-biomedical%technique	1009	1017	abstract	36760344
was	O	1018	1021	abstract	36760344
used	O	1022	1026	abstract	36760344
to	O	1027	1029	abstract	36760344
predict	O	1030	1037	abstract	36760344
the	O	1038	1041	abstract	36760344
function	O	1042	1050	abstract	36760344
of	O	1051	1053	abstract	36760344
faecal	B-microbiome	1054	1060	abstract	36760344
microbiota	I-microbiome	1061	1071	abstract	36760344
.	O	1071	1072	abstract	36760344

In	O	1073	1075	abstract	36760344
addition	O	1076	1084	abstract	36760344
,	O	1084	1085	abstract	36760344
we	O	1086	1088	abstract	36760344
evaluated	O	1089	1098	abstract	36760344
biochemical	O	1099	1110	abstract	36760344
indices	O	1111	1118	abstract	36760344
in	O	1119	1121	abstract	36760344
the	O	1122	1125	abstract	36760344
plasma	O	1126	1132	abstract	36760344
.	O	1132	1133	abstract	36760344

The	O	1134	1137	abstract	36760344
-diversity	O	1138	1149	abstract	36760344
indices	O	1150	1157	abstract	36760344
of	O	1158	1160	abstract	36760344
the	O	1161	1164	abstract	36760344
meditation	O	1165	1175	abstract	36760344
and	O	1176	1179	abstract	36760344
control	O	1180	1187	abstract	36760344
groups	O	1188	1194	abstract	36760344
differed	O	1195	1203	abstract	36760344
significantly	O	1204	1217	abstract	36760344
.	O	1217	1218	abstract	36760344

At	O	1219	1221	abstract	36760344
the	O	1222	1225	abstract	36760344
genus	O	1226	1231	abstract	36760344
level	O	1232	1237	abstract	36760344
,	O	1237	1238	abstract	36760344
<	O	1239	1240	abstract	36760344
i	O	1240	1241	abstract	36760344
>	O	1241	1242	abstract	36760344
Prevotella</i	B-bacteria	1242	1255	abstract	36760344
>	O	1255	1256	abstract	36760344
and	O	1257	1260	abstract	36760344
<	O	1261	1262	abstract	36760344
i	O	1262	1263	abstract	36760344
>	O	1263	1264	abstract	36760344
Bacteroides</i	B-bacteria	1264	1278	abstract	36760344
>	O	1278	1279	abstract	36760344
were	O	1280	1284	abstract	36760344
significantly	O	1285	1298	abstract	36760344
enriched	O	1299	1307	abstract	36760344
in	O	1308	1310	abstract	36760344
the	O	1311	1314	abstract	36760344
meditation	O	1315	1325	abstract	36760344
group	O	1326	1331	abstract	36760344
.	O	1331	1332	abstract	36760344

According	O	1333	1342	abstract	36760344
to	O	1343	1345	abstract	36760344
the	O	1346	1349	abstract	36760344
LEfSe	B-statistical%technique	1350	1355	abstract	36760344
analysis	I-statistical%technique	1356	1364	abstract	36760344
,	O	1364	1365	abstract	36760344
two	O	1366	1369	abstract	36760344
beneficial	O	1370	1380	abstract	36760344
bacterial	O	1381	1390	abstract	36760344
genera	O	1391	1397	abstract	36760344
(	O	1398	1399	abstract	36760344
<	O	1399	1400	abstract	36760344
i	O	1400	1401	abstract	36760344
>	O	1401	1402	abstract	36760344
Megamonas</i	B-bacteria	1402	1414	abstract	36760344
>	O	1414	1415	abstract	36760344
and	O	1416	1419	abstract	36760344
<	O	1420	1421	abstract	36760344
i	O	1421	1422	abstract	36760344
>	O	1422	1423	abstract	36760344
Faecalibacterium</i	B-bacteria	1423	1442	abstract	36760344
>	O	1442	1443	abstract	36760344
)	O	1443	1444	abstract	36760344
were	O	1445	1449	abstract	36760344
significantly	O	1450	1463	abstract	36760344
enriched	O	1464	1472	abstract	36760344
in	O	1473	1475	abstract	36760344
the	O	1476	1479	abstract	36760344
meditation	O	1480	1490	abstract	36760344
group	O	1491	1496	abstract	36760344
.	O	1496	1497	abstract	36760344

Functional	O	1498	1508	abstract	36760344
predictive	O	1509	1519	abstract	36760344
analysis	O	1520	1528	abstract	36760344
further	O	1529	1536	abstract	36760344
showed	O	1537	1543	abstract	36760344
that	O	1544	1548	abstract	36760344
several	O	1549	1556	abstract	36760344
pathways-including	O	1557	1575	abstract	36760344
glycan	O	1576	1582	abstract	36760344
biosynthesis	O	1583	1595	abstract	36760344
,	O	1595	1596	abstract	36760344
metabolism	O	1597	1607	abstract	36760344
and	O	1608	1611	abstract	36760344
lipopolysaccharide	O	1612	1630	abstract	36760344
biosynthesis-were	O	1631	1648	abstract	36760344
significantly	O	1649	1662	abstract	36760344
enriched	O	1663	1671	abstract	36760344
in	O	1672	1674	abstract	36760344
the	O	1675	1678	abstract	36760344
meditation	O	1679	1689	abstract	36760344
group	O	1690	1695	abstract	36760344
.	O	1695	1696	abstract	36760344

Moreover	O	1697	1705	abstract	36760344
,	O	1705	1706	abstract	36760344
plasma	O	1707	1713	abstract	36760344
levels	O	1714	1720	abstract	36760344
of	O	1721	1723	abstract	36760344
clinical	O	1724	1732	abstract	36760344
risk	O	1733	1737	abstract	36760344
factors	O	1738	1745	abstract	36760344
were	O	1746	1750	abstract	36760344
significantly	O	1751	1764	abstract	36760344
decreased	O	1765	1774	abstract	36760344
in	O	1775	1777	abstract	36760344
the	O	1778	1781	abstract	36760344
meditation	O	1782	1792	abstract	36760344
group	O	1793	1798	abstract	36760344
,	O	1798	1799	abstract	36760344
including	O	1800	1809	abstract	36760344
total	O	1810	1815	abstract	36760344
cholesterol	O	1816	1827	abstract	36760344
and	O	1828	1831	abstract	36760344
apolipoprotein	B-gene	1832	1846	abstract	36760344
B.	I-gene	1847	1849	abstract	36760344
Long-term	O	1850	1859	abstract	36760344
traditional	O	1860	1871	abstract	36760344
Tibetan	O	1872	1879	abstract	36760344
Buddhist	O	1880	1888	abstract	36760344
meditation	O	1889	1899	abstract	36760344
may	O	1900	1903	abstract	36760344
positively	O	1904	1914	abstract	36760344
impact	O	1915	1921	abstract	36760344
physical	O	1922	1930	abstract	36760344
and	O	1931	1934	abstract	36760344
mental	O	1935	1941	abstract	36760344
health	O	1942	1948	abstract	36760344
.	O	1948	1949	abstract	36760344

We	O	1950	1952	abstract	36760344
confirmed	O	1953	1962	abstract	36760344
that	O	1963	1967	abstract	36760344
the	O	1968	1971	abstract	36760344
gut	O	1972	1975	abstract	36760344
microbiota	O	1976	1986	abstract	36760344
composition	O	1987	1998	abstract	36760344
differed	O	1999	2007	abstract	36760344
between	O	2008	2015	abstract	36760344
the	O	2016	2019	abstract	36760344
monks	B-human	2020	2025	abstract	36760344
and	O	2026	2029	abstract	36760344
control	B-human	2030	2037	abstract	36760344
subjects	I-human	2038	2046	abstract	36760344
.	O	2046	2047	abstract	36760344

The	O	2048	2051	abstract	36760344
microbiota	O	2052	2062	abstract	36760344
enriched	O	2063	2071	abstract	36760344
in	O	2072	2074	abstract	36760344
monks	B-human	2075	2080	abstract	36760344
was	O	2081	2084	abstract	36760344
associated	O	2085	2095	abstract	36760344
with	O	2096	2100	abstract	36760344
a	O	2101	2102	abstract	36760344
reduced	O	2103	2110	abstract	36760344
risk	O	2111	2115	abstract	36760344
of	O	2116	2118	abstract	36760344
anxiety	B-DDF	2119	2126	abstract	36760344
,	O	2126	2127	abstract	36760344
depression	B-DDF	2128	2138	abstract	36760344
and	O	2139	2142	abstract	36760344
cardiovascular	B-DDF	2143	2157	abstract	36760344
disease	I-DDF	2158	2165	abstract	36760344
and	O	2166	2169	abstract	36760344
could	O	2170	2175	abstract	36760344
enhance	O	2176	2183	abstract	36760344
immune	O	2184	2190	abstract	36760344
function	O	2191	2199	abstract	36760344
.	O	2199	2200	abstract	36760344

Overall	O	2201	2208	abstract	36760344
,	O	2208	2209	abstract	36760344
these	O	2210	2215	abstract	36760344
results	O	2216	2223	abstract	36760344
suggest	O	2224	2231	abstract	36760344
that	O	2232	2236	abstract	36760344
meditation	O	2237	2247	abstract	36760344
plays	O	2248	2253	abstract	36760344
a	O	2254	2255	abstract	36760344
positive	O	2256	2264	abstract	36760344
role	O	2265	2269	abstract	36760344
in	O	2270	2272	abstract	36760344
psychosomatic	O	2273	2286	abstract	36760344
conditions	O	2287	2297	abstract	36760344
and	O	2298	2301	abstract	36760344
well-being	O	2302	2312	abstract	36760344
.	O	2312	2313	abstract	36760344

Bugs	O	0	4	title	33722869
and	O	5	8	title	33722869
Brains	O	9	15	title	33722869
,	O	15	16	title	33722869
the	O	17	20	title	33722869
Gut	O	21	24	title	33722869
and	O	25	28	title	33722869
Mental	O	29	35	title	33722869
Health	O	36	42	title	33722869
Study	O	43	48	title	33722869
:	O	48	49	title	33722869
a	O	50	51	title	33722869
mixed-methods	O	52	65	title	33722869
study	O	66	71	title	33722869
investigating	O	72	85	title	33722869
microbiota	O	86	96	title	33722869
composition	O	97	108	title	33722869
and	O	109	112	title	33722869
function	O	113	121	title	33722869
in	O	122	124	title	33722869
anxiety	B-DDF	125	132	title	33722869
,	O	132	133	title	33722869
depression	B-DDF	134	144	title	33722869
and	O	145	148	title	33722869
irritable	B-DDF	149	158	title	33722869
bowel	I-DDF	159	164	title	33722869
syndrome	I-DDF	165	173	title	33722869
.	O	173	174	title	33722869

Research	O	0	8	abstract	33722869
has	O	9	12	abstract	33722869
highlighted	O	13	24	abstract	33722869
relationships	O	25	38	abstract	33722869
between	O	39	46	abstract	33722869
the	O	47	50	abstract	33722869
micro-organisms	O	51	66	abstract	33722869
that	O	67	71	abstract	33722869
inhabit	O	72	79	abstract	33722869
our	O	80	83	abstract	33722869
gastrointestinal	B-anatomical%location	84	100	abstract	33722869
tract	I-anatomical%location	101	106	abstract	33722869
(	O	107	108	abstract	33722869
oral	B-microbiome	108	112	abstract	33722869
and	I-microbiome	113	116	abstract	33722869
gut	I-microbiome	117	120	abstract	33722869
microbiota	I-microbiome	121	131	abstract	33722869
)	O	131	132	abstract	33722869
with	O	133	137	abstract	33722869
host	O	138	142	abstract	33722869
mood	O	143	147	abstract	33722869
and	O	148	151	abstract	33722869
gastrointestinal	O	152	168	abstract	33722869
functioning	O	169	180	abstract	33722869
.	O	180	181	abstract	33722869

Mental	B-DDF	182	188	abstract	33722869
health	I-DDF	189	195	abstract	33722869
disorders	I-DDF	196	205	abstract	33722869
and	O	206	209	abstract	33722869
functional	B-DDF	210	220	abstract	33722869
gastrointestinal	I-DDF	221	237	abstract	33722869
disorders	I-DDF	238	247	abstract	33722869
co-occur	O	248	256	abstract	33722869
at	O	257	259	abstract	33722869
high	O	260	264	abstract	33722869
rates	O	265	270	abstract	33722869
,	O	270	271	abstract	33722869
although	O	272	280	abstract	33722869
the	O	281	284	abstract	33722869
mechanisms	O	285	295	abstract	33722869
underlying	O	296	306	abstract	33722869
these	O	307	312	abstract	33722869
associations	O	313	325	abstract	33722869
remain	O	326	332	abstract	33722869
unclear	O	333	340	abstract	33722869
.	O	340	341	abstract	33722869

The	O	342	345	abstract	33722869
Bugs	O	346	350	abstract	33722869
and	O	351	354	abstract	33722869
Brains	O	355	361	abstract	33722869
Study	O	362	367	abstract	33722869
aims	O	368	372	abstract	33722869
to	O	373	375	abstract	33722869
investigate	O	376	387	abstract	33722869
complex	O	388	395	abstract	33722869
relationships	O	396	409	abstract	33722869
between	O	410	417	abstract	33722869
anxiety/depression	B-DDF	418	436	abstract	33722869
and	O	437	440	abstract	33722869
irritable	B-DDF	441	450	abstract	33722869
bowel	I-DDF	451	456	abstract	33722869
syndrome	I-DDF	457	465	abstract	33722869
(	O	466	467	abstract	33722869
IBS	B-DDF	467	470	abstract	33722869
)	O	470	471	abstract	33722869
in	O	472	474	abstract	33722869
two	O	475	478	abstract	33722869
ways	O	479	483	abstract	33722869
.	O	483	484	abstract	33722869

First	O	485	490	abstract	33722869
,	O	490	491	abstract	33722869
its	O	492	495	abstract	33722869
primary	O	496	503	abstract	33722869
component	O	504	513	abstract	33722869
will	O	514	518	abstract	33722869
compare	O	519	526	abstract	33722869
the	O	527	530	abstract	33722869
gut	B-microbiome	531	534	abstract	33722869
and	I-microbiome	535	538	abstract	33722869
oral	I-microbiome	539	543	abstract	33722869
microbiota	I-microbiome	544	554	abstract	33722869
in	O	555	557	abstract	33722869
females	B-human	558	565	abstract	33722869
with	O	566	570	abstract	33722869
anxiety/depression	B-DDF	571	589	abstract	33722869
and/or	O	590	596	abstract	33722869
IBS	B-DDF	597	600	abstract	33722869
relative	O	601	609	abstract	33722869
to	O	610	612	abstract	33722869
controls	B-human	613	621	abstract	33722869
,	O	621	622	abstract	33722869
and	O	623	626	abstract	33722869
investigate	O	627	638	abstract	33722869
underlying	O	639	649	abstract	33722869
physiological	O	650	663	abstract	33722869
,	O	663	664	abstract	33722869
endocrine	O	665	674	abstract	33722869
and	O	675	678	abstract	33722869
immune	O	679	685	abstract	33722869
factors	O	686	693	abstract	33722869
,	O	693	694	abstract	33722869
as	O	695	697	abstract	33722869
well	O	698	702	abstract	33722869
as	O	703	705	abstract	33722869
associations	O	706	718	abstract	33722869
with	O	719	723	abstract	33722869
diet	O	724	728	abstract	33722869
and	O	729	732	abstract	33722869
psychosocial	O	733	745	abstract	33722869
factors	O	746	753	abstract	33722869
.	O	753	754	abstract	33722869

In	O	755	757	abstract	33722869
an	O	758	760	abstract	33722869
ancillary	O	761	770	abstract	33722869
component	O	771	780	abstract	33722869
,	O	780	781	abstract	33722869
the	O	782	785	abstract	33722869
study	O	786	791	abstract	33722869
will	O	792	796	abstract	33722869
also	O	797	801	abstract	33722869
investigate	O	802	813	abstract	33722869
gastrointestinal	B-DDF	814	830	abstract	33722869
and	I-DDF	831	834	abstract	33722869
mental	I-DDF	835	841	abstract	33722869
health	I-DDF	842	848	abstract	33722869
symptoms	I-DDF	849	857	abstract	33722869
in	O	858	860	abstract	33722869
a	O	861	862	abstract	33722869
larger	O	863	869	abstract	33722869
sample	O	870	876	abstract	33722869
,	O	876	877	abstract	33722869
and	O	878	881	abstract	33722869
explore	O	882	889	abstract	33722869
relationships	O	890	903	abstract	33722869
with	O	904	908	abstract	33722869
diet	O	909	913	abstract	33722869
,	O	913	914	abstract	33722869
exercise	O	915	923	abstract	33722869
,	O	923	924	abstract	33722869
oral	O	925	929	abstract	33722869
health	O	930	936	abstract	33722869
,	O	936	937	abstract	33722869
substance	O	938	947	abstract	33722869
use	O	948	951	abstract	33722869
,	O	951	952	abstract	33722869
medical	O	953	960	abstract	33722869
history	O	961	968	abstract	33722869
,	O	968	969	abstract	33722869
early	O	970	975	abstract	33722869
life	O	976	980	abstract	33722869
adversity	O	981	990	abstract	33722869
and	O	991	994	abstract	33722869
psychosocial	O	995	1007	abstract	33722869
factors	O	1008	1015	abstract	33722869
.	O	1015	1016	abstract	33722869

The	O	1017	1020	abstract	33722869
Bugs	O	1021	1025	abstract	33722869
and	O	1026	1029	abstract	33722869
Brains	O	1030	1036	abstract	33722869
Study	O	1037	1042	abstract	33722869
aims	O	1043	1047	abstract	33722869
to	O	1048	1050	abstract	33722869
recruit	O	1051	1058	abstract	33722869
160	O	1059	1062	abstract	33722869
females	B-human	1063	1070	abstract	33722869
to	O	1071	1073	abstract	33722869
the	O	1074	1077	abstract	33722869
primary	O	1078	1085	abstract	33722869
component	O	1086	1095	abstract	33722869
:	O	1095	1096	abstract	33722869
(	O	1097	1098	abstract	33722869
1	O	1098	1099	abstract	33722869
)	O	1099	1100	abstract	33722869
40	O	1101	1103	abstract	33722869
controls	B-human	1104	1112	abstract	33722869
;	O	1112	1113	abstract	33722869
(	O	1114	1115	abstract	33722869
2	O	1115	1116	abstract	33722869
)	O	1116	1117	abstract	33722869
40	O	1118	1120	abstract	33722869
participants	B-human	1121	1133	abstract	33722869
with	O	1134	1138	abstract	33722869
a	O	1139	1140	abstract	33722869
depressive/anxiety	B-DDF	1141	1159	abstract	33722869
disorder	I-DDF	1160	1168	abstract	33722869
,	O	1168	1169	abstract	33722869
but	O	1170	1173	abstract	33722869
no	O	1174	1176	abstract	33722869
IBS	B-DDF	1177	1180	abstract	33722869
;	O	1180	1181	abstract	33722869
(	O	1182	1183	abstract	33722869
3	O	1183	1184	abstract	33722869
)	O	1184	1185	abstract	33722869
40	O	1186	1188	abstract	33722869
participants	B-human	1189	1201	abstract	33722869
with	O	1202	1206	abstract	33722869
IBS	B-DDF	1207	1210	abstract	33722869
,	O	1210	1211	abstract	33722869
but	O	1212	1215	abstract	33722869
no	O	1216	1218	abstract	33722869
depressive/anxiety	B-DDF	1219	1237	abstract	33722869
disorder	I-DDF	1238	1246	abstract	33722869
and	O	1247	1250	abstract	33722869
(	O	1251	1252	abstract	33722869
4	O	1252	1253	abstract	33722869
)	O	1253	1254	abstract	33722869
40	O	1255	1257	abstract	33722869
participants	B-human	1258	1270	abstract	33722869
with	O	1271	1275	abstract	33722869
both	O	1276	1280	abstract	33722869
depressive/anxiety	B-DDF	1281	1299	abstract	33722869
disorder	I-DDF	1300	1308	abstract	33722869
and	O	1309	1312	abstract	33722869
IBS	B-DDF	1313	1316	abstract	33722869
.	O	1316	1317	abstract	33722869

Participation	O	1318	1331	abstract	33722869
is	O	1332	1334	abstract	33722869
completed	O	1335	1344	abstract	33722869
within	O	1345	1351	abstract	33722869
1	O	1352	1353	abstract	33722869
	O	1353	1354	abstract	33722869
month	O	1354	1359	abstract	33722869
,	O	1359	1360	abstract	33722869
and	O	1361	1364	abstract	33722869
involves	O	1365	1373	abstract	33722869
comprehensive	O	1374	1387	abstract	33722869
questionnaires	O	1388	1402	abstract	33722869
,	O	1402	1403	abstract	33722869
anthropometrics	O	1404	1419	abstract	33722869
,	O	1419	1420	abstract	33722869
a	O	1421	1422	abstract	33722869
diagnostic	O	1423	1433	abstract	33722869
clinical	O	1434	1442	abstract	33722869
interview	O	1443	1452	abstract	33722869
,	O	1452	1453	abstract	33722869
collection	O	1454	1464	abstract	33722869
of	O	1465	1467	abstract	33722869
two	O	1468	1471	abstract	33722869
saliva	O	1472	1478	abstract	33722869
samples	O	1479	1486	abstract	33722869
,	O	1486	1487	abstract	33722869
and	O	1488	1491	abstract	33722869
stool	O	1492	1497	abstract	33722869
,	O	1497	1498	abstract	33722869
urine	O	1499	1504	abstract	33722869
and	O	1505	1508	abstract	33722869
hair	O	1509	1513	abstract	33722869
samples	O	1514	1521	abstract	33722869
.	O	1521	1522	abstract	33722869

This	O	1523	1527	abstract	33722869
study	O	1528	1533	abstract	33722869
aims	O	1534	1538	abstract	33722869
to	O	1539	1541	abstract	33722869
use	O	1542	1545	abstract	33722869
a	O	1546	1547	abstract	33722869
systems	O	1548	1555	abstract	33722869
biology	O	1556	1563	abstract	33722869
approach	O	1564	1572	abstract	33722869
to	O	1573	1575	abstract	33722869
characterise	O	1576	1588	abstract	33722869
oral	O	1589	1593	abstract	33722869
and	O	1594	1597	abstract	33722869
gut	O	1598	1601	abstract	33722869
microbial	O	1602	1611	abstract	33722869
composition	O	1612	1623	abstract	33722869
<	O	1624	1625	abstract	33722869
u	O	1625	1626	abstract	33722869
>	O	1626	1627	abstract	33722869
and</u	O	1627	1633	abstract	33722869
>	O	1633	1634	abstract	33722869
function	O	1635	1643	abstract	33722869
using	O	1644	1649	abstract	33722869
16S	B-biomedical%technique	1650	1653	abstract	33722869
rRNA	I-biomedical%technique	1654	1658	abstract	33722869
gene	I-biomedical%technique	1659	1663	abstract	33722869
sequencing	I-biomedical%technique	1664	1674	abstract	33722869
and	O	1675	1678	abstract	33722869
nuclear	B-biomedical%technique	1679	1686	abstract	33722869
MR	I-biomedical%technique	1687	1689	abstract	33722869
spectroscopy	I-biomedical%technique	1690	1702	abstract	33722869
.	O	1702	1703	abstract	33722869

As	O	1704	1706	abstract	33722869
part	O	1707	1711	abstract	33722869
of	O	1712	1714	abstract	33722869
the	O	1715	1718	abstract	33722869
ancillary	O	1719	1728	abstract	33722869
component	O	1729	1738	abstract	33722869
,	O	1738	1739	abstract	33722869
it	O	1740	1742	abstract	33722869
will	O	1743	1747	abstract	33722869
collect	O	1748	1755	abstract	33722869
questionnaire	O	1756	1769	abstract	33722869
data	O	1770	1774	abstract	33722869
from	O	1775	1779	abstract	33722869
1000	O	1780	1784	abstract	33722869
participants	B-human	1785	1797	abstract	33722869
aged	I-human	1798	1802	abstract	33722869
18	I-human	1803	1805	abstract	33722869
-	I-human	1805	1806	abstract	33722869
40	I-human	1806	1808	abstract	33722869
years	I-human	1809	1814	abstract	33722869
,	O	1814	1815	abstract	33722869
capturing	O	1816	1825	abstract	33722869
mental	O	1826	1832	abstract	33722869
health	O	1833	1839	abstract	33722869
,	O	1839	1840	abstract	33722869
gastrointestinal	O	1841	1857	abstract	33722869
health	O	1858	1864	abstract	33722869
,	O	1864	1865	abstract	33722869
oral	O	1866	1870	abstract	33722869
health	O	1871	1877	abstract	33722869
,	O	1877	1878	abstract	33722869
diet	O	1879	1883	abstract	33722869
and	O	1884	1887	abstract	33722869
psychosocial	O	1888	1900	abstract	33722869
factors	O	1901	1908	abstract	33722869
.	O	1908	1909	abstract	33722869

Approval	O	1910	1918	abstract	33722869
was	O	1919	1922	abstract	33722869
granted	O	1923	1930	abstract	33722869
by	O	1931	1933	abstract	33722869
the	O	1934	1937	abstract	33722869
University	O	1938	1948	abstract	33722869
of	O	1949	1951	abstract	33722869
Melbourne	O	1952	1961	abstract	33722869
Human	O	1962	1967	abstract	33722869
Research	O	1968	1976	abstract	33722869
Ethics	O	1977	1983	abstract	33722869
Committee	O	1984	1993	abstract	33722869
(	O	1994	1995	abstract	33722869
#	O	1995	1996	abstract	33722869
1749221	O	1996	2003	abstract	33722869
)	O	2003	2004	abstract	33722869
.	O	2004	2005	abstract	33722869

All	O	2006	2009	abstract	33722869
participants	B-human	2010	2022	abstract	33722869
voluntarily	O	2023	2034	abstract	33722869
provided	O	2035	2043	abstract	33722869
informed	O	2044	2052	abstract	33722869
consent	O	2053	2060	abstract	33722869
.	O	2060	2061	abstract	33722869

Results	O	2062	2069	abstract	33722869
will	O	2070	2074	abstract	33722869
be	O	2075	2077	abstract	33722869
published	O	2078	2087	abstract	33722869
in	O	2088	2090	abstract	33722869
peer-reviewed	O	2091	2104	abstract	33722869
journals	O	2105	2113	abstract	33722869
and	O	2114	2117	abstract	33722869
presented	O	2118	2127	abstract	33722869
at	O	2128	2130	abstract	33722869
scientific	O	2131	2141	abstract	33722869
conferences	O	2142	2153	abstract	33722869
.	O	2153	2154	abstract	33722869

Changes	O	0	7	title	34776854
in	O	8	10	title	34776854
the	O	11	14	title	34776854
Gut	B-microbiome	15	18	title	34776854
Microbiome	I-microbiome	19	29	title	34776854
and	O	30	33	title	34776854
Predicted	O	34	43	title	34776854
Functional	O	44	54	title	34776854
Metabolic	O	55	64	title	34776854
Effects	O	65	72	title	34776854
in	O	73	75	title	34776854
an	O	76	78	title	34776854
Australian	O	79	89	title	34776854
Parkinson	B-DDF	90	99	title	34776854
's	I-DDF	99	101	title	34776854
Disease	I-DDF	102	109	title	34776854
Cohort	O	110	116	title	34776854
.	O	116	117	title	34776854

<	O	0	1	abstract	34776854
b	O	1	2	abstract	34776854
>	O	2	3	abstract	34776854
Background:</b	O	3	17	abstract	34776854
>	O	17	18	abstract	34776854
There	O	19	24	abstract	34776854
has	O	25	28	abstract	34776854
been	O	29	33	abstract	34776854
increasing	O	34	44	abstract	34776854
recognition	O	45	56	abstract	34776854
of	O	57	59	abstract	34776854
the	O	60	63	abstract	34776854
importance	O	64	74	abstract	34776854
of	O	75	77	abstract	34776854
the	O	78	81	abstract	34776854
gut	B-microbiome	82	85	abstract	34776854
microbiome	I-microbiome	86	96	abstract	34776854
in	O	97	99	abstract	34776854
Parkinson	B-DDF	100	109	abstract	34776854
's	I-DDF	109	111	abstract	34776854
disease	I-DDF	112	119	abstract	34776854
(	O	120	121	abstract	34776854
PD	B-DDF	121	123	abstract	34776854
)	O	123	124	abstract	34776854
,	O	124	125	abstract	34776854
but	O	126	129	abstract	34776854
the	O	130	133	abstract	34776854
influence	O	134	143	abstract	34776854
of	O	144	146	abstract	34776854
geographic	O	147	157	abstract	34776854
location	O	158	166	abstract	34776854
has	O	167	170	abstract	34776854
received	O	171	179	abstract	34776854
little	O	180	186	abstract	34776854
attention	O	187	196	abstract	34776854
.	O	196	197	abstract	34776854

The	O	198	201	abstract	34776854
present	O	202	209	abstract	34776854
study	O	210	215	abstract	34776854
characterized	O	216	229	abstract	34776854
the	O	230	233	abstract	34776854
gut	B-microbiome	234	237	abstract	34776854
microbiota	I-microbiome	238	248	abstract	34776854
and	O	249	252	abstract	34776854
associated	O	253	263	abstract	34776854
changes	O	264	271	abstract	34776854
in	O	272	274	abstract	34776854
host	O	275	279	abstract	34776854
metabolic	O	280	289	abstract	34776854
pathways	O	290	298	abstract	34776854
in	O	299	301	abstract	34776854
an	O	302	304	abstract	34776854
Australian	O	305	315	abstract	34776854
cohort	O	316	322	abstract	34776854
of	O	323	325	abstract	34776854
people	B-human	326	332	abstract	34776854
with	I-human	333	337	abstract	34776854
PD	I-human	338	340	abstract	34776854
(	O	341	342	abstract	34776854
PwP	B-human	342	345	abstract	34776854
)	O	345	346	abstract	34776854
.	O	346	347	abstract	34776854

<	O	348	349	abstract	34776854
b	O	349	350	abstract	34776854
>	O	350	351	abstract	34776854
Methods:</b	O	351	362	abstract	34776854
>	O	362	363	abstract	34776854
The	O	364	367	abstract	34776854
study	O	368	373	abstract	34776854
involved	O	374	382	abstract	34776854
recruitment	O	383	394	abstract	34776854
and	O	395	398	abstract	34776854
assessment	O	399	409	abstract	34776854
of	O	410	412	abstract	34776854
87	O	413	415	abstract	34776854
PwP	B-human	416	419	abstract	34776854
from	O	420	424	abstract	34776854
multiple	O	425	433	abstract	34776854
Movement	O	434	442	abstract	34776854
Disorders	O	443	452	abstract	34776854
Clinics	O	453	460	abstract	34776854
in	O	461	463	abstract	34776854
Australia	O	464	473	abstract	34776854
and	O	474	477	abstract	34776854
47	O	478	480	abstract	34776854
healthy	B-human	481	488	abstract	34776854
controls	I-human	489	497	abstract	34776854
.	O	497	498	abstract	34776854

Illumina	B-biomedical%technique	499	507	abstract	34776854
sequencing	I-biomedical%technique	508	518	abstract	34776854
of	O	519	521	abstract	34776854
the	O	522	525	abstract	34776854
V3	O	526	528	abstract	34776854
and	O	529	532	abstract	34776854
V4	O	533	535	abstract	34776854
regions	O	536	543	abstract	34776854
of	O	544	546	abstract	34776854
the	O	547	550	abstract	34776854
16S	B-gene	551	554	abstract	34776854
rRNA	I-gene	555	559	abstract	34776854
gene	I-gene	560	564	abstract	34776854
was	O	565	568	abstract	34776854
used	O	569	573	abstract	34776854
to	O	574	576	abstract	34776854
distinguish	O	577	588	abstract	34776854
inter-cohort	O	589	601	abstract	34776854
differences	O	602	613	abstract	34776854
in	O	614	616	abstract	34776854
gut	B-microbiome	617	620	abstract	34776854
microbiota	I-microbiome	621	631	abstract	34776854
;	O	631	632	abstract	34776854
KEGG	B-biomedical%technique	633	637	abstract	34776854
analysis	I-biomedical%technique	638	646	abstract	34776854
was	O	647	650	abstract	34776854
subsequently	O	651	663	abstract	34776854
performed	O	664	673	abstract	34776854
to	O	674	676	abstract	34776854
predict	O	677	684	abstract	34776854
functional	O	685	695	abstract	34776854
changes	O	696	703	abstract	34776854
in	O	704	706	abstract	34776854
host	O	707	711	abstract	34776854
metabolic	O	712	721	abstract	34776854
pathways	O	722	730	abstract	34776854
.	O	730	731	abstract	34776854

<	O	732	733	abstract	34776854
b	O	733	734	abstract	34776854
>	O	734	735	abstract	34776854
Results:</b	O	735	746	abstract	34776854
>	O	746	747	abstract	34776854
The	O	748	751	abstract	34776854
current	O	752	759	abstract	34776854
findings	O	760	768	abstract	34776854
identified	O	769	779	abstract	34776854
significant	O	780	791	abstract	34776854
differences	O	792	803	abstract	34776854
in	O	804	806	abstract	34776854
relative	O	807	815	abstract	34776854
abundance	O	816	825	abstract	34776854
and	O	826	829	abstract	34776854
diversity	O	830	839	abstract	34776854
of	O	840	842	abstract	34776854
microbial	O	843	852	abstract	34776854
operational	O	853	864	abstract	34776854
taxonomic	O	865	874	abstract	34776854
units	O	875	880	abstract	34776854
(	O	881	882	abstract	34776854
OTUs	O	882	886	abstract	34776854
)	O	886	887	abstract	34776854
,	O	887	888	abstract	34776854
and	O	889	892	abstract	34776854
specific	O	893	901	abstract	34776854
bacterial	O	902	911	abstract	34776854
taxa	O	912	916	abstract	34776854
between	O	917	924	abstract	34776854
PwP	B-human	925	928	abstract	34776854
and	O	929	932	abstract	34776854
control	B-human	933	940	abstract	34776854
groups	I-human	941	947	abstract	34776854
.	O	947	948	abstract	34776854

Alpha	O	949	954	abstract	34776854
diversity	O	955	964	abstract	34776854
was	O	965	968	abstract	34776854
significantly	O	969	982	abstract	34776854
reduced	O	983	990	abstract	34776854
in	O	991	993	abstract	34776854
PwP	B-human	994	997	abstract	34776854
when	O	998	1002	abstract	34776854
compared	O	1003	1011	abstract	34776854
to	O	1012	1014	abstract	34776854
controls	O	1015	1023	abstract	34776854
.	O	1023	1024	abstract	34776854

Differences	O	1025	1036	abstract	34776854
were	O	1037	1041	abstract	34776854
found	O	1042	1047	abstract	34776854
in	O	1048	1050	abstract	34776854
two	O	1051	1054	abstract	34776854
phyla	O	1055	1060	abstract	34776854
(	O	1061	1062	abstract	34776854
Synergistetes	B-bacteria	1062	1075	abstract	34776854
and	O	1076	1079	abstract	34776854
Proteobacteria	B-bacteria	1080	1094	abstract	34776854
;	O	1094	1095	abstract	34776854
both	O	1096	1100	abstract	34776854
increased	O	1101	1110	abstract	34776854
in	O	1111	1113	abstract	34776854
PwP	B-human	1114	1117	abstract	34776854
)	O	1117	1118	abstract	34776854
,	O	1118	1119	abstract	34776854
and	O	1120	1123	abstract	34776854
five	O	1124	1128	abstract	34776854
genera	O	1129	1135	abstract	34776854
(	O	1136	1137	abstract	34776854
C	O	1137	1138	abstract	34776854
<	O	1138	1139	abstract	34776854
i	O	1139	1140	abstract	34776854
>	O	1140	1141	abstract	34776854
olidextribacter	B-bacteria	1141	1156	abstract	34776854
,	O	1156	1157	abstract	34776854
Intestinibacter	B-bacteria	1158	1173	abstract	34776854
,	O	1173	1174	abstract	34776854
Kineothrix	B-bacteria	1175	1185	abstract	34776854
,	O	1185	1186	abstract	34776854
Agathobaculum</i	B-bacteria	1187	1203	abstract	34776854
>	O	1203	1204	abstract	34776854
,	O	1204	1205	abstract	34776854
and	O	1206	1209	abstract	34776854
<	O	1210	1211	abstract	34776854
i	O	1211	1212	abstract	34776854
>	O	1212	1213	abstract	34776854
Roseburia</i	B-bacteria	1213	1225	abstract	34776854
>	O	1225	1226	abstract	34776854
;	O	1226	1227	abstract	34776854
all	O	1228	1231	abstract	34776854
decreased	O	1232	1241	abstract	34776854
in	O	1242	1244	abstract	34776854
PwP	B-human	1245	1248	abstract	34776854
)	O	1248	1249	abstract	34776854
.	O	1249	1250	abstract	34776854

Within	O	1251	1257	abstract	34776854
the	O	1258	1261	abstract	34776854
PD	B-human	1262	1264	abstract	34776854
cohort	I-human	1265	1271	abstract	34776854
,	O	1271	1272	abstract	34776854
there	O	1273	1278	abstract	34776854
was	O	1279	1282	abstract	34776854
no	O	1283	1285	abstract	34776854
association	O	1286	1297	abstract	34776854
identified	O	1298	1308	abstract	34776854
between	O	1309	1316	abstract	34776854
microbial	O	1317	1326	abstract	34776854
composition	O	1327	1338	abstract	34776854
and	O	1339	1342	abstract	34776854
gender	O	1343	1349	abstract	34776854
,	O	1349	1350	abstract	34776854
constipation	B-DDF	1351	1363	abstract	34776854
or	O	1364	1366	abstract	34776854
use	O	1367	1370	abstract	34776854
of	O	1371	1373	abstract	34776854
gastrointestinal	O	1374	1390	abstract	34776854
medication	O	1391	1401	abstract	34776854
.	O	1401	1402	abstract	34776854

Furthermore	O	1403	1414	abstract	34776854
,	O	1414	1415	abstract	34776854
KEGG	B-biomedical%technique	1416	1420	abstract	34776854
analysis	I-biomedical%technique	1421	1429	abstract	34776854
identified	O	1430	1440	abstract	34776854
15	O	1441	1443	abstract	34776854
upregulated	O	1444	1455	abstract	34776854
and	O	1456	1459	abstract	34776854
11	O	1460	1462	abstract	34776854
downregulated	O	1463	1476	abstract	34776854
metabolic	O	1477	1486	abstract	34776854
pathways	O	1487	1495	abstract	34776854
which	O	1496	1501	abstract	34776854
were	O	1502	1506	abstract	34776854
predicted	O	1507	1516	abstract	34776854
to	O	1517	1519	abstract	34776854
be	O	1520	1522	abstract	34776854
significantly	O	1523	1536	abstract	34776854
altered	O	1537	1544	abstract	34776854
in	O	1545	1547	abstract	34776854
PwP.	B-human	1548	1552	abstract	34776854
<	O	1553	1554	abstract	34776854
b	O	1554	1555	abstract	34776854
>	O	1555	1556	abstract	34776854
Conclusion:</b	O	1556	1570	abstract	34776854
>	O	1570	1571	abstract	34776854
This	O	1572	1576	abstract	34776854
study	O	1577	1582	abstract	34776854
provides	O	1583	1591	abstract	34776854
the	O	1592	1595	abstract	34776854
first	O	1596	1601	abstract	34776854
comprehensive	O	1602	1615	abstract	34776854
characterization	O	1616	1632	abstract	34776854
of	O	1633	1635	abstract	34776854
the	O	1636	1639	abstract	34776854
gut	B-microbiome	1640	1643	abstract	34776854
microbiome	I-microbiome	1644	1654	abstract	34776854
and	O	1655	1658	abstract	34776854
predicted	O	1659	1668	abstract	34776854
functional	O	1669	1679	abstract	34776854
metabolic	O	1680	1689	abstract	34776854
effects	O	1690	1697	abstract	34776854
in	O	1698	1700	abstract	34776854
a	O	1701	1702	abstract	34776854
southern	B-human	1703	1711	abstract	34776854
hemisphere	I-human	1712	1722	abstract	34776854
PD	I-human	1723	1725	abstract	34776854
population	I-human	1726	1736	abstract	34776854
,	O	1736	1737	abstract	34776854
further	O	1738	1745	abstract	34776854
exploring	O	1746	1755	abstract	34776854
the	O	1756	1759	abstract	34776854
possible	O	1760	1768	abstract	34776854
mechanisms	O	1769	1779	abstract	34776854
whereby	O	1780	1787	abstract	34776854
the	O	1788	1791	abstract	34776854
gut	B-microbiome	1792	1795	abstract	34776854
microbiota	I-microbiome	1796	1806	abstract	34776854
may	O	1807	1810	abstract	34776854
exert	O	1811	1816	abstract	34776854
their	O	1817	1822	abstract	34776854
influence	O	1823	1832	abstract	34776854
on	O	1833	1835	abstract	34776854
this	O	1836	1840	abstract	34776854
disease	O	1841	1848	abstract	34776854
,	O	1848	1849	abstract	34776854
and	O	1850	1853	abstract	34776854
providing	O	1854	1863	abstract	34776854
evidence	O	1864	1872	abstract	34776854
for	O	1873	1876	abstract	34776854
the	O	1877	1880	abstract	34776854
incorporation	O	1881	1894	abstract	34776854
of	O	1895	1897	abstract	34776854
such	O	1898	1902	abstract	34776854
data	O	1903	1907	abstract	34776854
in	O	1908	1910	abstract	34776854
future	O	1911	1917	abstract	34776854
individualized	O	1918	1932	abstract	34776854
therapeutic	O	1933	1944	abstract	34776854
strategies	O	1945	1955	abstract	34776854
.	O	1955	1956	abstract	34776854

The	O	0	3	title	28976454
Gut	B-anatomical%location	4	7	title	28976454
and	O	8	11	title	28976454
Its	O	12	15	title	28976454
Microbiome	O	16	26	title	28976454
as	O	27	29	title	28976454
Related	O	30	37	title	28976454
to	O	38	40	title	28976454
Central	O	41	48	title	28976454
Nervous	O	49	56	title	28976454
System	O	57	63	title	28976454
Functioning	O	64	75	title	28976454
and	O	76	79	title	28976454
Psychological	O	80	93	title	28976454
Well-being	O	94	104	title	28976454
:	O	104	105	title	28976454
Introduction	O	106	118	title	28976454
to	O	119	121	title	28976454
the	O	122	125	title	28976454
Special	O	126	133	title	28976454
Issue	O	134	139	title	28976454
of	O	140	142	title	28976454
Psychosomatic	O	143	156	title	28976454
Medicine	O	157	165	title	28976454
.	O	165	166	title	28976454

Accumulating	O	0	12	abstract	28976454
evidence	O	13	21	abstract	28976454
indicates	O	22	31	abstract	28976454
bidirectional	O	32	45	abstract	28976454
associations	O	46	58	abstract	28976454
between	O	59	66	abstract	28976454
the	O	67	70	abstract	28976454
brain	B-anatomical%location	71	76	abstract	28976454
and	O	77	80	abstract	28976454
the	O	81	84	abstract	28976454
gut	B-microbiome	85	88	abstract	28976454
microbiome	I-microbiome	89	99	abstract	28976454
with	O	100	104	abstract	28976454
both	O	105	109	abstract	28976454
top-down	O	110	118	abstract	28976454
and	O	119	122	abstract	28976454
bottom-up	O	123	132	abstract	28976454
processes	O	133	142	abstract	28976454
.	O	142	143	abstract	28976454

This	O	144	148	abstract	28976454
article	O	149	156	abstract	28976454
describes	O	157	166	abstract	28976454
new	O	167	170	abstract	28976454
developments	O	171	183	abstract	28976454
in	O	184	186	abstract	28976454
brain-gut	O	187	196	abstract	28976454
interactions	O	197	209	abstract	28976454
as	O	210	212	abstract	28976454
an	O	213	215	abstract	28976454
introduction	O	216	228	abstract	28976454
to	O	229	231	abstract	28976454
a	O	232	233	abstract	28976454
special	O	234	241	abstract	28976454
issue	O	242	247	abstract	28976454
of	O	248	250	abstract	28976454
Psychosomatic	O	251	264	abstract	28976454
Medicine	O	265	273	abstract	28976454
,	O	273	274	abstract	28976454
based	O	275	280	abstract	28976454
on	O	281	283	abstract	28976454
a	O	284	285	abstract	28976454
joint	O	286	291	abstract	28976454
symposium	O	292	301	abstract	28976454
of	O	302	304	abstract	28976454
the	O	305	308	abstract	28976454
American	O	309	317	abstract	28976454
Psychosomatic	O	318	331	abstract	28976454
Society	O	332	339	abstract	28976454
and	O	340	343	abstract	28976454
the	O	344	347	abstract	28976454
American	O	348	356	abstract	28976454
Gastroenterological	O	357	376	abstract	28976454
Association	O	377	388	abstract	28976454
.	O	388	389	abstract	28976454

Literature	O	390	400	abstract	28976454
review	O	401	407	abstract	28976454
articles	O	408	416	abstract	28976454
indicate	O	417	425	abstract	28976454
that	O	426	430	abstract	28976454
several	O	431	438	abstract	28976454
psychiatric	B-DDF	439	450	abstract	28976454
disorders	I-DDF	451	460	abstract	28976454
are	O	461	464	abstract	28976454
associated	O	465	475	abstract	28976454
with	O	476	480	abstract	28976454
altered	O	481	488	abstract	28976454
gut	B-microbiome	489	492	abstract	28976454
microbiota	I-microbiome	493	503	abstract	28976454
,	O	503	504	abstract	28976454
whereas	O	505	512	abstract	28976454
evidence	O	513	521	abstract	28976454
linking	O	522	529	abstract	28976454
functional	B-DDF	530	540	abstract	28976454
gastrointestinal	I-DDF	541	557	abstract	28976454
disorders	I-DDF	558	567	abstract	28976454
and	O	568	571	abstract	28976454
dysbiosis	B-DDF	572	581	abstract	28976454
has	O	582	585	abstract	28976454
not	O	586	589	abstract	28976454
been	O	590	594	abstract	28976454
firmly	O	595	601	abstract	28976454
established	O	602	613	abstract	28976454
.	O	613	614	abstract	28976454

The	O	615	618	abstract	28976454
association	O	619	630	abstract	28976454
between	O	631	638	abstract	28976454
dysbiosis	B-DDF	639	648	abstract	28976454
with	O	649	653	abstract	28976454
obesity	B-DDF	654	661	abstract	28976454
,	O	661	662	abstract	28976454
metabolic	B-DDF	663	672	abstract	28976454
syndrome	I-DDF	673	681	abstract	28976454
,	O	681	682	abstract	28976454
and	O	683	686	abstract	28976454
Type	B-DDF	687	691	abstract	28976454
2	I-DDF	692	693	abstract	28976454
diabetes	I-DDF	694	702	abstract	28976454
mellitus	I-DDF	703	711	abstract	28976454
is	O	712	714	abstract	28976454
still	O	715	720	abstract	28976454
inconclusive	O	721	733	abstract	28976454
,	O	733	734	abstract	28976454
but	O	735	738	abstract	28976454
evidence	O	739	747	abstract	28976454
suggests	O	748	756	abstract	28976454
that	O	757	761	abstract	28976454
bariatric	O	762	771	abstract	28976454
surgery	O	772	779	abstract	28976454
may	O	780	783	abstract	28976454
favorably	O	784	793	abstract	28976454
alter	O	794	799	abstract	28976454
the	O	800	803	abstract	28976454
gut	O	804	807	abstract	28976454
microbial	O	808	817	abstract	28976454
community	O	818	827	abstract	28976454
structure	O	828	837	abstract	28976454
.	O	837	838	abstract	28976454

Consistent	O	839	849	abstract	28976454
with	O	850	854	abstract	28976454
the	O	855	858	abstract	28976454
literature	O	859	869	abstract	28976454
linking	O	870	877	abstract	28976454
psychiatric	B-DDF	878	889	abstract	28976454
disorders	I-DDF	890	899	abstract	28976454
with	O	900	904	abstract	28976454
dysbiosis	B-DDF	905	914	abstract	28976454
is	O	915	917	abstract	28976454
that	O	918	922	abstract	28976454
life	O	923	927	abstract	28976454
adversity	O	928	937	abstract	28976454
during	O	938	944	abstract	28976454
childhood	O	945	954	abstract	28976454
and	O	955	958	abstract	28976454
certain	O	959	966	abstract	28976454
temperaments	O	967	979	abstract	28976454
that	O	980	984	abstract	28976454
develop	O	985	992	abstract	28976454
early	O	993	998	abstract	28976454
in	O	999	1001	abstract	28976454
life	O	1002	1006	abstract	28976454
are	O	1007	1010	abstract	28976454
associated	O	1011	1021	abstract	28976454
with	O	1022	1026	abstract	28976454
altered	O	1027	1034	abstract	28976454
gut	B-microbiome	1035	1038	abstract	28976454
microbiota	I-microbiome	1039	1049	abstract	28976454
,	O	1049	1050	abstract	28976454
particularly	O	1051	1063	abstract	28976454
the	O	1064	1067	abstract	28976454
Prevotella	B-bacteria	1068	1078	abstract	28976454
species	I-bacteria	1079	1086	abstract	28976454
.	O	1086	1087	abstract	28976454

Some	O	1088	1092	abstract	28976454
studies	O	1093	1100	abstract	28976454
reported	O	1101	1109	abstract	28976454
in	O	1110	1112	abstract	28976454
this	O	1113	1117	abstract	28976454
issue	O	1118	1123	abstract	28976454
support	O	1124	1131	abstract	28976454
the	O	1132	1135	abstract	28976454
hypothesis	O	1136	1146	abstract	28976454
that	O	1147	1151	abstract	28976454
brain-gut	O	1152	1161	abstract	28976454
interactions	O	1162	1174	abstract	28976454
are	O	1175	1178	abstract	28976454
adversely	O	1179	1188	abstract	28976454
influenced	O	1189	1199	abstract	28976454
by	O	1200	1202	abstract	28976454
reduced	O	1203	1210	abstract	28976454
functional	O	1211	1221	abstract	28976454
activation	O	1222	1232	abstract	28976454
of	O	1233	1235	abstract	28976454
the	O	1236	1239	abstract	28976454
hippocampus	B-anatomical%location	1240	1251	abstract	28976454
and	O	1252	1255	abstract	28976454
autonomic	O	1256	1265	abstract	28976454
nervous	O	1266	1273	abstract	28976454
system	O	1274	1280	abstract	28976454
dysregulation	O	1281	1294	abstract	28976454
.	O	1294	1295	abstract	28976454

The	O	1296	1299	abstract	28976454
evidence	O	1300	1308	abstract	28976454
for	O	1309	1312	abstract	28976454
the	O	1313	1316	abstract	28976454
effects	O	1317	1324	abstract	28976454
of	O	1325	1327	abstract	28976454
probiotics	B-dietary%supplement	1328	1338	abstract	28976454
in	O	1339	1341	abstract	28976454
the	O	1342	1345	abstract	28976454
treatment	O	1346	1355	abstract	28976454
of	O	1356	1358	abstract	28976454
Clostridium	B-DDF	1359	1370	abstract	28976454
difficile	I-DDF	1371	1380	abstract	28976454
colitis	I-DDF	1381	1388	abstract	28976454
is	O	1389	1391	abstract	28976454
relatively	O	1392	1402	abstract	28976454
well	O	1403	1407	abstract	28976454
established	O	1408	1419	abstract	28976454
,	O	1419	1420	abstract	28976454
but	O	1421	1424	abstract	28976454
effects	O	1425	1432	abstract	28976454
on	O	1433	1435	abstract	28976454
mental	O	1436	1442	abstract	28976454
health	O	1443	1449	abstract	28976454
and	O	1450	1453	abstract	28976454
psychophysiological	O	1454	1473	abstract	28976454
stress	O	1474	1480	abstract	28976454
reactivity	O	1481	1491	abstract	28976454
are	O	1492	1495	abstract	28976454
either	O	1496	1502	abstract	28976454
inconclusive	O	1503	1515	abstract	28976454
or	O	1516	1518	abstract	28976454
still	O	1519	1524	abstract	28976454
in	O	1525	1527	abstract	28976454
progress	O	1528	1536	abstract	28976454
.	O	1536	1537	abstract	28976454

To	O	1538	1540	abstract	28976454
conceptualize	O	1541	1554	abstract	28976454
brain-gut	O	1555	1564	abstract	28976454
interactions	O	1565	1577	abstract	28976454
,	O	1577	1578	abstract	28976454
a	O	1579	1580	abstract	28976454
holistic	O	1581	1589	abstract	28976454
,	O	1589	1590	abstract	28976454
systems-based	O	1591	1604	abstract	28976454
perspective	O	1605	1616	abstract	28976454
on	O	1617	1619	abstract	28976454
health	O	1620	1626	abstract	28976454
and	O	1627	1630	abstract	28976454
disease	O	1631	1638	abstract	28976454
is	O	1639	1641	abstract	28976454
needed	O	1642	1648	abstract	28976454
,	O	1648	1649	abstract	28976454
integrating	O	1650	1661	abstract	28976454
gut	B-microbiome	1662	1665	abstract	28976454
microbial	I-microbiome	1666	1675	abstract	28976454
with	O	1676	1680	abstract	28976454
environmental	O	1681	1694	abstract	28976454
ecology	O	1695	1702	abstract	28976454
.	O	1702	1703	abstract	28976454

More	O	1704	1708	abstract	28976454
translational	O	1709	1722	abstract	28976454
research	O	1723	1731	abstract	28976454
is	O	1732	1734	abstract	28976454
needed	O	1735	1741	abstract	28976454
to	O	1742	1744	abstract	28976454
examine	O	1745	1752	abstract	28976454
the	O	1753	1756	abstract	28976454
mental	O	1757	1763	abstract	28976454
and	O	1764	1767	abstract	28976454
physical	O	1768	1776	abstract	28976454
health	O	1777	1783	abstract	28976454
effects	O	1784	1791	abstract	28976454
of	O	1792	1794	abstract	28976454
prebiotics	B-dietary%supplement	1795	1805	abstract	28976454
and	O	1806	1809	abstract	28976454
probiotics	B-dietary%supplement	1810	1820	abstract	28976454
,	O	1820	1821	abstract	28976454
in	O	1822	1824	abstract	28976454
well-phenotyped	O	1825	1840	abstract	28976454
human	O	1841	1846	abstract	28976454
populations	O	1847	1858	abstract	28976454
with	O	1859	1863	abstract	28976454
sufficiently	O	1864	1876	abstract	28976454
large	O	1877	1882	abstract	28976454
sample	O	1883	1889	abstract	28976454
sizes	O	1890	1895	abstract	28976454
.	O	1895	1896	abstract	28976454

Gender	O	0	6	title	31053995
specific	O	7	15	title	31053995
decrease	O	16	24	title	31053995
of	O	25	27	title	31053995
a	O	28	29	title	31053995
set	O	30	33	title	31053995
of	O	34	36	title	31053995
circulating	O	37	48	title	31053995
N-acylphosphatidyl	B-chemical	49	67	title	31053995
ethanolamines	I-chemical	68	81	title	31053995
(	O	82	83	title	31053995
NAPEs	B-chemical	83	88	title	31053995
)	O	88	89	title	31053995
in	O	90	92	title	31053995
the	O	93	96	title	31053995
plasma	O	97	103	title	31053995
of	O	104	106	title	31053995
Parkinson	B-human	107	116	title	31053995
's	I-human	116	118	title	31053995
disease	I-human	119	126	title	31053995
patients	I-human	127	135	title	31053995
.	O	135	136	title	31053995

Current	O	0	7	abstract	31053995
markers	O	8	15	abstract	31053995
of	O	16	18	abstract	31053995
Parkinson	B-DDF	19	28	abstract	31053995
's	I-DDF	28	30	abstract	31053995
disease	I-DDF	31	38	abstract	31053995
(	O	39	40	abstract	31053995
PD	B-DDF	40	42	abstract	31053995
)	O	42	43	abstract	31053995
fail	O	44	48	abstract	31053995
to	O	49	51	abstract	31053995
detect	O	52	58	abstract	31053995
the	O	59	62	abstract	31053995
early	O	63	68	abstract	31053995
progression	O	69	80	abstract	31053995
of	O	81	83	abstract	31053995
disease	O	84	91	abstract	31053995
state	O	92	97	abstract	31053995
.	O	97	98	abstract	31053995

Conversely	O	99	109	abstract	31053995
,	O	109	110	abstract	31053995
current	O	111	118	abstract	31053995
omics	B-biomedical%technique	119	124	abstract	31053995
techniques	I-biomedical%technique	125	135	abstract	31053995
allow	O	136	141	abstract	31053995
the	O	142	145	abstract	31053995
investigation	O	146	159	abstract	31053995
of	O	160	162	abstract	31053995
hundreds	O	163	171	abstract	31053995
of	O	172	174	abstract	31053995
molecules	O	175	184	abstract	31053995
potentially	O	185	196	abstract	31053995
altered	O	197	204	abstract	31053995
by	O	205	207	abstract	31053995
disease	O	208	215	abstract	31053995
conditions	O	216	226	abstract	31053995
.	O	226	227	abstract	31053995

Based	O	228	233	abstract	31053995
on	O	234	236	abstract	31053995
evidence	O	237	245	abstract	31053995
previously	O	246	256	abstract	31053995
collected	O	257	266	abstract	31053995
by	O	267	269	abstract	31053995
our	O	270	273	abstract	31053995
group	O	274	279	abstract	31053995
in	O	280	282	abstract	31053995
a	O	283	284	abstract	31053995
mouse	O	285	290	abstract	31053995
model	O	291	296	abstract	31053995
of	O	297	299	abstract	31053995
PD	B-DDF	300	302	abstract	31053995
,	O	302	303	abstract	31053995
we	O	304	306	abstract	31053995
speculated	O	307	317	abstract	31053995
that	O	318	322	abstract	31053995
a	O	323	324	abstract	31053995
particular	O	325	335	abstract	31053995
set	O	336	339	abstract	31053995
of	O	340	342	abstract	31053995
circulating	B-chemical	343	354	abstract	31053995
lipids	I-chemical	355	361	abstract	31053995
might	O	362	367	abstract	31053995
be	O	368	370	abstract	31053995
significantly	O	371	384	abstract	31053995
altered	O	385	392	abstract	31053995
by	O	393	395	abstract	31053995
the	O	396	399	abstract	31053995
pathology	O	400	409	abstract	31053995
.	O	409	410	abstract	31053995

The	O	411	414	abstract	31053995
aim	O	415	418	abstract	31053995
of	O	419	421	abstract	31053995
current	O	422	429	abstract	31053995
study	O	430	435	abstract	31053995
was	O	436	439	abstract	31053995
to	O	440	442	abstract	31053995
evaluate	O	443	451	abstract	31053995
the	O	452	455	abstract	31053995
potential	O	456	465	abstract	31053995
of	O	466	468	abstract	31053995
a	O	469	470	abstract	31053995
particular	O	471	481	abstract	31053995
set	O	482	485	abstract	31053995
of	O	486	488	abstract	31053995
N-acyl-phosphatidylethanolamines	B-chemical	489	521	abstract	31053995
(	O	522	523	abstract	31053995
NAPEs	B-chemical	523	528	abstract	31053995
)	O	528	529	abstract	31053995
as	O	530	532	abstract	31053995
potential	O	533	542	abstract	31053995
non-invasive	O	543	555	abstract	31053995
plasma	O	556	562	abstract	31053995
markers	O	563	570	abstract	31053995
of	O	571	573	abstract	31053995
ongoing	O	574	581	abstract	31053995
neurodegeneration	O	582	599	abstract	31053995
from	O	600	604	abstract	31053995
Parkinson	B-DDF	605	614	abstract	31053995
's	I-DDF	614	616	abstract	31053995
disease	I-DDF	617	624	abstract	31053995
in	O	625	627	abstract	31053995
human	B-human	628	633	abstract	31053995
subjects	I-human	634	642	abstract	31053995
.	O	642	643	abstract	31053995

A	O	644	645	abstract	31053995
panel	O	646	651	abstract	31053995
of	O	652	654	abstract	31053995
seven	O	655	660	abstract	31053995
NAPEs	B-chemical	661	666	abstract	31053995
were	O	667	671	abstract	31053995
quantified	O	672	682	abstract	31053995
by	O	683	685	abstract	31053995
LC-MS/MS	B-biomedical%technique	686	694	abstract	31053995
in	O	695	697	abstract	31053995
the	O	698	701	abstract	31053995
plasma	O	702	708	abstract	31053995
of	O	709	711	abstract	31053995
587	O	712	715	abstract	31053995
individuals	B-human	716	727	abstract	31053995
(	O	728	729	abstract	31053995
healthy	B-human	729	736	abstract	31053995
controls	I-human	737	745	abstract	31053995
,	O	745	746	abstract	31053995
n	O	747	748	abstract	31053995
	O	748	749	abstract	31053995
=	O	749	750	abstract	31053995
	O	750	751	abstract	31053995
319	O	751	754	abstract	31053995
;	O	754	755	abstract	31053995
Parkinson	B-DDF	756	765	abstract	31053995
's	I-DDF	765	767	abstract	31053995
disease	I-DDF	768	775	abstract	31053995
,	O	775	776	abstract	31053995
n	O	777	778	abstract	31053995
	O	778	779	abstract	31053995
=	O	779	780	abstract	31053995
	O	780	781	abstract	31053995
268	O	781	784	abstract	31053995
)	O	784	785	abstract	31053995
;	O	785	786	abstract	31053995
Random	B-statistical%technique	787	793	abstract	31053995
Forest	I-statistical%technique	794	800	abstract	31053995
classification	I-statistical%technique	801	815	abstract	31053995
and	O	816	819	abstract	31053995
statistical	O	820	831	abstract	31053995
modeling	O	832	840	abstract	31053995
was	O	841	844	abstract	31053995
applied	O	845	852	abstract	31053995
to	O	853	855	abstract	31053995
compare	O	856	863	abstract	31053995
Parkinson	B-DDF	864	873	abstract	31053995
's	I-DDF	873	875	abstract	31053995
disease	I-DDF	876	883	abstract	31053995
versus	O	884	890	abstract	31053995
controls	B-human	891	899	abstract	31053995
.	O	899	900	abstract	31053995

All	O	901	904	abstract	31053995
p-values	O	905	913	abstract	31053995
obtained	O	914	922	abstract	31053995
in	O	923	925	abstract	31053995
different	O	926	935	abstract	31053995
tests	O	936	941	abstract	31053995
were	O	942	946	abstract	31053995
corrected	O	947	956	abstract	31053995
for	O	957	960	abstract	31053995
multiplicity	O	961	973	abstract	31053995
by	O	974	976	abstract	31053995
controlling	O	977	988	abstract	31053995
the	O	989	992	abstract	31053995
false	B-statistical%technique	993	998	abstract	31053995
discovery	I-statistical%technique	999	1008	abstract	31053995
rate	I-statistical%technique	1009	1013	abstract	31053995
(	I-statistical%technique	1014	1015	abstract	31053995
FDR	I-statistical%technique	1015	1018	abstract	31053995
)	I-statistical%technique	1018	1019	abstract	31053995
.	O	1019	1020	abstract	31053995

The	O	1021	1024	abstract	31053995
results	O	1025	1032	abstract	31053995
indicate	O	1033	1041	abstract	31053995
that	O	1042	1046	abstract	31053995
this	O	1047	1051	abstract	31053995
panel	O	1052	1057	abstract	31053995
of	O	1058	1060	abstract	31053995
NAPEs	B-chemical	1061	1066	abstract	31053995
is	O	1067	1069	abstract	31053995
able	O	1070	1074	abstract	31053995
to	O	1075	1077	abstract	31053995
distinguish	O	1078	1089	abstract	31053995
female	B-human	1090	1096	abstract	31053995
PD	I-human	1097	1099	abstract	31053995
patients	I-human	1100	1108	abstract	31053995
from	O	1109	1113	abstract	31053995
the	O	1114	1117	abstract	31053995
corresponding	O	1118	1131	abstract	31053995
healthy	B-human	1132	1139	abstract	31053995
controls	I-human	1140	1148	abstract	31053995
.	O	1148	1149	abstract	31053995

Further	O	1150	1157	abstract	31053995
to	O	1158	1160	abstract	31053995
this	O	1161	1165	abstract	31053995
,	O	1165	1166	abstract	31053995
the	O	1167	1170	abstract	31053995
observed	O	1171	1179	abstract	31053995
downregulation	O	1180	1194	abstract	31053995
of	O	1195	1197	abstract	31053995
these	O	1198	1203	abstract	31053995
NAPEs	B-chemical	1204	1209	abstract	31053995
is	O	1210	1212	abstract	31053995
in	O	1213	1215	abstract	31053995
line	O	1216	1220	abstract	31053995
with	O	1221	1225	abstract	31053995
the	O	1226	1229	abstract	31053995
results	O	1230	1237	abstract	31053995
in	O	1238	1240	abstract	31053995
plasma	O	1241	1247	abstract	31053995
of	O	1248	1250	abstract	31053995
a	O	1251	1252	abstract	31053995
mouse	O	1253	1258	abstract	31053995
model	O	1259	1264	abstract	31053995
of	O	1265	1267	abstract	31053995
Parkinson	B-DDF	1268	1277	abstract	31053995
's	I-DDF	1277	1279	abstract	31053995
(	O	1280	1281	abstract	31053995
6-OHDA	B-animal	1281	1287	abstract	31053995
)	O	1287	1288	abstract	31053995
.	O	1288	1289	abstract	31053995

In	O	1290	1292	abstract	31053995
the	O	1293	1296	abstract	31053995
current	O	1297	1304	abstract	31053995
study	O	1305	1310	abstract	31053995
we	O	1311	1313	abstract	31053995
have	O	1314	1318	abstract	31053995
shown	O	1319	1324	abstract	31053995
the	O	1325	1328	abstract	31053995
downregulation	O	1329	1343	abstract	31053995
of	O	1344	1346	abstract	31053995
NAPEs	B-chemical	1347	1352	abstract	31053995
in	O	1353	1355	abstract	31053995
plasma	O	1356	1362	abstract	31053995
of	O	1363	1365	abstract	31053995
PD	B-human	1366	1368	abstract	31053995
patients	I-human	1369	1377	abstract	31053995
and	O	1378	1381	abstract	31053995
we	O	1382	1384	abstract	31053995
thus	O	1385	1389	abstract	31053995
speculate	O	1390	1399	abstract	31053995
that	O	1400	1404	abstract	31053995
these	O	1405	1410	abstract	31053995
lipids	B-chemical	1411	1417	abstract	31053995
might	O	1418	1423	abstract	31053995
serve	O	1424	1429	abstract	31053995
as	O	1430	1432	abstract	31053995
candidate	O	1433	1442	abstract	31053995
biomarkers	O	1443	1453	abstract	31053995
for	O	1454	1457	abstract	31053995
PD	B-DDF	1458	1460	abstract	31053995
.	O	1460	1461	abstract	31053995

We	O	1462	1464	abstract	31053995
also	O	1465	1469	abstract	31053995
suggest	O	1470	1477	abstract	31053995
a	O	1478	1479	abstract	31053995
molecular	O	1480	1489	abstract	31053995
mechanism	O	1490	1499	abstract	31053995
,	O	1499	1500	abstract	31053995
explaining	O	1501	1511	abstract	31053995
our	O	1512	1515	abstract	31053995
findings	O	1516	1524	abstract	31053995
,	O	1524	1525	abstract	31053995
which	O	1526	1531	abstract	31053995
involves	O	1532	1540	abstract	31053995
gut	B-microbiome	1541	1544	abstract	31053995
microbiota	I-microbiome	1545	1555	abstract	31053995
.	O	1555	1556	abstract	31053995

Bipolar	B-DDF	0	7	title	38576868
disorder	I-DDF	8	16	title	38576868
and	O	17	20	title	38576868
the	O	21	24	title	38576868
gut	B-microbiome	25	28	title	38576868
microbiota	I-microbiome	29	39	title	38576868
:	O	39	40	title	38576868
a	O	41	42	title	38576868
bibliometric	O	43	55	title	38576868
analysis	O	56	64	title	38576868
.	O	64	65	title	38576868

Previous	O	0	8	abstract	38576868
studies	O	9	16	abstract	38576868
have	O	17	21	abstract	38576868
explored	O	22	30	abstract	38576868
the	O	31	34	abstract	38576868
relationship	O	35	47	abstract	38576868
between	O	48	55	abstract	38576868
bipolar	B-DDF	56	63	abstract	38576868
disorder	I-DDF	64	72	abstract	38576868
and	O	73	76	abstract	38576868
gut	B-microbiome	77	80	abstract	38576868
microbiota	I-microbiome	81	91	abstract	38576868
.	O	91	92	abstract	38576868

However	O	93	100	abstract	38576868
,	O	100	101	abstract	38576868
there	O	102	107	abstract	38576868
has	O	108	111	abstract	38576868
been	O	112	116	abstract	38576868
no	O	117	119	abstract	38576868
bibliometric	O	120	132	abstract	38576868
analysis	O	133	141	abstract	38576868
to	O	142	144	abstract	38576868
summarize	O	145	154	abstract	38576868
and	O	155	158	abstract	38576868
analyze	O	159	166	abstract	38576868
these	O	167	172	abstract	38576868
publications	O	173	185	abstract	38576868
.	O	185	186	abstract	38576868

Our	O	187	190	abstract	38576868
objective	O	191	200	abstract	38576868
was	O	201	204	abstract	38576868
to	O	205	207	abstract	38576868
perform	O	208	215	abstract	38576868
a	O	216	217	abstract	38576868
bibliometric	O	218	230	abstract	38576868
analysis	O	231	239	abstract	38576868
to	O	240	242	abstract	38576868
investigate	O	243	254	abstract	38576868
the	O	255	258	abstract	38576868
current	O	259	266	abstract	38576868
status	O	267	273	abstract	38576868
and	O	274	277	abstract	38576868
frontiers	O	278	287	abstract	38576868
of	O	288	290	abstract	38576868
the	O	291	294	abstract	38576868
publications	O	295	307	abstract	38576868
in	O	308	310	abstract	38576868
the	O	311	314	abstract	38576868
field	O	315	320	abstract	38576868
of	O	321	323	abstract	38576868
the	O	324	327	abstract	38576868
association	O	328	339	abstract	38576868
between	O	340	347	abstract	38576868
bipolar	B-DDF	348	355	abstract	38576868
disorder	I-DDF	356	364	abstract	38576868
and	O	365	368	abstract	38576868
the	O	369	372	abstract	38576868
gut	B-microbiome	373	376	abstract	38576868
microbiota	I-microbiome	377	387	abstract	38576868
.	O	387	388	abstract	38576868

We	O	389	391	abstract	38576868
retrieved	O	392	401	abstract	38576868
publications	O	402	414	abstract	38576868
concerning	O	415	425	abstract	38576868
the	O	426	429	abstract	38576868
interplay	O	430	439	abstract	38576868
between	O	440	447	abstract	38576868
the	O	448	451	abstract	38576868
gut	B-microbiome	452	455	abstract	38576868
microbiota	I-microbiome	456	466	abstract	38576868
and	O	467	470	abstract	38576868
bipolar	B-DDF	471	478	abstract	38576868
disorder	I-DDF	479	487	abstract	38576868
from	O	488	492	abstract	38576868
the	O	493	496	abstract	38576868
Web	O	497	500	abstract	38576868
of	O	501	503	abstract	38576868
Science	O	504	511	abstract	38576868
Core	O	512	516	abstract	38576868
Collection	O	517	527	abstract	38576868
(	O	528	529	abstract	38576868
WoSCC	O	529	534	abstract	38576868
)	O	534	535	abstract	38576868
.	O	535	536	abstract	38576868

The	O	537	540	abstract	38576868
analysis	O	541	549	abstract	38576868
was	O	550	553	abstract	38576868
executed	O	554	562	abstract	38576868
using	O	563	568	abstract	38576868
WoSCC	O	569	574	abstract	38576868
's	O	574	576	abstract	38576868
literature	O	577	587	abstract	38576868
analysis	O	588	596	abstract	38576868
tool	O	597	601	abstract	38576868
and	O	602	605	abstract	38576868
VOSviewer	O	606	615	abstract	38576868
1.6.16	O	616	622	abstract	38576868
.	O	622	623	abstract	38576868

In	O	624	626	abstract	38576868
total	O	627	632	abstract	38576868
,	O	632	633	abstract	38576868
we	O	634	636	abstract	38576868
identified	O	637	647	abstract	38576868
177	O	648	651	abstract	38576868
publications	O	652	664	abstract	38576868
originating	O	665	676	abstract	38576868
from	O	677	681	abstract	38576868
362	O	682	685	abstract	38576868
institutions	O	686	698	abstract	38576868
across	O	699	705	abstract	38576868
39	O	706	708	abstract	38576868
countries/regions	O	709	726	abstract	38576868
,	O	726	727	abstract	38576868
and	O	728	731	abstract	38576868
these	O	732	737	abstract	38576868
articles	O	738	746	abstract	38576868
were	O	747	751	abstract	38576868
disseminated	O	752	764	abstract	38576868
in	O	765	767	abstract	38576868
104	O	768	771	abstract	38576868
different	O	772	781	abstract	38576868
journals	O	782	790	abstract	38576868
.	O	790	791	abstract	38576868

The	O	792	795	abstract	38576868
most	O	796	800	abstract	38576868
productive	O	801	811	abstract	38576868
institutions	O	812	824	abstract	38576868
,	O	824	825	abstract	38576868
authors	O	826	833	abstract	38576868
,	O	833	834	abstract	38576868
countries/regions	O	835	852	abstract	38576868
,	O	852	853	abstract	38576868
and	O	854	857	abstract	38576868
journals	O	858	866	abstract	38576868
were	O	867	871	abstract	38576868
Zhejiang	O	872	880	abstract	38576868
University	O	881	891	abstract	38576868
contributing	O	892	904	abstract	38576868
18	O	905	907	abstract	38576868
publications	O	908	920	abstract	38576868
,	O	920	921	abstract	38576868
Shaohua	O	922	929	abstract	38576868
Hu	O	930	932	abstract	38576868
authoring	O	933	942	abstract	38576868
12	O	943	945	abstract	38576868
publications	O	946	958	abstract	38576868
,	O	958	959	abstract	38576868
China	O	960	965	abstract	38576868
with	O	966	970	abstract	38576868
53	O	971	973	abstract	38576868
publications	O	974	986	abstract	38576868
,	O	986	987	abstract	38576868
and	O	988	991	abstract	38576868
<	O	992	993	abstract	38576868
i	O	993	994	abstract	38576868
>	O	994	995	abstract	38576868
Frontiers	O	995	1004	abstract	38576868
in	O	1005	1007	abstract	38576868
Psychiatry</i	O	1008	1021	abstract	38576868
>	O	1021	1022	abstract	38576868
with	O	1023	1027	abstract	38576868
11	O	1028	1030	abstract	38576868
publications	O	1031	1043	abstract	38576868
.	O	1043	1044	abstract	38576868

The	O	1045	1048	abstract	38576868
first	O	1049	1054	abstract	38576868
high-cited	O	1055	1065	abstract	38576868
document	O	1066	1074	abstract	38576868
was	O	1075	1078	abstract	38576868
published	O	1079	1088	abstract	38576868
in	O	1089	1091	abstract	38576868
the	O	1092	1095	abstract	38576868
Journal	O	1096	1103	abstract	38576868
of	O	1104	1106	abstract	38576868
Psychiatric	O	1107	1118	abstract	38576868
Research	O	1119	1127	abstract	38576868
in	O	1128	1130	abstract	38576868
2017	O	1131	1135	abstract	38576868
,	O	1135	1136	abstract	38576868
and	O	1137	1140	abstract	38576868
authored	O	1141	1149	abstract	38576868
by	O	1150	1152	abstract	38576868
Evans	O	1153	1158	abstract	38576868
.	O	1158	1159	abstract	38576868

In	O	1160	1162	abstract	38576868
this	O	1163	1167	abstract	38576868
article	O	1168	1175	abstract	38576868
,	O	1175	1176	abstract	38576868
they	O	1177	1181	abstract	38576868
found	O	1182	1187	abstract	38576868
gut	O	1188	1191	abstract	38576868
microbiome	O	1192	1202	abstract	38576868
composition	O	1203	1214	abstract	38576868
was	O	1215	1218	abstract	38576868
associated	O	1219	1229	abstract	38576868
with	O	1230	1234	abstract	38576868
BD	B-DDF	1235	1237	abstract	38576868
and	O	1238	1241	abstract	38576868
its	O	1242	1245	abstract	38576868
illness	O	1246	1253	abstract	38576868
severity	O	1254	1262	abstract	38576868
,	O	1262	1263	abstract	38576868
and	O	1264	1267	abstract	38576868
they	O	1268	1272	abstract	38576868
concluded	O	1273	1282	abstract	38576868
that	O	1283	1287	abstract	38576868
targeting	O	1288	1297	abstract	38576868
the	O	1298	1301	abstract	38576868
gut	B-microbiome	1302	1305	abstract	38576868
microbiota	I-microbiome	1306	1316	abstract	38576868
may	O	1317	1320	abstract	38576868
be	O	1321	1323	abstract	38576868
helpful	O	1324	1331	abstract	38576868
to	O	1332	1334	abstract	38576868
develop	O	1335	1342	abstract	38576868
the	O	1343	1346	abstract	38576868
effective	O	1347	1356	abstract	38576868
treatment	O	1357	1366	abstract	38576868
for	O	1367	1370	abstract	38576868
bipolar	B-DDF	1371	1378	abstract	38576868
disorder	I-DDF	1379	1387	abstract	38576868
.	O	1387	1388	abstract	38576868

The	O	1389	1392	abstract	38576868
top	O	1393	1396	abstract	38576868
5	O	1397	1398	abstract	38576868
keywords	O	1399	1407	abstract	38576868
with	O	1408	1412	abstract	38576868
the	O	1413	1416	abstract	38576868
highest	O	1417	1424	abstract	38576868
frequency	O	1425	1434	abstract	38576868
except	O	1435	1441	abstract	38576868
for	O	1442	1445	abstract	38576868
bipolar	B-DDF	1446	1453	abstract	38576868
disorder	I-DDF	1454	1462	abstract	38576868
and	O	1463	1466	abstract	38576868
gut	B-microbiome	1467	1470	abstract	38576868
microbiota	I-microbiome	1471	1481	abstract	38576868
were	O	1482	1486	abstract	38576868
as	O	1487	1489	abstract	38576868
follows	O	1490	1497	abstract	38576868
:	O	1497	1498	abstract	38576868
depression	B-DDF	1499	1509	abstract	38576868
,	O	1509	1510	abstract	38576868
inflammation	B-DDF	1511	1523	abstract	38576868
,	O	1523	1524	abstract	38576868
probiotic	B-dietary%supplement	1525	1534	abstract	38576868
,	O	1534	1535	abstract	38576868
gut-brain	O	1536	1545	abstract	38576868
axis	O	1546	1550	abstract	38576868
,	O	1550	1551	abstract	38576868
and	O	1552	1555	abstract	38576868
anxiety	B-DDF	1556	1563	abstract	38576868
.	O	1563	1564	abstract	38576868

In	O	1565	1567	abstract	38576868
conclusion	O	1568	1578	abstract	38576868
,	O	1578	1579	abstract	38576868
this	O	1580	1584	abstract	38576868
is	O	1585	1587	abstract	38576868
the	O	1588	1591	abstract	38576868
first	O	1592	1597	abstract	38576868
bibliometric	O	1598	1610	abstract	38576868
analysis	O	1611	1619	abstract	38576868
to	O	1620	1622	abstract	38576868
explore	O	1623	1630	abstract	38576868
the	O	1631	1634	abstract	38576868
publications	O	1635	1647	abstract	38576868
in	O	1648	1650	abstract	38576868
the	O	1651	1654	abstract	38576868
field	O	1655	1660	abstract	38576868
of	O	1661	1663	abstract	38576868
the	O	1664	1667	abstract	38576868
association	O	1668	1679	abstract	38576868
between	O	1680	1687	abstract	38576868
bipolar	B-DDF	1688	1695	abstract	38576868
disorder	I-DDF	1696	1704	abstract	38576868
and	O	1705	1708	abstract	38576868
the	O	1709	1712	abstract	38576868
gut	B-microbiome	1713	1716	abstract	38576868
microbiota	I-microbiome	1717	1727	abstract	38576868
.	O	1727	1728	abstract	38576868

The	O	1729	1732	abstract	38576868
main	O	1733	1737	abstract	38576868
research	O	1738	1746	abstract	38576868
hotspots	O	1747	1755	abstract	38576868
regarding	O	1756	1765	abstract	38576868
this	O	1766	1770	abstract	38576868
field	O	1771	1776	abstract	38576868
were	O	1777	1781	abstract	38576868
the	O	1782	1785	abstract	38576868
characteristics	O	1786	1801	abstract	38576868
,	O	1801	1802	abstract	38576868
abundance	O	1803	1812	abstract	38576868
,	O	1812	1813	abstract	38576868
and	O	1814	1817	abstract	38576868
diversity	O	1818	1827	abstract	38576868
of	O	1828	1830	abstract	38576868
gut	B-microbiome	1831	1834	abstract	38576868
microbiome	I-microbiome	1835	1845	abstract	38576868
in	O	1846	1848	abstract	38576868
bipolar	B-DDF	1849	1856	abstract	38576868
disorder	I-DDF	1857	1865	abstract	38576868
,	O	1865	1866	abstract	38576868
the	O	1867	1870	abstract	38576868
role	O	1871	1875	abstract	38576868
of	O	1876	1878	abstract	38576868
treatment	O	1879	1888	abstract	38576868
and	O	1889	1892	abstract	38576868
gut	B-microbiome	1893	1896	abstract	38576868
microbiome	I-microbiome	1897	1907	abstract	38576868
in	O	1908	1910	abstract	38576868
bipolar	B-DDF	1911	1918	abstract	38576868
disorder	I-DDF	1919	1927	abstract	38576868
,	O	1927	1928	abstract	38576868
microbiome-brain	O	1929	1945	abstract	38576868
connections	O	1946	1957	abstract	38576868
in	O	1958	1960	abstract	38576868
bipolar	B-DDF	1961	1968	abstract	38576868
disorder	I-DDF	1969	1977	abstract	38576868
,	O	1977	1978	abstract	38576868
and	O	1979	1982	abstract	38576868
interventions	O	1983	1996	abstract	38576868
for	O	1997	2000	abstract	38576868
bipolar	B-DDF	2001	2008	abstract	38576868
disorder	I-DDF	2009	2017	abstract	38576868
based	O	2018	2023	abstract	38576868
on	O	2024	2026	abstract	38576868
microbiota	O	2027	2037	abstract	38576868
composition	O	2038	2049	abstract	38576868
modification	O	2050	2062	abstract	38576868
.	O	2062	2063	abstract	38576868

The	O	2064	2067	abstract	38576868
number	O	2068	2074	abstract	38576868
of	O	2075	2077	abstract	38576868
studies	O	2078	2085	abstract	38576868
about	O	2086	2091	abstract	38576868
the	O	2092	2095	abstract	38576868
association	O	2096	2107	abstract	38576868
between	O	2108	2115	abstract	38576868
gut	B-microbiome	2116	2119	abstract	38576868
microbiota	I-microbiome	2120	2130	abstract	38576868
and	O	2131	2134	abstract	38576868
bipolar	B-DDF	2135	2142	abstract	38576868
disorder	I-DDF	2143	2151	abstract	38576868
is	O	2152	2154	abstract	38576868
relatively	O	2155	2165	abstract	38576868
small	O	2166	2171	abstract	38576868
,	O	2171	2172	abstract	38576868
and	O	2173	2176	abstract	38576868
more	O	2177	2181	abstract	38576868
studies	O	2182	2189	abstract	38576868
are	O	2190	2193	abstract	38576868
needed	O	2194	2200	abstract	38576868
to	O	2201	2203	abstract	38576868
expand	O	2204	2210	abstract	38576868
our	O	2211	2214	abstract	38576868
understanding	O	2215	2228	abstract	38576868
the	O	2229	2232	abstract	38576868
association	O	2233	2244	abstract	38576868
between	O	2245	2252	abstract	38576868
gut	B-microbiome	2253	2256	abstract	38576868
microbiota	I-microbiome	2257	2267	abstract	38576868
and	O	2268	2271	abstract	38576868
bipolar	B-DDF	2272	2279	abstract	38576868
disorder	I-DDF	2280	2288	abstract	38576868
.	O	2288	2289	abstract	38576868

Pharmacomicrobiomics	B-microbiome	0	20	title	37511699
of	O	21	23	title	37511699
Antidepressants	B-drug	24	39	title	37511699
in	O	40	42	title	37511699
Depression	B-DDF	43	53	title	37511699
:	O	53	54	title	37511699
A	O	55	56	title	37511699
Systematic	O	57	67	title	37511699
Review	O	68	74	title	37511699
.	O	74	75	title	37511699

This	O	0	4	abstract	37511699
systematic	O	5	15	abstract	37511699
review	O	16	22	abstract	37511699
evaluated	O	23	32	abstract	37511699
the	O	33	36	abstract	37511699
animal	O	37	43	abstract	37511699
and	O	44	47	abstract	37511699
human	O	48	53	abstract	37511699
evidence	O	54	62	abstract	37511699
for	O	63	66	abstract	37511699
pharmacomicrobiomics	O	67	87	abstract	37511699
(	O	88	89	abstract	37511699
PMx	O	89	92	abstract	37511699
)	O	92	93	abstract	37511699
interactions	O	94	106	abstract	37511699
of	O	107	109	abstract	37511699
antidepressant	B-drug	110	124	abstract	37511699
medications	I-drug	125	136	abstract	37511699
.	O	136	137	abstract	37511699

Studies	O	138	145	abstract	37511699
of	O	146	148	abstract	37511699
gut	O	149	152	abstract	37511699
microbiota	O	153	163	abstract	37511699
effects	O	164	171	abstract	37511699
on	O	172	174	abstract	37511699
functional	O	175	185	abstract	37511699
and	O	186	189	abstract	37511699
behavioral	O	190	200	abstract	37511699
effects	O	201	208	abstract	37511699
of	O	209	211	abstract	37511699
antidepressants	B-drug	212	227	abstract	37511699
in	O	228	230	abstract	37511699
human	O	231	236	abstract	37511699
and	O	237	240	abstract	37511699
animal	O	241	247	abstract	37511699
models	O	248	254	abstract	37511699
were	O	255	259	abstract	37511699
identified	O	260	270	abstract	37511699
from	O	271	275	abstract	37511699
PubMed	O	276	282	abstract	37511699
up	O	283	285	abstract	37511699
to	O	286	288	abstract	37511699
December	O	289	297	abstract	37511699
2022	O	298	302	abstract	37511699
.	O	302	303	abstract	37511699

Risk	O	304	308	abstract	37511699
of	O	309	311	abstract	37511699
bias	O	312	316	abstract	37511699
was	O	317	320	abstract	37511699
assessed	O	321	329	abstract	37511699
,	O	329	330	abstract	37511699
and	O	331	334	abstract	37511699
results	O	335	342	abstract	37511699
are	O	343	346	abstract	37511699
presented	O	347	356	abstract	37511699
as	O	357	359	abstract	37511699
a	O	360	361	abstract	37511699
systematic	O	362	372	abstract	37511699
review	O	373	379	abstract	37511699
following	O	380	389	abstract	37511699
PRISMA	O	390	396	abstract	37511699
guidelines	O	397	407	abstract	37511699
.	O	407	408	abstract	37511699

A	O	409	410	abstract	37511699
total	O	411	416	abstract	37511699
of	O	417	419	abstract	37511699
28	O	420	422	abstract	37511699
(	O	423	424	abstract	37511699
21	O	424	426	abstract	37511699
animal	O	427	433	abstract	37511699
,	O	433	434	abstract	37511699
7	O	435	436	abstract	37511699
human	O	437	442	abstract	37511699
)	O	442	443	abstract	37511699
studies	O	444	451	abstract	37511699
were	O	452	456	abstract	37511699
included	O	457	465	abstract	37511699
in	O	466	468	abstract	37511699
the	O	469	472	abstract	37511699
review	O	473	479	abstract	37511699
.	O	479	480	abstract	37511699

The	O	481	484	abstract	37511699
reviewed	O	485	493	abstract	37511699
papers	O	494	500	abstract	37511699
converged	O	501	510	abstract	37511699
on	O	511	513	abstract	37511699
three	O	514	519	abstract	37511699
themes	O	520	526	abstract	37511699
:	O	526	527	abstract	37511699
(	O	528	529	abstract	37511699
1	O	529	530	abstract	37511699
)	O	530	531	abstract	37511699
Antidepressants	B-drug	532	547	abstract	37511699
can	O	548	551	abstract	37511699
alter	O	552	557	abstract	37511699
the	O	558	561	abstract	37511699
composition	O	562	573	abstract	37511699
and	O	574	577	abstract	37511699
metabolites	O	578	589	abstract	37511699
of	O	590	592	abstract	37511699
gut	B-microbiome	593	596	abstract	37511699
microbiota	I-microbiome	597	607	abstract	37511699
,	O	607	608	abstract	37511699
(	O	609	610	abstract	37511699
2	O	610	611	abstract	37511699
)	O	611	612	abstract	37511699
gut	B-microbiome	613	616	abstract	37511699
microbiota	I-microbiome	617	627	abstract	37511699
can	O	628	631	abstract	37511699
alter	O	632	637	abstract	37511699
the	O	638	641	abstract	37511699
bioavailability	O	642	657	abstract	37511699
of	O	658	660	abstract	37511699
certain	O	661	668	abstract	37511699
antidepressants	B-drug	669	684	abstract	37511699
,	O	684	685	abstract	37511699
and	O	686	689	abstract	37511699
(	O	690	691	abstract	37511699
3	O	691	692	abstract	37511699
)	O	692	693	abstract	37511699
gut	B-microbiome	694	697	abstract	37511699
microbiota	I-microbiome	698	708	abstract	37511699
may	O	709	712	abstract	37511699
modulate	O	713	721	abstract	37511699
the	O	722	725	abstract	37511699
clinical	O	726	734	abstract	37511699
or	O	735	737	abstract	37511699
modeled	O	738	745	abstract	37511699
mood	O	746	750	abstract	37511699
modifying	O	751	760	abstract	37511699
effects	O	761	768	abstract	37511699
of	O	769	771	abstract	37511699
antidepressants	B-drug	772	787	abstract	37511699
.	O	787	788	abstract	37511699

The	O	789	792	abstract	37511699
majority	O	793	801	abstract	37511699
(	O	802	803	abstract	37511699
n	O	803	804	abstract	37511699
=	O	805	806	abstract	37511699
22	O	807	809	abstract	37511699
)	O	809	810	abstract	37511699
of	O	811	813	abstract	37511699
studies	O	814	821	abstract	37511699
had	O	822	825	abstract	37511699
at	O	826	828	abstract	37511699
least	O	829	834	abstract	37511699
moderate	O	835	843	abstract	37511699
levels	O	844	850	abstract	37511699
of	O	851	853	abstract	37511699
bias	O	854	858	abstract	37511699
present	O	859	866	abstract	37511699
.	O	866	867	abstract	37511699

While	O	868	873	abstract	37511699
strong	O	874	880	abstract	37511699
evidence	O	881	889	abstract	37511699
is	O	890	892	abstract	37511699
still	O	893	898	abstract	37511699
lacking	O	899	906	abstract	37511699
to	O	907	909	abstract	37511699
understand	O	910	920	abstract	37511699
the	O	921	924	abstract	37511699
clinical	O	925	933	abstract	37511699
role	O	934	938	abstract	37511699
of	O	939	941	abstract	37511699
antidepressant	B-drug	942	956	abstract	37511699
PMx	I-drug	957	960	abstract	37511699
in	O	961	963	abstract	37511699
human	O	964	969	abstract	37511699
health	O	970	976	abstract	37511699
,	O	976	977	abstract	37511699
there	O	978	983	abstract	37511699
is	O	984	986	abstract	37511699
evidence	O	987	995	abstract	37511699
for	O	996	999	abstract	37511699
interactions	O	1000	1012	abstract	37511699
among	O	1013	1018	abstract	37511699
antidepressants	B-drug	1019	1034	abstract	37511699
,	O	1034	1035	abstract	37511699
microbiota	O	1036	1046	abstract	37511699
changes	O	1047	1054	abstract	37511699
,	O	1054	1055	abstract	37511699
microbiota	O	1056	1066	abstract	37511699
metabolite	O	1067	1077	abstract	37511699
changes	O	1078	1085	abstract	37511699
,	O	1085	1086	abstract	37511699
and	O	1087	1090	abstract	37511699
behavior	O	1091	1099	abstract	37511699
.	O	1099	1100	abstract	37511699

Well-controlled	O	1101	1116	abstract	37511699
studies	O	1117	1124	abstract	37511699
of	O	1125	1127	abstract	37511699
the	O	1128	1131	abstract	37511699
mediating	O	1132	1141	abstract	37511699
and	O	1142	1145	abstract	37511699
moderating	O	1146	1156	abstract	37511699
effects	O	1157	1164	abstract	37511699
of	O	1165	1167	abstract	37511699
baseline	O	1168	1176	abstract	37511699
and	O	1177	1180	abstract	37511699
treatment-emergent	O	1181	1199	abstract	37511699
changes	O	1200	1207	abstract	37511699
in	O	1208	1210	abstract	37511699
microbiota	O	1211	1221	abstract	37511699
on	O	1222	1224	abstract	37511699
therapeutic	O	1225	1236	abstract	37511699
and	O	1237	1240	abstract	37511699
adverse	O	1241	1248	abstract	37511699
responses	O	1249	1258	abstract	37511699
to	O	1259	1261	abstract	37511699
antidepressants	B-drug	1262	1277	abstract	37511699
are	O	1278	1281	abstract	37511699
needed	O	1282	1288	abstract	37511699
to	O	1289	1291	abstract	37511699
better	O	1292	1298	abstract	37511699
establish	O	1299	1308	abstract	37511699
a	O	1309	1310	abstract	37511699
potential	O	1311	1320	abstract	37511699
role	O	1321	1325	abstract	37511699
of	O	1326	1328	abstract	37511699
PMx	O	1329	1332	abstract	37511699
in	O	1333	1335	abstract	37511699
personalizing	O	1336	1349	abstract	37511699
antidepressant	O	1350	1364	abstract	37511699
treatment	O	1365	1374	abstract	37511699
selection	O	1375	1384	abstract	37511699
and	O	1385	1388	abstract	37511699
response	O	1389	1397	abstract	37511699
prediction	O	1398	1408	abstract	37511699
.	O	1408	1409	abstract	37511699

Gastrointestinal	B-biomedical%technique	0	16	title	37464164
and	I-biomedical%technique	17	20	title	37464164
Microbiome	I-biomedical%technique	21	31	title	37464164
Profiling	I-biomedical%technique	32	41	title	37464164
in	O	42	44	title	37464164
Rodent	O	45	51	title	37464164
Models	O	52	58	title	37464164
of	O	59	61	title	37464164
Neurological	B-DDF	62	74	title	37464164
and	I-DDF	75	78	title	37464164
Psychiatric	I-DDF	79	90	title	37464164
Disorders	I-DDF	91	100	title	37464164
.	O	100	101	title	37464164

Mice	O	0	4	abstract	37464164
and	O	5	8	abstract	37464164
other	O	9	14	abstract	37464164
rodent	O	15	21	abstract	37464164
models	O	22	28	abstract	37464164
have	O	29	33	abstract	37464164
been	O	34	38	abstract	37464164
widely	O	39	45	abstract	37464164
used	O	46	50	abstract	37464164
to	O	51	53	abstract	37464164
understand	O	54	64	abstract	37464164
the	O	65	68	abstract	37464164
role	O	69	73	abstract	37464164
of	O	74	76	abstract	37464164
the	O	77	80	abstract	37464164
gut	B-microbiome	81	84	abstract	37464164
microbiome	I-microbiome	85	95	abstract	37464164
in	O	96	98	abstract	37464164
various	O	99	106	abstract	37464164
neurological	B-DDF	107	119	abstract	37464164
and	I-DDF	120	123	abstract	37464164
psychiatric	I-DDF	124	135	abstract	37464164
disorders	I-DDF	136	145	abstract	37464164
.	O	145	146	abstract	37464164

Here	O	147	151	abstract	37464164
we	O	152	154	abstract	37464164
describe	O	155	163	abstract	37464164
a	O	164	165	abstract	37464164
protocol	O	166	174	abstract	37464164
to	O	175	177	abstract	37464164
characterize	O	178	190	abstract	37464164
the	O	191	194	abstract	37464164
structural	O	195	205	abstract	37464164
and	O	206	209	abstract	37464164
functional	O	210	220	abstract	37464164
phenotype	O	221	230	abstract	37464164
of	O	231	233	abstract	37464164
the	O	234	237	abstract	37464164
rodent	B-anatomical%location	238	244	abstract	37464164
gut	I-anatomical%location	245	248	abstract	37464164
and	O	249	252	abstract	37464164
to	O	253	255	abstract	37464164
examine	O	256	263	abstract	37464164
the	O	264	267	abstract	37464164
gut	B-microbiome	268	271	abstract	37464164
microbiota	I-microbiome	272	282	abstract	37464164
composition	O	283	294	abstract	37464164
through	O	295	302	abstract	37464164
V4	B-biomedical%technique	303	305	abstract	37464164
16S	I-biomedical%technique	306	309	abstract	37464164
rRNA	I-biomedical%technique	310	314	abstract	37464164
gene	I-biomedical%technique	315	319	abstract	37464164
sequencing	I-biomedical%technique	320	330	abstract	37464164
and	O	331	334	abstract	37464164
microbiome	B-biomedical%technique	335	345	abstract	37464164
profiling	I-biomedical%technique	346	355	abstract	37464164
.	O	355	356	abstract	37464164

This	O	357	361	abstract	37464164
protocol	O	362	370	abstract	37464164
will	O	371	375	abstract	37464164
have	O	376	380	abstract	37464164
utility	O	381	388	abstract	37464164
for	O	389	392	abstract	37464164
those	O	393	398	abstract	37464164
investigating	O	399	412	abstract	37464164
the	O	413	416	abstract	37464164
gut	B-anatomical%location	417	420	abstract	37464164
,	O	420	421	abstract	37464164
and	O	422	425	abstract	37464164
associated	O	426	436	abstract	37464164
microbiota	O	437	447	abstract	37464164
,	O	447	448	abstract	37464164
in	O	449	451	abstract	37464164
a	O	452	453	abstract	37464164
wide	O	454	458	abstract	37464164
range	O	459	464	abstract	37464164
of	O	465	467	abstract	37464164
different	O	468	477	abstract	37464164
rodent	O	478	484	abstract	37464164
models	O	485	491	abstract	37464164
of	O	492	494	abstract	37464164
human	O	495	500	abstract	37464164
disorders	O	501	510	abstract	37464164
.	O	510	511	abstract	37464164

Gut	B-microbiome	0	3	title	37368331
Microbiota	I-microbiome	4	14	title	37368331
and	O	15	18	title	37368331
Its	O	19	22	title	37368331
Repercussion	O	23	35	title	37368331
in	O	36	38	title	37368331
Parkinson	B-DDF	39	48	title	37368331
's	I-DDF	48	50	title	37368331
Disease	I-DDF	51	58	title	37368331
:	O	58	59	title	37368331
A	O	60	61	title	37368331
Systematic	O	62	72	title	37368331
Review	O	73	79	title	37368331
in	O	80	82	title	37368331
Occidental	B-human	83	93	title	37368331
Patients	I-human	94	102	title	37368331
.	O	102	103	title	37368331

(	O	0	1	abstract	37368331
1	O	1	2	abstract	37368331
)	O	2	3	abstract	37368331
Background	O	4	14	abstract	37368331
:	O	14	15	abstract	37368331
Parkinson	B-DDF	16	25	abstract	37368331
's	I-DDF	25	27	abstract	37368331
disease	I-DDF	28	35	abstract	37368331
(	O	36	37	abstract	37368331
PD	B-DDF	37	39	abstract	37368331
)	O	39	40	abstract	37368331
is	O	41	43	abstract	37368331
a	O	44	45	abstract	37368331
relatively	O	46	56	abstract	37368331
common	O	57	63	abstract	37368331
and	O	64	67	abstract	37368331
complex	O	68	75	abstract	37368331
pathology	O	76	85	abstract	37368331
,	O	85	86	abstract	37368331
and	O	87	90	abstract	37368331
some	O	91	95	abstract	37368331
of	O	96	98	abstract	37368331
its	O	99	102	abstract	37368331
mechanisms	O	103	113	abstract	37368331
remain	O	114	120	abstract	37368331
to	O	121	123	abstract	37368331
be	O	124	126	abstract	37368331
elucidated	O	127	137	abstract	37368331
.	O	137	138	abstract	37368331

Change	O	139	145	abstract	37368331
in	O	146	148	abstract	37368331
host	B-microbiome	149	153	abstract	37368331
microbiota	I-microbiome	154	164	abstract	37368331
is	O	165	167	abstract	37368331
related	O	168	175	abstract	37368331
to	O	176	178	abstract	37368331
the	O	179	182	abstract	37368331
pathophysiology	O	183	198	abstract	37368331
of	O	199	201	abstract	37368331
numerous	O	202	210	abstract	37368331
diseases	O	211	219	abstract	37368331
.	O	219	220	abstract	37368331

This	O	221	225	abstract	37368331
systematic	O	226	236	abstract	37368331
review	O	237	243	abstract	37368331
aims	O	244	248	abstract	37368331
to	O	249	251	abstract	37368331
gather	O	252	258	abstract	37368331
existing	O	259	267	abstract	37368331
data	O	268	272	abstract	37368331
on	O	273	275	abstract	37368331
the	O	276	279	abstract	37368331
occidental	O	280	290	abstract	37368331
hemisphere	O	291	301	abstract	37368331
,	O	301	302	abstract	37368331
compare	O	303	310	abstract	37368331
it	O	311	313	abstract	37368331
,	O	313	314	abstract	37368331
and	O	315	318	abstract	37368331
search	O	319	325	abstract	37368331
for	O	326	329	abstract	37368331
any	O	330	333	abstract	37368331
significant	O	334	345	abstract	37368331
association	O	346	357	abstract	37368331
between	O	358	365	abstract	37368331
Parkinson	B-DDF	366	375	abstract	37368331
's	I-DDF	375	377	abstract	37368331
disease	I-DDF	378	385	abstract	37368331
and	O	386	389	abstract	37368331
gut	B-DDF	390	393	abstract	37368331
microbiota	I-DDF	394	404	abstract	37368331
dysbiosis	I-DDF	405	414	abstract	37368331
.	O	414	415	abstract	37368331

(	O	416	417	abstract	37368331
2	O	417	418	abstract	37368331
)	O	418	419	abstract	37368331
Methods	O	420	427	abstract	37368331
:	O	427	428	abstract	37368331
Preferred	O	429	438	abstract	37368331
Reporting	O	439	448	abstract	37368331
Items	O	449	454	abstract	37368331
for	O	455	458	abstract	37368331
Systematic	O	459	469	abstract	37368331
Review	O	470	476	abstract	37368331
and	O	477	480	abstract	37368331
Meta-Analysis	O	481	494	abstract	37368331
(	O	495	496	abstract	37368331
PRISMA	O	496	502	abstract	37368331
)	O	502	503	abstract	37368331
and	O	504	507	abstract	37368331
Meta-analyses	O	508	521	abstract	37368331
Of	O	522	524	abstract	37368331
Observational	O	525	538	abstract	37368331
Studies	O	539	546	abstract	37368331
in	O	547	549	abstract	37368331
Epidemiology	O	550	562	abstract	37368331
(	O	563	564	abstract	37368331
MOOSE	O	564	569	abstract	37368331
)	O	569	570	abstract	37368331
protocols	O	571	580	abstract	37368331
were	O	581	585	abstract	37368331
used	O	586	590	abstract	37368331
for	O	591	594	abstract	37368331
this	O	595	599	abstract	37368331
systematic	O	600	610	abstract	37368331
review	O	611	617	abstract	37368331
.	O	617	618	abstract	37368331

PubMed	O	619	625	abstract	37368331
was	O	626	629	abstract	37368331
used	O	630	634	abstract	37368331
as	O	635	637	abstract	37368331
the	O	638	641	abstract	37368331
database	O	642	650	abstract	37368331
search	O	651	657	abstract	37368331
engine	O	658	664	abstract	37368331
.	O	664	665	abstract	37368331

Of	O	666	668	abstract	37368331
the	O	669	672	abstract	37368331
166	O	673	676	abstract	37368331
studies	O	677	684	abstract	37368331
found	O	685	690	abstract	37368331
,	O	690	691	abstract	37368331
only	O	692	696	abstract	37368331
10	O	697	699	abstract	37368331
were	O	700	704	abstract	37368331
used	O	705	709	abstract	37368331
,	O	709	710	abstract	37368331
as	O	711	713	abstract	37368331
they	O	714	718	abstract	37368331
met	O	719	722	abstract	37368331
our	O	723	726	abstract	37368331
inclusion	O	727	736	abstract	37368331
criteria	O	737	745	abstract	37368331
:	O	745	746	abstract	37368331
case-control	O	747	759	abstract	37368331
studies	O	760	767	abstract	37368331
,	O	767	768	abstract	37368331
studies	O	769	776	abstract	37368331
that	O	777	781	abstract	37368331
assessed	O	782	790	abstract	37368331
the	O	791	794	abstract	37368331
correlation	O	795	806	abstract	37368331
of	O	807	809	abstract	37368331
PD	B-DDF	810	812	abstract	37368331
and	O	813	816	abstract	37368331
gut	B-microbiome	817	820	abstract	37368331
microbiome	I-microbiome	821	831	abstract	37368331
,	O	831	832	abstract	37368331
studies	O	833	840	abstract	37368331
that	O	841	845	abstract	37368331
took	O	846	850	abstract	37368331
place	O	851	856	abstract	37368331
in	O	857	859	abstract	37368331
occidental	O	860	870	abstract	37368331
regions	O	871	878	abstract	37368331
,	O	878	879	abstract	37368331
and	O	880	883	abstract	37368331
studies	O	884	891	abstract	37368331
that	O	892	896	abstract	37368331
were	O	897	901	abstract	37368331
performed	O	902	911	abstract	37368331
on	O	912	914	abstract	37368331
humans	O	915	921	abstract	37368331
and	O	922	925	abstract	37368331
were	O	926	930	abstract	37368331
written	O	931	938	abstract	37368331
in	O	939	941	abstract	37368331
English	O	942	949	abstract	37368331
.	O	949	950	abstract	37368331

The	O	951	954	abstract	37368331
Newcastle-Ottawa	O	955	971	abstract	37368331
Scale	O	972	977	abstract	37368331
was	O	978	981	abstract	37368331
used	O	982	986	abstract	37368331
as	O	987	989	abstract	37368331
the	O	990	993	abstract	37368331
assessment	O	994	1004	abstract	37368331
tool	O	1005	1009	abstract	37368331
for	O	1010	1013	abstract	37368331
overall	O	1014	1021	abstract	37368331
risk	O	1022	1026	abstract	37368331
of	O	1027	1029	abstract	37368331
bias	O	1030	1034	abstract	37368331
in	O	1035	1037	abstract	37368331
this	O	1038	1042	abstract	37368331
systematic	O	1043	1053	abstract	37368331
review	O	1054	1060	abstract	37368331
.	O	1060	1061	abstract	37368331

(	O	1062	1063	abstract	37368331
3	O	1063	1064	abstract	37368331
)	O	1064	1065	abstract	37368331
Results	O	1066	1073	abstract	37368331
:	O	1073	1074	abstract	37368331
The	O	1075	1078	abstract	37368331
studies	O	1079	1086	abstract	37368331
analyzed	O	1087	1095	abstract	37368331
were	O	1096	1100	abstract	37368331
divided	O	1101	1108	abstract	37368331
into	O	1109	1113	abstract	37368331
three	O	1114	1119	abstract	37368331
geographic	O	1120	1130	abstract	37368331
areas	O	1131	1136	abstract	37368331
:	O	1136	1137	abstract	37368331
Region	O	1138	1144	abstract	37368331
1	O	1145	1146	abstract	37368331
:	O	1146	1147	abstract	37368331
United	O	1148	1154	abstract	37368331
States	O	1155	1161	abstract	37368331
of	O	1162	1164	abstract	37368331
America	O	1165	1172	abstract	37368331
and	O	1173	1176	abstract	37368331
Canada	O	1177	1183	abstract	37368331
;	O	1183	1184	abstract	37368331
Region	O	1185	1191	abstract	37368331
2	O	1192	1193	abstract	37368331
:	O	1193	1194	abstract	37368331
Germany	O	1195	1202	abstract	37368331
,	O	1202	1203	abstract	37368331
Ireland	O	1204	1211	abstract	37368331
,	O	1211	1212	abstract	37368331
and	O	1213	1216	abstract	37368331
Finland	O	1217	1224	abstract	37368331
;	O	1224	1225	abstract	37368331
and	O	1226	1229	abstract	37368331
Region	O	1230	1236	abstract	37368331
3	O	1237	1238	abstract	37368331
:	O	1238	1239	abstract	37368331
Italy	O	1240	1245	abstract	37368331
;	O	1245	1246	abstract	37368331
based	O	1247	1252	abstract	37368331
on	O	1253	1255	abstract	37368331
geographical	O	1256	1268	abstract	37368331
similarities	O	1269	1281	abstract	37368331
among	O	1282	1287	abstract	37368331
these	O	1288	1293	abstract	37368331
populations	B-human	1294	1305	abstract	37368331
.	O	1305	1306	abstract	37368331

The	O	1307	1310	abstract	37368331
following	O	1311	1320	abstract	37368331
statistically	O	1321	1334	abstract	37368331
significant	O	1335	1346	abstract	37368331
results	O	1347	1354	abstract	37368331
were	O	1355	1359	abstract	37368331
described	O	1360	1369	abstract	37368331
in	O	1370	1372	abstract	37368331
PD	B-human	1373	1375	abstract	37368331
patients	I-human	1376	1384	abstract	37368331
,	O	1384	1385	abstract	37368331
compared	O	1386	1394	abstract	37368331
with	O	1395	1399	abstract	37368331
non-PD	B-human	1400	1406	abstract	37368331
controls	I-human	1407	1415	abstract	37368331
.	O	1415	1416	abstract	37368331

In	O	1417	1419	abstract	37368331
the	O	1420	1423	abstract	37368331
first	O	1424	1429	abstract	37368331
region	O	1430	1436	abstract	37368331
,	O	1436	1437	abstract	37368331
a	O	1438	1439	abstract	37368331
significant	O	1440	1451	abstract	37368331
increase	O	1452	1460	abstract	37368331
in	O	1461	1463	abstract	37368331
the	O	1464	1467	abstract	37368331
following	O	1468	1477	abstract	37368331
bacteria	O	1478	1486	abstract	37368331
was	O	1487	1490	abstract	37368331
seen	O	1491	1495	abstract	37368331
:	O	1495	1496	abstract	37368331
1	O	1497	1498	abstract	37368331
.	O	1498	1499	abstract	37368331

Phylum	O	1500	1506	abstract	37368331
:	O	1506	1507	abstract	37368331
Actinobacteriota	B-bacteria	1508	1524	abstract	37368331
and	O	1525	1528	abstract	37368331
its	O	1529	1532	abstract	37368331
Genus	O	1533	1538	abstract	37368331
:	O	1538	1539	abstract	37368331
<	O	1540	1541	abstract	37368331
i	O	1541	1542	abstract	37368331
>	O	1542	1543	abstract	37368331
Bifidobacterium</i	B-bacteria	1543	1561	abstract	37368331
>	O	1561	1562	abstract	37368331
;	O	1562	1563	abstract	37368331
2	O	1564	1565	abstract	37368331
.	O	1565	1566	abstract	37368331

Phylum	O	1567	1573	abstract	37368331
:	O	1573	1574	abstract	37368331
Verrucomicrobiota	B-bacteria	1575	1592	abstract	37368331
and	O	1593	1596	abstract	37368331
its	O	1597	1600	abstract	37368331
Genus	O	1601	1606	abstract	37368331
:	O	1606	1607	abstract	37368331
<	O	1608	1609	abstract	37368331
i	O	1609	1610	abstract	37368331
>	O	1610	1611	abstract	37368331
Akkermansia</i	B-bacteria	1611	1625	abstract	37368331
>	O	1625	1626	abstract	37368331
;	O	1626	1627	abstract	37368331
3	O	1628	1629	abstract	37368331
.	O	1629	1630	abstract	37368331

Genus	O	1631	1636	abstract	37368331
:	O	1636	1637	abstract	37368331
<	O	1638	1639	abstract	37368331
i	O	1639	1640	abstract	37368331
>	O	1640	1641	abstract	37368331
Enterococcus</i	B-bacteria	1641	1656	abstract	37368331
>	O	1656	1657	abstract	37368331
,	O	1657	1658	abstract	37368331
<	O	1659	1660	abstract	37368331
i	O	1660	1661	abstract	37368331
>	O	1661	1662	abstract	37368331
Hungatella</i	B-bacteria	1662	1675	abstract	37368331
>	O	1675	1676	abstract	37368331
,	O	1676	1677	abstract	37368331
<	O	1678	1679	abstract	37368331
i	O	1679	1680	abstract	37368331
>	O	1680	1681	abstract	37368331
Lactobacillus</i	B-bacteria	1681	1697	abstract	37368331
>	O	1697	1698	abstract	37368331
,	O	1698	1699	abstract	37368331
and	O	1700	1703	abstract	37368331
<	O	1704	1705	abstract	37368331
i	O	1705	1706	abstract	37368331
>	O	1706	1707	abstract	37368331
Oscillospira</i	B-bacteria	1707	1722	abstract	37368331
>	O	1722	1723	abstract	37368331
of	O	1724	1726	abstract	37368331
the	O	1727	1730	abstract	37368331
Phylum	O	1731	1737	abstract	37368331
:	O	1737	1738	abstract	37368331
Firmicutes	B-bacteria	1739	1749	abstract	37368331
;	O	1749	1750	abstract	37368331
4	O	1751	1752	abstract	37368331
.	O	1752	1753	abstract	37368331

Family	O	1754	1760	abstract	37368331
:	O	1760	1761	abstract	37368331
<	O	1762	1763	abstract	37368331
i	O	1763	1764	abstract	37368331
>	O	1764	1765	abstract	37368331
Ruminococcaceae</i	B-bacteria	1765	1783	abstract	37368331
>	O	1783	1784	abstract	37368331
of	O	1785	1787	abstract	37368331
Phylum	O	1788	1794	abstract	37368331
:	O	1794	1795	abstract	37368331
Firmicutes	B-bacteria	1796	1806	abstract	37368331
;	O	1806	1807	abstract	37368331
5	O	1808	1809	abstract	37368331
.	O	1809	1810	abstract	37368331

Phylum	O	1811	1817	abstract	37368331
:	O	1817	1818	abstract	37368331
Bacteroidetes	B-bacteria	1819	1832	abstract	37368331
and	O	1833	1836	abstract	37368331
its	O	1837	1840	abstract	37368331
Genus	O	1841	1846	abstract	37368331
:	O	1846	1847	abstract	37368331
<	O	1848	1849	abstract	37368331
i	O	1849	1850	abstract	37368331
>	O	1850	1851	abstract	37368331
Bacteroides</i	B-bacteria	1851	1865	abstract	37368331
>	O	1865	1866	abstract	37368331
;	O	1866	1867	abstract	37368331
6	O	1868	1869	abstract	37368331
.	O	1869	1870	abstract	37368331

Phylum	O	1871	1877	abstract	37368331
:	O	1877	1878	abstract	37368331
Proteobacteria	B-bacteria	1879	1893	abstract	37368331
.	O	1893	1894	abstract	37368331

A	O	1895	1896	abstract	37368331
significant	O	1897	1908	abstract	37368331
decrease	O	1909	1917	abstract	37368331
was	O	1918	1921	abstract	37368331
described	O	1922	1931	abstract	37368331
in	O	1932	1934	abstract	37368331
the	O	1935	1938	abstract	37368331
Family	O	1939	1945	abstract	37368331
:	O	1945	1946	abstract	37368331
<	O	1947	1948	abstract	37368331
i	O	1948	1949	abstract	37368331
>	O	1949	1950	abstract	37368331
Lachnospiraceae</i	B-bacteria	1950	1968	abstract	37368331
>	O	1968	1969	abstract	37368331
and	O	1970	1973	abstract	37368331
its	O	1974	1977	abstract	37368331
Genus	O	1978	1983	abstract	37368331
:	O	1983	1984	abstract	37368331
<	O	1985	1986	abstract	37368331
i	O	1986	1987	abstract	37368331
>	O	1987	1988	abstract	37368331
Blautia</i	B-bacteria	1988	1998	abstract	37368331
>	O	1998	1999	abstract	37368331
,	O	1999	2000	abstract	37368331
<	O	2001	2002	abstract	37368331
i	O	2002	2003	abstract	37368331
>	O	2003	2004	abstract	37368331
Coprococcus</i	B-bacteria	2004	2018	abstract	37368331
>	O	2018	2019	abstract	37368331
,	O	2019	2020	abstract	37368331
and	O	2021	2024	abstract	37368331
<	O	2025	2026	abstract	37368331
i	O	2026	2027	abstract	37368331
>	O	2027	2028	abstract	37368331
Roseburia</i	B-bacteria	2028	2040	abstract	37368331
>	O	2040	2041	abstract	37368331
,	O	2041	2042	abstract	37368331
which	O	2043	2048	abstract	37368331
belong	O	2049	2055	abstract	37368331
to	O	2056	2058	abstract	37368331
the	O	2059	2062	abstract	37368331
Phylum	O	2063	2069	abstract	37368331
:	O	2069	2070	abstract	37368331
Firmicutes	B-bacteria	2071	2081	abstract	37368331
.	O	2081	2082	abstract	37368331

In	O	2083	2085	abstract	37368331
the	O	2086	2089	abstract	37368331
second	O	2090	2096	abstract	37368331
region	O	2097	2103	abstract	37368331
,	O	2103	2104	abstract	37368331
a	O	2105	2106	abstract	37368331
raised	O	2107	2113	abstract	37368331
number	O	2114	2120	abstract	37368331
of	O	2121	2123	abstract	37368331
:	O	2123	2124	abstract	37368331
1	O	2125	2126	abstract	37368331
.	O	2126	2127	abstract	37368331

Phylum	O	2128	2134	abstract	37368331
:	O	2134	2135	abstract	37368331
Verrucomicrobiota	B-bacteria	2136	2153	abstract	37368331
,	O	2153	2154	abstract	37368331
its	O	2155	2158	abstract	37368331
Genus	O	2159	2164	abstract	37368331
:	O	2164	2165	abstract	37368331
<	O	2166	2167	abstract	37368331
i	O	2167	2168	abstract	37368331
>	O	2168	2169	abstract	37368331
Akkermansia</i	B-bacteria	2169	2183	abstract	37368331
>	O	2183	2184	abstract	37368331
,	O	2184	2185	abstract	37368331
and	O	2186	2189	abstract	37368331
its	O	2190	2193	abstract	37368331
Species	O	2194	2201	abstract	37368331
:	O	2201	2202	abstract	37368331
<	O	2203	2204	abstract	37368331
i	O	2204	2205	abstract	37368331
>	O	2205	2206	abstract	37368331
Akkermansia	B-bacteria	2206	2217	abstract	37368331
muciniphila</i	I-bacteria	2218	2232	abstract	37368331
>	O	2232	2233	abstract	37368331
;	O	2233	2234	abstract	37368331
2	O	2235	2236	abstract	37368331
.	O	2236	2237	abstract	37368331

Family	O	2238	2244	abstract	37368331
:	O	2244	2245	abstract	37368331
<	O	2246	2247	abstract	37368331
i	O	2247	2248	abstract	37368331
>	O	2248	2249	abstract	37368331
Verrucomicrobiaceae</i	B-bacteria	2249	2271	abstract	37368331
>	O	2271	2272	abstract	37368331
of	O	2273	2275	abstract	37368331
the	O	2276	2279	abstract	37368331
Phylum	O	2280	2286	abstract	37368331
:	O	2286	2287	abstract	37368331
Verrucomicrobiota	B-bacteria	2288	2305	abstract	37368331
;	O	2305	2306	abstract	37368331
3	O	2307	2308	abstract	37368331
.	O	2308	2309	abstract	37368331

Genus	O	2310	2315	abstract	37368331
:	O	2315	2316	abstract	37368331
<	O	2317	2318	abstract	37368331
i	O	2318	2319	abstract	37368331
>	O	2319	2320	abstract	37368331
Lactobacillus</i	B-bacteria	2320	2336	abstract	37368331
>	O	2336	2337	abstract	37368331
and	O	2338	2341	abstract	37368331
<	O	2342	2343	abstract	37368331
i	O	2343	2344	abstract	37368331
>	O	2344	2345	abstract	37368331
Roseburia</i	B-bacteria	2345	2357	abstract	37368331
>	O	2357	2358	abstract	37368331
of	O	2359	2361	abstract	37368331
the	O	2362	2365	abstract	37368331
Phylum	O	2366	2372	abstract	37368331
:	O	2372	2373	abstract	37368331
Firmicutes	B-bacteria	2374	2384	abstract	37368331
;	O	2384	2385	abstract	37368331
4	O	2386	2387	abstract	37368331
.	O	2387	2388	abstract	37368331
Family	O	2389	2395	abstract	37368331
:	O	2395	2396	abstract	37368331
<	O	2397	2398	abstract	37368331
i	O	2398	2399	abstract	37368331
>	O	2399	2400	abstract	37368331
Lactobacillaceae</i	B-bacteria	2400	2419	abstract	37368331
>	O	2419	2420	abstract	37368331
of	O	2421	2423	abstract	37368331
the	O	2424	2427	abstract	37368331
Phylum	O	2428	2434	abstract	37368331
:	O	2434	2435	abstract	37368331
Firmicutes	B-bacteria	2436	2446	abstract	37368331
;	O	2446	2447	abstract	37368331
5	O	2448	2449	abstract	37368331
.	O	2449	2450	abstract	37368331

Family	O	2451	2457	abstract	37368331
:	O	2457	2458	abstract	37368331
<	O	2459	2460	abstract	37368331
i	O	2460	2461	abstract	37368331
>	O	2461	2462	abstract	37368331
Barnesiellaceae</i	B-bacteria	2462	2480	abstract	37368331
>	O	2480	2481	abstract	37368331
of	O	2482	2484	abstract	37368331
the	O	2485	2488	abstract	37368331
Phylum	O	2489	2495	abstract	37368331
:	O	2495	2496	abstract	37368331
Bacteroidetes	B-bacteria	2497	2510	abstract	37368331
;	O	2510	2511	abstract	37368331
6	O	2512	2513	abstract	37368331
.	O	2513	2514	abstract	37368331

Genus	O	2515	2520	abstract	37368331
:	O	2520	2521	abstract	37368331
<	O	2522	2523	abstract	37368331
i	O	2523	2524	abstract	37368331
>	O	2524	2525	abstract	37368331
Bifidobacterium</i	B-bacteria	2525	2543	abstract	37368331
>	O	2543	2544	abstract	37368331
of	O	2545	2547	abstract	37368331
the	O	2548	2551	abstract	37368331
Phylum	O	2552	2558	abstract	37368331
:	O	2558	2559	abstract	37368331
Actinobacteriota	B-bacteria	2560	2576	abstract	37368331
;	O	2576	2577	abstract	37368331
7	O	2578	2579	abstract	37368331
.	O	2579	2580	abstract	37368331

Species	O	2581	2588	abstract	37368331
:	O	2588	2589	abstract	37368331
<	O	2590	2591	abstract	37368331
i	O	2591	2592	abstract	37368331
>	O	2592	2593	abstract	37368331
Bilophila	B-bacteria	2593	2602	abstract	37368331
wadsworthia</i	I-bacteria	2603	2617	abstract	37368331
>	O	2617	2618	abstract	37368331
of	O	2619	2621	abstract	37368331
the	O	2622	2625	abstract	37368331
Phylum	O	2626	2632	abstract	37368331
:	O	2632	2633	abstract	37368331
Thermodesulfobacteriota	B-bacteria	2634	2657	abstract	37368331
,	O	2657	2658	abstract	37368331
was	O	2659	2662	abstract	37368331
identified	O	2663	2673	abstract	37368331
.	O	2673	2674	abstract	37368331

Only	O	2675	2679	abstract	37368331
one	O	2680	2683	abstract	37368331
Genus	O	2684	2689	abstract	37368331
:	O	2689	2690	abstract	37368331
<	O	2691	2692	abstract	37368331
i	O	2692	2693	abstract	37368331
>	O	2693	2694	abstract	37368331
Prevotella</i	B-bacteria	2694	2707	abstract	37368331
>	O	2707	2708	abstract	37368331
of	O	2709	2711	abstract	37368331
the	O	2712	2715	abstract	37368331
Phylum	O	2716	2722	abstract	37368331
:	O	2722	2723	abstract	37368331
Bacteroidetes	B-bacteria	2724	2737	abstract	37368331
was	O	2738	2741	abstract	37368331
decreased	O	2742	2751	abstract	37368331
.	O	2751	2752	abstract	37368331

In	O	2753	2755	abstract	37368331
the	O	2756	2759	abstract	37368331
third	O	2760	2765	abstract	37368331
and	O	2766	2769	abstract	37368331
last	O	2770	2774	abstract	37368331
region	O	2775	2781	abstract	37368331
,	O	2781	2782	abstract	37368331
an	O	2783	2785	abstract	37368331
augmented	O	2786	2795	abstract	37368331
number	O	2796	2802	abstract	37368331
of	O	2803	2805	abstract	37368331
these	O	2806	2811	abstract	37368331
bacteria	O	2812	2820	abstract	37368331
were	O	2821	2825	abstract	37368331
found	O	2826	2831	abstract	37368331
:	O	2831	2832	abstract	37368331
1	O	2833	2834	abstract	37368331
.	O	2834	2835	abstract	37368331

Phylum	O	2836	2842	abstract	37368331
:	O	2842	2843	abstract	37368331
Verrucomicrobiota	B-bacteria	2844	2861	abstract	37368331
and	O	2862	2865	abstract	37368331
its	O	2866	2869	abstract	37368331
Genus	O	2870	2875	abstract	37368331
:	O	2875	2876	abstract	37368331
<	O	2877	2878	abstract	37368331
i	O	2878	2879	abstract	37368331
>	O	2879	2880	abstract	37368331
Akkermansia</i	B-bacteria	2880	2894	abstract	37368331
>	O	2894	2895	abstract	37368331
;	O	2895	2896	abstract	37368331
2	O	2897	2898	abstract	37368331
.	O	2898	2899	abstract	37368331

Family	O	2900	2906	abstract	37368331
:	O	2906	2907	abstract	37368331
<	O	2908	2909	abstract	37368331
i	O	2909	2910	abstract	37368331
>	O	2910	2911	abstract	37368331
Bifidobacteriaceae</i	B-bacteria	2911	2932	abstract	37368331
>	O	2932	2933	abstract	37368331
and	O	2934	2937	abstract	37368331
<	O	2938	2939	abstract	37368331
i	O	2939	2940	abstract	37368331
>	O	2940	2941	abstract	37368331
Coriobacteriaceae</i	B-bacteria	2941	2961	abstract	37368331
>	O	2961	2962	abstract	37368331
of	O	2963	2965	abstract	37368331
the	O	2966	2969	abstract	37368331
Phylum	O	2970	2976	abstract	37368331
:	O	2976	2977	abstract	37368331
Actinobacteriota	B-bacteria	2978	2994	abstract	37368331
;	O	2994	2995	abstract	37368331
3	O	2996	2997	abstract	37368331
.	O	2997	2998	abstract	37368331

Phylum	O	2999	3005	abstract	37368331
:	O	3005	3006	abstract	37368331
Firmicutes	B-bacteria	3007	3017	abstract	37368331
and	O	3018	3021	abstract	37368331
its	O	3022	3025	abstract	37368331
Family	O	3026	3032	abstract	37368331
:	O	3032	3033	abstract	37368331
<	O	3034	3035	abstract	37368331
i	O	3035	3036	abstract	37368331
>	O	3036	3037	abstract	37368331
Christensenellaceae</i	B-bacteria	3037	3059	abstract	37368331
>	O	3059	3060	abstract	37368331
and	O	3061	3064	abstract	37368331
<	O	3065	3066	abstract	37368331
i	O	3066	3067	abstract	37368331
>	O	3067	3068	abstract	37368331
Lactobacillaceae</i	B-bacteria	3068	3087	abstract	37368331
>	O	3087	3088	abstract	37368331
;	O	3088	3089	abstract	37368331
4	O	3090	3091	abstract	37368331
.	O	3091	3092	abstract	37368331
Family	O	3093	3099	abstract	37368331
:	O	3099	3100	abstract	37368331
<	O	3101	3102	abstract	37368331
i	O	3102	3103	abstract	37368331
>	O	3103	3104	abstract	37368331
Enterococcaceae</i	B-bacteria	3104	3122	abstract	37368331
>	O	3122	3123	abstract	37368331
and	O	3124	3127	abstract	37368331
its	O	3128	3131	abstract	37368331
Genus	O	3132	3137	abstract	37368331
:	O	3137	3138	abstract	37368331
<	O	3139	3140	abstract	37368331
i	O	3140	3141	abstract	37368331
>	O	3141	3142	abstract	37368331
Enterococcus</i	B-bacteria	3142	3157	abstract	37368331
>	O	3157	3158	abstract	37368331
,	O	3158	3159	abstract	37368331
of	O	3160	3162	abstract	37368331
the	O	3163	3166	abstract	37368331
Phylum	O	3167	3173	abstract	37368331
:	O	3173	3174	abstract	37368331
Firmicutes	B-bacteria	3175	3185	abstract	37368331
;	O	3185	3186	abstract	37368331
5	O	3187	3188	abstract	37368331
.	O	3188	3189	abstract	37368331

Genus	O	3190	3195	abstract	37368331
:	O	3195	3196	abstract	37368331
<	O	3197	3198	abstract	37368331
i	O	3198	3199	abstract	37368331
>	O	3199	3200	abstract	37368331
Lactococcus</i	B-bacteria	3200	3214	abstract	37368331
>	O	3214	3215	abstract	37368331
and	O	3216	3219	abstract	37368331
<	O	3220	3221	abstract	37368331
i	O	3221	3222	abstract	37368331
>	O	3222	3223	abstract	37368331
Oscillospira</i	B-bacteria	3223	3238	abstract	37368331
>	O	3238	3239	abstract	37368331
,	O	3239	3240	abstract	37368331
of	O	3241	3243	abstract	37368331
the	O	3244	3247	abstract	37368331
Phylum	O	3248	3254	abstract	37368331
:	O	3254	3255	abstract	37368331
Firmicutes	B-bacteria	3256	3266	abstract	37368331
;	O	3266	3267	abstract	37368331
6	O	3268	3269	abstract	37368331
.	O	3269	3270	abstract	37368331

Phylum	O	3271	3277	abstract	37368331
:	O	3277	3278	abstract	37368331
Proteobacteria	B-bacteria	3279	3293	abstract	37368331
,	O	3293	3294	abstract	37368331
its	O	3295	3298	abstract	37368331
Family	O	3299	3305	abstract	37368331
:	O	3305	3306	abstract	37368331
<	O	3307	3308	abstract	37368331
i	O	3308	3309	abstract	37368331
>	O	3309	3310	abstract	37368331
Enterobacteriaceae</i	B-bacteria	3310	3331	abstract	37368331
>	O	3331	3332	abstract	37368331
,	O	3332	3333	abstract	37368331
and	O	3334	3337	abstract	37368331
the	O	3338	3341	abstract	37368331
Genus	O	3342	3347	abstract	37368331
:	O	3347	3348	abstract	37368331
<	O	3349	3350	abstract	37368331
i	O	3350	3351	abstract	37368331
>	O	3351	3352	abstract	37368331
Citrobacter</i	B-bacteria	3352	3366	abstract	37368331
>	O	3366	3367	abstract	37368331
,	O	3367	3368	abstract	37368331
<	O	3369	3370	abstract	37368331
i	O	3370	3371	abstract	37368331
>	O	3371	3372	abstract	37368331
Klebsiella</i	B-bacteria	3372	3385	abstract	37368331
>	O	3385	3386	abstract	37368331
,	O	3386	3387	abstract	37368331
<	O	3388	3389	abstract	37368331
i	O	3389	3390	abstract	37368331
>	O	3390	3391	abstract	37368331
Salmonella</i	B-bacteria	3391	3404	abstract	37368331
>	O	3404	3405	abstract	37368331
,	O	3405	3406	abstract	37368331
and	O	3407	3410	abstract	37368331
<	O	3411	3412	abstract	37368331
i	O	3412	3413	abstract	37368331
>	O	3413	3414	abstract	37368331
Shigella</i	B-bacteria	3414	3425	abstract	37368331
>	O	3425	3426	abstract	37368331
;	O	3426	3427	abstract	37368331
7	O	3428	3429	abstract	37368331
.	O	3429	3430	abstract	37368331

Genus	O	3431	3436	abstract	37368331
:	O	3436	3437	abstract	37368331
<	O	3438	3439	abstract	37368331
i	O	3439	3440	abstract	37368331
>	O	3440	3441	abstract	37368331
ParaBacteroides</i	B-bacteria	3441	3459	abstract	37368331
>	O	3459	3460	abstract	37368331
of	O	3461	3463	abstract	37368331
the	O	3464	3467	abstract	37368331
Phylum	O	3468	3474	abstract	37368331
:	O	3474	3475	abstract	37368331
Bacteroidetes	B-bacteria	3476	3489	abstract	37368331
.	O	3489	3490	abstract	37368331

In	O	3491	3493	abstract	37368331
contrast	O	3494	3502	abstract	37368331
,	O	3502	3503	abstract	37368331
a	O	3504	3505	abstract	37368331
significant	O	3506	3517	abstract	37368331
decrease	O	3518	3526	abstract	37368331
in	O	3527	3529	abstract	37368331
1	O	3530	3531	abstract	37368331
.	O	3531	3532	abstract	37368331
Phylum	O	3533	3539	abstract	37368331
:	O	3539	3540	abstract	37368331
Firmicutes	B-bacteria	3541	3551	abstract	37368331
,	O	3551	3552	abstract	37368331
its	O	3553	3556	abstract	37368331
Family	O	3557	3563	abstract	37368331
:	O	3563	3564	abstract	37368331
<	O	3565	3566	abstract	37368331
i	O	3566	3567	abstract	37368331
>	O	3567	3568	abstract	37368331
Lachnospiraceae</i	B-bacteria	3568	3586	abstract	37368331
>	O	3586	3587	abstract	37368331
,	O	3587	3588	abstract	37368331
and	O	3589	3592	abstract	37368331
its	O	3593	3596	abstract	37368331
Genus	O	3597	3602	abstract	37368331
:	O	3602	3603	abstract	37368331
<	O	3604	3605	abstract	37368331
i	O	3605	3606	abstract	37368331
>	O	3606	3607	abstract	37368331
Roseburia</i	B-bacteria	3607	3619	abstract	37368331
>	O	3619	3620	abstract	37368331
and	O	3621	3624	abstract	37368331
2	O	3625	3626	abstract	37368331
.	O	3626	3627	abstract	37368331

Genus	O	3628	3633	abstract	37368331
:	O	3633	3634	abstract	37368331
<	O	3635	3636	abstract	37368331
i	O	3636	3637	abstract	37368331
>	O	3637	3638	abstract	37368331
Ruminococcus</i	B-bacteria	3638	3653	abstract	37368331
>	O	3653	3654	abstract	37368331
of	O	3655	3657	abstract	37368331
the	O	3658	3661	abstract	37368331
Phylum	O	3662	3668	abstract	37368331
:	O	3668	3669	abstract	37368331
Firmicutes	B-bacteria	3670	3680	abstract	37368331
,	O	3680	3681	abstract	37368331
was	O	3682	3685	abstract	37368331
described	O	3686	3695	abstract	37368331
.	O	3695	3696	abstract	37368331

(	O	3697	3698	abstract	37368331
4	O	3698	3699	abstract	37368331
)	O	3699	3700	abstract	37368331
Conclusion	O	3701	3711	abstract	37368331
:	O	3711	3712	abstract	37368331
A	O	3713	3714	abstract	37368331
significant	O	3715	3726	abstract	37368331
gut	B-DDF	3727	3730	abstract	37368331
dysbiosis	I-DDF	3731	3740	abstract	37368331
,	O	3740	3741	abstract	37368331
involving	O	3742	3751	abstract	37368331
multiple	O	3752	3760	abstract	37368331
bacterial	O	3761	3770	abstract	37368331
taxa	O	3771	3775	abstract	37368331
,	O	3775	3776	abstract	37368331
was	O	3777	3780	abstract	37368331
found	O	3781	3786	abstract	37368331
in	O	3787	3789	abstract	37368331
PD	B-human	3790	3792	abstract	37368331
patients	I-human	3793	3801	abstract	37368331
compared	O	3802	3810	abstract	37368331
to	O	3811	3813	abstract	37368331
healthy	B-human	3814	3821	abstract	37368331
people	I-human	3822	3828	abstract	37368331
in	O	3829	3831	abstract	37368331
the	O	3832	3835	abstract	37368331
occidental	O	3836	3846	abstract	37368331
regions	O	3847	3854	abstract	37368331
.	O	3854	3855	abstract	37368331

However	O	3856	3863	abstract	37368331
,	O	3863	3864	abstract	37368331
more	O	3865	3869	abstract	37368331
studies	O	3870	3877	abstract	37368331
are	O	3878	3881	abstract	37368331
needed	O	3882	3888	abstract	37368331
to	O	3889	3891	abstract	37368331
find	O	3892	3896	abstract	37368331
the	O	3897	3900	abstract	37368331
precise	O	3901	3908	abstract	37368331
pathophysiologic	O	3909	3925	abstract	37368331
involvement	O	3926	3937	abstract	37368331
of	O	3938	3940	abstract	37368331
other	O	3941	3946	abstract	37368331
groups	O	3947	3953	abstract	37368331
of	O	3954	3956	abstract	37368331
pathogens	O	3957	3966	abstract	37368331
,	O	3966	3967	abstract	37368331
such	O	3968	3972	abstract	37368331
as	O	3973	3975	abstract	37368331
fungi	O	3976	3981	abstract	37368331
and	O	3982	3985	abstract	37368331
parasites	O	3986	3995	abstract	37368331
,	O	3995	3996	abstract	37368331
in	O	3997	3999	abstract	37368331
the	O	4000	4003	abstract	37368331
development	O	4004	4015	abstract	37368331
and	O	4016	4019	abstract	37368331
progression	O	4020	4031	abstract	37368331
of	O	4032	4034	abstract	37368331
PD	B-DDF	4035	4037	abstract	37368331
.	O	4037	4038	abstract	37368331

Sex-specific	O	0	12	title	37396336
effects	O	13	20	title	37396336
of	O	21	23	title	37396336
voluntary	B-biomedical%technique	24	33	title	37396336
wheel	I-biomedical%technique	34	39	title	37396336
running	I-biomedical%technique	40	47	title	37396336
on	O	48	50	title	37396336
behavior	O	51	59	title	37396336
and	O	60	63	title	37396336
the	O	64	67	title	37396336
gut	O	68	71	title	37396336
microbiota-immune-brain	O	72	95	title	37396336
axis	O	96	100	title	37396336
in	O	101	103	title	37396336
mice	B-animal	104	108	title	37396336
.	O	108	109	title	37396336

Physical	O	0	8	abstract	37396336
exercise	O	9	17	abstract	37396336
has	O	18	21	abstract	37396336
been	O	22	26	abstract	37396336
positioned	O	27	37	abstract	37396336
as	O	38	40	abstract	37396336
a	O	41	42	abstract	37396336
promising	O	43	52	abstract	37396336
strategy	O	53	61	abstract	37396336
to	O	62	64	abstract	37396336
prevent	O	65	72	abstract	37396336
and/or	O	73	79	abstract	37396336
alleviate	O	80	89	abstract	37396336
anxiety	B-DDF	90	97	abstract	37396336
and	O	98	101	abstract	37396336
depression	B-DDF	102	112	abstract	37396336
,	O	112	113	abstract	37396336
but	O	114	117	abstract	37396336
the	O	118	121	abstract	37396336
biological	O	122	132	abstract	37396336
processes	O	133	142	abstract	37396336
associated	O	143	153	abstract	37396336
with	O	154	158	abstract	37396336
its	O	159	162	abstract	37396336
effects	O	163	170	abstract	37396336
on	O	171	173	abstract	37396336
mental	O	174	180	abstract	37396336
health	O	181	187	abstract	37396336
have	O	188	192	abstract	37396336
yet	O	193	196	abstract	37396336
to	O	197	199	abstract	37396336
be	O	200	202	abstract	37396336
entirely	O	203	211	abstract	37396336
determined	O	212	222	abstract	37396336
.	O	222	223	abstract	37396336

Although	O	224	232	abstract	37396336
the	O	233	236	abstract	37396336
prevalence	O	237	247	abstract	37396336
of	O	248	250	abstract	37396336
depression	B-DDF	251	261	abstract	37396336
and	O	262	265	abstract	37396336
anxiety	B-DDF	266	273	abstract	37396336
in	O	274	276	abstract	37396336
women	B-human	277	282	abstract	37396336
is	O	283	285	abstract	37396336
about	O	286	291	abstract	37396336
twice	O	292	297	abstract	37396336
that	O	298	302	abstract	37396336
of	O	303	305	abstract	37396336
men	B-human	306	309	abstract	37396336
,	O	309	310	abstract	37396336
very	O	311	315	abstract	37396336
few	O	316	319	abstract	37396336
studies	O	320	327	abstract	37396336
have	O	328	332	abstract	37396336
examined	O	333	341	abstract	37396336
whether	O	342	349	abstract	37396336
physical	O	350	358	abstract	37396336
exercise	O	359	367	abstract	37396336
could	O	368	373	abstract	37396336
affect	O	374	380	abstract	37396336
mental	O	381	387	abstract	37396336
health	O	388	394	abstract	37396336
differently	O	395	406	abstract	37396336
according	O	407	416	abstract	37396336
to	O	417	419	abstract	37396336
sex	O	420	423	abstract	37396336
.	O	423	424	abstract	37396336

This	O	425	429	abstract	37396336
study	O	430	435	abstract	37396336
examined	O	436	444	abstract	37396336
,	O	444	445	abstract	37396336
in	O	446	448	abstract	37396336
singly-housed	B-animal	449	462	abstract	37396336
mice	I-animal	463	467	abstract	37396336
,	O	467	468	abstract	37396336
the	O	469	472	abstract	37396336
sex-specific	O	473	485	abstract	37396336
effects	O	486	493	abstract	37396336
of	O	494	496	abstract	37396336
voluntary	O	497	506	abstract	37396336
exercise	O	507	515	abstract	37396336
on	O	516	518	abstract	37396336
depressive-	O	519	530	abstract	37396336
and	O	531	534	abstract	37396336
anxiety-like	O	535	547	abstract	37396336
behaviors	O	548	557	abstract	37396336
as	O	558	560	abstract	37396336
well	O	561	565	abstract	37396336
as	O	566	568	abstract	37396336
on	O	569	571	abstract	37396336
different	O	572	581	abstract	37396336
markers	O	582	589	abstract	37396336
along	O	590	595	abstract	37396336
the	O	596	599	abstract	37396336
gut	O	600	603	abstract	37396336
microbiota-immune-brain	O	604	627	abstract	37396336
axis	O	628	632	abstract	37396336
.	O	632	633	abstract	37396336

Male	O	634	638	abstract	37396336
and	O	639	642	abstract	37396336
female	O	643	649	abstract	37396336
C57BL/6N	B-animal	650	658	abstract	37396336
mice	I-animal	659	663	abstract	37396336
had	O	664	667	abstract	37396336
voluntary	O	668	677	abstract	37396336
access	O	678	684	abstract	37396336
to	O	685	687	abstract	37396336
running	O	688	695	abstract	37396336
wheels	O	696	702	abstract	37396336
in	O	703	705	abstract	37396336
their	O	706	711	abstract	37396336
home-cages	O	712	722	abstract	37396336
for	O	723	726	abstract	37396336
24	O	727	729	abstract	37396336
days	O	730	734	abstract	37396336
or	O	735	737	abstract	37396336
were	O	738	742	abstract	37396336
left	O	743	747	abstract	37396336
undisturbed	O	748	759	abstract	37396336
in	O	760	762	abstract	37396336
identical	O	763	772	abstract	37396336
home-cages	O	773	783	abstract	37396336
without	O	784	791	abstract	37396336
running	O	792	799	abstract	37396336
wheels	O	800	806	abstract	37396336
.	O	806	807	abstract	37396336

Behaviors	O	808	817	abstract	37396336
were	O	818	822	abstract	37396336
then	O	823	827	abstract	37396336
examined	O	828	836	abstract	37396336
in	O	837	839	abstract	37396336
the	O	840	843	abstract	37396336
open	O	844	848	abstract	37396336
field	O	849	854	abstract	37396336
,	O	854	855	abstract	37396336
splash	B-biomedical%technique	856	862	abstract	37396336
,	O	862	863	abstract	37396336
elevated	B-biomedical%technique	864	872	abstract	37396336
plus	I-biomedical%technique	873	877	abstract	37396336
maze	I-biomedical%technique	878	882	abstract	37396336
,	O	882	883	abstract	37396336
and	O	884	887	abstract	37396336
tail	B-biomedical%technique	888	892	abstract	37396336
suspension	I-biomedical%technique	893	903	abstract	37396336
tests	I-biomedical%technique	904	909	abstract	37396336
.	O	909	910	abstract	37396336

Gene	O	911	915	abstract	37396336
expression	O	916	926	abstract	37396336
of	O	927	929	abstract	37396336
pro-inflammatory	B-chemical	930	946	abstract	37396336
cytokines	I-chemical	947	956	abstract	37396336
,	O	956	957	abstract	37396336
microglia	B-gene	958	967	abstract	37396336
activation-related	I-gene	968	986	abstract	37396336
genes	I-gene	987	992	abstract	37396336
,	O	992	993	abstract	37396336
and	O	994	997	abstract	37396336
tight	B-chemical	998	1003	abstract	37396336
junction	I-chemical	1004	1012	abstract	37396336
proteins	I-chemical	1013	1021	abstract	37396336
was	O	1022	1025	abstract	37396336
determined	O	1026	1036	abstract	37396336
in	O	1037	1039	abstract	37396336
the	O	1040	1043	abstract	37396336
jejunum	B-anatomical%location	1044	1051	abstract	37396336
and	O	1052	1055	abstract	37396336
the	O	1056	1059	abstract	37396336
hippocampus	B-anatomical%location	1060	1071	abstract	37396336
,	O	1071	1072	abstract	37396336
while	O	1073	1078	abstract	37396336
microbiota	O	1079	1089	abstract	37396336
composition	O	1090	1101	abstract	37396336
and	O	1102	1105	abstract	37396336
predicted	O	1106	1115	abstract	37396336
function	O	1116	1124	abstract	37396336
were	O	1125	1129	abstract	37396336
verified	O	1130	1138	abstract	37396336
in	O	1139	1141	abstract	37396336
cecum	B-anatomical%location	1142	1147	abstract	37396336
contents	O	1148	1156	abstract	37396336
.	O	1156	1157	abstract	37396336

Voluntary	O	1158	1167	abstract	37396336
exercise	O	1168	1176	abstract	37396336
reduced	O	1177	1184	abstract	37396336
anxiety-like	B-DDF	1185	1197	abstract	37396336
behaviors	I-DDF	1198	1207	abstract	37396336
and	O	1208	1211	abstract	37396336
altered	O	1212	1219	abstract	37396336
grooming	O	1220	1228	abstract	37396336
patterns	O	1229	1237	abstract	37396336
in	O	1238	1240	abstract	37396336
males	B-animal	1241	1246	abstract	37396336
exclusively	O	1247	1258	abstract	37396336
.	O	1258	1259	abstract	37396336

Although	O	1260	1268	abstract	37396336
the	O	1269	1272	abstract	37396336
exercise	O	1273	1281	abstract	37396336
intervention	O	1282	1294	abstract	37396336
resulted	O	1295	1303	abstract	37396336
in	O	1304	1306	abstract	37396336
changes	O	1307	1314	abstract	37396336
to	O	1315	1317	abstract	37396336
brain	B-DDF	1318	1323	abstract	37396336
inflammatory	I-DDF	1324	1336	abstract	37396336
activity	I-DDF	1337	1345	abstract	37396336
and	O	1346	1349	abstract	37396336
to	O	1350	1352	abstract	37396336
cecal	B-microbiome	1353	1358	abstract	37396336
microbiota	I-microbiome	1359	1369	abstract	37396336
composition	O	1370	1381	abstract	37396336
and	O	1382	1385	abstract	37396336
inferred	O	1386	1394	abstract	37396336
function	O	1395	1403	abstract	37396336
in	O	1404	1406	abstract	37396336
both	O	1407	1411	abstract	37396336
sexes	O	1412	1417	abstract	37396336
,	O	1417	1418	abstract	37396336
reductions	O	1419	1429	abstract	37396336
in	O	1430	1432	abstract	37396336
the	O	1433	1436	abstract	37396336
jejunal	B-DDF	1437	1444	abstract	37396336
expression	I-DDF	1445	1455	abstract	37396336
of	I-DDF	1456	1458	abstract	37396336
pro-inflammatory	I-DDF	1459	1475	abstract	37396336
markers	I-DDF	1476	1483	abstract	37396336
were	O	1484	1488	abstract	37396336
observed	O	1489	1497	abstract	37396336
in	O	1498	1500	abstract	37396336
females	B-animal	1501	1508	abstract	37396336
only	O	1509	1513	abstract	37396336
.	O	1513	1514	abstract	37396336

These	O	1515	1520	abstract	37396336
findings	O	1521	1529	abstract	37396336
support	O	1530	1537	abstract	37396336
the	O	1538	1541	abstract	37396336
view	O	1542	1546	abstract	37396336
that	O	1547	1551	abstract	37396336
voluntary	O	1552	1561	abstract	37396336
exercise	O	1562	1570	abstract	37396336
,	O	1570	1571	abstract	37396336
even	O	1572	1576	abstract	37396336
when	O	1577	1581	abstract	37396336
performed	O	1582	1591	abstract	37396336
during	O	1592	1598	abstract	37396336
a	O	1599	1600	abstract	37396336
short	O	1601	1606	abstract	37396336
period	O	1607	1613	abstract	37396336
,	O	1613	1614	abstract	37396336
is	O	1615	1617	abstract	37396336
beneficial	O	1618	1628	abstract	37396336
for	O	1629	1632	abstract	37396336
mental	O	1633	1639	abstract	37396336
and	O	1640	1643	abstract	37396336
intestinal	O	1644	1654	abstract	37396336
health	O	1655	1661	abstract	37396336
and	O	1662	1665	abstract	37396336
that	O	1666	1670	abstract	37396336
its	O	1671	1674	abstract	37396336
sex-specific	O	1675	1687	abstract	37396336
effects	O	1688	1695	abstract	37396336
on	O	1696	1698	abstract	37396336
behavior	O	1699	1707	abstract	37396336
could	O	1708	1713	abstract	37396336
be	O	1714	1716	abstract	37396336
,	O	1716	1717	abstract	37396336
at	O	1718	1720	abstract	37396336
least	O	1721	1726	abstract	37396336
in	O	1727	1729	abstract	37396336
part	O	1730	1734	abstract	37396336
,	O	1734	1735	abstract	37396336
related	O	1736	1743	abstract	37396336
to	O	1744	1746	abstract	37396336
some	O	1747	1751	abstract	37396336
components	O	1752	1762	abstract	37396336
of	O	1763	1765	abstract	37396336
the	O	1766	1769	abstract	37396336
gut	O	1770	1773	abstract	37396336
microbiota-immune-brain	O	1774	1797	abstract	37396336
axis	O	1798	1802	abstract	37396336
.	O	1802	1803	abstract	37396336

Porphyra	B-chemical	0	8	title	36517709
haitanensis	I-chemical	9	20	title	36517709
Polysaccharides	I-chemical	21	36	title	36517709
Attenuates	O	37	47	title	36517709
Blood	B-chemical	48	53	title	36517709
Lipid	I-chemical	54	59	title	36517709
via	O	60	63	title	36517709
Gut-Liver	O	64	73	title	36517709
Axis	O	74	78	title	36517709
in	O	79	81	title	36517709
Diet-Induced	B-animal	82	94	title	36517709
High-Fat	I-animal	95	103	title	36517709
Mesocricetus	I-animal	104	116	title	36517709
auratus	I-animal	117	124	title	36517709
through	O	125	132	title	36517709
Multiple	B-biomedical%technique	133	141	title	36517709
Integrated	I-biomedical%technique	142	152	title	36517709
Omics	I-biomedical%technique	153	158	title	36517709
.	O	158	159	title	36517709

Hyperlipidemia	B-DDF	0	14	abstract	36517709
is	O	15	17	abstract	36517709
currently	O	18	27	abstract	36517709
a	O	28	29	abstract	36517709
global	O	30	36	abstract	36517709
public	O	37	43	abstract	36517709
health	O	44	50	abstract	36517709
problem	O	51	58	abstract	36517709
severely	O	59	67	abstract	36517709
affecting	O	68	77	abstract	36517709
people	O	78	84	abstract	36517709
's	O	84	86	abstract	36517709
physical	O	87	95	abstract	36517709
and	O	96	99	abstract	36517709
mental	O	100	106	abstract	36517709
health	O	107	113	abstract	36517709
,	O	113	114	abstract	36517709
as	O	115	117	abstract	36517709
well	O	118	122	abstract	36517709
as	O	123	125	abstract	36517709
their	O	126	131	abstract	36517709
quality	O	132	139	abstract	36517709
of	O	140	142	abstract	36517709
life	O	143	147	abstract	36517709
.	O	147	148	abstract	36517709

The	O	149	152	abstract	36517709
present	O	153	160	abstract	36517709
study	O	161	166	abstract	36517709
is	O	167	169	abstract	36517709
aimed	O	170	175	abstract	36517709
at	O	176	178	abstract	36517709
revealing	O	179	188	abstract	36517709
the	O	189	192	abstract	36517709
mechanism	O	193	202	abstract	36517709
of	O	203	205	abstract	36517709
Porphyra	B-chemical	206	214	abstract	36517709
haitanensis	I-chemical	215	226	abstract	36517709
polysaccharide	I-chemical	227	241	abstract	36517709
(	O	242	243	abstract	36517709
PHP	B-chemical	243	246	abstract	36517709
)	O	246	247	abstract	36517709
in	O	248	250	abstract	36517709
decreasing	O	251	261	abstract	36517709
blood	B-chemical	262	267	abstract	36517709
lipids	I-chemical	268	274	abstract	36517709
by	O	275	277	abstract	36517709
acting	O	278	284	abstract	36517709
through	O	285	292	abstract	36517709
gut-liver	O	293	302	abstract	36517709
axis	O	303	307	abstract	36517709
in	O	308	310	abstract	36517709
Mesocricetus	B-animal	311	323	abstract	36517709
auratus	I-animal	324	331	abstract	36517709
fed	O	332	335	abstract	36517709
a	O	336	337	abstract	36517709
high-fat	O	338	346	abstract	36517709
diet	O	347	351	abstract	36517709
.	O	351	352	abstract	36517709

PHP	B-chemical	353	356	abstract	36517709
significantly	O	357	370	abstract	36517709
prevented	O	371	380	abstract	36517709
increases	O	381	390	abstract	36517709
in	O	391	393	abstract	36517709
serum	B-chemical	394	399	abstract	36517709
total	I-chemical	400	405	abstract	36517709
cholesterol	I-chemical	406	417	abstract	36517709
,	O	417	418	abstract	36517709
triglycerides	B-chemical	419	432	abstract	36517709
and	O	433	436	abstract	36517709
low-density	B-chemical	437	448	abstract	36517709
lipoprotein	I-chemical	449	460	abstract	36517709
cholesterol	I-chemical	461	472	abstract	36517709
,	O	472	473	abstract	36517709
and	O	474	477	abstract	36517709
alleviated	O	478	488	abstract	36517709
damage	O	489	495	abstract	36517709
to	O	496	498	abstract	36517709
liver	O	499	504	abstract	36517709
cells	O	505	510	abstract	36517709
induced	O	511	518	abstract	36517709
by	O	519	521	abstract	36517709
a	O	522	523	abstract	36517709
high-fat	O	524	532	abstract	36517709
diet	O	533	537	abstract	36517709
M.	B-animal	538	540	abstract	36517709
auratus	I-animal	541	548	abstract	36517709
,	O	548	549	abstract	36517709
in	O	550	552	abstract	36517709
a	O	553	554	abstract	36517709
dose-dependent	O	555	569	abstract	36517709
manner	O	570	576	abstract	36517709
.	O	576	577	abstract	36517709

PHP	B-chemical	578	581	abstract	36517709
promotes	O	582	590	abstract	36517709
proliferation	O	591	604	abstract	36517709
of	O	605	607	abstract	36517709
Muribaculaceae	B-bacteria	608	622	abstract	36517709
and	O	623	626	abstract	36517709
Faecalibaculum	B-bacteria	627	641	abstract	36517709
,	O	641	642	abstract	36517709
thereby	O	643	650	abstract	36517709
enhancing	O	651	660	abstract	36517709
the	O	661	664	abstract	36517709
production	O	665	675	abstract	36517709
of	O	676	678	abstract	36517709
butyric	B-chemical	679	686	abstract	36517709
acid	I-chemical	687	691	abstract	36517709
both	O	692	696	abstract	36517709
in	O	697	699	abstract	36517709
the	O	700	703	abstract	36517709
colon	B-anatomical%location	704	709	abstract	36517709
and	O	710	713	abstract	36517709
liver	B-anatomical%location	714	719	abstract	36517709
,	O	719	720	abstract	36517709
particularly	O	721	733	abstract	36517709
high-dose	B-chemical	734	743	abstract	36517709
PHP	I-chemical	744	747	abstract	36517709
(	O	748	749	abstract	36517709
HPHP	B-chemical	749	753	abstract	36517709
)	O	753	754	abstract	36517709
.	O	754	755	abstract	36517709

Low-dose	B-chemical	756	764	abstract	36517709
PHP	I-chemical	765	768	abstract	36517709
(	O	769	770	abstract	36517709
LPHP	B-chemical	770	774	abstract	36517709
)	O	774	775	abstract	36517709
promotes	O	776	784	abstract	36517709
the	O	785	788	abstract	36517709
expression	O	789	799	abstract	36517709
of	O	800	802	abstract	36517709
phosphatidylcholine	B-chemical	803	822	abstract	36517709
metabolites	I-chemical	823	834	abstract	36517709
and	O	835	838	abstract	36517709
fatty	B-gene	839	844	abstract	36517709
acid	I-gene	845	849	abstract	36517709
transport	I-gene	850	859	abstract	36517709
genes	I-gene	860	865	abstract	36517709
,	O	865	866	abstract	36517709
and	O	867	870	abstract	36517709
inhibits	O	871	879	abstract	36517709
the	O	880	883	abstract	36517709
expression	O	884	894	abstract	36517709
of	O	895	897	abstract	36517709
genes	O	898	903	abstract	36517709
involved	O	904	912	abstract	36517709
in	O	913	915	abstract	36517709
fat	O	916	919	abstract	36517709
degradation	O	920	931	abstract	36517709
(	O	932	933	abstract	36517709
Abhd5	B-gene	933	938	abstract	36517709
)	O	938	939	abstract	36517709
,	O	939	940	abstract	36517709
adipogenesis	B-gene	941	953	abstract	36517709
(	O	954	955	abstract	36517709
Me1	B-gene	955	958	abstract	36517709
)	O	958	959	abstract	36517709
,	O	959	960	abstract	36517709
fatty	O	961	966	abstract	36517709
acid	O	967	971	abstract	36517709
synthesis	O	972	981	abstract	36517709
(	O	982	983	abstract	36517709
Fasn	B-gene	983	987	abstract	36517709
and	O	988	991	abstract	36517709
Pnpla3	B-gene	992	998	abstract	36517709
)	O	998	999	abstract	36517709
,	O	999	1000	abstract	36517709
and	O	1001	1004	abstract	36517709
fatty	O	1005	1010	abstract	36517709
acid	O	1011	1015	abstract	36517709
chain	O	1016	1021	abstract	36517709
elongation	O	1022	1032	abstract	36517709
(	O	1033	1034	abstract	36517709
Elovl6	B-gene	1034	1040	abstract	36517709
)	O	1040	1041	abstract	36517709
in	O	1042	1044	abstract	36517709
the	O	1045	1048	abstract	36517709
liver	B-anatomical%location	1049	1054	abstract	36517709
.	O	1054	1055	abstract	36517709

However	O	1056	1063	abstract	36517709
,	O	1063	1064	abstract	36517709
HPHP	B-chemical	1065	1069	abstract	36517709
inhibits	O	1070	1078	abstract	36517709
the	O	1079	1082	abstract	36517709
expression	O	1083	1093	abstract	36517709
of	O	1094	1096	abstract	36517709
triglyceride	B-chemical	1097	1109	abstract	36517709
metabolites	I-chemical	1110	1121	abstract	36517709
and	O	1122	1125	abstract	36517709
promotes	O	1126	1134	abstract	36517709
the	O	1135	1138	abstract	36517709
expression	O	1139	1149	abstract	36517709
of	O	1150	1152	abstract	36517709
fatty	O	1153	1158	abstract	36517709
acid	O	1159	1163	abstract	36517709
transporter	O	1164	1175	abstract	36517709
(	O	1176	1177	abstract	36517709
CD36	B-chemical	1177	1181	abstract	36517709
)	O	1181	1182	abstract	36517709
,	O	1182	1183	abstract	36517709
fatty	O	1184	1189	abstract	36517709
acid	O	1190	1194	abstract	36517709
oxidation	O	1195	1204	abstract	36517709
(	O	1205	1206	abstract	36517709
Acacb	B-chemical	1206	1211	abstract	36517709
)	O	1211	1212	abstract	36517709
,	O	1212	1213	abstract	36517709
and	O	1214	1217	abstract	36517709
peroxisome	B-gene	1218	1228	abstract	36517709
proliferator-activated	I-gene	1229	1251	abstract	36517709
receptor	I-gene	1252	1260	abstract	36517709
gamma	I-gene	1261	1266	abstract	36517709
(	I-gene	1267	1268	abstract	36517709
PPARg	I-gene	1268	1273	abstract	36517709
)	I-gene	1273	1274	abstract	36517709
	I-gene	1274	1275	abstract	36517709
genes	I-gene	1275	1280	abstract	36517709
in	O	1281	1283	abstract	36517709
the	O	1284	1287	abstract	36517709
liver	B-anatomical%location	1288	1293	abstract	36517709
.	O	1293	1294	abstract	36517709

PHP	B-chemical	1295	1298	abstract	36517709
regulates	O	1299	1308	abstract	36517709
lipid	O	1309	1314	abstract	36517709
metabolism	O	1315	1325	abstract	36517709
through	O	1326	1333	abstract	36517709
the	O	1334	1337	abstract	36517709
gut	B-microbiome	1338	1341	abstract	36517709
microbiota	I-microbiome	1342	1352	abstract	36517709
,	O	1352	1353	abstract	36517709
and	O	1354	1357	abstract	36517709
the	O	1358	1361	abstract	36517709
gut-liver	O	1362	1371	abstract	36517709
axis	O	1372	1376	abstract	36517709
plays	O	1377	1382	abstract	36517709
an	O	1383	1385	abstract	36517709
important	O	1386	1395	abstract	36517709
role	O	1396	1400	abstract	36517709
in	O	1401	1403	abstract	36517709
its	O	1404	1407	abstract	36517709
hypolipidemic	O	1408	1421	abstract	36517709
effects	O	1422	1429	abstract	36517709
.	O	1429	1430	abstract	36517709

Intricate	O	0	9	title	37978477
role	O	10	14	title	37978477
of	O	15	17	title	37978477
intestinal	B-microbiome	18	28	title	37978477
microbe	I-microbiome	29	36	title	37978477
and	O	37	40	title	37978477
metabolite	O	41	51	title	37978477
in	O	52	54	title	37978477
schizophrenia	B-DDF	55	68	title	37978477
.	O	68	69	title	37978477

The	O	0	3	abstract	37978477
brain-gut	O	4	13	abstract	37978477
axis	O	14	18	abstract	37978477
has	O	19	22	abstract	37978477
gained	O	23	29	abstract	37978477
increasing	O	30	40	abstract	37978477
attention	O	41	50	abstract	37978477
due	O	51	54	abstract	37978477
to	O	55	57	abstract	37978477
its	O	58	61	abstract	37978477
contribution	O	62	74	abstract	37978477
to	O	75	77	abstract	37978477
the	O	78	81	abstract	37978477
etiology	O	82	90	abstract	37978477
of	O	91	93	abstract	37978477
various	O	94	101	abstract	37978477
central	B-DDF	102	109	abstract	37978477
nervous	I-DDF	110	117	abstract	37978477
system	I-DDF	118	124	abstract	37978477
disorders	I-DDF	125	134	abstract	37978477
.	O	134	135	abstract	37978477

This	O	136	140	abstract	37978477
study	O	141	146	abstract	37978477
aims	O	147	151	abstract	37978477
to	O	152	154	abstract	37978477
elucidate	O	155	164	abstract	37978477
the	O	165	168	abstract	37978477
hypothesis	O	169	179	abstract	37978477
that	O	180	184	abstract	37978477
schizophrenia	B-DDF	185	198	abstract	37978477
is	O	199	201	abstract	37978477
associated	O	202	212	abstract	37978477
with	O	213	217	abstract	37978477
disturbances	O	218	230	abstract	37978477
in	O	231	233	abstract	37978477
intestinal	B-microbiome	234	244	abstract	37978477
microflora	I-microbiome	245	255	abstract	37978477
and	O	256	259	abstract	37978477
imbalance	O	260	269	abstract	37978477
in	O	270	272	abstract	37978477
intestinal	B-chemical	273	283	abstract	37978477
metabolites	I-chemical	284	295	abstract	37978477
.	O	295	296	abstract	37978477

By	O	297	299	abstract	37978477
exploring	O	300	309	abstract	37978477
the	O	310	313	abstract	37978477
intricate	O	314	323	abstract	37978477
relationship	O	324	336	abstract	37978477
between	O	337	344	abstract	37978477
the	O	345	348	abstract	37978477
gut	B-anatomical%location	349	352	abstract	37978477
and	O	353	356	abstract	37978477
the	O	357	360	abstract	37978477
brain	B-anatomical%location	361	366	abstract	37978477
,	O	366	367	abstract	37978477
with	O	368	372	abstract	37978477
the	O	373	376	abstract	37978477
goal	O	377	381	abstract	37978477
of	O	382	384	abstract	37978477
offering	O	385	393	abstract	37978477
fresh	O	394	399	abstract	37978477
perspectives	O	400	412	abstract	37978477
and	O	413	416	abstract	37978477
valuable	O	417	425	abstract	37978477
insights	O	426	434	abstract	37978477
into	O	435	439	abstract	37978477
the	O	440	443	abstract	37978477
potential	O	444	453	abstract	37978477
contribution	O	454	466	abstract	37978477
of	O	467	469	abstract	37978477
intestinal	B-DDF	470	480	abstract	37978477
microbial	I-DDF	481	490	abstract	37978477
and	I-DDF	491	494	abstract	37978477
metabolites	I-DDF	495	506	abstract	37978477
dysbiosis	I-DDF	507	516	abstract	37978477
to	O	517	519	abstract	37978477
the	O	520	523	abstract	37978477
etiology	O	524	532	abstract	37978477
of	O	533	535	abstract	37978477
schizophrenia	B-DDF	536	549	abstract	37978477
.	O	549	550	abstract	37978477

In	O	551	553	abstract	37978477
this	O	554	558	abstract	37978477
study	O	559	564	abstract	37978477
,	O	564	565	abstract	37978477
we	O	566	568	abstract	37978477
used	O	569	573	abstract	37978477
a	O	574	575	abstract	37978477
16S	B-biomedical%technique	576	579	abstract	37978477
ribosomal	I-biomedical%technique	580	589	abstract	37978477
RNA	I-biomedical%technique	590	593	abstract	37978477
(	I-biomedical%technique	594	595	abstract	37978477
16S	I-biomedical%technique	595	598	abstract	37978477
rRNA	I-biomedical%technique	599	603	abstract	37978477
)	I-biomedical%technique	603	604	abstract	37978477
gene	I-biomedical%technique	605	609	abstract	37978477
sequence-based	I-biomedical%technique	610	624	abstract	37978477
approach	I-biomedical%technique	625	633	abstract	37978477
and	O	634	637	abstract	37978477
an	O	638	640	abstract	37978477
untargeted	B-biomedical%technique	641	651	abstract	37978477
liquid	I-biomedical%technique	652	658	abstract	37978477
chromatography-mass	I-biomedical%technique	659	678	abstract	37978477
spectrometry-based	I-biomedical%technique	679	697	abstract	37978477
metabolic	I-biomedical%technique	698	707	abstract	37978477
profiling	I-biomedical%technique	708	717	abstract	37978477
approach	I-biomedical%technique	718	726	abstract	37978477
to	O	727	729	abstract	37978477
measure	O	730	737	abstract	37978477
the	O	738	741	abstract	37978477
gut	B-microbiome	742	745	abstract	37978477
microbiome	I-microbiome	746	756	abstract	37978477
and	O	757	760	abstract	37978477
microbial	B-chemical	761	770	abstract	37978477
metabolites	I-chemical	771	782	abstract	37978477
from	O	783	787	abstract	37978477
44	O	788	790	abstract	37978477
healthy	B-human	791	798	abstract	37978477
controls	I-human	799	807	abstract	37978477
,	O	807	808	abstract	37978477
41	O	809	811	abstract	37978477
acute	B-human	812	817	abstract	37978477
patients	I-human	818	826	abstract	37978477
,	O	826	827	abstract	37978477
and	O	828	831	abstract	37978477
39	O	832	834	abstract	37978477
remission	B-human	835	844	abstract	37978477
patients	I-human	845	853	abstract	37978477
,	O	853	854	abstract	37978477
to	O	855	857	abstract	37978477
evaluate	O	858	866	abstract	37978477
whether	O	867	874	abstract	37978477
microbial	B-DDF	875	884	abstract	37978477
dysbiosis	I-DDF	885	894	abstract	37978477
and	O	895	898	abstract	37978477
microbial	O	899	908	abstract	37978477
metabolite	O	909	919	abstract	37978477
biomarkers	O	920	930	abstract	37978477
were	O	931	935	abstract	37978477
linked	O	936	942	abstract	37978477
with	O	943	947	abstract	37978477
the	O	948	951	abstract	37978477
severity	O	952	960	abstract	37978477
of	O	961	963	abstract	37978477
schizophrenic	O	964	977	abstract	37978477
symptoms	O	978	986	abstract	37978477
.	O	986	987	abstract	37978477

Here	O	988	992	abstract	37978477
,	O	992	993	abstract	37978477
we	O	994	996	abstract	37978477
identified	O	997	1007	abstract	37978477
20	O	1008	1010	abstract	37978477
dominant	O	1011	1019	abstract	37978477
disturbances	O	1020	1032	abstract	37978477
in	O	1033	1035	abstract	37978477
the	O	1036	1039	abstract	37978477
gut	B-human	1040	1043	abstract	37978477
microbial	I-human	1044	1053	abstract	37978477
composition	I-human	1054	1065	abstract	37978477
of	I-human	1066	1068	abstract	37978477
patients	I-human	1069	1077	abstract	37978477
compared	O	1078	1086	abstract	37978477
with	O	1087	1091	abstract	37978477
healthy	B-human	1092	1099	abstract	37978477
controls	I-human	1100	1108	abstract	37978477
,	O	1108	1109	abstract	37978477
with	O	1110	1114	abstract	37978477
3	O	1115	1116	abstract	37978477
orders	O	1117	1123	abstract	37978477
,	O	1123	1124	abstract	37978477
4	O	1125	1126	abstract	37978477
families	O	1127	1135	abstract	37978477
,	O	1135	1136	abstract	37978477
9	O	1137	1138	abstract	37978477
genera	O	1139	1145	abstract	37978477
,	O	1145	1146	abstract	37978477
and	O	1147	1150	abstract	37978477
4	O	1151	1152	abstract	37978477
species	O	1153	1160	abstract	37978477
.	O	1160	1161	abstract	37978477

Several	O	1162	1169	abstract	37978477
unique	O	1170	1176	abstract	37978477
bacterial	O	1177	1186	abstract	37978477
taxa	O	1187	1191	abstract	37978477
associated	O	1192	1202	abstract	37978477
with	O	1203	1207	abstract	37978477
schizophrenia	B-DDF	1208	1221	abstract	37978477
severity	O	1222	1230	abstract	37978477
.	O	1230	1231	abstract	37978477

Compared	O	1232	1240	abstract	37978477
with	O	1241	1245	abstract	37978477
healthy	B-human	1246	1253	abstract	37978477
controls	I-human	1254	1262	abstract	37978477
,	O	1262	1263	abstract	37978477
145	O	1264	1267	abstract	37978477
unusual	O	1268	1275	abstract	37978477
microflora	B-chemical	1276	1286	abstract	37978477
metabolites	I-chemical	1287	1298	abstract	37978477
were	O	1299	1303	abstract	37978477
detected	O	1304	1312	abstract	37978477
in	O	1313	1315	abstract	37978477
the	O	1316	1319	abstract	37978477
acute	O	1320	1325	abstract	37978477
and	O	1326	1329	abstract	37978477
remission	O	1330	1339	abstract	37978477
groups	O	1340	1346	abstract	37978477
,	O	1346	1347	abstract	37978477
which	O	1348	1353	abstract	37978477
were	O	1354	1358	abstract	37978477
mainly	O	1359	1365	abstract	37978477
involved	O	1366	1374	abstract	37978477
in	O	1375	1377	abstract	37978477
environmental	O	1378	1391	abstract	37978477
information	O	1392	1403	abstract	37978477
processing	O	1404	1414	abstract	37978477
,	O	1414	1415	abstract	37978477
metabolism	O	1416	1426	abstract	37978477
,	O	1426	1427	abstract	37978477
organismal	O	1428	1438	abstract	37978477
systems	O	1439	1446	abstract	37978477
,	O	1446	1447	abstract	37978477
and	O	1448	1451	abstract	37978477
human	O	1452	1457	abstract	37978477
diseases	O	1458	1466	abstract	37978477
in	O	1467	1469	abstract	37978477
the	O	1470	1473	abstract	37978477
Kyoto	O	1474	1479	abstract	37978477
encyclopedia	O	1480	1492	abstract	37978477
of	O	1493	1495	abstract	37978477
genes	O	1496	1501	abstract	37978477
and	O	1502	1505	abstract	37978477
genomes	O	1506	1513	abstract	37978477
pathway	O	1514	1521	abstract	37978477
.	O	1521	1522	abstract	37978477

The	O	1523	1526	abstract	37978477
Sankey	O	1527	1533	abstract	37978477
diagram	O	1534	1541	abstract	37978477
showed	O	1542	1548	abstract	37978477
that	O	1549	1553	abstract	37978477
4	O	1554	1555	abstract	37978477
abnormal	O	1556	1564	abstract	37978477
intestinal	O	1565	1575	abstract	37978477
and	O	1576	1579	abstract	37978477
4	O	1580	1581	abstract	37978477
anomalous	O	1582	1591	abstract	37978477
intestinal	O	1592	1602	abstract	37978477
microbial	B-chemical	1603	1612	abstract	37978477
metabolites	I-chemical	1613	1624	abstract	37978477
were	O	1625	1629	abstract	37978477
associated	O	1630	1640	abstract	37978477
with	O	1641	1645	abstract	37978477
psychiatric	B-DDF	1646	1657	abstract	37978477
clinical	I-DDF	1658	1666	abstract	37978477
symptoms	I-DDF	1667	1675	abstract	37978477
.	O	1675	1676	abstract	37978477

These	O	1677	1682	abstract	37978477
findings	O	1683	1691	abstract	37978477
suggest	O	1692	1699	abstract	37978477
a	O	1700	1701	abstract	37978477
possible	O	1702	1710	abstract	37978477
interactive	O	1711	1722	abstract	37978477
influence	O	1723	1732	abstract	37978477
of	O	1733	1735	abstract	37978477
the	O	1736	1739	abstract	37978477
gut	B-microbiome	1740	1743	abstract	37978477
microbiota	I-microbiome	1744	1754	abstract	37978477
and	O	1755	1758	abstract	37978477
their	O	1759	1764	abstract	37978477
metabolites	O	1765	1776	abstract	37978477
on	O	1777	1779	abstract	37978477
the	O	1780	1783	abstract	37978477
pathophysiology	O	1784	1799	abstract	37978477
of	O	1800	1802	abstract	37978477
schizophrenia	B-DDF	1803	1816	abstract	37978477
.	O	1816	1817	abstract	37978477

Affective	B-DDF	0	9	title	33713734
disorders	I-DDF	10	19	title	33713734
impact	O	20	26	title	33713734
prevalence	O	27	37	title	33713734
of	O	38	40	title	33713734
Flavonifractor	B-bacteria	41	55	title	33713734
and	O	56	59	title	33713734
abundance	O	60	69	title	33713734
of	O	70	72	title	33713734
Christensenellaceae	B-bacteria	73	92	title	33713734
in	O	93	95	title	33713734
gut	B-microbiome	96	99	title	33713734
microbiota	I-microbiome	100	110	title	33713734
.	O	110	111	title	33713734

Background	O	0	10	abstract	33713734
Affective	B-DDF	11	20	abstract	33713734
disorders	I-DDF	21	30	abstract	33713734
(	O	31	32	abstract	33713734
AD	B-DDF	32	34	abstract	33713734
)	O	34	35	abstract	33713734
have	O	36	40	abstract	33713734
been	O	41	45	abstract	33713734
associated	O	46	56	abstract	33713734
with	O	57	61	abstract	33713734
a	O	62	63	abstract	33713734
higher	O	64	70	abstract	33713734
prevalence	O	71	81	abstract	33713734
of	O	82	84	abstract	33713734
the	O	85	88	abstract	33713734
gut	B-bacteria	89	92	abstract	33713734
Flavonifractor	I-bacteria	93	107	abstract	33713734
genus	I-bacteria	108	113	abstract	33713734
and	O	114	117	abstract	33713734
a	O	118	119	abstract	33713734
lower	O	120	125	abstract	33713734
abundance	O	126	135	abstract	33713734
of	O	136	138	abstract	33713734
the	O	139	142	abstract	33713734
gut	B-bacteria	143	146	abstract	33713734
Christensenellaceae	I-bacteria	147	166	abstract	33713734
family	I-bacteria	167	173	abstract	33713734
.	O	173	174	abstract	33713734

Objective	O	175	184	abstract	33713734
and	O	185	188	abstract	33713734
methods	O	189	196	abstract	33713734
By	O	197	199	abstract	33713734
pooling	O	200	207	abstract	33713734
two	O	208	211	abstract	33713734
independent	O	212	223	abstract	33713734
study	O	224	229	abstract	33713734
samples	O	230	237	abstract	33713734
of	O	238	240	abstract	33713734
patients	B-human	241	249	abstract	33713734
with	O	250	254	abstract	33713734
AD	B-DDF	255	257	abstract	33713734
(	O	258	259	abstract	33713734
n	O	259	260	abstract	33713734
	O	260	261	abstract	33713734
=	O	261	262	abstract	33713734
	O	262	263	abstract	33713734
176	O	263	266	abstract	33713734
)	O	266	267	abstract	33713734
,	O	267	268	abstract	33713734
their	O	269	274	abstract	33713734
unaffected	B-human	275	285	abstract	33713734
first-degree	I-human	286	298	abstract	33713734
relatives	I-human	299	308	abstract	33713734
(	O	309	310	abstract	33713734
n	O	310	311	abstract	33713734
	O	311	312	abstract	33713734
=	O	312	313	abstract	33713734
	O	313	314	abstract	33713734
70	O	314	316	abstract	33713734
)	O	316	317	abstract	33713734
and	O	318	321	abstract	33713734
healthy	B-human	322	329	abstract	33713734
controls	I-human	330	338	abstract	33713734
(	O	339	340	abstract	33713734
n	O	340	341	abstract	33713734
	O	341	342	abstract	33713734
=	O	342	343	abstract	33713734
	O	343	344	abstract	33713734
101	O	344	347	abstract	33713734
)	O	347	348	abstract	33713734
we	O	349	351	abstract	33713734
aimed	O	352	357	abstract	33713734
to	O	358	360	abstract	33713734
replicate	O	361	370	abstract	33713734
and	O	371	374	abstract	33713734
extend	O	375	381	abstract	33713734
our	O	382	385	abstract	33713734
prior	O	386	391	abstract	33713734
findings	O	392	400	abstract	33713734
of	O	401	403	abstract	33713734
differential	O	404	416	abstract	33713734
Flavonifractor	B-bacteria	417	431	abstract	33713734
prevalence	O	432	442	abstract	33713734
and	O	443	446	abstract	33713734
Christensenellaceae	B-bacteria	447	466	abstract	33713734
abundance	O	467	476	abstract	33713734
when	O	477	481	abstract	33713734
comparing	O	482	491	abstract	33713734
patients	B-human	492	500	abstract	33713734
with	O	501	505	abstract	33713734
AD	B-DDF	506	508	abstract	33713734
and	O	509	512	abstract	33713734
healthy	B-human	513	520	abstract	33713734
controls	I-human	521	529	abstract	33713734
.	O	529	530	abstract	33713734

The	O	531	534	abstract	33713734
gut	B-microbiome	535	538	abstract	33713734
microbiota	I-microbiome	539	549	abstract	33713734
was	O	550	553	abstract	33713734
profiled	O	554	562	abstract	33713734
using	O	563	568	abstract	33713734
16S	B-biomedical%technique	569	572	abstract	33713734
rRNA	I-biomedical%technique	573	577	abstract	33713734
gene	I-biomedical%technique	578	582	abstract	33713734
amplicon	I-biomedical%technique	583	591	abstract	33713734
sequencing	I-biomedical%technique	592	602	abstract	33713734
.	O	602	603	abstract	33713734

Results	O	604	611	abstract	33713734
The	O	612	615	abstract	33713734
pattern	O	616	623	abstract	33713734
of	O	624	626	abstract	33713734
higher	O	627	633	abstract	33713734
prevalence	O	634	644	abstract	33713734
of	O	645	647	abstract	33713734
Flavonifractor	B-bacteria	648	662	abstract	33713734
and	O	663	666	abstract	33713734
lower	O	667	672	abstract	33713734
Centered	O	673	681	abstract	33713734
Log-Ratio	O	682	691	abstract	33713734
(	O	692	693	abstract	33713734
CLR	O	693	696	abstract	33713734
)	O	696	697	abstract	33713734
abundance	O	698	707	abstract	33713734
of	O	708	710	abstract	33713734
Christensenellaceae	B-bacteria	711	730	abstract	33713734
was	O	731	734	abstract	33713734
associated	O	735	745	abstract	33713734
with	O	746	750	abstract	33713734
AD	B-DDF	751	753	abstract	33713734
.	O	753	754	abstract	33713734

In	O	755	757	abstract	33713734
generalized	O	758	769	abstract	33713734
linear	O	770	776	abstract	33713734
models	O	777	783	abstract	33713734
the	O	784	787	abstract	33713734
CLR	O	788	791	abstract	33713734
abundance	O	792	801	abstract	33713734
of	O	802	804	abstract	33713734
Christensenellaceae	B-bacteria	805	824	abstract	33713734
was	O	825	828	abstract	33713734
lower	O	829	834	abstract	33713734
in	O	835	837	abstract	33713734
patients	B-human	838	846	abstract	33713734
with	O	847	851	abstract	33713734
AD	B-DDF	852	854	abstract	33713734
(	O	855	856	abstract	33713734
p	O	856	857	abstract	33713734
	O	857	858	abstract	33713734
=	O	858	859	abstract	33713734
	O	859	860	abstract	33713734
0.024	O	860	865	abstract	33713734
)	O	865	866	abstract	33713734
,	O	866	867	abstract	33713734
and	O	868	871	abstract	33713734
in	O	872	874	abstract	33713734
smokers	B-human	875	882	abstract	33713734
(	O	883	884	abstract	33713734
p	O	884	885	abstract	33713734
	O	885	886	abstract	33713734
=	O	886	887	abstract	33713734
	O	887	888	abstract	33713734
1.9	O	888	891	abstract	33713734
*	O	891	892	abstract	33713734
10<sup>-4</sup	O	892	906	abstract	33713734
>	O	906	907	abstract	33713734
)	O	907	908	abstract	33713734
,	O	908	909	abstract	33713734
and	O	910	913	abstract	33713734
inversely	O	914	923	abstract	33713734
associated	O	924	934	abstract	33713734
with	O	935	939	abstract	33713734
increasing	O	940	950	abstract	33713734
waist	O	951	956	abstract	33713734
circumference	O	957	970	abstract	33713734
(	O	971	972	abstract	33713734
p	O	972	973	abstract	33713734
	O	973	974	abstract	33713734
=	O	974	975	abstract	33713734
	O	975	976	abstract	33713734
0.031	O	976	981	abstract	33713734
)	O	981	982	abstract	33713734
.	O	982	983	abstract	33713734

The	O	984	987	abstract	33713734
prevalence	O	988	998	abstract	33713734
of	O	999	1001	abstract	33713734
Flavonifractor	B-bacteria	1002	1016	abstract	33713734
was	O	1017	1020	abstract	33713734
higher	O	1021	1027	abstract	33713734
in	O	1028	1030	abstract	33713734
patients	B-human	1031	1039	abstract	33713734
with	O	1040	1044	abstract	33713734
AD	B-DDF	1045	1047	abstract	33713734
(	O	1048	1049	abstract	33713734
p	O	1049	1050	abstract	33713734
	O	1050	1051	abstract	33713734
=	O	1051	1052	abstract	33713734
	O	1052	1053	abstract	33713734
0.033	O	1053	1058	abstract	33713734
)	O	1058	1059	abstract	33713734
and	O	1060	1063	abstract	33713734
in	O	1064	1066	abstract	33713734
smokers	B-human	1067	1074	abstract	33713734
(	O	1075	1076	abstract	33713734
p	O	1076	1077	abstract	33713734
	O	1077	1078	abstract	33713734
=	O	1078	1079	abstract	33713734
	O	1079	1080	abstract	33713734
0.036	O	1080	1085	abstract	33713734
)	O	1085	1086	abstract	33713734
.	O	1086	1087	abstract	33713734

No	O	1088	1090	abstract	33713734
impact	O	1091	1097	abstract	33713734
of	O	1098	1100	abstract	33713734
psychotropic	B-drug	1101	1113	abstract	33713734
medication	I-drug	1114	1124	abstract	33713734
was	O	1125	1128	abstract	33713734
found	O	1129	1134	abstract	33713734
.	O	1134	1135	abstract	33713734

The	O	1136	1139	abstract	33713734
CLR	O	1140	1143	abstract	33713734
abundance	O	1144	1153	abstract	33713734
of	O	1154	1156	abstract	33713734
Christensenellaceae	B-bacteria	1157	1176	abstract	33713734
(	O	1177	1178	abstract	33713734
p	O	1178	1179	abstract	33713734
	O	1179	1180	abstract	33713734
=	O	1180	1181	abstract	33713734
	O	1181	1182	abstract	33713734
0.041	O	1182	1187	abstract	33713734
)	O	1187	1188	abstract	33713734
,	O	1188	1189	abstract	33713734
but	O	1190	1193	abstract	33713734
not	O	1194	1197	abstract	33713734
the	O	1198	1201	abstract	33713734
prevalence	O	1202	1212	abstract	33713734
of	O	1213	1215	abstract	33713734
Flavonifractor	B-bacteria	1216	1230	abstract	33713734
(	O	1231	1232	abstract	33713734
p	O	1232	1233	abstract	33713734
	O	1233	1234	abstract	33713734
=	O	1234	1235	abstract	33713734
	O	1235	1236	abstract	33713734
0.20	O	1236	1240	abstract	33713734
)	O	1240	1241	abstract	33713734
could	O	1242	1247	abstract	33713734
distinguish	O	1248	1259	abstract	33713734
non-smoking	B-human	1260	1271	abstract	33713734
patients	I-human	1272	1280	abstract	33713734
with	O	1281	1285	abstract	33713734
AD	B-DDF	1286	1288	abstract	33713734
from	O	1289	1293	abstract	33713734
non-smoking	B-human	1294	1305	abstract	33713734
healthy	I-human	1306	1313	abstract	33713734
controls	I-human	1314	1322	abstract	33713734
,	O	1322	1323	abstract	33713734
whereas	O	1324	1331	abstract	33713734
no	O	1332	1334	abstract	33713734
such	O	1335	1339	abstract	33713734
associations	O	1340	1352	abstract	33713734
were	O	1353	1357	abstract	33713734
found	O	1358	1363	abstract	33713734
in	O	1364	1366	abstract	33713734
smokers	B-human	1367	1374	abstract	33713734
.	O	1374	1375	abstract	33713734

Unaffected	B-human	1376	1386	abstract	33713734
relatives	I-human	1387	1396	abstract	33713734
neither	O	1397	1404	abstract	33713734
differed	O	1405	1413	abstract	33713734
from	O	1414	1418	abstract	33713734
patients	B-human	1419	1427	abstract	33713734
with	O	1428	1432	abstract	33713734
AD	B-DDF	1433	1435	abstract	33713734
nor	O	1436	1439	abstract	33713734
from	O	1440	1444	abstract	33713734
healthy	B-human	1445	1452	abstract	33713734
controls	I-human	1453	1461	abstract	33713734
.	O	1461	1462	abstract	33713734

Conclusion	O	1463	1473	abstract	33713734
Compared	O	1474	1482	abstract	33713734
with	O	1483	1487	abstract	33713734
findings	O	1488	1496	abstract	33713734
in	O	1497	1499	abstract	33713734
healthy	B-human	1500	1507	abstract	33713734
controls	I-human	1508	1516	abstract	33713734
,	O	1516	1517	abstract	33713734
AD	B-DDF	1518	1520	abstract	33713734
was	O	1521	1524	abstract	33713734
associated	O	1525	1535	abstract	33713734
with	O	1536	1540	abstract	33713734
a	O	1541	1542	abstract	33713734
significantly	O	1543	1556	abstract	33713734
lower	O	1557	1562	abstract	33713734
CLR	O	1563	1566	abstract	33713734
abundance	O	1567	1576	abstract	33713734
of	O	1577	1579	abstract	33713734
the	O	1580	1583	abstract	33713734
health-linked	O	1584	1597	abstract	33713734
Christensenellaceae	B-bacteria	1598	1617	abstract	33713734
and	O	1618	1621	abstract	33713734
a	O	1622	1623	abstract	33713734
significantly	O	1624	1637	abstract	33713734
higher	O	1638	1644	abstract	33713734
prevalence	O	1645	1655	abstract	33713734
of	O	1656	1658	abstract	33713734
Flavonifractor	B-bacteria	1659	1673	abstract	33713734
;	O	1673	1674	abstract	33713734
findings	O	1675	1683	abstract	33713734
that	O	1684	1688	abstract	33713734
are	O	1689	1692	abstract	33713734
associated	O	1693	1703	abstract	33713734
with	O	1704	1708	abstract	33713734
enhanced	B-DDF	1709	1717	abstract	33713734
oxidative	I-DDF	1718	1727	abstract	33713734
stress	I-DDF	1728	1734	abstract	33713734
and	O	1735	1738	abstract	33713734
systemic	B-DDF	1739	1747	abstract	33713734
low-grade	I-DDF	1748	1757	abstract	33713734
inflammation	I-DDF	1758	1770	abstract	33713734
.	O	1770	1771	abstract	33713734

If	O	1772	1774	abstract	33713734
our	O	1775	1778	abstract	33713734
observations	O	1779	1791	abstract	33713734
are	O	1792	1795	abstract	33713734
validated	O	1796	1805	abstract	33713734
in	O	1806	1808	abstract	33713734
future	O	1809	1815	abstract	33713734
independent	O	1816	1827	abstract	33713734
studies	O	1828	1835	abstract	33713734
,	O	1835	1836	abstract	33713734
they	O	1837	1841	abstract	33713734
support	O	1842	1849	abstract	33713734
the	O	1850	1853	abstract	33713734
notion	O	1854	1860	abstract	33713734
that	O	1861	1865	abstract	33713734
parts	O	1866	1871	abstract	33713734
of	O	1872	1874	abstract	33713734
aberrant	O	1875	1883	abstract	33713734
gut	B-microbiome	1884	1887	abstract	33713734
microbiota	I-microbiome	1888	1898	abstract	33713734
are	O	1899	1902	abstract	33713734
shared	O	1903	1909	abstract	33713734
by	O	1910	1912	abstract	33713734
AD	B-DDF	1913	1915	abstract	33713734
and	O	1916	1919	abstract	33713734
states	B-DDF	1920	1926	abstract	33713734
of	I-DDF	1927	1929	abstract	33713734
dysmetabolism	I-DDF	1930	1943	abstract	33713734
.	O	1943	1944	abstract	33713734

Targeting	O	0	9	title	34830610
the	O	10	13	title	34830610
Gut	B-microbiome	14	17	title	34830610
Microbiome	I-microbiome	18	28	title	34830610
in	O	29	31	title	34830610
Prader-Willi	B-DDF	32	44	title	34830610
Syndrome	I-DDF	45	53	title	34830610
.	O	53	54	title	34830610

Overwhelming	O	0	12	abstract	34830610
evidence	O	13	21	abstract	34830610
demonstrates	O	22	34	abstract	34830610
an	O	35	37	abstract	34830610
important	O	38	47	abstract	34830610
role	O	48	52	abstract	34830610
of	O	53	55	abstract	34830610
the	O	56	59	abstract	34830610
gut	B-microbiome	60	63	abstract	34830610
microbiome	I-microbiome	64	74	abstract	34830610
in	O	75	77	abstract	34830610
the	O	78	81	abstract	34830610
development	O	82	93	abstract	34830610
of	O	94	96	abstract	34830610
a	O	97	98	abstract	34830610
wide	O	99	103	abstract	34830610
range	O	104	109	abstract	34830610
of	O	110	112	abstract	34830610
diseases	O	113	121	abstract	34830610
,	O	121	122	abstract	34830610
including	O	123	132	abstract	34830610
obesity	B-DDF	133	140	abstract	34830610
,	O	140	141	abstract	34830610
metabolic	B-DDF	142	151	abstract	34830610
disorders	I-DDF	152	161	abstract	34830610
,	O	161	162	abstract	34830610
and	O	163	166	abstract	34830610
mental	B-DDF	167	173	abstract	34830610
health	I-DDF	174	180	abstract	34830610
symptoms	I-DDF	181	189	abstract	34830610
.	O	189	190	abstract	34830610

Indeed	O	191	197	abstract	34830610
,	O	197	198	abstract	34830610
interventions	O	199	212	abstract	34830610
targeting	O	213	222	abstract	34830610
the	O	223	226	abstract	34830610
gut	B-microbiome	227	230	abstract	34830610
microbiome	I-microbiome	231	241	abstract	34830610
are	O	242	245	abstract	34830610
being	O	246	251	abstract	34830610
actively	O	252	260	abstract	34830610
investigated	O	261	273	abstract	34830610
as	O	274	276	abstract	34830610
a	O	277	278	abstract	34830610
therapeutic	O	279	290	abstract	34830610
strategy	O	291	299	abstract	34830610
to	O	300	302	abstract	34830610
tackle	O	303	309	abstract	34830610
these	O	310	315	abstract	34830610
diseases	O	316	324	abstract	34830610
.	O	324	325	abstract	34830610

Given	O	326	331	abstract	34830610
that	O	332	336	abstract	34830610
obesity	B-DDF	337	344	abstract	34830610
and	O	345	348	abstract	34830610
mental	O	349	355	abstract	34830610
health	O	356	362	abstract	34830610
symptoms	O	363	371	abstract	34830610
are	O	372	375	abstract	34830610
both	O	376	380	abstract	34830610
hallmarks	O	381	390	abstract	34830610
of	O	391	393	abstract	34830610
Prader-Willi	B-DDF	394	406	abstract	34830610
syndrome	I-DDF	407	415	abstract	34830610
,	O	415	416	abstract	34830610
targeting	O	417	426	abstract	34830610
the	O	427	430	abstract	34830610
gut	B-microbiome	431	434	abstract	34830610
microbiome	I-microbiome	435	445	abstract	34830610
may	O	446	449	abstract	34830610
be	O	450	452	abstract	34830610
a	O	453	454	abstract	34830610
promising	O	455	464	abstract	34830610
therapeutical	O	465	478	abstract	34830610
strategy	O	479	487	abstract	34830610
.	O	487	488	abstract	34830610

Only	O	489	493	abstract	34830610
a	O	494	495	abstract	34830610
few	O	496	499	abstract	34830610
studies	O	500	507	abstract	34830610
have	O	508	512	abstract	34830610
investigated	O	513	525	abstract	34830610
the	O	526	529	abstract	34830610
gut	B-microbiome	530	533	abstract	34830610
microbiome	I-microbiome	534	544	abstract	34830610
in	O	545	547	abstract	34830610
the	O	548	551	abstract	34830610
context	O	552	559	abstract	34830610
of	O	560	562	abstract	34830610
Prader-Willi	B-DDF	563	575	abstract	34830610
syndrome	I-DDF	576	584	abstract	34830610
and	O	585	588	abstract	34830610
assessed	O	589	597	abstract	34830610
the	O	598	601	abstract	34830610
efficacy	O	602	610	abstract	34830610
of	O	611	613	abstract	34830610
probiotic	B-dietary%supplement	614	623	abstract	34830610
supplementation	I-dietary%supplement	624	639	abstract	34830610
as	O	640	642	abstract	34830610
a	O	643	644	abstract	34830610
therapeutic	O	645	656	abstract	34830610
strategy	O	657	665	abstract	34830610
for	O	666	669	abstract	34830610
this	O	670	674	abstract	34830610
disease	O	675	682	abstract	34830610
.	O	682	683	abstract	34830610

Here	O	684	688	abstract	34830610
,	O	688	689	abstract	34830610
we	O	690	692	abstract	34830610
review	O	693	699	abstract	34830610
the	O	700	703	abstract	34830610
knowledge	O	704	713	abstract	34830610
obtained	O	714	722	abstract	34830610
to	O	723	725	abstract	34830610
this	O	726	730	abstract	34830610
date	O	731	735	abstract	34830610
regarding	O	736	745	abstract	34830610
the	O	746	749	abstract	34830610
gut	B-microbiome	750	753	abstract	34830610
microbiome	I-microbiome	754	764	abstract	34830610
in	O	765	767	abstract	34830610
individuals	O	768	779	abstract	34830610
with	O	780	784	abstract	34830610
Prader-Willi	B-DDF	785	797	abstract	34830610
syndrome	I-DDF	798	806	abstract	34830610
.	O	806	807	abstract	34830610

The	O	808	811	abstract	34830610
limited	O	812	819	abstract	34830610
evidence	O	820	828	abstract	34830610
available	O	829	838	abstract	34830610
indicate	O	839	847	abstract	34830610
that	O	848	852	abstract	34830610
probiotic	B-dietary%supplement	853	862	abstract	34830610
supplementation	I-dietary%supplement	863	878	abstract	34830610
improves	O	879	887	abstract	34830610
some	O	888	892	abstract	34830610
metabolic	O	893	902	abstract	34830610
and	O	903	906	abstract	34830610
mental	O	907	913	abstract	34830610
health	O	914	920	abstract	34830610
aspects	O	921	928	abstract	34830610
,	O	928	929	abstract	34830610
however	O	930	937	abstract	34830610
further	O	938	945	abstract	34830610
studies	O	946	953	abstract	34830610
are	O	954	957	abstract	34830610
warranted	O	958	967	abstract	34830610
to	O	968	970	abstract	34830610
determine	O	971	980	abstract	34830610
whether	O	981	988	abstract	34830610
targeting	O	989	998	abstract	34830610
the	O	999	1002	abstract	34830610
gut	B-microbiome	1003	1006	abstract	34830610
microbiome	I-microbiome	1007	1017	abstract	34830610
may	O	1018	1021	abstract	34830610
constitute	O	1022	1032	abstract	34830610
a	O	1033	1034	abstract	34830610
safe	O	1035	1039	abstract	34830610
and	O	1040	1043	abstract	34830610
efficient	O	1044	1053	abstract	34830610
strategy	O	1054	1062	abstract	34830610
to	O	1063	1065	abstract	34830610
treat	O	1066	1071	abstract	34830610
individuals	O	1072	1083	abstract	34830610
with	O	1084	1088	abstract	34830610
Prader-Willi	B-DDF	1089	1101	abstract	34830610
syndrome	I-DDF	1102	1110	abstract	34830610
.	O	1110	1111	abstract	34830610

Recognizing	O	0	11	title	29843470
Depression	B-DDF	12	22	title	29843470
from	O	23	27	title	29843470
the	O	28	31	title	29843470
MicrobiotaGutBrain	O	32	52	title	29843470
Axis	O	53	57	title	29843470
.	O	57	58	title	29843470

Major	B-DDF	0	5	abstract	29843470
depression	I-DDF	6	16	abstract	29843470
is	O	17	19	abstract	29843470
one	O	20	23	abstract	29843470
of	O	24	26	abstract	29843470
the	O	27	30	abstract	29843470
leading	O	31	38	abstract	29843470
causes	O	39	45	abstract	29843470
of	O	46	48	abstract	29843470
disability	B-DDF	49	59	abstract	29843470
,	O	59	60	abstract	29843470
morbidity	O	61	70	abstract	29843470
,	O	70	71	abstract	29843470
and	O	72	75	abstract	29843470
mortality	O	76	85	abstract	29843470
worldwide	O	86	95	abstract	29843470
.	O	95	96	abstract	29843470

The	O	97	100	abstract	29843470
braingut	O	101	110	abstract	29843470
axis	O	111	115	abstract	29843470
functions	O	116	125	abstract	29843470
are	O	126	129	abstract	29843470
disturbed	O	130	139	abstract	29843470
,	O	139	140	abstract	29843470
revealed	O	141	149	abstract	29843470
by	O	150	152	abstract	29843470
a	O	153	154	abstract	29843470
dysfunction	O	155	166	abstract	29843470
of	O	167	169	abstract	29843470
the	O	170	173	abstract	29843470
brain	B-anatomical%location	174	179	abstract	29843470
,	O	179	180	abstract	29843470
immune	O	181	187	abstract	29843470
system	O	188	194	abstract	29843470
,	O	194	195	abstract	29843470
endocrine	O	196	205	abstract	29843470
system	O	206	212	abstract	29843470
,	O	212	213	abstract	29843470
and	O	214	217	abstract	29843470
gut	B-anatomical%location	218	221	abstract	29843470
.	O	221	222	abstract	29843470

Traditional	O	223	234	abstract	29843470
depression	O	235	245	abstract	29843470
treatments	O	246	256	abstract	29843470
all	O	257	260	abstract	29843470
target	O	261	267	abstract	29843470
the	O	268	271	abstract	29843470
brain	B-anatomical%location	272	277	abstract	29843470
,	O	277	278	abstract	29843470
with	O	279	283	abstract	29843470
different	O	284	293	abstract	29843470
drugs	B-drug	294	299	abstract	29843470
and/or	O	300	306	abstract	29843470
psychotherapy	O	307	320	abstract	29843470
.	O	320	321	abstract	29843470

Unfortunately	O	322	335	abstract	29843470
,	O	335	336	abstract	29843470
most	O	337	341	abstract	29843470
of	O	342	344	abstract	29843470
the	O	345	348	abstract	29843470
patients	B-human	349	357	abstract	29843470
have	O	358	362	abstract	29843470
never	O	363	368	abstract	29843470
received	O	369	377	abstract	29843470
any	O	378	381	abstract	29843470
treatment	O	382	391	abstract	29843470
.	O	391	392	abstract	29843470

Studies	O	393	400	abstract	29843470
indicate	O	401	409	abstract	29843470
that	O	410	414	abstract	29843470
gut	B-microbiome	415	418	abstract	29843470
microbiota	I-microbiome	419	429	abstract	29843470
could	O	430	435	abstract	29843470
be	O	436	438	abstract	29843470
a	O	439	440	abstract	29843470
direct	O	441	447	abstract	29843470
cause	O	448	453	abstract	29843470
for	O	454	457	abstract	29843470
the	O	458	461	abstract	29843470
disorder	O	462	470	abstract	29843470
.	O	470	471	abstract	29843470

Abnormal	O	472	480	abstract	29843470
microbiota	O	481	491	abstract	29843470
and	O	492	495	abstract	29843470
the	O	496	499	abstract	29843470
microbiotagutbrain	B-DDF	500	520	abstract	29843470
dysfunction	I-DDF	521	532	abstract	29843470
may	O	533	536	abstract	29843470
cause	O	537	542	abstract	29843470
mental	B-DDF	543	549	abstract	29843470
disorders	I-DDF	550	559	abstract	29843470
,	O	559	560	abstract	29843470
while	O	561	566	abstract	29843470
correcting	O	567	577	abstract	29843470
these	O	578	583	abstract	29843470
disturbance	O	584	595	abstract	29843470
could	O	596	601	abstract	29843470
alleviate	O	602	611	abstract	29843470
depression	B-DDF	612	622	abstract	29843470
.	O	622	623	abstract	29843470

Nowadays	O	624	632	abstract	29843470
,	O	632	633	abstract	29843470
the	O	634	637	abstract	29843470
gut	B-microbiome	638	641	abstract	29843470
microbiota	I-microbiome	642	652	abstract	29843470
modulation	O	653	663	abstract	29843470
has	O	664	667	abstract	29843470
become	O	668	674	abstract	29843470
a	O	675	676	abstract	29843470
hot	O	677	680	abstract	29843470
topic	O	681	686	abstract	29843470
in	O	687	689	abstract	29843470
treatment	O	690	699	abstract	29843470
research	O	700	708	abstract	29843470
of	O	709	711	abstract	29843470
mental	B-DDF	712	718	abstract	29843470
disorders	I-DDF	719	728	abstract	29843470
.	O	728	729	abstract	29843470

Depression	B-DDF	730	740	abstract	29843470
is	O	741	743	abstract	29843470
closely	O	744	751	abstract	29843470
related	O	752	759	abstract	29843470
with	O	760	764	abstract	29843470
the	O	765	768	abstract	29843470
health	O	769	775	abstract	29843470
condition	O	776	785	abstract	29843470
of	O	786	788	abstract	29843470
the	O	789	792	abstract	29843470
braingut	O	793	802	abstract	29843470
axis	O	803	807	abstract	29843470
,	O	807	808	abstract	29843470
and	O	809	812	abstract	29843470
maintaining/restoring	O	813	834	abstract	29843470
the	O	835	838	abstract	29843470
normal	O	839	845	abstract	29843470
condition	O	846	855	abstract	29843470
of	O	856	858	abstract	29843470
gut	B-microbiome	859	862	abstract	29843470
microbiota	I-microbiome	863	873	abstract	29843470
helps	O	874	879	abstract	29843470
in	O	880	882	abstract	29843470
the	O	883	886	abstract	29843470
prevention/therapy	O	887	905	abstract	29843470
of	O	906	908	abstract	29843470
mental	B-DDF	909	915	abstract	29843470
disorders	I-DDF	916	925	abstract	29843470
.	O	925	926	abstract	29843470

The	O	0	3	title	32469834
human	B-microbiome	4	9	title	32469834
gut	I-microbiome	10	13	title	32469834
microbiota	I-microbiome	14	24	title	32469834
and	O	25	28	title	32469834
depression	B-DDF	29	39	title	32469834
:	O	39	40	title	32469834
widely	O	41	47	title	32469834
reviewed	O	48	56	title	32469834
,	O	56	57	title	32469834
yet	O	58	61	title	32469834
poorly	O	62	68	title	32469834
understood	O	69	79	title	32469834
.	O	79	80	title	32469834

A	O	0	1	abstract	32469834
large	O	2	7	abstract	32469834
number	O	8	14	abstract	32469834
of	O	15	17	abstract	32469834
existing	O	18	26	abstract	32469834
reviews	O	27	34	abstract	32469834
have	O	35	39	abstract	32469834
discussed	O	40	49	abstract	32469834
the	O	50	53	abstract	32469834
role	O	54	58	abstract	32469834
of	O	59	61	abstract	32469834
the	O	62	65	abstract	32469834
gut	B-microbiome	66	69	abstract	32469834
microbiota	I-microbiome	70	80	abstract	32469834
in	O	81	83	abstract	32469834
affective	B-DDF	84	93	abstract	32469834
disorders	I-DDF	94	103	abstract	32469834
,	O	103	104	abstract	32469834
though	O	105	111	abstract	32469834
syntheses	O	112	121	abstract	32469834
have	O	122	126	abstract	32469834
been	O	127	131	abstract	32469834
overwhelmingly	O	132	146	abstract	32469834
narrative	O	147	156	abstract	32469834
in	O	157	159	abstract	32469834
their	O	160	165	abstract	32469834
focus	O	166	171	abstract	32469834
.	O	171	172	abstract	32469834

In	O	173	175	abstract	32469834
this	O	176	180	abstract	32469834
correspondence	O	181	195	abstract	32469834
,	O	195	196	abstract	32469834
we	O	197	199	abstract	32469834
compliment	O	200	210	abstract	32469834
Sanada	O	211	217	abstract	32469834
et	O	218	220	abstract	32469834
	O	220	221	abstract	32469834
al.	O	221	224	abstract	32469834
(	O	225	226	abstract	32469834
2020	O	226	230	abstract	32469834
)	O	230	231	abstract	32469834
on	O	232	234	abstract	32469834
their	O	235	240	abstract	32469834
recent	O	241	247	abstract	32469834
systematic	O	248	258	abstract	32469834
review	O	259	265	abstract	32469834
of	O	266	268	abstract	32469834
the	O	269	272	abstract	32469834
gut	B-microbiome	273	276	abstract	32469834
microbiota	I-microbiome	277	287	abstract	32469834
in	O	288	290	abstract	32469834
Major	B-DDF	291	296	abstract	32469834
Depressive	I-DDF	297	307	abstract	32469834
Disorder	I-DDF	308	316	abstract	32469834
(	O	317	318	abstract	32469834
MDD	B-DDF	318	321	abstract	32469834
)	O	321	322	abstract	32469834
,	O	322	323	abstract	32469834
the	O	324	327	abstract	32469834
first	O	328	333	abstract	32469834
to	O	334	336	abstract	32469834
incorporate	O	337	348	abstract	32469834
a	O	349	350	abstract	32469834
meta-analysis	O	351	364	abstract	32469834
.	O	364	365	abstract	32469834

We	O	366	368	abstract	32469834
also	O	369	373	abstract	32469834
comment	O	374	381	abstract	32469834
on	O	382	384	abstract	32469834
how	O	385	388	abstract	32469834
this	O	389	393	abstract	32469834
synthesis	O	394	403	abstract	32469834
should	O	404	410	abstract	32469834
be	O	411	413	abstract	32469834
extended	O	414	422	abstract	32469834
in	O	423	425	abstract	32469834
future	O	426	432	abstract	32469834
research	O	433	441	abstract	32469834
.	O	441	442	abstract	32469834

Sanada	O	443	449	abstract	32469834
et	O	450	452	abstract	32469834
	O	452	453	abstract	32469834
al.	O	453	456	abstract	32469834
(	O	457	458	abstract	32469834
2020	O	458	462	abstract	32469834
)	O	462	463	abstract	32469834
conducted	O	464	473	abstract	32469834
a	O	474	475	abstract	32469834
meta-analysis	O	476	489	abstract	32469834
of	O	490	492	abstract	32469834
alpha	O	493	498	abstract	32469834
diversity	O	499	508	abstract	32469834
in	O	509	511	abstract	32469834
participants	B-human	512	524	abstract	32469834
with	O	525	529	abstract	32469834
MDD	B-DDF	530	533	abstract	32469834
compared	O	534	542	abstract	32469834
to	O	543	545	abstract	32469834
controls	B-human	546	554	abstract	32469834
,	O	554	555	abstract	32469834
whereby	O	556	563	abstract	32469834
they	O	564	568	abstract	32469834
unexpectedly	O	569	581	abstract	32469834
observed	O	582	590	abstract	32469834
no	O	591	593	abstract	32469834
significant	O	594	605	abstract	32469834
difference	O	606	616	abstract	32469834
between	O	617	624	abstract	32469834
groups	O	625	631	abstract	32469834
.	O	631	632	abstract	32469834

A	O	633	634	abstract	32469834
meta-analysis	O	635	648	abstract	32469834
was	O	649	652	abstract	32469834
only	O	653	657	abstract	32469834
able	O	658	662	abstract	32469834
to	O	663	665	abstract	32469834
be	O	666	668	abstract	32469834
performed	O	669	678	abstract	32469834
on	O	679	681	abstract	32469834
alpha	O	682	687	abstract	32469834
diversity	O	688	697	abstract	32469834
indices	O	698	705	abstract	32469834
.	O	705	706	abstract	32469834

Future	O	707	713	abstract	32469834
research	O	714	722	abstract	32469834
should	O	723	729	abstract	32469834
consider	O	730	738	abstract	32469834
research	O	739	747	abstract	32469834
quality	O	748	755	abstract	32469834
,	O	755	756	abstract	32469834
other	O	757	762	abstract	32469834
forms	O	763	768	abstract	32469834
of	O	769	771	abstract	32469834
depression	B-DDF	772	782	abstract	32469834
,	O	782	783	abstract	32469834
incorporate	O	784	795	abstract	32469834
comprehensive	O	796	809	abstract	32469834
meta-analyses	O	810	823	abstract	32469834
,	O	823	824	abstract	32469834
where	O	825	830	abstract	32469834
possible	O	831	839	abstract	32469834
,	O	839	840	abstract	32469834
as	O	841	843	abstract	32469834
well	O	844	848	abstract	32469834
as	O	849	851	abstract	32469834
investigate	O	852	863	abstract	32469834
associations	O	864	876	abstract	32469834
between	O	877	884	abstract	32469834
anxiety/depression	B-DDF	885	903	abstract	32469834
symptom	I-DDF	904	911	abstract	32469834
measures	O	912	920	abstract	32469834
and	O	921	924	abstract	32469834
the	O	925	928	abstract	32469834
gut	B-microbiome	929	932	abstract	32469834
microbiota	I-microbiome	933	943	abstract	32469834
.	O	943	944	abstract	32469834

Further	O	945	952	abstract	32469834
consideration	O	953	966	abstract	32469834
of	O	967	969	abstract	32469834
papers	O	970	976	abstract	32469834
which	O	977	982	abstract	32469834
incorporate	O	983	994	abstract	32469834
functional	O	995	1005	abstract	32469834
analyses	O	1006	1014	abstract	32469834
(	O	1015	1016	abstract	32469834
e.g.	O	1016	1020	abstract	32469834
,	O	1020	1021	abstract	32469834
metabolomics	B-biomedical%technique	1022	1034	abstract	32469834
)	O	1034	1035	abstract	32469834
is	O	1036	1038	abstract	32469834
required	O	1039	1047	abstract	32469834
to	O	1048	1050	abstract	32469834
integrate	O	1051	1060	abstract	32469834
this	O	1061	1065	abstract	32469834
body	O	1066	1070	abstract	32469834
of	O	1071	1073	abstract	32469834
literature	O	1074	1084	abstract	32469834
.	O	1084	1085	abstract	32469834

Research	O	1086	1094	abstract	32469834
investigating	O	1095	1108	abstract	32469834
the	O	1109	1112	abstract	32469834
microbiota-gut-brain	O	1113	1133	abstract	32469834
axis	O	1134	1138	abstract	32469834
in	O	1139	1141	abstract	32469834
affective	B-DDF	1142	1151	abstract	32469834
disorders	I-DDF	1152	1161	abstract	32469834
has	O	1162	1165	abstract	32469834
been	O	1166	1170	abstract	32469834
met	O	1171	1174	abstract	32469834
with	O	1175	1179	abstract	32469834
great	O	1180	1185	abstract	32469834
enthusiasm	O	1186	1196	abstract	32469834
,	O	1196	1197	abstract	32469834
offering	O	1198	1206	abstract	32469834
promising	O	1207	1216	abstract	32469834
direction	O	1217	1226	abstract	32469834
for	O	1227	1230	abstract	32469834
novel	O	1231	1236	abstract	32469834
therapeutics	O	1237	1249	abstract	32469834
in	O	1250	1252	abstract	32469834
conditions	O	1253	1263	abstract	32469834
such	O	1264	1268	abstract	32469834
as	O	1269	1271	abstract	32469834
depression	B-DDF	1272	1282	abstract	32469834
.	O	1282	1283	abstract	32469834

We	O	1284	1286	abstract	32469834
encourage	O	1287	1296	abstract	32469834
further	O	1297	1304	abstract	32469834
systematic	O	1305	1315	abstract	32469834
reviews	O	1316	1323	abstract	32469834
in	O	1324	1326	abstract	32469834
this	O	1327	1331	abstract	32469834
space	O	1332	1337	abstract	32469834
,	O	1337	1338	abstract	32469834
particularly	O	1339	1351	abstract	32469834
which	O	1352	1357	abstract	32469834
consider	O	1358	1366	abstract	32469834
research	O	1367	1375	abstract	32469834
quality	O	1376	1383	abstract	32469834
and	O	1384	1387	abstract	32469834
incorporate	O	1388	1399	abstract	32469834
comprehensive	O	1400	1413	abstract	32469834
meta-analyses	O	1414	1427	abstract	32469834
.	O	1427	1428	abstract	32469834

Causality	O	0	9	title	37960197
Investigation	O	10	23	title	37960197
between	O	24	31	title	37960197
Gut	B-microbiome	32	35	title	37960197
Microbiota	I-microbiome	36	46	title	37960197
,	O	46	47	title	37960197
Derived	O	48	55	title	37960197
Metabolites	O	56	67	title	37960197
,	O	67	68	title	37960197
and	O	69	72	title	37960197
Obstructive	B-DDF	73	84	title	37960197
Sleep	I-DDF	85	90	title	37960197
Apnea	I-DDF	91	96	title	37960197
:	O	96	97	title	37960197
A	O	98	99	title	37960197
Bidirectional	O	100	113	title	37960197
Mendelian	O	114	123	title	37960197
Randomization	O	124	137	title	37960197
Study	O	138	143	title	37960197
.	O	143	144	title	37960197

Various	O	0	7	abstract	37960197
studies	O	8	15	abstract	37960197
have	O	16	20	abstract	37960197
highlighted	O	21	32	abstract	37960197
the	O	33	36	abstract	37960197
important	O	37	46	abstract	37960197
associations	O	47	59	abstract	37960197
between	O	60	67	abstract	37960197
obstructive	B-DDF	68	79	abstract	37960197
sleep	I-DDF	80	85	abstract	37960197
apnea	I-DDF	86	91	abstract	37960197
(	O	92	93	abstract	37960197
OSA	B-DDF	93	96	abstract	37960197
)	O	96	97	abstract	37960197
and	O	98	101	abstract	37960197
gut	B-microbiome	102	105	abstract	37960197
microbiota	I-microbiome	106	116	abstract	37960197
and	O	117	120	abstract	37960197
related	O	121	128	abstract	37960197
metabolites	O	129	140	abstract	37960197
.	O	140	141	abstract	37960197

Nevertheless	O	142	154	abstract	37960197
,	O	154	155	abstract	37960197
the	O	156	159	abstract	37960197
establishment	O	160	173	abstract	37960197
of	O	174	176	abstract	37960197
causal	O	177	183	abstract	37960197
relationships	O	184	197	abstract	37960197
between	O	198	205	abstract	37960197
these	O	206	211	abstract	37960197
associations	O	212	224	abstract	37960197
remains	O	225	232	abstract	37960197
to	O	233	235	abstract	37960197
be	O	236	238	abstract	37960197
determined	O	239	249	abstract	37960197
.	O	249	250	abstract	37960197

Multiple	O	251	259	abstract	37960197
mendelian	B-statistical%technique	260	269	abstract	37960197
randomization	I-statistical%technique	270	283	abstract	37960197
(	I-statistical%technique	284	285	abstract	37960197
MR	I-statistical%technique	285	287	abstract	37960197
)	I-statistical%technique	287	288	abstract	37960197
analyses	I-statistical%technique	289	297	abstract	37960197
were	O	298	302	abstract	37960197
performed	O	303	312	abstract	37960197
to	O	313	315	abstract	37960197
genetically	O	316	327	abstract	37960197
predict	O	328	335	abstract	37960197
the	O	336	339	abstract	37960197
causative	O	340	349	abstract	37960197
impact	O	350	356	abstract	37960197
of	O	357	359	abstract	37960197
196	O	360	363	abstract	37960197
gut	B-microbiome	364	367	abstract	37960197
microbiota	I-microbiome	368	378	abstract	37960197
and	O	379	382	abstract	37960197
83	O	383	385	abstract	37960197
metabolites	O	386	397	abstract	37960197
on	O	398	400	abstract	37960197
OSA	B-DDF	401	404	abstract	37960197
.	O	404	405	abstract	37960197

Two-sample	B-statistical%technique	406	416	abstract	37960197
MR	I-statistical%technique	417	419	abstract	37960197
was	O	420	423	abstract	37960197
used	O	424	428	abstract	37960197
to	O	429	431	abstract	37960197
assess	O	432	438	abstract	37960197
the	O	439	442	abstract	37960197
potential	O	443	452	abstract	37960197
association	O	453	464	abstract	37960197
,	O	464	465	abstract	37960197
and	O	466	469	abstract	37960197
causality	O	470	479	abstract	37960197
was	O	480	483	abstract	37960197
evaluated	O	484	493	abstract	37960197
using	O	494	499	abstract	37960197
inverse	B-statistical%technique	500	507	abstract	37960197
variance	I-statistical%technique	508	516	abstract	37960197
weighted	I-statistical%technique	517	525	abstract	37960197
(	I-statistical%technique	526	527	abstract	37960197
IVW	I-statistical%technique	527	530	abstract	37960197
)	I-statistical%technique	530	531	abstract	37960197
,	I-statistical%technique	531	532	abstract	37960197
MR-Egger	I-statistical%technique	533	541	abstract	37960197
,	I-statistical%technique	541	542	abstract	37960197
and	I-statistical%technique	543	546	abstract	37960197
weighted	I-statistical%technique	547	555	abstract	37960197
median	I-statistical%technique	556	562	abstract	37960197
(	I-statistical%technique	563	564	abstract	37960197
WM	I-statistical%technique	564	566	abstract	37960197
)	I-statistical%technique	566	567	abstract	37960197
methods	I-statistical%technique	568	575	abstract	37960197
.	O	575	576	abstract	37960197

Multivariable	B-statistical%technique	577	590	abstract	37960197
MR	I-statistical%technique	591	593	abstract	37960197
(	O	594	595	abstract	37960197
MVMR	B-statistical%technique	595	599	abstract	37960197
)	O	599	600	abstract	37960197
was	O	601	604	abstract	37960197
employed	O	605	613	abstract	37960197
to	O	614	616	abstract	37960197
ascertain	O	617	626	abstract	37960197
the	O	627	630	abstract	37960197
causal	O	631	637	abstract	37960197
independence	O	638	650	abstract	37960197
between	O	651	658	abstract	37960197
gut	B-microbiome	659	662	abstract	37960197
microbiota	I-microbiome	663	673	abstract	37960197
and	O	674	677	abstract	37960197
the	O	678	681	abstract	37960197
metabolites	O	682	693	abstract	37960197
linked	O	694	700	abstract	37960197
to	O	701	703	abstract	37960197
OSA	B-DDF	704	707	abstract	37960197
.	O	707	708	abstract	37960197

Additionally	O	709	721	abstract	37960197
,	O	721	722	abstract	37960197
Cochran	B-statistical%technique	723	730	abstract	37960197
's	I-statistical%technique	730	732	abstract	37960197
Q	I-statistical%technique	733	734	abstract	37960197
test	I-statistical%technique	735	739	abstract	37960197
,	O	739	740	abstract	37960197
the	O	741	744	abstract	37960197
MR	B-statistical%technique	745	747	abstract	37960197
Egger	I-statistical%technique	748	753	abstract	37960197
intercept	I-statistical%technique	754	763	abstract	37960197
test	I-statistical%technique	764	768	abstract	37960197
and	O	769	772	abstract	37960197
the	O	773	776	abstract	37960197
MR	B-statistical%technique	777	779	abstract	37960197
Steiger	I-statistical%technique	780	787	abstract	37960197
test	I-statistical%technique	788	792	abstract	37960197
were	O	793	797	abstract	37960197
used	O	798	802	abstract	37960197
for	O	803	806	abstract	37960197
the	O	807	810	abstract	37960197
sensitivity	B-statistical%technique	811	822	abstract	37960197
analyses	I-statistical%technique	823	831	abstract	37960197
.	O	831	832	abstract	37960197

The	O	833	836	abstract	37960197
analysis	O	837	845	abstract	37960197
of	O	846	848	abstract	37960197
the	O	849	852	abstract	37960197
196	O	853	856	abstract	37960197
gut	B-microbiome	857	860	abstract	37960197
microbiota	I-microbiome	861	871	abstract	37960197
revealed	O	872	880	abstract	37960197
that	O	881	885	abstract	37960197
<	B-bacteria	886	887	abstract	37960197
i	I-bacteria	887	888	abstract	37960197
>	I-bacteria	888	889	abstract	37960197
genus</i>_<i	I-bacteria	889	901	abstract	37960197
>	I-bacteria	901	902	abstract	37960197
Ruminococcaceae</i	I-bacteria	902	920	abstract	37960197
>	I-bacteria	920	921	abstract	37960197
(	O	922	923	abstract	37960197
<	O	923	924	abstract	37960197
i	O	924	925	abstract	37960197
>	O	925	926	abstract	37960197
UCG009</i	B-bacteria	926	935	abstract	37960197
>	O	935	936	abstract	37960197
)	O	936	937	abstract	37960197
(	O	938	939	abstract	37960197
P	O	939	940	abstract	37960197
<	O	940	941	abstract	37960197
sub	O	941	944	abstract	37960197
>	O	944	945	abstract	37960197
IVW</sub	O	945	953	abstract	37960197
>	O	953	954	abstract	37960197
=	O	955	956	abstract	37960197
0.010	O	957	962	abstract	37960197
)	O	962	963	abstract	37960197
and	O	964	967	abstract	37960197
<	B-bacteria	968	969	abstract	37960197
i	I-bacteria	969	970	abstract	37960197
>	I-bacteria	970	971	abstract	37960197
genus</i>_<i	I-bacteria	971	983	abstract	37960197
>	I-bacteria	983	984	abstract	37960197
Subdoligranulum</i	I-bacteria	984	1002	abstract	37960197
>	I-bacteria	1002	1003	abstract	37960197
(	O	1004	1005	abstract	37960197
P	O	1005	1006	abstract	37960197
<	O	1006	1007	abstract	37960197
sub	O	1007	1010	abstract	37960197
>	O	1010	1011	abstract	37960197
IVW</sub	O	1011	1019	abstract	37960197
>	O	1019	1020	abstract	37960197
=	O	1021	1022	abstract	37960197
0.041	O	1023	1028	abstract	37960197
)	O	1028	1029	abstract	37960197
were	O	1030	1034	abstract	37960197
associated	O	1035	1045	abstract	37960197
with	O	1046	1050	abstract	37960197
an	O	1051	1053	abstract	37960197
increased	O	1054	1063	abstract	37960197
risk	O	1064	1068	abstract	37960197
of	O	1069	1071	abstract	37960197
OSA	B-DDF	1072	1075	abstract	37960197
onset	I-DDF	1076	1081	abstract	37960197
.	O	1081	1082	abstract	37960197

Conversely	O	1083	1093	abstract	37960197
,	O	1093	1094	abstract	37960197
<	B-bacteria	1095	1096	abstract	37960197
i	I-bacteria	1096	1097	abstract	37960197
>	I-bacteria	1097	1098	abstract	37960197
Family</i>_<i	I-bacteria	1098	1111	abstract	37960197
>	I-bacteria	1111	1112	abstract	37960197
Ruminococcaceae</i	I-bacteria	1112	1130	abstract	37960197
>	I-bacteria	1130	1131	abstract	37960197
(	O	1132	1133	abstract	37960197
P	O	1133	1134	abstract	37960197
<	O	1134	1135	abstract	37960197
sub	O	1135	1138	abstract	37960197
>	O	1138	1139	abstract	37960197
IVW</sub	O	1139	1147	abstract	37960197
>	O	1147	1148	abstract	37960197
=	O	1149	1150	abstract	37960197
0.030	O	1151	1156	abstract	37960197
)	O	1156	1157	abstract	37960197
,	O	1157	1158	abstract	37960197
<	B-bacteria	1159	1160	abstract	37960197
i	I-bacteria	1160	1161	abstract	37960197
>	I-bacteria	1161	1162	abstract	37960197
genus</i>_<i	I-bacteria	1162	1174	abstract	37960197
>	I-bacteria	1174	1175	abstract	37960197
Coprococcus2</i	I-bacteria	1175	1190	abstract	37960197
>	I-bacteria	1190	1191	abstract	37960197
(	O	1192	1193	abstract	37960197
P	O	1193	1194	abstract	37960197
<	O	1194	1195	abstract	37960197
sub	O	1195	1198	abstract	37960197
>	O	1198	1199	abstract	37960197
WM</sub	O	1199	1206	abstract	37960197
>	O	1206	1207	abstract	37960197
=	O	1208	1209	abstract	37960197
0.025	O	1210	1215	abstract	37960197
)	O	1215	1216	abstract	37960197
,	O	1216	1217	abstract	37960197
<	B-bacteria	1218	1219	abstract	37960197
i	I-bacteria	1219	1220	abstract	37960197
>	I-bacteria	1220	1221	abstract	37960197
genus</i>_<i	I-bacteria	1221	1233	abstract	37960197
>	I-bacteria	1233	1234	abstract	37960197
Eggerthella</i	I-bacteria	1234	1248	abstract	37960197
>	I-bacteria	1248	1249	abstract	37960197
(	O	1250	1251	abstract	37960197
P	O	1251	1252	abstract	37960197
<	O	1252	1253	abstract	37960197
sub	O	1253	1256	abstract	37960197
>	O	1256	1257	abstract	37960197
IVW</sub	O	1257	1265	abstract	37960197
>	O	1265	1266	abstract	37960197
=	O	1267	1268	abstract	37960197
0.011	O	1269	1274	abstract	37960197
)	O	1274	1275	abstract	37960197
,	O	1275	1276	abstract	37960197
and	O	1277	1280	abstract	37960197
<	B-bacteria	1281	1282	abstract	37960197
i	I-bacteria	1282	1283	abstract	37960197
>	I-bacteria	1283	1284	abstract	37960197
genus</i>_<i	I-bacteria	1284	1296	abstract	37960197
>	I-bacteria	1296	1297	abstract	37960197
Eubacterium</i	I-bacteria	1297	1311	abstract	37960197
>	I-bacteria	1311	1312	abstract	37960197
(	O	1313	1314	abstract	37960197
<	B-bacteria	1314	1315	abstract	37960197
i	I-bacteria	1315	1316	abstract	37960197
>	I-bacteria	1316	1317	abstract	37960197
xylanophilum</i>_<i	I-bacteria	1317	1336	abstract	37960197
>	I-bacteria	1336	1337	abstract	37960197
group</i	I-bacteria	1337	1345	abstract	37960197
>	I-bacteria	1345	1346	abstract	37960197
)	O	1346	1347	abstract	37960197
(	O	1348	1349	abstract	37960197
P	O	1349	1350	abstract	37960197
<	O	1350	1351	abstract	37960197
sub	O	1351	1354	abstract	37960197
>	O	1354	1355	abstract	37960197
IVW</sub	O	1355	1363	abstract	37960197
>	O	1363	1364	abstract	37960197
=	O	1365	1366	abstract	37960197
0.001	O	1367	1372	abstract	37960197
)	O	1372	1373	abstract	37960197
were	O	1374	1378	abstract	37960197
negatively	O	1379	1389	abstract	37960197
related	O	1390	1397	abstract	37960197
to	O	1398	1400	abstract	37960197
the	O	1401	1404	abstract	37960197
risk	O	1405	1409	abstract	37960197
of	O	1410	1412	abstract	37960197
OSA	B-DDF	1413	1416	abstract	37960197
.	O	1416	1417	abstract	37960197

Among	O	1418	1423	abstract	37960197
the	O	1424	1427	abstract	37960197
83	O	1428	1430	abstract	37960197
metabolites	O	1431	1442	abstract	37960197
evaluated	O	1443	1452	abstract	37960197
,	O	1452	1453	abstract	37960197
3-dehydrocarnitine	B-chemical	1454	1472	abstract	37960197
,	O	1472	1473	abstract	37960197
epiandrosterone	B-chemical	1474	1489	abstract	37960197
sulfate	I-chemical	1490	1497	abstract	37960197
,	O	1497	1498	abstract	37960197
and	O	1499	1502	abstract	37960197
leucine	B-chemical	1503	1510	abstract	37960197
were	O	1511	1515	abstract	37960197
determined	O	1516	1526	abstract	37960197
to	O	1527	1529	abstract	37960197
be	O	1530	1532	abstract	37960197
potential	O	1533	1542	abstract	37960197
independent	O	1543	1554	abstract	37960197
risk	O	1555	1559	abstract	37960197
factors	O	1560	1567	abstract	37960197
associated	O	1568	1578	abstract	37960197
with	O	1579	1583	abstract	37960197
OSA	B-DDF	1584	1587	abstract	37960197
.	O	1587	1588	abstract	37960197

Moreover	O	1589	1597	abstract	37960197
,	O	1597	1598	abstract	37960197
the	O	1599	1602	abstract	37960197
reverse	B-statistical%technique	1603	1610	abstract	37960197
MR	I-statistical%technique	1611	1613	abstract	37960197
analysis	I-statistical%technique	1614	1622	abstract	37960197
demonstrated	O	1623	1635	abstract	37960197
a	O	1636	1637	abstract	37960197
suggestive	O	1638	1648	abstract	37960197
association	O	1649	1660	abstract	37960197
between	O	1661	1668	abstract	37960197
OSA	O	1669	1672	abstract	37960197
exposure	O	1673	1681	abstract	37960197
and	O	1682	1685	abstract	37960197
six	O	1686	1689	abstract	37960197
microbiota	O	1690	1700	abstract	37960197
taxa	O	1701	1705	abstract	37960197
.	O	1705	1706	abstract	37960197

This	O	1707	1711	abstract	37960197
study	O	1712	1717	abstract	37960197
offers	O	1718	1724	abstract	37960197
compelling	O	1725	1735	abstract	37960197
evidence	O	1736	1744	abstract	37960197
regarding	O	1745	1754	abstract	37960197
the	O	1755	1758	abstract	37960197
potential	O	1759	1768	abstract	37960197
beneficial	O	1769	1779	abstract	37960197
or	O	1780	1782	abstract	37960197
detrimental	O	1783	1794	abstract	37960197
causative	O	1795	1804	abstract	37960197
impact	O	1805	1811	abstract	37960197
of	O	1812	1814	abstract	37960197
the	O	1815	1818	abstract	37960197
gut	B-microbiome	1819	1822	abstract	37960197
microbiota	I-microbiome	1823	1833	abstract	37960197
and	O	1834	1837	abstract	37960197
its	O	1838	1841	abstract	37960197
associated	O	1842	1852	abstract	37960197
metabolites	O	1853	1864	abstract	37960197
on	O	1865	1867	abstract	37960197
OSA	O	1868	1871	abstract	37960197
risk	O	1872	1876	abstract	37960197
,	O	1876	1877	abstract	37960197
thereby	O	1878	1885	abstract	37960197
providing	O	1886	1895	abstract	37960197
new	O	1896	1899	abstract	37960197
insights	O	1900	1908	abstract	37960197
into	O	1909	1913	abstract	37960197
the	O	1914	1917	abstract	37960197
mechanisms	O	1918	1928	abstract	37960197
of	O	1929	1931	abstract	37960197
gut	O	1932	1935	abstract	37960197
microbiome-mediated	O	1936	1955	abstract	37960197
OSA	O	1956	1959	abstract	37960197
development	O	1960	1971	abstract	37960197
.	O	1971	1972	abstract	37960197

Gut	O	0	3	title	30707176
microbiota	O	4	14	title	30707176
analysis	O	15	23	title	30707176
and	O	24	27	title	30707176
its	O	28	31	title	30707176
significance	O	32	44	title	30707176
in	O	45	47	title	30707176
vasovagal	B-DDF	48	57	title	30707176
syncope	I-DDF	58	65	title	30707176
in	O	66	68	title	30707176
children	B-human	69	77	title	30707176
.	O	77	78	title	30707176

Vasovagal	B-DDF	0	9	abstract	30707176
syncope	I-DDF	10	17	abstract	30707176
(	O	18	19	abstract	30707176
VVS	B-DDF	19	22	abstract	30707176
)	O	22	23	abstract	30707176
is	O	24	26	abstract	30707176
common	O	27	33	abstract	30707176
in	O	34	36	abstract	30707176
children	B-human	37	45	abstract	30707176
and	O	46	49	abstract	30707176
greatly	O	50	57	abstract	30707176
affect	O	58	64	abstract	30707176
both	O	65	69	abstract	30707176
physical	O	70	78	abstract	30707176
and	O	79	82	abstract	30707176
mental	O	83	89	abstract	30707176
health	O	90	96	abstract	30707176
.	O	96	97	abstract	30707176

But	O	98	101	abstract	30707176
the	O	102	105	abstract	30707176
mechanisms	O	106	116	abstract	30707176
have	O	117	121	abstract	30707176
not	O	122	125	abstract	30707176
been	O	126	130	abstract	30707176
completely	O	131	141	abstract	30707176
explained	O	142	151	abstract	30707176
.	O	151	152	abstract	30707176

This	O	153	157	abstract	30707176
study	O	158	163	abstract	30707176
was	O	164	167	abstract	30707176
designed	O	168	176	abstract	30707176
to	O	177	179	abstract	30707176
analyze	O	180	187	abstract	30707176
the	O	188	191	abstract	30707176
gut	B-microbiome	192	195	abstract	30707176
microbiota	I-microbiome	196	206	abstract	30707176
in	O	207	209	abstract	30707176
children	B-human	210	218	abstract	30707176
with	O	219	223	abstract	30707176
VVS	B-DDF	224	227	abstract	30707176
and	O	228	231	abstract	30707176
explore	O	232	239	abstract	30707176
its	O	240	243	abstract	30707176
clinical	O	244	252	abstract	30707176
significance	O	253	265	abstract	30707176
.	O	265	266	abstract	30707176

Fecal	O	267	272	abstract	30707176
samples	O	273	280	abstract	30707176
from	O	281	285	abstract	30707176
20	O	286	288	abstract	30707176
VVS	B-human	289	292	abstract	30707176
children	I-human	293	301	abstract	30707176
and	O	302	305	abstract	30707176
20	O	306	308	abstract	30707176
matched	B-human	309	316	abstract	30707176
controls	I-human	317	325	abstract	30707176
were	O	326	330	abstract	30707176
collected	O	331	340	abstract	30707176
,	O	340	341	abstract	30707176
and	O	342	345	abstract	30707176
the	O	346	349	abstract	30707176
microbiota	O	350	360	abstract	30707176
were	O	361	365	abstract	30707176
analyzed	O	366	374	abstract	30707176
by	O	375	377	abstract	30707176
16S	B-biomedical%technique	378	381	abstract	30707176
rRNA	I-biomedical%technique	382	386	abstract	30707176
gene	I-biomedical%technique	387	391	abstract	30707176
sequencing	I-biomedical%technique	392	402	abstract	30707176
.	O	402	403	abstract	30707176

The	O	404	407	abstract	30707176
diversity	O	408	417	abstract	30707176
and	O	418	421	abstract	30707176
microbiota	O	422	432	abstract	30707176
compositions	O	433	445	abstract	30707176
of	O	446	448	abstract	30707176
the	O	449	452	abstract	30707176
VVS	B-human	453	456	abstract	30707176
cases	I-human	457	462	abstract	30707176
and	O	463	466	abstract	30707176
controls	B-human	467	475	abstract	30707176
were	O	476	480	abstract	30707176
compared	O	481	489	abstract	30707176
with	O	490	494	abstract	30707176
the	O	495	498	abstract	30707176
independent	B-statistical%technique	499	510	abstract	30707176
sample	I-statistical%technique	511	517	abstract	30707176
t	I-statistical%technique	518	519	abstract	30707176
test	I-statistical%technique	520	524	abstract	30707176
or	O	525	527	abstract	30707176
Mann-Whitney	B-statistical%technique	528	540	abstract	30707176
U	I-statistical%technique	541	542	abstract	30707176
test	I-statistical%technique	543	547	abstract	30707176
.	O	547	548	abstract	30707176

The	O	549	552	abstract	30707176
correlation	O	553	564	abstract	30707176
between	O	565	572	abstract	30707176
the	O	573	576	abstract	30707176
predominant	B-bacteria	577	588	abstract	30707176
bacteria	I-bacteria	589	597	abstract	30707176
and	O	598	601	abstract	30707176
clinical	B-DDF	602	610	abstract	30707176
symptoms	I-DDF	611	619	abstract	30707176
was	O	620	623	abstract	30707176
analyzed	O	624	632	abstract	30707176
using	O	633	638	abstract	30707176
Pearson	B-statistical%technique	639	646	abstract	30707176
or	I-statistical%technique	647	649	abstract	30707176
Spearman	I-statistical%technique	650	658	abstract	30707176
correlation	I-statistical%technique	659	670	abstract	30707176
test	I-statistical%technique	671	675	abstract	30707176
.	O	675	676	abstract	30707176

No	O	677	679	abstract	30707176
significant	O	680	691	abstract	30707176
differences	O	692	703	abstract	30707176
in	O	704	706	abstract	30707176
diversity	O	707	716	abstract	30707176
were	O	717	721	abstract	30707176
evident	O	722	729	abstract	30707176
between	O	730	737	abstract	30707176
VVS	B-human	738	741	abstract	30707176
and	I-human	742	745	abstract	30707176
controls	I-human	746	754	abstract	30707176
(	O	755	756	abstract	30707176
P	O	756	757	abstract	30707176
	O	757	758	abstract	30707176
>	O	758	759	abstract	30707176
	O	759	760	abstract	30707176
0.05	O	760	764	abstract	30707176
)	O	764	765	abstract	30707176
.	O	765	766	abstract	30707176

At	O	767	769	abstract	30707176
the	O	770	773	abstract	30707176
family	O	774	780	abstract	30707176
level	O	781	786	abstract	30707176
,	O	786	787	abstract	30707176
the	O	788	791	abstract	30707176
relative	O	792	800	abstract	30707176
abundance	O	801	810	abstract	30707176
of	O	811	813	abstract	30707176
Ruminococcaceae	B-bacteria	814	829	abstract	30707176
was	O	830	833	abstract	30707176
significantly	O	834	847	abstract	30707176
higher	O	848	854	abstract	30707176
in	O	855	857	abstract	30707176
VVS	B-human	858	861	abstract	30707176
children	I-human	862	870	abstract	30707176
than	O	871	875	abstract	30707176
in	O	876	878	abstract	30707176
controls	B-human	879	887	abstract	30707176
(	O	888	889	abstract	30707176
median	O	889	895	abstract	30707176
[	O	896	897	abstract	30707176
Q1	O	897	899	abstract	30707176
,	O	899	900	abstract	30707176
Q3	O	901	903	abstract	30707176
]	O	903	904	abstract	30707176
:	O	904	905	abstract	30707176
22.10	O	906	911	abstract	30707176
%	O	911	912	abstract	30707176
[	O	913	914	abstract	30707176
16.89	O	914	919	abstract	30707176
%	O	919	920	abstract	30707176
,	O	920	921	abstract	30707176
27.36	O	922	927	abstract	30707176
%	O	927	928	abstract	30707176
]	O	928	929	abstract	30707176
vs.	O	930	933	abstract	30707176
13.92	O	934	939	abstract	30707176
%	O	939	940	abstract	30707176
[	O	941	942	abstract	30707176
10.31	O	942	947	abstract	30707176
%	O	947	948	abstract	30707176
,	O	948	949	abstract	30707176
20.18	O	950	955	abstract	30707176
%	O	955	956	abstract	30707176
]	O	956	957	abstract	30707176
,	O	957	958	abstract	30707176
Z	O	959	960	abstract	30707176
	O	960	961	abstract	30707176
=	O	961	962	abstract	30707176
	O	962	963	abstract	30707176
-2.40	O	963	968	abstract	30707176
,	O	968	969	abstract	30707176
P	O	970	971	abstract	30707176
	O	971	972	abstract	30707176
<	O	972	973	abstract	30707176
	O	973	974	abstract	30707176
0.05	O	974	978	abstract	30707176
)	O	978	979	abstract	30707176
,	O	979	980	abstract	30707176
and	O	981	984	abstract	30707176
LEfSe	B-statistical%technique	985	990	abstract	30707176
analysis	I-statistical%technique	991	999	abstract	30707176
revealed	O	1000	1008	abstract	30707176
Ruminococcaceae	B-bacteria	1009	1024	abstract	30707176
as	O	1025	1027	abstract	30707176
a	O	1028	1029	abstract	30707176
discriminative	O	1030	1044	abstract	30707176
feature	O	1045	1052	abstract	30707176
(	O	1053	1054	abstract	30707176
linear	B-statistical%technique	1054	1060	abstract	30707176
discriminant	I-statistical%technique	1061	1073	abstract	30707176
analysis	I-statistical%technique	1074	1082	abstract	30707176
[	O	1083	1084	abstract	30707176
LDA	B-statistical%technique	1084	1087	abstract	30707176
]	O	1087	1088	abstract	30707176
score	O	1089	1094	abstract	30707176
	O	1094	1095	abstract	30707176
>	O	1095	1096	abstract	30707176
	O	1096	1097	abstract	30707176
4	O	1097	1098	abstract	30707176
,	O	1098	1099	abstract	30707176
P	O	1100	1101	abstract	30707176
	O	1101	1102	abstract	30707176
<	O	1102	1103	abstract	30707176
	O	1103	1104	abstract	30707176
0.05	O	1104	1108	abstract	30707176
)	O	1108	1109	abstract	30707176
.	O	1109	1110	abstract	30707176

The	O	1111	1114	abstract	30707176
relative	O	1115	1123	abstract	30707176
abundance	O	1124	1133	abstract	30707176
of	O	1134	1136	abstract	30707176
Ruminococcaceae	B-bacteria	1137	1152	abstract	30707176
in	O	1153	1155	abstract	30707176
VVS	B-human	1156	1159	abstract	30707176
patients	I-human	1160	1168	abstract	30707176
was	O	1169	1172	abstract	30707176
positively	O	1173	1183	abstract	30707176
correlated	O	1184	1194	abstract	30707176
with	O	1195	1199	abstract	30707176
the	O	1200	1203	abstract	30707176
frequency	O	1204	1213	abstract	30707176
of	O	1214	1216	abstract	30707176
syncope	B-DDF	1217	1224	abstract	30707176
(	O	1225	1226	abstract	30707176
r	O	1226	1227	abstract	30707176
	O	1227	1228	abstract	30707176
=	O	1228	1229	abstract	30707176
	O	1229	1230	abstract	30707176
0.616	O	1230	1235	abstract	30707176
,	O	1235	1236	abstract	30707176
P	O	1237	1238	abstract	30707176
	O	1238	1239	abstract	30707176
<	O	1239	1240	abstract	30707176
	O	1240	1241	abstract	30707176
0.01	O	1241	1245	abstract	30707176
)	O	1245	1246	abstract	30707176
.	O	1246	1247	abstract	30707176

In	O	1248	1250	abstract	30707176
terms	O	1251	1256	abstract	30707176
of	O	1257	1259	abstract	30707176
its	O	1260	1263	abstract	30707176
correlation	O	1264	1275	abstract	30707176
with	O	1276	1280	abstract	30707176
hemodynamics	O	1281	1293	abstract	30707176
,	O	1293	1294	abstract	30707176
we	O	1295	1297	abstract	30707176
showed	O	1298	1304	abstract	30707176
that	O	1305	1309	abstract	30707176
relative	O	1310	1318	abstract	30707176
abundance	O	1319	1328	abstract	30707176
of	O	1329	1331	abstract	30707176
Ruminococcaceae	B-bacteria	1332	1347	abstract	30707176
was	O	1348	1351	abstract	30707176
negatively	O	1352	1362	abstract	30707176
correlated	O	1363	1373	abstract	30707176
with	O	1374	1378	abstract	30707176
the	O	1379	1382	abstract	30707176
systolic	B-DDF	1383	1391	abstract	30707176
and	I-DDF	1392	1395	abstract	30707176
diastolic	I-DDF	1396	1405	abstract	30707176
pressure	I-DDF	1406	1414	abstract	30707176
reduction	I-DDF	1415	1424	abstract	30707176
at	O	1425	1427	abstract	30707176
the	O	1428	1431	abstract	30707176
positive	O	1432	1440	abstract	30707176
response	O	1441	1449	abstract	30707176
in	O	1450	1452	abstract	30707176
head-up	B-biomedical%technique	1453	1460	abstract	30707176
tilt	I-biomedical%technique	1461	1465	abstract	30707176
test	I-biomedical%technique	1466	1470	abstract	30707176
(	O	1471	1472	abstract	30707176
HUTT	B-biomedical%technique	1472	1476	abstract	30707176
;	O	1476	1477	abstract	30707176
r	O	1478	1479	abstract	30707176
	O	1479	1480	abstract	30707176
=	O	1480	1481	abstract	30707176
	O	1481	1482	abstract	30707176
-0.489	O	1482	1488	abstract	30707176
and	O	1489	1492	abstract	30707176
-0.448	O	1493	1499	abstract	30707176
,	O	1499	1500	abstract	30707176
all	O	1501	1504	abstract	30707176
P	O	1505	1506	abstract	30707176
	O	1506	1507	abstract	30707176
<	O	1507	1508	abstract	30707176
	O	1508	1509	abstract	30707176
0.05	O	1509	1513	abstract	30707176
)	O	1513	1514	abstract	30707176
,	O	1514	1515	abstract	30707176
but	O	1516	1519	abstract	30707176
was	O	1520	1523	abstract	30707176
positively	O	1524	1534	abstract	30707176
correlated	O	1535	1545	abstract	30707176
with	O	1546	1550	abstract	30707176
the	O	1551	1554	abstract	30707176
mean	B-DDF	1555	1559	abstract	30707176
pressure	I-DDF	1560	1568	abstract	30707176
drop	I-DDF	1569	1573	abstract	30707176
and	O	1574	1577	abstract	30707176
decline	O	1578	1585	abstract	30707176
rate	O	1586	1590	abstract	30707176
(	O	1591	1592	abstract	30707176
r	O	1592	1593	abstract	30707176
	O	1593	1594	abstract	30707176
=	O	1594	1595	abstract	30707176
	O	1595	1596	abstract	30707176
0.489	O	1596	1601	abstract	30707176
and	O	1602	1605	abstract	30707176
0.467	O	1606	1611	abstract	30707176
,	O	1611	1612	abstract	30707176
all	O	1613	1616	abstract	30707176
P	O	1617	1618	abstract	30707176
	O	1618	1619	abstract	30707176
<	O	1619	1620	abstract	30707176
	O	1620	1621	abstract	30707176
0.05	O	1621	1625	abstract	30707176
)	O	1625	1626	abstract	30707176
as	O	1627	1629	abstract	30707176
well	O	1630	1634	abstract	30707176
as	O	1635	1637	abstract	30707176
diastolic	B-DDF	1638	1647	abstract	30707176
pressure	I-DDF	1648	1656	abstract	30707176
drop	I-DDF	1657	1661	abstract	30707176
and	O	1662	1665	abstract	30707176
decline	O	1666	1673	abstract	30707176
rate	O	1674	1678	abstract	30707176
at	O	1679	1681	abstract	30707176
the	O	1682	1685	abstract	30707176
HUTT	O	1686	1690	abstract	30707176
positive	O	1691	1699	abstract	30707176
response	O	1700	1708	abstract	30707176
(	O	1709	1710	abstract	30707176
r	O	1710	1711	abstract	30707176
	O	1711	1712	abstract	30707176
=	O	1712	1713	abstract	30707176
	O	1713	1714	abstract	30707176
0.579	O	1714	1719	abstract	30707176
and	O	1720	1723	abstract	30707176
0.589	O	1724	1729	abstract	30707176
,	O	1729	1730	abstract	30707176
all	O	1731	1734	abstract	30707176
P	O	1735	1736	abstract	30707176
	O	1736	1737	abstract	30707176
<	O	1737	1738	abstract	30707176
	O	1738	1739	abstract	30707176
0.01	O	1739	1743	abstract	30707176
)	O	1743	1744	abstract	30707176
in	O	1745	1747	abstract	30707176
VVS	B-human	1748	1751	abstract	30707176
patients	I-human	1752	1760	abstract	30707176
.	O	1760	1761	abstract	30707176

Ruminococcaceae	B-bacteria	1762	1777	abstract	30707176
was	O	1778	1781	abstract	30707176
the	O	1782	1785	abstract	30707176
predominant	O	1786	1797	abstract	30707176
gut	B-bacteria	1798	1801	abstract	30707176
bacteria	I-bacteria	1802	1810	abstract	30707176
and	O	1811	1814	abstract	30707176
was	O	1815	1818	abstract	30707176
associated	O	1819	1829	abstract	30707176
with	O	1830	1834	abstract	30707176
the	O	1835	1838	abstract	30707176
clinical	O	1839	1847	abstract	30707176
symptoms	O	1848	1856	abstract	30707176
and	O	1857	1860	abstract	30707176
hemodynamics	O	1861	1873	abstract	30707176
of	O	1874	1876	abstract	30707176
VVS	B-DDF	1877	1880	abstract	30707176
,	O	1880	1881	abstract	30707176
suggesting	O	1882	1892	abstract	30707176
that	O	1893	1897	abstract	30707176
gut	B-microbiome	1898	1901	abstract	30707176
microbiota	I-microbiome	1902	1912	abstract	30707176
might	O	1913	1918	abstract	30707176
be	O	1919	1921	abstract	30707176
involved	O	1922	1930	abstract	30707176
in	O	1931	1933	abstract	30707176
the	O	1934	1937	abstract	30707176
development	O	1938	1949	abstract	30707176
of	O	1950	1952	abstract	30707176
VVS	B-DDF	1953	1956	abstract	30707176
.	O	1956	1957	abstract	30707176

A	O	0	1	title	38139446
Pilot	O	2	7	title	38139446
Interaction	O	8	19	title	38139446
Analysis	O	20	28	title	38139446
of	O	29	31	title	38139446
Gut	B-microbiome	32	35	title	38139446
Microbiota	I-microbiome	36	46	title	38139446
and	O	47	50	title	38139446
Peripheral	O	51	61	title	38139446
Markers	O	62	69	title	38139446
of	O	70	72	title	38139446
Aging	O	73	78	title	38139446
in	O	79	81	title	38139446
Severe	B-DDF	82	88	title	38139446
Psychiatric	I-DDF	89	100	title	38139446
Disorders	I-DDF	101	110	title	38139446
:	O	110	111	title	38139446
A	O	112	113	title	38139446
Role	O	114	118	title	38139446
for	O	119	122	title	38139446
<	O	123	124	title	38139446
i	O	124	125	title	38139446
>	O	125	126	title	38139446
Lachnoclostridium</i	B-bacteria	126	146	title	38139446
>	O	146	147	title	38139446
?	O	147	148	title	38139446

Excessive	O	0	9	abstract	38139446
predominance	O	10	22	abstract	38139446
of	O	23	25	abstract	38139446
pathological	O	26	38	abstract	38139446
species	O	39	46	abstract	38139446
in	O	47	49	abstract	38139446
the	O	50	53	abstract	38139446
gut	B-microbiome	54	57	abstract	38139446
microbiota	I-microbiome	58	68	abstract	38139446
could	O	69	74	abstract	38139446
increase	O	75	83	abstract	38139446
the	O	84	87	abstract	38139446
production	O	88	98	abstract	38139446
of	O	99	101	abstract	38139446
inflammatory	O	102	114	abstract	38139446
mediators	O	115	124	abstract	38139446
at	O	125	127	abstract	38139446
the	O	128	131	abstract	38139446
gut	O	132	135	abstract	38139446
level	O	136	141	abstract	38139446
and	O	142	145	abstract	38139446
,	O	145	146	abstract	38139446
via	O	147	150	abstract	38139446
modification	O	151	163	abstract	38139446
of	O	164	166	abstract	38139446
the	O	167	170	abstract	38139446
gut-blood	O	171	180	abstract	38139446
barrier	O	181	188	abstract	38139446
,	O	188	189	abstract	38139446
at	O	190	192	abstract	38139446
the	O	193	196	abstract	38139446
systemic	O	197	205	abstract	38139446
level	O	206	211	abstract	38139446
.	O	211	212	abstract	38139446

This	O	213	217	abstract	38139446
pro-inflammatory	B-DDF	218	234	abstract	38139446
state	I-DDF	235	240	abstract	38139446
could	O	241	246	abstract	38139446
,	O	246	247	abstract	38139446
in	O	248	250	abstract	38139446
turn	O	251	255	abstract	38139446
,	O	255	256	abstract	38139446
increase	O	257	265	abstract	38139446
biological	O	266	276	abstract	38139446
aging	O	277	282	abstract	38139446
that	O	283	287	abstract	38139446
is	O	288	290	abstract	38139446
generally	O	291	300	abstract	38139446
proxied	O	301	308	abstract	38139446
by	O	309	311	abstract	38139446
telomere	O	312	320	abstract	38139446
shortening	O	321	331	abstract	38139446
.	O	331	332	abstract	38139446

In	O	333	335	abstract	38139446
this	O	336	340	abstract	38139446
study	O	341	346	abstract	38139446
,	O	346	347	abstract	38139446
we	O	348	350	abstract	38139446
present	O	351	358	abstract	38139446
findings	O	359	367	abstract	38139446
from	O	368	372	abstract	38139446
a	O	373	374	abstract	38139446
secondary	O	375	384	abstract	38139446
interaction	O	385	396	abstract	38139446
analysis	O	397	405	abstract	38139446
of	O	406	408	abstract	38139446
gut	B-microbiome	409	412	abstract	38139446
microbiota	I-microbiome	413	423	abstract	38139446
,	O	423	424	abstract	38139446
aging	O	425	430	abstract	38139446
,	O	430	431	abstract	38139446
and	O	432	435	abstract	38139446
inflammatory	O	436	448	abstract	38139446
marker	O	449	455	abstract	38139446
data	O	456	460	abstract	38139446
from	O	461	465	abstract	38139446
a	O	466	467	abstract	38139446
cohort	O	468	474	abstract	38139446
of	O	475	477	abstract	38139446
patients	B-human	478	486	abstract	38139446
with	O	487	491	abstract	38139446
different	O	492	501	abstract	38139446
diagnoses	O	502	511	abstract	38139446
of	O	512	514	abstract	38139446
severe	B-DDF	515	521	abstract	38139446
mental	I-DDF	522	528	abstract	38139446
disorders	I-DDF	529	538	abstract	38139446
.	O	538	539	abstract	38139446

We	O	540	542	abstract	38139446
analyzed	O	543	551	abstract	38139446
15	O	552	554	abstract	38139446
controls	B-human	555	563	abstract	38139446
,	O	563	564	abstract	38139446
35	O	565	567	abstract	38139446
patients	B-human	568	576	abstract	38139446
with	I-human	577	581	abstract	38139446
schizophrenia	I-human	582	595	abstract	38139446
(	O	596	597	abstract	38139446
SCZ	B-DDF	597	600	abstract	38139446
)	O	600	601	abstract	38139446
,	O	601	602	abstract	38139446
and	O	603	606	abstract	38139446
31	O	607	609	abstract	38139446
patients	B-human	610	618	abstract	38139446
with	O	619	623	abstract	38139446
major	B-DDF	624	629	abstract	38139446
depressive	I-DDF	630	640	abstract	38139446
disorder	I-DDF	641	649	abstract	38139446
(	O	650	651	abstract	38139446
MDD	B-DDF	651	654	abstract	38139446
)	O	654	655	abstract	38139446
recruited	O	656	665	abstract	38139446
among	O	666	671	abstract	38139446
those	O	672	677	abstract	38139446
attending	O	678	687	abstract	38139446
a	O	688	689	abstract	38139446
community	O	690	699	abstract	38139446
mental	O	700	706	abstract	38139446
health	O	707	713	abstract	38139446
center	O	714	720	abstract	38139446
(	O	721	722	abstract	38139446
50	O	722	724	abstract	38139446
males	B-human	725	730	abstract	38139446
and	O	731	734	abstract	38139446
31	O	735	737	abstract	38139446
females	B-human	738	745	abstract	38139446
,	O	745	746	abstract	38139446
mean	O	747	751	abstract	38139446
and	O	752	755	abstract	38139446
median	O	756	762	abstract	38139446
age	O	763	766	abstract	38139446
46.8	O	767	771	abstract	38139446
and	O	772	775	abstract	38139446
46.3	O	776	780	abstract	38139446
years	O	781	786	abstract	38139446
,	O	786	787	abstract	38139446
respectively	O	788	800	abstract	38139446
)	O	800	801	abstract	38139446
.	O	801	802	abstract	38139446

We	O	803	805	abstract	38139446
performed	O	806	815	abstract	38139446
16S	B-biomedical%technique	816	819	abstract	38139446
rRNA	I-biomedical%technique	820	824	abstract	38139446
sequencing	I-biomedical%technique	825	835	abstract	38139446
as	O	836	838	abstract	38139446
well	O	839	843	abstract	38139446
as	O	844	846	abstract	38139446
measurement	O	847	858	abstract	38139446
of	O	859	861	abstract	38139446
telomere	O	862	870	abstract	38139446
length	O	871	877	abstract	38139446
via	O	878	881	abstract	38139446
quantitative	B-biomedical%technique	882	894	abstract	38139446
fluorescence	I-biomedical%technique	895	907	abstract	38139446
in	I-biomedical%technique	908	910	abstract	38139446
situ	I-biomedical%technique	911	915	abstract	38139446
hybridization	I-biomedical%technique	916	929	abstract	38139446
and	O	930	933	abstract	38139446
high-sensitivity	B-biomedical%technique	934	950	abstract	38139446
C-reactive	I-biomedical%technique	951	961	abstract	38139446
protein	I-biomedical%technique	962	969	abstract	38139446
.	O	969	970	abstract	38139446

We	O	971	973	abstract	38139446
applied	O	974	981	abstract	38139446
statistical	B-statistical%technique	982	993	abstract	38139446
modeling	I-statistical%technique	994	1002	abstract	38139446
with	I-statistical%technique	1003	1007	abstract	38139446
logistic	I-statistical%technique	1008	1016	abstract	38139446
regression	I-statistical%technique	1017	1027	abstract	38139446
to	O	1028	1030	abstract	38139446
test	O	1031	1035	abstract	38139446
for	O	1036	1039	abstract	38139446
interaction	O	1040	1051	abstract	38139446
between	O	1052	1059	abstract	38139446
gut	B-microbiome	1060	1063	abstract	38139446
microbiota	I-microbiome	1064	1074	abstract	38139446
and	O	1075	1078	abstract	38139446
these	O	1079	1084	abstract	38139446
markers	O	1085	1092	abstract	38139446
.	O	1092	1093	abstract	38139446

Our	O	1094	1097	abstract	38139446
results	O	1098	1105	abstract	38139446
showed	O	1106	1112	abstract	38139446
statistically	O	1113	1126	abstract	38139446
significant	O	1127	1138	abstract	38139446
interactions	O	1139	1151	abstract	38139446
between	O	1152	1159	abstract	38139446
telomere	O	1160	1168	abstract	38139446
length	O	1169	1175	abstract	38139446
and	O	1176	1179	abstract	38139446
gut	B-microbiome	1180	1183	abstract	38139446
microbiota	I-microbiome	1184	1194	abstract	38139446
pointing	O	1195	1203	abstract	38139446
to	O	1204	1206	abstract	38139446
the	O	1207	1210	abstract	38139446
genus	O	1211	1216	abstract	38139446
<	O	1217	1218	abstract	38139446
i	O	1218	1219	abstract	38139446
>	O	1219	1220	abstract	38139446
Lachnostridium</i	B-bacteria	1220	1237	abstract	38139446
>	O	1237	1238	abstract	38139446
,	O	1238	1239	abstract	38139446
which	O	1240	1245	abstract	38139446
remained	O	1246	1254	abstract	38139446
significantly	O	1255	1268	abstract	38139446
associated	O	1269	1279	abstract	38139446
with	O	1280	1284	abstract	38139446
a	O	1285	1286	abstract	38139446
reduced	O	1287	1294	abstract	38139446
likelihood	O	1295	1305	abstract	38139446
of	O	1306	1308	abstract	38139446
MDD	B-DDF	1309	1312	abstract	38139446
even	O	1313	1317	abstract	38139446
after	O	1318	1323	abstract	38139446
adjustment	O	1324	1334	abstract	38139446
for	O	1335	1338	abstract	38139446
a	O	1339	1340	abstract	38139446
series	O	1341	1347	abstract	38139446
of	O	1348	1350	abstract	38139446
covariates	O	1351	1361	abstract	38139446
.	O	1361	1362	abstract	38139446

Although	O	1363	1371	abstract	38139446
exploratory	O	1372	1383	abstract	38139446
,	O	1383	1384	abstract	38139446
these	O	1385	1390	abstract	38139446
findings	O	1391	1399	abstract	38139446
show	O	1400	1404	abstract	38139446
that	O	1405	1409	abstract	38139446
specific	O	1410	1418	abstract	38139446
gut	B-microbiome	1419	1422	abstract	38139446
microbiota	I-microbiome	1423	1433	abstract	38139446
signatures	O	1434	1444	abstract	38139446
overexpressing	O	1445	1459	abstract	38139446
<	O	1460	1461	abstract	38139446
i	O	1461	1462	abstract	38139446
>	O	1462	1463	abstract	38139446
Lachnoclostridium</i	B-bacteria	1463	1483	abstract	38139446
>	O	1483	1484	abstract	38139446
and	O	1485	1488	abstract	38139446
interacting	O	1489	1500	abstract	38139446
with	O	1501	1505	abstract	38139446
biological	O	1506	1516	abstract	38139446
aging	O	1517	1522	abstract	38139446
could	O	1523	1528	abstract	38139446
modulate	O	1529	1537	abstract	38139446
the	O	1538	1541	abstract	38139446
liability	O	1542	1551	abstract	38139446
for	O	1552	1555	abstract	38139446
MDD	B-DDF	1556	1559	abstract	38139446
.	O	1559	1560	abstract	38139446

Bacillus	B-dietary%supplement	0	8	title	37209162
licheniformis	I-dietary%supplement	9	22	title	37209162
prevents	O	23	31	title	37209162
and	O	32	35	title	37209162
reduces	O	36	43	title	37209162
anxiety-like	B-DDF	44	56	title	37209162
and	I-DDF	57	60	title	37209162
depression-like	I-DDF	61	76	title	37209162
behaviours	I-DDF	77	87	title	37209162
.	O	87	88	title	37209162

As	O	0	2	abstract	37209162
common	O	3	9	abstract	37209162
mental	B-DDF	10	16	abstract	37209162
disorders	I-DDF	17	26	abstract	37209162
,	O	26	27	abstract	37209162
depression	B-DDF	28	38	abstract	37209162
and	O	39	42	abstract	37209162
anxiety	B-DDF	43	50	abstract	37209162
impact	O	51	57	abstract	37209162
people	O	58	64	abstract	37209162
all	O	65	68	abstract	37209162
around	O	69	75	abstract	37209162
the	O	76	79	abstract	37209162
world	O	80	85	abstract	37209162
.	O	85	86	abstract	37209162

Recent	O	87	93	abstract	37209162
studies	O	94	101	abstract	37209162
have	O	102	106	abstract	37209162
found	O	107	112	abstract	37209162
that	O	113	117	abstract	37209162
the	O	118	121	abstract	37209162
gut	B-microbiome	122	125	abstract	37209162
microbiome	I-microbiome	126	136	abstract	37209162
plays	O	137	142	abstract	37209162
an	O	143	145	abstract	37209162
important	O	146	155	abstract	37209162
role	O	156	160	abstract	37209162
in	O	161	163	abstract	37209162
mental	O	164	170	abstract	37209162
health	O	171	177	abstract	37209162
.	O	177	178	abstract	37209162

It	O	179	181	abstract	37209162
is	O	182	184	abstract	37209162
becoming	O	185	193	abstract	37209162
possible	O	194	202	abstract	37209162
to	O	203	205	abstract	37209162
treat	O	206	211	abstract	37209162
mental	B-DDF	212	218	abstract	37209162
disorders	I-DDF	219	228	abstract	37209162
by	O	229	231	abstract	37209162
regulating	O	232	242	abstract	37209162
the	O	243	246	abstract	37209162
composition	O	247	258	abstract	37209162
of	O	259	261	abstract	37209162
the	O	262	265	abstract	37209162
gut	B-microbiome	266	269	abstract	37209162
microbiota	I-microbiome	270	280	abstract	37209162
.	O	280	281	abstract	37209162

Bacillus	B-dietary%supplement	282	290	abstract	37209162
licheniformis	I-dietary%supplement	291	304	abstract	37209162
is	O	305	307	abstract	37209162
a	O	308	309	abstract	37209162
probiotic	B-dietary%supplement	310	319	abstract	37209162
used	O	320	324	abstract	37209162
to	O	325	327	abstract	37209162
treat	O	328	333	abstract	37209162
gut	B-DDF	334	337	abstract	37209162
diseases	I-DDF	338	346	abstract	37209162
through	O	347	354	abstract	37209162
balancing	O	355	364	abstract	37209162
the	O	365	368	abstract	37209162
gut	B-microbiome	369	372	abstract	37209162
microbiome	I-microbiome	373	383	abstract	37209162
during	O	384	390	abstract	37209162
lasting	O	391	398	abstract	37209162
years	O	399	404	abstract	37209162
.	O	404	405	abstract	37209162

Considering	O	406	417	abstract	37209162
the	O	418	421	abstract	37209162
role	O	422	426	abstract	37209162
of	O	427	429	abstract	37209162
gut	B-microbiome	430	433	abstract	37209162
microbiota	I-microbiome	434	444	abstract	37209162
in	O	445	447	abstract	37209162
the	O	448	451	abstract	37209162
gut-brain	O	452	461	abstract	37209162
axis	O	462	466	abstract	37209162
,	O	466	467	abstract	37209162
this	O	468	472	abstract	37209162
study	O	473	478	abstract	37209162
used	O	479	483	abstract	37209162
chronic	B-animal	484	491	abstract	37209162
unpredictable	I-animal	492	505	abstract	37209162
mild	I-animal	506	510	abstract	37209162
stress	I-animal	511	517	abstract	37209162
(	I-animal	518	519	abstract	37209162
CUMS	I-animal	519	523	abstract	37209162
)	I-animal	523	524	abstract	37209162
model	I-animal	525	530	abstract	37209162
rats	I-animal	531	535	abstract	37209162
to	O	536	538	abstract	37209162
explore	O	539	546	abstract	37209162
whether	O	547	554	abstract	37209162
Bacillus	B-dietary%supplement	555	563	abstract	37209162
licheniformis	I-dietary%supplement	564	577	abstract	37209162
can	O	578	581	abstract	37209162
prevent	O	582	589	abstract	37209162
and	O	590	593	abstract	37209162
treat	O	594	599	abstract	37209162
depression	B-DDF	600	610	abstract	37209162
and	O	611	614	abstract	37209162
anxiety	B-DDF	615	622	abstract	37209162
.	O	622	623	abstract	37209162

We	O	624	626	abstract	37209162
found	O	627	632	abstract	37209162
that	O	633	637	abstract	37209162
B.	B-dietary%supplement	638	640	abstract	37209162
licheniformis	I-dietary%supplement	641	654	abstract	37209162
reduced	O	655	662	abstract	37209162
the	O	663	666	abstract	37209162
depressive-like	B-DDF	667	682	abstract	37209162
and	I-DDF	683	686	abstract	37209162
anxiety-like	I-DDF	687	699	abstract	37209162
behaviours	I-DDF	700	710	abstract	37209162
of	O	711	713	abstract	37209162
the	O	714	717	abstract	37209162
rats	B-animal	718	722	abstract	37209162
during	O	723	729	abstract	37209162
the	O	730	733	abstract	37209162
CUMS	O	734	738	abstract	37209162
process	O	739	746	abstract	37209162
.	O	746	747	abstract	37209162

Meanwhile	O	748	757	abstract	37209162
,	O	757	758	abstract	37209162
B.	B-dietary%supplement	759	761	abstract	37209162
licheniformis	I-dietary%supplement	762	775	abstract	37209162
changed	O	776	783	abstract	37209162
the	O	784	787	abstract	37209162
gut	B-microbiome	788	791	abstract	37209162
microbiota	I-microbiome	792	802	abstract	37209162
composition	O	803	814	abstract	37209162
;	O	814	815	abstract	37209162
increased	O	816	825	abstract	37209162
the	O	826	829	abstract	37209162
short	B-chemical	830	835	abstract	37209162
chain	I-chemical	836	841	abstract	37209162
fatty	I-chemical	842	847	abstract	37209162
acids	I-chemical	848	853	abstract	37209162
(	O	854	855	abstract	37209162
SCFAs	B-chemical	855	860	abstract	37209162
)	O	860	861	abstract	37209162
in	O	862	864	abstract	37209162
the	O	865	868	abstract	37209162
colon	B-anatomical%location	869	874	abstract	37209162
,	O	874	875	abstract	37209162
decreased	O	876	885	abstract	37209162
kynurenine	B-chemical	886	896	abstract	37209162
,	O	896	897	abstract	37209162
norepinephrine	B-chemical	898	912	abstract	37209162
,	O	912	913	abstract	37209162
and	O	914	917	abstract	37209162
glutamate	B-chemical	918	927	abstract	37209162
levels	O	928	934	abstract	37209162
;	O	934	935	abstract	37209162
and	O	936	939	abstract	37209162
increased	O	940	949	abstract	37209162
the	O	950	953	abstract	37209162
tryptophan	B-chemical	954	964	abstract	37209162
,	O	964	965	abstract	37209162
dopamine	B-chemical	966	974	abstract	37209162
,	O	974	975	abstract	37209162
epinephrine	B-chemical	976	987	abstract	37209162
,	O	987	988	abstract	37209162
and	O	989	992	abstract	37209162
-aminobutyric	B-chemical	993	1007	abstract	37209162
acid	I-chemical	1008	1012	abstract	37209162
(	O	1013	1014	abstract	37209162
GABA	B-chemical	1014	1018	abstract	37209162
)	O	1018	1019	abstract	37209162
in	O	1020	1022	abstract	37209162
the	O	1023	1026	abstract	37209162
brain	B-anatomical%location	1027	1032	abstract	37209162
.	O	1032	1033	abstract	37209162

After	O	1034	1039	abstract	37209162
correlation	B-statistical%technique	1040	1051	abstract	37209162
analysis	I-statistical%technique	1052	1060	abstract	37209162
,	O	1060	1061	abstract	37209162
we	O	1062	1064	abstract	37209162
found	O	1065	1070	abstract	37209162
Parabacteroides	B-bacteria	1071	1086	abstract	37209162
,	O	1086	1087	abstract	37209162
Anaerostipes	B-bacteria	1088	1100	abstract	37209162
,	O	1100	1101	abstract	37209162
Ruminococcus-2	B-bacteria	1102	1116	abstract	37209162
,	O	1116	1117	abstract	37209162
and	O	1118	1121	abstract	37209162
Blautia	B-bacteria	1122	1129	abstract	37209162
showed	O	1130	1136	abstract	37209162
significant	O	1137	1148	abstract	37209162
correlation	O	1149	1160	abstract	37209162
with	O	1161	1165	abstract	37209162
neurotransmitters	O	1166	1183	abstract	37209162
and	O	1184	1187	abstract	37209162
SCFAs	B-chemical	1188	1193	abstract	37209162
,	O	1193	1194	abstract	37209162
indicating	O	1195	1205	abstract	37209162
the	O	1206	1209	abstract	37209162
gut	B-microbiome	1210	1213	abstract	37209162
microbiome	I-microbiome	1214	1224	abstract	37209162
plays	O	1225	1230	abstract	37209162
an	O	1231	1233	abstract	37209162
important	O	1234	1243	abstract	37209162
role	O	1244	1248	abstract	37209162
in	O	1249	1251	abstract	37209162
B.	B-dietary%supplement	1252	1254	abstract	37209162
licheniformis	I-dietary%supplement	1255	1268	abstract	37209162
reducing	O	1269	1277	abstract	37209162
depressive-like	B-DDF	1278	1293	abstract	37209162
behaviours	I-DDF	1294	1304	abstract	37209162
.	O	1304	1305	abstract	37209162

Therefore	O	1306	1315	abstract	37209162
,	O	1315	1316	abstract	37209162
this	O	1317	1321	abstract	37209162
study	O	1322	1327	abstract	37209162
suggested	O	1328	1337	abstract	37209162
B.	B-dietary%supplement	1338	1340	abstract	37209162
licheniformis	I-dietary%supplement	1341	1354	abstract	37209162
may	O	1355	1358	abstract	37209162
prevent	O	1359	1366	abstract	37209162
depressive-like	B-DDF	1367	1382	abstract	37209162
and	I-DDF	1383	1386	abstract	37209162
anxiety-like	I-DDF	1387	1399	abstract	37209162
behaviours	I-DDF	1400	1410	abstract	37209162
while	O	1411	1416	abstract	37209162
regulating	O	1417	1427	abstract	37209162
the	O	1428	1431	abstract	37209162
gut	O	1432	1435	abstract	37209162
microbiota	O	1436	1446	abstract	37209162
composition	O	1447	1458	abstract	37209162
and	O	1459	1462	abstract	37209162
increasing	O	1463	1473	abstract	37209162
the	O	1474	1477	abstract	37209162
SCFA	B-chemical	1478	1482	abstract	37209162
levels	O	1483	1489	abstract	37209162
in	O	1490	1492	abstract	37209162
the	O	1493	1496	abstract	37209162
colon	B-anatomical%location	1497	1502	abstract	37209162
to	O	1503	1505	abstract	37209162
alter	O	1506	1511	abstract	37209162
the	O	1512	1515	abstract	37209162
levels	O	1516	1522	abstract	37209162
of	O	1523	1525	abstract	37209162
the	O	1526	1529	abstract	37209162
neurotransmitters	O	1530	1547	abstract	37209162
in	O	1548	1550	abstract	37209162
the	O	1551	1554	abstract	37209162
brain	B-anatomical%location	1555	1560	abstract	37209162
.	O	1560	1561	abstract	37209162

KEY	O	1562	1565	abstract	37209162
POINTS	O	1566	1572	abstract	37209162
:	O	1572	1573	abstract	37209162
	O	1574	1575	abstract	37209162
B.	B-dietary%supplement	1576	1578	abstract	37209162
licheniformis	I-dietary%supplement	1579	1592	abstract	37209162
reduced	O	1593	1600	abstract	37209162
depressive-like	B-DDF	1601	1616	abstract	37209162
and	I-DDF	1617	1620	abstract	37209162
anxiety-like	I-DDF	1621	1633	abstract	37209162
behaviours	I-DDF	1634	1644	abstract	37209162
induced	O	1645	1652	abstract	37209162
by	O	1653	1655	abstract	37209162
the	O	1656	1659	abstract	37209162
chronic	B-DDF	1660	1667	abstract	37209162
unpredictable	I-DDF	1668	1681	abstract	37209162
mild	I-DDF	1682	1686	abstract	37209162
stress	I-DDF	1687	1693	abstract	37209162
.	O	1693	1694	abstract	37209162

	O	1695	1696	abstract	37209162
GABA	B-chemical	1697	1701	abstract	37209162
levels	O	1702	1708	abstract	37209162
in	O	1709	1711	abstract	37209162
the	O	1712	1715	abstract	37209162
brain	B-anatomical%location	1716	1721	abstract	37209162
are	O	1722	1725	abstract	37209162
assonated	O	1726	1735	abstract	37209162
with	O	1736	1740	abstract	37209162
B.	B-dietary%supplement	1741	1743	abstract	37209162
licheniformis	I-dietary%supplement	1744	1757	abstract	37209162
regulating	O	1758	1768	abstract	37209162
depressive-like	B-DDF	1769	1784	abstract	37209162
and	I-DDF	1785	1788	abstract	37209162
anxiety-like	I-DDF	1789	1801	abstract	37209162
behaviours	I-DDF	1802	1812	abstract	37209162
.	O	1812	1813	abstract	37209162

	O	1814	1815	abstract	37209162
Gut	O	1816	1819	abstract	37209162
microbiota	O	1820	1830	abstract	37209162
composition	O	1831	1842	abstract	37209162
alteration	O	1843	1853	abstract	37209162
followed	O	1854	1862	abstract	37209162
by	O	1863	1865	abstract	37209162
metabolic	O	1866	1875	abstract	37209162
changes	O	1876	1883	abstract	37209162
may	O	1884	1887	abstract	37209162
play	O	1888	1892	abstract	37209162
a	O	1893	1894	abstract	37209162
role	O	1895	1899	abstract	37209162
in	O	1900	1902	abstract	37209162
the	O	1903	1906	abstract	37209162
GABA	B-chemical	1907	1911	abstract	37209162
levels	O	1912	1918	abstract	37209162
increase	O	1919	1927	abstract	37209162
.	O	1927	1928	abstract	37209162

High-cholesterol	B-dietary%supplement	0	16	title	36738999
diet	I-dietary%supplement	17	21	title	36738999
promotes	O	22	30	title	36738999
depression-	B-DDF	31	42	title	36738999
and	I-DDF	43	46	title	36738999
anxiety-like	I-DDF	47	59	title	36738999
behaviors	I-DDF	60	69	title	36738999
in	O	70	72	title	36738999
mice	B-animal	73	77	title	36738999
by	O	78	80	title	36738999
impact	O	81	87	title	36738999
gut	B-microbiome	88	91	title	36738999
microbe	I-microbiome	92	99	title	36738999
and	O	100	103	title	36738999
neuroinflammation	B-DDF	104	121	title	36738999
.	O	121	122	title	36738999

Neuropsychiatric	B-DDF	0	16	abstract	36738999
disorders	I-DDF	17	26	abstract	36738999
,	O	26	27	abstract	36738999
including	O	28	37	abstract	36738999
anxiety	B-DDF	38	45	abstract	36738999
and	O	46	49	abstract	36738999
depression	B-DDF	50	60	abstract	36738999
,	O	60	61	abstract	36738999
are	O	62	65	abstract	36738999
one	O	66	69	abstract	36738999
of	O	70	72	abstract	36738999
the	O	73	76	abstract	36738999
most	O	77	81	abstract	36738999
common	O	82	88	abstract	36738999
mental	B-DDF	89	95	abstract	36738999
illnesses	I-DDF	96	105	abstract	36738999
worldwide	O	106	115	abstract	36738999
.	O	115	116	abstract	36738999

A	O	117	118	abstract	36738999
growing	O	119	126	abstract	36738999
body	O	127	131	abstract	36738999
of	O	132	134	abstract	36738999
evidence	O	135	143	abstract	36738999
shows	O	144	149	abstract	36738999
that	O	150	154	abstract	36738999
there	O	155	160	abstract	36738999
is	O	161	163	abstract	36738999
a	O	164	165	abstract	36738999
complex	O	166	173	abstract	36738999
relationship	O	174	186	abstract	36738999
between	O	187	194	abstract	36738999
dietary	O	195	202	abstract	36738999
patterns	O	203	211	abstract	36738999
and	O	212	215	abstract	36738999
mental	O	216	222	abstract	36738999
health	O	223	229	abstract	36738999
.	O	229	230	abstract	36738999

In	O	231	233	abstract	36738999
our	O	234	237	abstract	36738999
study	O	238	243	abstract	36738999
,	O	243	244	abstract	36738999
C57BL/6J	B-animal	245	253	abstract	36738999
mice	I-animal	254	258	abstract	36738999
were	O	259	263	abstract	36738999
divided	O	264	271	abstract	36738999
into	O	272	276	abstract	36738999
three	O	277	282	abstract	36738999
groups	O	283	289	abstract	36738999
:	O	289	290	abstract	36738999
control	O	291	298	abstract	36738999
diet	O	299	303	abstract	36738999
group	O	304	309	abstract	36738999
(	O	310	311	abstract	36738999
CON	O	311	314	abstract	36738999
,	O	314	315	abstract	36738999
10	O	316	318	abstract	36738999
	O	318	319	abstract	36738999
%	O	319	320	abstract	36738999
	O	320	321	abstract	36738999
kcal	O	321	325	abstract	36738999
fat	O	326	329	abstract	36738999
)	O	329	330	abstract	36738999
,	O	330	331	abstract	36738999
high-cholesterol	O	332	348	abstract	36738999
diet	O	349	353	abstract	36738999
model	O	354	359	abstract	36738999
group	O	360	365	abstract	36738999
(	O	366	367	abstract	36738999
HCD	O	367	370	abstract	36738999
,	O	370	371	abstract	36738999
42.0	O	372	376	abstract	36738999
	O	376	377	abstract	36738999
%	O	377	378	abstract	36738999
	O	378	379	abstract	36738999
kcal	O	379	383	abstract	36738999
fat	O	384	387	abstract	36738999
	O	387	388	abstract	36738999
+	O	388	389	abstract	36738999
	O	389	390	abstract	36738999
1.25	O	390	394	abstract	36738999
	O	394	395	abstract	36738999
%	O	395	396	abstract	36738999
	O	396	397	abstract	36738999
kcal	O	397	401	abstract	36738999
Cholesterol	B-chemical	402	413	abstract	36738999
)	O	413	414	abstract	36738999
,	O	414	415	abstract	36738999
and	O	416	419	abstract	36738999
chronic	O	420	427	abstract	36738999
restraint	O	428	437	abstract	36738999
stress	O	438	444	abstract	36738999
group	O	445	450	abstract	36738999
(	O	451	452	abstract	36738999
CRS	O	452	455	abstract	36738999
,	O	455	456	abstract	36738999
10	O	457	459	abstract	36738999
	O	459	460	abstract	36738999
%	O	460	461	abstract	36738999
	O	461	462	abstract	36738999
kcal	O	462	466	abstract	36738999
fat	O	467	470	abstract	36738999
)	O	470	471	abstract	36738999
which	O	472	477	abstract	36738999
as	O	478	480	abstract	36738999
a	O	481	482	abstract	36738999
positive	O	483	491	abstract	36738999
control	O	492	499	abstract	36738999
group	O	500	505	abstract	36738999
for	O	506	509	abstract	36738999
the	O	510	513	abstract	36738999
depression	O	514	524	abstract	36738999
model	O	525	530	abstract	36738999
.	O	530	531	abstract	36738999

Six	O	532	535	abstract	36738999
weeks	O	536	541	abstract	36738999
later	O	542	547	abstract	36738999
,	O	547	548	abstract	36738999
depressive-	B-DDF	549	560	abstract	36738999
and	I-DDF	561	564	abstract	36738999
anxiety-like	I-DDF	565	577	abstract	36738999
behavior	I-DDF	578	586	abstract	36738999
were	O	587	591	abstract	36738999
evaluated	O	592	601	abstract	36738999
for	O	602	605	abstract	36738999
using	O	606	611	abstract	36738999
the	O	612	615	abstract	36738999
OFT	B-biomedical%technique	616	619	abstract	36738999
,	O	619	620	abstract	36738999
SPT	B-biomedical%technique	621	624	abstract	36738999
and	O	625	628	abstract	36738999
TST	B-biomedical%technique	629	632	abstract	36738999
.	O	632	633	abstract	36738999

Glucose	B-DDF	634	641	abstract	36738999
intolerance	I-DDF	642	653	abstract	36738999
and	O	654	657	abstract	36738999
liver	B-DDF	658	663	abstract	36738999
fat	I-DDF	664	667	abstract	36738999
were	O	668	672	abstract	36738999
detected	O	673	681	abstract	36738999
by	O	682	684	abstract	36738999
IGTT	B-biomedical%technique	685	689	abstract	36738999
and	O	690	693	abstract	36738999
liver	B-biomedical%technique	694	699	abstract	36738999
lipid	I-biomedical%technique	700	705	abstract	36738999
kit	I-biomedical%technique	706	709	abstract	36738999
.	O	709	710	abstract	36738999

The	O	711	714	abstract	36738999
expression	O	715	725	abstract	36738999
of	O	726	728	abstract	36738999
peripheral	B-DDF	729	739	abstract	36738999
and	I-DDF	740	743	abstract	36738999
central	I-DDF	744	751	abstract	36738999
inflammation	I-DDF	752	764	abstract	36738999
was	O	765	768	abstract	36738999
detected	O	769	777	abstract	36738999
by	O	778	780	abstract	36738999
LEGEND	B-biomedical%technique	781	787	abstract	36738999
plex	I-biomedical%technique	788	792	abstract	36738999
kits	I-biomedical%technique	793	797	abstract	36738999
.	O	797	798	abstract	36738999

5-HT	B-chemical	799	803	abstract	36738999
(	O	804	805	abstract	36738999
also	O	805	809	abstract	36738999
named	O	810	815	abstract	36738999
5-hydroxytryptamine	B-chemical	816	835	abstract	36738999
,	O	835	836	abstract	36738999
5-HT	B-chemical	837	841	abstract	36738999
)	O	841	842	abstract	36738999
and	O	843	846	abstract	36738999
related	O	847	854	abstract	36738999
receptors	O	855	864	abstract	36738999
expression	O	865	875	abstract	36738999
were	O	876	880	abstract	36738999
monitored	O	881	890	abstract	36738999
by	O	891	893	abstract	36738999
ELISA	B-biomedical%technique	894	899	abstract	36738999
,	O	899	900	abstract	36738999
RT-PCR	B-biomedical%technique	901	907	abstract	36738999
and	O	908	911	abstract	36738999
Western	B-biomedical%technique	912	919	abstract	36738999
blot	I-biomedical%technique	920	924	abstract	36738999
.	O	924	925	abstract	36738999

Meantime	O	926	934	abstract	36738999
,	O	934	935	abstract	36738999
gut	O	936	939	abstract	36738999
microbe	O	940	947	abstract	36738999
of	O	948	950	abstract	36738999
stool	O	951	956	abstract	36738999
samples	O	957	964	abstract	36738999
was	O	965	968	abstract	36738999
performed	O	969	978	abstract	36738999
by	O	979	981	abstract	36738999
16S	B-biomedical%technique	982	985	abstract	36738999
rRNA	I-biomedical%technique	986	990	abstract	36738999
gene	I-biomedical%technique	991	995	abstract	36738999
sequencing	I-biomedical%technique	996	1006	abstract	36738999
.	O	1006	1007	abstract	36738999

Similar	O	1008	1015	abstract	36738999
to	O	1016	1018	abstract	36738999
CRS	O	1019	1022	abstract	36738999
model	O	1023	1028	abstract	36738999
,	O	1028	1029	abstract	36738999
short-term	O	1030	1040	abstract	36738999
HCD	O	1041	1044	abstract	36738999
intervention	O	1045	1057	abstract	36738999
induced	O	1058	1065	abstract	36738999
anxiety	B-DDF	1066	1073	abstract	36738999
and	I-DDF	1074	1077	abstract	36738999
depression-like	I-DDF	1078	1093	abstract	36738999
behavior	I-DDF	1094	1102	abstract	36738999
behavioral	I-DDF	1103	1113	abstract	36738999
abnormalities	I-DDF	1114	1127	abstract	36738999
in	O	1128	1130	abstract	36738999
mice	B-animal	1131	1135	abstract	36738999
.	O	1135	1136	abstract	36738999

HCD	O	1137	1140	abstract	36738999
consumption	O	1141	1152	abstract	36738999
resulted	O	1153	1161	abstract	36738999
in	O	1162	1164	abstract	36738999
significantly	O	1165	1178	abstract	36738999
increased	O	1179	1188	abstract	36738999
body	O	1189	1193	abstract	36738999
weight	O	1194	1200	abstract	36738999
,	O	1200	1201	abstract	36738999
liver	O	1202	1207	abstract	36738999
fat	O	1208	1211	abstract	36738999
(	O	1212	1213	abstract	36738999
LDL-C	B-chemical	1213	1218	abstract	36738999
,	O	1218	1219	abstract	36738999
TC	B-chemical	1220	1222	abstract	36738999
,	O	1222	1223	abstract	36738999
TG	B-chemical	1224	1226	abstract	36738999
)	O	1226	1227	abstract	36738999
,	O	1227	1228	abstract	36738999
peripheral	O	1229	1239	abstract	36738999
inflammation	O	1240	1252	abstract	36738999
(	O	1253	1254	abstract	36738999
IL-1	B-chemical	1254	1259	abstract	36738999
,	O	1259	1260	abstract	36738999
MCP-1	B-chemical	1261	1266	abstract	36738999
,	O	1266	1267	abstract	36738999
IL-17A	B-chemical	1268	1274	abstract	36738999
)	O	1274	1275	abstract	36738999
and	O	1276	1279	abstract	36738999
neuroinflammation	O	1280	1297	abstract	36738999
(	O	1298	1299	abstract	36738999
MCP-1	B-chemical	1299	1304	abstract	36738999
)	O	1304	1305	abstract	36738999
.	O	1305	1306	abstract	36738999

The	O	1307	1310	abstract	36738999
concentration	O	1311	1324	abstract	36738999
of	O	1325	1327	abstract	36738999
5-HT	B-chemical	1328	1332	abstract	36738999
increased	O	1333	1342	abstract	36738999
in	O	1343	1345	abstract	36738999
the	O	1346	1349	abstract	36738999
hippocampus	B-anatomical%location	1350	1361	abstract	36738999
,	O	1361	1362	abstract	36738999
meanwhile	O	1363	1372	abstract	36738999
,	O	1372	1373	abstract	36738999
the	O	1374	1377	abstract	36738999
expression	O	1378	1388	abstract	36738999
of	O	1389	1391	abstract	36738999
5-HT	B-gene	1392	1396	abstract	36738999
receptor	I-gene	1397	1405	abstract	36738999
HTR2A	I-gene	1406	1411	abstract	36738999
was	O	1412	1415	abstract	36738999
distinct	O	1416	1424	abstract	36738999
in	O	1425	1427	abstract	36738999
different	O	1428	1437	abstract	36738999
regions	O	1438	1445	abstract	36738999
of	O	1446	1448	abstract	36738999
the	O	1449	1452	abstract	36738999
brain	O	1453	1458	abstract	36738999
tissue	O	1459	1465	abstract	36738999
.	O	1465	1466	abstract	36738999

More	O	1467	1471	abstract	36738999
importantly	O	1472	1483	abstract	36738999
,	O	1483	1484	abstract	36738999
we	O	1485	1487	abstract	36738999
found	O	1488	1493	abstract	36738999
that	O	1494	1498	abstract	36738999
compared	O	1499	1507	abstract	36738999
with	O	1508	1512	abstract	36738999
the	O	1513	1516	abstract	36738999
CON	O	1517	1520	abstract	36738999
diet	O	1521	1525	abstract	36738999
,	O	1525	1526	abstract	36738999
HCD	B-DDF	1527	1530	abstract	36738999
induced	O	1531	1538	abstract	36738999
the	O	1539	1542	abstract	36738999
decrease	O	1543	1551	abstract	36738999
of	O	1552	1554	abstract	36738999
intestinal	O	1555	1565	abstract	36738999
flora	O	1566	1571	abstract	36738999
diversity	O	1572	1581	abstract	36738999
,	O	1581	1582	abstract	36738999
especially	O	1583	1593	abstract	36738999
the	O	1594	1597	abstract	36738999
decrease	O	1598	1606	abstract	36738999
the	O	1607	1610	abstract	36738999
relative	O	1611	1619	abstract	36738999
abundance	O	1620	1629	abstract	36738999
of	O	1630	1632	abstract	36738999
Akkermansia_muciniphila	B-bacteria	1633	1656	abstract	36738999
,	O	1656	1657	abstract	36738999
which	O	1658	1663	abstract	36738999
was	O	1664	1667	abstract	36738999
statistically	O	1668	1681	abstract	36738999
significant	O	1682	1693	abstract	36738999
.	O	1693	1694	abstract	36738999

Further	O	1695	1702	abstract	36738999
,	O	1702	1703	abstract	36738999
Pearson	B-statistical%technique	1704	1711	abstract	36738999
correlation	I-statistical%technique	1712	1723	abstract	36738999
analysis	I-statistical%technique	1724	1732	abstract	36738999
showed	O	1733	1739	abstract	36738999
that	O	1740	1744	abstract	36738999
Akkermansia_muciniphila	B-bacteria	1745	1768	abstract	36738999
was	O	1769	1772	abstract	36738999
significantly	O	1773	1786	abstract	36738999
negatively	O	1787	1797	abstract	36738999
correlated	O	1798	1808	abstract	36738999
with	O	1809	1813	abstract	36738999
the	O	1814	1817	abstract	36738999
concentration	O	1818	1831	abstract	36738999
of	O	1832	1834	abstract	36738999
MCP-1	B-chemical	1835	1840	abstract	36738999
,	O	1840	1841	abstract	36738999
IL-17A	B-chemical	1842	1848	abstract	36738999
in	O	1849	1851	abstract	36738999
serum	O	1852	1857	abstract	36738999
and	O	1858	1861	abstract	36738999
5-HT	B-chemical	1862	1866	abstract	36738999
in	O	1867	1869	abstract	36738999
hippocampus	B-anatomical%location	1870	1881	abstract	36738999
.	O	1881	1882	abstract	36738999

Therefore	O	1883	1892	abstract	36738999
,	O	1892	1893	abstract	36738999
we	O	1894	1896	abstract	36738999
speculated	O	1897	1907	abstract	36738999
that	O	1908	1912	abstract	36738999
the	O	1913	1916	abstract	36738999
disorder	B-DDF	1917	1925	abstract	36738999
of	I-DDF	1926	1928	abstract	36738999
neuroinflammation	I-DDF	1929	1946	abstract	36738999
induced	O	1947	1954	abstract	36738999
by	O	1955	1957	abstract	36738999
HCD	O	1958	1961	abstract	36738999
consumption	O	1962	1973	abstract	36738999
promotes	O	1974	1982	abstract	36738999
depression-	B-DDF	1983	1994	abstract	36738999
and	I-DDF	1995	1998	abstract	36738999
anxiety-like	I-DDF	1999	2011	abstract	36738999
behaviors	I-DDF	2012	2021	abstract	36738999
in	O	2022	2024	abstract	36738999
mice	B-animal	2025	2029	abstract	36738999
through	O	2030	2037	abstract	36738999
the	O	2038	2041	abstract	36738999
gut	O	2042	2045	abstract	36738999
microbe	O	2046	2053	abstract	36738999
.	O	2053	2054	abstract	36738999

Multi-Omics	B-biomedical%technique	0	11	title	37627638
Approach	I-biomedical%technique	12	20	title	37627638
Reveals	O	21	28	title	37627638
Prebiotic	O	29	38	title	37627638
and	O	39	42	title	37627638
Potential	O	43	52	title	37627638
Antioxidant	O	53	64	title	37627638
Effects	O	65	72	title	37627638
of	O	73	75	title	37627638
Essential	O	76	85	title	37627638
Oils	O	86	90	title	37627638
from	O	91	95	title	37627638
the	O	96	99	title	37627638
Mediterranean	O	100	113	title	37627638
Diet	O	114	118	title	37627638
on	O	119	121	title	37627638
Cardiometabolic	B-DDF	122	137	title	37627638
Disorder	I-DDF	138	146	title	37627638
Using	O	147	152	title	37627638
Humanized	B-animal	153	162	title	37627638
Gnotobiotic	I-animal	163	174	title	37627638
Mice	I-animal	175	179	title	37627638
.	O	179	180	title	37627638

Essential	O	0	9	abstract	37627638
oils	O	10	14	abstract	37627638
sourced	O	15	22	abstract	37627638
from	O	23	27	abstract	37627638
herbs	O	28	33	abstract	37627638
commonly	O	34	42	abstract	37627638
used	O	43	47	abstract	37627638
in	O	48	50	abstract	37627638
the	O	51	54	abstract	37627638
Mediterranean	O	55	68	abstract	37627638
diet	O	69	73	abstract	37627638
have	O	74	78	abstract	37627638
demonstrated	O	79	91	abstract	37627638
advantageous	O	92	104	abstract	37627638
attributes	O	105	115	abstract	37627638
as	O	116	118	abstract	37627638
nutraceuticals	B-chemical	119	133	abstract	37627638
and	O	134	137	abstract	37627638
prebiotics	B-dietary%supplement	138	148	abstract	37627638
within	O	149	155	abstract	37627638
a	O	156	157	abstract	37627638
model	O	158	163	abstract	37627638
of	O	164	166	abstract	37627638
severe	B-DDF	167	173	abstract	37627638
cardiometabolic	I-DDF	174	189	abstract	37627638
disorder	I-DDF	190	198	abstract	37627638
.	O	198	199	abstract	37627638

The	O	200	203	abstract	37627638
primary	O	204	211	abstract	37627638
objective	O	212	221	abstract	37627638
of	O	222	224	abstract	37627638
this	O	225	229	abstract	37627638
study	O	230	235	abstract	37627638
was	O	236	239	abstract	37627638
to	O	240	242	abstract	37627638
assess	O	243	249	abstract	37627638
the	O	250	253	abstract	37627638
influences	O	254	264	abstract	37627638
exerted	O	265	272	abstract	37627638
by	O	273	275	abstract	37627638
essential	O	276	285	abstract	37627638
oils	O	286	290	abstract	37627638
derived	O	291	298	abstract	37627638
from	O	299	303	abstract	37627638
thyme	B-food	304	309	abstract	37627638
(	O	310	311	abstract	37627638
<	O	311	312	abstract	37627638
i	O	312	313	abstract	37627638
>	O	313	314	abstract	37627638
Thymus	B-food	314	320	abstract	37627638
vulgaris</i	I-food	321	332	abstract	37627638
>	O	332	333	abstract	37627638
)	O	333	334	abstract	37627638
and	O	335	338	abstract	37627638
oregano	B-food	339	346	abstract	37627638
(	O	347	348	abstract	37627638
<	O	348	349	abstract	37627638
i	O	349	350	abstract	37627638
>	O	350	351	abstract	37627638
Origanum	B-food	351	359	abstract	37627638
vulgare</i	I-food	360	370	abstract	37627638
>	O	370	371	abstract	37627638
)	O	371	372	abstract	37627638
via	O	373	376	abstract	37627638
a	O	377	378	abstract	37627638
comprehensive	O	379	392	abstract	37627638
multi-omics	B-biomedical%technique	393	404	abstract	37627638
approach	I-biomedical%technique	405	413	abstract	37627638
within	O	414	420	abstract	37627638
a	O	421	422	abstract	37627638
gnotobiotic	O	423	434	abstract	37627638
murine	O	435	441	abstract	37627638
model	O	442	447	abstract	37627638
featuring	O	448	457	abstract	37627638
colonic	B-microbiome	458	465	abstract	37627638
microbiota	I-microbiome	466	476	abstract	37627638
acquired	O	477	485	abstract	37627638
from	O	486	490	abstract	37627638
patients	B-human	491	499	abstract	37627638
diagnosed	O	500	509	abstract	37627638
with	O	510	514	abstract	37627638
coronary	B-DDF	515	523	abstract	37627638
artery	I-DDF	524	530	abstract	37627638
disease	I-DDF	531	538	abstract	37627638
(	O	539	540	abstract	37627638
CAD	B-DDF	540	543	abstract	37627638
)	O	543	544	abstract	37627638
and	O	545	548	abstract	37627638
type-2	B-DDF	549	555	abstract	37627638
diabetes	I-DDF	556	564	abstract	37627638
mellitus	I-DDF	565	573	abstract	37627638
(	O	574	575	abstract	37627638
T2DM	B-DDF	575	579	abstract	37627638
)	O	579	580	abstract	37627638
.	O	580	581	abstract	37627638

Our	O	582	585	abstract	37627638
findings	O	586	594	abstract	37627638
demonstrated	O	595	607	abstract	37627638
prebiotic	B-dietary%supplement	608	617	abstract	37627638
and	O	618	621	abstract	37627638
potential	O	622	631	abstract	37627638
antioxidant	O	632	643	abstract	37627638
effects	O	644	651	abstract	37627638
elicited	O	652	660	abstract	37627638
by	O	661	663	abstract	37627638
these	O	664	669	abstract	37627638
essential	O	670	679	abstract	37627638
oils	O	680	684	abstract	37627638
.	O	684	685	abstract	37627638

We	O	686	688	abstract	37627638
observed	O	689	697	abstract	37627638
a	O	698	699	abstract	37627638
substantial	O	700	711	abstract	37627638
increase	O	712	720	abstract	37627638
in	O	721	723	abstract	37627638
the	O	724	727	abstract	37627638
relative	O	728	736	abstract	37627638
abundance	O	737	746	abstract	37627638
of	O	747	749	abstract	37627638
the	O	750	753	abstract	37627638
<	O	754	755	abstract	37627638
i	O	755	756	abstract	37627638
>	O	756	757	abstract	37627638
Lactobacillus</i	B-bacteria	757	773	abstract	37627638
>	O	773	774	abstract	37627638
genus	O	775	780	abstract	37627638
in	O	781	783	abstract	37627638
the	O	784	787	abstract	37627638
gut	B-microbiome	788	791	abstract	37627638
microbiota	I-microbiome	792	802	abstract	37627638
,	O	802	803	abstract	37627638
accompanied	O	804	815	abstract	37627638
by	O	816	818	abstract	37627638
higher	O	819	825	abstract	37627638
levels	O	826	832	abstract	37627638
of	O	833	835	abstract	37627638
short-chain	B-chemical	836	847	abstract	37627638
fatty	I-chemical	848	853	abstract	37627638
acids	I-chemical	854	859	abstract	37627638
and	O	860	863	abstract	37627638
a	O	864	865	abstract	37627638
reduction	O	866	875	abstract	37627638
in	O	876	878	abstract	37627638
trimethylamine	B-chemical	879	893	abstract	37627638
N-oxide	I-chemical	894	901	abstract	37627638
levels	O	902	908	abstract	37627638
and	O	909	912	abstract	37627638
protein	O	913	920	abstract	37627638
oxidation	O	921	930	abstract	37627638
in	O	931	933	abstract	37627638
the	O	934	937	abstract	37627638
plasma	O	938	944	abstract	37627638
.	O	944	945	abstract	37627638

Moreover	O	946	954	abstract	37627638
,	O	954	955	abstract	37627638
functional	B-biomedical%technique	956	966	abstract	37627638
enrichment	I-biomedical%technique	967	977	abstract	37627638
analysis	I-biomedical%technique	978	986	abstract	37627638
of	O	987	989	abstract	37627638
the	O	990	993	abstract	37627638
cardiac	O	994	1001	abstract	37627638
tissue	O	1002	1008	abstract	37627638
proteome	O	1009	1017	abstract	37627638
unveiled	O	1018	1026	abstract	37627638
an	O	1027	1029	abstract	37627638
over-representation	O	1030	1049	abstract	37627638
of	O	1050	1052	abstract	37627638
pathways	O	1053	1061	abstract	37627638
related	O	1062	1069	abstract	37627638
to	O	1070	1072	abstract	37627638
mitochondrial	O	1073	1086	abstract	37627638
function	O	1087	1095	abstract	37627638
,	O	1095	1096	abstract	37627638
oxidative	O	1097	1106	abstract	37627638
stress	O	1107	1113	abstract	37627638
,	O	1113	1114	abstract	37627638
and	O	1115	1118	abstract	37627638
cardiac	O	1119	1126	abstract	37627638
contraction	O	1127	1138	abstract	37627638
.	O	1138	1139	abstract	37627638

These	O	1140	1145	abstract	37627638
findings	O	1146	1154	abstract	37627638
provide	O	1155	1162	abstract	37627638
compelling	O	1163	1173	abstract	37627638
evidence	O	1174	1182	abstract	37627638
of	O	1183	1185	abstract	37627638
the	O	1186	1189	abstract	37627638
prebiotic	O	1190	1199	abstract	37627638
and	O	1200	1203	abstract	37627638
antioxidant	O	1204	1215	abstract	37627638
actions	O	1216	1223	abstract	37627638
of	O	1224	1226	abstract	37627638
thyme-	O	1227	1233	abstract	37627638
and	O	1234	1237	abstract	37627638
oregano-derived	O	1238	1253	abstract	37627638
essential	O	1254	1263	abstract	37627638
oils	O	1264	1268	abstract	37627638
,	O	1268	1269	abstract	37627638
which	O	1270	1275	abstract	37627638
extend	O	1276	1282	abstract	37627638
to	O	1283	1285	abstract	37627638
cardiac	O	1286	1293	abstract	37627638
function	O	1294	1302	abstract	37627638
.	O	1302	1303	abstract	37627638

These	O	1304	1309	abstract	37627638
results	O	1310	1317	abstract	37627638
encourage	O	1318	1327	abstract	37627638
further	O	1328	1335	abstract	37627638
investigation	O	1336	1349	abstract	37627638
into	O	1350	1354	abstract	37627638
the	O	1355	1358	abstract	37627638
promising	O	1359	1368	abstract	37627638
utility	O	1369	1376	abstract	37627638
of	O	1377	1379	abstract	37627638
essential	O	1380	1389	abstract	37627638
oils	O	1390	1394	abstract	37627638
derived	O	1395	1402	abstract	37627638
from	O	1403	1407	abstract	37627638
herbs	O	1408	1413	abstract	37627638
commonly	O	1414	1422	abstract	37627638
used	O	1423	1427	abstract	37627638
in	O	1428	1430	abstract	37627638
the	O	1431	1434	abstract	37627638
Mediterranean	O	1435	1448	abstract	37627638
diet	O	1449	1453	abstract	37627638
as	O	1454	1456	abstract	37627638
potential	O	1457	1466	abstract	37627638
nutraceutical	O	1467	1480	abstract	37627638
interventions	O	1481	1494	abstract	37627638
for	O	1495	1498	abstract	37627638
mitigating	O	1499	1509	abstract	37627638
chronic	B-DDF	1510	1517	abstract	37627638
diseases	I-DDF	1518	1526	abstract	37627638
linked	O	1527	1533	abstract	37627638
to	O	1534	1536	abstract	37627638
CAD	B-DDF	1537	1540	abstract	37627638
and	O	1541	1544	abstract	37627638
T2DM	B-DDF	1545	1549	abstract	37627638
.	O	1549	1550	abstract	37627638

Alteration	O	0	10	title	30394313
of	O	11	13	title	30394313
gut	B-chemical	14	17	title	30394313
microbiota-associated	I-chemical	18	39	title	30394313
epitopes	I-chemical	40	48	title	30394313
in	O	49	51	title	30394313
children	B-human	52	60	title	30394313
with	O	61	65	title	30394313
autism	B-DDF	66	72	title	30394313
spectrum	I-DDF	73	81	title	30394313
disorders	I-DDF	82	91	title	30394313
.	O	91	92	title	30394313

Autism	B-DDF	0	6	abstract	30394313
spectrum	I-DDF	7	15	abstract	30394313
disorder	I-DDF	16	24	abstract	30394313
(	O	25	26	abstract	30394313
ASD	B-DDF	26	29	abstract	30394313
)	O	29	30	abstract	30394313
affects	O	31	38	abstract	30394313
1	O	39	40	abstract	30394313
%	O	40	41	abstract	30394313
of	O	42	44	abstract	30394313
children	B-human	45	53	abstract	30394313
and	O	54	57	abstract	30394313
has	O	58	61	abstract	30394313
no	O	62	64	abstract	30394313
cure	O	65	69	abstract	30394313
.	O	69	70	abstract	30394313

Gastrointestinal	B-DDF	71	87	abstract	30394313
(	I-DDF	88	89	abstract	30394313
GI	I-DDF	89	91	abstract	30394313
)	I-DDF	91	92	abstract	30394313
problems	I-DDF	93	101	abstract	30394313
are	O	102	105	abstract	30394313
common	O	106	112	abstract	30394313
in	O	113	115	abstract	30394313
children	B-human	116	124	abstract	30394313
with	O	125	129	abstract	30394313
ASD	B-DDF	130	133	abstract	30394313
,	O	133	134	abstract	30394313
and	O	135	138	abstract	30394313
although	O	139	147	abstract	30394313
gut	B-microbiome	148	151	abstract	30394313
microbiota	I-microbiome	152	162	abstract	30394313
is	O	163	165	abstract	30394313
known	O	166	171	abstract	30394313
to	O	172	174	abstract	30394313
play	O	175	179	abstract	30394313
an	O	180	182	abstract	30394313
important	O	183	192	abstract	30394313
role	O	193	197	abstract	30394313
in	O	198	200	abstract	30394313
ASD	B-DDF	201	204	abstract	30394313
through	O	205	212	abstract	30394313
the	O	213	216	abstract	30394313
gut-brain	O	217	226	abstract	30394313
axis	O	227	231	abstract	30394313
,	O	231	232	abstract	30394313
the	O	233	236	abstract	30394313
specific	O	237	245	abstract	30394313
mechanism	O	246	255	abstract	30394313
is	O	256	258	abstract	30394313
unknown	O	259	266	abstract	30394313
.	O	266	267	abstract	30394313

Recent	O	268	274	abstract	30394313
evidence	O	275	283	abstract	30394313
suggests	O	284	292	abstract	30394313
that	O	293	297	abstract	30394313
gut	B-microbiome	298	301	abstract	30394313
microbiota	I-microbiome	302	312	abstract	30394313
may	O	313	316	abstract	30394313
participate	O	317	328	abstract	30394313
in	O	329	331	abstract	30394313
the	O	332	335	abstract	30394313
pathogenesis	O	336	348	abstract	30394313
of	O	349	351	abstract	30394313
ASD	B-DDF	352	355	abstract	30394313
through	O	356	363	abstract	30394313
immune-	O	364	371	abstract	30394313
and	O	372	375	abstract	30394313
inflammation-mediated	O	376	397	abstract	30394313
pathways	O	398	406	abstract	30394313
.	O	406	407	abstract	30394313

Here	O	408	412	abstract	30394313
,	O	412	413	abstract	30394313
we	O	414	416	abstract	30394313
identified	O	417	427	abstract	30394313
potentially	B-chemical	428	439	abstract	30394313
immunogenic	I-chemical	440	451	abstract	30394313
epitopes	I-chemical	452	460	abstract	30394313
derived	O	461	468	abstract	30394313
from	O	469	473	abstract	30394313
gut	B-microbiome	474	477	abstract	30394313
microbiota	I-microbiome	478	488	abstract	30394313
in	O	489	491	abstract	30394313
stool	O	492	497	abstract	30394313
samples	O	498	505	abstract	30394313
from	O	506	510	abstract	30394313
ASD	B-human	511	514	abstract	30394313
children	I-human	515	523	abstract	30394313
with	O	524	528	abstract	30394313
and	O	529	532	abstract	30394313
without	O	533	540	abstract	30394313
GI	O	541	543	abstract	30394313
problems	O	544	552	abstract	30394313
and	O	553	556	abstract	30394313
typically	B-human	557	566	abstract	30394313
developing	I-human	567	577	abstract	30394313
(	I-human	578	579	abstract	30394313
TD	I-human	579	581	abstract	30394313
)	I-human	581	582	abstract	30394313
children	I-human	583	591	abstract	30394313
.	O	591	592	abstract	30394313

Candidate	O	593	602	abstract	30394313
gut	B-chemical	603	606	abstract	30394313
microbiota-associated	I-chemical	607	628	abstract	30394313
epitopes	I-chemical	629	637	abstract	30394313
(	I-chemical	638	639	abstract	30394313
MEs	I-chemical	639	642	abstract	30394313
)	I-chemical	642	643	abstract	30394313
were	O	644	648	abstract	30394313
identified	O	649	659	abstract	30394313
by	O	660	662	abstract	30394313
blast	B-biomedical%technique	663	668	abstract	30394313
shotgun	I-biomedical%technique	669	676	abstract	30394313
metagenomic	I-biomedical%technique	677	688	abstract	30394313
sequencing	I-biomedical%technique	689	699	abstract	30394313
of	O	700	702	abstract	30394313
fecal	O	703	708	abstract	30394313
samples	O	709	716	abstract	30394313
from	O	717	721	abstract	30394313
43	O	722	724	abstract	30394313
ASD	B-human	725	728	abstract	30394313
children	I-human	729	737	abstract	30394313
(	O	738	739	abstract	30394313
19	O	739	741	abstract	30394313
with	O	742	746	abstract	30394313
and	O	747	750	abstract	30394313
24	O	751	753	abstract	30394313
without	O	754	761	abstract	30394313
GI	O	762	764	abstract	30394313
involvement	O	765	776	abstract	30394313
)	O	776	777	abstract	30394313
and	O	778	781	abstract	30394313
31	O	782	784	abstract	30394313
sex-	O	785	789	abstract	30394313
and	O	790	793	abstract	30394313
age-matched	O	794	805	abstract	30394313
typically	B-human	806	815	abstract	30394313
developing	I-human	816	826	abstract	30394313
(	I-human	827	828	abstract	30394313
TD	I-human	828	830	abstract	30394313
)	I-human	830	831	abstract	30394313
children	I-human	832	840	abstract	30394313
.	O	840	841	abstract	30394313

Potentially	B-chemical	842	853	abstract	30394313
immunogenic	I-chemical	854	865	abstract	30394313
epitopes	I-chemical	866	874	abstract	30394313
were	O	875	879	abstract	30394313
screened	O	880	888	abstract	30394313
against	O	889	896	abstract	30394313
a	O	897	898	abstract	30394313
predictive	O	899	909	abstract	30394313
human	O	910	915	abstract	30394313
Immune	O	916	922	abstract	30394313
Epitope	O	923	930	abstract	30394313
Database	O	931	939	abstract	30394313
.	O	939	940	abstract	30394313

The	O	941	944	abstract	30394313
composition	O	945	956	abstract	30394313
and	O	957	960	abstract	30394313
abundance	O	961	970	abstract	30394313
of	O	971	973	abstract	30394313
candidate	B-chemical	974	983	abstract	30394313
MEs	I-chemical	984	987	abstract	30394313
were	O	988	992	abstract	30394313
compared	O	993	1001	abstract	30394313
between	O	1002	1009	abstract	30394313
the	O	1010	1013	abstract	30394313
three	O	1014	1019	abstract	30394313
groups	O	1020	1026	abstract	30394313
of	O	1027	1029	abstract	30394313
children	B-human	1030	1038	abstract	30394313
.	O	1038	1039	abstract	30394313

MEs	B-chemical	1040	1043	abstract	30394313
identified	O	1044	1054	abstract	30394313
in	O	1055	1057	abstract	30394313
ASD	B-human	1058	1061	abstract	30394313
children	I-human	1062	1070	abstract	30394313
with	O	1071	1075	abstract	30394313
GI	O	1076	1078	abstract	30394313
problems	O	1079	1087	abstract	30394313
were	O	1088	1092	abstract	30394313
significantly	O	1093	1106	abstract	30394313
more	O	1107	1111	abstract	30394313
diverse	O	1112	1119	abstract	30394313
than	O	1120	1124	abstract	30394313
those	O	1125	1130	abstract	30394313
in	O	1131	1133	abstract	30394313
TD	B-human	1134	1136	abstract	30394313
children	I-human	1137	1145	abstract	30394313
.	O	1145	1146	abstract	30394313

ME	O	1147	1149	abstract	30394313
composition	O	1150	1161	abstract	30394313
could	O	1162	1167	abstract	30394313
discriminate	O	1168	1180	abstract	30394313
between	O	1181	1188	abstract	30394313
the	O	1189	1192	abstract	30394313
three	O	1193	1198	abstract	30394313
groups	O	1199	1205	abstract	30394313
of	O	1206	1208	abstract	30394313
children	B-human	1209	1217	abstract	30394313
.	O	1217	1218	abstract	30394313

We	O	1219	1221	abstract	30394313
identified	O	1222	1232	abstract	30394313
34	O	1233	1235	abstract	30394313
MEs	B-chemical	1236	1239	abstract	30394313
that	O	1240	1244	abstract	30394313
were	O	1245	1249	abstract	30394313
significantly	O	1250	1263	abstract	30394313
more	O	1264	1268	abstract	30394313
or	O	1269	1271	abstract	30394313
less	O	1272	1276	abstract	30394313
abundant	O	1277	1285	abstract	30394313
in	O	1286	1288	abstract	30394313
ASD	B-human	1289	1292	abstract	30394313
children	I-human	1293	1301	abstract	30394313
than	O	1302	1306	abstract	30394313
TD	B-human	1307	1309	abstract	30394313
children	I-human	1310	1318	abstract	30394313
,	O	1318	1319	abstract	30394313
most	O	1320	1324	abstract	30394313
(	O	1325	1326	abstract	30394313
29/34	O	1326	1331	abstract	30394313
)	O	1331	1332	abstract	30394313
of	O	1333	1335	abstract	30394313
the	O	1336	1339	abstract	30394313
differences	O	1340	1351	abstract	30394313
in	O	1352	1354	abstract	30394313
MEs	B-chemical	1355	1358	abstract	30394313
were	O	1359	1363	abstract	30394313
reduced	O	1364	1371	abstract	30394313
in	O	1372	1374	abstract	30394313
ASD	B-DDF	1375	1378	abstract	30394313
and	O	1379	1382	abstract	30394313
associated	O	1383	1393	abstract	30394313
with	O	1394	1398	abstract	30394313
abnormal	O	1399	1407	abstract	30394313
gut	B-chemical	1408	1411	abstract	30394313
IgA	I-chemical	1412	1415	abstract	30394313
level	I-chemical	1416	1421	abstract	30394313
and	O	1422	1425	abstract	30394313
altered	O	1426	1433	abstract	30394313
gut	B-microbiome	1434	1437	abstract	30394313
microbiota	I-microbiome	1438	1448	abstract	30394313
composition	O	1449	1460	abstract	30394313
,	O	1460	1461	abstract	30394313
these	O	1462	1467	abstract	30394313
MEs	B-chemical	1468	1471	abstract	30394313
were	O	1472	1476	abstract	30394313
limited	O	1477	1484	abstract	30394313
effected	O	1485	1493	abstract	30394313
by	O	1494	1496	abstract	30394313
clinical	O	1497	1505	abstract	30394313
factors	O	1506	1513	abstract	30394313
such	O	1514	1518	abstract	30394313
as	O	1519	1521	abstract	30394313
age	O	1522	1525	abstract	30394313
,	O	1525	1526	abstract	30394313
gender	O	1527	1533	abstract	30394313
,	O	1533	1534	abstract	30394313
and	O	1535	1538	abstract	30394313
GI	O	1539	1541	abstract	30394313
problems	O	1542	1550	abstract	30394313
,	O	1550	1551	abstract	30394313
of	O	1552	1554	abstract	30394313
which	O	1555	1560	abstract	30394313
eleven	O	1561	1567	abstract	30394313
MEs	B-chemical	1568	1571	abstract	30394313
were	O	1572	1576	abstract	30394313
pathogenic	O	1577	1587	abstract	30394313
microorganisms	O	1588	1602	abstract	30394313
peptides	O	1603	1611	abstract	30394313
with	O	1612	1616	abstract	30394313
strong	O	1617	1623	abstract	30394313
T	O	1624	1625	abstract	30394313
or	O	1626	1628	abstract	30394313
B	O	1629	1630	abstract	30394313
cell	O	1631	1635	abstract	30394313
response	O	1636	1644	abstract	30394313
,	O	1644	1645	abstract	30394313
nine	O	1646	1650	abstract	30394313
MEs	B-chemical	1651	1654	abstract	30394313
showed	O	1655	1661	abstract	30394313
high	O	1662	1666	abstract	30394313
homology	O	1667	1675	abstract	30394313
to	O	1676	1678	abstract	30394313
peptides	B-chemical	1679	1687	abstract	30394313
from	O	1688	1692	abstract	30394313
human	O	1693	1698	abstract	30394313
self	O	1699	1703	abstract	30394313
proteins	O	1704	1712	abstract	30394313
associated	O	1713	1723	abstract	30394313
with	O	1724	1728	abstract	30394313
autoimmune	B-DDF	1729	1739	abstract	30394313
disease	I-DDF	1740	1747	abstract	30394313
occurrence	O	1748	1758	abstract	30394313
,	O	1758	1759	abstract	30394313
eliciting	O	1760	1769	abstract	30394313
immune	O	1770	1776	abstract	30394313
attack	O	1777	1783	abstract	30394313
against	O	1784	1791	abstract	30394313
hematopoietic	O	1792	1805	abstract	30394313
stem	O	1806	1810	abstract	30394313
cells	O	1811	1816	abstract	30394313
and	O	1817	1820	abstract	30394313
inhibition	O	1821	1831	abstract	30394313
antigen	O	1832	1839	abstract	30394313
binding	O	1840	1847	abstract	30394313
.	O	1847	1848	abstract	30394313

We	O	1849	1851	abstract	30394313
also	O	1852	1856	abstract	30394313
found	O	1857	1862	abstract	30394313
that	O	1863	1867	abstract	30394313
the	O	1868	1871	abstract	30394313
abundance	O	1872	1881	abstract	30394313
of	O	1882	1884	abstract	30394313
five	O	1885	1889	abstract	30394313
MEs	B-chemical	1890	1893	abstract	30394313
were	O	1894	1898	abstract	30394313
increased	O	1899	1908	abstract	30394313
in	O	1909	1911	abstract	30394313
ASD	B-DDF	1912	1915	abstract	30394313
,	O	1915	1916	abstract	30394313
including	O	1917	1926	abstract	30394313
three	O	1927	1932	abstract	30394313
human	O	1933	1938	abstract	30394313
self	O	1939	1943	abstract	30394313
proteins	O	1944	1952	abstract	30394313
,	O	1952	1953	abstract	30394313
gap	B-chemical	1954	1957	abstract	30394313
junction	I-chemical	1958	1966	abstract	30394313
alpha-1	I-chemical	1967	1974	abstract	30394313
(	O	1975	1976	abstract	30394313
GJA1	B-chemical	1976	1980	abstract	30394313
)	O	1980	1981	abstract	30394313
,	O	1981	1982	abstract	30394313
paired	B-chemical	1983	1989	abstract	30394313
box	I-chemical	1990	1993	abstract	30394313
protein	I-chemical	1994	2001	abstract	30394313
Pax-3	I-chemical	2002	2007	abstract	30394313
(	O	2008	2009	abstract	30394313
PAX3	B-chemical	2009	2013	abstract	30394313
)	O	2013	2014	abstract	30394313
and	O	2015	2018	abstract	30394313
eyes	B-chemical	2019	2023	abstract	30394313
absent	I-chemical	2024	2030	abstract	30394313
homolog	I-chemical	2031	2038	abstract	30394313
1	I-chemical	2039	2040	abstract	30394313
isoform	I-chemical	2041	2048	abstract	30394313
4	I-chemical	2049	2050	abstract	30394313
(	O	2051	2052	abstract	30394313
EYA1	B-chemical	2052	2056	abstract	30394313
)	O	2056	2057	abstract	30394313
which	O	2058	2063	abstract	30394313
associated	O	2064	2074	abstract	30394313
with	O	2075	2079	abstract	30394313
cancer	B-DDF	2080	2086	abstract	30394313
,	O	2086	2087	abstract	30394313
and	O	2088	2091	abstract	30394313
a	O	2092	2093	abstract	30394313
ME	B-chemical	2094	2096	abstract	30394313
with	O	2097	2101	abstract	30394313
homology	O	2102	2110	abstract	30394313
to	O	2111	2113	abstract	30394313
a	O	2114	2115	abstract	30394313
Listeriolysin	B-chemical	2116	2129	abstract	30394313
O	I-chemical	2130	2131	abstract	30394313
peptide	I-chemical	2132	2139	abstract	30394313
from	O	2140	2144	abstract	30394313
the	O	2145	2148	abstract	30394313
pathogenic	O	2149	2159	abstract	30394313
bacterium	O	2160	2169	abstract	30394313
Listeria	B-bacteria	2170	2178	abstract	30394313
monocytogenes	I-bacteria	2179	2192	abstract	30394313
was	O	2193	2196	abstract	30394313
significantly	O	2197	2210	abstract	30394313
increased	O	2211	2220	abstract	30394313
in	O	2221	2223	abstract	30394313
ASD	B-human	2224	2227	abstract	30394313
children	I-human	2228	2236	abstract	30394313
compared	O	2237	2245	abstract	30394313
with	O	2246	2250	abstract	30394313
TD	B-human	2251	2253	abstract	30394313
children	I-human	2254	2262	abstract	30394313
.	O	2262	2263	abstract	30394313

Our	O	2264	2267	abstract	30394313
findings	O	2268	2276	abstract	30394313
demonstrate	O	2277	2288	abstract	30394313
the	O	2289	2292	abstract	30394313
abnormal	O	2293	2301	abstract	30394313
of	O	2302	2304	abstract	30394313
MEs	B-chemical	2305	2308	abstract	30394313
composition	O	2309	2320	abstract	30394313
in	O	2321	2323	abstract	30394313
the	O	2324	2327	abstract	30394313
gut	B-anatomical%location	2328	2331	abstract	30394313
of	O	2332	2334	abstract	30394313
children	B-human	2335	2343	abstract	30394313
with	O	2344	2348	abstract	30394313
ASD	B-DDF	2349	2352	abstract	30394313
,	O	2352	2353	abstract	30394313
moreover	O	2354	2362	abstract	30394313
,	O	2362	2363	abstract	30394313
the	O	2364	2367	abstract	30394313
abnormality	O	2368	2379	abstract	30394313
in	O	2380	2382	abstract	30394313
MEs	O	2383	2386	abstract	30394313
composition	O	2387	2398	abstract	30394313
was	O	2399	2402	abstract	30394313
associated	O	2403	2413	abstract	30394313
with	O	2414	2418	abstract	30394313
abnormal	O	2419	2427	abstract	30394313
gut	B-chemical	2428	2431	abstract	30394313
IgA	I-chemical	2432	2435	abstract	30394313
levels	I-chemical	2436	2442	abstract	30394313
and	O	2443	2446	abstract	30394313
altered	O	2447	2454	abstract	30394313
gut	B-microbiome	2455	2458	abstract	30394313
microbiota	I-microbiome	2459	2469	abstract	30394313
composition	O	2470	2481	abstract	30394313
,	O	2481	2482	abstract	30394313
this	O	2483	2487	abstract	30394313
abnormality	O	2488	2499	abstract	30394313
also	O	2500	2504	abstract	30394313
suggests	O	2505	2513	abstract	30394313
that	O	2514	2518	abstract	30394313
there	O	2519	2524	abstract	30394313
may	O	2525	2528	abstract	30394313
be	O	2529	2531	abstract	30394313
abnormalities	O	2532	2545	abstract	30394313
in	O	2546	2548	abstract	30394313
intestinal	O	2549	2559	abstract	30394313
immunity	O	2560	2568	abstract	30394313
in	O	2569	2571	abstract	30394313
children	B-human	2572	2580	abstract	30394313
with	O	2581	2585	abstract	30394313
ASD	B-DDF	2586	2589	abstract	30394313
;	O	2589	2590	abstract	30394313
In	O	2591	2593	abstract	30394313
all	O	2594	2597	abstract	30394313
,	O	2597	2598	abstract	30394313
thirty-four	O	2599	2610	abstract	30394313
MEs	B-chemical	2611	2614	abstract	30394313
identified	O	2615	2625	abstract	30394313
were	O	2626	2630	abstract	30394313
potential	O	2631	2640	abstract	30394313
biomarker	O	2641	2650	abstract	30394313
of	O	2651	2653	abstract	30394313
ASD	B-DDF	2654	2657	abstract	30394313
,	O	2657	2658	abstract	30394313
and	O	2659	2662	abstract	30394313
alterations	O	2663	2674	abstract	30394313
in	O	2675	2677	abstract	30394313
MEs	B-chemical	2678	2681	abstract	30394313
may	O	2682	2685	abstract	30394313
contribute	O	2686	2696	abstract	30394313
to	O	2697	2699	abstract	30394313
abnormalities	O	2700	2713	abstract	30394313
in	O	2714	2716	abstract	30394313
gut	O	2717	2720	abstract	30394313
immunity	O	2721	2729	abstract	30394313
and/or	O	2730	2736	abstract	30394313
homeostasis	O	2737	2748	abstract	30394313
in	O	2749	2751	abstract	30394313
ASD	B-human	2752	2755	abstract	30394313
children	I-human	2756	2764	abstract	30394313
.	O	2764	2765	abstract	30394313

Further	O	2766	2773	abstract	30394313
study	O	2774	2779	abstract	30394313
of	O	2780	2782	abstract	30394313
the	O	2783	2786	abstract	30394313
MEs	B-chemical	2787	2790	abstract	30394313
identified	O	2791	2801	abstract	30394313
here	O	2802	2806	abstract	30394313
may	O	2807	2810	abstract	30394313
advance	O	2811	2818	abstract	30394313
our	O	2819	2822	abstract	30394313
understanding	O	2823	2836	abstract	30394313
of	O	2837	2839	abstract	30394313
the	O	2840	2843	abstract	30394313
pathogenesis	O	2844	2856	abstract	30394313
of	O	2857	2859	abstract	30394313
ASD	B-DDF	2860	2863	abstract	30394313
.	O	2863	2864	abstract	30394313

Association	O	0	11	title	34393849
Between	O	12	19	title	34393849
Abundance	O	20	29	title	34393849
of	O	30	32	title	34393849
<	O	33	34	title	34393849
i	O	34	35	title	34393849
>	O	35	36	title	34393849
Haemophilus</i	B-bacteria	36	50	title	34393849
>	O	50	51	title	34393849
in	O	52	54	title	34393849
the	O	55	58	title	34393849
Gut	B-microbiome	59	62	title	34393849
Microbiota	I-microbiome	63	73	title	34393849
and	O	74	77	title	34393849
Negative	O	78	86	title	34393849
Symptoms	O	87	95	title	34393849
of	O	96	98	title	34393849
Schizophrenia	B-DDF	99	112	title	34393849
.	O	112	113	title	34393849

Increasing	O	0	10	abstract	34393849
evidence	O	11	19	abstract	34393849
indicates	O	20	29	abstract	34393849
an	O	30	32	abstract	34393849
interaction	O	33	44	abstract	34393849
between	O	45	52	abstract	34393849
dysbiosis	B-DDF	53	62	abstract	34393849
of	I-DDF	63	65	abstract	34393849
the	I-DDF	66	69	abstract	34393849
microbiota	I-DDF	70	80	abstract	34393849
and	O	81	84	abstract	34393849
the	O	85	88	abstract	34393849
pathogenesis	O	89	101	abstract	34393849
of	O	102	104	abstract	34393849
schizophrenia	B-DDF	105	118	abstract	34393849
.	O	118	119	abstract	34393849

However	O	120	127	abstract	34393849
,	O	127	128	abstract	34393849
limited	O	129	136	abstract	34393849
information	O	137	148	abstract	34393849
is	O	149	151	abstract	34393849
available	O	152	161	abstract	34393849
on	O	162	164	abstract	34393849
the	O	165	168	abstract	34393849
specific	O	169	177	abstract	34393849
microbial	O	178	187	abstract	34393849
communities	O	188	199	abstract	34393849
associated	O	200	210	abstract	34393849
with	O	211	215	abstract	34393849
symptoms	O	216	224	abstract	34393849
of	O	225	227	abstract	34393849
schizophrenia	B-DDF	228	241	abstract	34393849
.	O	241	242	abstract	34393849

Therefore	O	243	252	abstract	34393849
,	O	252	253	abstract	34393849
this	O	254	258	abstract	34393849
study	O	259	264	abstract	34393849
aimed	O	265	270	abstract	34393849
to	O	271	273	abstract	34393849
investigate	O	274	285	abstract	34393849
gut	B-DDF	286	289	abstract	34393849
microbiota	I-DDF	290	300	abstract	34393849
dysbiosis	I-DDF	301	310	abstract	34393849
and	O	311	314	abstract	34393849
its	O	315	318	abstract	34393849
relationship	O	319	331	abstract	34393849
with	O	332	336	abstract	34393849
psychopathologies	O	337	354	abstract	34393849
in	O	355	357	abstract	34393849
schizophrenia	B-DDF	358	371	abstract	34393849
.	O	371	372	abstract	34393849

We	O	373	375	abstract	34393849
recruited	O	376	385	abstract	34393849
126	O	386	389	abstract	34393849
participants	B-human	390	402	abstract	34393849
and	O	403	406	abstract	34393849
divided	O	407	414	abstract	34393849
them	O	415	419	abstract	34393849
into	O	420	424	abstract	34393849
three	O	425	430	abstract	34393849
groups	O	431	437	abstract	34393849
according	O	438	447	abstract	34393849
to	O	448	450	abstract	34393849
the	O	451	454	abstract	34393849
Diagnostic	O	455	465	abstract	34393849
and	O	466	469	abstract	34393849
Statistical	O	470	481	abstract	34393849
Manual	O	482	488	abstract	34393849
of	O	489	491	abstract	34393849
Mental	O	492	498	abstract	34393849
Disorders	O	499	508	abstract	34393849
,	O	508	509	abstract	34393849
Fifth	O	510	515	abstract	34393849
Edition	O	516	523	abstract	34393849
,	O	523	524	abstract	34393849
criteria-acute	B-human	525	539	abstract	34393849
group	I-human	540	545	abstract	34393849
(	I-human	546	547	abstract	34393849
patients	I-human	547	555	abstract	34393849
with	I-human	556	560	abstract	34393849
acute	I-human	561	566	abstract	34393849
schizophrenia	I-human	567	580	abstract	34393849
)	I-human	580	581	abstract	34393849
,	O	581	582	abstract	34393849
remission	B-human	583	592	abstract	34393849
group	I-human	593	598	abstract	34393849
(	I-human	599	600	abstract	34393849
patients	I-human	600	608	abstract	34393849
with	I-human	609	613	abstract	34393849
schizophrenia	I-human	614	627	abstract	34393849
in	I-human	628	630	abstract	34393849
remission	I-human	631	640	abstract	34393849
)	I-human	640	641	abstract	34393849
,	O	641	642	abstract	34393849
and	O	643	646	abstract	34393849
control	B-human	647	654	abstract	34393849
group	I-human	655	660	abstract	34393849
(	I-human	661	662	abstract	34393849
healthy	I-human	662	669	abstract	34393849
controls	I-human	670	678	abstract	34393849
)	I-human	678	679	abstract	34393849
.	O	679	680	abstract	34393849

Psychotic	B-DDF	681	690	abstract	34393849
symptoms	I-DDF	691	699	abstract	34393849
were	O	700	704	abstract	34393849
evaluated	O	705	714	abstract	34393849
using	O	715	720	abstract	34393849
the	O	721	724	abstract	34393849
Positive	O	725	733	abstract	34393849
and	O	734	737	abstract	34393849
Negative	O	738	746	abstract	34393849
Syndrome	O	747	755	abstract	34393849
Scale	O	756	761	abstract	34393849
.	O	761	762	abstract	34393849

Microbiota	O	763	773	abstract	34393849
compositions	O	774	786	abstract	34393849
,	O	786	787	abstract	34393849
diversity	O	788	797	abstract	34393849
and	O	798	801	abstract	34393849
community	O	802	811	abstract	34393849
structure	O	812	821	abstract	34393849
were	O	822	826	abstract	34393849
evaluated	O	827	836	abstract	34393849
using	O	837	842	abstract	34393849
16S	B-biomedical%technique	843	846	abstract	34393849
rRNA	I-biomedical%technique	847	851	abstract	34393849
sequencing	I-biomedical%technique	852	862	abstract	34393849
.	O	862	863	abstract	34393849

Pearson	B-statistical%technique	864	871	abstract	34393849
's	I-statistical%technique	871	873	abstract	34393849
correlation	I-statistical%technique	874	885	abstract	34393849
analysis	I-statistical%technique	886	894	abstract	34393849
was	O	895	898	abstract	34393849
used	O	899	903	abstract	34393849
to	O	904	906	abstract	34393849
evaluate	O	907	915	abstract	34393849
the	O	916	919	abstract	34393849
association	O	920	931	abstract	34393849
between	O	932	939	abstract	34393849
bacterial	O	940	949	abstract	34393849
taxa	O	950	954	abstract	34393849
and	O	955	958	abstract	34393849
psychotic	O	959	968	abstract	34393849
symptoms	O	969	977	abstract	34393849
.	O	977	978	abstract	34393849

The	O	979	982	abstract	34393849
beta-diversity	O	983	997	abstract	34393849
of	O	998	1000	abstract	34393849
microbiota	O	1001	1011	abstract	34393849
composition	O	1012	1023	abstract	34393849
in	O	1024	1026	abstract	34393849
the	O	1027	1030	abstract	34393849
acute	B-human	1031	1036	abstract	34393849
group	I-human	1037	1042	abstract	34393849
was	O	1043	1046	abstract	34393849
distinct	O	1047	1055	abstract	34393849
from	O	1056	1060	abstract	34393849
that	O	1061	1065	abstract	34393849
in	O	1066	1068	abstract	34393849
the	O	1069	1072	abstract	34393849
remission	B-human	1073	1082	abstract	34393849
and	I-human	1083	1086	abstract	34393849
control	I-human	1087	1094	abstract	34393849
groups	I-human	1095	1101	abstract	34393849
(	O	1102	1103	abstract	34393849
PC1	O	1103	1106	abstract	34393849
=	O	1107	1108	abstract	34393849
21.11	O	1109	1114	abstract	34393849
%	O	1114	1115	abstract	34393849
vs.	O	1116	1119	abstract	34393849
PC2	O	1120	1123	abstract	34393849
=	O	1124	1125	abstract	34393849
12.86	O	1126	1131	abstract	34393849
%	O	1131	1132	abstract	34393849
,	O	1132	1133	abstract	34393849
<	O	1134	1135	abstract	34393849
i	O	1135	1136	abstract	34393849
>	O	1136	1137	abstract	34393849
P</i	O	1137	1141	abstract	34393849
>	O	1141	1142	abstract	34393849
=	O	1143	1144	abstract	34393849
0.021	O	1145	1150	abstract	34393849
)	O	1150	1151	abstract	34393849
.	O	1151	1152	abstract	34393849

Furthermore	O	1153	1164	abstract	34393849
,	O	1164	1165	abstract	34393849
Pearson	B-statistical%technique	1166	1173	abstract	34393849
's	I-statistical%technique	1173	1175	abstract	34393849
correlation	I-statistical%technique	1176	1187	abstract	34393849
analysis	I-statistical%technique	1188	1196	abstract	34393849
revealed	O	1197	1205	abstract	34393849
that	O	1206	1210	abstract	34393849
abundance	O	1211	1220	abstract	34393849
of	O	1221	1223	abstract	34393849
<	O	1224	1225	abstract	34393849
i	O	1225	1226	abstract	34393849
>	O	1226	1227	abstract	34393849
Haemophilu</i	B-bacteria	1227	1240	abstract	34393849
>	O	1240	1241	abstract	34393849
s	O	1241	1242	abstract	34393849
was	O	1243	1246	abstract	34393849
positively	O	1247	1257	abstract	34393849
correlated	O	1258	1268	abstract	34393849
with	O	1269	1273	abstract	34393849
negative	O	1274	1282	abstract	34393849
psychiatric	O	1283	1294	abstract	34393849
symptoms	O	1295	1303	abstract	34393849
(	O	1304	1305	abstract	34393849
<	O	1305	1306	abstract	34393849
i	O	1306	1307	abstract	34393849
>	O	1307	1308	abstract	34393849
r</i	O	1308	1312	abstract	34393849
>	O	1312	1313	abstract	34393849
=	O	1314	1315	abstract	34393849
0.303	O	1316	1321	abstract	34393849
,	O	1321	1322	abstract	34393849
<	O	1323	1324	abstract	34393849
i	O	1324	1325	abstract	34393849
>	O	1325	1326	abstract	34393849
P</i	O	1326	1330	abstract	34393849
>	O	1330	1331	abstract	34393849
=	O	1332	1333	abstract	34393849
0.021	O	1334	1339	abstract	34393849
)	O	1339	1340	abstract	34393849
,	O	1340	1341	abstract	34393849
while	O	1342	1347	abstract	34393849
abundance	O	1348	1357	abstract	34393849
of	O	1358	1360	abstract	34393849
<	O	1361	1362	abstract	34393849
i	O	1362	1363	abstract	34393849
>	O	1363	1364	abstract	34393849
Coprococcus</i	B-bacteria	1364	1378	abstract	34393849
>	O	1378	1379	abstract	34393849
was	O	1380	1383	abstract	34393849
negatively	O	1384	1394	abstract	34393849
correlated	O	1395	1405	abstract	34393849
with	O	1406	1410	abstract	34393849
negative	O	1411	1419	abstract	34393849
psychiatric	O	1420	1431	abstract	34393849
symptoms	O	1432	1440	abstract	34393849
(	O	1441	1442	abstract	34393849
<	O	1442	1443	abstract	34393849
i	O	1443	1444	abstract	34393849
>	O	1444	1445	abstract	34393849
r</i	O	1445	1449	abstract	34393849
>	O	1449	1450	abstract	34393849
=	O	1451	1452	abstract	34393849
-<i>0.285	O	1453	1462	abstract	34393849
,	O	1462	1463	abstract	34393849
P</i	O	1464	1468	abstract	34393849
>	O	1468	1469	abstract	34393849
=	O	1470	1471	abstract	34393849
<	O	1472	1473	abstract	34393849
i>0.025</i	O	1473	1483	abstract	34393849
>	O	1483	1484	abstract	34393849
)	O	1484	1485	abstract	34393849
.	O	1485	1486	abstract	34393849

Moreover	O	1487	1495	abstract	34393849
,	O	1495	1496	abstract	34393849
abundance	O	1497	1506	abstract	34393849
of	O	1507	1509	abstract	34393849
<	O	1510	1511	abstract	34393849
i	O	1511	1512	abstract	34393849
>	O	1512	1513	abstract	34393849
Haemophilus</i	B-bacteria	1513	1527	abstract	34393849
>	O	1527	1528	abstract	34393849
was	O	1529	1532	abstract	34393849
positively	O	1533	1543	abstract	34393849
correlated	O	1544	1554	abstract	34393849
with	O	1555	1559	abstract	34393849
cognition	O	1560	1569	abstract	34393849
(	O	1570	1571	abstract	34393849
<	O	1571	1572	abstract	34393849
i	O	1572	1573	abstract	34393849
>	O	1573	1574	abstract	34393849
r</i	O	1574	1578	abstract	34393849
>	O	1578	1579	abstract	34393849
=	O	1580	1581	abstract	34393849
0.428	O	1582	1587	abstract	34393849
,	O	1587	1588	abstract	34393849
<	O	1589	1590	abstract	34393849
i	O	1590	1591	abstract	34393849
>	O	1591	1592	abstract	34393849
P</i	O	1592	1596	abstract	34393849
>	O	1596	1597	abstract	34393849
=	O	1598	1599	abstract	34393849
0.009	O	1600	1605	abstract	34393849
)	O	1605	1606	abstract	34393849
,	O	1606	1607	abstract	34393849
excitement	O	1608	1618	abstract	34393849
(	O	1619	1620	abstract	34393849
<	O	1620	1621	abstract	34393849
i	O	1621	1622	abstract	34393849
>	O	1622	1623	abstract	34393849
r</i	O	1623	1627	abstract	34393849
>	O	1627	1628	abstract	34393849
=	O	1629	1630	abstract	34393849
0.266	O	1631	1636	abstract	34393849
,	O	1636	1637	abstract	34393849
<	O	1638	1639	abstract	34393849
i	O	1639	1640	abstract	34393849
>	O	1640	1641	abstract	34393849
P</i	O	1641	1645	abstract	34393849
>	O	1645	1646	abstract	34393849
=	O	1647	1648	abstract	34393849
0.037	O	1649	1654	abstract	34393849
)	O	1654	1655	abstract	34393849
,	O	1655	1656	abstract	34393849
and	O	1657	1660	abstract	34393849
depression	B-DDF	1661	1671	abstract	34393849
(	O	1672	1673	abstract	34393849
<	O	1673	1674	abstract	34393849
i	O	1674	1675	abstract	34393849
>	O	1675	1676	abstract	34393849
r</i	O	1676	1680	abstract	34393849
>	O	1680	1681	abstract	34393849
=	O	1682	1683	abstract	34393849
0.295	O	1684	1689	abstract	34393849
,	O	1689	1690	abstract	34393849
<	O	1691	1692	abstract	34393849
i	O	1692	1693	abstract	34393849
>	O	1693	1694	abstract	34393849
P</i	O	1694	1698	abstract	34393849
>	O	1698	1699	abstract	34393849
=	O	1700	1701	abstract	34393849
0.020	O	1702	1707	abstract	34393849
)	O	1707	1708	abstract	34393849
.	O	1708	1709	abstract	34393849

The	O	1710	1713	abstract	34393849
study	O	1714	1719	abstract	34393849
findings	O	1720	1728	abstract	34393849
suggest	O	1729	1736	abstract	34393849
that	O	1737	1741	abstract	34393849
alterations	O	1742	1753	abstract	34393849
in	O	1754	1756	abstract	34393849
certain	O	1757	1764	abstract	34393849
gut	B-microbiome	1765	1768	abstract	34393849
microbiota	I-microbiome	1769	1779	abstract	34393849
may	O	1780	1783	abstract	34393849
interfere	O	1784	1793	abstract	34393849
with	O	1794	1798	abstract	34393849
psychological	O	1799	1812	abstract	34393849
symptoms	O	1813	1821	abstract	34393849
in	O	1822	1824	abstract	34393849
schizophrenia	B-DDF	1825	1838	abstract	34393849
.	O	1838	1839	abstract	34393849

Our	O	1840	1843	abstract	34393849
results	O	1844	1851	abstract	34393849
provide	O	1852	1859	abstract	34393849
evidence	O	1860	1868	abstract	34393849
that	O	1869	1873	abstract	34393849
may	O	1874	1877	abstract	34393849
help	O	1878	1882	abstract	34393849
in	O	1883	1885	abstract	34393849
the	O	1886	1889	abstract	34393849
development	O	1890	1901	abstract	34393849
of	O	1902	1904	abstract	34393849
therapeutic	O	1905	1916	abstract	34393849
strategies	O	1917	1927	abstract	34393849
using	O	1928	1933	abstract	34393849
microbial-based	O	1934	1949	abstract	34393849
targets	O	1950	1957	abstract	34393849
.	O	1957	1958	abstract	34393849

The	O	1959	1962	abstract	34393849
data	O	1963	1967	abstract	34393849
that	O	1968	1972	abstract	34393849
support	O	1973	1980	abstract	34393849
the	O	1981	1984	abstract	34393849
findings	O	1985	1993	abstract	34393849
of	O	1994	1996	abstract	34393849
this	O	1997	2001	abstract	34393849
study	O	2002	2007	abstract	34393849
have	O	2008	2012	abstract	34393849
been	O	2013	2017	abstract	34393849
deposited	O	2018	2027	abstract	34393849
in	O	2028	2030	abstract	34393849
the	O	2031	2034	abstract	34393849
NCBI	O	2035	2039	abstract	34393849
(	O	2040	2041	abstract	34393849
https://submit.ncbi.nlm.nih.gov/	O	2041	2073	abstract	34393849
)	O	2073	2074	abstract	34393849
with	O	2075	2079	abstract	34393849
accession	O	2080	2089	abstract	34393849
number	O	2090	2096	abstract	34393849
SUB9453991	O	2097	2107	abstract	34393849
.	O	2107	2108	abstract	34393849

Gastrointestinal	O	0	16	title	37606895
involvement	O	17	28	title	37606895
in	O	29	31	title	37606895
post-acute	B-DDF	32	42	title	37606895
Coronavirus	I-DDF	43	54	title	37606895
disease	I-DDF	55	62	title	37606895
(COVID)-19	I-DDF	63	73	title	37606895
syndrome	I-DDF	74	82	title	37606895
.	O	82	83	title	37606895

Ten	O	0	3	abstract	37606895
percentage	O	4	14	abstract	37606895
of	O	15	17	abstract	37606895
patients	B-human	18	26	abstract	37606895
with	O	27	31	abstract	37606895
coronavirus	B-DDF	32	43	abstract	37606895
disease	I-DDF	44	51	abstract	37606895
(COVID)-19	B-DDF	52	62	abstract	37606895
report	O	63	69	abstract	37606895
having	O	70	76	abstract	37606895
gastrointestinal	B-DDF	77	93	abstract	37606895
(	I-DDF	94	95	abstract	37606895
GI	I-DDF	95	97	abstract	37606895
)	I-DDF	97	98	abstract	37606895
symptoms	I-DDF	99	107	abstract	37606895
as	O	108	110	abstract	37606895
severe	B-DDF	111	117	abstract	37606895
acute	I-DDF	118	123	abstract	37606895
respiratory	I-DDF	124	135	abstract	37606895
syndrome	I-DDF	136	144	abstract	37606895
coronavirus-2	I-DDF	145	158	abstract	37606895
(	O	159	160	abstract	37606895
SARS-CoV2	B-DDF	160	169	abstract	37606895
)	O	169	170	abstract	37606895
not	O	171	174	abstract	37606895
only	O	175	179	abstract	37606895
infects	O	180	187	abstract	37606895
the	O	188	191	abstract	37606895
pulmonary	B-anatomical%location	192	201	abstract	37606895
but	O	202	205	abstract	37606895
also	O	206	210	abstract	37606895
the	O	211	214	abstract	37606895
GI	B-anatomical%location	215	217	abstract	37606895
tract	I-anatomical%location	218	223	abstract	37606895
.	O	223	224	abstract	37606895

GI	B-DDF	225	227	abstract	37606895
infections	I-DDF	228	238	abstract	37606895
including	O	239	248	abstract	37606895
that	O	249	253	abstract	37606895
due	O	254	257	abstract	37606895
to	O	258	260	abstract	37606895
viral	B-DDF	261	266	abstract	37606895
infection	I-DDF	267	276	abstract	37606895
is	O	277	279	abstract	37606895
known	O	280	285	abstract	37606895
to	O	286	288	abstract	37606895
cause	O	289	294	abstract	37606895
postinfection	B-DDF	295	308	abstract	37606895
disorders	I-DDF	309	318	abstract	37606895
of	I-DDF	319	321	abstract	37606895
gut-brain	I-DDF	322	331	abstract	37606895
interaction	I-DDF	332	343	abstract	37606895
(	O	344	345	abstract	37606895
DGBI	B-DDF	345	349	abstract	37606895
)	O	349	350	abstract	37606895
;	O	350	351	abstract	37606895
hence	O	352	357	abstract	37606895
,	O	357	358	abstract	37606895
we	O	359	361	abstract	37606895
wish	O	362	366	abstract	37606895
to	O	367	369	abstract	37606895
review	O	370	376	abstract	37606895
the	O	377	380	abstract	37606895
long-term	O	381	390	abstract	37606895
GI	O	391	393	abstract	37606895
consequences	O	394	406	abstract	37606895
following	O	407	416	abstract	37606895
COVID-19	B-DDF	417	425	abstract	37606895
,	O	425	426	abstract	37606895
particularly	O	427	439	abstract	37606895
post-COVID-19	B-DDF	440	453	abstract	37606895
DGBI	I-DDF	454	458	abstract	37606895
.	O	458	459	abstract	37606895

At	O	460	462	abstract	37606895
least	O	463	468	abstract	37606895
12	O	469	471	abstract	37606895
cohort	O	472	478	abstract	37606895
studies	O	479	486	abstract	37606895
,	O	486	487	abstract	37606895
four	O	488	492	abstract	37606895
of	O	493	495	abstract	37606895
which	O	496	501	abstract	37606895
also	O	502	506	abstract	37606895
included	O	507	515	abstract	37606895
controls	O	516	524	abstract	37606895
documented	O	525	535	abstract	37606895
the	O	536	539	abstract	37606895
occurrence	O	540	550	abstract	37606895
of	O	551	553	abstract	37606895
post-COVID-19	B-DDF	554	567	abstract	37606895
DGBI	I-DDF	568	572	abstract	37606895
,	O	572	573	abstract	37606895
particularly	O	574	586	abstract	37606895
IBS	B-DDF	587	590	abstract	37606895
following	O	591	600	abstract	37606895
COVID-19	B-DDF	601	609	abstract	37606895
.	O	609	610	abstract	37606895

The	O	611	614	abstract	37606895
risk	O	615	619	abstract	37606895
factors	O	620	627	abstract	37606895
for	O	628	631	abstract	37606895
post-COVID-19	B-DDF	632	645	abstract	37606895
DGBI	I-DDF	646	650	abstract	37606895
included	O	651	659	abstract	37606895
female	O	660	666	abstract	37606895
gender	O	667	673	abstract	37606895
,	O	673	674	abstract	37606895
symptomatic	B-DDF	675	686	abstract	37606895
COVID-19	I-DDF	687	695	abstract	37606895
,	O	695	696	abstract	37606895
particularly	O	697	709	abstract	37606895
GI	B-DDF	710	712	abstract	37606895
symptoms	I-DDF	713	721	abstract	37606895
,	O	721	722	abstract	37606895
the	O	723	726	abstract	37606895
severity	O	727	735	abstract	37606895
of	O	736	738	abstract	37606895
COVID-19	B-DDF	739	747	abstract	37606895
,	O	747	748	abstract	37606895
the	O	749	752	abstract	37606895
occurrence	O	753	763	abstract	37606895
of	O	764	766	abstract	37606895
anosmia	B-DDF	767	774	abstract	37606895
and	O	775	778	abstract	37606895
ageusia	B-DDF	779	786	abstract	37606895
,	O	786	787	abstract	37606895
use	O	788	791	abstract	37606895
of	O	792	794	abstract	37606895
antibiotics	B-drug	795	806	abstract	37606895
and	O	807	810	abstract	37606895
hospitalization	O	811	826	abstract	37606895
during	O	827	833	abstract	37606895
the	O	834	837	abstract	37606895
acute	O	838	843	abstract	37606895
illness	O	844	851	abstract	37606895
,	O	851	852	abstract	37606895
persistent	O	853	863	abstract	37606895
GI	B-DDF	864	866	abstract	37606895
symptoms	I-DDF	867	875	abstract	37606895
beyond	O	876	882	abstract	37606895
1	O	883	884	abstract	37606895
month	O	885	890	abstract	37606895
after	O	891	896	abstract	37606895
recovery	O	897	905	abstract	37606895
,	O	905	906	abstract	37606895
presence	O	907	915	abstract	37606895
of	O	916	918	abstract	37606895
mental	O	919	925	abstract	37606895
health	O	926	932	abstract	37606895
factors	O	933	940	abstract	37606895
,	O	940	941	abstract	37606895
The	O	942	945	abstract	37606895
putative	O	946	954	abstract	37606895
mechanisms	O	955	965	abstract	37606895
for	O	966	969	abstract	37606895
post-COVID-19	B-DDF	970	983	abstract	37606895
DGBI	I-DDF	984	988	abstract	37606895
include	O	989	996	abstract	37606895
altered	B-DDF	997	1004	abstract	37606895
gut	I-DDF	1005	1008	abstract	37606895
motility	I-DDF	1009	1017	abstract	37606895
,	O	1017	1018	abstract	37606895
visceral	B-DDF	1019	1027	abstract	37606895
hypersensitivity	I-DDF	1028	1044	abstract	37606895
,	O	1044	1045	abstract	37606895
gut	B-DDF	1046	1049	abstract	37606895
microbiota	I-DDF	1050	1060	abstract	37606895
dysbiosis	I-DDF	1061	1070	abstract	37606895
,	O	1070	1071	abstract	37606895
GI	B-DDF	1072	1074	abstract	37606895
inflammation	I-DDF	1075	1087	abstract	37606895
,	O	1087	1088	abstract	37606895
and	O	1089	1092	abstract	37606895
immune	O	1093	1099	abstract	37606895
activation	O	1100	1110	abstract	37606895
,	O	1110	1111	abstract	37606895
changes	B-DDF	1112	1119	abstract	37606895
in	I-DDF	1120	1122	abstract	37606895
intestinal	I-DDF	1123	1133	abstract	37606895
permeability	I-DDF	1134	1146	abstract	37606895
,	O	1146	1147	abstract	37606895
and	O	1148	1151	abstract	37606895
alterations	B-DDF	1152	1163	abstract	37606895
in	I-DDF	1164	1166	abstract	37606895
the	I-DDF	1167	1170	abstract	37606895
enteroendocrine	I-DDF	1171	1186	abstract	37606895
system	I-DDF	1187	1193	abstract	37606895
and	O	1194	1197	abstract	37606895
serotonin	O	1198	1207	abstract	37606895
metabolism	O	1208	1218	abstract	37606895
.	O	1218	1219	abstract	37606895

Long-term	O	1220	1229	abstract	37606895
sequelae	O	1230	1238	abstract	37606895
of	O	1239	1241	abstract	37606895
SARS-CoV2	B-DDF	1242	1251	abstract	37606895
infection	I-DDF	1252	1261	abstract	37606895
may	O	1262	1265	abstract	37606895
persist	O	1266	1273	abstract	37606895
even	O	1274	1278	abstract	37606895
after	O	1279	1284	abstract	37606895
recovery	O	1285	1293	abstract	37606895
from	O	1294	1298	abstract	37606895
COVID-19	B-DDF	1299	1307	abstract	37606895
.	O	1307	1308	abstract	37606895

Patients	B-human	1309	1317	abstract	37606895
with	O	1318	1322	abstract	37606895
COVID-19	B-DDF	1323	1331	abstract	37606895
are	O	1332	1335	abstract	37606895
more	O	1336	1340	abstract	37606895
likely	O	1341	1347	abstract	37606895
to	O	1348	1350	abstract	37606895
develop	O	1351	1358	abstract	37606895
post-COVID-19	B-DDF	1359	1372	abstract	37606895
IBS	I-DDF	1373	1376	abstract	37606895
than	O	1377	1381	abstract	37606895
healthy	B-human	1382	1389	abstract	37606895
controls	I-human	1390	1398	abstract	37606895
.	O	1398	1399	abstract	37606895

Post-COVID-19	B-DDF	1400	1413	abstract	37606895
IBS	I-DDF	1414	1417	abstract	37606895
may	O	1418	1421	abstract	37606895
pose	O	1422	1426	abstract	37606895
a	O	1427	1428	abstract	37606895
substantial	O	1429	1440	abstract	37606895
healthcare	O	1441	1451	abstract	37606895
burden	O	1452	1458	abstract	37606895
to	O	1459	1461	abstract	37606895
society	O	1462	1469	abstract	37606895
.	O	1469	1470	abstract	37606895

Along	O	0	5	title	38508549
the	O	6	9	title	38508549
microbiota-gut-brain	O	10	30	title	38508549
axis	O	31	35	title	38508549
:	O	35	36	title	38508549
Use	O	37	40	title	38508549
of	O	41	43	title	38508549
plant	B-dietary%supplement	44	49	title	38508549
polysaccharides	I-dietary%supplement	50	65	title	38508549
to	O	66	68	title	38508549
improve	O	69	76	title	38508549
mental	B-DDF	77	83	title	38508549
disorders	I-DDF	84	93	title	38508549
.	O	93	94	title	38508549

With	O	0	4	abstract	38508549
the	O	5	8	abstract	38508549
development	O	9	20	abstract	38508549
of	O	21	23	abstract	38508549
gut	O	24	27	abstract	38508549
microbiota-specific	O	28	47	abstract	38508549
interventions	O	48	61	abstract	38508549
for	O	62	65	abstract	38508549
mental	B-DDF	66	72	abstract	38508549
disorders	I-DDF	73	82	abstract	38508549
,	O	82	83	abstract	38508549
the	O	84	87	abstract	38508549
interactions	O	88	100	abstract	38508549
between	O	101	108	abstract	38508549
plant	B-dietary%supplement	109	114	abstract	38508549
polysaccharides	I-dietary%supplement	115	130	abstract	38508549
and	O	131	134	abstract	38508549
microbiota	O	135	145	abstract	38508549
in	O	146	148	abstract	38508549
the	O	149	152	abstract	38508549
intestinal	O	153	163	abstract	38508549
and	O	164	167	abstract	38508549
their	O	168	173	abstract	38508549
consequent	O	174	184	abstract	38508549
effects	O	185	192	abstract	38508549
are	O	193	196	abstract	38508549
becoming	O	197	205	abstract	38508549
increasingly	O	206	218	abstract	38508549
important	O	219	228	abstract	38508549
.	O	228	229	abstract	38508549

In	O	230	232	abstract	38508549
this	O	233	237	abstract	38508549
review	O	238	244	abstract	38508549
,	O	244	245	abstract	38508549
we	O	246	248	abstract	38508549
discussed	O	249	258	abstract	38508549
the	O	259	262	abstract	38508549
role	O	263	267	abstract	38508549
of	O	268	270	abstract	38508549
plant	B-dietary%supplement	271	276	abstract	38508549
polysaccharides	I-dietary%supplement	277	292	abstract	38508549
in	O	293	295	abstract	38508549
improving	O	296	305	abstract	38508549
various	O	306	313	abstract	38508549
mental	B-DDF	314	320	abstract	38508549
disorders	I-DDF	321	330	abstract	38508549
via	O	331	334	abstract	38508549
the	O	335	338	abstract	38508549
microbiota-gut-brain	O	339	359	abstract	38508549
axis	O	360	364	abstract	38508549
.	O	364	365	abstract	38508549

The	O	366	369	abstract	38508549
chemical	O	370	378	abstract	38508549
and	O	379	382	abstract	38508549
structural	O	383	393	abstract	38508549
characteristics	O	394	409	abstract	38508549
and	O	410	413	abstract	38508549
metabolites	O	414	425	abstract	38508549
of	O	426	428	abstract	38508549
these	O	429	434	abstract	38508549
plant	B-dietary%supplement	435	440	abstract	38508549
polysaccharides	I-dietary%supplement	441	456	abstract	38508549
were	O	457	461	abstract	38508549
summarised	O	462	472	abstract	38508549
.	O	472	473	abstract	38508549

Plant	B-dietary%supplement	474	479	abstract	38508549
polysaccharides	I-dietary%supplement	480	495	abstract	38508549
and	O	496	499	abstract	38508549
their	O	500	505	abstract	38508549
metabolites	O	506	517	abstract	38508549
have	O	518	522	abstract	38508549
great	O	523	528	abstract	38508549
potential	O	529	538	abstract	38508549
for	O	539	542	abstract	38508549
reshaping	O	543	552	abstract	38508549
gut	B-microbiome	553	556	abstract	38508549
microbiota	I-microbiome	557	567	abstract	38508549
profiles	O	568	576	abstract	38508549
through	O	577	584	abstract	38508549
gut	O	585	588	abstract	38508549
microbiota-dependent	O	589	609	abstract	38508549
fermentation	O	610	622	abstract	38508549
.	O	622	623	abstract	38508549

Along	O	624	629	abstract	38508549
the	O	630	633	abstract	38508549
microbiota-gut-brain	O	634	654	abstract	38508549
axis	O	655	659	abstract	38508549
,	O	659	660	abstract	38508549
the	O	661	664	abstract	38508549
consequent	O	665	675	abstract	38508549
pharmacological	O	676	691	abstract	38508549
processes	O	692	701	abstract	38508549
that	O	702	706	abstract	38508549
lead	O	707	711	abstract	38508549
to	O	712	714	abstract	38508549
the	O	715	718	abstract	38508549
elimination	O	719	730	abstract	38508549
of	O	731	733	abstract	38508549
the	O	734	737	abstract	38508549
symptoms	O	738	746	abstract	38508549
of	O	747	749	abstract	38508549
mental	B-DDF	750	756	abstract	38508549
disorders	I-DDF	757	766	abstract	38508549
include	O	767	774	abstract	38508549
1	O	775	776	abstract	38508549
)	O	776	777	abstract	38508549
regulation	O	778	788	abstract	38508549
of	O	789	791	abstract	38508549
the	O	792	795	abstract	38508549
central	B-chemical	796	803	abstract	38508549
monoamine	I-chemical	804	813	abstract	38508549
neurotransmitters	I-chemical	814	831	abstract	38508549
,	O	831	832	abstract	38508549
amino	B-chemical	833	838	abstract	38508549
acid	I-chemical	839	843	abstract	38508549
transmitters	I-chemical	844	856	abstract	38508549
and	O	857	860	abstract	38508549
cholinergic	O	861	872	abstract	38508549
signalling	O	873	883	abstract	38508549
system	O	884	890	abstract	38508549
;	O	890	891	abstract	38508549
2	O	892	893	abstract	38508549
)	O	893	894	abstract	38508549
alleviation	O	895	906	abstract	38508549
of	O	907	909	abstract	38508549
central	B-DDF	910	917	abstract	38508549
and	I-DDF	918	921	abstract	38508549
peripheral	I-DDF	922	932	abstract	38508549
inflammation	I-DDF	933	945	abstract	38508549
mainly	O	946	952	abstract	38508549
through	O	953	960	abstract	38508549
the	O	961	964	abstract	38508549
NLRP3/NF-B-related	O	965	984	abstract	38508549
signalling	O	985	995	abstract	38508549
pathway	O	996	1003	abstract	38508549
;	O	1003	1004	abstract	38508549
3	O	1005	1006	abstract	38508549
)	O	1006	1007	abstract	38508549
inhibition	O	1008	1018	abstract	38508549
of	O	1019	1021	abstract	38508549
neuronal	O	1022	1030	abstract	38508549
apoptosis	O	1031	1040	abstract	38508549
;	O	1040	1041	abstract	38508549
and	O	1042	1045	abstract	38508549
4	O	1046	1047	abstract	38508549
)	O	1047	1048	abstract	38508549
enhancement	O	1049	1060	abstract	38508549
of	O	1061	1063	abstract	38508549
antioxidant	O	1064	1075	abstract	38508549
activities	O	1076	1086	abstract	38508549
.	O	1086	1087	abstract	38508549

According	O	1088	1097	abstract	38508549
to	O	1098	1100	abstract	38508549
this	O	1101	1105	abstract	38508549
review	O	1106	1112	abstract	38508549
,	O	1112	1113	abstract	38508549
monosaccharide	B-chemical	1114	1128	abstract	38508549
glucose	I-chemical	1129	1136	abstract	38508549
and	O	1137	1140	abstract	38508549
structure	B-chemical	1141	1150	abstract	38508549
-4--Glcp-(1	I-chemical	1151	1164	abstract	38508549
are	O	1165	1168	abstract	38508549
the	O	1169	1172	abstract	38508549
most	O	1173	1177	abstract	38508549
potent	O	1178	1184	abstract	38508549
compositions	O	1185	1197	abstract	38508549
of	O	1198	1200	abstract	38508549
the	O	1201	1204	abstract	38508549
most	O	1205	1209	abstract	38508549
reported	O	1210	1218	abstract	38508549
plant	B-dietary%supplement	1219	1224	abstract	38508549
polysaccharides	I-dietary%supplement	1225	1240	abstract	38508549
.	O	1240	1241	abstract	38508549

However	O	1242	1249	abstract	38508549
,	O	1249	1250	abstract	38508549
the	O	1251	1254	abstract	38508549
causal	O	1255	1261	abstract	38508549
structure-activity	O	1262	1280	abstract	38508549
relationship	O	1281	1293	abstract	38508549
remains	O	1294	1301	abstract	38508549
to	O	1302	1304	abstract	38508549
be	O	1305	1307	abstract	38508549
extensively	O	1308	1319	abstract	38508549
explored	O	1320	1328	abstract	38508549
.	O	1328	1329	abstract	38508549

Moreover	O	1330	1338	abstract	38508549
,	O	1338	1339	abstract	38508549
mechanistic	O	1340	1351	abstract	38508549
elucidation	O	1352	1363	abstract	38508549
,	O	1363	1364	abstract	38508549
safety	O	1365	1371	abstract	38508549
verification	O	1372	1384	abstract	38508549
,	O	1384	1385	abstract	38508549
and	O	1386	1389	abstract	38508549
additional	O	1390	1400	abstract	38508549
rigorous	O	1401	1409	abstract	38508549
human	O	1410	1415	abstract	38508549
studies	O	1416	1423	abstract	38508549
are	O	1424	1427	abstract	38508549
expected	O	1428	1436	abstract	38508549
to	O	1437	1439	abstract	38508549
advance	O	1440	1447	abstract	38508549
plant	O	1448	1453	abstract	38508549
polysaccharide-based	O	1454	1474	abstract	38508549
product	O	1475	1482	abstract	38508549
development	O	1483	1494	abstract	38508549
targeting	O	1495	1504	abstract	38508549
the	O	1505	1508	abstract	38508549
microbiota-gut-brain	O	1509	1529	abstract	38508549
axis	O	1530	1534	abstract	38508549
for	O	1535	1538	abstract	38508549
people	B-human	1539	1545	abstract	38508549
with	O	1546	1550	abstract	38508549
mental	B-DDF	1551	1557	abstract	38508549
disorders	I-DDF	1558	1567	abstract	38508549
.	O	1567	1568	abstract	38508549

Inflammatory	B-microbiome	0	12	title	36564391
microbes	I-microbiome	13	21	title	36564391
and	I-microbiome	22	25	title	36564391
genes	I-microbiome	26	31	title	36564391
as	O	32	34	title	36564391
potential	O	35	44	title	36564391
biomarkers	O	45	55	title	36564391
of	O	56	58	title	36564391
Parkinson	B-DDF	59	68	title	36564391
's	I-DDF	68	70	title	36564391
disease	I-DDF	71	78	title	36564391
.	O	78	79	title	36564391

As	O	0	2	abstract	36564391
the	O	3	6	abstract	36564391
second-largest	O	7	21	abstract	36564391
neurodegenerative	O	22	39	abstract	36564391
disease	O	40	47	abstract	36564391
in	O	48	50	abstract	36564391
the	O	51	54	abstract	36564391
world	O	55	60	abstract	36564391
,	O	60	61	abstract	36564391
Parkinson	B-DDF	62	71	abstract	36564391
's	I-DDF	71	73	abstract	36564391
disease	I-DDF	74	81	abstract	36564391
(	O	82	83	abstract	36564391
PD	B-DDF	83	85	abstract	36564391
)	O	85	86	abstract	36564391
has	O	87	90	abstract	36564391
brought	O	91	98	abstract	36564391
a	O	99	100	abstract	36564391
severe	O	101	107	abstract	36564391
economic	O	108	116	abstract	36564391
and	O	117	120	abstract	36564391
medical	O	121	128	abstract	36564391
burden	O	129	135	abstract	36564391
to	O	136	138	abstract	36564391
our	O	139	142	abstract	36564391
society	O	143	150	abstract	36564391
.	O	150	151	abstract	36564391

Growing	O	152	159	abstract	36564391
evidence	O	160	168	abstract	36564391
in	O	169	171	abstract	36564391
recent	O	172	178	abstract	36564391
years	O	179	184	abstract	36564391
suggests	O	185	193	abstract	36564391
that	O	194	198	abstract	36564391
the	O	199	202	abstract	36564391
gut	B-microbiome	203	206	abstract	36564391
microbiome	I-microbiome	207	217	abstract	36564391
may	O	218	221	abstract	36564391
influence	O	222	231	abstract	36564391
PD	B-DDF	232	234	abstract	36564391
,	O	234	235	abstract	36564391
but	O	236	239	abstract	36564391
the	O	240	243	abstract	36564391
exact	O	244	249	abstract	36564391
pathogenesis	O	250	262	abstract	36564391
of	O	263	265	abstract	36564391
PD	B-DDF	266	268	abstract	36564391
remains	O	269	276	abstract	36564391
unclear	O	277	284	abstract	36564391
.	O	284	285	abstract	36564391

In	O	286	288	abstract	36564391
addition	O	289	297	abstract	36564391
,	O	297	298	abstract	36564391
the	O	299	302	abstract	36564391
current	O	303	310	abstract	36564391
diagnosis	O	311	320	abstract	36564391
of	O	321	323	abstract	36564391
PD	B-DDF	324	326	abstract	36564391
could	O	327	332	abstract	36564391
be	O	333	335	abstract	36564391
inaccurate	O	336	346	abstract	36564391
and	O	347	350	abstract	36564391
expensive	O	351	360	abstract	36564391
.	O	360	361	abstract	36564391

In	O	362	364	abstract	36564391
this	O	365	369	abstract	36564391
study	O	370	375	abstract	36564391
,	O	375	376	abstract	36564391
the	O	377	380	abstract	36564391
largest	O	381	388	abstract	36564391
meta-analysis	O	389	402	abstract	36564391
currently	O	403	412	abstract	36564391
of	O	413	415	abstract	36564391
the	O	416	419	abstract	36564391
gut	B-microbiome	420	423	abstract	36564391
microbiome	I-microbiome	424	434	abstract	36564391
in	O	435	437	abstract	36564391
PD	B-DDF	438	440	abstract	36564391
was	O	441	444	abstract	36564391
analyzed	O	445	453	abstract	36564391
,	O	453	454	abstract	36564391
including	O	455	464	abstract	36564391
2269	O	465	469	abstract	36564391
samples	O	470	477	abstract	36564391
by	O	478	480	abstract	36564391
16S	B-gene	481	484	abstract	36564391
rRNA	I-gene	485	489	abstract	36564391
gene	I-gene	490	494	abstract	36564391
and	O	495	498	abstract	36564391
236	O	499	502	abstract	36564391
samples	O	503	510	abstract	36564391
by	O	511	513	abstract	36564391
shotgun	B-biomedical%technique	514	521	abstract	36564391
metagenomics	I-biomedical%technique	522	534	abstract	36564391
,	O	534	535	abstract	36564391
aiming	O	536	542	abstract	36564391
to	O	543	545	abstract	36564391
reveal	O	546	552	abstract	36564391
the	O	553	556	abstract	36564391
connection	O	557	567	abstract	36564391
between	O	568	575	abstract	36564391
PD	B-DDF	576	578	abstract	36564391
and	O	579	582	abstract	36564391
gut	B-microbiome	583	586	abstract	36564391
microbiome	I-microbiome	587	597	abstract	36564391
and	O	598	601	abstract	36564391
establish	O	602	611	abstract	36564391
a	O	612	613	abstract	36564391
model	O	614	619	abstract	36564391
to	O	620	622	abstract	36564391
predict	O	623	630	abstract	36564391
PD	B-DDF	631	633	abstract	36564391
.	O	633	634	abstract	36564391

The	O	635	638	abstract	36564391
results	O	639	646	abstract	36564391
showed	O	647	653	abstract	36564391
that	O	654	658	abstract	36564391
the	O	659	662	abstract	36564391
relative	O	663	671	abstract	36564391
abundances	O	672	682	abstract	36564391
of	O	683	685	abstract	36564391
potential	O	686	695	abstract	36564391
pro-inflammatory	B-microbiome	696	712	abstract	36564391
bacteria	I-microbiome	713	721	abstract	36564391
,	I-microbiome	721	722	abstract	36564391
genes	I-microbiome	723	728	abstract	36564391
and	I-microbiome	729	732	abstract	36564391
pathways	I-microbiome	733	741	abstract	36564391
were	O	742	746	abstract	36564391
significantly	O	747	760	abstract	36564391
increased	O	761	770	abstract	36564391
in	O	771	773	abstract	36564391
PD	B-DDF	774	776	abstract	36564391
,	O	776	777	abstract	36564391
while	O	778	783	abstract	36564391
potential	O	784	793	abstract	36564391
anti-inflammatory	B-microbiome	794	811	abstract	36564391
bacteria	I-microbiome	812	820	abstract	36564391
,	I-microbiome	820	821	abstract	36564391
genes	I-microbiome	822	827	abstract	36564391
and	I-microbiome	828	831	abstract	36564391
pathways	I-microbiome	832	840	abstract	36564391
were	O	841	845	abstract	36564391
significantly	O	846	859	abstract	36564391
decreased	O	860	869	abstract	36564391
.	O	869	870	abstract	36564391

These	O	871	876	abstract	36564391
changes	O	877	884	abstract	36564391
may	O	885	888	abstract	36564391
lead	O	889	893	abstract	36564391
to	O	894	896	abstract	36564391
a	O	897	898	abstract	36564391
decrease	O	899	907	abstract	36564391
in	O	908	910	abstract	36564391
potential	O	911	920	abstract	36564391
anti-inflammatory	O	921	938	abstract	36564391
substances	O	939	949	abstract	36564391
(	O	950	951	abstract	36564391
short-chain	B-chemical	951	962	abstract	36564391
fatty	I-chemical	963	968	abstract	36564391
acids	I-chemical	969	974	abstract	36564391
)	O	974	975	abstract	36564391
and	O	976	979	abstract	36564391
an	O	980	982	abstract	36564391
increase	O	983	991	abstract	36564391
in	O	992	994	abstract	36564391
potential	O	995	1004	abstract	36564391
pro-inflammatory	O	1005	1021	abstract	36564391
substances	O	1022	1032	abstract	36564391
(	O	1033	1034	abstract	36564391
lipopolysaccharides	B-chemical	1034	1053	abstract	36564391
,	O	1053	1054	abstract	36564391
hydrogen	B-chemical	1055	1063	abstract	36564391
sulfide	I-chemical	1064	1071	abstract	36564391
and	O	1072	1075	abstract	36564391
glutamate	B-chemical	1076	1085	abstract	36564391
)	O	1085	1086	abstract	36564391
.	O	1086	1087	abstract	36564391

Notably	O	1088	1095	abstract	36564391
,	O	1095	1096	abstract	36564391
the	O	1097	1100	abstract	36564391
results	O	1101	1108	abstract	36564391
of	O	1109	1111	abstract	36564391
16S	B-biomedical%technique	1112	1115	abstract	36564391
rRNA	I-biomedical%technique	1116	1120	abstract	36564391
gene	I-biomedical%technique	1121	1125	abstract	36564391
and	I-biomedical%technique	1126	1129	abstract	36564391
shotgun	I-biomedical%technique	1130	1137	abstract	36564391
metagenomic	I-biomedical%technique	1138	1149	abstract	36564391
analysis	I-biomedical%technique	1150	1158	abstract	36564391
have	O	1159	1163	abstract	36564391
consistently	O	1164	1176	abstract	36564391
identified	O	1177	1187	abstract	36564391
five	O	1188	1192	abstract	36564391
decreased	O	1193	1202	abstract	36564391
genera	O	1203	1209	abstract	36564391
(	O	1210	1211	abstract	36564391
Roseburia	B-bacteria	1211	1220	abstract	36564391
,	O	1220	1221	abstract	36564391
Faecalibacterium	B-bacteria	1222	1238	abstract	36564391
,	O	1238	1239	abstract	36564391
Blautia	B-bacteria	1240	1247	abstract	36564391
,	O	1247	1248	abstract	36564391
Lachnospira	B-bacteria	1249	1260	abstract	36564391
,	O	1260	1261	abstract	36564391
and	O	1262	1265	abstract	36564391
Prevotella	B-bacteria	1266	1276	abstract	36564391
)	O	1276	1277	abstract	36564391
and	O	1278	1281	abstract	36564391
five	O	1282	1286	abstract	36564391
increased	O	1287	1296	abstract	36564391
genera	O	1297	1303	abstract	36564391
(	O	1304	1305	abstract	36564391
Streptococcus	B-bacteria	1305	1318	abstract	36564391
,	O	1318	1319	abstract	36564391
Bifidobacterium	B-bacteria	1320	1335	abstract	36564391
,	O	1335	1336	abstract	36564391
Lactobacillus	B-bacteria	1337	1350	abstract	36564391
,	O	1350	1351	abstract	36564391
Akkermansia	B-bacteria	1352	1363	abstract	36564391
,	O	1363	1364	abstract	36564391
and	O	1365	1368	abstract	36564391
Desulfovibrio	B-bacteria	1369	1382	abstract	36564391
)	O	1382	1383	abstract	36564391
in	O	1384	1386	abstract	36564391
PD	B-DDF	1387	1389	abstract	36564391
.	O	1389	1390	abstract	36564391

Furthermore	O	1391	1402	abstract	36564391
,	O	1402	1403	abstract	36564391
random	B-statistical%technique	1404	1410	abstract	36564391
forest	I-statistical%technique	1411	1417	abstract	36564391
models	I-statistical%technique	1418	1424	abstract	36564391
performed	O	1425	1434	abstract	36564391
well	O	1435	1439	abstract	36564391
for	O	1440	1443	abstract	36564391
PD	B-DDF	1444	1446	abstract	36564391
prediction	O	1447	1457	abstract	36564391
based	O	1458	1463	abstract	36564391
on	O	1464	1466	abstract	36564391
11	O	1467	1469	abstract	36564391
genera	O	1470	1476	abstract	36564391
(	O	1477	1478	abstract	36564391
accuracy	O	1478	1486	abstract	36564391
>	O	1487	1488	abstract	36564391
80	O	1489	1491	abstract	36564391
%	O	1491	1492	abstract	36564391
)	O	1492	1493	abstract	36564391
or	O	1494	1496	abstract	36564391
6	O	1497	1498	abstract	36564391
genes	O	1499	1504	abstract	36564391
(	O	1505	1506	abstract	36564391
accuracy	O	1506	1514	abstract	36564391
>	O	1515	1516	abstract	36564391
90	O	1517	1519	abstract	36564391
%	O	1519	1520	abstract	36564391
)	O	1520	1521	abstract	36564391
related	O	1522	1529	abstract	36564391
to	O	1530	1532	abstract	36564391
inflammation	O	1533	1545	abstract	36564391
.	O	1545	1546	abstract	36564391

Finally	O	1547	1554	abstract	36564391
,	O	1554	1555	abstract	36564391
a	O	1556	1557	abstract	36564391
possible	O	1558	1566	abstract	36564391
mechanism	O	1567	1576	abstract	36564391
was	O	1577	1580	abstract	36564391
presented	O	1581	1590	abstract	36564391
to	O	1591	1593	abstract	36564391
explain	O	1594	1601	abstract	36564391
the	O	1602	1605	abstract	36564391
pathogenesis	O	1606	1618	abstract	36564391
of	O	1619	1621	abstract	36564391
inflammation	O	1622	1634	abstract	36564391
leading	O	1635	1642	abstract	36564391
to	O	1643	1645	abstract	36564391
PD	B-DDF	1646	1648	abstract	36564391
.	O	1648	1649	abstract	36564391

Our	O	1650	1653	abstract	36564391
results	O	1654	1661	abstract	36564391
provided	O	1662	1670	abstract	36564391
further	O	1671	1678	abstract	36564391
insights	O	1679	1687	abstract	36564391
into	O	1688	1692	abstract	36564391
the	O	1693	1696	abstract	36564391
prediction	O	1697	1707	abstract	36564391
and	O	1708	1711	abstract	36564391
treatment	O	1712	1721	abstract	36564391
of	O	1722	1724	abstract	36564391
PD	B-DDF	1725	1727	abstract	36564391
based	O	1728	1733	abstract	36564391
on	O	1734	1736	abstract	36564391
inflammation	O	1737	1749	abstract	36564391
.	O	1749	1750	abstract	36564391

Positive	B-microbiome	0	8	title	37095530
mood-related	I-microbiome	9	21	title	37095530
gut	I-microbiome	22	25	title	37095530
microbiota	I-microbiome	26	36	title	37095530
in	O	37	39	title	37095530
a	O	40	41	title	37095530
long-term	O	42	51	title	37095530
closed	O	52	58	title	37095530
environment	O	59	70	title	37095530
:	O	70	71	title	37095530
a	O	72	73	title	37095530
multiomics	O	74	84	title	37095530
study	O	85	90	title	37095530
based	O	91	96	title	37095530
on	O	97	99	title	37095530
the	O	100	103	title	37095530
"	O	104	105	title	37095530
Lunar	O	105	110	title	37095530
Palace	O	111	117	title	37095530
365	O	118	121	title	37095530
"	O	121	122	title	37095530
experiment	O	123	133	title	37095530
.	O	133	134	title	37095530

Psychological	O	0	13	abstract	37095530
health	O	14	20	abstract	37095530
risk	O	21	25	abstract	37095530
is	O	26	28	abstract	37095530
one	O	29	32	abstract	37095530
of	O	33	35	abstract	37095530
the	O	36	39	abstract	37095530
most	O	40	44	abstract	37095530
severe	O	45	51	abstract	37095530
and	O	52	55	abstract	37095530
complex	O	56	63	abstract	37095530
risks	O	64	69	abstract	37095530
in	O	70	72	abstract	37095530
manned	O	73	79	abstract	37095530
deep-space	O	80	90	abstract	37095530
exploration	O	91	102	abstract	37095530
and	O	103	106	abstract	37095530
long-term	O	107	116	abstract	37095530
closed	O	117	123	abstract	37095530
environments	O	124	136	abstract	37095530
.	O	136	137	abstract	37095530

Recently	O	138	146	abstract	37095530
,	O	146	147	abstract	37095530
with	O	148	152	abstract	37095530
the	O	153	156	abstract	37095530
in-depth	O	157	165	abstract	37095530
research	O	166	174	abstract	37095530
of	O	175	177	abstract	37095530
the	O	178	181	abstract	37095530
microbiota-gut-brain	O	182	202	abstract	37095530
axis	O	203	207	abstract	37095530
,	O	207	208	abstract	37095530
gut	B-microbiome	209	212	abstract	37095530
microbiota	I-microbiome	213	223	abstract	37095530
has	O	224	227	abstract	37095530
been	O	228	232	abstract	37095530
considered	O	233	243	abstract	37095530
a	O	244	245	abstract	37095530
new	O	246	249	abstract	37095530
approach	O	250	258	abstract	37095530
to	O	259	261	abstract	37095530
maintain	O	262	270	abstract	37095530
and	O	271	274	abstract	37095530
improve	O	275	282	abstract	37095530
psychological	O	283	296	abstract	37095530
health	O	297	303	abstract	37095530
.	O	303	304	abstract	37095530

However	O	305	312	abstract	37095530
,	O	312	313	abstract	37095530
the	O	314	317	abstract	37095530
correlation	O	318	329	abstract	37095530
between	O	330	337	abstract	37095530
gut	B-microbiome	338	341	abstract	37095530
microbiota	I-microbiome	342	352	abstract	37095530
and	O	353	356	abstract	37095530
psychological	O	357	370	abstract	37095530
changes	O	371	378	abstract	37095530
inside	O	379	385	abstract	37095530
long-term	O	386	395	abstract	37095530
closed	O	396	402	abstract	37095530
environments	O	403	415	abstract	37095530
is	O	416	418	abstract	37095530
still	O	419	424	abstract	37095530
poorly	O	425	431	abstract	37095530
understood	O	432	442	abstract	37095530
.	O	442	443	abstract	37095530

Herein	O	444	450	abstract	37095530
,	O	450	451	abstract	37095530
we	O	452	454	abstract	37095530
used	O	455	459	abstract	37095530
the	O	460	463	abstract	37095530
"	O	464	465	abstract	37095530
Lunar	O	465	470	abstract	37095530
Palace	O	471	477	abstract	37095530
365	O	478	481	abstract	37095530
"	O	481	482	abstract	37095530
mission	O	483	490	abstract	37095530
,	O	490	491	abstract	37095530
a	O	492	493	abstract	37095530
1-year-long	O	494	505	abstract	37095530
isolation	O	506	515	abstract	37095530
study	O	516	521	abstract	37095530
in	O	522	524	abstract	37095530
the	O	525	528	abstract	37095530
Lunar	O	529	534	abstract	37095530
Palace	O	535	541	abstract	37095530
1	O	542	543	abstract	37095530
(	O	544	545	abstract	37095530
a	O	545	546	abstract	37095530
closed	O	547	553	abstract	37095530
manned	O	554	560	abstract	37095530
Bioregenerative	O	561	576	abstract	37095530
Life	O	577	581	abstract	37095530
Support	O	582	589	abstract	37095530
System	O	590	596	abstract	37095530
facility	O	597	605	abstract	37095530
with	O	606	610	abstract	37095530
excellent	O	611	620	abstract	37095530
performance	O	621	632	abstract	37095530
)	O	632	633	abstract	37095530
,	O	633	634	abstract	37095530
to	O	635	637	abstract	37095530
investigate	O	638	649	abstract	37095530
the	O	650	653	abstract	37095530
correlation	O	654	665	abstract	37095530
between	O	666	673	abstract	37095530
gut	B-microbiome	674	677	abstract	37095530
microbiota	I-microbiome	678	688	abstract	37095530
and	O	689	692	abstract	37095530
psychological	B-DDF	693	706	abstract	37095530
changes	I-DDF	707	714	abstract	37095530
,	O	714	715	abstract	37095530
in	O	716	718	abstract	37095530
order	O	719	724	abstract	37095530
to	O	725	727	abstract	37095530
find	O	728	732	abstract	37095530
some	O	733	737	abstract	37095530
new	O	738	741	abstract	37095530
potential	O	742	751	abstract	37095530
psychobiotics	B-bacteria	752	765	abstract	37095530
to	O	766	768	abstract	37095530
maintain	O	769	777	abstract	37095530
and	O	778	781	abstract	37095530
improve	O	782	789	abstract	37095530
the	O	790	793	abstract	37095530
psychological	O	794	807	abstract	37095530
health	O	808	814	abstract	37095530
of	O	815	817	abstract	37095530
crew	B-human	818	822	abstract	37095530
members	I-human	823	830	abstract	37095530
.	O	830	831	abstract	37095530

We	O	832	834	abstract	37095530
report	O	835	841	abstract	37095530
some	O	842	846	abstract	37095530
altered	B-DDF	847	854	abstract	37095530
gut	I-DDF	855	858	abstract	37095530
microbiota	I-DDF	859	869	abstract	37095530
that	O	870	874	abstract	37095530
were	O	875	879	abstract	37095530
associated	O	880	890	abstract	37095530
with	O	891	895	abstract	37095530
psychological	O	896	909	abstract	37095530
changes	O	910	917	abstract	37095530
in	O	918	920	abstract	37095530
the	O	921	924	abstract	37095530
long-term	O	925	934	abstract	37095530
closed	O	935	941	abstract	37095530
environment	O	942	953	abstract	37095530
.	O	953	954	abstract	37095530

Four	O	955	959	abstract	37095530
potential	O	960	969	abstract	37095530
psychobiotics	B-bacteria	970	983	abstract	37095530
(	O	984	985	abstract	37095530
Bacteroides	B-bacteria	985	996	abstract	37095530
uniformis	I-bacteria	997	1006	abstract	37095530
,	O	1006	1007	abstract	37095530
Roseburia	B-bacteria	1008	1017	abstract	37095530
inulinivorans	I-bacteria	1018	1031	abstract	37095530
,	O	1031	1032	abstract	37095530
Eubacterium	B-bacteria	1033	1044	abstract	37095530
rectale	I-bacteria	1045	1052	abstract	37095530
,	O	1052	1053	abstract	37095530
and	O	1054	1057	abstract	37095530
Faecalibacterium	B-bacteria	1058	1074	abstract	37095530
prausnitzii	I-bacteria	1075	1086	abstract	37095530
)	O	1086	1087	abstract	37095530
were	O	1088	1092	abstract	37095530
identified	O	1093	1103	abstract	37095530
.	O	1103	1104	abstract	37095530

On	O	1105	1107	abstract	37095530
the	O	1108	1111	abstract	37095530
basis	O	1112	1117	abstract	37095530
of	O	1118	1120	abstract	37095530
metagenomic	O	1121	1132	abstract	37095530
,	O	1132	1133	abstract	37095530
metaproteomic	O	1134	1147	abstract	37095530
,	O	1147	1148	abstract	37095530
and	O	1149	1152	abstract	37095530
metabolomic	O	1153	1164	abstract	37095530
analyses	O	1165	1173	abstract	37095530
,	O	1173	1174	abstract	37095530
the	O	1175	1178	abstract	37095530
four	O	1179	1183	abstract	37095530
potential	O	1184	1193	abstract	37095530
psychobiotics	B-bacteria	1194	1207	abstract	37095530
improved	O	1208	1216	abstract	37095530
mood	O	1217	1221	abstract	37095530
mainly	O	1222	1228	abstract	37095530
through	O	1229	1236	abstract	37095530
three	O	1237	1242	abstract	37095530
pathways	O	1243	1251	abstract	37095530
related	O	1252	1259	abstract	37095530
to	O	1260	1262	abstract	37095530
nervous	O	1263	1270	abstract	37095530
system	O	1271	1277	abstract	37095530
functions	O	1278	1287	abstract	37095530
:	O	1287	1288	abstract	37095530
first	O	1289	1294	abstract	37095530
,	O	1294	1295	abstract	37095530
by	O	1296	1298	abstract	37095530
fermenting	O	1299	1309	abstract	37095530
dietary	O	1310	1317	abstract	37095530
fibers	O	1318	1324	abstract	37095530
,	O	1324	1325	abstract	37095530
they	O	1326	1330	abstract	37095530
may	O	1331	1334	abstract	37095530
produce	O	1335	1342	abstract	37095530
short-chain	B-chemical	1343	1354	abstract	37095530
fatty	I-chemical	1355	1360	abstract	37095530
acids	I-chemical	1361	1366	abstract	37095530
,	O	1366	1367	abstract	37095530
such	O	1368	1372	abstract	37095530
as	O	1373	1375	abstract	37095530
butyric	B-chemical	1376	1383	abstract	37095530
and	O	1384	1387	abstract	37095530
propionic	B-chemical	1388	1397	abstract	37095530
acids	I-chemical	1398	1403	abstract	37095530
;	O	1403	1404	abstract	37095530
second	O	1405	1411	abstract	37095530
,	O	1411	1412	abstract	37095530
they	O	1413	1417	abstract	37095530
may	O	1418	1421	abstract	37095530
regulate	O	1422	1430	abstract	37095530
amino	O	1431	1436	abstract	37095530
acid	O	1437	1441	abstract	37095530
metabolism	O	1442	1452	abstract	37095530
pathways	O	1453	1461	abstract	37095530
of	O	1462	1464	abstract	37095530
aspartic	B-chemical	1465	1473	abstract	37095530
acid	I-chemical	1474	1478	abstract	37095530
,	O	1478	1479	abstract	37095530
glutamic	B-chemical	1480	1488	abstract	37095530
acid	I-chemical	1489	1493	abstract	37095530
,	O	1493	1494	abstract	37095530
tryptophan	B-chemical	1495	1505	abstract	37095530
,	O	1505	1506	abstract	37095530
etc	O	1507	1510	abstract	37095530
.	O	1510	1511	abstract	37095530
(	O	1512	1513	abstract	37095530
e.g.	O	1513	1517	abstract	37095530
,	O	1517	1518	abstract	37095530
converting	O	1519	1529	abstract	37095530
glutamic	B-chemical	1530	1538	abstract	37095530
acid	I-chemical	1539	1543	abstract	37095530
to	O	1544	1546	abstract	37095530
gamma-aminobutyric	B-chemical	1547	1565	abstract	37095530
acid	I-chemical	1566	1570	abstract	37095530
;	O	1570	1571	abstract	37095530
converting	O	1572	1582	abstract	37095530
tryptophan	B-chemical	1583	1593	abstract	37095530
to	O	1594	1596	abstract	37095530
serotonin	B-chemical	1597	1606	abstract	37095530
,	O	1606	1607	abstract	37095530
kynurenic	B-chemical	1608	1617	abstract	37095530
acid	I-chemical	1618	1622	abstract	37095530
,	O	1622	1623	abstract	37095530
or	O	1624	1626	abstract	37095530
tryptamine	B-chemical	1627	1637	abstract	37095530
)	O	1637	1638	abstract	37095530
;	O	1638	1639	abstract	37095530
and	O	1640	1643	abstract	37095530
third	O	1644	1649	abstract	37095530
,	O	1649	1650	abstract	37095530
they	O	1651	1655	abstract	37095530
may	O	1656	1659	abstract	37095530
regulate	O	1660	1668	abstract	37095530
other	O	1669	1674	abstract	37095530
pathways	O	1675	1683	abstract	37095530
,	O	1683	1684	abstract	37095530
such	O	1685	1689	abstract	37095530
as	O	1690	1692	abstract	37095530
taurine	O	1693	1700	abstract	37095530
and	O	1701	1704	abstract	37095530
cortisol	O	1705	1713	abstract	37095530
metabolism	O	1714	1724	abstract	37095530
.	O	1724	1725	abstract	37095530

Furthermore	O	1726	1737	abstract	37095530
,	O	1737	1738	abstract	37095530
the	O	1739	1742	abstract	37095530
results	O	1743	1750	abstract	37095530
of	O	1751	1753	abstract	37095530
animal	O	1754	1760	abstract	37095530
experiments	O	1761	1772	abstract	37095530
confirmed	O	1773	1782	abstract	37095530
the	O	1783	1786	abstract	37095530
positive	O	1787	1795	abstract	37095530
regulatory	O	1796	1806	abstract	37095530
effect	O	1807	1813	abstract	37095530
and	O	1814	1817	abstract	37095530
mechanism	O	1818	1827	abstract	37095530
of	O	1828	1830	abstract	37095530
these	O	1831	1836	abstract	37095530
potential	O	1837	1846	abstract	37095530
psychobiotics	O	1847	1860	abstract	37095530
on	O	1861	1863	abstract	37095530
mood	O	1864	1868	abstract	37095530
.	O	1868	1869	abstract	37095530

These	O	1870	1875	abstract	37095530
observations	O	1876	1888	abstract	37095530
reveal	O	1889	1895	abstract	37095530
that	O	1896	1900	abstract	37095530
gut	B-microbiome	1901	1904	abstract	37095530
microbiota	I-microbiome	1905	1915	abstract	37095530
contributed	O	1916	1927	abstract	37095530
to	O	1928	1930	abstract	37095530
a	O	1931	1932	abstract	37095530
robust	O	1933	1939	abstract	37095530
effect	O	1940	1946	abstract	37095530
on	O	1947	1949	abstract	37095530
the	O	1950	1953	abstract	37095530
maintenance	O	1954	1965	abstract	37095530
and	O	1966	1969	abstract	37095530
improvement	O	1970	1981	abstract	37095530
of	O	1982	1984	abstract	37095530
mental	O	1985	1991	abstract	37095530
health	O	1992	1998	abstract	37095530
in	O	1999	2001	abstract	37095530
a	O	2002	2003	abstract	37095530
long-term	O	2004	2013	abstract	37095530
closed	O	2014	2020	abstract	37095530
environment	O	2021	2032	abstract	37095530
.	O	2032	2033	abstract	37095530

Our	O	2034	2037	abstract	37095530
findings	O	2038	2046	abstract	37095530
represent	O	2047	2056	abstract	37095530
a	O	2057	2058	abstract	37095530
key	O	2059	2062	abstract	37095530
step	O	2063	2067	abstract	37095530
towards	O	2068	2075	abstract	37095530
a	O	2076	2077	abstract	37095530
better	O	2078	2084	abstract	37095530
understanding	O	2085	2098	abstract	37095530
the	O	2099	2102	abstract	37095530
role	O	2103	2107	abstract	37095530
of	O	2108	2110	abstract	37095530
the	O	2111	2114	abstract	37095530
gut	B-microbiome	2115	2118	abstract	37095530
microbiome	I-microbiome	2119	2129	abstract	37095530
in	O	2130	2132	abstract	37095530
mammalian	O	2133	2142	abstract	37095530
mental	O	2143	2149	abstract	37095530
health	O	2150	2156	abstract	37095530
during	O	2157	2163	abstract	37095530
space	O	2164	2169	abstract	37095530
flight	O	2170	2176	abstract	37095530
and	O	2177	2180	abstract	37095530
provide	O	2181	2188	abstract	37095530
a	O	2189	2190	abstract	37095530
basis	O	2191	2196	abstract	37095530
for	O	2197	2200	abstract	37095530
future	O	2201	2207	abstract	37095530
efforts	O	2208	2215	abstract	37095530
to	O	2216	2218	abstract	37095530
develop	O	2219	2226	abstract	37095530
microbiota-based	O	2227	2243	abstract	37095530
countermeasures	O	2244	2259	abstract	37095530
that	O	2260	2264	abstract	37095530
mitigate	O	2265	2273	abstract	37095530
risks	O	2274	2279	abstract	37095530
to	O	2280	2282	abstract	37095530
crew	O	2283	2287	abstract	37095530
mental	O	2288	2294	abstract	37095530
health	O	2295	2301	abstract	37095530
during	O	2302	2308	abstract	37095530
future	O	2309	2315	abstract	37095530
long-term	O	2316	2325	abstract	37095530
human	O	2326	2331	abstract	37095530
space	O	2332	2337	abstract	37095530
expeditions	O	2338	2349	abstract	37095530
on	O	2350	2352	abstract	37095530
the	O	2353	2356	abstract	37095530
moon	O	2357	2361	abstract	37095530
or	O	2362	2364	abstract	37095530
Mars	O	2365	2369	abstract	37095530
.	O	2369	2370	abstract	37095530

This	O	2371	2375	abstract	37095530
study	O	2376	2381	abstract	37095530
also	O	2382	2386	abstract	37095530
provides	O	2387	2395	abstract	37095530
an	O	2396	2398	abstract	37095530
essential	O	2399	2408	abstract	37095530
reference	O	2409	2418	abstract	37095530
for	O	2419	2422	abstract	37095530
future	O	2423	2429	abstract	37095530
applications	O	2430	2442	abstract	37095530
of	O	2443	2445	abstract	37095530
psychobiotics	O	2446	2459	abstract	37095530
to	O	2460	2462	abstract	37095530
neuropsychiatric	O	2463	2479	abstract	37095530
treatments	O	2480	2490	abstract	37095530
.	O	2490	2491	abstract	37095530

Video	O	2492	2497	abstract	37095530
Abstract	O	2498	2506	abstract	37095530
.	O	2506	2507	abstract	37095530

The	O	0	3	title	35083314
small	B-microbiome	4	9	title	35083314
bowel	I-microbiome	10	15	title	35083314
microbiome	I-microbiome	16	26	title	35083314
changes	O	27	34	title	35083314
significantly	O	35	48	title	35083314
with	O	49	53	title	35083314
age	O	54	57	title	35083314
and	O	58	61	title	35083314
aspects	O	62	69	title	35083314
of	O	70	72	title	35083314
the	O	73	76	title	35083314
ageing	O	77	83	title	35083314
process	O	84	91	title	35083314
.	O	91	92	title	35083314

Gut	B-DDF	0	3	abstract	35083314
microbiome	I-DDF	4	14	abstract	35083314
changes	I-DDF	15	22	abstract	35083314
have	O	23	27	abstract	35083314
been	O	28	32	abstract	35083314
associated	O	33	43	abstract	35083314
with	O	44	48	abstract	35083314
human	O	49	54	abstract	35083314
ageing	O	55	61	abstract	35083314
and	O	62	65	abstract	35083314
implicated	O	66	76	abstract	35083314
in	O	77	79	abstract	35083314
age-related	B-DDF	80	91	abstract	35083314
diseases	I-DDF	92	100	abstract	35083314
including	O	101	110	abstract	35083314
Alzheimer	B-DDF	111	120	abstract	35083314
's	I-DDF	120	122	abstract	35083314
disease	I-DDF	123	130	abstract	35083314
and	O	131	134	abstract	35083314
Parkinson	B-DDF	135	144	abstract	35083314
's	I-DDF	144	146	abstract	35083314
disease	I-DDF	147	154	abstract	35083314
.	O	154	155	abstract	35083314

However	O	156	163	abstract	35083314
,	O	163	164	abstract	35083314
studies	O	165	172	abstract	35083314
to	O	173	175	abstract	35083314
date	O	176	180	abstract	35083314
have	O	181	185	abstract	35083314
used	O	186	190	abstract	35083314
stool	O	191	196	abstract	35083314
samples	O	197	204	abstract	35083314
,	O	204	205	abstract	35083314
which	O	206	211	abstract	35083314
do	O	212	214	abstract	35083314
not	O	215	218	abstract	35083314
represent	O	219	228	abstract	35083314
the	O	229	232	abstract	35083314
entire	O	233	239	abstract	35083314
gut	B-anatomical%location	240	243	abstract	35083314
.	O	243	244	abstract	35083314

Although	O	245	253	abstract	35083314
more	O	254	258	abstract	35083314
challenging	O	259	270	abstract	35083314
to	O	271	273	abstract	35083314
access	O	274	280	abstract	35083314
,	O	280	281	abstract	35083314
the	O	282	285	abstract	35083314
small	B-anatomical%location	286	291	abstract	35083314
intestine	I-anatomical%location	292	301	abstract	35083314
plays	O	302	307	abstract	35083314
critical	O	308	316	abstract	35083314
roles	O	317	322	abstract	35083314
in	O	323	325	abstract	35083314
host	O	326	330	abstract	35083314
metabolism	O	331	341	abstract	35083314
and	O	342	345	abstract	35083314
immune	O	346	352	abstract	35083314
function	O	353	361	abstract	35083314
.	O	361	362	abstract	35083314

In	O	363	365	abstract	35083314
this	O	366	370	abstract	35083314
paper	O	371	376	abstract	35083314
(	O	377	378	abstract	35083314
Leite	O	378	383	abstract	35083314
<	O	384	385	abstract	35083314
i	O	385	386	abstract	35083314
>	O	386	387	abstract	35083314
et	O	387	389	abstract	35083314
al.</i	O	390	396	abstract	35083314
>	O	396	397	abstract	35083314
(	O	398	399	abstract	35083314
2021	O	399	403	abstract	35083314
)	O	403	404	abstract	35083314
,	O	404	405	abstract	35083314
Cell	O	406	410	abstract	35083314
Reports	O	411	418	abstract	35083314
,	O	418	419	abstract	35083314
doi	O	420	423	abstract	35083314
:	O	423	424	abstract	35083314
10.1016/j.celrep.2021.109765	O	425	453	abstract	35083314
)	O	453	454	abstract	35083314
,	O	454	455	abstract	35083314
we	O	456	458	abstract	35083314
demonstrate	O	459	470	abstract	35083314
significant	O	471	482	abstract	35083314
differences	O	483	494	abstract	35083314
in	O	495	497	abstract	35083314
the	O	498	501	abstract	35083314
small	B-microbiome	502	507	abstract	35083314
intestinal	I-microbiome	508	518	abstract	35083314
microbiome	I-microbiome	519	529	abstract	35083314
in	O	530	532	abstract	35083314
older	B-human	533	538	abstract	35083314
subjects	I-human	539	547	abstract	35083314
,	O	547	548	abstract	35083314
using	O	549	554	abstract	35083314
duodenal	B-biomedical%technique	555	563	abstract	35083314
aspirates	I-biomedical%technique	564	573	abstract	35083314
from	O	574	578	abstract	35083314
251	O	579	582	abstract	35083314
subjects	O	583	591	abstract	35083314
aged	O	592	596	abstract	35083314
18	O	597	599	abstract	35083314
-	O	599	600	abstract	35083314
80	O	600	602	abstract	35083314
years	O	603	608	abstract	35083314
.	O	608	609	abstract	35083314

Differences	O	610	621	abstract	35083314
included	O	622	630	abstract	35083314
significantly	O	631	644	abstract	35083314
decreased	O	645	654	abstract	35083314
microbial	O	655	664	abstract	35083314
diversity	O	665	674	abstract	35083314
in	O	675	677	abstract	35083314
older	B-human	678	683	abstract	35083314
subjects	I-human	684	692	abstract	35083314
,	O	692	693	abstract	35083314
driven	O	694	700	abstract	35083314
by	O	701	703	abstract	35083314
increased	O	704	713	abstract	35083314
relative	O	714	722	abstract	35083314
abundance	O	723	732	abstract	35083314
of	O	733	735	abstract	35083314
phylum	B-bacteria	736	742	abstract	35083314
Proteobacteria	I-bacteria	743	757	abstract	35083314
,	O	757	758	abstract	35083314
particularly	O	759	771	abstract	35083314
family	O	772	778	abstract	35083314
Enterobacteriaceae	B-bacteria	779	797	abstract	35083314
and	O	798	801	abstract	35083314
coliform	B-bacteria	802	810	abstract	35083314
genera	I-bacteria	811	817	abstract	35083314
<	O	818	819	abstract	35083314
i	O	819	820	abstract	35083314
>	O	820	821	abstract	35083314
Escherichia</i	B-bacteria	821	835	abstract	35083314
>	O	835	836	abstract	35083314
and	O	837	840	abstract	35083314
<	O	841	842	abstract	35083314
i	O	842	843	abstract	35083314
>	O	843	844	abstract	35083314
Klebsiella.</i	B-bacteria	844	858	abstract	35083314
>	O	858	859	abstract	35083314
Moreover	O	860	868	abstract	35083314
,	O	868	869	abstract	35083314
while	O	870	875	abstract	35083314
this	O	876	880	abstract	35083314
decreased	O	881	890	abstract	35083314
diversity	O	891	900	abstract	35083314
was	O	901	904	abstract	35083314
associated	O	905	915	abstract	35083314
with	O	916	920	abstract	35083314
the	O	921	924	abstract	35083314
'	O	925	926	abstract	35083314
ageing	O	926	932	abstract	35083314
process	O	933	940	abstract	35083314
'	O	940	941	abstract	35083314
(	O	942	943	abstract	35083314
comprising	O	943	953	abstract	35083314
chronologic	O	954	965	abstract	35083314
age	O	966	969	abstract	35083314
,	O	969	970	abstract	35083314
number	O	971	977	abstract	35083314
of	O	978	980	abstract	35083314
medications	O	981	992	abstract	35083314
,	O	992	993	abstract	35083314
and	O	994	997	abstract	35083314
number	O	998	1004	abstract	35083314
of	O	1005	1007	abstract	35083314
concomitant	O	1008	1019	abstract	35083314
diseases	O	1020	1028	abstract	35083314
)	O	1028	1029	abstract	35083314
,	O	1029	1030	abstract	35083314
changes	O	1031	1038	abstract	35083314
in	O	1039	1041	abstract	35083314
certain	O	1042	1049	abstract	35083314
taxa	O	1050	1054	abstract	35083314
were	O	1055	1059	abstract	35083314
found	O	1060	1065	abstract	35083314
to	O	1066	1068	abstract	35083314
be	O	1069	1071	abstract	35083314
associated	O	1072	1082	abstract	35083314
with	O	1083	1087	abstract	35083314
number	O	1088	1094	abstract	35083314
of	O	1095	1097	abstract	35083314
medications	O	1098	1109	abstract	35083314
alone	O	1110	1115	abstract	35083314
(	O	1116	1117	abstract	35083314
<	O	1117	1118	abstract	35083314
i	O	1118	1119	abstract	35083314
>	O	1119	1120	abstract	35083314
Klebsiella</i	B-bacteria	1120	1133	abstract	35083314
>	O	1133	1134	abstract	35083314
)	O	1134	1135	abstract	35083314
,	O	1135	1136	abstract	35083314
number	O	1137	1143	abstract	35083314
of	O	1144	1146	abstract	35083314
diseases	O	1147	1155	abstract	35083314
alone	O	1156	1161	abstract	35083314
(	O	1162	1163	abstract	35083314
<	O	1163	1164	abstract	35083314
i	O	1164	1165	abstract	35083314
>	O	1165	1166	abstract	35083314
Clostridium	B-bacteria	1166	1177	abstract	35083314
,	O	1177	1178	abstract	35083314
Bilophila</i	B-bacteria	1179	1191	abstract	35083314
>	O	1191	1192	abstract	35083314
)	O	1192	1193	abstract	35083314
,	O	1193	1194	abstract	35083314
or	O	1195	1197	abstract	35083314
chronologic	O	1198	1209	abstract	35083314
age	O	1210	1213	abstract	35083314
alone	O	1214	1219	abstract	35083314
(	O	1220	1221	abstract	35083314
<	O	1221	1222	abstract	35083314
i	O	1222	1223	abstract	35083314
>	O	1223	1224	abstract	35083314
Escherichia</i	B-bacteria	1224	1238	abstract	35083314
>	O	1238	1239	abstract	35083314
,	O	1239	1240	abstract	35083314
<	O	1241	1242	abstract	35083314
i	O	1242	1243	abstract	35083314
>	O	1243	1244	abstract	35083314
Lactobacillus	B-bacteria	1244	1257	abstract	35083314
,	O	1257	1258	abstract	35083314
Enterococcus</i	B-bacteria	1259	1274	abstract	35083314
>	O	1274	1275	abstract	35083314
)	O	1275	1276	abstract	35083314
.	O	1276	1277	abstract	35083314

Lastly	O	1278	1284	abstract	35083314
,	O	1284	1285	abstract	35083314
many	O	1286	1290	abstract	35083314
taxa	O	1291	1295	abstract	35083314
associated	O	1296	1306	abstract	35083314
with	O	1307	1311	abstract	35083314
increasing	O	1312	1322	abstract	35083314
chronologic	O	1323	1334	abstract	35083314
age	O	1335	1338	abstract	35083314
were	O	1339	1343	abstract	35083314
anaerobes	O	1344	1353	abstract	35083314
.	O	1353	1354	abstract	35083314

These	O	1355	1360	abstract	35083314
changes	O	1361	1368	abstract	35083314
may	O	1369	1372	abstract	35083314
contribute	O	1373	1383	abstract	35083314
to	O	1384	1386	abstract	35083314
changes	O	1387	1394	abstract	35083314
in	O	1395	1397	abstract	35083314
human	O	1398	1403	abstract	35083314
health	O	1404	1410	abstract	35083314
that	O	1411	1415	abstract	35083314
occur	O	1416	1421	abstract	35083314
during	O	1422	1428	abstract	35083314
the	O	1429	1432	abstract	35083314
ageing	O	1433	1439	abstract	35083314
process	O	1440	1447	abstract	35083314
.	O	1447	1448	abstract	35083314

Insights	O	0	8	title	37377497
into	O	9	13	title	37377497
the	O	14	17	title	37377497
potential	O	18	27	title	37377497
benefits	O	28	36	title	37377497
of	O	37	39	title	37377497
triphala	B-dietary%supplement	40	48	title	37377497
polyphenols	I-dietary%supplement	49	60	title	37377497
toward	O	61	67	title	37377497
the	O	68	71	title	37377497
promotion	O	72	81	title	37377497
of	O	82	84	title	37377497
resilience	O	85	95	title	37377497
against	O	96	103	title	37377497
stress-induced	B-DDF	104	118	title	37377497
depression	I-DDF	119	129	title	37377497
and	O	130	133	title	37377497
cognitive	B-DDF	134	143	title	37377497
impairment	I-DDF	144	154	title	37377497
.	O	154	155	title	37377497

In	O	0	2	abstract	37377497
response	O	3	11	abstract	37377497
to	O	12	14	abstract	37377497
environmental	O	15	28	abstract	37377497
challenges	O	29	39	abstract	37377497
,	O	39	40	abstract	37377497
stress	B-DDF	41	47	abstract	37377497
is	O	48	50	abstract	37377497
a	O	51	52	abstract	37377497
common	O	53	59	abstract	37377497
reaction	O	60	68	abstract	37377497
,	O	68	69	abstract	37377497
but	O	70	73	abstract	37377497
dysregulation	O	74	87	abstract	37377497
of	O	88	90	abstract	37377497
the	O	91	94	abstract	37377497
stress	O	95	101	abstract	37377497
response	O	102	110	abstract	37377497
can	O	111	114	abstract	37377497
lead	O	115	119	abstract	37377497
to	O	120	122	abstract	37377497
neuropsychiatric	B-DDF	123	139	abstract	37377497
disorders	I-DDF	140	149	abstract	37377497
,	O	149	150	abstract	37377497
including	O	151	160	abstract	37377497
depression	B-DDF	161	171	abstract	37377497
and	O	172	175	abstract	37377497
cognitive	B-DDF	176	185	abstract	37377497
impairment	I-DDF	186	196	abstract	37377497
.	O	196	197	abstract	37377497

Particularly	O	198	210	abstract	37377497
,	O	210	211	abstract	37377497
there	O	212	217	abstract	37377497
is	O	218	220	abstract	37377497
ample	O	221	226	abstract	37377497
evidence	O	227	235	abstract	37377497
that	O	236	240	abstract	37377497
overexposure	O	241	253	abstract	37377497
to	O	254	256	abstract	37377497
mental	B-DDF	257	263	abstract	37377497
stress	I-DDF	264	270	abstract	37377497
can	O	271	274	abstract	37377497
have	O	275	279	abstract	37377497
lasting	O	280	287	abstract	37377497
detrimental	O	288	299	abstract	37377497
consequences	O	300	312	abstract	37377497
for	O	313	316	abstract	37377497
psychological	O	317	330	abstract	37377497
health	O	331	337	abstract	37377497
,	O	337	338	abstract	37377497
cognitive	O	339	348	abstract	37377497
function	O	349	357	abstract	37377497
,	O	357	358	abstract	37377497
and	O	359	362	abstract	37377497
ultimately	O	363	373	abstract	37377497
well-being	O	374	384	abstract	37377497
.	O	384	385	abstract	37377497

In	O	386	388	abstract	37377497
fact	O	389	393	abstract	37377497
,	O	393	394	abstract	37377497
some	O	395	399	abstract	37377497
individuals	O	400	411	abstract	37377497
are	O	412	415	abstract	37377497
resilient	O	416	425	abstract	37377497
to	O	426	428	abstract	37377497
the	O	429	432	abstract	37377497
same	O	433	437	abstract	37377497
stressor	O	438	446	abstract	37377497
.	O	446	447	abstract	37377497

A	O	448	449	abstract	37377497
major	O	450	455	abstract	37377497
benefit	O	456	463	abstract	37377497
of	O	464	466	abstract	37377497
enhancing	O	467	476	abstract	37377497
stress	O	477	483	abstract	37377497
resilience	O	484	494	abstract	37377497
in	O	495	497	abstract	37377497
at-risk	B-human	498	505	abstract	37377497
groups	I-human	506	512	abstract	37377497
is	O	513	515	abstract	37377497
that	O	516	520	abstract	37377497
it	O	521	523	abstract	37377497
may	O	524	527	abstract	37377497
help	O	528	532	abstract	37377497
prevent	O	533	540	abstract	37377497
the	O	541	544	abstract	37377497
onset	O	545	550	abstract	37377497
of	O	551	553	abstract	37377497
stress-induced	B-DDF	554	568	abstract	37377497
mental	I-DDF	569	575	abstract	37377497
health	I-DDF	576	582	abstract	37377497
problems	I-DDF	583	591	abstract	37377497
.	O	591	592	abstract	37377497

A	O	593	594	abstract	37377497
potential	O	595	604	abstract	37377497
therapeutic	O	605	616	abstract	37377497
strategy	O	617	625	abstract	37377497
for	O	626	629	abstract	37377497
maintaining	O	630	641	abstract	37377497
a	O	642	643	abstract	37377497
healthy	O	644	651	abstract	37377497
life	O	652	656	abstract	37377497
is	O	657	659	abstract	37377497
to	O	660	662	abstract	37377497
address	O	663	670	abstract	37377497
stress-induced	O	671	685	abstract	37377497
health	O	686	692	abstract	37377497
problems	O	693	701	abstract	37377497
with	O	702	706	abstract	37377497
botanicals	O	707	717	abstract	37377497
or	O	718	720	abstract	37377497
dietary	O	721	728	abstract	37377497
supplements	O	729	740	abstract	37377497
such	O	741	745	abstract	37377497
as	O	746	748	abstract	37377497
polyphenols	B-dietary%supplement	749	760	abstract	37377497
.	O	760	761	abstract	37377497

Triphala	B-dietary%supplement	762	770	abstract	37377497
,	O	770	771	abstract	37377497
also	O	772	776	abstract	37377497
known	O	777	782	abstract	37377497
as	O	783	785	abstract	37377497
Zhe	B-dietary%supplement	786	789	abstract	37377497
Busong	I-dietary%supplement	790	796	abstract	37377497
decoction	I-dietary%supplement	797	806	abstract	37377497
in	O	807	809	abstract	37377497
Tibetan	O	810	817	abstract	37377497
,	O	817	818	abstract	37377497
is	O	819	821	abstract	37377497
a	O	822	823	abstract	37377497
well-recognized	O	824	839	abstract	37377497
<	O	840	841	abstract	37377497
i	O	841	842	abstract	37377497
>	O	842	843	abstract	37377497
Ayurvedic</i	O	843	855	abstract	37377497
>	O	855	856	abstract	37377497
polyherbal	O	857	867	abstract	37377497
medicine	O	868	876	abstract	37377497
comprising	O	877	887	abstract	37377497
dried	O	888	893	abstract	37377497
fruits	O	894	900	abstract	37377497
from	O	901	905	abstract	37377497
three	O	906	911	abstract	37377497
different	O	912	921	abstract	37377497
plant	O	922	927	abstract	37377497
species	O	928	935	abstract	37377497
.	O	935	936	abstract	37377497

As	O	937	939	abstract	37377497
a	O	940	941	abstract	37377497
promising	O	942	951	abstract	37377497
food-sourced	O	952	964	abstract	37377497
phytotherapy	O	965	977	abstract	37377497
,	O	977	978	abstract	37377497
triphala	B-dietary%supplement	979	987	abstract	37377497
polyphenols	I-dietary%supplement	988	999	abstract	37377497
have	O	1000	1004	abstract	37377497
been	O	1005	1009	abstract	37377497
used	O	1010	1014	abstract	37377497
throughout	O	1015	1025	abstract	37377497
history	O	1026	1033	abstract	37377497
to	O	1034	1036	abstract	37377497
treat	O	1037	1042	abstract	37377497
a	O	1043	1044	abstract	37377497
variety	O	1045	1052	abstract	37377497
of	O	1053	1055	abstract	37377497
medical	O	1056	1063	abstract	37377497
conditions	O	1064	1074	abstract	37377497
,	O	1074	1075	abstract	37377497
including	O	1076	1085	abstract	37377497
brain	O	1086	1091	abstract	37377497
health	O	1092	1098	abstract	37377497
maintenance	O	1099	1110	abstract	37377497
.	O	1110	1111	abstract	37377497

Nevertheless	O	1112	1124	abstract	37377497
,	O	1124	1125	abstract	37377497
a	O	1126	1127	abstract	37377497
comprehensive	O	1128	1141	abstract	37377497
review	O	1142	1148	abstract	37377497
is	O	1149	1151	abstract	37377497
still	O	1152	1157	abstract	37377497
lacking	O	1158	1165	abstract	37377497
.	O	1165	1166	abstract	37377497

Here	O	1167	1171	abstract	37377497
,	O	1171	1172	abstract	37377497
the	O	1173	1176	abstract	37377497
primary	O	1177	1184	abstract	37377497
objective	O	1185	1194	abstract	37377497
of	O	1195	1197	abstract	37377497
this	O	1198	1202	abstract	37377497
review	O	1203	1209	abstract	37377497
article	O	1210	1217	abstract	37377497
is	O	1218	1220	abstract	37377497
to	O	1221	1223	abstract	37377497
provide	O	1224	1231	abstract	37377497
an	O	1232	1234	abstract	37377497
overview	O	1235	1243	abstract	37377497
of	O	1244	1246	abstract	37377497
the	O	1247	1250	abstract	37377497
classification	O	1251	1265	abstract	37377497
,	O	1265	1266	abstract	37377497
safety	O	1267	1273	abstract	37377497
,	O	1273	1274	abstract	37377497
and	O	1275	1278	abstract	37377497
pharmacokinetics	O	1279	1295	abstract	37377497
of	O	1296	1298	abstract	37377497
triphala	B-dietary%supplement	1299	1307	abstract	37377497
polyphenols	I-dietary%supplement	1308	1319	abstract	37377497
,	O	1319	1320	abstract	37377497
as	O	1321	1323	abstract	37377497
well	O	1324	1328	abstract	37377497
as	O	1329	1331	abstract	37377497
recommendations	O	1332	1347	abstract	37377497
for	O	1348	1351	abstract	37377497
the	O	1352	1355	abstract	37377497
development	O	1356	1367	abstract	37377497
of	O	1368	1370	abstract	37377497
triphala	B-dietary%supplement	1371	1379	abstract	37377497
polyphenols	I-dietary%supplement	1380	1391	abstract	37377497
as	O	1392	1394	abstract	37377497
a	O	1395	1396	abstract	37377497
novel	O	1397	1402	abstract	37377497
therapeutic	O	1403	1414	abstract	37377497
strategy	O	1415	1423	abstract	37377497
for	O	1424	1427	abstract	37377497
promoting	O	1428	1437	abstract	37377497
resilience	O	1438	1448	abstract	37377497
in	O	1449	1451	abstract	37377497
susceptible	O	1452	1463	abstract	37377497
individuals	O	1464	1475	abstract	37377497
.	O	1475	1476	abstract	37377497

Additionally	O	1477	1489	abstract	37377497
,	O	1489	1490	abstract	37377497
we	O	1491	1493	abstract	37377497
summarize	O	1494	1503	abstract	37377497
recent	O	1504	1510	abstract	37377497
advances	O	1511	1519	abstract	37377497
demonstrating	O	1520	1533	abstract	37377497
that	O	1534	1538	abstract	37377497
triphala	B-dietary%supplement	1539	1547	abstract	37377497
polyphenols	I-dietary%supplement	1548	1559	abstract	37377497
are	O	1560	1563	abstract	37377497
beneficial	O	1564	1574	abstract	37377497
to	O	1575	1577	abstract	37377497
cognitive	O	1578	1587	abstract	37377497
and	O	1588	1591	abstract	37377497
psychological	O	1592	1605	abstract	37377497
resilience	O	1606	1616	abstract	37377497
by	O	1617	1619	abstract	37377497
regulating	O	1620	1630	abstract	37377497
5-hydroxytryptamine	B-chemical	1631	1650	abstract	37377497
(	O	1651	1652	abstract	37377497
5-HT	B-chemical	1652	1656	abstract	37377497
)	O	1656	1657	abstract	37377497
and	O	1658	1661	abstract	37377497
brain-derived	B-chemical	1662	1675	abstract	37377497
neurotrophic	I-chemical	1676	1688	abstract	37377497
factor	I-chemical	1689	1695	abstract	37377497
(	O	1696	1697	abstract	37377497
BDNF	B-chemical	1697	1701	abstract	37377497
)	O	1701	1702	abstract	37377497
receptors	O	1703	1712	abstract	37377497
,	O	1712	1713	abstract	37377497
gut	B-microbiome	1714	1717	abstract	37377497
microbiota	I-microbiome	1718	1728	abstract	37377497
,	O	1728	1729	abstract	37377497
and	O	1730	1733	abstract	37377497
antioxidant-related	O	1734	1753	abstract	37377497
signaling	O	1754	1763	abstract	37377497
pathways	O	1764	1772	abstract	37377497
.	O	1772	1773	abstract	37377497

Overall	O	1774	1781	abstract	37377497
,	O	1781	1782	abstract	37377497
scientific	O	1783	1793	abstract	37377497
exploration	O	1794	1805	abstract	37377497
of	O	1806	1808	abstract	37377497
triphala	B-dietary%supplement	1809	1817	abstract	37377497
polyphenols	I-dietary%supplement	1818	1829	abstract	37377497
is	O	1830	1832	abstract	37377497
warranted	O	1833	1842	abstract	37377497
to	O	1843	1845	abstract	37377497
understand	O	1846	1856	abstract	37377497
their	O	1857	1862	abstract	37377497
therapeutic	O	1863	1874	abstract	37377497
efficacy	O	1875	1883	abstract	37377497
.	O	1883	1884	abstract	37377497

In	O	1885	1887	abstract	37377497
addition	O	1888	1896	abstract	37377497
to	O	1897	1899	abstract	37377497
providing	O	1900	1909	abstract	37377497
novel	O	1910	1915	abstract	37377497
insights	O	1916	1924	abstract	37377497
into	O	1925	1929	abstract	37377497
the	O	1930	1933	abstract	37377497
mechanisms	O	1934	1944	abstract	37377497
of	O	1945	1947	abstract	37377497
triphala	B-dietary%supplement	1948	1956	abstract	37377497
polyphenols	I-dietary%supplement	1957	1968	abstract	37377497
for	O	1969	1972	abstract	37377497
promoting	O	1973	1982	abstract	37377497
stress	O	1983	1989	abstract	37377497
resilience	O	1990	2000	abstract	37377497
,	O	2000	2001	abstract	37377497
blood	O	2002	2007	abstract	37377497
brain	O	2008	2013	abstract	37377497
barrier	O	2014	2021	abstract	37377497
(	O	2022	2023	abstract	37377497
BBB	O	2023	2026	abstract	37377497
)	O	2026	2027	abstract	37377497
permeability	O	2028	2040	abstract	37377497
and	O	2041	2044	abstract	37377497
systemic	O	2045	2053	abstract	37377497
bioavailability	O	2054	2069	abstract	37377497
of	O	2070	2072	abstract	37377497
triphala	B-dietary%supplement	2073	2081	abstract	37377497
polyphenols	I-dietary%supplement	2082	2093	abstract	37377497
also	O	2094	2098	abstract	37377497
need	O	2099	2103	abstract	37377497
to	O	2104	2106	abstract	37377497
be	O	2107	2109	abstract	37377497
improved	O	2110	2118	abstract	37377497
by	O	2119	2121	abstract	37377497
the	O	2122	2125	abstract	37377497
research	O	2126	2134	abstract	37377497
community	O	2135	2144	abstract	37377497
.	O	2144	2145	abstract	37377497

Moreover	O	2146	2154	abstract	37377497
,	O	2154	2155	abstract	37377497
well-designed	O	2156	2169	abstract	37377497
clinical	O	2170	2178	abstract	37377497
trials	O	2179	2185	abstract	37377497
are	O	2186	2189	abstract	37377497
needed	O	2190	2196	abstract	37377497
to	O	2197	2199	abstract	37377497
increase	O	2200	2208	abstract	37377497
the	O	2209	2212	abstract	37377497
scientific	O	2213	2223	abstract	37377497
validity	O	2224	2232	abstract	37377497
of	O	2233	2235	abstract	37377497
triphala	O	2236	2244	abstract	37377497
polyphenols	O	2245	2256	abstract	37377497
'	O	2256	2257	abstract	37377497
beneficial	O	2258	2268	abstract	37377497
effects	O	2269	2276	abstract	37377497
for	O	2277	2280	abstract	37377497
preventing	O	2281	2291	abstract	37377497
and	O	2292	2295	abstract	37377497
treating	O	2296	2304	abstract	37377497
cognitive	B-DDF	2305	2314	abstract	37377497
impairment	I-DDF	2315	2325	abstract	37377497
and	O	2326	2329	abstract	37377497
psychological	B-DDF	2330	2343	abstract	37377497
dysfunction	I-DDF	2344	2355	abstract	37377497
.	O	2355	2356	abstract	37377497

How	O	0	3	title	37207228
Toll-like	B-chemical	4	13	title	37207228
receptors	I-chemical	14	23	title	37207228
influence	O	24	33	title	37207228
Parkinson	B-DDF	34	43	title	37207228
's	I-DDF	43	45	title	37207228
disease	I-DDF	46	53	title	37207228
in	O	54	56	title	37207228
the	O	57	60	title	37207228
microbiome-gut-brain	O	61	81	title	37207228
axis	O	82	86	title	37207228
.	O	86	87	title	37207228

Recently	O	0	8	abstract	37207228
,	O	8	9	abstract	37207228
a	O	10	11	abstract	37207228
large	O	12	17	abstract	37207228
number	O	18	24	abstract	37207228
of	O	25	27	abstract	37207228
experimenters	O	28	41	abstract	37207228
have	O	42	46	abstract	37207228
found	O	47	52	abstract	37207228
that	O	53	57	abstract	37207228
the	O	58	61	abstract	37207228
pathogenesis	O	62	74	abstract	37207228
of	O	75	77	abstract	37207228
Parkinson	B-DDF	78	87	abstract	37207228
's	I-DDF	87	89	abstract	37207228
disease	I-DDF	90	97	abstract	37207228
may	O	98	101	abstract	37207228
be	O	102	104	abstract	37207228
related	O	105	112	abstract	37207228
to	O	113	115	abstract	37207228
the	O	116	119	abstract	37207228
gut	B-microbiome	120	123	abstract	37207228
microbiome	I-microbiome	124	134	abstract	37207228
and	O	135	138	abstract	37207228
proposed	O	139	147	abstract	37207228
the	O	148	151	abstract	37207228
microbiome-gut-brain	O	152	172	abstract	37207228
axis	O	173	177	abstract	37207228
.	O	177	178	abstract	37207228

Studies	O	179	186	abstract	37207228
have	O	187	191	abstract	37207228
shown	O	192	197	abstract	37207228
that	O	198	202	abstract	37207228
Toll-like	B-chemical	203	212	abstract	37207228
receptors	I-chemical	213	222	abstract	37207228
,	O	222	223	abstract	37207228
especially	O	224	234	abstract	37207228
Toll-like	B-chemical	235	244	abstract	37207228
receptor	I-chemical	245	253	abstract	37207228
2	I-chemical	254	255	abstract	37207228
(	O	256	257	abstract	37207228
TLR2	B-chemical	257	261	abstract	37207228
)	O	261	262	abstract	37207228
and	O	263	266	abstract	37207228
Toll-like	B-chemical	267	276	abstract	37207228
receptor	I-chemical	277	285	abstract	37207228
4	I-chemical	286	287	abstract	37207228
(	O	288	289	abstract	37207228
TLR4	B-chemical	289	293	abstract	37207228
)	O	293	294	abstract	37207228
,	O	294	295	abstract	37207228
are	O	296	299	abstract	37207228
key	O	300	303	abstract	37207228
mediators	O	304	313	abstract	37207228
of	O	314	316	abstract	37207228
gut	O	317	320	abstract	37207228
homeostasis	O	321	332	abstract	37207228
.	O	332	333	abstract	37207228

In	O	334	336	abstract	37207228
addition	O	337	345	abstract	37207228
to	O	346	348	abstract	37207228
their	O	349	354	abstract	37207228
established	O	355	366	abstract	37207228
role	O	367	371	abstract	37207228
in	O	372	374	abstract	37207228
innate	O	375	381	abstract	37207228
immunity	O	382	390	abstract	37207228
throughout	O	391	401	abstract	37207228
the	O	402	405	abstract	37207228
body	O	406	410	abstract	37207228
,	O	410	411	abstract	37207228
research	O	412	420	abstract	37207228
is	O	421	423	abstract	37207228
increasingly	O	424	436	abstract	37207228
showing	O	437	444	abstract	37207228
that	O	445	449	abstract	37207228
the	O	450	453	abstract	37207228
Toll-like	O	454	463	abstract	37207228
receptor	O	464	472	abstract	37207228
2	O	473	474	abstract	37207228
and	O	475	478	abstract	37207228
Toll-like	O	479	488	abstract	37207228
receptor	O	489	497	abstract	37207228
4	O	498	499	abstract	37207228
signaling	O	500	509	abstract	37207228
pathways	O	510	518	abstract	37207228
shape	O	519	524	abstract	37207228
the	O	525	528	abstract	37207228
development	O	529	540	abstract	37207228
and	O	541	544	abstract	37207228
function	O	545	553	abstract	37207228
of	O	554	556	abstract	37207228
the	O	557	560	abstract	37207228
gut	B-anatomical%location	561	564	abstract	37207228
and	O	565	568	abstract	37207228
enteric	B-anatomical%location	569	576	abstract	37207228
nervous	I-anatomical%location	577	584	abstract	37207228
system	I-anatomical%location	585	591	abstract	37207228
.	O	591	592	abstract	37207228

Notably	O	593	600	abstract	37207228
,	O	600	601	abstract	37207228
Toll-like	B-chemical	602	611	abstract	37207228
receptor	I-chemical	612	620	abstract	37207228
2	I-chemical	621	622	abstract	37207228
and	O	623	626	abstract	37207228
Toll-like	B-chemical	627	636	abstract	37207228
receptor	I-chemical	637	645	abstract	37207228
4	I-chemical	646	647	abstract	37207228
are	O	648	651	abstract	37207228
dysregulated	O	652	664	abstract	37207228
in	O	665	667	abstract	37207228
Parkinson	B-human	668	677	abstract	37207228
's	I-human	677	679	abstract	37207228
disease	I-human	680	687	abstract	37207228
patients	I-human	688	696	abstract	37207228
and	O	697	700	abstract	37207228
may	O	701	704	abstract	37207228
therefore	O	705	714	abstract	37207228
be	O	715	717	abstract	37207228
identified	O	718	728	abstract	37207228
as	O	729	731	abstract	37207228
the	O	732	735	abstract	37207228
core	O	736	740	abstract	37207228
of	O	741	743	abstract	37207228
early	O	744	749	abstract	37207228
gut	B-DDF	750	753	abstract	37207228
dysfunction	I-DDF	754	765	abstract	37207228
in	O	766	768	abstract	37207228
Parkinson	B-DDF	769	778	abstract	37207228
's	I-DDF	778	780	abstract	37207228
disease	I-DDF	781	788	abstract	37207228
.	O	788	789	abstract	37207228

To	O	790	792	abstract	37207228
better	O	793	799	abstract	37207228
understand	O	800	810	abstract	37207228
the	O	811	814	abstract	37207228
contribution	O	815	827	abstract	37207228
of	O	828	830	abstract	37207228
Toll-like	B-DDF	831	840	abstract	37207228
receptor	I-DDF	841	849	abstract	37207228
2	I-DDF	850	851	abstract	37207228
and	I-DDF	852	855	abstract	37207228
Toll-like	I-DDF	856	865	abstract	37207228
receptor	I-DDF	866	874	abstract	37207228
4	I-DDF	875	876	abstract	37207228
dysfunction	I-DDF	877	888	abstract	37207228
in	O	889	891	abstract	37207228
the	O	892	895	abstract	37207228
gut	B-anatomical%location	896	899	abstract	37207228
to	O	900	902	abstract	37207228
early	O	903	908	abstract	37207228
-synuclein	O	909	920	abstract	37207228
aggregation	O	921	932	abstract	37207228
,	O	932	933	abstract	37207228
we	O	934	936	abstract	37207228
discussed	O	937	946	abstract	37207228
the	O	947	950	abstract	37207228
structural	O	951	961	abstract	37207228
function	O	962	970	abstract	37207228
of	O	971	973	abstract	37207228
Toll-like	B-chemical	974	983	abstract	37207228
receptor	I-chemical	984	992	abstract	37207228
2	I-chemical	993	994	abstract	37207228
and	O	995	998	abstract	37207228
Toll-like	B-chemical	999	1008	abstract	37207228
receptor	I-chemical	1009	1017	abstract	37207228
4	I-chemical	1018	1019	abstract	37207228
and	O	1020	1023	abstract	37207228
signal	O	1024	1030	abstract	37207228
transduction	O	1031	1043	abstract	37207228
of	O	1044	1046	abstract	37207228
Toll-like	B-chemical	1047	1056	abstract	37207228
receptor	I-chemical	1057	1065	abstract	37207228
2	I-chemical	1066	1067	abstract	37207228
and	O	1068	1071	abstract	37207228
Toll-like	B-chemical	1072	1081	abstract	37207228
receptor	I-chemical	1082	1090	abstract	37207228
4	I-chemical	1091	1092	abstract	37207228
in	O	1093	1095	abstract	37207228
Parkinson	B-DDF	1096	1105	abstract	37207228
's	I-DDF	1105	1107	abstract	37207228
disease	I-DDF	1108	1115	abstract	37207228
by	O	1116	1118	abstract	37207228
reviewing	O	1119	1128	abstract	37207228
clinical	O	1129	1137	abstract	37207228
,	O	1137	1138	abstract	37207228
animal	O	1139	1145	abstract	37207228
models	O	1146	1152	abstract	37207228
,	O	1152	1153	abstract	37207228
and	O	1154	1157	abstract	37207228
<	O	1158	1159	abstract	37207228
i	O	1159	1160	abstract	37207228
>	O	1160	1161	abstract	37207228
in	O	1161	1163	abstract	37207228
vitro</i	O	1164	1172	abstract	37207228
>	O	1172	1173	abstract	37207228
studies	O	1174	1181	abstract	37207228
.	O	1181	1182	abstract	37207228

We	O	1183	1185	abstract	37207228
also	O	1186	1190	abstract	37207228
present	O	1191	1198	abstract	37207228
a	O	1199	1200	abstract	37207228
conceptual	O	1201	1211	abstract	37207228
model	O	1212	1217	abstract	37207228
of	O	1218	1220	abstract	37207228
the	O	1221	1224	abstract	37207228
pathogenesis	O	1225	1237	abstract	37207228
of	O	1238	1240	abstract	37207228
Parkinson	B-DDF	1241	1250	abstract	37207228
's	I-DDF	1250	1252	abstract	37207228
disease	I-DDF	1253	1260	abstract	37207228
,	O	1260	1261	abstract	37207228
in	O	1262	1264	abstract	37207228
which	O	1265	1270	abstract	37207228
microbial	B-DDF	1271	1280	abstract	37207228
dysbiosis	I-DDF	1281	1290	abstract	37207228
alters	O	1291	1297	abstract	37207228
the	O	1298	1301	abstract	37207228
gut	B-anatomical%location	1302	1305	abstract	37207228
barrier	I-anatomical%location	1306	1313	abstract	37207228
as	O	1314	1316	abstract	37207228
well	O	1317	1321	abstract	37207228
as	O	1322	1324	abstract	37207228
the	O	1325	1328	abstract	37207228
Toll-like	O	1329	1338	abstract	37207228
receptor	O	1339	1347	abstract	37207228
2	O	1348	1349	abstract	37207228
and	O	1350	1353	abstract	37207228
Toll-like	O	1354	1363	abstract	37207228
receptor	O	1364	1372	abstract	37207228
4	O	1373	1374	abstract	37207228
signaling	O	1375	1384	abstract	37207228
pathways	O	1385	1393	abstract	37207228
,	O	1393	1394	abstract	37207228
ultimately	O	1395	1405	abstract	37207228
leading	O	1406	1413	abstract	37207228
to	O	1414	1416	abstract	37207228
a	O	1417	1418	abstract	37207228
positive	O	1419	1427	abstract	37207228
feedback	O	1428	1436	abstract	37207228
loop	O	1437	1441	abstract	37207228
for	O	1442	1445	abstract	37207228
chronic	B-DDF	1446	1453	abstract	37207228
gut	I-DDF	1454	1457	abstract	37207228
dysfunction	I-DDF	1458	1469	abstract	37207228
,	O	1469	1470	abstract	37207228
promoting	O	1471	1480	abstract	37207228
-synuclein	O	1481	1492	abstract	37207228
aggregation	O	1493	1504	abstract	37207228
in	O	1505	1507	abstract	37207228
the	O	1508	1511	abstract	37207228
gut	B-anatomical%location	1512	1515	abstract	37207228
and	O	1516	1519	abstract	37207228
vagus	B-anatomical%location	1520	1525	abstract	37207228
nerve	I-anatomical%location	1526	1531	abstract	37207228
.	O	1531	1532	abstract	37207228

The	O	0	3	title	38707924
influence	O	4	13	title	38707924
of	O	14	16	title	38707924
the	O	17	20	title	38707924
gut-brain	O	21	30	title	38707924
axis	O	31	35	title	38707924
on	O	36	38	title	38707924
anxiety	B-DDF	39	46	title	38707924
and	O	47	50	title	38707924
depression	B-DDF	51	61	title	38707924
:	O	61	62	title	38707924
A	O	63	64	title	38707924
review	O	65	71	title	38707924
of	O	72	74	title	38707924
the	O	75	78	title	38707924
literature	O	79	89	title	38707924
on	O	90	92	title	38707924
the	O	93	96	title	38707924
use	O	97	100	title	38707924
of	O	101	103	title	38707924
probiotics	B-dietary%supplement	104	114	title	38707924
.	O	114	115	title	38707924

This	O	0	4	abstract	38707924
review	O	5	11	abstract	38707924
aims	O	12	16	abstract	38707924
to	O	17	19	abstract	38707924
argue	O	20	25	abstract	38707924
how	O	26	29	abstract	38707924
using	O	30	35	abstract	38707924
probiotics	B-dietary%supplement	36	46	abstract	38707924
can	O	47	50	abstract	38707924
improve	O	51	58	abstract	38707924
anxiety	B-DDF	59	66	abstract	38707924
and	O	67	70	abstract	38707924
depressive	B-DDF	71	81	abstract	38707924
behaviour	I-DDF	82	91	abstract	38707924
without	O	92	99	abstract	38707924
adverse	O	100	107	abstract	38707924
effects	O	108	115	abstract	38707924
,	O	115	116	abstract	38707924
also	O	117	121	abstract	38707924
exploring	O	122	131	abstract	38707924
the	O	132	135	abstract	38707924
impact	O	136	142	abstract	38707924
of	O	143	145	abstract	38707924
postbiotics	B-dietary%supplement	146	157	abstract	38707924
on	O	158	160	abstract	38707924
it	O	161	163	abstract	38707924
.	O	163	164	abstract	38707924

Specifically	O	165	177	abstract	38707924
,	O	177	178	abstract	38707924
probiotics	B-dietary%supplement	179	189	abstract	38707924
have	O	190	194	abstract	38707924
drawn	O	195	200	abstract	38707924
more	O	201	205	abstract	38707924
attention	O	206	215	abstract	38707924
as	O	216	218	abstract	38707924
effective	O	219	228	abstract	38707924
alternative	O	229	240	abstract	38707924
treatments	O	241	251	abstract	38707924
,	O	251	252	abstract	38707924
considering	O	253	264	abstract	38707924
the	O	265	268	abstract	38707924
rising	O	269	275	abstract	38707924
cost	O	276	280	abstract	38707924
of	O	281	283	abstract	38707924
antidepressant	B-drug	284	298	abstract	38707924
and	O	299	302	abstract	38707924
anti-anxiety	B-drug	303	315	abstract	38707924
drugs	I-drug	316	321	abstract	38707924
and	O	322	325	abstract	38707924
the	O	326	329	abstract	38707924
high	O	330	334	abstract	38707924
risk	O	335	339	abstract	38707924
of	O	340	342	abstract	38707924
side	O	343	347	abstract	38707924
effects	O	348	355	abstract	38707924
.	O	355	356	abstract	38707924

Depression	B-DDF	357	367	abstract	38707924
and	O	368	371	abstract	38707924
anxiety	B-DDF	372	379	abstract	38707924
disorders	I-DDF	380	389	abstract	38707924
are	O	390	393	abstract	38707924
among	O	394	399	abstract	38707924
the	O	400	403	abstract	38707924
most	O	404	408	abstract	38707924
common	O	409	415	abstract	38707924
mental	B-DDF	416	422	abstract	38707924
illnesses	I-DDF	423	432	abstract	38707924
in	O	433	435	abstract	38707924
the	O	436	439	abstract	38707924
world	O	440	445	abstract	38707924
's	O	445	447	abstract	38707924
population	O	448	458	abstract	38707924
,	O	458	459	abstract	38707924
characterised	O	460	473	abstract	38707924
by	O	474	476	abstract	38707924
low	O	477	480	abstract	38707924
mood	O	481	485	abstract	38707924
,	O	485	486	abstract	38707924
poor	O	487	491	abstract	38707924
general	O	492	499	abstract	38707924
interest	O	500	508	abstract	38707924
,	O	508	509	abstract	38707924
and	O	510	513	abstract	38707924
cognitive	B-DDF	514	523	abstract	38707924
or	I-DDF	524	526	abstract	38707924
motor	I-DDF	527	532	abstract	38707924
dysfunction	I-DDF	533	544	abstract	38707924
.	O	544	545	abstract	38707924

Thus	O	546	550	abstract	38707924
,	O	550	551	abstract	38707924
this	O	552	556	abstract	38707924
study	O	557	562	abstract	38707924
analysed	O	563	571	abstract	38707924
published	O	572	581	abstract	38707924
literature	O	582	592	abstract	38707924
on	O	593	595	abstract	38707924
anxiety	B-DDF	596	603	abstract	38707924
,	O	603	604	abstract	38707924
depression	B-DDF	605	615	abstract	38707924
,	O	615	616	abstract	38707924
and	O	617	620	abstract	38707924
probiotic	B-dietary%supplement	621	630	abstract	38707924
supplementation	I-dietary%supplement	631	646	abstract	38707924
from	O	647	651	abstract	38707924
PubMed	O	652	658	abstract	38707924
and	O	659	662	abstract	38707924
Scopus	O	663	669	abstract	38707924
,	O	669	670	abstract	38707924
focusing	O	671	679	abstract	38707924
on	O	680	682	abstract	38707924
the	O	683	686	abstract	38707924
last	O	687	691	abstract	38707924
twenty	O	692	698	abstract	38707924
years	O	699	704	abstract	38707924
.	O	704	705	abstract	38707924

This	O	706	710	abstract	38707924
study	O	711	716	abstract	38707924
focused	O	717	724	abstract	38707924
on	O	725	727	abstract	38707924
the	O	728	731	abstract	38707924
effect	O	732	738	abstract	38707924
of	O	739	741	abstract	38707924
probiotics	B-dietary%supplement	742	752	abstract	38707924
on	O	753	755	abstract	38707924
mental	B-DDF	756	762	abstract	38707924
health	I-DDF	763	769	abstract	38707924
as	O	770	772	abstract	38707924
they	O	773	777	abstract	38707924
have	O	778	782	abstract	38707924
drawn	O	783	788	abstract	38707924
more	O	789	793	abstract	38707924
attention	O	794	803	abstract	38707924
because	O	804	811	abstract	38707924
of	O	812	814	abstract	38707924
their	O	815	820	abstract	38707924
extensive	O	821	830	abstract	38707924
clinical	O	831	839	abstract	38707924
applications	O	840	852	abstract	38707924
and	O	853	856	abstract	38707924
positive	O	857	865	abstract	38707924
impact	O	866	872	abstract	38707924
on	O	873	875	abstract	38707924
various	O	876	883	abstract	38707924
diseases	O	884	892	abstract	38707924
.	O	892	893	abstract	38707924

Numerous	O	894	902	abstract	38707924
studies	O	903	910	abstract	38707924
have	O	911	915	abstract	38707924
demonstrated	O	916	928	abstract	38707924
how	O	929	932	abstract	38707924
the	O	933	936	abstract	38707924
gut	B-microbiome	937	940	abstract	38707924
microbiota	I-microbiome	941	951	abstract	38707924
might	O	952	957	abstract	38707924
be	O	958	960	abstract	38707924
critical	O	961	969	abstract	38707924
for	O	970	973	abstract	38707924
mood	O	974	978	abstract	38707924
regulation	O	979	989	abstract	38707924
and	O	990	993	abstract	38707924
how	O	994	997	abstract	38707924
probiotics	B-dietary%supplement	998	1008	abstract	38707924
can	O	1009	1012	abstract	38707924
affect	O	1013	1019	abstract	38707924
host	O	1020	1024	abstract	38707924
health	O	1025	1031	abstract	38707924
by	O	1032	1034	abstract	38707924
regulating	O	1035	1045	abstract	38707924
the	O	1046	1049	abstract	38707924
gut-brain	O	1050	1059	abstract	38707924
axis	O	1060	1064	abstract	38707924
.	O	1064	1065	abstract	38707924

By	O	1066	1068	abstract	38707924
comparing	O	1069	1078	abstract	38707924
the	O	1079	1082	abstract	38707924
different	O	1083	1092	abstract	38707924
works	O	1093	1098	abstract	38707924
analysed	O	1099	1107	abstract	38707924
,	O	1107	1108	abstract	38707924
it	O	1109	1111	abstract	38707924
was	O	1112	1115	abstract	38707924
possible	O	1116	1124	abstract	38707924
to	O	1125	1127	abstract	38707924
identify	O	1128	1136	abstract	38707924
a	O	1137	1138	abstract	38707924
strategy	O	1139	1147	abstract	38707924
by	O	1148	1150	abstract	38707924
which	O	1151	1156	abstract	38707924
they	O	1157	1161	abstract	38707924
are	O	1162	1165	abstract	38707924
selected	O	1166	1174	abstract	38707924
and	O	1175	1178	abstract	38707924
employed	O	1179	1187	abstract	38707924
and	O	1188	1191	abstract	38707924
,	O	1191	1192	abstract	38707924
at	O	1193	1195	abstract	38707924
the	O	1196	1199	abstract	38707924
same	O	1200	1204	abstract	38707924
time	O	1205	1209	abstract	38707924
,	O	1209	1210	abstract	38707924
to	O	1211	1213	abstract	38707924
assess	O	1214	1220	abstract	38707924
how	O	1221	1224	abstract	38707924
the	O	1225	1228	abstract	38707924
effect	O	1229	1235	abstract	38707924
of	O	1236	1238	abstract	38707924
probiotics	B-dietary%supplement	1239	1249	abstract	38707924
can	O	1250	1253	abstract	38707924
be	O	1254	1256	abstract	38707924
optimised	O	1257	1266	abstract	38707924
using	O	1267	1272	abstract	38707924
postbiotics	B-dietary%supplement	1273	1284	abstract	38707924
,	O	1284	1285	abstract	38707924
an	O	1286	1288	abstract	38707924
innovation	O	1289	1299	abstract	38707924
to	O	1300	1302	abstract	38707924
improve	O	1303	1310	abstract	38707924
mental	O	1311	1317	abstract	38707924
well-being	O	1318	1328	abstract	38707924
in	O	1329	1331	abstract	38707924
humans	B-human	1332	1338	abstract	38707924
.	O	1338	1339	abstract	38707924

Possible	O	0	8	title	30584306
association	O	9	20	title	30584306
of	O	21	23	title	30584306
Firmicutes	B-bacteria	24	34	title	30584306
in	O	35	37	title	30584306
the	O	38	41	title	30584306
gut	B-microbiome	42	45	title	30584306
microbiota	I-microbiome	46	56	title	30584306
of	O	57	59	title	30584306
patients	B-human	60	68	title	30584306
with	O	69	73	title	30584306
major	B-DDF	74	79	title	30584306
depressive	I-DDF	80	90	title	30584306
disorder	I-DDF	91	99	title	30584306
.	O	99	100	title	30584306

Gut	B-microbiome	0	3	abstract	30584306
microbiota	I-microbiome	4	14	abstract	30584306
can	O	15	18	abstract	30584306
affect	O	19	25	abstract	30584306
human	O	26	31	abstract	30584306
behavior	O	32	40	abstract	30584306
and	O	41	44	abstract	30584306
mood	O	45	49	abstract	30584306
in	O	50	52	abstract	30584306
many	O	53	57	abstract	30584306
ways	O	58	62	abstract	30584306
.	O	62	63	abstract	30584306

Several	O	64	71	abstract	30584306
studies	O	72	79	abstract	30584306
have	O	80	84	abstract	30584306
shown	O	85	90	abstract	30584306
that	O	91	95	abstract	30584306
patients	B-human	96	104	abstract	30584306
with	O	105	109	abstract	30584306
depression	B-DDF	110	120	abstract	30584306
were	O	121	125	abstract	30584306
also	O	126	130	abstract	30584306
accompanied	O	131	142	abstract	30584306
with	O	143	147	abstract	30584306
gut	B-DDF	148	151	abstract	30584306
microbiota	I-DDF	152	162	abstract	30584306
disorder	I-DDF	163	171	abstract	30584306
,	O	171	172	abstract	30584306
in	O	173	175	abstract	30584306
which	O	176	181	abstract	30584306
Firmicutes	B-bacteria	182	192	abstract	30584306
are	O	193	196	abstract	30584306
related	O	197	204	abstract	30584306
to	O	205	207	abstract	30584306
the	O	208	211	abstract	30584306
protective	O	212	222	abstract	30584306
function	O	223	231	abstract	30584306
of	O	232	234	abstract	30584306
intestinal	B-microbiome	235	245	abstract	30584306
barrier	I-microbiome	246	253	abstract	30584306
.	O	253	254	abstract	30584306

In	O	255	257	abstract	30584306
this	O	258	262	abstract	30584306
study	O	263	268	abstract	30584306
,	O	268	269	abstract	30584306
we	O	270	272	abstract	30584306
explore	O	273	280	abstract	30584306
the	O	281	284	abstract	30584306
changes	O	285	292	abstract	30584306
and	O	293	296	abstract	30584306
effects	O	297	304	abstract	30584306
of	O	305	307	abstract	30584306
Firmicutes	B-bacteria	308	318	abstract	30584306
in	O	319	321	abstract	30584306
the	O	322	325	abstract	30584306
patients	B-human	326	334	abstract	30584306
with	O	335	339	abstract	30584306
major	B-DDF	340	345	abstract	30584306
depressive	I-DDF	346	356	abstract	30584306
disorder	I-DDF	357	365	abstract	30584306
(	O	366	367	abstract	30584306
MDD	B-DDF	367	370	abstract	30584306
)	O	370	371	abstract	30584306
.	O	371	372	abstract	30584306

We	O	373	375	abstract	30584306
recruited	O	376	385	abstract	30584306
54	O	386	388	abstract	30584306
subjects	O	389	397	abstract	30584306
,	O	397	398	abstract	30584306
including	O	399	408	abstract	30584306
27	O	409	411	abstract	30584306
patients	B-human	412	420	abstract	30584306
with	O	421	425	abstract	30584306
MDD	B-DDF	426	429	abstract	30584306
.	O	429	430	abstract	30584306

Fecal	O	431	436	abstract	30584306
samples	O	437	444	abstract	30584306
were	O	445	449	abstract	30584306
collected	O	450	459	abstract	30584306
for	O	460	463	abstract	30584306
identification	O	464	478	abstract	30584306
by	O	479	481	abstract	30584306
16S	B-biomedical%technique	482	485	abstract	30584306
rRNA	I-biomedical%technique	486	490	abstract	30584306
sequencing	I-biomedical%technique	491	501	abstract	30584306
and	O	502	505	abstract	30584306
bioinformatics	B-biomedical%technique	506	520	abstract	30584306
analysis	I-biomedical%technique	521	529	abstract	30584306
.	O	529	530	abstract	30584306

The	O	531	534	abstract	30584306
study	O	535	540	abstract	30584306
shows	O	541	546	abstract	30584306
that	O	547	551	abstract	30584306
the	O	552	555	abstract	30584306
alpha	O	556	561	abstract	30584306
diversity	O	562	571	abstract	30584306
indices	O	572	579	abstract	30584306
of	O	580	582	abstract	30584306
MDD	B-human	583	586	abstract	30584306
patients	I-human	587	595	abstract	30584306
are	O	596	599	abstract	30584306
lower	O	600	605	abstract	30584306
than	O	606	610	abstract	30584306
those	O	611	616	abstract	30584306
of	O	617	619	abstract	30584306
the	O	620	623	abstract	30584306
healthy	B-human	624	631	abstract	30584306
controls	I-human	632	640	abstract	30584306
.	O	640	641	abstract	30584306

Firmicutes	B-bacteria	642	652	abstract	30584306
is	O	653	655	abstract	30584306
the	O	656	659	abstract	30584306
most	O	660	664	abstract	30584306
significantly	O	665	678	abstract	30584306
decreased	O	679	688	abstract	30584306
phylum	O	689	695	abstract	30584306
in	O	696	698	abstract	30584306
the	O	699	702	abstract	30584306
MDD	O	703	706	abstract	30584306
samples	O	707	714	abstract	30584306
.	O	714	715	abstract	30584306

There	O	716	721	abstract	30584306
are	O	722	725	abstract	30584306
totally	O	726	733	abstract	30584306
13	O	734	736	abstract	30584306
taxonomic	O	737	746	abstract	30584306
biomarkers	O	747	757	abstract	30584306
with	O	758	762	abstract	30584306
<	O	763	764	abstract	30584306
i	O	764	765	abstract	30584306
>	O	765	766	abstract	30584306
P</i>-value	O	766	777	abstract	30584306
<	O	778	779	abstract	30584306
0.01	O	779	783	abstract	30584306
from	O	784	788	abstract	30584306
Firmicutes	B-bacteria	789	799	abstract	30584306
.	O	799	800	abstract	30584306

There	O	801	806	abstract	30584306
are	O	807	810	abstract	30584306
differences	O	811	822	abstract	30584306
in	O	823	825	abstract	30584306
17	O	826	828	abstract	30584306
KEGG	O	829	833	abstract	30584306
pathways	O	834	842	abstract	30584306
between	O	843	850	abstract	30584306
the	O	851	854	abstract	30584306
two	O	855	858	abstract	30584306
groups	O	859	865	abstract	30584306
.	O	865	866	abstract	30584306

This	O	867	871	abstract	30584306
study	O	872	877	abstract	30584306
found	O	878	883	abstract	30584306
that	O	884	888	abstract	30584306
there	O	889	894	abstract	30584306
is	O	895	897	abstract	30584306
a	O	898	899	abstract	30584306
significant	O	900	911	abstract	30584306
disorder	O	912	920	abstract	30584306
of	O	921	923	abstract	30584306
gut	B-microbiome	924	927	abstract	30584306
microbiota	I-microbiome	928	938	abstract	30584306
in	O	939	941	abstract	30584306
the	O	942	945	abstract	30584306
patients	B-human	946	954	abstract	30584306
with	O	955	959	abstract	30584306
depression	B-DDF	960	970	abstract	30584306
,	O	970	971	abstract	30584306
in	O	972	974	abstract	30584306
which	O	975	980	abstract	30584306
the	O	981	984	abstract	30584306
Firmicutes	B-bacteria	985	995	abstract	30584306
decreased	O	996	1005	abstract	30584306
significantly	O	1006	1019	abstract	30584306
.	O	1019	1020	abstract	30584306

Defects	O	1021	1028	abstract	30584306
of	O	1029	1031	abstract	30584306
the	O	1032	1035	abstract	30584306
Firmicutes	B-bacteria	1036	1046	abstract	30584306
may	O	1047	1050	abstract	30584306
lead	O	1051	1055	abstract	30584306
to	O	1056	1058	abstract	30584306
the	O	1059	1062	abstract	30584306
depression	O	1063	1073	abstract	30584306
in	O	1074	1076	abstract	30584306
short-chain	B-chemical	1077	1088	abstract	30584306
fatty	I-chemical	1089	1094	abstract	30584306
acids	I-chemical	1095	1100	abstract	30584306
,	O	1100	1101	abstract	30584306
which	O	1102	1107	abstract	30584306
could	O	1108	1113	abstract	30584306
account	O	1114	1121	abstract	30584306
for	O	1122	1125	abstract	30584306
the	O	1126	1129	abstract	30584306
physiological	O	1130	1143	abstract	30584306
basis	O	1144	1149	abstract	30584306
of	O	1150	1152	abstract	30584306
low-level	O	1153	1162	abstract	30584306
inflammation	O	1163	1175	abstract	30584306
of	O	1176	1178	abstract	30584306
depression	B-DDF	1179	1189	abstract	30584306
.	O	1189	1190	abstract	30584306

This	O	1191	1195	abstract	30584306
is	O	1196	1198	abstract	30584306
a	O	1199	1200	abstract	30584306
cross-sectional	O	1201	1216	abstract	30584306
study	O	1217	1222	abstract	30584306
and	O	1223	1226	abstract	30584306
the	O	1227	1230	abstract	30584306
sample	O	1231	1237	abstract	30584306
size	O	1238	1242	abstract	30584306
is	O	1243	1245	abstract	30584306
comparatively	O	1246	1259	abstract	30584306
small	O	1260	1265	abstract	30584306
.	O	1265	1266	abstract	30584306

Though	O	1267	1273	abstract	30584306
several	O	1274	1281	abstract	30584306
diet-related	O	1282	1294	abstract	30584306
factors	O	1295	1302	abstract	30584306
were	O	1303	1307	abstract	30584306
controlled	O	1308	1318	abstract	30584306
in	O	1319	1321	abstract	30584306
the	O	1322	1325	abstract	30584306
study	O	1326	1331	abstract	30584306
,	O	1331	1332	abstract	30584306
there	O	1333	1338	abstract	30584306
is	O	1339	1341	abstract	30584306
no	O	1342	1344	abstract	30584306
quantified	O	1345	1355	abstract	30584306
assessment	O	1356	1366	abstract	30584306
of	O	1367	1369	abstract	30584306
it	O	1370	1372	abstract	30584306
.	O	1372	1373	abstract	30584306

Memorable	O	0	9	title	34422879
Food	O	10	14	title	34422879
:	O	14	15	title	34422879
Fighting	O	16	24	title	34422879
Age-Related	B-DDF	25	36	title	34422879
Neurodegeneration	I-DDF	37	54	title	34422879
by	O	55	57	title	34422879
Precision	O	58	67	title	34422879
Nutrition	O	68	77	title	34422879
.	O	77	78	title	34422879

Healthcare	O	0	10	abstract	34422879
systems	O	11	18	abstract	34422879
worldwide	O	19	28	abstract	34422879
are	O	29	32	abstract	34422879
seriously	O	33	42	abstract	34422879
challenged	O	43	53	abstract	34422879
by	O	54	56	abstract	34422879
a	O	57	58	abstract	34422879
rising	O	59	65	abstract	34422879
prevalence	O	66	76	abstract	34422879
of	O	77	79	abstract	34422879
neurodegenerative	B-DDF	80	97	abstract	34422879
diseases	I-DDF	98	106	abstract	34422879
(	O	107	108	abstract	34422879
NDDs	B-DDF	108	112	abstract	34422879
)	O	112	113	abstract	34422879
,	O	113	114	abstract	34422879
which	O	115	120	abstract	34422879
mostly	O	121	127	abstract	34422879
,	O	127	128	abstract	34422879
but	O	129	132	abstract	34422879
not	O	133	136	abstract	34422879
exclusively	O	137	148	abstract	34422879
,	O	148	149	abstract	34422879
affect	O	150	156	abstract	34422879
the	O	157	160	abstract	34422879
ever-growing	O	161	173	abstract	34422879
population	O	174	184	abstract	34422879
of	O	185	187	abstract	34422879
the	O	188	191	abstract	34422879
elderly	O	192	199	abstract	34422879
.	O	199	200	abstract	34422879

The	O	201	204	abstract	34422879
most	O	205	209	abstract	34422879
known	O	210	215	abstract	34422879
neurodegenerative	B-DDF	216	233	abstract	34422879
diseases	I-DDF	234	242	abstract	34422879
are	O	243	246	abstract	34422879
Alzheimer	B-DDF	247	256	abstract	34422879
's	I-DDF	256	258	abstract	34422879
(	O	259	260	abstract	34422879
AD	B-DDF	260	262	abstract	34422879
)	O	262	263	abstract	34422879
and	O	264	267	abstract	34422879
Parkinson	B-DDF	268	277	abstract	34422879
's	I-DDF	277	279	abstract	34422879
disease	I-DDF	280	287	abstract	34422879
,	O	287	288	abstract	34422879
multiple	B-DDF	289	297	abstract	34422879
sclerosis	I-DDF	298	307	abstract	34422879
,	O	307	308	abstract	34422879
and	O	309	312	abstract	34422879
amyotrophic	B-DDF	313	324	abstract	34422879
lateral	I-DDF	325	332	abstract	34422879
sclerosis	I-DDF	333	342	abstract	34422879
,	O	342	343	abstract	34422879
but	O	344	347	abstract	34422879
some	O	348	352	abstract	34422879
viral	O	353	358	abstract	34422879
infections	O	359	369	abstract	34422879
of	O	370	372	abstract	34422879
the	O	373	376	abstract	34422879
brain	O	377	382	abstract	34422879
and	O	383	386	abstract	34422879
traumatic	B-DDF	387	396	abstract	34422879
brain	I-DDF	397	402	abstract	34422879
injury	I-DDF	403	409	abstract	34422879
may	O	410	413	abstract	34422879
also	O	414	418	abstract	34422879
cause	O	419	424	abstract	34422879
NDD	B-DDF	425	428	abstract	34422879
.	O	428	429	abstract	34422879

Typical	O	430	437	abstract	34422879
for	O	438	441	abstract	34422879
NDD	B-DDF	442	445	abstract	34422879
are	O	446	449	abstract	34422879
the	O	450	453	abstract	34422879
malfunctioning	B-DDF	454	468	abstract	34422879
of	I-DDF	469	471	abstract	34422879
neurons	I-DDF	472	479	abstract	34422879
and	O	480	483	abstract	34422879
their	O	484	489	abstract	34422879
irreversible	O	490	502	abstract	34422879
loss	O	503	507	abstract	34422879
,	O	507	508	abstract	34422879
which	O	509	514	abstract	34422879
often	O	515	520	abstract	34422879
progress	O	521	529	abstract	34422879
irreversibly	O	530	542	abstract	34422879
to	O	543	545	abstract	34422879
dementia	B-DDF	546	554	abstract	34422879
and	O	555	558	abstract	34422879
ultimately	O	559	569	abstract	34422879
to	O	570	572	abstract	34422879
death	B-DDF	573	578	abstract	34422879
.	O	578	579	abstract	34422879

Numerous	O	580	588	abstract	34422879
factors	O	589	596	abstract	34422879
are	O	597	600	abstract	34422879
involved	O	601	609	abstract	34422879
in	O	610	612	abstract	34422879
the	O	613	616	abstract	34422879
pathogenesis	O	617	629	abstract	34422879
of	O	630	632	abstract	34422879
NDD	B-DDF	633	636	abstract	34422879
:	O	636	637	abstract	34422879
genetic	O	638	645	abstract	34422879
variability	O	646	657	abstract	34422879
,	O	657	658	abstract	34422879
epigenetic	O	659	669	abstract	34422879
changes	O	670	677	abstract	34422879
,	O	677	678	abstract	34422879
extent	O	679	685	abstract	34422879
of	O	686	688	abstract	34422879
oxidative/nitrosative	O	689	710	abstract	34422879
stress	O	711	717	abstract	34422879
,	O	717	718	abstract	34422879
mitochondrial	B-DDF	719	732	abstract	34422879
dysfunction	I-DDF	733	744	abstract	34422879
,	O	744	745	abstract	34422879
and	O	746	749	abstract	34422879
DNA	O	750	753	abstract	34422879
damage	O	754	760	abstract	34422879
.	O	760	761	abstract	34422879

The	O	762	765	abstract	34422879
complex	O	766	773	abstract	34422879
interplay	O	774	783	abstract	34422879
of	O	784	786	abstract	34422879
all	O	787	790	abstract	34422879
the	O	791	794	abstract	34422879
above-mentioned	O	795	810	abstract	34422879
factors	O	811	818	abstract	34422879
may	O	819	822	abstract	34422879
be	O	823	825	abstract	34422879
a	O	826	827	abstract	34422879
fingerprint	O	828	839	abstract	34422879
of	O	840	842	abstract	34422879
neurodegeneration	O	843	860	abstract	34422879
,	O	860	861	abstract	34422879
with	O	862	866	abstract	34422879
different	O	867	876	abstract	34422879
diseases	O	877	885	abstract	34422879
being	O	886	891	abstract	34422879
affected	O	892	900	abstract	34422879
to	O	901	903	abstract	34422879
different	O	904	913	abstract	34422879
extents	O	914	921	abstract	34422879
by	O	922	924	abstract	34422879
particular	O	925	935	abstract	34422879
factors	O	936	943	abstract	34422879
.	O	943	944	abstract	34422879

There	O	945	950	abstract	34422879
is	O	951	953	abstract	34422879
a	O	954	955	abstract	34422879
voluminous	O	956	966	abstract	34422879
body	O	967	971	abstract	34422879
of	O	972	974	abstract	34422879
evidence	O	975	983	abstract	34422879
showing	O	984	991	abstract	34422879
the	O	992	995	abstract	34422879
benefits	O	996	1004	abstract	34422879
of	O	1005	1007	abstract	34422879
regular	O	1008	1015	abstract	34422879
exercise	O	1016	1024	abstract	34422879
to	O	1025	1027	abstract	34422879
brain	O	1028	1033	abstract	34422879
health	O	1034	1040	abstract	34422879
and	O	1041	1044	abstract	34422879
cognitive	O	1045	1054	abstract	34422879
functions	O	1055	1064	abstract	34422879
.	O	1064	1065	abstract	34422879

Moreover	O	1066	1074	abstract	34422879
,	O	1074	1075	abstract	34422879
the	O	1076	1079	abstract	34422879
importance	O	1080	1090	abstract	34422879
of	O	1091	1093	abstract	34422879
a	O	1094	1095	abstract	34422879
healthy	O	1096	1103	abstract	34422879
diet	O	1104	1108	abstract	34422879
,	O	1108	1109	abstract	34422879
balanced	O	1110	1118	abstract	34422879
in	O	1119	1121	abstract	34422879
macro-	B-chemical	1122	1128	abstract	34422879
and	I-chemical	1129	1132	abstract	34422879
micro-nutrients	I-chemical	1133	1148	abstract	34422879
,	O	1148	1149	abstract	34422879
in	O	1150	1152	abstract	34422879
preventing	O	1153	1163	abstract	34422879
neurodegeneration	O	1164	1181	abstract	34422879
and	O	1182	1185	abstract	34422879
slowing	O	1186	1193	abstract	34422879
down	O	1194	1198	abstract	34422879
a	O	1199	1200	abstract	34422879
progression	O	1201	1212	abstract	34422879
to	O	1213	1215	abstract	34422879
full-blown	O	1216	1226	abstract	34422879
disease	O	1227	1234	abstract	34422879
is	O	1235	1237	abstract	34422879
evident	O	1238	1245	abstract	34422879
.	O	1245	1246	abstract	34422879

Individuals	O	1247	1258	abstract	34422879
affected	O	1259	1267	abstract	34422879
by	O	1268	1270	abstract	34422879
NDD	B-DDF	1271	1274	abstract	34422879
almost	O	1275	1281	abstract	34422879
inevitably	O	1282	1292	abstract	34422879
have	O	1293	1297	abstract	34422879
low-grade	B-DDF	1298	1307	abstract	34422879
inflammation	I-DDF	1308	1320	abstract	34422879
and	I-DDF	1321	1324	abstract	34422879
anomalies	I-DDF	1325	1334	abstract	34422879
in	O	1335	1337	abstract	34422879
lipid	O	1338	1343	abstract	34422879
metabolism	O	1344	1354	abstract	34422879
.	O	1354	1355	abstract	34422879

Metabolic	O	1356	1365	abstract	34422879
and	O	1366	1369	abstract	34422879
lipid	O	1370	1375	abstract	34422879
profiles	O	1376	1384	abstract	34422879
in	O	1385	1387	abstract	34422879
NDD	B-DDF	1388	1391	abstract	34422879
can	O	1392	1395	abstract	34422879
be	O	1396	1398	abstract	34422879
improved	O	1399	1407	abstract	34422879
by	O	1408	1410	abstract	34422879
the	O	1411	1414	abstract	34422879
Mediterranean	O	1415	1428	abstract	34422879
diet	O	1429	1433	abstract	34422879
.	O	1433	1434	abstract	34422879

Many	O	1435	1439	abstract	34422879
studies	O	1440	1447	abstract	34422879
have	O	1448	1452	abstract	34422879
associated	O	1453	1463	abstract	34422879
the	O	1464	1467	abstract	34422879
Mediterranean	O	1468	1481	abstract	34422879
diet	O	1482	1486	abstract	34422879
with	O	1487	1491	abstract	34422879
a	O	1492	1493	abstract	34422879
decreased	O	1494	1503	abstract	34422879
risk	O	1504	1508	abstract	34422879
of	O	1509	1511	abstract	34422879
dementia	B-DDF	1512	1520	abstract	34422879
and	O	1521	1524	abstract	34422879
AD	B-DDF	1525	1527	abstract	34422879
,	O	1527	1528	abstract	34422879
but	O	1529	1532	abstract	34422879
a	O	1533	1534	abstract	34422879
cause-and-effect	O	1535	1551	abstract	34422879
relationship	O	1552	1564	abstract	34422879
has	O	1565	1568	abstract	34422879
not	O	1569	1572	abstract	34422879
been	O	1573	1577	abstract	34422879
deduced	O	1578	1585	abstract	34422879
.	O	1585	1586	abstract	34422879

Studies	O	1587	1594	abstract	34422879
with	O	1595	1599	abstract	34422879
caloric	O	1600	1607	abstract	34422879
restriction	O	1608	1619	abstract	34422879
showed	O	1620	1626	abstract	34422879
neuroprotective	O	1627	1642	abstract	34422879
effects	O	1643	1650	abstract	34422879
in	O	1651	1653	abstract	34422879
animal	O	1654	1660	abstract	34422879
models	O	1661	1667	abstract	34422879
,	O	1667	1668	abstract	34422879
but	O	1669	1672	abstract	34422879
the	O	1673	1676	abstract	34422879
results	O	1677	1684	abstract	34422879
in	O	1685	1687	abstract	34422879
humans	B-human	1688	1694	abstract	34422879
are	O	1695	1698	abstract	34422879
inconsistent	O	1699	1711	abstract	34422879
.	O	1711	1712	abstract	34422879

The	O	1713	1716	abstract	34422879
pathologies	O	1717	1728	abstract	34422879
of	O	1729	1731	abstract	34422879
NDD	B-DDF	1732	1735	abstract	34422879
are	O	1736	1739	abstract	34422879
complex	O	1740	1747	abstract	34422879
and	O	1748	1751	abstract	34422879
there	O	1752	1757	abstract	34422879
is	O	1758	1760	abstract	34422879
a	O	1761	1762	abstract	34422879
great	O	1763	1768	abstract	34422879
inter-individual	O	1769	1785	abstract	34422879
(epi)genetic	O	1786	1798	abstract	34422879
variance	O	1799	1807	abstract	34422879
within	O	1808	1814	abstract	34422879
any	O	1815	1818	abstract	34422879
population	O	1819	1829	abstract	34422879
.	O	1829	1830	abstract	34422879

Furthermore	O	1831	1842	abstract	34422879
,	O	1842	1843	abstract	34422879
the	O	1844	1847	abstract	34422879
gut	B-microbiome	1848	1851	abstract	34422879
microbiome	I-microbiome	1852	1862	abstract	34422879
,	O	1862	1863	abstract	34422879
being	O	1864	1869	abstract	34422879
deeply	O	1870	1876	abstract	34422879
involved	O	1877	1885	abstract	34422879
in	O	1886	1888	abstract	34422879
nutrient	O	1889	1897	abstract	34422879
uptake	O	1898	1904	abstract	34422879
and	O	1905	1908	abstract	34422879
lipid	O	1909	1914	abstract	34422879
metabolism	O	1915	1925	abstract	34422879
,	O	1925	1926	abstract	34422879
also	O	1927	1931	abstract	34422879
represents	O	1932	1942	abstract	34422879
a	O	1943	1944	abstract	34422879
pillar	O	1945	1951	abstract	34422879
of	O	1952	1954	abstract	34422879
the	O	1955	1958	abstract	34422879
gut	O	1959	1962	abstract	34422879
microbiome-brain	O	1963	1979	abstract	34422879
axis	O	1980	1984	abstract	34422879
and	O	1985	1988	abstract	34422879
is	O	1989	1991	abstract	34422879
linked	O	1992	1998	abstract	34422879
with	O	1999	2003	abstract	34422879
the	O	2004	2007	abstract	34422879
pathogenesis	O	2008	2020	abstract	34422879
of	O	2021	2023	abstract	34422879
NDD	B-DDF	2024	2027	abstract	34422879
.	O	2027	2028	abstract	34422879

Numerous	O	2029	2037	abstract	34422879
studies	O	2038	2045	abstract	34422879
on	O	2046	2048	abstract	34422879
the	O	2049	2052	abstract	34422879
role	O	2053	2057	abstract	34422879
of	O	2058	2060	abstract	34422879
different	O	2061	2070	abstract	34422879
micronutrients	B-chemical	2071	2085	abstract	34422879
(	O	2086	2087	abstract	34422879
omega-3	B-chemical	2087	2094	abstract	34422879
fatty	I-chemical	2095	2100	abstract	34422879
acids	I-chemical	2101	2106	abstract	34422879
,	O	2106	2107	abstract	34422879
bioactive	B-chemical	2108	2117	abstract	34422879
polyphenols	I-chemical	2118	2129	abstract	34422879
from	O	2130	2134	abstract	34422879
fruit	O	2135	2140	abstract	34422879
and	O	2141	2144	abstract	34422879
medicinal	O	2145	2154	abstract	34422879
plants	O	2155	2161	abstract	34422879
)	O	2161	2162	abstract	34422879
in	O	2163	2165	abstract	34422879
the	O	2166	2169	abstract	34422879
prevention	O	2170	2180	abstract	34422879
,	O	2180	2181	abstract	34422879
prediction	O	2182	2192	abstract	34422879
,	O	2192	2193	abstract	34422879
and	O	2194	2197	abstract	34422879
treatment	O	2198	2207	abstract	34422879
of	O	2208	2210	abstract	34422879
NDD	B-DDF	2211	2214	abstract	34422879
have	O	2215	2219	abstract	34422879
been	O	2220	2224	abstract	34422879
conducted	O	2225	2234	abstract	34422879
,	O	2234	2235	abstract	34422879
but	O	2236	2239	abstract	34422879
we	O	2240	2242	abstract	34422879
are	O	2243	2246	abstract	34422879
still	O	2247	2252	abstract	34422879
far	O	2253	2256	abstract	34422879
away	O	2257	2261	abstract	34422879
from	O	2262	2266	abstract	34422879
a	O	2267	2268	abstract	34422879
personalized	O	2269	2281	abstract	34422879
diet	O	2282	2286	abstract	34422879
plan	O	2287	2291	abstract	34422879
for	O	2292	2295	abstract	34422879
individual	O	2296	2306	abstract	34422879
NDD	B-DDF	2307	2310	abstract	34422879
patients	O	2311	2319	abstract	34422879
.	O	2319	2320	abstract	34422879

For	O	2321	2324	abstract	34422879
this	O	2325	2329	abstract	34422879
to	O	2330	2332	abstract	34422879
be	O	2333	2335	abstract	34422879
realized	O	2336	2344	abstract	34422879
,	O	2344	2345	abstract	34422879
large-scale	O	2346	2357	abstract	34422879
cohorts	O	2358	2365	abstract	34422879
that	O	2366	2370	abstract	34422879
would	O	2371	2376	abstract	34422879
include	O	2377	2384	abstract	34422879
the	O	2385	2388	abstract	34422879
precise	O	2389	2396	abstract	34422879
monitoring	O	2397	2407	abstract	34422879
of	O	2408	2410	abstract	34422879
food	O	2411	2415	abstract	34422879
intake	O	2416	2422	abstract	34422879
,	O	2422	2423	abstract	34422879
mapping	O	2424	2431	abstract	34422879
of	O	2432	2434	abstract	34422879
genetic	O	2435	2442	abstract	34422879
variants	O	2443	2451	abstract	34422879
,	O	2451	2452	abstract	34422879
epigenetic	O	2453	2463	abstract	34422879
data	O	2464	2468	abstract	34422879
,	O	2468	2469	abstract	34422879
microbiome	O	2470	2480	abstract	34422879
studies	O	2481	2488	abstract	34422879
,	O	2488	2489	abstract	34422879
and	O	2490	2493	abstract	34422879
metabolome	O	2494	2504	abstract	34422879
,	O	2504	2505	abstract	34422879
lipidome	O	2506	2514	abstract	34422879
,	O	2514	2515	abstract	34422879
and	O	2516	2519	abstract	34422879
transcriptome	O	2520	2533	abstract	34422879
data	O	2534	2538	abstract	34422879
are	O	2539	2542	abstract	34422879
needed	O	2543	2549	abstract	34422879
.	O	2549	2550	abstract	34422879

Letter	O	0	6	title	26927355
to	O	7	9	title	26927355
the	O	10	13	title	26927355
Editor	O	14	20	title	26927355
:	O	20	21	title	26927355
The	O	22	25	title	26927355
Surge	O	26	31	title	26927355
of	O	32	34	title	26927355
Type	B-DDF	35	39	title	26927355
2	I-DDF	40	41	title	26927355
Diabetes	I-DDF	42	50	title	26927355
Mellitus	I-DDF	51	59	title	26927355
in	O	60	62	title	26927355
China	O	63	68	title	26927355
-	O	69	70	title	26927355
an	O	71	73	title	26927355
International	O	74	87	title	26927355
Alert	O	88	93	title	26927355
:	O	93	94	title	26927355
Physical	O	95	103	title	26927355
Exercise	O	104	112	title	26927355
and	O	113	116	title	26927355
Low-Caloric	B-food	117	128	title	26927355
Diet	I-food	129	133	title	26927355
May	O	134	137	title	26927355
Reduce	O	138	144	title	26927355
the	O	145	148	title	26927355
Risks	O	149	154	title	26927355
of	O	155	157	title	26927355
Type	B-DDF	158	162	title	26927355
2	I-DDF	163	164	title	26927355
Diabetes	I-DDF	165	173	title	26927355
Mellitus	I-DDF	174	182	title	26927355
and	O	183	186	title	26927355
Dementia	B-DDF	187	195	title	26927355
.	O	195	196	title	26927355

The	O	0	3	abstract	26927355
prevalence	O	4	14	abstract	26927355
of	O	15	17	abstract	26927355
diabetes	B-DDF	18	26	abstract	26927355
in	O	27	29	abstract	26927355
China	O	30	35	abstract	26927355
has	O	36	39	abstract	26927355
surged	O	40	46	abstract	26927355
from	O	47	51	abstract	26927355
0.67	O	52	56	abstract	26927355
%	O	56	57	abstract	26927355
before	O	58	64	abstract	26927355
1980	O	65	69	abstract	26927355
to	O	70	72	abstract	26927355
11.6	O	73	77	abstract	26927355
%	O	77	78	abstract	26927355
currently	O	79	88	abstract	26927355
.	O	88	89	abstract	26927355

It	O	90	92	abstract	26927355
is	O	93	95	abstract	26927355
even	O	96	100	abstract	26927355
higher	O	101	107	abstract	26927355
than	O	108	112	abstract	26927355
the	O	113	116	abstract	26927355
prevalence	O	117	127	abstract	26927355
in	O	128	130	abstract	26927355
the	O	131	134	abstract	26927355
United	O	135	141	abstract	26927355
States	O	142	148	abstract	26927355
.	O	148	149	abstract	26927355

Certainly	O	150	159	abstract	26927355
,	O	159	160	abstract	26927355
China	O	161	166	abstract	26927355
's	O	166	168	abstract	26927355
economic	O	169	177	abstract	26927355
open-ups	O	178	186	abstract	26927355
,	O	186	187	abstract	26927355
improving	O	188	197	abstract	26927355
living	O	198	204	abstract	26927355
standard	O	205	213	abstract	26927355
,	O	213	214	abstract	26927355
and	O	215	218	abstract	26927355
modernization	O	219	232	abstract	26927355
have	O	233	237	abstract	26927355
propagated	O	238	248	abstract	26927355
the	O	249	252	abstract	26927355
surge	O	253	258	abstract	26927355
.	O	258	259	abstract	26927355

From	O	260	264	abstract	26927355
a	O	265	266	abstract	26927355
traditional	O	267	278	abstract	26927355
public-health	O	279	292	abstract	26927355
point	O	293	298	abstract	26927355
of	O	299	301	abstract	26927355
view	O	302	306	abstract	26927355
,	O	306	307	abstract	26927355
increased	O	308	317	abstract	26927355
food	O	318	322	abstract	26927355
intake	O	323	329	abstract	26927355
and	O	330	333	abstract	26927355
decreased	O	334	343	abstract	26927355
exercise	O	344	352	abstract	26927355
were	O	353	357	abstract	26927355
the	O	358	361	abstract	26927355
main	O	362	366	abstract	26927355
contributors	O	367	379	abstract	26927355
.	O	379	380	abstract	26927355

A	O	381	382	abstract	26927355
new	O	383	386	abstract	26927355
knowledge	O	387	396	abstract	26927355
of	O	397	399	abstract	26927355
colon	B-microbiome	400	405	abstract	26927355
microbiota	I-microbiome	406	416	abstract	26927355
could	O	417	422	abstract	26927355
be	O	423	425	abstract	26927355
applied	O	426	433	abstract	26927355
to	O	434	436	abstract	26927355
provide	O	437	444	abstract	26927355
a	O	445	446	abstract	26927355
second	O	447	453	abstract	26927355
harvest	O	454	461	abstract	26927355
of	O	462	464	abstract	26927355
food	O	465	469	abstract	26927355
energy	O	470	476	abstract	26927355
;	O	476	477	abstract	26927355
for	O	478	481	abstract	26927355
example	O	482	489	abstract	26927355
,	O	489	490	abstract	26927355
large	O	491	496	abstract	26927355
molecules	O	497	506	abstract	26927355
of	O	507	509	abstract	26927355
carbohydrates	B-chemical	510	523	abstract	26927355
,	O	523	524	abstract	26927355
which	O	525	530	abstract	26927355
are	O	531	534	abstract	26927355
undigested	O	535	545	abstract	26927355
by	O	546	548	abstract	26927355
the	O	549	552	abstract	26927355
stomach	B-anatomical%location	553	560	abstract	26927355
and	O	561	564	abstract	26927355
small	B-anatomical%location	565	570	abstract	26927355
intestine	I-anatomical%location	571	580	abstract	26927355
,	O	580	581	abstract	26927355
produce	O	582	589	abstract	26927355
by-products	O	590	601	abstract	26927355
that	O	602	606	abstract	26927355
the	O	607	610	abstract	26927355
body	O	611	615	abstract	26927355
can	O	616	619	abstract	26927355
absorb	O	620	626	abstract	26927355
in	O	627	629	abstract	26927355
the	O	630	633	abstract	26927355
colon	B-anatomical%location	634	639	abstract	26927355
.	O	639	640	abstract	26927355

Colon	B-microbiome	641	646	abstract	26927355
microbiota	I-microbiome	647	657	abstract	26927355
can	O	658	661	abstract	26927355
ferment	O	662	669	abstract	26927355
these	O	670	675	abstract	26927355
carbohydrates	B-chemical	676	689	abstract	26927355
to	O	690	692	abstract	26927355
the	O	693	696	abstract	26927355
short-chain	B-chemical	697	708	abstract	26927355
fatty	I-chemical	709	714	abstract	26927355
acid	I-chemical	715	719	abstract	26927355
butyrate	I-chemical	720	728	abstract	26927355
.	O	728	729	abstract	26927355

This	O	730	734	abstract	26927355
is	O	735	737	abstract	26927355
an	O	738	740	abstract	26927355
energy	O	741	747	abstract	26927355
source	O	748	754	abstract	26927355
that	O	755	759	abstract	26927355
may	O	760	763	abstract	26927355
even	O	764	768	abstract	26927355
cause	O	769	774	abstract	26927355
nonalcoholic	B-DDF	775	787	abstract	26927355
fatty	I-DDF	788	793	abstract	26927355
liver	I-DDF	794	799	abstract	26927355
.	O	799	800	abstract	26927355

How	O	801	804	abstract	26927355
these	O	805	810	abstract	26927355
colon	B-microbiome	811	816	abstract	26927355
microbiota	I-microbiome	817	827	abstract	26927355
contribute	O	828	838	abstract	26927355
to	O	839	841	abstract	26927355
the	O	842	845	abstract	26927355
surge	O	846	851	abstract	26927355
of	O	852	854	abstract	26927355
diabetes	B-DDF	855	863	abstract	26927355
and	O	864	867	abstract	26927355
whether	O	868	875	abstract	26927355
this	O	876	880	abstract	26927355
new	O	881	884	abstract	26927355
knowledge	O	885	894	abstract	26927355
can	O	895	898	abstract	26927355
be	O	899	901	abstract	26927355
used	O	902	906	abstract	26927355
to	O	907	909	abstract	26927355
control	O	910	917	abstract	26927355
diabetes	B-DDF	918	926	abstract	26927355
and	O	927	930	abstract	26927355
metabolic	B-DDF	931	940	abstract	26927355
syndrome	I-DDF	941	949	abstract	26927355
are	O	950	953	abstract	26927355
questions	O	954	963	abstract	26927355
for	O	964	967	abstract	26927355
future	O	968	974	abstract	26927355
scientific	O	975	985	abstract	26927355
studies	O	986	993	abstract	26927355
.	O	993	994	abstract	26927355

Clinically	O	995	1005	abstract	26927355
,	O	1005	1006	abstract	26927355
however	O	1007	1014	abstract	26927355
,	O	1014	1015	abstract	26927355
colon	B-microbiome	1016	1021	abstract	26927355
microbiota	I-microbiome	1022	1032	abstract	26927355
have	O	1033	1037	abstract	26927355
had	O	1038	1041	abstract	26927355
immediate	O	1042	1051	abstract	26927355
applications	O	1052	1064	abstract	26927355
;	O	1064	1065	abstract	26927355
fecal	B-microbiome	1066	1071	abstract	26927355
microbiota	I-microbiome	1072	1082	abstract	26927355
have	O	1083	1087	abstract	26927355
been	O	1088	1092	abstract	26927355
transplanted	O	1093	1105	abstract	26927355
from	O	1106	1110	abstract	26927355
healthy	B-human	1111	1118	abstract	26927355
persons	I-human	1119	1126	abstract	26927355
to	O	1127	1129	abstract	26927355
treat	O	1130	1135	abstract	26927355
recurrent	O	1136	1145	abstract	26927355
Clostridium	B-DDF	1146	1157	abstract	26927355
difficile	I-DDF	1158	1167	abstract	26927355
infection	I-DDF	1168	1177	abstract	26927355
at	O	1178	1180	abstract	26927355
Mayo	O	1181	1185	abstract	26927355
Clinic	O	1186	1192	abstract	26927355
.	O	1192	1193	abstract	26927355

In	O	1194	1196	abstract	26927355
addition	O	1197	1205	abstract	26927355
,	O	1205	1206	abstract	26927355
a	O	1207	1208	abstract	26927355
stool	B-biomedical%technique	1209	1214	abstract	26927355
biobank	I-biomedical%technique	1215	1222	abstract	26927355
of	O	1223	1225	abstract	26927355
healthy	B-human	1226	1233	abstract	26927355
persons	I-human	1234	1241	abstract	26927355
was	O	1242	1245	abstract	26927355
established	O	1246	1257	abstract	26927355
at	O	1258	1260	abstract	26927355
Mayo	O	1261	1265	abstract	26927355
Clinic	O	1266	1272	abstract	26927355
for	O	1273	1276	abstract	26927355
future	O	1277	1283	abstract	26927355
clinical	O	1284	1292	abstract	26927355
applications	O	1293	1305	abstract	26927355
.	O	1305	1306	abstract	26927355

Microbial	O	0	9	title	38409102
composition	O	10	21	title	38409102
,	O	21	22	title	38409102
functionality	O	23	36	title	38409102
,	O	36	37	title	38409102
and	O	38	41	title	38409102
stress	O	42	48	title	38409102
resilience	O	49	59	title	38409102
or	O	60	62	title	38409102
susceptibility	O	63	77	title	38409102
:	O	77	78	title	38409102
unraveling	O	79	89	title	38409102
sex-specific	O	90	102	title	38409102
patterns	O	103	111	title	38409102
.	O	111	112	title	38409102

Following	O	0	9	abstract	38409102
exposure	O	10	18	abstract	38409102
to	O	19	21	abstract	38409102
traumatic	B-DDF	22	31	abstract	38409102
stress	I-DDF	32	38	abstract	38409102
,	O	38	39	abstract	38409102
women	B-human	40	45	abstract	38409102
are	O	46	49	abstract	38409102
twice	O	50	55	abstract	38409102
as	O	56	58	abstract	38409102
likely	O	59	65	abstract	38409102
as	O	66	68	abstract	38409102
men	B-human	69	72	abstract	38409102
to	O	73	75	abstract	38409102
develop	O	76	83	abstract	38409102
mood	B-DDF	84	88	abstract	38409102
disorders	I-DDF	89	98	abstract	38409102
.	O	98	99	abstract	38409102

Yet	O	100	103	abstract	38409102
,	O	103	104	abstract	38409102
individual	O	105	115	abstract	38409102
responses	O	116	125	abstract	38409102
to	O	126	128	abstract	38409102
such	O	129	133	abstract	38409102
stress	B-DDF	134	140	abstract	38409102
vary	O	141	145	abstract	38409102
,	O	145	146	abstract	38409102
with	O	147	151	abstract	38409102
some	O	152	156	abstract	38409102
people	B-human	157	163	abstract	38409102
developing	O	164	174	abstract	38409102
stress-induced	B-DDF	175	189	abstract	38409102
psychopathologies	I-DDF	190	207	abstract	38409102
while	O	208	213	abstract	38409102
others	O	214	220	abstract	38409102
exhibit	O	221	228	abstract	38409102
resilience	O	229	239	abstract	38409102
.	O	239	240	abstract	38409102

The	O	241	244	abstract	38409102
factors	O	245	252	abstract	38409102
influencing	O	253	264	abstract	38409102
sex-related	O	265	276	abstract	38409102
disparities	O	277	288	abstract	38409102
in	O	289	291	abstract	38409102
affective	B-DDF	292	301	abstract	38409102
disorders	I-DDF	302	311	abstract	38409102
as	O	312	314	abstract	38409102
well	O	315	319	abstract	38409102
as	O	320	322	abstract	38409102
variations	O	323	333	abstract	38409102
in	O	334	336	abstract	38409102
resilience	O	337	347	abstract	38409102
remain	O	348	354	abstract	38409102
unclear	O	355	362	abstract	38409102
;	O	362	363	abstract	38409102
however	O	364	371	abstract	38409102
,	O	371	372	abstract	38409102
emerging	O	373	381	abstract	38409102
evidence	O	382	390	abstract	38409102
suggests	O	391	399	abstract	38409102
differences	O	400	411	abstract	38409102
in	O	412	414	abstract	38409102
the	O	415	418	abstract	38409102
gut	B-microbiome	419	422	abstract	38409102
microbiota	I-microbiome	423	433	abstract	38409102
play	O	434	438	abstract	38409102
a	O	439	440	abstract	38409102
role	O	441	445	abstract	38409102
.	O	445	446	abstract	38409102

In	O	447	449	abstract	38409102
this	O	450	454	abstract	38409102
study	O	455	460	abstract	38409102
,	O	460	461	abstract	38409102
using	O	462	467	abstract	38409102
the	O	468	471	abstract	38409102
single	B-biomedical%technique	472	478	abstract	38409102
prolonged	I-biomedical%technique	479	488	abstract	38409102
stress	I-biomedical%technique	489	495	abstract	38409102
(	I-biomedical%technique	496	497	abstract	38409102
SPS	I-biomedical%technique	497	500	abstract	38409102
)	I-biomedical%technique	500	501	abstract	38409102
model	I-biomedical%technique	502	507	abstract	38409102
of	O	508	510	abstract	38409102
post-traumatic	B-DDF	511	525	abstract	38409102
stress	I-DDF	526	532	abstract	38409102
disorder	I-DDF	533	541	abstract	38409102
,	O	541	542	abstract	38409102
we	O	543	545	abstract	38409102
investigated	O	546	558	abstract	38409102
pre-	O	559	563	abstract	38409102
and	O	564	567	abstract	38409102
post-existing	O	568	581	abstract	38409102
differences	O	582	593	abstract	38409102
in	O	594	596	abstract	38409102
microbial	O	597	606	abstract	38409102
composition	O	607	618	abstract	38409102
,	O	618	619	abstract	38409102
functionality	O	620	633	abstract	38409102
,	O	633	634	abstract	38409102
and	O	635	638	abstract	38409102
metabolites	O	639	650	abstract	38409102
that	O	651	655	abstract	38409102
affect	O	656	662	abstract	38409102
stress	O	663	669	abstract	38409102
susceptibility	O	670	684	abstract	38409102
or	O	685	687	abstract	38409102
resilience	O	688	698	abstract	38409102
in	O	699	701	abstract	38409102
each	O	702	706	abstract	38409102
sex	O	707	710	abstract	38409102
.	O	710	711	abstract	38409102

Male	B-animal	712	716	abstract	38409102
and	I-animal	717	720	abstract	38409102
female	I-animal	721	727	abstract	38409102
Sprague-Dawley	I-animal	728	742	abstract	38409102
rats	I-animal	743	747	abstract	38409102
were	O	748	752	abstract	38409102
randomly	O	753	761	abstract	38409102
assigned	O	762	770	abstract	38409102
to	O	771	773	abstract	38409102
control	O	774	781	abstract	38409102
or	O	782	784	abstract	38409102
SPS	O	785	788	abstract	38409102
groups	O	789	795	abstract	38409102
.	O	795	796	abstract	38409102

Two	O	797	800	abstract	38409102
weeks	O	801	806	abstract	38409102
following	O	807	816	abstract	38409102
SPS	B-biomedical%technique	817	820	abstract	38409102
,	O	820	821	abstract	38409102
the	O	822	825	abstract	38409102
animals	O	826	833	abstract	38409102
were	O	834	838	abstract	38409102
exposed	O	839	846	abstract	38409102
to	O	847	849	abstract	38409102
a	O	850	851	abstract	38409102
battery	O	852	859	abstract	38409102
of	O	860	862	abstract	38409102
behavioral	B-biomedical%technique	863	873	abstract	38409102
tests	I-biomedical%technique	874	879	abstract	38409102
and	O	880	883	abstract	38409102
decapitated	O	884	895	abstract	38409102
a	O	896	897	abstract	38409102
day	O	898	901	abstract	38409102
later	O	902	907	abstract	38409102
.	O	907	908	abstract	38409102

Based	O	909	914	abstract	38409102
on	O	915	917	abstract	38409102
their	O	918	923	abstract	38409102
anxiety	B-biomedical%technique	924	931	abstract	38409102
index	I-biomedical%technique	932	937	abstract	38409102
,	O	937	938	abstract	38409102
they	O	939	943	abstract	38409102
were	O	944	948	abstract	38409102
further	O	949	956	abstract	38409102
categorized	O	957	968	abstract	38409102
as	O	969	971	abstract	38409102
SPS-resilient	O	972	985	abstract	38409102
(	O	986	987	abstract	38409102
SPS-R	O	987	992	abstract	38409102
)	O	992	993	abstract	38409102
or	O	994	996	abstract	38409102
SPS-susceptible	O	997	1012	abstract	38409102
(	O	1013	1014	abstract	38409102
SPS-S	O	1014	1019	abstract	38409102
)	O	1019	1020	abstract	38409102
.	O	1020	1021	abstract	38409102

On	O	1022	1024	abstract	38409102
the	O	1025	1028	abstract	38409102
day	O	1029	1032	abstract	38409102
of	O	1033	1035	abstract	38409102
dissection	O	1036	1046	abstract	38409102
,	O	1046	1047	abstract	38409102
cecum	B-anatomical%location	1048	1053	abstract	38409102
,	O	1053	1054	abstract	38409102
and	O	1055	1058	abstract	38409102
selected	B-anatomical%location	1059	1067	abstract	38409102
brain	I-anatomical%location	1068	1073	abstract	38409102
tissues	I-anatomical%location	1074	1081	abstract	38409102
were	O	1082	1086	abstract	38409102
isolated	O	1087	1095	abstract	38409102
.	O	1095	1096	abstract	38409102

Stool	O	1097	1102	abstract	38409102
samples	O	1103	1110	abstract	38409102
were	O	1111	1115	abstract	38409102
collected	O	1116	1125	abstract	38409102
before	O	1126	1132	abstract	38409102
and	O	1133	1136	abstract	38409102
after	O	1137	1142	abstract	38409102
SPS	B-biomedical%technique	1143	1146	abstract	38409102
,	O	1146	1147	abstract	38409102
whereas	O	1148	1155	abstract	38409102
urine	O	1156	1161	abstract	38409102
samples	O	1162	1169	abstract	38409102
were	O	1170	1174	abstract	38409102
taken	O	1175	1180	abstract	38409102
before	O	1181	1187	abstract	38409102
and	O	1188	1191	abstract	38409102
30	O	1192	1194	abstract	38409102
	O	1194	1195	abstract	38409102
min	O	1195	1198	abstract	38409102
into	O	1199	1203	abstract	38409102
the	O	1204	1207	abstract	38409102
SPS	B-biomedical%technique	1208	1211	abstract	38409102
.	O	1211	1212	abstract	38409102

Before	O	1213	1219	abstract	38409102
SPS	O	1220	1223	abstract	38409102
exposure	O	1224	1232	abstract	38409102
,	O	1232	1233	abstract	38409102
the	O	1234	1237	abstract	38409102
sympathoadrenal	O	1238	1253	abstract	38409102
axis	O	1254	1258	abstract	38409102
exhibited	O	1259	1268	abstract	38409102
alterations	O	1269	1280	abstract	38409102
within	O	1281	1287	abstract	38409102
male	O	1288	1292	abstract	38409102
subgroups	O	1293	1302	abstract	38409102
only	O	1303	1307	abstract	38409102
.	O	1307	1308	abstract	38409102

Expression	O	1309	1319	abstract	38409102
of	O	1320	1322	abstract	38409102
tight	B-gene	1323	1328	abstract	38409102
junction	I-gene	1329	1337	abstract	38409102
protein	I-gene	1338	1345	abstract	38409102
claudin-5	I-gene	1346	1355	abstract	38409102
was	O	1356	1359	abstract	38409102
lower	O	1360	1365	abstract	38409102
in	O	1366	1368	abstract	38409102
brain	O	1369	1374	abstract	38409102
of	O	1375	1377	abstract	38409102
SPS-S	B-animal	1378	1383	abstract	38409102
males	I-animal	1384	1389	abstract	38409102
,	O	1389	1390	abstract	38409102
but	O	1391	1394	abstract	38409102
higher	O	1395	1401	abstract	38409102
in	O	1402	1404	abstract	38409102
SPS-R	B-animal	1405	1410	abstract	38409102
females	I-animal	1411	1418	abstract	38409102
following	O	1419	1428	abstract	38409102
SPS	B-biomedical%technique	1429	1432	abstract	38409102
.	O	1432	1433	abstract	38409102

Across	O	1434	1440	abstract	38409102
the	O	1441	1444	abstract	38409102
study	O	1445	1450	abstract	38409102
,	O	1450	1451	abstract	38409102
alpha	O	1452	1457	abstract	38409102
diversity	O	1458	1467	abstract	38409102
remained	O	1468	1476	abstract	38409102
consistently	O	1477	1489	abstract	38409102
lower	O	1490	1495	abstract	38409102
in	O	1496	1498	abstract	38409102
males	O	1499	1504	abstract	38409102
compared	O	1505	1513	abstract	38409102
to	O	1514	1516	abstract	38409102
females	O	1517	1524	abstract	38409102
.	O	1524	1525	abstract	38409102

Beta	O	1526	1530	abstract	38409102
diversity	O	1531	1540	abstract	38409102
revealed	O	1541	1549	abstract	38409102
distinct	O	1550	1558	abstract	38409102
separations	O	1559	1570	abstract	38409102
between	O	1571	1578	abstract	38409102
male	O	1579	1583	abstract	38409102
and	O	1584	1587	abstract	38409102
female	O	1588	1594	abstract	38409102
susceptible	O	1595	1606	abstract	38409102
groups	O	1607	1613	abstract	38409102
before	O	1614	1620	abstract	38409102
SPS	B-biomedical%technique	1621	1624	abstract	38409102
,	O	1624	1625	abstract	38409102
with	O	1626	1630	abstract	38409102
this	O	1631	1635	abstract	38409102
separation	O	1636	1646	abstract	38409102
becoming	O	1647	1655	abstract	38409102
evident	O	1656	1663	abstract	38409102
in	O	1664	1666	abstract	38409102
the	O	1667	1670	abstract	38409102
resilient	O	1671	1680	abstract	38409102
groups	O	1681	1687	abstract	38409102
following	O	1688	1697	abstract	38409102
SPS	B-biomedical%technique	1698	1701	abstract	38409102
.	O	1701	1702	abstract	38409102

At	O	1703	1705	abstract	38409102
the	O	1706	1709	abstract	38409102
genus	O	1710	1715	abstract	38409102
level	O	1716	1721	abstract	38409102
,	O	1721	1722	abstract	38409102
Lactobacillus	B-bacteria	1723	1736	abstract	38409102
,	O	1736	1737	abstract	38409102
Lachnospiraceae_Incertae_Sedis	B-bacteria	1738	1768	abstract	38409102
,	O	1768	1769	abstract	38409102
and	O	1770	1773	abstract	38409102
Barnesiella	B-bacteria	1774	1785	abstract	38409102
exhibited	O	1786	1795	abstract	38409102
sex-specific	O	1796	1808	abstract	38409102
alterations	O	1809	1820	abstract	38409102
,	O	1820	1821	abstract	38409102
displaying	O	1822	1832	abstract	38409102
opposing	O	1833	1841	abstract	38409102
abundances	O	1842	1852	abstract	38409102
in	O	1853	1855	abstract	38409102
each	O	1856	1860	abstract	38409102
sex	O	1861	1864	abstract	38409102
.	O	1864	1865	abstract	38409102

Additionally	O	1866	1878	abstract	38409102
,	O	1878	1879	abstract	38409102
sex-specific	O	1880	1892	abstract	38409102
changes	O	1893	1900	abstract	38409102
were	O	1901	1905	abstract	38409102
observed	O	1906	1914	abstract	38409102
in	O	1915	1917	abstract	38409102
microbial	O	1918	1927	abstract	38409102
predictive	O	1928	1938	abstract	38409102
functionality	O	1939	1952	abstract	38409102
and	O	1953	1956	abstract	38409102
targeted	O	1957	1965	abstract	38409102
functional	O	1966	1976	abstract	38409102
modules	O	1977	1984	abstract	38409102
both	O	1985	1989	abstract	38409102
before	O	1990	1996	abstract	38409102
and	O	1997	2000	abstract	38409102
after	O	2001	2006	abstract	38409102
SPS	B-biomedical%technique	2007	2010	abstract	38409102
.	O	2010	2011	abstract	38409102

Alterations	O	2012	2023	abstract	38409102
in	O	2024	2026	abstract	38409102
the	O	2027	2030	abstract	38409102
microbial	B-chemical	2031	2040	abstract	38409102
short-chain	I-chemical	2041	2052	abstract	38409102
fatty	I-chemical	2053	2058	abstract	38409102
acids	I-chemical	2059	2064	abstract	38409102
(	O	2065	2066	abstract	38409102
SCFAs	B-chemical	2066	2071	abstract	38409102
)	O	2071	2072	abstract	38409102
,	O	2072	2073	abstract	38409102
were	O	2074	2078	abstract	38409102
also	O	2079	2083	abstract	38409102
observed	O	2084	2092	abstract	38409102
,	O	2092	2093	abstract	38409102
with	O	2094	2098	abstract	38409102
major	O	2099	2104	abstract	38409102
and	O	2105	2108	abstract	38409102
minor	O	2109	2114	abstract	38409102
SCFAs	B-chemical	2115	2120	abstract	38409102
being	O	2121	2126	abstract	38409102
lower	O	2127	2132	abstract	38409102
in	O	2133	2135	abstract	38409102
SPS-susceptible	B-animal	2136	2151	abstract	38409102
males	I-animal	2152	2157	abstract	38409102
whereas	O	2158	2165	abstract	38409102
branched-chain	B-chemical	2166	2180	abstract	38409102
SCFAs	I-chemical	2181	2186	abstract	38409102
being	O	2187	2192	abstract	38409102
higher	O	2193	2199	abstract	38409102
in	O	2200	2202	abstract	38409102
SPS-susceptible	B-animal	2203	2218	abstract	38409102
females	I-animal	2219	2226	abstract	38409102
.	O	2226	2227	abstract	38409102

This	O	2228	2232	abstract	38409102
study	O	2233	2238	abstract	38409102
highlights	O	2239	2249	abstract	38409102
distinct	O	2250	2258	abstract	38409102
pre-	O	2259	2263	abstract	38409102
and	O	2264	2267	abstract	38409102
post-trauma	O	2268	2279	abstract	38409102
differences	O	2280	2291	abstract	38409102
in	O	2292	2294	abstract	38409102
microbial	O	2295	2304	abstract	38409102
composition	O	2305	2316	abstract	38409102
,	O	2316	2317	abstract	38409102
functionality	O	2318	2331	abstract	38409102
,	O	2331	2332	abstract	38409102
and	O	2333	2336	abstract	38409102
metabolites	O	2337	2348	abstract	38409102
,	O	2348	2349	abstract	38409102
associated	O	2350	2360	abstract	38409102
with	O	2361	2365	abstract	38409102
stress	O	2366	2372	abstract	38409102
resilience	O	2373	2383	abstract	38409102
in	O	2384	2386	abstract	38409102
male	B-animal	2387	2391	abstract	38409102
and	I-animal	2392	2395	abstract	38409102
female	I-animal	2396	2402	abstract	38409102
rats	I-animal	2403	2407	abstract	38409102
.	O	2407	2408	abstract	38409102

The	O	2409	2412	abstract	38409102
findings	O	2413	2421	abstract	38409102
underscore	O	2422	2432	abstract	38409102
the	O	2433	2436	abstract	38409102
importance	O	2437	2447	abstract	38409102
of	O	2448	2450	abstract	38409102
developing	O	2451	2461	abstract	38409102
sex-specific	O	2462	2474	abstract	38409102
therapeutic	O	2475	2486	abstract	38409102
strategies	O	2487	2497	abstract	38409102
to	O	2498	2500	abstract	38409102
effectively	O	2501	2512	abstract	38409102
address	O	2513	2520	abstract	38409102
stress-related	B-DDF	2521	2535	abstract	38409102
disorders	I-DDF	2536	2545	abstract	38409102
.	O	2545	2546	abstract	38409102

Highlights	O	2547	2557	abstract	38409102
SPS	B-biomedical%technique	2558	2561	abstract	38409102
model	I-biomedical%technique	2562	2567	abstract	38409102
induces	O	2568	2575	abstract	38409102
divergent	O	2576	2585	abstract	38409102
anxiety	O	2586	2593	abstract	38409102
and	O	2594	2597	abstract	38409102
social	O	2598	2604	abstract	38409102
behavioral	O	2605	2615	abstract	38409102
responses	O	2616	2625	abstract	38409102
to	O	2626	2628	abstract	38409102
traumatic	B-DDF	2629	2638	abstract	38409102
stress	I-DDF	2639	2645	abstract	38409102
in	O	2646	2648	abstract	38409102
both	O	2649	2653	abstract	38409102
male	B-animal	2654	2658	abstract	38409102
and	I-animal	2659	2662	abstract	38409102
female	I-animal	2663	2669	abstract	38409102
rodents	I-animal	2670	2677	abstract	38409102
.	O	2677	2678	abstract	38409102

SPS-resilient	B-animal	2679	2692	abstract	38409102
females	I-animal	2693	2700	abstract	38409102
displayed	O	2701	2710	abstract	38409102
less	O	2711	2715	abstract	38409102
anxiety-like	O	2716	2728	abstract	38409102
behavior	O	2729	2737	abstract	38409102
and	O	2738	2741	abstract	38409102
initiated	O	2742	2751	abstract	38409102
more	O	2752	2756	abstract	38409102
interactions	O	2757	2769	abstract	38409102
towards	O	2770	2777	abstract	38409102
a	O	2778	2779	abstract	38409102
juvenile	B-animal	2780	2788	abstract	38409102
rat	I-animal	2789	2792	abstract	38409102
than	O	2793	2797	abstract	38409102
SPS-resilient	B-animal	2798	2811	abstract	38409102
males	I-animal	2812	2817	abstract	38409102
.	O	2817	2818	abstract	38409102

Sex-specific	O	2819	2831	abstract	38409102
pre-existing	O	2832	2844	abstract	38409102
and	O	2845	2848	abstract	38409102
SPS-induced	O	2849	2860	abstract	38409102
differences	O	2861	2872	abstract	38409102
in	O	2873	2875	abstract	38409102
the	O	2876	2879	abstract	38409102
gut	O	2880	2883	abstract	38409102
microbial	O	2884	2893	abstract	38409102
composition	O	2894	2905	abstract	38409102
and	O	2906	2909	abstract	38409102
predictive	O	2910	2920	abstract	38409102
functionality	O	2921	2934	abstract	38409102
were	O	2935	2939	abstract	38409102
observed	O	2940	2948	abstract	38409102
in	O	2949	2951	abstract	38409102
susceptible	O	2952	2963	abstract	38409102
and	O	2964	2967	abstract	38409102
resilient	O	2968	2977	abstract	38409102
rats	O	2978	2982	abstract	38409102
.	O	2982	2983	abstract	38409102

SPS-resilient	B-animal	2984	2997	abstract	38409102
males	I-animal	2998	3003	abstract	38409102
displayed	O	3004	3013	abstract	38409102
elevated	O	3014	3022	abstract	38409102
cecal	B-chemical	3023	3028	abstract	38409102
acetate	I-chemical	3029	3036	abstract	38409102
levels	O	3037	3043	abstract	38409102
,	O	3043	3044	abstract	38409102
whereas	O	3045	3052	abstract	38409102
SPS-susceptible	B-animal	3053	3068	abstract	38409102
females	I-animal	3069	3076	abstract	38409102
exhibited	O	3077	3086	abstract	38409102
heightened	O	3087	3097	abstract	38409102
branched-chain	O	3098	3112	abstract	38409102
SCFAs	B-chemical	3113	3118	abstract	38409102
.	O	3118	3119	abstract	38409102

Exploring	O	0	9	title	38318337
the	O	10	13	title	38318337
interplay	O	14	23	title	38318337
between	O	24	31	title	38318337
running	O	32	39	title	38318337
exercises	O	40	49	title	38318337
,	O	49	50	title	38318337
microbial	O	51	60	title	38318337
diversity	O	61	70	title	38318337
,	O	70	71	title	38318337
and	O	72	75	title	38318337
tryptophan	O	76	86	title	38318337
metabolism	O	87	97	title	38318337
along	O	98	103	title	38318337
the	O	104	107	title	38318337
microbiota-gut-brain	O	108	128	title	38318337
axis	O	129	133	title	38318337
.	O	133	134	title	38318337

The	O	0	3	abstract	38318337
emergent	O	4	12	abstract	38318337
recognition	O	13	24	abstract	38318337
of	O	25	27	abstract	38318337
the	O	28	31	abstract	38318337
gut-brain	O	32	41	abstract	38318337
axis	O	42	46	abstract	38318337
connection	O	47	57	abstract	38318337
has	O	58	61	abstract	38318337
shed	O	62	66	abstract	38318337
light	O	67	72	abstract	38318337
on	O	73	75	abstract	38318337
the	O	76	79	abstract	38318337
role	O	80	84	abstract	38318337
of	O	85	87	abstract	38318337
the	O	88	91	abstract	38318337
microbiota	O	92	102	abstract	38318337
in	O	103	105	abstract	38318337
modulating	O	106	116	abstract	38318337
the	O	117	120	abstract	38318337
gut-brain	O	121	130	abstract	38318337
axis	O	131	135	abstract	38318337
's	O	135	137	abstract	38318337
functions	O	138	147	abstract	38318337
.	O	147	148	abstract	38318337

Several	O	149	156	abstract	38318337
microbial	B-chemical	157	166	abstract	38318337
metabolites	I-chemical	167	178	abstract	38318337
,	O	178	179	abstract	38318337
such	O	180	184	abstract	38318337
as	O	185	187	abstract	38318337
serotonin	B-chemical	188	197	abstract	38318337
,	O	197	198	abstract	38318337
kynurenine	B-chemical	199	209	abstract	38318337
,	O	209	210	abstract	38318337
tryptamine	B-chemical	211	221	abstract	38318337
,	O	221	222	abstract	38318337
indole	B-chemical	223	229	abstract	38318337
,	O	229	230	abstract	38318337
and	O	231	234	abstract	38318337
their	O	235	240	abstract	38318337
derivatives	O	241	252	abstract	38318337
originating	O	253	264	abstract	38318337
from	O	265	269	abstract	38318337
tryptophan	O	270	280	abstract	38318337
metabolism	O	281	291	abstract	38318337
have	O	292	296	abstract	38318337
been	O	297	301	abstract	38318337
implicated	O	302	312	abstract	38318337
in	O	313	315	abstract	38318337
influencing	O	316	327	abstract	38318337
this	O	328	332	abstract	38318337
axis	O	333	337	abstract	38318337
.	O	337	338	abstract	38318337

In	O	339	341	abstract	38318337
our	O	342	345	abstract	38318337
study	O	346	351	abstract	38318337
,	O	351	352	abstract	38318337
we	O	353	355	abstract	38318337
aimed	O	356	361	abstract	38318337
to	O	362	364	abstract	38318337
investigate	O	365	376	abstract	38318337
the	O	377	380	abstract	38318337
impact	O	381	387	abstract	38318337
of	O	388	390	abstract	38318337
running	O	391	398	abstract	38318337
exercises	O	399	408	abstract	38318337
on	O	409	411	abstract	38318337
microbial	O	412	421	abstract	38318337
tryptophan	O	422	432	abstract	38318337
metabolism	O	433	443	abstract	38318337
using	O	444	449	abstract	38318337
a	O	450	451	abstract	38318337
mouse	B-animal	452	457	abstract	38318337
model	I-animal	458	463	abstract	38318337
.	O	463	464	abstract	38318337

We	O	465	467	abstract	38318337
conducted	O	468	477	abstract	38318337
a	O	478	479	abstract	38318337
multi-omics	B-biomedical%technique	480	491	abstract	38318337
analysis	I-biomedical%technique	492	500	abstract	38318337
to	O	501	503	abstract	38318337
obtain	O	504	510	abstract	38318337
a	O	511	512	abstract	38318337
comprehensive	O	513	526	abstract	38318337
insight	O	527	534	abstract	38318337
into	O	535	539	abstract	38318337
the	O	540	543	abstract	38318337
changes	O	544	551	abstract	38318337
in	O	552	554	abstract	38318337
tryptophan	O	555	565	abstract	38318337
metabolism	O	566	576	abstract	38318337
along	O	577	582	abstract	38318337
the	O	583	586	abstract	38318337
microbiota-gut-brain	O	587	607	abstract	38318337
axis	O	608	612	abstract	38318337
induced	O	613	620	abstract	38318337
by	O	621	623	abstract	38318337
running	O	624	631	abstract	38318337
exercises	O	632	641	abstract	38318337
.	O	641	642	abstract	38318337

The	O	643	646	abstract	38318337
analyses	O	647	655	abstract	38318337
integrated	O	656	666	abstract	38318337
multiple	O	667	675	abstract	38318337
components	O	676	686	abstract	38318337
,	O	686	687	abstract	38318337
such	O	688	692	abstract	38318337
as	O	693	695	abstract	38318337
tryptophan	O	696	706	abstract	38318337
changes	O	707	714	abstract	38318337
and	O	715	718	abstract	38318337
metabolite	O	719	729	abstract	38318337
levels	O	730	736	abstract	38318337
in	O	737	739	abstract	38318337
the	O	740	743	abstract	38318337
gut	B-anatomical%location	744	747	abstract	38318337
,	O	747	748	abstract	38318337
blood	B-anatomical%location	749	754	abstract	38318337
,	O	754	755	abstract	38318337
hippocampus	B-anatomical%location	756	767	abstract	38318337
,	O	767	768	abstract	38318337
and	O	769	772	abstract	38318337
brainstem	B-anatomical%location	773	782	abstract	38318337
.	O	782	783	abstract	38318337

Fecal	B-microbiome	784	789	abstract	38318337
microbiota	I-microbiome	790	800	abstract	38318337
analysis	O	801	809	abstract	38318337
aimed	O	810	815	abstract	38318337
to	O	816	818	abstract	38318337
examine	O	819	826	abstract	38318337
the	O	827	830	abstract	38318337
composition	O	831	842	abstract	38318337
and	O	843	846	abstract	38318337
diversity	O	847	856	abstract	38318337
of	O	857	859	abstract	38318337
the	O	860	863	abstract	38318337
gut	B-microbiome	864	867	abstract	38318337
microbiota	I-microbiome	868	878	abstract	38318337
,	O	878	879	abstract	38318337
and	O	880	883	abstract	38318337
taxon-function	B-biomedical%technique	884	898	abstract	38318337
analysis	I-biomedical%technique	899	907	abstract	38318337
explored	O	908	916	abstract	38318337
the	O	917	920	abstract	38318337
associations	O	921	933	abstract	38318337
between	O	934	941	abstract	38318337
specific	O	942	950	abstract	38318337
microbial	O	951	960	abstract	38318337
taxa	O	961	965	abstract	38318337
and	O	966	969	abstract	38318337
functional	O	970	980	abstract	38318337
activities	O	981	991	abstract	38318337
in	O	992	994	abstract	38318337
tryptophan	O	995	1005	abstract	38318337
metabolism	O	1006	1016	abstract	38318337
.	O	1016	1017	abstract	38318337

Our	O	1018	1021	abstract	38318337
findings	O	1022	1030	abstract	38318337
revealed	O	1031	1039	abstract	38318337
significant	O	1040	1051	abstract	38318337
alterations	O	1052	1063	abstract	38318337
in	O	1064	1066	abstract	38318337
tryptophan	O	1067	1077	abstract	38318337
metabolism	O	1078	1088	abstract	38318337
across	O	1089	1095	abstract	38318337
multiple	O	1096	1104	abstract	38318337
sites	O	1105	1110	abstract	38318337
,	O	1110	1111	abstract	38318337
including	O	1112	1121	abstract	38318337
the	O	1122	1125	abstract	38318337
gut	B-anatomical%location	1126	1129	abstract	38318337
,	O	1129	1130	abstract	38318337
blood	B-anatomical%location	1131	1136	abstract	38318337
,	O	1136	1137	abstract	38318337
hippocampus	B-anatomical%location	1138	1149	abstract	38318337
,	O	1149	1150	abstract	38318337
and	O	1151	1154	abstract	38318337
brainstem	B-anatomical%location	1155	1164	abstract	38318337
.	O	1164	1165	abstract	38318337

The	O	1166	1169	abstract	38318337
outcomes	O	1170	1178	abstract	38318337
indicate	O	1179	1187	abstract	38318337
a	O	1188	1189	abstract	38318337
shift	O	1190	1195	abstract	38318337
in	O	1196	1198	abstract	38318337
microbiota	O	1199	1209	abstract	38318337
diversity	O	1210	1219	abstract	38318337
and	O	1220	1223	abstract	38318337
tryptophan	O	1224	1234	abstract	38318337
metabolizing	O	1235	1247	abstract	38318337
capabilities	O	1248	1260	abstract	38318337
within	O	1261	1267	abstract	38318337
the	O	1268	1271	abstract	38318337
running	O	1272	1279	abstract	38318337
group	O	1280	1285	abstract	38318337
,	O	1285	1286	abstract	38318337
linked	O	1287	1293	abstract	38318337
to	O	1294	1296	abstract	38318337
increased	O	1297	1306	abstract	38318337
tryptophan	O	1307	1317	abstract	38318337
transportation	O	1318	1332	abstract	38318337
to	O	1333	1335	abstract	38318337
the	O	1336	1339	abstract	38318337
hippocampus	B-anatomical%location	1340	1351	abstract	38318337
and	O	1352	1355	abstract	38318337
brainstem	B-anatomical%location	1356	1365	abstract	38318337
through	O	1366	1373	abstract	38318337
circulation	O	1374	1385	abstract	38318337
.	O	1385	1386	abstract	38318337

Moreover	O	1387	1395	abstract	38318337
,	O	1395	1396	abstract	38318337
the	O	1397	1400	abstract	38318337
symbiotic	O	1401	1410	abstract	38318337
association	O	1411	1422	abstract	38318337
between	O	1423	1430	abstract	38318337
<	O	1431	1432	abstract	38318337
i	O	1432	1433	abstract	38318337
>	O	1433	1434	abstract	38318337
Romboutsia</i	B-bacteria	1434	1447	abstract	38318337
>	O	1447	1448	abstract	38318337
and	O	1449	1452	abstract	38318337
<	O	1453	1454	abstract	38318337
i	O	1454	1455	abstract	38318337
>	O	1455	1456	abstract	38318337
A.	B-bacteria	1456	1458	abstract	38318337
muciniphila</i	I-bacteria	1459	1473	abstract	38318337
>	O	1473	1474	abstract	38318337
indicated	O	1475	1484	abstract	38318337
their	O	1485	1490	abstract	38318337
potential	O	1491	1500	abstract	38318337
contribution	O	1501	1513	abstract	38318337
to	O	1514	1516	abstract	38318337
modifying	O	1517	1526	abstract	38318337
the	O	1527	1530	abstract	38318337
gut	B-anatomical%location	1531	1534	abstract	38318337
microenvironment	O	1535	1551	abstract	38318337
and	O	1552	1555	abstract	38318337
influencing	O	1556	1567	abstract	38318337
tryptophan	O	1568	1578	abstract	38318337
transport	O	1579	1588	abstract	38318337
to	O	1589	1591	abstract	38318337
the	O	1592	1595	abstract	38318337
hippocampus	B-anatomical%location	1596	1607	abstract	38318337
and	O	1608	1611	abstract	38318337
brainstem	B-anatomical%location	1612	1621	abstract	38318337
.	O	1621	1622	abstract	38318337

These	O	1623	1628	abstract	38318337
findings	O	1629	1637	abstract	38318337
have	O	1638	1642	abstract	38318337
potential	O	1643	1652	abstract	38318337
applications	O	1653	1665	abstract	38318337
for	O	1666	1669	abstract	38318337
developing	O	1670	1680	abstract	38318337
microbiota-based	O	1681	1697	abstract	38318337
approaches	O	1698	1708	abstract	38318337
in	O	1709	1711	abstract	38318337
the	O	1712	1715	abstract	38318337
context	O	1716	1723	abstract	38318337
of	O	1724	1726	abstract	38318337
exercise	O	1727	1735	abstract	38318337
for	O	1736	1739	abstract	38318337
neurological	B-DDF	1740	1752	abstract	38318337
diseases	I-DDF	1753	1761	abstract	38318337
,	O	1761	1762	abstract	38318337
especially	O	1763	1773	abstract	38318337
on	O	1774	1776	abstract	38318337
mental	O	1777	1783	abstract	38318337
health	O	1784	1790	abstract	38318337
and	O	1791	1794	abstract	38318337
overall	O	1795	1802	abstract	38318337
well-being	O	1803	1813	abstract	38318337
.	O	1813	1814	abstract	38318337

Probiotics	B-dietary%supplement	0	10	title	33105830
in	O	11	13	title	33105830
Treatment	O	14	23	title	33105830
of	O	24	26	title	33105830
Viral	B-DDF	27	32	title	33105830
Respiratory	I-DDF	33	44	title	33105830
Infections	I-DDF	45	55	title	33105830
and	O	56	59	title	33105830
Neuroinflammatory	B-DDF	60	77	title	33105830
Disorders	I-DDF	78	87	title	33105830
.	O	87	88	title	33105830

Inflammation	B-DDF	0	12	abstract	33105830
is	O	13	15	abstract	33105830
a	O	16	17	abstract	33105830
biological	O	18	28	abstract	33105830
response	O	29	37	abstract	33105830
to	O	38	40	abstract	33105830
the	O	41	44	abstract	33105830
activation	O	45	55	abstract	33105830
of	O	56	58	abstract	33105830
the	O	59	62	abstract	33105830
immune	O	63	69	abstract	33105830
system	O	70	76	abstract	33105830
by	O	77	79	abstract	33105830
various	O	80	87	abstract	33105830
infectious	O	88	98	abstract	33105830
or	O	99	101	abstract	33105830
non-infectious	O	102	116	abstract	33105830
agents	O	117	123	abstract	33105830
,	O	123	124	abstract	33105830
which	O	125	130	abstract	33105830
may	O	131	134	abstract	33105830
lead	O	135	139	abstract	33105830
to	O	140	142	abstract	33105830
tissue	B-DDF	143	149	abstract	33105830
damage	I-DDF	150	156	abstract	33105830
and	O	157	160	abstract	33105830
various	O	161	168	abstract	33105830
diseases	O	169	177	abstract	33105830
.	O	177	178	abstract	33105830

Gut	B-microbiome	179	182	abstract	33105830
commensal	I-microbiome	183	192	abstract	33105830
bacteria	I-microbiome	193	201	abstract	33105830
maintain	O	202	210	abstract	33105830
a	O	211	212	abstract	33105830
symbiotic	O	213	222	abstract	33105830
relationship	O	223	235	abstract	33105830
with	O	236	240	abstract	33105830
the	O	241	244	abstract	33105830
host	O	245	249	abstract	33105830
and	O	250	253	abstract	33105830
display	O	254	261	abstract	33105830
a	O	262	263	abstract	33105830
critical	O	264	272	abstract	33105830
function	O	273	281	abstract	33105830
in	O	282	284	abstract	33105830
the	O	285	288	abstract	33105830
homeostasis	O	289	300	abstract	33105830
of	O	301	303	abstract	33105830
the	O	304	307	abstract	33105830
host	O	308	312	abstract	33105830
immune	O	313	319	abstract	33105830
system	O	320	326	abstract	33105830
.	O	326	327	abstract	33105830

Disturbance	O	328	339	abstract	33105830
to	O	340	342	abstract	33105830
the	O	343	346	abstract	33105830
gut	B-microbiome	347	350	abstract	33105830
microbiota	I-microbiome	351	361	abstract	33105830
leads	O	362	367	abstract	33105830
to	O	368	370	abstract	33105830
immune	B-DDF	371	377	abstract	33105830
dysfunction	I-DDF	378	389	abstract	33105830
both	O	390	394	abstract	33105830
locally	O	395	402	abstract	33105830
and	O	403	406	abstract	33105830
at	O	407	409	abstract	33105830
distant	O	410	417	abstract	33105830
sites	O	418	423	abstract	33105830
,	O	423	424	abstract	33105830
which	O	425	430	abstract	33105830
causes	O	431	437	abstract	33105830
inflammatory	B-DDF	438	450	abstract	33105830
conditions	I-DDF	451	461	abstract	33105830
not	O	462	465	abstract	33105830
only	O	466	470	abstract	33105830
in	O	471	473	abstract	33105830
the	O	474	477	abstract	33105830
intestine	B-anatomical%location	478	487	abstract	33105830
but	O	488	491	abstract	33105830
also	O	492	496	abstract	33105830
in	O	497	499	abstract	33105830
the	O	500	503	abstract	33105830
other	O	504	509	abstract	33105830
organs	O	510	516	abstract	33105830
such	O	517	521	abstract	33105830
as	O	522	524	abstract	33105830
lungs	B-anatomical%location	525	530	abstract	33105830
and	O	531	534	abstract	33105830
brain	B-anatomical%location	535	540	abstract	33105830
,	O	540	541	abstract	33105830
and	O	542	545	abstract	33105830
may	O	546	549	abstract	33105830
induce	O	550	556	abstract	33105830
a	O	557	558	abstract	33105830
disease	O	559	566	abstract	33105830
state	O	567	572	abstract	33105830
.	O	572	573	abstract	33105830

Probiotics	B-dietary%supplement	574	584	abstract	33105830
are	O	585	588	abstract	33105830
well	O	589	593	abstract	33105830
known	O	594	599	abstract	33105830
to	O	600	602	abstract	33105830
reinforce	O	603	612	abstract	33105830
immunity	O	613	621	abstract	33105830
and	O	622	625	abstract	33105830
counteract	O	626	636	abstract	33105830
inflammation	B-DDF	637	649	abstract	33105830
by	O	650	652	abstract	33105830
restoring	O	653	662	abstract	33105830
symbiosis	O	663	672	abstract	33105830
within	O	673	679	abstract	33105830
the	O	680	683	abstract	33105830
gut	B-microbiome	684	687	abstract	33105830
microbiota	I-microbiome	688	698	abstract	33105830
.	O	698	699	abstract	33105830

As	O	700	702	abstract	33105830
a	O	703	704	abstract	33105830
result	O	705	711	abstract	33105830
,	O	711	712	abstract	33105830
probiotics	B-dietary%supplement	713	723	abstract	33105830
protect	O	724	731	abstract	33105830
against	O	732	739	abstract	33105830
various	O	740	747	abstract	33105830
diseases	O	748	756	abstract	33105830
,	O	756	757	abstract	33105830
including	O	758	767	abstract	33105830
respiratory	B-DDF	768	779	abstract	33105830
infections	I-DDF	780	790	abstract	33105830
and	O	791	794	abstract	33105830
neuroinflammatory	B-DDF	795	812	abstract	33105830
disorders	I-DDF	813	822	abstract	33105830
.	O	822	823	abstract	33105830

A	O	824	825	abstract	33105830
growing	O	826	833	abstract	33105830
body	O	834	838	abstract	33105830
of	O	839	841	abstract	33105830
research	O	842	850	abstract	33105830
supports	O	851	859	abstract	33105830
the	O	860	863	abstract	33105830
beneficial	O	864	874	abstract	33105830
role	O	875	879	abstract	33105830
of	O	880	882	abstract	33105830
probiotics	B-dietary%supplement	883	893	abstract	33105830
in	O	894	896	abstract	33105830
lung	O	897	901	abstract	33105830
and	O	902	905	abstract	33105830
mental	O	906	912	abstract	33105830
health	O	913	919	abstract	33105830
through	O	920	927	abstract	33105830
modulating	O	928	938	abstract	33105830
the	O	939	942	abstract	33105830
gut-lung	O	943	951	abstract	33105830
and	O	952	955	abstract	33105830
gut-brain	O	956	965	abstract	33105830
axes	O	966	970	abstract	33105830
.	O	970	971	abstract	33105830

In	O	972	974	abstract	33105830
the	O	975	978	abstract	33105830
current	O	979	986	abstract	33105830
paper	O	987	992	abstract	33105830
,	O	992	993	abstract	33105830
we	O	994	996	abstract	33105830
discuss	O	997	1004	abstract	33105830
the	O	1005	1008	abstract	33105830
potential	O	1009	1018	abstract	33105830
role	O	1019	1023	abstract	33105830
of	O	1024	1026	abstract	33105830
probiotics	B-dietary%supplement	1027	1037	abstract	33105830
in	O	1038	1040	abstract	33105830
the	O	1041	1044	abstract	33105830
treatment	O	1045	1054	abstract	33105830
of	O	1055	1057	abstract	33105830
viral	B-DDF	1058	1063	abstract	33105830
respiratory	I-DDF	1064	1075	abstract	33105830
infections	I-DDF	1076	1086	abstract	33105830
,	O	1086	1087	abstract	33105830
including	O	1088	1097	abstract	33105830
the	O	1098	1101	abstract	33105830
COVID-19	B-DDF	1102	1110	abstract	33105830
disease	I-DDF	1111	1118	abstract	33105830
,	O	1118	1119	abstract	33105830
as	O	1120	1122	abstract	33105830
major	O	1123	1128	abstract	33105830
public	O	1129	1135	abstract	33105830
health	O	1136	1142	abstract	33105830
crisis	O	1143	1149	abstract	33105830
in	O	1150	1152	abstract	33105830
2020	O	1153	1157	abstract	33105830
,	O	1157	1158	abstract	33105830
and	O	1159	1162	abstract	33105830
influenza	B-DDF	1163	1172	abstract	33105830
virus	I-DDF	1173	1178	abstract	33105830
infection	I-DDF	1179	1188	abstract	33105830
,	O	1188	1189	abstract	33105830
as	O	1190	1192	abstract	33105830
well	O	1193	1197	abstract	33105830
as	O	1198	1200	abstract	33105830
treatment	O	1201	1210	abstract	33105830
of	O	1211	1213	abstract	33105830
neurological	B-DDF	1214	1226	abstract	33105830
disorders	I-DDF	1227	1236	abstract	33105830
like	O	1237	1241	abstract	33105830
multiple	B-DDF	1242	1250	abstract	33105830
sclerosis	I-DDF	1251	1260	abstract	33105830
and	O	1261	1264	abstract	33105830
other	O	1265	1270	abstract	33105830
mental	B-DDF	1271	1277	abstract	33105830
illnesses	I-DDF	1278	1287	abstract	33105830
.	O	1287	1288	abstract	33105830

PROFAST	O	0	7	title	33212907
:	O	7	8	title	33212907
A	O	9	10	title	33212907
Randomized	O	11	21	title	33212907
Trial	O	22	27	title	33212907
Assessing	O	28	37	title	33212907
the	O	38	41	title	33212907
Effects	O	42	49	title	33212907
of	O	50	52	title	33212907
Intermittent	O	53	65	title	33212907
Fasting	O	66	73	title	33212907
and	O	74	77	title	33212907
<	B-dietary%supplement	78	79	title	33212907
i	I-dietary%supplement	79	80	title	33212907
>	I-dietary%supplement	80	81	title	33212907
Lacticaseibacillus	I-dietary%supplement	81	99	title	33212907
rhamnosus</i	I-dietary%supplement	100	112	title	33212907
>	I-dietary%supplement	112	113	title	33212907
Probiotic	I-dietary%supplement	114	123	title	33212907
among	O	124	129	title	33212907
People	B-human	130	136	title	33212907
with	O	137	141	title	33212907
Prediabetes	B-DDF	142	153	title	33212907
.	O	153	154	title	33212907

Both	O	0	4	abstract	33212907
intermittent	O	5	17	abstract	33212907
fasting	O	18	25	abstract	33212907
and	O	26	29	abstract	33212907
specific	O	30	38	abstract	33212907
probiotics	B-dietary%supplement	39	49	abstract	33212907
have	O	50	54	abstract	33212907
shown	O	55	60	abstract	33212907
promise	O	61	68	abstract	33212907
in	O	69	71	abstract	33212907
improving	O	72	81	abstract	33212907
glucose	O	82	89	abstract	33212907
tolerance	O	90	99	abstract	33212907
with	O	100	104	abstract	33212907
a	O	105	106	abstract	33212907
potential	O	107	116	abstract	33212907
for	O	117	120	abstract	33212907
synergistic	O	121	132	abstract	33212907
effects	O	133	140	abstract	33212907
through	O	141	148	abstract	33212907
alterations	O	149	160	abstract	33212907
to	O	161	163	abstract	33212907
gut	B-microbiome	164	167	abstract	33212907
microbiota	I-microbiome	168	178	abstract	33212907
.	O	178	179	abstract	33212907

In	O	180	182	abstract	33212907
this	O	183	187	abstract	33212907
randomized	B-biomedical%technique	188	198	abstract	33212907
,	I-biomedical%technique	198	199	abstract	33212907
double-blinded	I-biomedical%technique	200	214	abstract	33212907
,	I-biomedical%technique	214	215	abstract	33212907
two-arm	I-biomedical%technique	216	223	abstract	33212907
feasibility	I-biomedical%technique	224	235	abstract	33212907
study	I-biomedical%technique	236	241	abstract	33212907
,	O	241	242	abstract	33212907
we	O	243	245	abstract	33212907
investigated	O	246	258	abstract	33212907
whether	O	259	266	abstract	33212907
intermittent	O	267	279	abstract	33212907
fasting	O	280	287	abstract	33212907
,	O	287	288	abstract	33212907
supplemented	O	289	301	abstract	33212907
with	O	302	306	abstract	33212907
<	B-dietary%supplement	307	308	abstract	33212907
i	I-dietary%supplement	308	309	abstract	33212907
>	I-dietary%supplement	309	310	abstract	33212907
Lacticaseibacillus	I-dietary%supplement	310	328	abstract	33212907
rhamnosus</i	I-dietary%supplement	329	341	abstract	33212907
>	I-dietary%supplement	341	342	abstract	33212907
HN001	I-dietary%supplement	343	348	abstract	33212907
probiotic	I-dietary%supplement	349	358	abstract	33212907
,	O	358	359	abstract	33212907
reduces	O	360	367	abstract	33212907
HbA1c	B-chemical	368	373	abstract	33212907
in	O	374	376	abstract	33212907
individuals	B-human	377	388	abstract	33212907
with	O	389	393	abstract	33212907
prediabetes	B-DDF	394	405	abstract	33212907
.	O	405	406	abstract	33212907

All	O	407	410	abstract	33212907
participants	B-human	411	423	abstract	33212907
with	O	424	428	abstract	33212907
HbA1c	B-chemical	429	434	abstract	33212907
40	O	435	437	abstract	33212907
-	O	437	438	abstract	33212907
50	O	438	440	abstract	33212907
mmol/mol	O	441	449	abstract	33212907
commenced	O	450	459	abstract	33212907
intermittent	O	460	472	abstract	33212907
fasting	O	473	480	abstract	33212907
(	O	481	482	abstract	33212907
2	O	482	483	abstract	33212907
days	O	484	488	abstract	33212907
per	O	489	492	abstract	33212907
week	O	493	497	abstract	33212907
of	O	498	500	abstract	33212907
calorie	O	501	508	abstract	33212907
restriction	O	509	520	abstract	33212907
to	O	521	523	abstract	33212907
600	O	524	527	abstract	33212907
-	O	527	528	abstract	33212907
650	O	528	531	abstract	33212907
kcal/day	O	532	540	abstract	33212907
)	O	540	541	abstract	33212907
and	O	542	545	abstract	33212907
were	O	546	550	abstract	33212907
randomized	O	551	561	abstract	33212907
1:1	O	562	565	abstract	33212907
to	O	566	568	abstract	33212907
either	O	569	575	abstract	33212907
daily	B-dietary%supplement	576	581	abstract	33212907
probiotic	I-dietary%supplement	582	591	abstract	33212907
(	O	592	593	abstract	33212907
<	B-dietary%supplement	593	594	abstract	33212907
i	I-dietary%supplement	594	595	abstract	33212907
>	I-dietary%supplement	595	596	abstract	33212907
Lacticaseibacillus	I-dietary%supplement	596	614	abstract	33212907
rhamnosus</i	I-dietary%supplement	615	627	abstract	33212907
>	I-dietary%supplement	627	628	abstract	33212907
HN001	I-dietary%supplement	629	634	abstract	33212907
)	O	634	635	abstract	33212907
or	O	636	638	abstract	33212907
placebo	O	639	646	abstract	33212907
for	O	647	650	abstract	33212907
12	O	651	653	abstract	33212907
weeks	O	654	659	abstract	33212907
.	O	659	660	abstract	33212907

The	O	661	664	abstract	33212907
primary	O	665	672	abstract	33212907
outcome	O	673	680	abstract	33212907
was	O	681	684	abstract	33212907
a	O	685	686	abstract	33212907
change	O	687	693	abstract	33212907
in	O	694	696	abstract	33212907
HbA1c	B-chemical	697	702	abstract	33212907
.	O	702	703	abstract	33212907

Secondary	O	704	713	abstract	33212907
outcomes	O	714	722	abstract	33212907
included	O	723	731	abstract	33212907
changes	O	732	739	abstract	33212907
in	O	740	742	abstract	33212907
anthropometry	O	743	756	abstract	33212907
,	O	756	757	abstract	33212907
body	O	758	762	abstract	33212907
composition	O	763	774	abstract	33212907
,	O	774	775	abstract	33212907
glucoregulatory	O	776	791	abstract	33212907
markers	O	792	799	abstract	33212907
,	O	799	800	abstract	33212907
lipids	B-chemical	801	807	abstract	33212907
,	O	807	808	abstract	33212907
hunger	B-chemical	809	815	abstract	33212907
hormones	I-chemical	816	824	abstract	33212907
,	O	824	825	abstract	33212907
liver	O	826	831	abstract	33212907
enzymes	O	832	839	abstract	33212907
,	O	839	840	abstract	33212907
inflammatory	O	841	853	abstract	33212907
markers	O	854	861	abstract	33212907
,	O	861	862	abstract	33212907
gut	B-chemical	863	866	abstract	33212907
hormones	I-chemical	867	875	abstract	33212907
,	O	875	876	abstract	33212907
calorie	O	877	884	abstract	33212907
and	O	885	888	abstract	33212907
macronutrient	O	889	902	abstract	33212907
intake	O	903	909	abstract	33212907
,	O	909	910	abstract	33212907
quality	O	911	918	abstract	33212907
of	O	919	921	abstract	33212907
life	O	922	926	abstract	33212907
,	O	926	927	abstract	33212907
hunger	O	928	934	abstract	33212907
,	O	934	935	abstract	33212907
mood	O	936	940	abstract	33212907
and	O	941	944	abstract	33212907
eating	O	945	951	abstract	33212907
behavior	O	952	960	abstract	33212907
.	O	960	961	abstract	33212907

Of	O	962	964	abstract	33212907
33	O	965	967	abstract	33212907
participants	B-human	968	980	abstract	33212907
who	O	981	984	abstract	33212907
commenced	O	985	994	abstract	33212907
the	O	995	998	abstract	33212907
trial	O	999	1004	abstract	33212907
,	O	1004	1005	abstract	33212907
26	O	1006	1008	abstract	33212907
participants	B-human	1009	1021	abstract	33212907
(	O	1022	1023	abstract	33212907
mean	O	1023	1027	abstract	33212907
age	O	1028	1031	abstract	33212907
52	O	1032	1034	abstract	33212907
years	O	1035	1040	abstract	33212907
,	O	1040	1041	abstract	33212907
body	O	1042	1046	abstract	33212907
mass	O	1047	1051	abstract	33212907
index	O	1052	1057	abstract	33212907
(	O	1058	1059	abstract	33212907
BMI	O	1059	1062	abstract	33212907
)	O	1062	1063	abstract	33212907
34.7	O	1064	1068	abstract	33212907
kg/m	O	1069	1073	abstract	33212907
<	O	1073	1074	abstract	33212907
sup>2</sup	O	1074	1084	abstract	33212907
>	O	1084	1085	abstract	33212907
)	O	1085	1086	abstract	33212907
completed	O	1087	1096	abstract	33212907
the	O	1097	1100	abstract	33212907
intervention	O	1101	1113	abstract	33212907
(	O	1114	1115	abstract	33212907
<	O	1115	1116	abstract	33212907
i	O	1116	1117	abstract	33212907
>	O	1117	1118	abstract	33212907
n</i	O	1118	1122	abstract	33212907
>	O	1122	1123	abstract	33212907
=	O	1124	1125	abstract	33212907
11	O	1126	1128	abstract	33212907
placebo	B-drug	1129	1136	abstract	33212907
,	O	1136	1137	abstract	33212907
<	O	1138	1139	abstract	33212907
i	O	1139	1140	abstract	33212907
>	O	1140	1141	abstract	33212907
n</i	O	1141	1145	abstract	33212907
>	O	1145	1146	abstract	33212907
=	O	1147	1148	abstract	33212907
15	O	1149	1151	abstract	33212907
probiotic	B-dietary%supplement	1152	1161	abstract	33212907
)	O	1161	1162	abstract	33212907
.	O	1162	1163	abstract	33212907

HbA1c	B-chemical	1164	1169	abstract	33212907
decreased	O	1170	1179	abstract	33212907
from	O	1180	1184	abstract	33212907
43	O	1185	1187	abstract	33212907
	O	1188	1189	abstract	33212907
2.7	O	1190	1193	abstract	33212907
mmol/mol	O	1194	1202	abstract	33212907
to	O	1203	1205	abstract	33212907
41	O	1206	1208	abstract	33212907
	O	1209	1210	abstract	33212907
2.3	O	1211	1214	abstract	33212907
mmol/mol	O	1215	1223	abstract	33212907
,	O	1223	1224	abstract	33212907
<	O	1225	1226	abstract	33212907
i	O	1226	1227	abstract	33212907
>	O	1227	1228	abstract	33212907
p</i	O	1228	1232	abstract	33212907
>	O	1232	1233	abstract	33212907
<	O	1234	1235	abstract	33212907
0.001	O	1236	1241	abstract	33212907
,	O	1241	1242	abstract	33212907
with	O	1243	1247	abstract	33212907
average	O	1248	1255	abstract	33212907
of	O	1256	1258	abstract	33212907
5	O	1259	1260	abstract	33212907
%	O	1260	1261	abstract	33212907
weight	O	1262	1268	abstract	33212907
loss	O	1269	1273	abstract	33212907
.	O	1273	1274	abstract	33212907

No	O	1275	1277	abstract	33212907
significant	O	1278	1289	abstract	33212907
between-group	O	1290	1303	abstract	33212907
differences	O	1304	1315	abstract	33212907
were	O	1316	1320	abstract	33212907
seen	O	1321	1325	abstract	33212907
in	O	1326	1328	abstract	33212907
primary	O	1329	1336	abstract	33212907
or	O	1337	1339	abstract	33212907
secondary	O	1340	1349	abstract	33212907
outcomes	O	1350	1358	abstract	33212907
except	O	1359	1365	abstract	33212907
for	O	1366	1369	abstract	33212907
social	O	1370	1376	abstract	33212907
functioning	O	1377	1388	abstract	33212907
(	O	1389	1390	abstract	33212907
<	O	1390	1391	abstract	33212907
i	O	1391	1392	abstract	33212907
>	O	1392	1393	abstract	33212907
p</i	O	1393	1397	abstract	33212907
>	O	1397	1398	abstract	33212907
=	O	1399	1400	abstract	33212907
0.050	O	1401	1406	abstract	33212907
)	O	1406	1407	abstract	33212907
and	O	1408	1411	abstract	33212907
mental	O	1412	1418	abstract	33212907
health	O	1419	1425	abstract	33212907
(	O	1426	1427	abstract	33212907
<	O	1427	1428	abstract	33212907
i	O	1428	1429	abstract	33212907
>	O	1429	1430	abstract	33212907
p</i	O	1430	1434	abstract	33212907
>	O	1434	1435	abstract	33212907
=	O	1436	1437	abstract	33212907
0.007	O	1438	1443	abstract	33212907
)	O	1443	1444	abstract	33212907
scores	O	1445	1451	abstract	33212907
as	O	1452	1454	abstract	33212907
improvements	O	1455	1467	abstract	33212907
were	O	1468	1472	abstract	33212907
seen	O	1473	1477	abstract	33212907
in	O	1478	1480	abstract	33212907
the	O	1481	1484	abstract	33212907
probiotic	B-human	1485	1494	abstract	33212907
group	I-human	1495	1500	abstract	33212907
,	O	1500	1501	abstract	33212907
but	O	1502	1505	abstract	33212907
not	O	1506	1509	abstract	33212907
in	O	1510	1512	abstract	33212907
the	O	1513	1516	abstract	33212907
placebo	B-human	1517	1524	abstract	33212907
group	I-human	1525	1530	abstract	33212907
.	O	1530	1531	abstract	33212907

This	O	1532	1536	abstract	33212907
study	O	1537	1542	abstract	33212907
shows	O	1543	1548	abstract	33212907
additional	O	1549	1559	abstract	33212907
psychological	O	1560	1573	abstract	33212907
benefits	O	1574	1582	abstract	33212907
of	O	1583	1585	abstract	33212907
probiotic	B-dietary%supplement	1586	1595	abstract	33212907
supplementation	I-dietary%supplement	1596	1611	abstract	33212907
during	O	1612	1618	abstract	33212907
intermittent	O	1619	1631	abstract	33212907
fasting	O	1632	1639	abstract	33212907
to	O	1640	1642	abstract	33212907
achieve	O	1643	1650	abstract	33212907
weight	O	1651	1657	abstract	33212907
loss	O	1658	1662	abstract	33212907
and	O	1663	1666	abstract	33212907
glycemic	O	1667	1675	abstract	33212907
improvement	O	1676	1687	abstract	33212907
in	O	1688	1690	abstract	33212907
prediabetes	B-DDF	1691	1702	abstract	33212907
.	O	1702	1703	abstract	33212907

The	O	0	3	title	36698474
different	O	4	13	title	36698474
trends	O	14	20	title	36698474
in	O	21	23	title	36698474
the	O	24	27	title	36698474
burden	O	28	34	title	36698474
of	O	35	37	title	36698474
neurological	B-DDF	38	50	title	36698474
and	I-DDF	51	54	title	36698474
mental	I-DDF	55	61	title	36698474
disorders	I-DDF	62	71	title	36698474
following	O	72	81	title	36698474
dietary	O	82	89	title	36698474
transition	O	90	100	title	36698474
in	O	101	103	title	36698474
China	O	104	109	title	36698474
,	O	109	110	title	36698474
the	O	111	114	title	36698474
USA	O	115	118	title	36698474
,	O	118	119	title	36698474
and	O	120	123	title	36698474
the	O	124	127	title	36698474
world	O	128	133	title	36698474
:	O	133	134	title	36698474
An	O	135	137	title	36698474
extension	O	138	147	title	36698474
analysis	O	148	156	title	36698474
for	O	157	160	title	36698474
the	O	161	164	title	36698474
Global	O	165	171	title	36698474
Burden	O	172	178	title	36698474
of	O	179	181	title	36698474
Disease	O	182	189	title	36698474
Study	O	190	195	title	36698474
2019	O	196	200	title	36698474
.	O	200	201	title	36698474

The	O	0	3	abstract	36698474
highly	O	4	10	abstract	36698474
processed	O	11	20	abstract	36698474
western	O	21	28	abstract	36698474
diet	O	29	33	abstract	36698474
is	O	34	36	abstract	36698474
substituting	O	37	49	abstract	36698474
the	O	50	53	abstract	36698474
low-processed	O	54	67	abstract	36698474
traditional	O	68	79	abstract	36698474
diet	O	80	84	abstract	36698474
in	O	85	87	abstract	36698474
the	O	88	91	abstract	36698474
last	O	92	96	abstract	36698474
decades	O	97	104	abstract	36698474
globally	O	105	113	abstract	36698474
.	O	113	114	abstract	36698474

Increasing	O	115	125	abstract	36698474
research	O	126	134	abstract	36698474
found	O	135	140	abstract	36698474
that	O	141	145	abstract	36698474
a	O	146	147	abstract	36698474
diet	O	148	152	abstract	36698474
with	O	153	157	abstract	36698474
poor	O	158	162	abstract	36698474
quality	O	163	170	abstract	36698474
such	O	171	175	abstract	36698474
as	O	176	178	abstract	36698474
western	O	179	186	abstract	36698474
diet	O	187	191	abstract	36698474
disrupts	O	192	200	abstract	36698474
gut	B-microbiome	201	204	abstract	36698474
microbiota	I-microbiome	205	215	abstract	36698474
and	O	216	219	abstract	36698474
increases	O	220	229	abstract	36698474
the	O	230	233	abstract	36698474
susceptibility	O	234	248	abstract	36698474
to	O	249	251	abstract	36698474
various	O	252	259	abstract	36698474
neurological	B-DDF	260	272	abstract	36698474
and	I-DDF	273	276	abstract	36698474
mental	I-DDF	277	283	abstract	36698474
disorders	I-DDF	284	293	abstract	36698474
,	O	293	294	abstract	36698474
while	O	295	300	abstract	36698474
a	O	301	302	abstract	36698474
balanced	O	303	311	abstract	36698474
diet	O	312	316	abstract	36698474
regulates	O	317	326	abstract	36698474
gut	B-microbiome	327	330	abstract	36698474
microbiota	I-microbiome	331	341	abstract	36698474
and	O	342	345	abstract	36698474
prevents	O	346	354	abstract	36698474
and	O	355	358	abstract	36698474
alleviates	O	359	369	abstract	36698474
the	O	370	373	abstract	36698474
neurological	B-DDF	374	386	abstract	36698474
and	I-DDF	387	390	abstract	36698474
mental	I-DDF	391	397	abstract	36698474
disorders	I-DDF	398	407	abstract	36698474
.	O	407	408	abstract	36698474

Yet	O	409	412	abstract	36698474
,	O	412	413	abstract	36698474
there	O	414	419	abstract	36698474
is	O	420	422	abstract	36698474
limited	O	423	430	abstract	36698474
research	O	431	439	abstract	36698474
on	O	440	442	abstract	36698474
the	O	443	446	abstract	36698474
association	O	447	458	abstract	36698474
between	O	459	466	abstract	36698474
the	O	467	470	abstract	36698474
disease	O	471	478	abstract	36698474
burden	O	479	485	abstract	36698474
expanding	O	486	495	abstract	36698474
of	O	496	498	abstract	36698474
neurological	B-DDF	499	511	abstract	36698474
and	I-DDF	512	515	abstract	36698474
mental	I-DDF	516	522	abstract	36698474
disorders	I-DDF	523	532	abstract	36698474
with	O	533	537	abstract	36698474
a	O	538	539	abstract	36698474
dietary	O	540	547	abstract	36698474
transition	O	548	558	abstract	36698474
.	O	558	559	abstract	36698474

We	O	560	562	abstract	36698474
compared	O	563	571	abstract	36698474
the	O	572	575	abstract	36698474
disability-adjusted	O	576	595	abstract	36698474
life-years	O	596	606	abstract	36698474
(	O	607	608	abstract	36698474
DALYs	O	608	613	abstract	36698474
)	O	613	614	abstract	36698474
trend	O	615	620	abstract	36698474
by	O	621	623	abstract	36698474
age	O	624	627	abstract	36698474
for	O	628	631	abstract	36698474
neurological	B-DDF	632	644	abstract	36698474
and	I-DDF	645	648	abstract	36698474
mental	I-DDF	649	655	abstract	36698474
disorders	I-DDF	656	665	abstract	36698474
in	O	666	668	abstract	36698474
China	O	669	674	abstract	36698474
,	O	674	675	abstract	36698474
in	O	676	678	abstract	36698474
the	O	679	682	abstract	36698474
United	O	683	689	abstract	36698474
States	O	690	696	abstract	36698474
of	O	697	699	abstract	36698474
America	O	700	707	abstract	36698474
(	O	708	709	abstract	36698474
USA	O	709	712	abstract	36698474
)	O	712	713	abstract	36698474
,	O	713	714	abstract	36698474
and	O	715	718	abstract	36698474
across	O	719	725	abstract	36698474
the	O	726	729	abstract	36698474
world	O	730	735	abstract	36698474
from	O	736	740	abstract	36698474
1990	O	741	745	abstract	36698474
to	O	746	748	abstract	36698474
2019	O	749	753	abstract	36698474
,	O	753	754	abstract	36698474
evaluated	O	755	764	abstract	36698474
the	O	765	768	abstract	36698474
dietary	O	769	776	abstract	36698474
transition	O	777	787	abstract	36698474
in	O	788	790	abstract	36698474
the	O	791	794	abstract	36698474
past	O	795	799	abstract	36698474
60	O	800	802	abstract	36698474
years	O	803	808	abstract	36698474
,	O	808	809	abstract	36698474
and	O	810	813	abstract	36698474
analyzed	O	814	822	abstract	36698474
the	O	823	826	abstract	36698474
association	O	827	838	abstract	36698474
between	O	839	846	abstract	36698474
the	O	847	850	abstract	36698474
burden	O	851	857	abstract	36698474
trend	O	858	863	abstract	36698474
of	O	864	866	abstract	36698474
the	O	867	870	abstract	36698474
two	O	871	874	abstract	36698474
disorders	O	875	884	abstract	36698474
with	O	885	889	abstract	36698474
the	O	890	893	abstract	36698474
changes	O	894	901	abstract	36698474
in	O	902	904	abstract	36698474
diet	O	905	909	abstract	36698474
composition	O	910	921	abstract	36698474
and	O	922	925	abstract	36698474
food	O	926	930	abstract	36698474
production	O	931	941	abstract	36698474
.	O	941	942	abstract	36698474

We	O	943	945	abstract	36698474
identified	O	946	956	abstract	36698474
an	O	957	959	abstract	36698474
age-related	O	960	971	abstract	36698474
upward	O	972	978	abstract	36698474
pattern	O	979	986	abstract	36698474
in	O	987	989	abstract	36698474
disease	O	990	997	abstract	36698474
burden	O	998	1004	abstract	36698474
in	O	1005	1007	abstract	36698474
China	O	1008	1013	abstract	36698474
.	O	1013	1014	abstract	36698474

Compared	O	1015	1023	abstract	36698474
with	O	1024	1028	abstract	36698474
the	O	1029	1032	abstract	36698474
USA	O	1033	1036	abstract	36698474
and	O	1037	1040	abstract	36698474
the	O	1041	1044	abstract	36698474
world	O	1045	1050	abstract	36698474
,	O	1050	1051	abstract	36698474
the	O	1052	1055	abstract	36698474
Chinese	O	1056	1063	abstract	36698474
neurological	O	1064	1076	abstract	36698474
and	O	1077	1080	abstract	36698474
mental	O	1081	1087	abstract	36698474
disorders	O	1088	1097	abstract	36698474
DALY	O	1098	1102	abstract	36698474
percent	O	1103	1110	abstract	36698474
was	O	1111	1114	abstract	36698474
least	O	1115	1120	abstract	36698474
in	O	1121	1123	abstract	36698474
the	O	1124	1127	abstract	36698474
generation	B-human	1128	1138	abstract	36698474
over	I-human	1139	1143	abstract	36698474
75	I-human	1144	1146	abstract	36698474
but	O	1147	1150	abstract	36698474
rapidly	O	1151	1158	abstract	36698474
increased	O	1159	1168	abstract	36698474
in	O	1169	1171	abstract	36698474
younger	B-human	1172	1179	abstract	36698474
generations	I-human	1180	1191	abstract	36698474
and	O	1192	1195	abstract	36698474
surpassed	O	1196	1205	abstract	36698474
the	O	1206	1209	abstract	36698474
USA	O	1210	1213	abstract	36698474
and/or	O	1214	1220	abstract	36698474
the	O	1221	1224	abstract	36698474
world	O	1225	1230	abstract	36698474
in	O	1231	1233	abstract	36698474
the	O	1234	1237	abstract	36698474
last	O	1238	1242	abstract	36698474
decades	O	1243	1250	abstract	36698474
.	O	1250	1251	abstract	36698474

The	O	1252	1255	abstract	36698474
age-related	O	1256	1267	abstract	36698474
upward	O	1268	1274	abstract	36698474
pattern	O	1275	1282	abstract	36698474
in	O	1283	1285	abstract	36698474
Chinese	O	1286	1293	abstract	36698474
disease	O	1294	1301	abstract	36698474
burdens	O	1302	1309	abstract	36698474
had	O	1310	1313	abstract	36698474
not	O	1314	1317	abstract	36698474
only	O	1318	1322	abstract	36698474
shown	O	1323	1328	abstract	36698474
in	O	1329	1331	abstract	36698474
the	O	1332	1335	abstract	36698474
presence	O	1336	1344	abstract	36698474
of	O	1345	1347	abstract	36698474
cardiovascular	B-DDF	1348	1362	abstract	36698474
diseases	I-DDF	1363	1371	abstract	36698474
,	O	1371	1372	abstract	36698474
neoplasms	B-DDF	1373	1382	abstract	36698474
,	O	1382	1383	abstract	36698474
and	O	1384	1387	abstract	36698474
diabetes	B-DDF	1388	1396	abstract	36698474
mellitus	I-DDF	1397	1405	abstract	36698474
but	O	1406	1409	abstract	36698474
also	O	1410	1414	abstract	36698474
appeared	O	1415	1423	abstract	36698474
in	O	1424	1426	abstract	36698474
the	O	1427	1430	abstract	36698474
presence	O	1431	1439	abstract	36698474
of	O	1440	1442	abstract	36698474
depressive	B-DDF	1443	1453	abstract	36698474
disorders	I-DDF	1454	1463	abstract	36698474
,	O	1463	1464	abstract	36698474
Parkinson	B-DDF	1465	1474	abstract	36698474
's	I-DDF	1474	1476	abstract	36698474
disease	I-DDF	1477	1484	abstract	36698474
,	O	1484	1485	abstract	36698474
Alzheimer	B-DDF	1486	1495	abstract	36698474
's	I-DDF	1495	1497	abstract	36698474
disease	I-DDF	1498	1505	abstract	36698474
and	O	1506	1509	abstract	36698474
other	O	1510	1515	abstract	36698474
dementias	B-DDF	1516	1525	abstract	36698474
,	O	1525	1526	abstract	36698474
schizophrenia	B-DDF	1527	1540	abstract	36698474
,	O	1540	1541	abstract	36698474
headache	B-DDF	1542	1550	abstract	36698474
disorders	I-DDF	1551	1560	abstract	36698474
,	O	1560	1561	abstract	36698474
anxiety	B-DDF	1562	1569	abstract	36698474
disorders	I-DDF	1570	1579	abstract	36698474
,	O	1579	1580	abstract	36698474
conduct	B-DDF	1581	1588	abstract	36698474
disorders	I-DDF	1589	1598	abstract	36698474
,	O	1598	1599	abstract	36698474
autism	B-DDF	1600	1606	abstract	36698474
spectrum	I-DDF	1607	1615	abstract	36698474
disorders	I-DDF	1616	1625	abstract	36698474
,	O	1625	1626	abstract	36698474
and	O	1627	1630	abstract	36698474
eating	B-DDF	1631	1637	abstract	36698474
disorders	I-DDF	1638	1647	abstract	36698474
,	O	1647	1648	abstract	36698474
successively	O	1649	1661	abstract	36698474
.	O	1661	1662	abstract	36698474

Additionally	O	1663	1675	abstract	36698474
,	O	1675	1676	abstract	36698474
the	O	1677	1680	abstract	36698474
upward	O	1681	1687	abstract	36698474
trend	O	1688	1693	abstract	36698474
was	O	1694	1697	abstract	36698474
associated	O	1698	1708	abstract	36698474
with	O	1709	1713	abstract	36698474
the	O	1714	1717	abstract	36698474
dramatic	O	1718	1726	abstract	36698474
dietary	O	1727	1734	abstract	36698474
transition	O	1735	1745	abstract	36698474
including	O	1746	1755	abstract	36698474
a	O	1756	1757	abstract	36698474
reduction	O	1758	1767	abstract	36698474
in	O	1768	1770	abstract	36698474
dietary	O	1771	1778	abstract	36698474
quality	O	1779	1786	abstract	36698474
and	O	1787	1790	abstract	36698474
food	O	1791	1795	abstract	36698474
production	O	1796	1806	abstract	36698474
sustainability	O	1807	1821	abstract	36698474
,	O	1821	1822	abstract	36698474
during	O	1823	1829	abstract	36698474
which	O	1830	1835	abstract	36698474
the	O	1836	1839	abstract	36698474
younger	B-human	1840	1847	abstract	36698474
generation	I-human	1848	1858	abstract	36698474
is	O	1859	1861	abstract	36698474
more	O	1862	1866	abstract	36698474
affected	O	1867	1875	abstract	36698474
than	O	1876	1880	abstract	36698474
the	O	1881	1884	abstract	36698474
older	O	1885	1890	abstract	36698474
.	O	1890	1891	abstract	36698474

Following	O	1892	1901	abstract	36698474
the	O	1902	1905	abstract	36698474
increase	O	1906	1914	abstract	36698474
in	O	1915	1917	abstract	36698474
total	O	1918	1923	abstract	36698474
calorie	O	1924	1931	abstract	36698474
intake	O	1932	1938	abstract	36698474
,	O	1938	1939	abstract	36698474
alcohol	O	1940	1947	abstract	36698474
intake	O	1948	1954	abstract	36698474
,	O	1954	1955	abstract	36698474
ratios	O	1956	1962	abstract	36698474
of	O	1963	1965	abstract	36698474
animal	B-food	1966	1972	abstract	36698474
to	I-food	1973	1975	abstract	36698474
vegetal	I-food	1976	1983	abstract	36698474
foods	I-food	1984	1989	abstract	36698474
,	O	1989	1990	abstract	36698474
and	O	1991	1994	abstract	36698474
poultry	B-food	1995	2002	abstract	36698474
meat	I-food	2003	2007	abstract	36698474
to	O	2008	2010	abstract	36698474
pulses	O	2011	2017	abstract	36698474
,	O	2017	2018	abstract	36698474
the	O	2019	2022	abstract	36698474
burdens	O	2023	2030	abstract	36698474
of	O	2031	2033	abstract	36698474
the	O	2034	2037	abstract	36698474
above	O	2038	2043	abstract	36698474
diseases	O	2044	2052	abstract	36698474
continuously	O	2053	2065	abstract	36698474
rose	O	2066	2070	abstract	36698474
.	O	2070	2071	abstract	36698474

Then	O	2072	2076	abstract	36698474
,	O	2076	2077	abstract	36698474
following	O	2078	2087	abstract	36698474
the	O	2088	2091	abstract	36698474
rise	O	2092	2096	abstract	36698474
of	O	2097	2099	abstract	36698474
the	O	2100	2103	abstract	36698474
ratios	O	2104	2110	abstract	36698474
of	O	2111	2113	abstract	36698474
meat	B-food	2114	2118	abstract	36698474
to	O	2119	2121	abstract	36698474
pulses	O	2122	2128	abstract	36698474
,	O	2128	2129	abstract	36698474
eggs	B-food	2130	2134	abstract	36698474
to	O	2135	2137	abstract	36698474
pulses	O	2138	2144	abstract	36698474
,	O	2144	2145	abstract	36698474
and	O	2146	2149	abstract	36698474
pork	B-food	2150	2154	abstract	36698474
to	O	2155	2157	abstract	36698474
pulses	O	2158	2164	abstract	36698474
,	O	2164	2165	abstract	36698474
the	O	2166	2169	abstract	36698474
usage	O	2170	2175	abstract	36698474
of	O	2176	2178	abstract	36698474
fertilizers	B-chemical	2179	2190	abstract	36698474
,	O	2190	2191	abstract	36698474
the	O	2192	2195	abstract	36698474
farming	O	2196	2203	abstract	36698474
density	O	2204	2211	abstract	36698474
of	O	2212	2214	abstract	36698474
pigs	B-animal	2215	2219	abstract	36698474
,	O	2219	2220	abstract	36698474
and	O	2221	2224	abstract	36698474
the	O	2225	2228	abstract	36698474
burdens	O	2229	2236	abstract	36698474
of	O	2237	2239	abstract	36698474
the	O	2240	2243	abstract	36698474
above	O	2244	2249	abstract	36698474
disease	O	2250	2257	abstract	36698474
except	O	2258	2264	abstract	36698474
diabetes	B-DDF	2265	2273	abstract	36698474
mellitus	I-DDF	2274	2282	abstract	36698474
were	O	2283	2287	abstract	36698474
also	O	2288	2292	abstract	36698474
ever-increasing	O	2293	2308	abstract	36698474
.	O	2308	2309	abstract	36698474

Even	O	2310	2314	abstract	36698474
the	O	2315	2318	abstract	36698474
usage	O	2319	2324	abstract	36698474
of	O	2325	2327	abstract	36698474
pesticides	B-chemical	2328	2338	abstract	36698474
was	O	2339	2342	abstract	36698474
positively	O	2343	2353	abstract	36698474
correlated	O	2354	2364	abstract	36698474
with	O	2365	2369	abstract	36698474
the	O	2370	2373	abstract	36698474
burdens	O	2374	2381	abstract	36698474
of	O	2382	2384	abstract	36698474
Parkinson	B-DDF	2385	2394	abstract	36698474
's	I-DDF	2394	2396	abstract	36698474
disease	I-DDF	2397	2404	abstract	36698474
,	O	2404	2405	abstract	36698474
schizophrenia	B-DDF	2406	2419	abstract	36698474
,	O	2419	2420	abstract	36698474
cardiovascular	B-DDF	2421	2435	abstract	36698474
diseases	I-DDF	2436	2444	abstract	36698474
,	O	2444	2445	abstract	36698474
and	O	2446	2449	abstract	36698474
neoplasms	B-DDF	2450	2459	abstract	36698474
.	O	2459	2460	abstract	36698474

Contrary	O	2461	2469	abstract	36698474
to	O	2470	2472	abstract	36698474
China	O	2473	2478	abstract	36698474
,	O	2478	2479	abstract	36698474
the	O	2480	2483	abstract	36698474
corresponding	O	2484	2497	abstract	36698474
burdens	O	2498	2505	abstract	36698474
of	O	2506	2508	abstract	36698474
the	O	2509	2512	abstract	36698474
USA	O	2513	2516	abstract	36698474
trended	O	2517	2524	abstract	36698474
to	O	2525	2527	abstract	36698474
reduce	O	2528	2534	abstract	36698474
with	O	2535	2539	abstract	36698474
the	O	2540	2543	abstract	36698474
improvements	O	2544	2556	abstract	36698474
in	O	2557	2559	abstract	36698474
diet	O	2560	2564	abstract	36698474
quality	O	2565	2572	abstract	36698474
and	O	2573	2576	abstract	36698474
food	O	2577	2581	abstract	36698474
production	O	2582	2592	abstract	36698474
sustainability	O	2593	2607	abstract	36698474
.	O	2607	2608	abstract	36698474

Our	O	2609	2612	abstract	36698474
results	O	2613	2620	abstract	36698474
suggest	O	2621	2628	abstract	36698474
that	O	2629	2633	abstract	36698474
improving	O	2634	2643	abstract	36698474
diet	O	2644	2648	abstract	36698474
quality	O	2649	2656	abstract	36698474
and	O	2657	2660	abstract	36698474
food	O	2661	2665	abstract	36698474
production	O	2666	2676	abstract	36698474
sustainability	O	2677	2691	abstract	36698474
might	O	2692	2697	abstract	36698474
be	O	2698	2700	abstract	36698474
a	O	2701	2702	abstract	36698474
promising	O	2703	2712	abstract	36698474
way	O	2713	2716	abstract	36698474
to	O	2717	2719	abstract	36698474
stop	O	2720	2724	abstract	36698474
the	O	2725	2728	abstract	36698474
expanding	O	2729	2738	abstract	36698474
burdens	O	2739	2746	abstract	36698474
of	O	2747	2749	abstract	36698474
neurological	B-DDF	2750	2762	abstract	36698474
and	I-DDF	2763	2766	abstract	36698474
mental	I-DDF	2767	2773	abstract	36698474
disorders	I-DDF	2774	2783	abstract	36698474
.	O	2783	2784	abstract	36698474

Study	O	0	5	title	37481569
of	O	6	8	title	37481569
the	O	9	12	title	37481569
gut	B-microbiome	13	16	title	37481569
microbiome	I-microbiome	17	27	title	37481569
in	O	28	30	title	37481569
Egyptian	B-human	31	39	title	37481569
patients	I-human	40	48	title	37481569
with	O	49	53	title	37481569
Parkinson	B-DDF	54	63	title	37481569
's	I-DDF	63	65	title	37481569
Disease	I-DDF	66	73	title	37481569
.	O	73	74	title	37481569

Recently	O	0	8	abstract	37481569
,	O	8	9	abstract	37481569
an	O	10	12	abstract	37481569
important	O	13	22	abstract	37481569
relationship	O	23	35	abstract	37481569
between	O	36	43	abstract	37481569
Parkinson	B-DDF	44	53	abstract	37481569
's	I-DDF	53	55	abstract	37481569
disease	I-DDF	56	63	abstract	37481569
and	O	64	67	abstract	37481569
the	O	68	71	abstract	37481569
gut	B-microbiome	72	75	abstract	37481569
microbiota	I-microbiome	76	86	abstract	37481569
,	O	86	87	abstract	37481569
through	O	88	95	abstract	37481569
the	O	96	99	abstract	37481569
brain-gut	O	100	109	abstract	37481569
axis	O	110	114	abstract	37481569
interactions	O	115	127	abstract	37481569
,	O	127	128	abstract	37481569
has	O	129	132	abstract	37481569
been	O	133	137	abstract	37481569
established	O	138	149	abstract	37481569
.	O	149	150	abstract	37481569

Previous	O	151	159	abstract	37481569
studies	O	160	167	abstract	37481569
have	O	168	172	abstract	37481569
declared	O	173	181	abstract	37481569
that	O	182	186	abstract	37481569
alterations	O	187	198	abstract	37481569
in	O	199	201	abstract	37481569
the	O	202	205	abstract	37481569
gut	B-microbiome	206	209	abstract	37481569
microbiota	I-microbiome	210	220	abstract	37481569
have	O	221	225	abstract	37481569
a	O	226	227	abstract	37481569
great	O	228	233	abstract	37481569
impact	O	234	240	abstract	37481569
on	O	241	243	abstract	37481569
the	O	244	247	abstract	37481569
pathogenesis	O	248	260	abstract	37481569
and	O	261	264	abstract	37481569
clinical	O	265	273	abstract	37481569
picture	O	274	281	abstract	37481569
of	O	282	284	abstract	37481569
Parkinson	B-DDF	285	294	abstract	37481569
's	I-DDF	294	296	abstract	37481569
disease	I-DDF	297	304	abstract	37481569
(	O	305	306	abstract	37481569
PD	B-DDF	306	308	abstract	37481569
)	O	308	309	abstract	37481569
.	O	309	310	abstract	37481569

The	O	311	314	abstract	37481569
present	O	315	322	abstract	37481569
study	O	323	328	abstract	37481569
aimed	O	329	334	abstract	37481569
to	O	335	337	abstract	37481569
identify	O	338	346	abstract	37481569
the	O	347	350	abstract	37481569
gut	B-microbiome	351	354	abstract	37481569
microbiome	I-microbiome	355	365	abstract	37481569
that	O	366	370	abstract	37481569
is	O	371	373	abstract	37481569
likely	O	374	380	abstract	37481569
related	O	381	388	abstract	37481569
to	O	389	391	abstract	37481569
Parkinson	B-DDF	392	401	abstract	37481569
's	I-DDF	401	403	abstract	37481569
disease	I-DDF	404	411	abstract	37481569
as	O	412	414	abstract	37481569
well	O	415	419	abstract	37481569
as	O	420	422	abstract	37481569
their	O	423	428	abstract	37481569
possible	O	429	437	abstract	37481569
relation	O	438	446	abstract	37481569
to	O	447	449	abstract	37481569
clinical	O	450	458	abstract	37481569
phenotypes	O	459	469	abstract	37481569
.	O	469	470	abstract	37481569

Thirty	O	471	477	abstract	37481569
patients	B-human	478	486	abstract	37481569
with	O	487	491	abstract	37481569
Parkinson	B-DDF	492	501	abstract	37481569
's	I-DDF	501	503	abstract	37481569
disease	I-DDF	504	511	abstract	37481569
,	O	511	512	abstract	37481569
who	O	513	516	abstract	37481569
presented	O	517	526	abstract	37481569
to	O	527	529	abstract	37481569
the	O	530	533	abstract	37481569
Parkinson	O	534	543	abstract	37481569
's	O	543	545	abstract	37481569
disease	O	546	553	abstract	37481569
Neurology	O	554	563	abstract	37481569
Clinic	O	564	570	abstract	37481569
of	O	571	573	abstract	37481569
Alexandria	O	574	584	abstract	37481569
University	O	585	595	abstract	37481569
Hospital	O	596	604	abstract	37481569
were	O	605	609	abstract	37481569
enrolled	O	610	618	abstract	37481569
in	O	619	621	abstract	37481569
our	O	622	625	abstract	37481569
study	O	626	631	abstract	37481569
.	O	631	632	abstract	37481569

A	O	633	634	abstract	37481569
cross-matching	O	635	649	abstract	37481569
control	O	650	657	abstract	37481569
group	O	658	663	abstract	37481569
of	O	664	666	abstract	37481569
35	O	667	669	abstract	37481569
healthy	B-human	670	677	abstract	37481569
subjects	I-human	678	686	abstract	37481569
of	O	687	689	abstract	37481569
similar	O	690	697	abstract	37481569
age	O	698	701	abstract	37481569
and	O	702	705	abstract	37481569
sex	O	706	709	abstract	37481569
were	O	710	714	abstract	37481569
included	O	715	723	abstract	37481569
.	O	723	724	abstract	37481569

Stool	O	725	730	abstract	37481569
specimens	O	731	740	abstract	37481569
were	O	741	745	abstract	37481569
taken	O	746	751	abstract	37481569
from	O	752	756	abstract	37481569
each	O	757	761	abstract	37481569
.	O	761	762	abstract	37481569

Quantitative	B-biomedical%technique	763	775	abstract	37481569
SYBR	I-biomedical%technique	776	780	abstract	37481569
Green	I-biomedical%technique	781	786	abstract	37481569
Real-Time	I-biomedical%technique	787	796	abstract	37481569
PCR	I-biomedical%technique	797	800	abstract	37481569
was	O	801	804	abstract	37481569
done	O	805	809	abstract	37481569
for	O	810	813	abstract	37481569
the	O	814	817	abstract	37481569
identification	O	818	832	abstract	37481569
and	O	833	836	abstract	37481569
quantitation	O	837	849	abstract	37481569
of	O	850	852	abstract	37481569
selected	O	853	861	abstract	37481569
bacterial	O	862	871	abstract	37481569
phyla	O	872	877	abstract	37481569
,	O	877	878	abstract	37481569
genera	O	879	885	abstract	37481569
and/or	O	886	892	abstract	37481569
species	O	893	900	abstract	37481569
.	O	900	901	abstract	37481569

There	O	902	907	abstract	37481569
was	O	908	911	abstract	37481569
a	O	912	913	abstract	37481569
significant	O	914	925	abstract	37481569
increase	O	926	934	abstract	37481569
in	O	935	937	abstract	37481569
Bacteroides	B-bacteria	938	949	abstract	37481569
and	O	950	953	abstract	37481569
a	O	954	955	abstract	37481569
significant	O	956	967	abstract	37481569
decrease	O	968	976	abstract	37481569
of	O	977	979	abstract	37481569
Firmicutes	B-bacteria	980	990	abstract	37481569
and	O	991	994	abstract	37481569
Firmicutes	O	995	1005	abstract	37481569
/	O	1006	1007	abstract	37481569
Bacteroidetes	O	1008	1021	abstract	37481569
ratio	O	1022	1027	abstract	37481569
and	O	1028	1031	abstract	37481569
Bifidobacteria	B-bacteria	1032	1046	abstract	37481569
in	O	1047	1049	abstract	37481569
PD	B-human	1050	1052	abstract	37481569
patients	I-human	1053	1061	abstract	37481569
.	O	1061	1062	abstract	37481569

Although	O	1063	1071	abstract	37481569
Prevotella	B-bacteria	1072	1082	abstract	37481569
was	O	1083	1086	abstract	37481569
decreased	O	1087	1096	abstract	37481569
among	O	1097	1102	abstract	37481569
PD	B-human	1103	1105	abstract	37481569
patients	I-human	1106	1114	abstract	37481569
relative	O	1115	1123	abstract	37481569
to	O	1124	1126	abstract	37481569
the	O	1127	1130	abstract	37481569
healthy	B-human	1131	1138	abstract	37481569
control	I-human	1139	1146	abstract	37481569
,	O	1146	1147	abstract	37481569
the	O	1148	1151	abstract	37481569
difference	O	1152	1162	abstract	37481569
was	O	1163	1166	abstract	37481569
not	O	1167	1170	abstract	37481569
statistically	O	1171	1184	abstract	37481569
significant	O	1185	1196	abstract	37481569
.	O	1196	1197	abstract	37481569

Comparing	O	1198	1207	abstract	37481569
the	O	1208	1211	abstract	37481569
PD	O	1212	1214	abstract	37481569
clinical	O	1215	1223	abstract	37481569
phenotypes	O	1224	1234	abstract	37481569
with	O	1235	1239	abstract	37481569
the	O	1240	1243	abstract	37481569
control	O	1244	1251	abstract	37481569
group	O	1252	1257	abstract	37481569
,	O	1257	1258	abstract	37481569
the	O	1259	1262	abstract	37481569
Mixed	O	1263	1268	abstract	37481569
phenotype	O	1269	1278	abstract	37481569
had	O	1279	1282	abstract	37481569
significantly	O	1283	1296	abstract	37481569
higher	O	1297	1303	abstract	37481569
Bacteroides	B-bacteria	1304	1315	abstract	37481569
,	O	1315	1316	abstract	37481569
Tremors	O	1317	1324	abstract	37481569
predominant	O	1325	1336	abstract	37481569
had	O	1337	1340	abstract	37481569
lower	O	1341	1346	abstract	37481569
Firmicutes	B-bacteria	1347	1357	abstract	37481569
and	O	1358	1361	abstract	37481569
Firmicutes	O	1362	1372	abstract	37481569
/	O	1373	1374	abstract	37481569
Bacteroidetes	O	1375	1388	abstract	37481569
ratio	O	1389	1394	abstract	37481569
,	O	1394	1395	abstract	37481569
and	O	1396	1399	abstract	37481569
both	O	1400	1404	abstract	37481569
tremors	B-DDF	1405	1412	abstract	37481569
and	O	1413	1416	abstract	37481569
postural	B-DDF	1417	1425	abstract	37481569
instability	I-DDF	1426	1437	abstract	37481569
and	O	1438	1441	abstract	37481569
gait	O	1442	1446	abstract	37481569
disability	O	1447	1457	abstract	37481569
(	O	1458	1459	abstract	37481569
PIGD	O	1459	1463	abstract	37481569
)	O	1463	1464	abstract	37481569
phenotypes	O	1465	1475	abstract	37481569
had	O	1476	1479	abstract	37481569
lower	O	1480	1485	abstract	37481569
Bifidobacteria	B-bacteria	1486	1500	abstract	37481569
.	O	1500	1501	abstract	37481569

However	O	1502	1509	abstract	37481569
,	O	1509	1510	abstract	37481569
there	O	1511	1516	abstract	37481569
was	O	1517	1520	abstract	37481569
no	O	1521	1523	abstract	37481569
statistically	O	1524	1537	abstract	37481569
significant	O	1538	1549	abstract	37481569
difference	O	1550	1560	abstract	37481569
between	O	1561	1568	abstract	37481569
these	O	1569	1574	abstract	37481569
phenotypes	O	1575	1585	abstract	37481569
.	O	1585	1586	abstract	37481569

Furthermore	O	1587	1598	abstract	37481569
,	O	1598	1599	abstract	37481569
when	O	1600	1604	abstract	37481569
comparing	O	1605	1614	abstract	37481569
tremors	O	1615	1622	abstract	37481569
and	O	1623	1626	abstract	37481569
non-tremors	O	1627	1638	abstract	37481569
predominant	O	1639	1650	abstract	37481569
phenotypes	O	1651	1661	abstract	37481569
;	O	1661	1662	abstract	37481569
Lactobacilli	B-bacteria	1663	1675	abstract	37481569
showed	O	1676	1682	abstract	37481569
a	O	1683	1684	abstract	37481569
significant	O	1685	1696	abstract	37481569
decrease	O	1697	1705	abstract	37481569
in	O	1706	1708	abstract	37481569
non-tremors	O	1709	1720	abstract	37481569
predominant	O	1721	1732	abstract	37481569
phenotypes	O	1733	1743	abstract	37481569
.	O	1743	1744	abstract	37481569

The	O	1745	1748	abstract	37481569
current	O	1749	1756	abstract	37481569
study	O	1757	1762	abstract	37481569
showed	O	1763	1769	abstract	37481569
evidence	O	1770	1778	abstract	37481569
of	O	1779	1781	abstract	37481569
changes	O	1782	1789	abstract	37481569
in	O	1790	1792	abstract	37481569
the	O	1793	1796	abstract	37481569
gut	B-microbiome	1797	1800	abstract	37481569
microbiome	I-microbiome	1801	1811	abstract	37481569
of	O	1812	1814	abstract	37481569
Parkinson	B-human	1815	1824	abstract	37481569
's	I-human	1824	1826	abstract	37481569
disease	I-human	1827	1834	abstract	37481569
patients	I-human	1835	1843	abstract	37481569
compared	O	1844	1852	abstract	37481569
to	O	1853	1855	abstract	37481569
the	O	1856	1859	abstract	37481569
healthy	B-human	1860	1867	abstract	37481569
controls	I-human	1868	1876	abstract	37481569
.	O	1876	1877	abstract	37481569

These	O	1878	1883	abstract	37481569
observations	O	1884	1896	abstract	37481569
may	O	1897	1900	abstract	37481569
highlight	O	1901	1910	abstract	37481569
the	O	1911	1914	abstract	37481569
importance	O	1915	1925	abstract	37481569
of	O	1926	1928	abstract	37481569
the	O	1929	1932	abstract	37481569
identification	O	1933	1947	abstract	37481569
of	O	1948	1950	abstract	37481569
microbiome	B-DDF	1951	1961	abstract	37481569
and	I-DDF	1962	1965	abstract	37481569
specific	I-DDF	1966	1974	abstract	37481569
bacterial	I-DDF	1975	1984	abstract	37481569
changes	I-DDF	1985	1992	abstract	37481569
that	O	1993	1997	abstract	37481569
can	O	1998	2001	abstract	37481569
be	O	2002	2004	abstract	37481569
targeted	O	2005	2013	abstract	37481569
for	O	2014	2017	abstract	37481569
the	O	2018	2021	abstract	37481569
treatment	O	2022	2031	abstract	37481569
of	O	2032	2034	abstract	37481569
Parkinson	B-DDF	2035	2044	abstract	37481569
's	I-DDF	2044	2046	abstract	37481569
disease	I-DDF	2047	2054	abstract	37481569
.	O	2054	2055	abstract	37481569

Impact	O	0	6	title	30818031
of	O	7	9	title	30818031
chemotherapy	O	10	22	title	30818031
on	O	23	25	title	30818031
the	O	26	29	title	30818031
association	O	30	41	title	30818031
between	O	42	49	title	30818031
fear	O	50	54	title	30818031
of	O	55	57	title	30818031
cancer	O	58	64	title	30818031
recurrence	O	65	75	title	30818031
and	O	76	79	title	30818031
the	O	80	83	title	30818031
gut	B-microbiome	84	87	title	30818031
microbiota	I-microbiome	88	98	title	30818031
in	O	99	101	title	30818031
breast	B-human	102	108	title	30818031
cancer	I-human	109	115	title	30818031
survivors	I-human	116	125	title	30818031
.	O	125	126	title	30818031

Dysfunctional	O	0	13	abstract	30818031
processing	O	14	24	abstract	30818031
of	O	25	27	abstract	30818031
fear	O	28	32	abstract	30818031
memory	O	33	39	abstract	30818031
may	O	40	43	abstract	30818031
be	O	44	46	abstract	30818031
involved	O	47	55	abstract	30818031
in	O	56	58	abstract	30818031
the	O	59	62	abstract	30818031
pathophysiology	O	63	78	abstract	30818031
of	O	79	81	abstract	30818031
fear	B-DDF	82	86	abstract	30818031
of	I-DDF	87	89	abstract	30818031
cancer	I-DDF	90	96	abstract	30818031
recurrence	I-DDF	97	107	abstract	30818031
(	O	108	109	abstract	30818031
FCR	B-DDF	109	112	abstract	30818031
)	O	112	113	abstract	30818031
,	O	113	114	abstract	30818031
which	O	115	120	abstract	30818031
is	O	121	123	abstract	30818031
cited	O	124	129	abstract	30818031
as	O	130	132	abstract	30818031
the	O	133	136	abstract	30818031
major	O	137	142	abstract	30818031
unmet	O	143	148	abstract	30818031
psychological	O	149	162	abstract	30818031
need	O	163	167	abstract	30818031
of	O	168	170	abstract	30818031
cancer	B-human	171	177	abstract	30818031
survivors	I-human	178	187	abstract	30818031
.	O	187	188	abstract	30818031

Emerging	O	189	197	abstract	30818031
evidence	O	198	206	abstract	30818031
has	O	207	210	abstract	30818031
shown	O	211	216	abstract	30818031
that	O	217	221	abstract	30818031
the	O	222	225	abstract	30818031
microbiota-gut-brain	O	226	246	abstract	30818031
(	O	247	248	abstract	30818031
MGB	O	248	251	abstract	30818031
)	O	251	252	abstract	30818031
axis	O	253	257	abstract	30818031
affects	O	258	265	abstract	30818031
depressive	B-DDF	266	276	abstract	30818031
and	I-DDF	277	280	abstract	30818031
anxiety	I-DDF	281	288	abstract	30818031
disorders	I-DDF	289	298	abstract	30818031
,	O	298	299	abstract	30818031
and	O	300	303	abstract	30818031
chemotherapy-associated	B-DDF	304	327	abstract	30818031
psychological	I-DDF	328	341	abstract	30818031
distress	I-DDF	342	350	abstract	30818031
.	O	350	351	abstract	30818031

We	O	352	354	abstract	30818031
therefore	O	355	364	abstract	30818031
hypothesized	O	365	377	abstract	30818031
that	O	378	382	abstract	30818031
the	O	383	386	abstract	30818031
gut	B-microbiome	387	390	abstract	30818031
microbiota	I-microbiome	391	401	abstract	30818031
is	O	402	404	abstract	30818031
associated	O	405	415	abstract	30818031
with	O	416	420	abstract	30818031
FCR	B-DDF	421	424	abstract	30818031
in	O	425	427	abstract	30818031
cancer	B-human	428	434	abstract	30818031
survivors	I-human	435	444	abstract	30818031
.	O	444	445	abstract	30818031

This	O	446	450	abstract	30818031
cross-sectional	O	451	466	abstract	30818031
study	O	467	472	abstract	30818031
enrolled	O	473	481	abstract	30818031
women	B-human	482	487	abstract	30818031
diagnosed	O	488	497	abstract	30818031
with	O	498	502	abstract	30818031
invasive	B-DDF	503	511	abstract	30818031
breast	I-DDF	512	518	abstract	30818031
cancer	I-DDF	519	525	abstract	30818031
who	O	526	529	abstract	30818031
were	O	530	534	abstract	30818031
not	O	535	538	abstract	30818031
currently	O	539	548	abstract	30818031
undergoing	O	549	559	abstract	30818031
chemotherapy	O	560	572	abstract	30818031
.	O	572	573	abstract	30818031

Fecal	O	574	579	abstract	30818031
samples	O	580	587	abstract	30818031
were	O	588	592	abstract	30818031
obtained	O	593	601	abstract	30818031
to	O	602	604	abstract	30818031
assess	O	605	611	abstract	30818031
the	O	612	615	abstract	30818031
gut	B-microbiome	616	619	abstract	30818031
microbiota	I-microbiome	620	630	abstract	30818031
.	O	630	631	abstract	30818031

FCR	O	632	635	abstract	30818031
grade	O	636	641	abstract	30818031
was	O	642	645	abstract	30818031
assessed	O	646	654	abstract	30818031
using	O	655	660	abstract	30818031
the	O	661	664	abstract	30818031
Concerns	O	665	673	abstract	30818031
About	O	674	679	abstract	30818031
Recurrence	O	680	690	abstract	30818031
Scale	O	691	696	abstract	30818031
(	O	697	698	abstract	30818031
CARS	O	698	702	abstract	30818031
)	O	702	703	abstract	30818031
.	O	703	704	abstract	30818031

Mean	O	705	709	abstract	30818031
age	O	710	713	abstract	30818031
of	O	714	716	abstract	30818031
the	O	717	720	abstract	30818031
participants	B-human	721	733	abstract	30818031
(	O	734	735	abstract	30818031
n	O	735	736	abstract	30818031
	O	736	737	abstract	30818031
=	O	737	738	abstract	30818031
	O	738	739	abstract	30818031
126	O	739	742	abstract	30818031
)	O	742	743	abstract	30818031
was	O	744	747	abstract	30818031
58	O	748	750	abstract	30818031
	O	750	751	abstract	30818031
years	O	751	756	abstract	30818031
;	O	756	757	abstract	30818031
47	O	758	760	abstract	30818031
%	O	760	761	abstract	30818031
had	O	762	765	abstract	30818031
stage	B-DDF	766	771	abstract	30818031
I	I-DDF	772	773	abstract	30818031
disease	I-DDF	774	781	abstract	30818031
.	O	781	782	abstract	30818031

Multiple	B-statistical%technique	783	791	abstract	30818031
regression	I-statistical%technique	792	802	abstract	30818031
analysis	I-statistical%technique	803	811	abstract	30818031
with	O	812	816	abstract	30818031
adjustment	O	817	827	abstract	30818031
for	O	828	831	abstract	30818031
possible	O	832	840	abstract	30818031
confounders	O	841	852	abstract	30818031
showed	O	853	859	abstract	30818031
that	O	860	864	abstract	30818031
the	O	865	868	abstract	30818031
relative	O	869	877	abstract	30818031
abundance	O	878	887	abstract	30818031
of	O	888	890	abstract	30818031
the	O	891	894	abstract	30818031
Bacteroides	B-bacteria	895	906	abstract	30818031
genus	I-bacteria	907	912	abstract	30818031
(	O	913	914	abstract	30818031
beta	O	914	918	abstract	30818031
	O	918	919	abstract	30818031
=	O	919	920	abstract	30818031
	O	920	921	abstract	30818031
0.180	O	921	926	abstract	30818031
,	O	926	927	abstract	30818031
p	O	928	929	abstract	30818031
	O	929	930	abstract	30818031
=	O	930	931	abstract	30818031
	O	931	932	abstract	30818031
0.03	O	932	936	abstract	30818031
)	O	936	937	abstract	30818031
was	O	938	941	abstract	30818031
significantly	O	942	955	abstract	30818031
and	O	956	959	abstract	30818031
directly	O	960	968	abstract	30818031
associated	O	969	979	abstract	30818031
with	O	980	984	abstract	30818031
FCR	B-DDF	985	988	abstract	30818031
.	O	988	989	abstract	30818031

In	O	990	992	abstract	30818031
the	O	993	996	abstract	30818031
57	O	997	999	abstract	30818031
participants	B-human	1000	1012	abstract	30818031
with	O	1013	1017	abstract	30818031
a	O	1018	1019	abstract	30818031
history	O	1020	1027	abstract	30818031
of	O	1028	1030	abstract	30818031
chemotherapy	O	1031	1043	abstract	30818031
,	O	1043	1044	abstract	30818031
higher	O	1045	1051	abstract	30818031
FCR	B-DDF	1052	1055	abstract	30818031
was	O	1056	1059	abstract	30818031
associated	O	1060	1070	abstract	30818031
with	O	1071	1075	abstract	30818031
lower	O	1076	1081	abstract	30818031
microbial	O	1082	1091	abstract	30818031
diversity	O	1092	1101	abstract	30818031
(	O	1102	1103	abstract	30818031
p	O	1103	1104	abstract	30818031
	O	1104	1105	abstract	30818031
=	O	1105	1106	abstract	30818031
	O	1106	1107	abstract	30818031
0.04	O	1107	1111	abstract	30818031
)	O	1111	1112	abstract	30818031
,	O	1112	1113	abstract	30818031
lower	O	1114	1119	abstract	30818031
relative	O	1120	1128	abstract	30818031
abundance	O	1129	1138	abstract	30818031
of	O	1139	1141	abstract	30818031
Firmicutes	B-bacteria	1142	1152	abstract	30818031
(	O	1153	1154	abstract	30818031
p	O	1154	1155	abstract	30818031
	O	1155	1156	abstract	30818031
=	O	1156	1157	abstract	30818031
	O	1157	1158	abstract	30818031
0.03	O	1158	1162	abstract	30818031
)	O	1162	1163	abstract	30818031
and	O	1164	1167	abstract	30818031
higher	O	1168	1174	abstract	30818031
relative	O	1175	1183	abstract	30818031
abundance	O	1184	1193	abstract	30818031
of	O	1194	1196	abstract	30818031
Bacteroidetes	B-bacteria	1197	1210	abstract	30818031
(	O	1211	1212	abstract	30818031
p	O	1212	1213	abstract	30818031
	O	1213	1214	abstract	30818031
=	O	1214	1215	abstract	30818031
	O	1215	1216	abstract	30818031
0.04	O	1216	1220	abstract	30818031
)	O	1220	1221	abstract	30818031
at	O	1222	1224	abstract	30818031
the	O	1225	1228	abstract	30818031
phylum	O	1229	1235	abstract	30818031
level	O	1236	1241	abstract	30818031
,	O	1241	1242	abstract	30818031
and	O	1243	1246	abstract	30818031
higher	O	1247	1253	abstract	30818031
relative	O	1254	1262	abstract	30818031
abundance	O	1263	1272	abstract	30818031
of	O	1273	1275	abstract	30818031
Bacteroides	B-bacteria	1276	1287	abstract	30818031
(	O	1288	1289	abstract	30818031
p	O	1289	1290	abstract	30818031
	O	1290	1291	abstract	30818031
<	O	1291	1292	abstract	30818031
	O	1292	1293	abstract	30818031
0.01	O	1293	1297	abstract	30818031
)	O	1297	1298	abstract	30818031
and	O	1299	1302	abstract	30818031
lower	O	1303	1308	abstract	30818031
relative	O	1309	1317	abstract	30818031
abundance	O	1318	1327	abstract	30818031
of	O	1328	1330	abstract	30818031
Lachnospiraceae.g	B-bacteria	1331	1348	abstract	30818031
(	O	1349	1350	abstract	30818031
p	O	1350	1351	abstract	30818031
	O	1351	1352	abstract	30818031
=	O	1352	1353	abstract	30818031
	O	1353	1354	abstract	30818031
0.03	O	1354	1358	abstract	30818031
)	O	1358	1359	abstract	30818031
and	O	1360	1363	abstract	30818031
Ruminococcus	B-bacteria	1364	1376	abstract	30818031
(	O	1377	1378	abstract	30818031
p	O	1378	1379	abstract	30818031
	O	1379	1380	abstract	30818031
=	O	1380	1381	abstract	30818031
	O	1381	1382	abstract	30818031
0.02	O	1382	1386	abstract	30818031
)	O	1386	1387	abstract	30818031
at	O	1388	1390	abstract	30818031
the	O	1391	1394	abstract	30818031
genus	O	1395	1400	abstract	30818031
level	O	1401	1406	abstract	30818031
.	O	1406	1407	abstract	30818031

Our	O	1408	1411	abstract	30818031
findings	O	1412	1420	abstract	30818031
provide	O	1421	1428	abstract	30818031
the	O	1429	1432	abstract	30818031
first	O	1433	1438	abstract	30818031
evidence	O	1439	1447	abstract	30818031
of	O	1448	1450	abstract	30818031
an	O	1451	1453	abstract	30818031
association	O	1454	1465	abstract	30818031
between	O	1466	1473	abstract	30818031
the	O	1474	1477	abstract	30818031
gut	B-microbiome	1478	1481	abstract	30818031
microbiota	I-microbiome	1482	1492	abstract	30818031
and	O	1493	1496	abstract	30818031
FCR	B-DDF	1497	1500	abstract	30818031
and	O	1501	1504	abstract	30818031
suggest	O	1505	1512	abstract	30818031
that	O	1513	1517	abstract	30818031
chemotherapy-induced	O	1518	1538	abstract	30818031
changes	O	1539	1546	abstract	30818031
in	O	1547	1549	abstract	30818031
gut	B-microbiome	1550	1553	abstract	30818031
microbiota	I-microbiome	1554	1564	abstract	30818031
can	O	1565	1568	abstract	30818031
influence	O	1569	1578	abstract	30818031
FCR	B-DDF	1579	1582	abstract	30818031
.	O	1582	1583	abstract	30818031

Further	O	1584	1591	abstract	30818031
studies	O	1592	1599	abstract	30818031
should	O	1600	1606	abstract	30818031
examine	O	1607	1614	abstract	30818031
the	O	1615	1618	abstract	30818031
effects	O	1619	1626	abstract	30818031
of	O	1627	1629	abstract	30818031
the	O	1630	1633	abstract	30818031
gut	B-microbiome	1634	1637	abstract	30818031
microbiota	I-microbiome	1638	1648	abstract	30818031
on	O	1649	1651	abstract	30818031
FCR	B-DDF	1652	1655	abstract	30818031
using	O	1656	1661	abstract	30818031
a	O	1662	1663	abstract	30818031
prospective	O	1664	1675	abstract	30818031
design	O	1676	1682	abstract	30818031
.	O	1682	1683	abstract	30818031

Features	O	0	8	title	37168424
of	O	9	11	title	37168424
gut	B-microbiome	12	15	title	37168424
microbiota	I-microbiome	16	26	title	37168424
and	O	27	30	title	37168424
short-chain	B-chemical	31	42	title	37168424
fatty	I-chemical	43	48	title	37168424
acids	I-chemical	49	54	title	37168424
in	O	55	57	title	37168424
patients	B-human	58	66	title	37168424
with	O	67	71	title	37168424
first-episode	B-DDF	72	85	title	37168424
depression	I-DDF	86	96	title	37168424
and	O	97	100	title	37168424
their	O	101	106	title	37168424
relationship	O	107	119	title	37168424
with	O	120	124	title	37168424
the	O	125	128	title	37168424
clinical	O	129	137	title	37168424
symptoms	O	138	146	title	37168424
.	O	146	147	title	37168424

To	O	0	2	abstract	37168424
compare	O	3	10	abstract	37168424
the	O	11	14	abstract	37168424
differences	O	15	26	abstract	37168424
in	O	27	29	abstract	37168424
gut	B-microbiome	30	33	abstract	37168424
microbiota	I-microbiome	34	44	abstract	37168424
and	O	45	48	abstract	37168424
short-chain	B-chemical	49	60	abstract	37168424
fatty	I-chemical	61	66	abstract	37168424
acids	I-chemical	67	72	abstract	37168424
(	O	73	74	abstract	37168424
SCFAs	B-chemical	74	79	abstract	37168424
;	O	79	80	abstract	37168424
metabolites	O	81	92	abstract	37168424
of	O	93	95	abstract	37168424
gut	B-microbiome	96	99	abstract	37168424
microbiota	I-microbiome	100	110	abstract	37168424
)	O	110	111	abstract	37168424
in	O	112	114	abstract	37168424
the	O	115	118	abstract	37168424
serum	O	119	124	abstract	37168424
of	O	125	127	abstract	37168424
patients	B-human	128	136	abstract	37168424
with	O	137	141	abstract	37168424
first-episode	B-DDF	142	155	abstract	37168424
depression	I-DDF	156	166	abstract	37168424
and	O	167	170	abstract	37168424
the	O	171	174	abstract	37168424
healthy	B-human	175	182	abstract	37168424
population	I-human	183	193	abstract	37168424
and	O	194	197	abstract	37168424
to	O	198	200	abstract	37168424
analyze	O	201	208	abstract	37168424
the	O	209	212	abstract	37168424
relationship	O	213	225	abstract	37168424
between	O	226	233	abstract	37168424
gut	B-microbiome	234	237	abstract	37168424
microbiota	I-microbiome	238	248	abstract	37168424
and	O	249	252	abstract	37168424
metabolite	B-chemical	253	263	abstract	37168424
SCFAs	I-chemical	264	269	abstract	37168424
and	O	270	273	abstract	37168424
the	O	274	277	abstract	37168424
clinical	O	278	286	abstract	37168424
symptoms	O	287	295	abstract	37168424
of	O	296	298	abstract	37168424
major	B-DDF	299	304	abstract	37168424
depressive	I-DDF	305	315	abstract	37168424
disorder	I-DDF	316	324	abstract	37168424
(	O	325	326	abstract	37168424
MDD	B-DDF	326	329	abstract	37168424
)	O	329	330	abstract	37168424
.	O	330	331	abstract	37168424

A	O	332	333	abstract	37168424
total	O	334	339	abstract	37168424
of	O	340	342	abstract	37168424
45	O	343	345	abstract	37168424
patients	B-human	346	354	abstract	37168424
with	O	355	359	abstract	37168424
first-episode	B-DDF	360	373	abstract	37168424
depression	I-DDF	374	384	abstract	37168424
and	O	385	388	abstract	37168424
22	O	389	391	abstract	37168424
healthy	B-human	392	399	abstract	37168424
volunteers	I-human	400	410	abstract	37168424
were	O	411	415	abstract	37168424
chosen	O	416	422	abstract	37168424
to	O	423	425	abstract	37168424
complete	O	426	434	abstract	37168424
relevant	O	435	443	abstract	37168424
scale	O	444	449	abstract	37168424
evaluations	O	450	461	abstract	37168424
,	O	461	462	abstract	37168424
and	O	463	466	abstract	37168424
feces	O	467	472	abstract	37168424
samples	O	473	480	abstract	37168424
and	O	481	484	abstract	37168424
venous	O	485	491	abstract	37168424
blood	O	492	497	abstract	37168424
samples	O	498	505	abstract	37168424
were	O	506	510	abstract	37168424
collected	O	511	520	abstract	37168424
.	O	520	521	abstract	37168424

The	O	522	525	abstract	37168424
16S	B-biomedical%technique	526	529	abstract	37168424
RNA	I-biomedical%technique	530	533	abstract	37168424
method	I-biomedical%technique	534	540	abstract	37168424
was	O	541	544	abstract	37168424
used	O	545	549	abstract	37168424
to	O	550	552	abstract	37168424
analyze	O	553	560	abstract	37168424
the	O	561	564	abstract	37168424
intestinal	B-microbiome	565	575	abstract	37168424
microflora	I-microbiome	576	586	abstract	37168424
and	O	587	590	abstract	37168424
the	O	591	594	abstract	37168424
characteristics	O	595	610	abstract	37168424
of	O	611	613	abstract	37168424
serum	O	614	619	abstract	37168424
SCFAs	O	620	625	abstract	37168424
detection	O	626	635	abstract	37168424
by	O	636	638	abstract	37168424
ELISA	B-biomedical%technique	639	644	abstract	37168424
kit	I-biomedical%technique	645	648	abstract	37168424
,	O	648	649	abstract	37168424
as	O	650	652	abstract	37168424
well	O	653	657	abstract	37168424
as	O	658	660	abstract	37168424
the	O	661	664	abstract	37168424
intestinal	O	665	675	abstract	37168424
flora	O	676	681	abstract	37168424
,	O	681	682	abstract	37168424
SCFAs	O	683	688	abstract	37168424
content	O	689	696	abstract	37168424
and	O	697	700	abstract	37168424
their	O	701	706	abstract	37168424
correlation	O	707	718	abstract	37168424
with	O	719	723	abstract	37168424
MDD	O	724	727	abstract	37168424
clinical	O	728	736	abstract	37168424
indicators	O	737	747	abstract	37168424
.	O	747	748	abstract	37168424

The	O	749	752	abstract	37168424
abundance	O	753	762	abstract	37168424
of	O	763	765	abstract	37168424
<	O	766	767	abstract	37168424
i	O	767	768	abstract	37168424
>	O	768	769	abstract	37168424
Akkermansia</i	B-bacteria	769	783	abstract	37168424
>	O	783	784	abstract	37168424
,	O	784	785	abstract	37168424
<	O	786	787	abstract	37168424
i	O	787	788	abstract	37168424
>	O	788	789	abstract	37168424
Megamonas</i	B-bacteria	789	801	abstract	37168424
>	O	801	802	abstract	37168424
,	O	802	803	abstract	37168424
<	O	804	805	abstract	37168424
i	O	805	806	abstract	37168424
>	O	806	807	abstract	37168424
Prevotellaceae	B-bacteria	807	821	abstract	37168424
NK3B31	I-bacteria	822	828	abstract	37168424
group</i	O	829	837	abstract	37168424
>	O	837	838	abstract	37168424
,	O	838	839	abstract	37168424
and	O	840	843	abstract	37168424
butyrate-producing	B-bacteria	844	862	abstract	37168424
bacteria	I-bacteria	863	871	abstract	37168424
,	O	871	872	abstract	37168424
<	O	873	874	abstract	37168424
i	O	874	875	abstract	37168424
>	O	875	876	abstract	37168424
Lachnospira</i	B-bacteria	876	890	abstract	37168424
>	O	890	891	abstract	37168424
,	O	891	892	abstract	37168424
<	O	893	894	abstract	37168424
i	O	894	895	abstract	37168424
>	O	895	896	abstract	37168424
Subdoligranulum</i	B-bacteria	896	914	abstract	37168424
>	O	914	915	abstract	37168424
,	O	915	916	abstract	37168424
<	O	917	918	abstract	37168424
i	O	918	919	abstract	37168424
>	O	919	920	abstract	37168424
Blautia</i	B-bacteria	920	930	abstract	37168424
>	O	930	931	abstract	37168424
,	O	931	932	abstract	37168424
and	O	933	936	abstract	37168424
<	O	937	938	abstract	37168424
i	O	938	939	abstract	37168424
>	O	939	940	abstract	37168424
Dialister</i	B-bacteria	940	952	abstract	37168424
>	O	952	953	abstract	37168424
,	O	953	954	abstract	37168424
and	O	955	958	abstract	37168424
acetate-producing	B-bacteria	959	976	abstract	37168424
bacteria	I-bacteria	977	985	abstract	37168424
,	O	985	986	abstract	37168424
<	O	987	988	abstract	37168424
i	O	988	989	abstract	37168424
>	O	989	990	abstract	37168424
Streptococcus</i	B-bacteria	990	1006	abstract	37168424
>	O	1006	1007	abstract	37168424
,	O	1007	1008	abstract	37168424
in	O	1009	1011	abstract	37168424
the	O	1012	1015	abstract	37168424
gut	B-microbiome	1016	1019	abstract	37168424
microbiota	I-microbiome	1020	1030	abstract	37168424
of	O	1031	1033	abstract	37168424
the	O	1034	1037	abstract	37168424
MDD	B-human	1038	1041	abstract	37168424
group	I-human	1042	1047	abstract	37168424
was	O	1048	1051	abstract	37168424
lower	O	1052	1057	abstract	37168424
than	O	1058	1062	abstract	37168424
that	O	1063	1067	abstract	37168424
in	O	1068	1070	abstract	37168424
the	O	1071	1074	abstract	37168424
control	B-human	1075	1082	abstract	37168424
(	I-human	1083	1084	abstract	37168424
C	I-human	1084	1085	abstract	37168424
)	I-human	1085	1086	abstract	37168424
group	I-human	1087	1092	abstract	37168424
.	O	1092	1093	abstract	37168424

The	O	1094	1097	abstract	37168424
abundance	O	1098	1107	abstract	37168424
of	O	1108	1110	abstract	37168424
<	O	1111	1112	abstract	37168424
i	O	1112	1113	abstract	37168424
>	O	1113	1114	abstract	37168424
Parasutterella</i	B-bacteria	1114	1131	abstract	37168424
>	O	1131	1132	abstract	37168424
in	O	1133	1135	abstract	37168424
the	O	1136	1139	abstract	37168424
MDD	B-human	1140	1143	abstract	37168424
group	I-human	1144	1149	abstract	37168424
was	O	1150	1153	abstract	37168424
higher	O	1154	1160	abstract	37168424
than	O	1161	1165	abstract	37168424
that	O	1166	1170	abstract	37168424
in	O	1171	1173	abstract	37168424
the	O	1174	1177	abstract	37168424
C	B-human	1178	1179	abstract	37168424
group	I-human	1180	1185	abstract	37168424
.	O	1185	1186	abstract	37168424

<	O	1187	1188	abstract	37168424
i	O	1188	1189	abstract	37168424
>	O	1189	1190	abstract	37168424
Dialister</i	B-bacteria	1190	1202	abstract	37168424
>	O	1202	1203	abstract	37168424
negatively	O	1204	1214	abstract	37168424
correlated	O	1215	1225	abstract	37168424
with	O	1226	1230	abstract	37168424
all	O	1231	1234	abstract	37168424
measured	O	1235	1243	abstract	37168424
clinical	O	1244	1252	abstract	37168424
symptoms	O	1253	1261	abstract	37168424
(	O	1262	1263	abstract	37168424
<	O	1263	1264	abstract	37168424
i	O	1264	1265	abstract	37168424
>	O	1265	1266	abstract	37168424
r</i	O	1266	1270	abstract	37168424
>	O	1270	1271	abstract	37168424
<	O	1272	1273	abstract	37168424
0	O	1274	1275	abstract	37168424
,	O	1275	1276	abstract	37168424
<	O	1277	1278	abstract	37168424
i	O	1278	1279	abstract	37168424
>	O	1279	1280	abstract	37168424
P</i	O	1280	1284	abstract	37168424
>	O	1284	1285	abstract	37168424
<	O	1286	1287	abstract	37168424
0.05	O	1288	1292	abstract	37168424
)	O	1292	1293	abstract	37168424
.	O	1293	1294	abstract	37168424

The	O	1295	1298	abstract	37168424
serum	O	1299	1304	abstract	37168424
SCFA	O	1305	1309	abstract	37168424
content	O	1310	1317	abstract	37168424
in	O	1318	1320	abstract	37168424
the	O	1321	1324	abstract	37168424
MDD	B-human	1325	1328	abstract	37168424
group	I-human	1329	1334	abstract	37168424
was	O	1335	1338	abstract	37168424
higher	O	1339	1345	abstract	37168424
than	O	1346	1350	abstract	37168424
that	O	1351	1355	abstract	37168424
in	O	1356	1358	abstract	37168424
the	O	1359	1362	abstract	37168424
C	B-human	1363	1364	abstract	37168424
group	I-human	1365	1370	abstract	37168424
,	O	1370	1371	abstract	37168424
and	O	1372	1375	abstract	37168424
the	O	1376	1379	abstract	37168424
content	O	1380	1387	abstract	37168424
positively	O	1388	1398	abstract	37168424
correlated	O	1399	1409	abstract	37168424
with	O	1410	1414	abstract	37168424
the	O	1415	1418	abstract	37168424
Hamilton	O	1419	1427	abstract	37168424
anxiety	O	1428	1435	abstract	37168424
scale	O	1436	1441	abstract	37168424
scores	O	1442	1448	abstract	37168424
(	O	1449	1450	abstract	37168424
<	O	1450	1451	abstract	37168424
i	O	1451	1452	abstract	37168424
>	O	1452	1453	abstract	37168424
r</i	O	1453	1457	abstract	37168424
>	O	1457	1458	abstract	37168424
=	O	1459	1460	abstract	37168424
0.584	O	1461	1466	abstract	37168424
,	O	1466	1467	abstract	37168424
<	O	1468	1469	abstract	37168424
i	O	1469	1470	abstract	37168424
>	O	1470	1471	abstract	37168424
P</i	O	1471	1475	abstract	37168424
>	O	1475	1476	abstract	37168424
<	O	1477	1478	abstract	37168424
0.05	O	1479	1483	abstract	37168424
)	O	1483	1484	abstract	37168424
.	O	1484	1485	abstract	37168424

The	O	1486	1489	abstract	37168424
results	O	1490	1497	abstract	37168424
demonstrated	O	1498	1510	abstract	37168424
that	O	1511	1515	abstract	37168424
the	O	1516	1519	abstract	37168424
MDD	B-human	1520	1523	abstract	37168424
group	I-human	1524	1529	abstract	37168424
differed	O	1530	1538	abstract	37168424
from	O	1539	1543	abstract	37168424
the	O	1544	1547	abstract	37168424
C	B-human	1548	1549	abstract	37168424
group	I-human	1550	1555	abstract	37168424
in	O	1556	1558	abstract	37168424
terms	O	1559	1564	abstract	37168424
of	O	1565	1567	abstract	37168424
gut	B-microbiome	1568	1571	abstract	37168424
microbiota	I-microbiome	1572	1582	abstract	37168424
and	O	1583	1586	abstract	37168424
SCFAs	B-chemical	1587	1592	abstract	37168424
in	O	1593	1595	abstract	37168424
the	O	1596	1599	abstract	37168424
serum	O	1600	1605	abstract	37168424
and	O	1606	1609	abstract	37168424
that	O	1610	1614	abstract	37168424
the	O	1615	1618	abstract	37168424
change	O	1619	1625	abstract	37168424
in	O	1626	1628	abstract	37168424
certain	O	1629	1636	abstract	37168424
intestinal	B-bacteria	1637	1647	abstract	37168424
bacteria	I-bacteria	1648	1656	abstract	37168424
might	O	1657	1662	abstract	37168424
participate	O	1663	1674	abstract	37168424
in	O	1675	1677	abstract	37168424
the	O	1678	1681	abstract	37168424
pathogenic	O	1682	1692	abstract	37168424
mechanism	O	1693	1702	abstract	37168424
of	O	1703	1705	abstract	37168424
MDD	B-DDF	1706	1709	abstract	37168424
.	O	1709	1710	abstract	37168424
